PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lu, BX; Su, YH; Das, S; Wang, HK; Wang, Y; Liu, J; Ren, DJ				Lu, Boxun; Su, Yanhua; Das, Sudipto; Wang, Haikun; Wang, Yan; Liu, Jin; Ren, Dejian			Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80	NATURE			English	Article							LOCUS-CERULEUS NEURONS; SUBSTANCE-P; TRP CHANNELS; SYMPATHETIC NEURONS; DOPAMINE NEURONS; RAT; EXCITATION; RECEPTORS; PROTEIN; TRANSMITTERS	Several neurotransmitters act through G- protein- coupled receptors to evoke a 'slow' excitation of neurons(1,2). These include peptides, such as substance P and neurotensin, as well as acetylcholine and noradrenaline. Unlike the fast ( approximately millisecond) ionotropic actions of small- molecule neurotransmitters, the slow excitation is not well understood at themolecular level, but can be mainly attributed to suppressing K+ currents and/or activating a nonselective cation channel(3-9). The molecular identity of this cation channel has yet to be determined; similarly, how the channel is activated and its relative contribution to neuronal excitability induced by the neuropeptides are unknown. Here we show that, in the mouse hippocampal and ventral tegmental area neurons, substance P and neurotensin activate a channel complex containing NALCN and a large previously unknown protein UNC-80. The activation by substance P through TACR1 (a G- protein- coupled receptor for substance P) occurs by means of a unique mechanism: it does not require G- protein activation but is dependent on Src family kinases. These findings identify NALCN as the cation channel activated by substance P receptor, and suggest that UNC- 80 and Src family kinases, rather than a G protein, are involved in the coupling from receptor to channel.	[Lu, Boxun; Su, Yanhua; Das, Sudipto; Wang, Haikun; Wang, Yan; Liu, Jin; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ren, DJ (corresponding author), Univ Penn, Dept Biol, 415 S University Ave, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu		wang, hai kun/0000-0002-4714-4672	American Heart Association; NIH; University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055293] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Clapham, C. Deutsch, I. Medina, B. Novarro, M. Schmidt and H. Xu for critically reading earlier versions of the manuscript, J. Xia for help with experiments, H. Yu and L. Yue for cDNA constructs, and Sanofi- Aventis for the gift of SR48692. This work was supported, in part, by funding from American Heart Association, the NIH and the University of Pennsylvania Research Foundation.	Aosaki T, 1996, J NEUROSCI, V16, P5141; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Farkas RH, 1996, J NEUROPHYSIOL, V76, P1968, DOI 10.1152/jn.1996.76.3.1968; GRACE AA, 1989, J NEUROSCI, V9, P3463; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; HILLE B, 2001, CHANNELS EXCITABLE M, P201; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; INOUE K, 1995, J NEUROPHYSIOL, V73, P736, DOI 10.1152/jn.1995.73.2.736; JAN YN, 1980, P NATL ACAD SCI-BIOL, V77, P5008, DOI 10.1073/pnas.77.8.5008; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; KANDEL E, 2000, PRINCIPLES NEURAL SC, P229; KUBA K, 1978, PROG NEUROBIOL, V11, P77, DOI 10.1016/0301-0082(78)90010-2; KUFFLER SW, 1983, J PHYSIOL-LONDON, V341, P257, DOI 10.1113/jphysiol.1983.sp014805; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; MASUKO S, 1992, NEUROSCIENCE, V49, P347, DOI 10.1016/0306-4522(92)90101-7; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Oh EJ, 2003, J NEUROPHYSIOL, V90, P2069, DOI 10.1152/jn.00026.2003; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SHEN KZ, 1992, NEUROSCIENCE, V50, P345, DOI 10.1016/0306-4522(92)90428-5; SHEN KZ, 1993, J PHYSIOL-LONDON, V462, P483, DOI 10.1113/jphysiol.1993.sp019565; SHEN KZ, 1992, J PHYSIOL-LONDON, V455, P471, DOI 10.1113/jphysiol.1992.sp019312; STANFIELD PR, 1985, NATURE, V315, P498, DOI 10.1038/315498a0; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	33	113	117	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					741	U10		10.1038/nature07579	http://dx.doi.org/10.1038/nature07579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19092807	Green Accepted			2022-12-28	WOS:000263064700045
J	Vasan, A; Kim, JY				Vasan, Ashwin; Kim, Jim Yong			Essential medicines pricing-reform needed	LANCET			English	Editorial Material							MIDDLE-INCOME COUNTRIES; CHRONIC DISEASES; PRICES; DRUGS		[Vasan, Ashwin; Kim, Jim Yong] Partners Hlth, Boston, MA USA; [Vasan, Ashwin] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London WC1E 7HT, England; [Kim, Jim Yong] Harvard Univ, Sch Publ Hlth, FXB Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Kim, Jim Yong] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Partners Healthcare System; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Vasan, A (corresponding author), Partners Hlth, Boston, MA USA.	ashwin.vasan@lshtm.ac.uk						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; CAMERON A, 2008, LANCET          1201; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Hagmann M, 2001, B WORLD HEALTH ORGAN, V79, P904; Laing RO, 2001, HEALTH POLICY PLANN, V16, P13, DOI 10.1093/heapol/16.1.13; Laing RO, 2000, INT J TUBERC LUNG D, V4, pS194; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Sharma DC, 2003, LANCET, V362, P1467, DOI 10.1016/S0140-6736(03)14735-6; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Vasan A, 2006, B WORLD HEALTH ORGAN, V84, P393, DOI 10.2471/BLT.05.025684; *WHO, 2008, MED PRIC INF; *WHO, 2008, DRUG REG STAT DAT AI; *WHO UNICEF UNAIDS, 2005, SOURC PRIC SEL MED D; 2008, CLINTON FDN SIGNS PR; 2008, CAMPAIGN ACCESS ESSE	16	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					191	193		10.1016/S0140-6736(08)61763-8	http://dx.doi.org/10.1016/S0140-6736(08)61763-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19042013				2022-12-28	WOS:000262537500007
J	Narbonne, P; Roy, R				Narbonne, Patrick; Roy, Richard			Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival	NATURE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; C-ELEGANS; LIFE-SPAN; SIGNALING PATHWAY; GENE-EXPRESSION; TISSUE; RESTRICTION; METABOLISM; HYPODERMIS; LONGEVITY	Many organisms can enter a dormant state or diapause to survive harsh environmental conditions for extended durations. When Caenorhabditis elegans larvae enter dauer they arrest feeding but remain active and motile, yet become stress- resistant, extremely long- lived and non- ageing(1). Entry into dauer is associated with a reduction in insulin- like signalling, the accumulation of nutritive resources and a concomitant global change in metabolism(2-5), yet the precise molecular and physiological processes that enable long- term survival in the absence of caloric intake remain largely unknown. We show here that C. elegans larvae that lack LKB1/ AMPK (AMP-activated protein kinase) signalling enter dauer normally, but then rapidly consume their stored energy and prematurely expire following vital organ failure. We found that this signalling pathway acts in adipose- like tissues to downregulate triglyceride hydrolysis so that these lipid reserves are rationed to last the entire duration of the arrest. Indeed, the downregulation of adipose triglyceride lipase (ATGL-1) activity suppresses both the rapid depletion of stored lipids and reduced life span of AMPK mutant dauers, while AMPK directly phosphorylates ATGL-1. Finally, we show that the slow release of energy during dauer is critical for appropriate long- term osmoregulation, which fails as triglyceride resources become depleted. These mechanisms may be essential for survival through diapause, hibernation, or long- term fasting in diverse organisms and may also underlie AMPK- dependent life span extension.	[Narbonne, Patrick; Roy, Richard] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Roy, R (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	richard.roy@mcgill.ca			Canadian Cancer Society; Canadian Institutes of Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank A. Fire, O. Hobert, I. Greenwald, D. Baillie, K. Nehrke, J. McGhee, M. Han, S. Li, E. Colella, M. Hebeisen, J. Ouellet, A. Shingina, M. Maduro, F. Solari, E. Greer, J. Lapointe, W. Yang and S. Hekimi for reagents, strains, constructs, help, advice and support. Some of the strains that were used in this analysis came from the Caenorhabditis Genetic Center (CGC), the C. elegans Gene Knockout Consortium, the Japan National Bioresource Project, and the Genome BC C. elegans Gene Expression Consortium. This work was supported by research grants from the Canadian Cancer Society and the Canadian Institutes of Health Research (CIHR) to R.R. P.N. is a recipient of an NSERC studentship. R. R. is a CIHR New Investigator.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Huang P, 2004, DEVELOPMENT, V131, P2595, DOI 10.1242/dev.01135; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; MADURO M, 1995, GENETICS, V141, P977; Masse I, 2005, DEV BIOL, V286, P91, DOI 10.1016/j.ydbio.2005.07.010; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; OKKEMA PG, 1993, GENETICS, V135, P385; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	30	231	247	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					210	U108		10.1038/nature07536	http://dx.doi.org/10.1038/nature07536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19052547				2022-12-28	WOS:000262360200036
J	Gebauer, D; Volkel, A; Colfen, H				Gebauer, Denis; Voelkel, Antje; Coelfen, Helmut			Stable Prenucleation Calcium Carbonate Clusters	SCIENCE			English	Article							BIOMINERALIZATION; NUCLEATION	Calcium carbonate forms scales, geological deposits, biominerals, and ocean sediments. Huge amounts of carbon dioxide are retained as carbonate ions, and calcium ions represent a major contribution to water hardness. Despite its relevance, little is known about the precipitation mechanism of calcium carbonate, and specified complex crystal structures challenge the classical view on nucleation considering the formation of metastable ion clusters. We demonstrate that dissolved calcium carbonate in fact contains stable prenucleation ion clusters forming even in undersaturated solution. The cluster formation can be characterized by means of equilibrium thermodynamics, applying a multiple- binding model, which allows for structural preformation. Stable clusters are the relevant species in calcium carbonate nucleation. Such mechanisms may also be important for the crystallization of other minerals.	[Gebauer, Denis; Voelkel, Antje; Coelfen, Helmut] Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Max Planck Society	Colfen, H (corresponding author), Max Planck Inst Colloids & Interfaces, Res Campus Golm,Muhlenberg 1, D-14424 Potsdam, Germany.	coelfen@mpikg.mpg.de	Gebauer, Denis/H-2408-2011	Gebauer, Denis/0000-0003-1612-051X	German Science Foundation [1117]; Max Planck Society	German Science Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	Financial support by the German Science Foundation priority program 1117 "Principles of Biomineralization" and the Max Planck Society are gratefully acknowledged. We thank M. Antonietti (MPI) and P. Bowen (Ecole Polytechnique Federale de Lausanne, Switzerland) for valuable discussions on the manuscript, A. Verch (MPI) for experimental assistance, and O. Paris and I. Zenke (both MPI) for SAXS analysis. D. G. thanks T. Ketterer and J. Thomas of Deutsche Metrohm for technical assistance.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Becker R, 1935, ANN PHYS-BERLIN, V24, P719; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Casey WH, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000118; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Faatz M, 2004, ADV MATER, V16, P996, DOI 10.1002/adma.200306565; Furrer G, 2002, SCIENCE, V297, P2245, DOI 10.1126/science.1076505; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Hasse B, 2000, CHEM-EUR J, V6, P3679, DOI 10.1002/1521-3765(20001016)6:20<3679::AID-CHEM3679>3.0.CO;2-#; Horn D, 2001, ANGEW CHEM INT EDIT, V40, P4331; Izmailov AF, 1999, J CRYST GROWTH, V196, P234, DOI 10.1016/S0022-0248(98)00830-6; Knezic D, 2004, J PHYS CHEM B, V108, P10672, DOI 10.1021/jp049586s; Lam RSK, 2007, CRYSTENGCOMM, V9, P1226, DOI 10.1039/b710895h; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; LARSON MA, 1991, ADVANCES IN INDUSTRIAL CRYSTALLIZATION, P20; LARSON MA, 1986, CHEM ENG SCI, V41, P1285, DOI 10.1016/0009-2509(86)87101-9; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Perry CC, 2003, REV MINERAL GEOCHEM, V54, P291, DOI 10.2113/0540291; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; Quigley D., 2008, J CHEM PHYS, V128, P4; Rieger J, 2007, FARADAY DISCUSS, V136, P265, DOI 10.1039/b701450c; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sinn CG, 2004, MACROMOLECULES, V37, P3444, DOI 10.1021/ma030550s; Volmer M, 1939, KINETIK PHASENBILDUN; Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	27	1107	1124	42	718	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1819	1822		10.1126/science.1164271	http://dx.doi.org/10.1126/science.1164271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095936	Green Submitted			2022-12-28	WOS:000261799400047
J	Seila, AC; Calabrese, JM; Levine, SS; Yeo, GW; Rahl, PB; Flynn, RA; Young, RA; Sharp, PA				Seila, Amy C.; Calabrese, J. Mauro; Levine, Stuart S.; Yeo, Gene W.; Rahl, Peter B.; Flynn, Ryan A.; Young, Richard A.; Sharp, Phillip A.			Divergent Transcription from Active Promoters	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; GENOME; POLYCOMB	Transcription initiation by RNA polymerase II ( RNAPII) is thought to occur unidirectionally from most genes. Here, we present evidence of widespread divergent transcription at protein- encoding gene promoters. Transcription start site- associated RNAs ( TSSa- RNAs) nonrandomly flank active promoters, with peaks of antisense and sense short RNAs at 250 nucleotides upstream and 50 nucleotides downstream of TSSs, respectively. Northern analysis shows that TSSa- RNAs are subsets of an RNA population 20 to 90 nucleotides in length. Promoter- associated RNAPII and H3K4- trimethylated histones, transcription initiation hallmarks, colocalize at sense and antisense TSSa- RNA positions; however, H3K79- dimethylated histones, characteristic of elongating RNAPII, are only present downstream of TSSs. These results suggest that divergent transcription over short distances is common for active promoters and may help promoter regions maintain a state poised for subsequent regulation.	[Seila, Amy C.; Calabrese, J. Mauro; Flynn, Ryan A.; Sharp, Phillip A.] MIT, Robert Koch Inst, Cambridge, MA 02139 USA; [Calabrese, J. Mauro; Young, Richard A.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Levine, Stuart S.; Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Yeo, Gene W.] Crick Jacobs Ctr Theoret & Computat Biol, Salk Inst, La Jolla, CA 92037 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Salk Institute	Sharp, PA (corresponding author), MIT, Robert Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Young, Richard A/F-6495-2012; Yeo, Gene/AAE-7676-2019	Young, Richard A/0000-0001-8855-8647; Yeo, Gene/0000-0002-0799-6037; Levine, Stuart/0000-0001-7363-562X; Flynn, Ryan/0000-0001-5013-0442	NIH [5-F32-HD051190, RO1-GM34277, HG002668]; Crick-Jacobs Center for Computational Biology; NCI Cancer Center Support (core) [PO1- CA42063, P30- CA14051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD051190] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, P01CA042063] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crick-Jacobs Center for Computational Biology; NCI Cancer Center Support (core)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Zheng, C. Whittaker, S. Hoersch, and A.F. Seila. A.C.S. was supported by NIH postdoctoral fellowship 5-F32-HD051190 and G.W.Y. by the Crick-Jacobs Center for Computational Biology. This work was supported by NIH grants RO1-GM34277 and HG002668, NCI grant PO1- CA42063, and the NCI Cancer Center Support (core) grant P30- CA14051. The data discussed in this publication have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus under accession numbers GSE13483 and GSE12680.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Kays AR, 2000, CHEM BIOL, V7, P601, DOI 10.1016/S1074-5521(00)00009-0; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; XIAO H, 1994, NUCLEIC ACIDS RES, V22, P1966, DOI 10.1093/nar/22.11.1966	16	658	684	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1849	1851		10.1126/science.1162253	http://dx.doi.org/10.1126/science.1162253			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056940	Green Accepted			2022-12-28	WOS:000261799400056
J	Box, JA; Bunch, JT; Tang, W; Baumann, P				Box, Jessica A.; Bunch, Jeremy T.; Tang, Wen; Baumann, Peter			Spliceosomal cleavage generates the 3 ' end of telomerase RNA	NATURE			English	Article							PRE-MESSENGER-RNA; FISSION YEAST TELOMERASE; SMALL NUCLEOLAR RNAS; SCHIZOSACCHAROMYCES-POMBE; DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; MUTATIONAL ANALYSIS; CATALYTIC SUBUNIT; APLASTIC-ANEMIA; U1 SNRNA	Telomeres cap the ends of chromosomes and provide a means to complete replication. The DNA portion of telomeres is synthesized by the enzyme telomerase using part of an RNA subunit as a template for reverse transcription. How the mature 39 end of telomerase RNA is generated has so far remained elusive. Here we show that in Schizosaccharomyces pombe telomerase RNA transcripts must be processed to generate functional telomerase. Characterization of the maturation pathway uncovered an unexpected role for the spliceosome, which normally catalyses splicing of pre- messenger RNA. The first spliceosomal cleavage reaction generates the mature 39 end of telomerase RNA ( TER1, the functional RNA encoded by the ter1(+) gene), releasing the active form of the RNA without exon ligation. Blocking the first step or permitting completion of splicing generates inactive forms of TER1 and causes progressive telomere shortening. We establish that 39 end processing of TER1 is critical for telomerase function and describe a previously unknown mechanism for RNA maturation that uses the ability of the spliceosome to mediate site- specific cleavage.	[Box, Jessica A.; Bunch, Jeremy T.; Tang, Wen; Baumann, Peter] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Tang, Wen; Baumann, Peter] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Baumann, P (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	peb@stowers-institute.org		Baumann, Peter/0000-0003-4892-1485	Stowers Institute for Medical Research; Pew Scholars; Biomedical Sciences Award	Stowers Institute for Medical Research; Pew Scholars; Biomedical Sciences Award	The authors thank H. Yang and the other members of the Baumann laboratory for help and discussions, Y. Tzfati and L. Tomaska for sharing results before publication, and A. Berglund, M. Blanchette, R. Conaway and T. Cech for discussions and comments on the manuscript. We also thank the Molecular Biology Core Facility for site- directed mutagenesis and sequencing, M. Gogol and R. Voelker for computational analysis, and D. Baumann and R. Helston for proofreading of the manuscript. This work was funded by the Stowers Institute for Medical Research and a Pew Scholars in the Biomedical Sciences Award to P. B.	Alvarez CJ, 1996, RNA, V2, P404; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Box JA, 2008, J BIOL CHEM, V283, P24224, DOI 10.1074/jbc.M802043200; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Burge CB, 1999, RNA WORLD, P525; Chapon C, 1997, RNA, V3, P1337; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; DOMDEY H, 1984, CELL, V39, P611, DOI 10.1016/0092-8674(84)90468-9; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Li SG, 2005, J BIOL CHEM, V280, P16446, DOI 10.1074/jbc.M500326200; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Romfo CM, 1997, NUCLEIC ACIDS RES, V25, P4658, DOI 10.1093/nar/25.22.4658; SERAPHIN B, 1989, GENE, V82, P145, DOI 10.1016/0378-1119(89)90039-5; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; ZHANG MQ, 1994, NUCLEIC ACIDS RES, V22, P1750, DOI 10.1093/nar/22.9.1750; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	34	76	78	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					910	U71		10.1038/nature07584	http://dx.doi.org/10.1038/nature07584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19052544				2022-12-28	WOS:000261768300036
J	Lebreton, A; Tomecki, R; Dziembowski, A; Seraphin, B				Lebreton, Alice; Tomecki, Rafal; Dziembowski, Andrzej; Seraphin, Bertrand			Endonucleolytic RNA cleavage by a eukaryotic exosome	NATURE			English	Article							MESSENGER-RNA; QUALITY-CONTROL; YEAST EXOSOME; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; ESCHERICHIA-COLI; COMPLEX; DEGRADATION; NUCLEASE; SUBUNIT	The exosome is a major eukaryotic nuclease located in both the nucleus and the cytoplasm that contributes to the processing, quality control and/ or turnover of a large number of cellular RNAs(1-6). This large macromolecular assembly has been described as a 3 '-> 5 ' exonuclease(1) and shown to contain a nine- subunit ring structure evolutionarily related to archaeal exosome- like complexes and bacterial polynucleotide phosphorylases. Recent results have shown that, unlike its prokaryotic counterparts, the yeast and human ring structures are catalytically inactive. In contrast, the exonucleolytic activity of the yeast exosome core was shown to be mediated by the RNB domain of the eukaryote- specific Dis3 subunit(7-9). Here we show, using in vitro assays, that yeast Dis3 has an additional endoribonuclease activity mediated by the PIN domain located at the amino terminus of this multidomain protein. Simultaneous inactivation of the endonucleolytic and exonucleolytic activities of the exosome core generates a synthetic growth phenotype in vivo, supporting a physiological function for the PIN domain. This activity is responsible for the cleavage of some natural exosome substrates, independently of exonucleolytic degradation. In contrast with current models, our results show that eukaryotic exosome cores have both endonucleolytic and exonucleolytic activities, mediated by two distinct domains of the Dis3 subunit. The mode of action of eukaryotic exosome cores in RNA processing and degradation should be reconsidered, taking into account the cooperation between its multiple ribonucleolytic activities.	[Tomecki, Rafal; Dziembowski, Andrzej] Warsaw Univ, Dept Genet & Biotechnol, Fac Biol, PL-02106 Warsaw, Poland; [Tomecki, Rafal; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Lebreton, Alice; Seraphin, Bertrand] CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France; [Lebreton, Alice; Seraphin, Bertrand] Univ Paris 11, F-91405 Orsay, France; [Lebreton, Alice; Seraphin, Bertrand] Univ Paris 06, F-75005 Paris, France	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Dziembowski, A (corresponding author), Warsaw Univ, Dept Genet & Biotechnol, Fac Biol, PL-02106 Warsaw, Poland.	andrzejd@ibb.waw.pl; seraphin@cgm.cnrs-gif.fr	Lebreton, Alice/M-8764-2015; Tomecki, Rafal/Y-8438-2019	Lebreton, Alice/0000-0002-6643-902X; Tomecki, Rafał/0000-0003-2880-0555; Tomecki, Rafal/0000-0003-2473-5004; Dziembowski, Andrzej/0000-0001-8492-7572; Seraphin, Bertrand/0000-0002-5168-1921	La Ligue contre le Cancer (Equipe Labellisee 2008); Agence Nationale de la Recherche project CUTs; CNRS; ESF RNA Quality program (project EUxosome); FP6 EU; Foundation for Polish Science; Faculty of Biology, University of Warsaw	La Ligue contre le Cancer (Equipe Labellisee 2008); Agence Nationale de la Recherche project CUTs(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); ESF RNA Quality program (project EUxosome); FP6 EU(European Commission); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Faculty of Biology, University of Warsaw	We thank E. Conti and J. Basquin for providing the Dis3 PIN domain expression construct and 6xHis- SUMO protease, and E. Conti, E. Lorentzen, J. Kufel and members of our groups for insightful discussions. This work was supported by La Ligue contre le Cancer (Equipe Labellisee 2008), Agence Nationale de la Recherche project CUTs, CNRS, ESF RNA Quality program (project EUxosome) and the FP6 EU grant 3D repertoire, and an EMBO installation grant. R. T. is the recipient of the Stipend for Young Researchers from the Foundation for Polish Science and was supported through a Faculty of Biology, University of Warsaw intramural grant.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; EBERLE AB, NATURE STRU IN PRESS; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; LIU Q, 2003, CELL, V127, P1223; Liu QS, 2007, CELL, V131, P188, DOI 10.1016/j.cell.2007.09.019; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; SCHAEFFER D, NATURE STRU IN PRESS; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	29	245	248	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					993	U87		10.1038/nature07480	http://dx.doi.org/10.1038/nature07480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19060886	Green Submitted			2022-12-28	WOS:000261768300055
J	Swartz, KJ				Swartz, Kenton J.			Sensing voltage across lipid membranes	NATURE			English	Review							SHAKER K+ CHANNEL; GATED POTASSIUM CHANNELS; FOCUSED ELECTRIC-FIELD; DEPENDENT K+; SODIUM-CHANNELS; GATING-CHARGE; S4 SEGMENT; SENSOR MOVEMENT; PROTON CHANNEL; TRANSMEMBRANE MOVEMENT	The detection of electrical potentials across lipid bilayers by specialized membrane proteins is required for many fundamental cellular processes such as the generation and propagation of nerve impulses. These membrane proteins possess modular voltage- sensing domains, a notable example being the S1- S4 domains of voltage- activated ion channels. Ground- breaking structural studies on these domains explain how voltage sensors are designed and reveal important interactions with the surrounding lipid membrane. Although further structures are needed to understand the conformational changes that occur during voltage sensing, the available data help to frame several key concepts that are fundamental to the mechanism of voltage sensing.	[Swartz, Kenton J.] NINDS, Porter Neurosci Res Ctr, Mol Physiol & Biophys Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Swartz, KJ (corresponding author), NINDS, Porter Neurosci Res Ctr, Mol Physiol & Biophys Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov			Intramural Research Program of the NINDS; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002945] Funding Source: NIH RePORTER	Intramural Research Program of the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I thank J. Diamond, J. Mindell, S. Silberberg and the members of the Swartz laboratory for discussions. I thank R. MacKinnon for providing coordinates for the paddle- chimera and those for the superimposed structures shown in Fig. 3. This work was supported by the Intramural Research Program of the NINDS, NIH.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Darman RB, 2006, J GEN PHYSIOL, V128, P687, DOI 10.1085/jgp.200609624; Freites JA, 2006, BIOPHYS J, V91, pL90, DOI 10.1529/biophysj.106.096065; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Galvani L, 1791, BONONIENSI SCI ARTIU, V7, P363, DOI DOI 10.1097/00000441-195402000-00023; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; KEYNES RD, 1974, J PHYSIOL-LONDON, V239, P393, DOI 10.1113/jphysiol.1974.sp010575; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nguyen TP, 2002, J GEN PHYSIOL, V120, P419, DOI 10.1085/jgp.20028636; Noceti F, 1996, J GEN PHYSIOL, V108, P143, DOI 10.1085/jgp.108.3.143; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Vamvouka M, 2008, PROTEIN SCI, V17, P506, DOI 10.1110/ps.073310008; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	87	230	235	3	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					891	897		10.1038/nature07620	http://dx.doi.org/10.1038/nature07620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092925	Green Accepted			2022-12-28	WOS:000261768300033
J	Barabas, AP				Barabas, A. P.			Not becoming a communist doctor	BRITISH MEDICAL JOURNAL			English	Editorial Material												andrasbarabas@hotmail.com						BARABAS A, 1965, BRIT MED J, V1, P782, DOI 10.1136/bmj.1.5437.782; DOMAHIDY M, 1989, ILYEN VOLT HAYNAL IM	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 12	2008	337								a2953	10.1136/bmj.a2953	http://dx.doi.org/10.1136/bmj.a2953			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CC	19074565				2022-12-28	WOS:000262777000005
J	Wilson, A; Laurenti, E; Oser, G; van der Wath, RC; Blanco-Bose, W; Jaworski, M; Offner, S; Dunant, CF; Eshkind, L; Bockamp, E; Lio, P; MacDonald, HR; Trumpp, A				Wilson, Anne; Laurenti, Elisa; Oser, Gabriela; van der Wath, Richard C.; Blanco-Bose, William; Jaworski, Maike; Offner, Sandra; Dunant, Cyrille F.; Eshkind, Leonid; Bockamp, Ernesto; Lio, Pietro; MacDonald, H. Robson; Trumpp, Andreas			Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair	CELL			English	Article							OSTEOBLASTIC NICHE; PROGENITOR CELLS; MOUSE MODEL; IN-VITRO; MARROW; CYCLE; LONG; CANCER; PROLIFERATION; QUIESCENCE	Bone marrow hematopoietic stem cells (HSCs) are crucial to maintain lifelong production of all blood cells. Although HSCs divide infrequently, it is thought that the entire HSC pool turns over every few weeks, suggesting that HSCs regularly enter and exit cell cycle. Here, we combine flow cytometry with label-retaining assays (BrdU and histone H2B-GFP) to identify a population of dormant mouse HSCs (d-HSCs) within the lin(-)Sca1(+)cKit(+)CD150(+)CD48(-)CD34(-) population. Computational modeling suggests that d-HSCs divide about every 145 days, or five times per lifetime. d-HSCs harbor the vast majority of multilineage long-term self-renewal activity. While they form a silent reservoir of the most potent HSCs during homeostasis, they are efficiently activated to self-renew in response to bone marrow injury or G-CSF stimulation. After re-establishment of homeostasis, activated HSCs return to dormancy, suggesting that HSCs are not stochastically entering the cell cycle but reversibly switch from dormancy to self-renewal under conditions of hematopoietic stress.	[Laurenti, Elisa; Oser, Gabriela; Blanco-Bose, William; Jaworski, Maike; Offner, Sandra; Trumpp, Andreas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Trumpp, Andreas] Deutsch Krebsforschungszentrum, Div Cell Biol, ZMBH Alliance, D-69120 Heidelberg, Germany; [Wilson, Anne; MacDonald, H. Robson] Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [van der Wath, Richard C.; Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB3 0FD, England; [Eshkind, Leonid; Bockamp, Ernesto] Johannes Gutenberg Univ Mainz, Lab Mol Mouse Genet, Inst Toxicol, D-55113 Mainz, Germany; [Dunant, Cyrille F.] LMC IMX, CH-1015 Lausanne, Switzerland; [Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ludwig Institute for Cancer Research; University of Lausanne; University of Cambridge; Johannes Gutenberg University of Mainz	Trumpp, A (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland.	a.trumpp@dkfz.de	P. Lió, Pietro Lio/AAV-3358-2021; Wilson, Anne/A-7131-2011; Trumpp, Andreas/Z-2141-2019	P. Lió, Pietro Lio/0000-0002-0540-5053; Trumpp, Andreas/0000-0002-6212-3466; Laurenti, Elisa/0000-0002-9917-9092; Bockamp, Ernesto/0000-0002-6181-1734; Dunant, Cyrille/0000-0001-5176-4439	Swiss National Science Foundation; Swiss Cancer League; EU-FP6 program "INTACT"; EU-FP7 progam "Eurosystem."; Bradlow Foundation; St. Johns College Cambridge	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU-FP6 program "INTACT"(European Commission); EU-FP7 progam "Eurosystem."(European Commission); Bradlow Foundation; St. Johns College Cambridge	We thank Dr. Christelle Adolphe for the initial breeding of the Scl-tTA; H2B-GFP mice; Christelle Dubey and Catherine Fumey for animal husbandry and genetic screening; Armin Ehninger for help with RT-PCR analysis; Joanna Roberts and Steven Merlin for FACS sorting; and the MIM facility for help with histology. This work was supported in part by grants to A. T. from the Swiss National Science Foundation, the Swiss Cancer League, the EU-FP6 program "INTACT" and the EU-FP7 progam "Eurosystem." R.C.v.d.W. would like to thank the Bradlow Foundation and St. Johns College Cambridge for financial support. The authors declare no financial conflict of interest.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Furness SGB, 2006, IMMUNOL RES, V34, P13, DOI 10.1385/IR:34:1:13; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bockamp E, 2006, BLOOD, V108, P1533, DOI 10.1182/blood-2005-12-012104; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Bradford GB, 1997, EXP HEMATOL, V25, P445; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Caldwell MA, 2005, EUR J NEUROSCI, V22, P2965, DOI 10.1111/j.1460-9568.2005.04504.x; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Challen GA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002357; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Colucci F, 1999, J IMMUNOL, V162, P2761; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; GRAF T, 2007, NATURE REV IMMUNOLOG; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jorgensen HG, 2006, CLIN CANCER RES, V12, P626, DOI 10.1158/1078-0432.CCR-05-0429; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; LERNER C, 1990, EXP HEMATOL, V18, P114; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Matsuoka S, 2001, BLOOD, V97, P419, DOI 10.1182/blood.V97.2.419; MITCHELL JB, 1983, INT J RADIAT ONCOL, V9, P457, DOI 10.1016/0360-3016(83)90061-5; MORSTYN G, 1985, EXP HEMATOL, V13, P289; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Punzel M, 2001, ANN NY ACAD SCI, V938, P72; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Quesenberry PJ, 2006, CURR OPIN HEMATOL, V13, P216, DOI 10.1097/01.moh.0000231417.08031.ac; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Siegl-Cachedenier I, 2007, GENE DEV, V21, P2234, DOI 10.1101/gad.430107; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Suda T, 2005, CORNEA, V24, pS12, DOI 10.1097/01.ico.0000178742.98716.65; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Wath RC, 2008, LECT N BIOINFORMAT, V5307, P387, DOI 10.1007/978-3-540-88562-7_26; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	67	1305	1346	2	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1118	1129		10.1016/j.cell.2008.10.048	http://dx.doi.org/10.1016/j.cell.2008.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19062086	Bronze			2022-12-28	WOS:000261642800027
J	Granick, S; Bae, SC				Granick, Steve; Bae, Sung Chul			CHEMISTRY A Curious Antipathy for Water	SCIENCE			English	Editorial Material							HYDROPHOBICITY; TRANSPORT		[Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Granick, S (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	sgranick@uiuc.edu	Bae, Sung C/A-3423-2008	Bae, Sung C/0000-0002-9765-6801				Ben-Amotz D, 2006, J PHYS CHEM B, V110, P19839, DOI 10.1021/jp061824r; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Janecek J, 2007, LANGMUIR, V23, P8417, DOI 10.1021/la700561q; Kalra A, 2004, J PHYS CHEM B, V108, P544, DOI 10.1021/jp035828x; Kalra A, 2003, P NATL ACAD SCI USA, V100, P10175, DOI 10.1073/pnas.1633354100; Kashimoto K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076102; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Maibaum L, 2003, J PHYS CHEM B, V107, P1189, DOI 10.1021/jp0267196; Mezger M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2931574; Poynor A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.039602; Poynor A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266101; Sovago M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173901; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; Wang HJ, 2008, SCIENCE, V322, P80, DOI 10.1126/science.1162412; Zhang XY, 2002, SCIENCE, V295, P663, DOI 10.1126/science.1066854	16	93	93	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1477	1478		10.1126/science.1167219	http://dx.doi.org/10.1126/science.1167219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056964				2022-12-28	WOS:000261377400027
J	Hermisson, J; McGregor, AP				Hermisson, Joachim; McGregor, Alistair P.			Pleiotropic scaling and QTL data	NATURE			English	Letter							COMPLEXITY; EVOLUTION; TRAITS; NUMBER; COST		[Hermisson, Joachim] Univ Vienna, Fak Math, A-1090 Vienna, Austria; [Hermisson, Joachim] Univ Vienna, Max F Perutz Labs, A-1090 Vienna, Austria; [McGregor, Alistair P.] Vet Med Univ Vienna, Inst Populat Genet, A-1210 Vienna, Austria	University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna	Hermisson, J (corresponding author), Univ Vienna, Fak Math, Nordbergstr 15, A-1090 Vienna, Austria.	joachim.hermisson@univie.ac.at		McGregor, Alistair/0000-0002-2908-2420				Kenney-Hunt JP, 2008, GENETICS, V178, P2275, DOI 10.1534/genetics.107.084434; Long AD, 1998, GENETICS, V149, P999; Martin G, 2006, EVOLUTION, V60, P893; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Orgogozo V, 2006, GENETICS, V173, P197, DOI 10.1534/genetics.105.054098; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; TURELLI M, 1985, GENETICS, V111, P165; WAGNER GP, 1988, J EVOLUTION BIOL, V1, P45, DOI 10.1046/j.1420-9101.1988.1010045.x; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; Wingreen NS, 2003, GENETICS, V164, P1221	10	15	15	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					E3	E4		10.1038/nature07452	http://dx.doi.org/10.1038/nature07452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052568	Green Published			2022-12-28	WOS:000261340000029
J	LeWitt, PA				LeWitt, Peter A.			Levodopa for the Treatment of Parkinson's Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY STANDARDS SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; MOTOR FLUCTUATIONS; PRACTICE PARAMETER; AMERICAN-ACADEMY; CONTROLLED-TRIAL; L-DOPA; PROGRESSION; DYSKINESIA; DEMENTIA		[LeWitt, Peter A.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [LeWitt, Peter A.] Wayne State Univ, Dept Neurol, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	LeWitt, PA (corresponding author), Henry Ford Hlth Syst, Franklin Pointe Med Ctr, 26400 W 12 Mile Rd,Suite 115, Southfield, MI 48034 USA.	palewitt@ameritech.net	LeWitt, Peter/AAW-4988-2020		Allergan; Boehringer Ingelheim; GlaxoSmithKline; Novartis; Schwarz Pharma; Solstice; Vernalis; Asubio; Brittania; Eisai; Impax; Kyowa; Merck; Neurim; Neuroderm; Neurologix; Orion; Prestwick; Santhera; Schering-Plough; Solvay; Spherics; Supernus; Valeant; XenoPort; Chelsea Therapeutics; Schering- Plough	Allergan(AbbVieAllergan); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Schwarz Pharma; Solstice; Vernalis; Asubio; Brittania; Eisai(Eisai Co Ltd); Impax; Kyowa; Merck(Merck & Company); Neurim; Neuroderm; Neurologix; Orion; Prestwick; Santhera; Schering-Plough(Merck & CompanySchering Plough Corporation); Solvay(Solvay SA); Spherics; Supernus; Valeant; XenoPort; Chelsea Therapeutics; Schering- Plough(Merck & CompanySchering Plough Corporation)	Dr. LeWitt reports receiving lecture fees from Allergan, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Schwarz Pharma (now UCB), Solstice, and Vernalis (now Ipsen), consulting fees from Asubio, Boehringer Ingelheim, Brittania, Eisai, GlaxoSmithKline, Impax, Kyowa, Merck, Neurim, Neuroderm, Neurologix, Novartis, Orion, Prestwick, Santhera, Schering- Plough, Schwarz Pharma, Solvay, Spherics, Supernus, Valeant, Vernalis, and XenoPort, and grant support from Boehringer Ingelheim, Chelsea Therapeutics, Novartis, Santhera, Schering- Plough, and Schwarz Pharma. No other potential conflict of interest relevant to this article was reported.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; CARTER JH, 1989, NEUROLOGY, V39, P552, DOI 10.1212/WNL.39.4.552; Chan PLS, 2007, PHARM RES-DORDR, V24, P791, DOI 10.1007/s11095-006-9202-3; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Gasser T, 2007, MOVEMENT DISORD, V22, pS343, DOI 10.1002/mds.21676; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; GOETZ CG, 2002, MOV DISORD S4, V17, pS1; Gomez-Esteban JC, 2007, EUR NEUROL, V57, P161, DOI 10.1159/000098468; Grosset KA, 2005, MOVEMENT DISORD, V20, P1397, DOI 10.1002/mds.20525; Hashimoto T, 2003, PARKINSONISM RELAT D, V9, pS25, DOI 10.1016/S1353-8020(02)00119-0; Holloway RG, 2005, ARCH NEUROL-CHICAGO, V62, P430; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; Hornykiewicz E, 2002, MOVEMENT DISORD, V17, P501, DOI 10.1002/mds.10115; Hughes TA, 2000, NEUROLOGY, V54, P1596, DOI 10.1212/WNL.54.8.1596; Jellinger KA, 2007, J NEURAL TRANSM-SUPP, P91; Khor SP, 2007, CURR CLIN PHARMACOL, V2, P234, DOI 10.2174/157488407781668802; Koller W, 1987, Adv Neurol, V45, P317; Koller WC, 1999, NEUROLOGY, V53, P1012, DOI 10.1212/WNL.53.5.1012; LEWITT P, 2003, OFFICE PRACTICE NEUR, P749; LeWittt PA, 2008, NEUROTHERAPEUTICS, V5, P210, DOI 10.1016/j.nurt.2008.01.007; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; MAYEUX R, 1985, NEW ENGL J MED, V313, P724, DOI 10.1056/NEJM198509193131204; Merims D, 2006, CLIN NEUROPHARMACOL, V29, P331, DOI 10.1097/01.WNF.0000236769.31279.19; Misu Y, 2003, PHARMACOL THERAPEUT, V97, P117, DOI 10.1016/S0163-7258(02)00325-X; Miyasaki JM, 2002, NEUROLOGY, V58, P11, DOI 10.1212/WNL.58.1.11; NELSON MV, 2005, PHARMACOTHERAPY PATH, P1089; *NIH CLIN EXC, 2006, PARK DIS GUID DIAGN; NUTT JG, 1984, CLIN NEUROPHARMACOL, V7, P35; Nutt JG, 2001, PARKINSONISM RELAT D, V8, P101, DOI 10.1016/S1353-8020(01)00024-4; NUTT JG, 1984, NEW ENGL J MED, V310, P483, DOI 10.1056/NEJM198402233100802; Nutt JG, 2000, NEUROLOGY, V55, pS33; Nutt JG, 2007, MOVEMENT DISORD, V22, P1, DOI 10.1002/mds.21060; Olanow CW, 2005, MOVEMENT DISORD, V20, P645, DOI 10.1002/mds.20519; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Penney JB, 1996, ANN NEUROL, V39, P37; Pierantozzi M, 2006, NEUROLOGY, V66, P1824, DOI 10.1212/01.wnl.0000221672.01272.ba; Postuma RB, 2004, NEUROLOGY, V63, P886, DOI 10.1212/01.WNL.0000137886.74175.5A; Potenza MN, 2007, NAT CLIN PRACT NEURO, V3, P664, DOI 10.1038/ncpneuro0680; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Schwid SR, 2005, ARCH NEUROL-CHICAGO, V62, P241; Senard JM, 2001, DRUG AGING, V18, P495, DOI 10.2165/00002512-200118070-00003; Stacy M, 2005, MOVEMENT DISORD, V20, P726, DOI 10.1002/mds.20383; Suchowersky O, 2006, NEUROLOGY, V67, P299; Suchowersky O, 2006, NEUROLOGY, V66, P976, DOI 10.1212/01.wnl.0000206363.57955.1b; *THOMS HEALTHC, 2007, 2007 DRUG TOP RED BO; Waters CH, 2004, MOVEMENT DISORD, V19, P426, DOI 10.1002/mds.20036; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; Wichmann T, 2003, ADV NEUROL, V91, P9; YAHR MD, 1969, ARCH NEUROL-CHICAGO, V21, P343, DOI 10.1001/archneur.1969.00480160015001; YAHR MD, 1972, NEW ENGL J MED, V287, P20, DOI 10.1056/NEJM197207062870105; Zanetti R, 2006, MELANOMA RES, V16, P201, DOI 10.1097/01.cmr.0000215043.61306.d7	55	177	196	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2468	2476		10.1056/NEJMct0800326	http://dx.doi.org/10.1056/NEJMct0800326			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378MT	19052127				2022-12-28	WOS:000261325900007
J	Howell, E; Bessman, E; Kravet, S; Kolodner, K; Marshall, R; Wright, S				Howell, Eric; Bessman, Edward; Kravet, Steven; Kolodner, Ken; Marshall, Robert; Wright, Scott			Active Bed Management by Hospitalists and Emergency Department Throughput	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LENGTH-OF-STAY; AMBULANCE DIVERSION; CARE-UNIT; IMPACT; ANTIBIOTICS; TIME	Background: When emergency departments are overcrowded, ambulances are diverted. Interventions focused primarily on emergency departments have had limited success. Objective: To discover whether an active bed management, quality improvement initiative could reduce ambulance diversion hours and emergency department throughput times. Design: Pre-post study that compared institutional data from November 2006 to February 2007 (intervention period) with data from November 2005 to February 2006 (control period). Setting: Johns Hopkins Bayview Medical Center, Baltimore, Maryland. Patients: All adult patients registered in the emergency department during the study periods. Intervention: Active bed management is a hospitalist-led, multifaceted intervention that consists of proactive management of hospital and departmental resources, including twice-daily bed management rounds in the intensive care unit and regular visits to the emergency department to assess congestion and flow; assignment of all admissions to the department of medicine and facilitating transfer from the emergency department to the appropriate care setting; and support from the "beddirector," who can mobilize additional resources in real time to augment hospital capacity to address emergency department throughput problems. Measurements: Emergency department throughput times and ambulance diversion hours. Results: The emergency department census was 8.8% higher during the intervention period than in the control period (17 573 patients vs. 16 148 patients). Throughput for patients who were admitted decreased by 98 minutes (SD, 10) (from 458 minutes in the control period to 360 minutes during the intervention period). Throughput for patients who were not admitted did not change (274 minutes vs. 269 minutes). The percentage of hours that the emergency department was on " yellow alert" ( ambulance diversion because of emergency department crowding) decreased 6%, and the percentage of hours on " red alert" ( ambulance diversion due to lack of intensive care unit beds in the hospital) decreased 27%. Staffing, length of stay, case-mix index, intensive care unit transfer rates, and mortality rates were stable across the 2 periods. Limitations: Pre-post designs are less effective than randomized, controlled trials on the study design hierarchy, and unidentified external forces may have influenced the results. The study was done at a single hospital, and the findings may not be generalizable to other institutions. Conclusion: Emergency department throughput and diversion status improved with the implementation of an active bed management process coordinated by hospitalists.	[Howell, Eric] Johns Hopkins Bayview Med Ctr, Collaborat Inpatient Med Serv, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Howell, E (corresponding author), Johns Hopkins Bayview Med Ctr, Collaborat Inpatient Med Serv, 4940 Eastern Ave, Baltimore, MD 21224 USA.	ehowell@jhmi.edu; swright@jhmi.edu			Wright is an Arnold P. Gold Foundation; Johns Hopkins Center for Innovative Medicine.	Wright is an Arnold P. Gold Foundation; Johns Hopkins Center for Innovative Medicine.	Dr. Wright is an Arnold P. Gold Foundation Professor of Medicine, and Drs. Kravet and Wright receive support as Miller-Coulson Family Scholars through the Johns Hopkins Center for Innovative Medicine.	Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Bond Kenneth, 2007, Healthc Q, V10, P32; Burt CW, 2006, ANN EMERG MED, V47, P317, DOI 10.1016/j.annemergmed.2005.12.001; Carr BG, 2007, J TRAUMA, V63, P9, DOI 10.1097/TA.0b013e31805d8f6b; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Falvo T, 2007, ACAD EMERG MED, V14, P58, DOI 10.1197/j.aem.2006.06.056; Fee C, 2007, ANN EMERG MED, V50, P501, DOI 10.1016/j.annemergmed.2007.08.003; Geer Robert, 2004, Healthc Financ Manage, V58, P70; Han JH, 2007, ACAD EMERG MED, V14, P338, DOI 10.1197/j.aem.2006.12.005; Holroyd BR, 2007, ACAD EMERG MED, V14, P702, DOI 10.1197/j.aem.2007.04.018; Institute of Medicine Committee on the Future of Emergency Care in the U.S. Health System, 2007, HOSP BAS EM CAR BREA; Kelen GD, 2001, ACAD EMERG MED, V8, P1095, DOI 10.1111/j.1553-2712.2001.tb01122.x; LITVAK E, 2002, ROOT CAUSE ANAL EMER; LYNN SG, 1991, ANN EMERG MED, V20, P287, DOI 10.1016/S0196-0644(05)80942-4; *MAR I EM MED SERV, 1994, REG 3 AL STAT SYST; McConnell KJ, 2006, ANN EMERG MED, V48, P702, DOI 10.1016/j.annemergmed.2006.05.001; McConnell KJ, 2005, ANN EMERG MED, V45, P471, DOI 10.1016/j.annemergmed.2004.10.032; MILLER JA, 2007, 2005 2006 SOC HOSP M; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Olshaker JS, 2006, J EMERG MED, V30, P351, DOI 10.1016/j.jemermed.2005.05.023; Patel PB, 2006, AM J EMERG MED, V24, P206, DOI 10.1016/j.ajem.2005.09.005; Pines JM, 2008, ANN EMERG MED, V51, P1, DOI 10.1016/j.annemergmed.2007.07.008; Pines JM, 2007, ANN EMERG MED, V50, P510, DOI 10.1016/j.annemergmed.2007.07.021; Quinn JV, 2007, AM J EMERG MED, V25, P559, DOI 10.1016/j.ajem.2006.11.034; Scalise D, 2006, HOSP HEALTH NETWORK, V80, P40; Schneider S, 2001, ACAD EMERG MED, V8, P1044, DOI 10.1111/j.1553-2712.2001.tb01113.x; Takakuwa KM, 2007, J EMERG MED, V32, P337, DOI 10.1016/j.jemermed.2006.07.031; Westley F., 2007, GETTING MAYBE WORLD	28	83	85	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					804	W166		10.7326/0003-4819-149-11-200812020-00006	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047027				2022-12-28	WOS:000261645300004
J	Jenny, C				Jenny, Carole			Supporting paediatricians who work in child maltreatment	LANCET			English	Editorial Material							SHAKEN-BABY-SYNDROME; TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN		[Jenny, Carole] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA	Brown University	Jenny, C (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA.	cjenny@lifespan.org						Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Block RW, 2006, J PEDIATR-US, V148, P711, DOI 10.1016/j.jpeds.2006.01.033; Clemetson CAB, 2004, MED HYPOTHESES, V62, P533, DOI 10.1016/j.mehy.2003.12.023; Donohoe M, 2003, AM J FOREN MED PATH, V24, P239, DOI 10.1097/01.paf.0000083635.85457.97; GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61707-9; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; *NAT ASS CHILDR HO, 2006, DEF CHILDR HOSP ROL; PATERSON CR, 1994, AM J MED GENET, V49, P187; Richards PG, 2006, ARCH DIS CHILD, V91, P205, DOI 10.1136/adc.2005.090761; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Talbert DG, 2005, MED HYPOTHESES, V64, P8, DOI 10.1016/j.mehy.2004.07.017; The Royal College of Pathologists and The Royal College of Paediatrics and Child Health, 2004, SUDD UN DEATH INF RE, P5; Williams C, 2007, PEDIATRICS, V119, P800, DOI 10.1542/peds.2006-1980	13	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					195	197		10.1016/S0140-6736(08)61703-1	http://dx.doi.org/10.1016/S0140-6736(08)61703-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19056115				2022-12-28	WOS:000262537500009
J	Sankaran, VG; Menne, TF; Xu, J; Akie, TE; Lettre, G; Van Handel, B; Mikkola, HKA; Hirschhorn, JN; Cantor, AB; Orkin, SH				Sankaran, Vijay G.; Menne, Tobias F.; Xu, Jian; Akie, Thomas E.; Lettre, Guillaume; Van Handel, Ben; Mikkola, Hanna K. A.; Hirschhorn, Joel N.; Cantor, Alan B.; Orkin, Stuart H.			Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; LOCUS-CONTROL REGION; ZINC-FINGER PROTEIN; BETA-THALASSEMIA; COMPLEX; DIFFERENTIATION; VARIANTS; RECRUITS; DISEASE; LINEAGE	Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the beta-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high- HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full- length forms of BCL11A is developmentally restricted to adult erythroid cells. Down- regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the beta- globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in beta- hemoglobin disorders.	[Sankaran, Vijay G.; Menne, Tobias F.; Xu, Jian; Akie, Thomas E.; Cantor, Alan B.; Orkin, Stuart H.] Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Sankaran, Vijay G.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Childrens Hosp, Div Genet Endocrinol, Boston, MA 02115 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Van Handel, Ben; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of California System; University of California Los Angeles; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston,Harvard Stem Cell Inst, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu		Cantor, Alan/0000-0002-5136-028X	National Heart, Lung, and Blood Institute; NIH [HL32262-26, HL32259-27]; Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases; Howard Hughes Medical Institute; Leukaemia Research and Kay Kendall Leukaemia Funds; Medical Scientist Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259, P01HL032262] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leukaemia Research and Kay Kendall Leukaemia Funds; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Snow, P. Tucker, G. Ippolito, B. Lee, M. Leid, T. Nakamura, D. Altshuler, E. Choy, and S. Bonakdar for providing reagents and suggestions. We are grateful to D. Nathan and A. Michelson for critical comments; D. Shao, N. Yudanin, and A. Soriano for experimental assistance; and C. Chen and V. Sankaran for assistance with data analysis. This work was supported by grants from the National Heart, Lung, and Blood Institute, NIH (HL32262-26 and HL32259-27), a Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases, NIH, and the Howard Hughes Medical Institute. T. F. M. was supported by the Leukaemia Research and Kay Kendall Leukaemia Funds. V. G. S. was supported by a Medical Scientist Training Program grant from the NIH. Array datasets are deposited at Gene Expression Omnibus (accession no. GSE 13285). A patent application related to this work was filed, and V.G.S. and S.H.O. are inventors on this patent.	Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; GARLICK RL, 1981, J BIOL CHEM, V256, P1727; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; PAPAYANNOPOULOU T, 1986, CELL, V46, P469, DOI 10.1016/0092-8674(86)90667-7; PESCHLE C, 1985, NATURE, V313, P235, DOI 10.1038/313235a0; Quek L, 2007, BRIT J HAEMATOL, V136, P353, DOI 10.1111/j.1365-2141.2006.06408.x; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105	26	598	648	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1839	1842		10.1126/science.1165409	http://dx.doi.org/10.1126/science.1165409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056937				2022-12-28	WOS:000261799400053
J	Vreeman, RC; Carroll, AE				Vreeman, Rachel C.; Carroll, Aaron E.			Festive medical myths	BRITISH MEDICAL JOURNAL			English	Editorial Material							ALCOHOL HANGOVER; MEAL PATTERNS; SUICIDE; RATS; SUGAR; CHILD		[Vreeman, Rachel C.; Carroll, Aaron E.] Indiana Univ, Sch Med, Childrens Hlth Serv Res, Indianapolis, IN 46202 USA; [Vreeman, Rachel C.; Carroll, Aaron E.] Indiana Univ, Sch Med, Ctr Hlth Policy & Professionalism Res, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Vreeman, RC (corresponding author), Indiana Univ, Sch Med, Childrens Hlth Serv Res, Indianapolis, IN 46202 USA.	rvreeman@iupui.edu						Ambade Vipul Namdeorao, 2007, J Forensic Leg Med, V14, P253, DOI 10.1016/j.jcfm.2006.08.001; Andersson I, 1996, EUR J CLIN NUTR, V50, P639; *ANN PUBL POL CTR, HOL SUIC LINK NEWSP; *ANN PUBL POL CTR, MED CONT PERP MYTH W; Bridges FS, 2004, PSYCHOL REP, V94, P723; Christoffel K K, 1988, Pediatr Emerg Care, V4, P32, DOI 10.1097/00006565-198803000-00011; CONSOLI A, 1981, Bollettino Societa Italiana Biologia Sperimentale, V57, P2322; Corcoran P, 2004, SUICIDE LIFE-THREAT, V34, P429, DOI 10.1521/suli.34.4.429.53735; Dubois L, 2008, PUBLIC HEALTH NUTR, V18, P1; Forslund HB, 2002, EUR J CLIN NUTR, V56, P740, DOI 10.1038/sj.ejcn.1601387; HILLARD JR, 1981, ARCH GEN PSYCHIAT, V38, P1377; HOOVER DW, 1994, J ABNORM CHILD PSYCH, V22, P501, DOI 10.1007/BF02168088; Howarth NC, 2007, INT J OBESITY, V31, P675, DOI 10.1038/sj.ijo.0803456; Jung TW, 2006, ALCOHOL ALCOHOLISM, V41, P231, DOI 10.1093/alcalc/agl013; KINSBOURNE M, 1994, NEW ENGL J MED, V330, P355, DOI 10.1056/NEJM199402033300511; Krenzelok EP, 1996, AM J EMERG MED, V14, P671, DOI 10.1016/S0735-6757(96)90086-8; Krummel DA, 1996, CRIT REV FOOD SCI, V36, P31, DOI 10.1080/10408399609527717; McGregor NR, 2007, ALCOHOL, V41, P469, DOI 10.1016/j.alcohol.2007.07.009; Nishi M, 2000, J Epidemiol, V10, P317; OCONNOR A, 2004, NY TIMES        1026; PANSER LA, 1995, ACTA PSYCHIAT SCAND, V92, P214, DOI 10.1111/j.1600-0447.1995.tb09571.x; Pittler MH, 2005, BMJ-BRIT MED J, V331, P1515, DOI 10.1136/bmj.331.7531.1515; Pretorius T, 2006, J APPL PHYSIOL, V101, P669, DOI 10.1152/japplphysiol.01241.2005; Sjoberg A, 2003, EUR J CLIN NUTR, V57, P1569, DOI 10.1038/sj.ejcn.1601726; STONE RP, 1971, TOXICON, V9, P301, DOI 10.1016/0041-0101(71)90088-2; *USA, 1970, US ARM SURV MAN FM 2, P148; Valtonen H, 2006, J AFFECT DISORDERS, V90, P201, DOI 10.1016/j.jad.2005.12.004; Venkataranganna MV, 2008, INDIAN J MED RES, V127, P460; Vreeman RC, 2007, BRIT MED J, V335, P1288, DOI 10.1136/bmj.39420.420370.25; Zonda Tamas, 2005, Arch Suicide Res, V9, P77, DOI 10.1080/13811110590512967; 2006, HARV HLTH LETT, V31, P3	31	4	4	1	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2008	337								a2769	10.1136/bmj.a2769	http://dx.doi.org/10.1136/bmj.a2769			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SW	19091758				2022-12-28	WOS:000262185000004
J	Deutman, ABC; Monnereau, C; Elemans, JAAW; Ercolani, G; Nolte, RJM; Rowan, AE				Deutman, Alexander B. C.; Monnereau, Cyrille; Elemans, Johannes A. A. W.; Ercolani, Gianfranco; Nolte, Roeland J. M.; Rowan, Alan E.			Mechanism of Threading a Polymer Through a Macrocyclic Ring	SCIENCE			English	Article							PROTEIN TRANSLOCATION; MOLECULAR SHUTTLE; ROTAXANE; THERMODYNAMICS; MEMBRANES; MACHINES; KINETICS	The translocation of biopolymers through pores and channels plays a fundamental role in numerous biological processes. We describe here the mechanism of the threading of a series of polymer chains through a synthetic macrocycle, which mimics these natural processes. The threading of polymers involves a kinetically favorable "entron" effect, which is associated with the initial filling of the cavity by the end of the polymer. A preassociation between the outside of the macrocycle and the polymer induces a process in which the polymer end loops back into the cavity of the macrocycle. This looping mechanism results in accelerated threading rates and unidirectional motion and is reminiscent of the protein translocation through membrane pores.	[Deutman, Alexander B. C.; Monnereau, Cyrille; Elemans, Johannes A. A. W.; Nolte, Roeland J. M.; Rowan, Alan E.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Ercolani, Gianfranco] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy	Radboud University Nijmegen; University of Rome Tor Vergata	Nolte, RJM (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	r.nolte@science.ru.nl; a.rowan@science.ru.nl	Rowan, Alan E/F-9702-2015; Nolte, Roeland/C-9930-2013; Ercolani, Gianfranco/AAH-2449-2019; Elemans, Johannes/D-4334-2012	Rowan, Alan E/0000-0003-0728-3851; Nolte, Roeland/0000-0002-5612-7815; Ercolani, Gianfranco/0000-0003-2437-3429; Elemans, Johannes/0000-0003-3825-7218	National Research School Combination Catalysis Controlled by Chemical Design; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni; Vidi and Vici; Koninklijke Nederlandse Akademie van Wetenschappen; Nanoned	National Research School Combination Catalysis Controlled by Chemical Design; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni(Netherlands Organization for Scientific Research (NWO)); Vidi and Vici; Koninklijke Nederlandse Akademie van Wetenschappen; Nanoned	This research was supported by a National Research School Combination Catalysis Controlled by Chemical Design grant, Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni, Vidi and Vici grants (J.A.A.W.E. and A.E.R.), a Koninklijke Nederlandse Akademie van Wetenschappen grant (R.J.M.N.), and a Nanoned grant (A.E.R. and R.J.M.N.).	Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Coumans RGE, 2006, P NATL ACAD SCI USA, V103, P19647, DOI 10.1073/pnas.0603036103; Galli C, 2000, EUR J ORG CHEM, V2000, P3117; HAMMETT LP, 1970, PHYS ORGANIC CHEM, P112; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Herrmann W, 1997, MACROMOLECULES, V30, P4966, DOI 10.1021/ma961373g; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kay ER, 2006, NATURE, V440, P286, DOI 10.1038/440286a; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Kolomeisky AB, 2008, BIOPHYS J, V94, P1547, DOI 10.1529/biophysj.107.122770; Liu Y, 2005, J AM CHEM SOC, V127, P9745, DOI 10.1021/ja051088p; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mandolini L., 1986, ADV PHYS ORG CHEM, V22, P1; Meller A, 2001, PHYS REV LETT, V86, P3435, DOI 10.1103/PhysRevLett.86.3435; Ramos PH, 2007, J AM CHEM SOC, V129, P5699, DOI 10.1021/ja068714i; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Slonkina E, 2003, J CHEM PHYS, V118, P7112, DOI 10.1063/1.1560932; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Thordarson P, 2003, J AM CHEM SOC, V125, P1186, DOI 10.1021/ja028463n; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752	25	84	87	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1668	1671		10.1126/science.1164647	http://dx.doi.org/10.1126/science.1164647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074344				2022-12-28	WOS:000261608300038
J	Lovell, JF; Billen, LP; Bindner, S; Shamas-Din, A; Fradin, C; Leber, B; Andrews, DW				Lovell, Jonathan F.; Billen, Lieven P.; Bindner, Scott; Shamas-Din, Aisha; Fradin, Cecile; Leber, Brian; Andrews, David W.			Membrane Binding by tBid Initiates an Ordered Series of Events Culminating in Membrane Permeabilization by Bax	CELL			English	Article							MITOCHONDRIAL-MEMBRANE; BCL-2 FAMILY; CONFORMATIONAL-CHANGE; APOPTOSIS; DEATH; DOMAIN; IDENTIFICATION; INDUCTION; MEMBERS	In normal circumstances, the Bcl-2 family dutifully governs when cells die. However, the rules of engagement between the pro- and antiapoptotic family members are still contested, and how Bax is transformed from a cytosolic monomer to an outer mitochondrial membrane-permeabilizing oligomer is unclear. With fluorescence techniques and an in vitro system, the combination of tBid and Bax produced dramatic membrane permeabilization. The membrane is not a passive partner in this process beause membranes are required for the protein-protein interactions to occur. Simultaneous measurements of these interactions revealed an ordered series of steps required for outer membrane permeabilization: ( 1) tBid rapidly binds to membranes, where ( 2) tBid interacts with Bax, causing ( 3) Bax insertion into membranes and ( 4) oligomerization, culminating in ( 5) membrane permeabilization. Bcl-XL prevents membrane- bound tBid from binding Bax. Bad releases tBid from Bcl-XL, restoring both tBid binding to Bax and membrane permeabilization.	[Lovell, Jonathan F.; Billen, Lieven P.; Bindner, Scott; Shamas-Din, Aisha; Fradin, Cecile; Leber, Brian; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Fradin, Cecile] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8N 3Z5, Canada; [Leber, Brian] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Andrews, DW (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	andrewsd@mcmaster.ca	Fradin, Cécile/D-9302-2011	Fradin, Cécile/0000-0001-8329-4953; Leber, Brian/0000-0001-5502-1480; Lovell, Jonathan/0000-0002-9052-884X; Andrews, David/0000-0002-9266-7157	Canadian Institute of Health Research (CIHR) [FRN12517]; Tier I Canada Research Chair in Membrane Biogenesis	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier I Canada Research Chair in Membrane Biogenesis(Canada Research Chairs)	This work was supported by grant FRN12517 from the Canadian Institute of Health Research (CIHR) to D. W. A. and B. L. and a Tier I Canada Research Chair in Membrane Biogenesis to D. W. A. L. P. B. is recipient of a CIHR Canada Graduate Scholarship.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basanez G, 2008, PLOS BIOL, V6, P1148, DOI 10.1371/journal.pbio.0060154; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim M, 2005, BIOCHEM BIOPH RES CO, V338, P1834, DOI 10.1016/j.bbrc.2005.10.155; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	25	447	455	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1074	1084		10.1016/j.cell.2008.11.010	http://dx.doi.org/10.1016/j.cell.2008.11.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19062087	Bronze			2022-12-28	WOS:000261642800023
J	Miyawaki, A				Miyawaki, Atsushi			Green Fluorescent Protein Glows Gold	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; AEQUOREA	The awarding of this year's Nobel Prize in Chemistry to Osamu Shimomura, Martin Chalfie, and Roger Tsien for their discovery and development of green fluorescent protein earns this humble jellyfish protein a place of honor in the biology research hall of fame.	[Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct & Dynam, Wako, Saitama 3510198, Japan; [Miyawaki, Atsushi] Japan Sci & Technol Agcy, ERATO, Wako, Saitama 3510198, Japan	RIKEN; Japan Science & Technology Agency (JST)	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Lab Cell Funct & Dynam, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235				CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; HASTINGS JW, 1969, BIOL BULL, V137, P402; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; O'Hagan R, 2005, INT REV NEUROBIOL, V69, P169, DOI 10.1016/S0074-7742(05)69006-X; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; SHIMOMURA O, 1979, FEBS LETT, V104, P220, DOI 10.1016/0014-5793(79)80818-2; SHIMOMURA O, 1998, DISCOVERY GREEN FLUO; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; TSIEN RY, 1994, CHEM ENG NEWS   0718, P34	14	22	24	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					987	990		10.1016/j.cell.2008.11.025	http://dx.doi.org/10.1016/j.cell.2008.11.025			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070562	Bronze			2022-12-28	WOS:000261642800007
J	Flint, J; Mott, R				Flint, Jonathan; Mott, Richard			Applying mouse complex-trait resources to behavioural genetics	NATURE			English	Article							LONG-TERM POTENTIATION; MUTANT MICE; COLLABORATIVE CROSS; INTERACTION NETWORK; CIRCADIAN BEHAVIOR; GENOME; LOCI; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION	Studies of the genetic basis of behaviour in mice are at a turning point. Soon, new resources will enable the behavioural function of all genes to be tested and the networks of genes, messenger RNAs and proteins involved in a particular behaviour to be identified. Using these resources, scientists will be able to analyse mouse behaviour at an unprecedented level of detail. Interpreting the new data, however, will require a shift in focus from gene- based approaches to network- based approaches.	[Flint, Jonathan; Mott, Richard] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Flint, J (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	jf@well.ox.ac.uk		Mott, Richard/0000-0002-1022-9330; Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the Wellcome Trust for support and are grateful to S. McCormick for comments on the manuscript.	Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Choudhary J, 2004, NAT NEUROSCI, V7, P440, DOI 10.1038/nn1240; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kishimoto T, 2000, NAT GENET, V24, P415, DOI 10.1038/74271; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Long AD, 1996, GENETICS, V144, P1497; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Payseur BA, 2007, GENETICS, V175, P1999, DOI 10.1534/genetics.106.067868; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tully T, 1996, COLD SPRING HARB SYM, V61, P207; Valdar W, 2006, GENETICS, V172, P1783, DOI 10.1534/genetics.104.039313; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	35	32	32	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					724	727		10.1038/nature07630	http://dx.doi.org/10.1038/nature07630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079048				2022-12-28	WOS:000261559900035
J	Yu, RC; Pesce, CG; Colman-Lerner, A; Lok, L; Pincus, D; Serra, E; Holl, M; Benjamin, K; Gordon, A; Brent, R				Yu, Richard C.; Pesce, C. Gustavo; Colman-Lerner, Alejandro; Lok, Larry; Pincus, David; Serra, Eduard; Holl, Mark; Benjamin, Kirsten; Gordon, Andrew; Brent, Roger			Negative feedback that improves information transmission in yeast signalling	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; MATING PATHWAY; PROTEIN-KINASE; STE5 SCAFFOLD; GENE NETWORKS; PHEROMONE; RECEPTOR; BINDING; TRANSDUCTION	Haploid Saccharomyces cerevisiae yeast cells use a prototypic cell signalling system to transmit information about the extracellular concentration of mating pheromone secreted by potential mating partners. The ability of cells to respond distinguishably to different pheromone concentrations depends on how much information about pheromone concentration the system can transmit. Here we show that the mitogen- activated protein kinase Fus3 mediates fast- acting negative feedback that adjusts the dose response of the downstream system response to match the dose response of receptor- ligand binding. This ` dose - response alignment', defined by a linear relationship between receptor occupancy and downstream response, can improve the fidelity of information transmission by making downstream responses corresponding to different receptor occupancies more distinguishable and reducing amplification of stochastic noise during signal transmission. We also show that one target of the feedback is a previously uncharacterized signal- promoting function of the regulator of G- protein signalling protein Sst2. Our work suggests that negative feedback is a general mechanism used in signalling systems to align dose responses and thereby increase the fidelity of information transmission.	[Yu, Richard C.; Pesce, C. Gustavo; Colman-Lerner, Alejandro; Lok, Larry; Pincus, David; Serra, Eduard; Benjamin, Kirsten; Gordon, Andrew; Brent, Roger] Inst Mol Sci, Berkeley, CA 94704 USA; [Holl, Mark] Univ Washington, Microscale Life Sci Ctr, Seattle, WA 98195 USA	The Molecular Sciences Institute; University of Washington; University of Washington Seattle	Yu, RC (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.	ryu@molsci.org; brent@molsci.org	Colman-Lerner, Alejandro/ABC-3808-2020; Serra, Eduard/K-1332-2013	Colman-Lerner, Alejandro/0000-0002-2557-8883; Serra, Eduard/0000-0003-2895-9857; Benjamin, Kirsten/0000-0003-4267-1972	Alpha Project at the Center for Quantitative Genome Function; NIH Center of Excellence in Genomic Science [P50 HG02370]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097479] Funding Source: NIH RePORTER	Alpha Project at the Center for Quantitative Genome Function; NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Abola, S. Andrews, A. Arkin, M. Bowen, L. Buck, C. Denby, A. Gann, D. Meldrum, T. Mitchison, C. Pabo, M. Ptashne, M. Reese, O. Resnekov, C. Ryan, M. Snyder, T. Thomson, A. E. Tsong and M. Wilson for discussions and/or comments on the manuscript, and O. Resnekov for help in articulating the requirements for fluidic induction devices. Work, including that of M. H. at the University of Washington, was supported by the Alpha Project at the Center for Quantitative Genome Function, an NIH Center of Excellence in Genomic Science under grant P50 HG02370 from the National Human Genome Research Institute to R. B.	AMIR SM, 1973, J BIOL CHEM, V248, P4092; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bajaj A, 2004, BIOCHEMISTRY-US, V43, P13564, DOI 10.1021/bi0494018; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Black H., 1934, ELECTRON ENG, V53, P114; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BLOOM E, 1980, J STEROID BIOCHEM, V12, P175, DOI 10.1016/0022-4731(80)90267-8; BRUN R, 1989, PAW PHYS ANAL WORKST; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; CUATRECASAS P, 1971, P NATL ACAD SCI USA, V68, P1264, DOI 10.1073/pnas.68.6.1264; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guthrie C., 1991, METHODS ENZYMOLOGY G; HEXIMER SP, 2007, SCI STKE, pPE2; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; JENNESS DD, 1986, MOL CELL BIOL, V6, P318, DOI 10.1128/MCB.6.1.318; KASAI M, 1971, J MEMBRANE BIOL, V6, P58, DOI 10.1007/BF01874114; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; LIN SY, 1970, AM J PHYSIOL, V218, P1319, DOI 10.1152/ajplegacy.1970.218.5.1319; Lindsley CW, 2008, CURR CANCER DRUG TAR, V8, P7, DOI 10.2174/156800908783497096; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rousseau G G, 1979, Monogr Endocrinol, V12, P49; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Schrick K, 1997, GENETICS, V147, P19; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Shao DY, 2006, BIOPHYS J, V91, P3986, DOI 10.1529/biophysj.106.081661; SIMONS SS, 1992, MOL ENDOCRINOL, V6, P995, DOI 10.1210/me.6.7.995; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100	47	160	162	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					755	761		10.1038/nature07513	http://dx.doi.org/10.1038/nature07513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079053	Green Accepted			2022-12-28	WOS:000261559900041
J	Keppler, H; Dubrovinsky, LS; Narygina, O; Kantor, I				Keppler, Hans; Dubrovinsky, Leonid S.; Narygina, Olga; Kantor, Innokenty			Optical Absorption and Radiative Thermal Conductivity of Silicate Perovskite to 125 Gigapascals	SCIENCE			English	Article							LOWER MANTLE; HEAT-TRANSFER; (MG,FE)SIO3 PEROVSKITE; SPECTRA; TEMPERATURE; IRON; GPA; RINGWOODITE; DEPENDENCE; PRESSURE	Mantle convection and plate tectonics are driven by the heat flow from Earth's core to the surface. The radiative contribution to heat transport is usually assumed to be negligible. Here, we report the near- infrared and optical absorption spectra of silicate perovskite, the main constituent of the lower mantle, to 125 gigapascals. Silicate perovskite remains quite transparent up to the pressures at the core- mantle boundary. Estimates of radiative thermal conductivity derived from these spectra approach 10 watts meter(-1) kelvin(-1) at lowermost mantle conditions, implying that heat conduction is dominated by radiation. However, the increase in radiative conductivity with temperature (T) is less pronounced than expected from a T(3) dependency.	[Keppler, Hans; Dubrovinsky, Leonid S.; Narygina, Olga; Kantor, Innokenty] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; [Kantor, Innokenty] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University of Bayreuth; United States Department of Energy (DOE); Argonne National Laboratory	Keppler, H (corresponding author), Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany.	hans.keppler@uni-bayreuth.de	Kantor, Innokenty/E-7326-2018	Kantor, Innokenty/0000-0001-5132-8354; Dubrovinsky, Leonid/0000-0002-3717-7585	German Science Foundation; DFG; Leibniz award	German Science Foundation(German Research Foundation (DFG)); DFG; Leibniz award(German Research Foundation (DFG))	This work was supported by German Science Foundation (DFG; Leibniz award to H. K.). A. Audetat took the photographs of the samples at high pressure.	Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Brewster M.Q., 1992, THERMAL RAD TRANSFER; Burns R. G, 1993, MINERALOGICAL APPL C; Deschamps F, 2004, EARTH PLANET SC LETT, V222, P161, DOI 10.1016/j.epsl.2004.02.024; Goncharov AF, 2006, SCIENCE, V312, P1205, DOI 10.1126/science.1125622; Keppler H, 2005, AM MINERAL, V90, P1209, DOI 10.2138/am.2005.1908; KEPPLER H, 1994, AM MINERAL, V79, P1215; Keppler H, 1999, CHEM GEOL, V158, P105, DOI 10.1016/S0009-2541(99)00021-2; Keppler H, 2007, AM MINERAL, V92, P433, DOI 10.2138/am.2007.2454; KUDOH Y, 1990, GEOPHYS RES LETT, V17, P1481, DOI 10.1029/GL017i010p01481; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Li J, 2004, P NATL ACAD SCI USA, V101, P14027, DOI 10.1073/pnas.0405804101; Lundin S, 2008, PHYS EARTH PLANET IN, V168, P97, DOI 10.1016/j.pepi.2008.05.002; MAO HK, 1972, SCIENCE, V176, P403, DOI 10.1126/science.176.4033.403; MATTSON SM, 1987, PHYS CHEM MINER, V14, P94, DOI 10.1007/BF00311152; MATYSKA C, 1994, EARTH PLANET SC LETT, V125, P255, DOI 10.1016/0012-821X(94)90219-4; Matyska C, 2005, EARTH PLANET SC LETT, V234, P71, DOI 10.1016/j.epsl.2004.10.040; Modest M., 2003, RAD HEAT TRANSFER, P1; Rosseland S., 1936, INT SERIES MONOGRAPH; Siegel R., 2001, THERMAL RAD HEAT TRA; Taran MN, 1998, NEUES JB MINER ABH, V172, P325; Ullrich K, 2002, PHYS CHEM MINER, V29, P409, DOI 10.1007/s00269-002-0248-4; van den Berg AP, 2001, GEOPHYS RES LETT, V28, P875, DOI 10.1029/2000GL011903; WALL A, 1986, MINERAL MAG, V50, P693, DOI 10.1180/minmag.1986.050.358.17; Xu YS, 2004, PHYS EARTH PLANET IN, V143, P321, DOI 10.1016/j.pepi.2004.03.005	25	84	88	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1529	1532		10.1126/science.1164609	http://dx.doi.org/10.1126/science.1164609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056982				2022-12-28	WOS:000261377400045
J	Mold, JE; Michaelsson, J; Burt, TD; Muench, MO; Beckerman, KP; Busch, MP; Lee, TH; Nixon, DF; McCune, JM				Mold, Jeff E.; Michaelsson, Jakob; Burt, Trevor D.; Muench, Marcus O.; Beckerman, Karen P.; Busch, Michael P.; Lee, Tzong-Hae; Nixon, Douglas F.; McCune, Joseph M.			Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero	SCIENCE			English	Article							MEDIATED LYMPHOLYSIS; HLA ANTIGENS; MICROCHIMERISM; LYMPHOCYTES; RESPONSES; TOLERANCE; ONTOGENY; BLOOD; TIME	As the immune system develops, T cells are selected or regulated to become tolerant of self antigens and reactive against foreign antigens. In mice, the induction of such tolerance is thought to be attributable to the deletion of self- reactive cells. Here, we show that the human fetal immune system takes advantage of an additional mechanism: the generation of regulatory T cells ( T-regs) that suppress fetal immune responses. We find that substantial numbers of maternal cells cross the placenta to reside in fetal lymph nodes, inducing the development of CD4+CD25(high)FoxP3+ T-regs that suppress fetal antimaternal immunity and persist at least until early adulthood. These findings reveal a form of antigen- specific tolerance in humans, induced in utero and probably active in regulating immune responses after birth.	[Mold, Jeff E.; Burt, Trevor D.; Nixon, Douglas F.; McCune, Joseph M.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA; [Mold, Jeff E.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Michaelsson, Jakob] Karolinska Univ Hosp, Karolinska Inst, Ctr Infect Med, Dept Med, S-14186 Huddinge, Sweden; [Burt, Trevor D.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA 94143 USA; [Muench, Marcus O.; Busch, Michael P.; Lee, Tzong-Hae] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94118 USA; [Muench, Marcus O.; Busch, Michael P.; Lee, Tzong-Hae] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94118 USA; [Beckerman, Karen P.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McCune, JM (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA.	mike.mccune@ucsf.edu	Nixon, Douglas/AAU-5734-2020; Muench, Marcus O./C-5025-2009	Nixon, Douglas/0000-0002-2801-1786; Muench, Marcus O./0000-0001-8946-6605; Burt, Trevor/0000-0001-7933-529X; Mold, Jeffrey/0000-0003-2195-2978	NIH [OD000329, AI40312, AI68498]; AIDS Biology Program of the AIDS Research Institute at UCSF; Swedish Research Council; National Institute of Child Health and Development [HD00850]; American Academy of Pediatrics; American Pediatric Society; Broad Medical Research Program of The Eli and Edythe L. Broad Foundation; National Blood Foundation; Blood Systems, Inc; UCSF Clinical and Translational Institute Clinical Research Center [RR024131]; Elizabeth Glaser Pediatric AIDS Foundation [PG-50804]; National Heart Lung and Blood Institute [HL083388]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040312, R37AI040312, R01AI068498] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Biology Program of the AIDS Research Institute at UCSF; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Academy of Pediatrics; American Pediatric Society; Broad Medical Research Program of The Eli and Edythe L. Broad Foundation; National Blood Foundation; Blood Systems, Inc; UCSF Clinical and Translational Institute Clinical Research Center; Elizabeth Glaser Pediatric AIDS Foundation; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the families who donated blood for the studies shown in Fig. 3. We also thank B. Kanwar, D. Favre, E. Trachtenberg, R. Derynck, and S. Fisher for technical assistance and valuable discussions. Support for this work was provided by grants from NIH to J. M. M (OD000329 and AI40312) and D. F. N. (AI68498) and from the AIDS Biology Program of the AIDS Research Institute at UCSF. J. M. is supported by the Swedish Research Council. T. D. B. is a National Institute of Child Health and Development fellow (HD00850) and was also funded by the American Academy of Pediatrics and the American Pediatric Society. M.O.M. was supported by grants from the Broad Medical Research Program of The Eli and Edythe L. Broad Foundation, National Blood Foundation, and Blood Systems, Inc. K.P.B. was supported by grants from the UCSF Clinical and Translational Institute Clinical Research Center (RR024131) and the Elizabeth Glaser Pediatric AIDS Foundation (PG-50804). M.P.B. and T.-H.L. were both supported by grants from the National Heart Lung and Blood Institute (HL083388). J. M. M. is a recipient of the NIH Director's Pioneer Award Program.	Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; FRIEDBER.SH, 1974, J IMMUNOL, V113, P1477; GITLIN D, 1964, J CLIN INVEST, V43, P1938, DOI 10.1172/JCI105068; GRANBERG C, 1980, CELL IMMUNOL, V51, P13, DOI 10.1016/0008-8749(80)90233-6; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jonsson AM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.047; Lee TH, 2006, TRANSFUSION, V46, P1870, DOI 10.1111/j.1537-2995.2006.00992.x; Loubiere LS, 2006, LAB INVEST, V86, P1185, DOI 10.1038/labinvest.3700471; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI17470; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; Rastogi D, 2007, J CLIN INVEST, V117, P1637, DOI 10.1172/JCI29466; RAYFIELD LS, 1980, CLIN EXP IMMUNOL, V42, P561; REMINGTON JS, 2006, INFECT DIS FETUS NEW, P11; SILVERSTEIN AM, 1964, SCIENCE, V144, P1423, DOI 10.1126/science.144.3625.1423; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; West LJ, 2002, HUM EXP TOXICOL, V21, P499, DOI 10.1191/0960327102ht288oa	24	551	562	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1562	1565		10.1126/science.1164511	http://dx.doi.org/10.1126/science.1164511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056990	Green Accepted			2022-12-28	WOS:000261377400054
J	de Brito, OM; Scorrano, L				de Brito, Olga Martins; Scorrano, Luca			Mitofusin 2 tethers endoplasmic reticulum to mitochondria	NATURE			English	Article							MAMMALIAN-CELLS; CA2+; APOPTOSIS; FUSION; DETERMINANTS; OSCILLATIONS; MICRODOMAINS; MUSCLE; BAX; ER	Juxtaposition between endoplasmic reticulum ( ER) and mitochondria is a common structural feature, providing the physical basis for intercommunication during Ca(2+) signalling; yet, the molecular mechanisms controlling this interaction are unknown. Here we show that mitofusin 2, a mitochondrial dynamin- related protein mutated in the inherited motor neuropathy Charcot - Marie - Tooth type IIa, is enriched at the ER - mitochondria interface. Ablation or silencing of mitofusin 2 in mouse embryonic fibroblasts and HeLa cells disrupts ER morphology and loosens ER - mitochondria interactions, thereby reducing the efficiency of mitochondrial Ca(2+) uptake in response to stimuli that generate inositol-1,4,5-trisphosphate. An in vitro assay as well as genetic and biochemical evidences support a model in which mitofusin 2 on the ER bridges the two organelles by engaging in homotypic and heterotypic complexes with mitofusin 1 or 2 on the surface of mitochondria. Thus, mitofusin 2 tethers ER to mitochondria, a juxtaposition required for efficient mitochondrial Ca(2+) uptake.	[de Brito, Olga Martins; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Geneva	Scorrano, L (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Via Orus 2, I-35129 Padua, Italy.	lscorrano@dti.telethon.it	Scorrano, Luca/K-3967-2019; Scorrano, Luca/A-6652-2008	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928	Telethon Italy; Compagnia di San Paolo Italy; United Mitochondrial Disease Foundation USA; Muscular Distrophy Association USA; Swiss National Science Foundation [3100A0-118171]	Telethon Italy(Fondazione Telethon); Compagnia di San Paolo Italy(Compagnia di San Paolo); United Mitochondrial Disease Foundation USA; Muscular Distrophy Association USA(Muscular Dystrophy Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	O.M.d.B. received a 'Bolsa de Doutoramento' of FCT Portugal. L. S. is senior scientist of the Dulbecco-Telethon Institute and EMBO YIP. This work was supported by Telethon Italy, Compagnia di San Paolo Italy, United Mitochondrial Disease Foundation USA, Muscular Distrophy Association USA and Swiss National Science Foundation 3100A0-118171.	Annis MG, 2001, ONCOGENE, V20, P1939, DOI 10.1038/sj.onc.1204288; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Mironov SL, 2006, J CELL SCI, V119, P4926, DOI 10.1242/jcs.03254; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rojo M, 2002, J CELL SCI, V115, P1663; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; SOLTYS BJ, 1992, BIOCHEM CELL BIOL, V70, P1174, DOI 10.1139/o92-163; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	35	1657	1672	6	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					605	U47		10.1038/nature07534	http://dx.doi.org/10.1038/nature07534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052620				2022-12-28	WOS:000261340000033
J	Boman, M				Boman, Magnus			Commentary: the joy of mesh	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Boman, Magnus] KTH, Forum 100, SE-16440 Kista, Sweden; [Boman, Magnus] Swedish Inst Comp Sci, SE-16429 Kista, Sweden	Royal Institute of Technology	Boman, M (corresponding author), KTH, Forum 100, SE-16440 Kista, Sweden.	mab@sics.se	Boman, Magnus/GXM-5227-2022					BUTTRICH S, MESH NETWORKING; *WIR AFR, DIY MESH GUID	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2008	337								a2500	10.1136/bmj.a2500	http://dx.doi.org/10.1136/bmj.a2500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NW	19052062				2022-12-28	WOS:000261890900006
J	Arroll, B; Fernando, A; Falloon, K				Arroll, Bruce; Fernando, Antonio, III; Falloon, Karen			10-Minute Consultation Sleep disorder (insomnia)	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arroll, Bruce; Fernando, Antonio, III; Falloon, Karen] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand	University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Private Bag 92019, Auckland 1, New Zealand.	b.arroll@auckland.ac.nz						Holbrook AM, 2004, BRIT MED J, V329, P1198, DOI 10.1136/bmj.329.7476.1198; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5	2	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 28	2008	337								a1245	10.1136/bmj.a1245	http://dx.doi.org/10.1136/bmj.a1245			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QD	19042934				2022-12-28	WOS:000261827800001
J	Gaillard, F; Malki, M; Iacono-Marziano, G; Pichavant, M; Scaillet, B				Gaillard, Fabrice; Malki, Mohammed; Iacono-Marziano, Giada; Pichavant, Michel; Scaillet, Bruno			Carbonatite Melts and Electrical Conductivity in the Asthenosphere	SCIENCE			English	Article							EARTHS MANTLE; MIDOCEAN RIDGES; OLIVINE; PRESSURE; DENSITY; WATER; BASALT; STATE	Electrically conductive regions in Earth's mantle have been interpreted to reflect the presence of either silicate melt or water dissolved in olivine. On the basis of laboratory measurements, we show that molten carbonates have electrical conductivities that are three orders of magnitude higher than those of molten silicate and five orders of magnitude higher than those of hydrated olivine. High conductivities in the asthenosphere probably indicate the presence of small amounts of carbonate melt in peridotite and can therefore be interpreted in terms of carbon concentration in the upper mantle. We show that the conductivity of the oceanic asthenosphere can be explained by 0.1 volume percent of carbonatite melts on average, which agrees with the carbon dioxide content of mid-ocean ridge basalts.	[Gaillard, Fabrice; Iacono-Marziano, Giada; Pichavant, Michel; Scaillet, Bruno] Univ Orleans, Univ Tours, Inst Sci Terre Orleans, CNRS,INSU,UMR 6113, F-41071 Orleans 2, France; [Malki, Mohammed] CNRS, CEMHTI, UPR3079, F-45071 Orleans 2, France; [Malki, Mohammed] Univ Orleans, Ecole Polytech, F-45072 Orleans 2, France; [Iacono-Marziano, Giada] Ist Nazl Geofis & Vulcanol, Sez Palermo, I-90146 Palermo, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Orleans; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; Istituto Nazionale Geofisica e Vulcanologia (INGV)	Gaillard, F (corresponding author), Univ Orleans, Univ Tours, Inst Sci Terre Orleans, CNRS,INSU,UMR 6113, Campus Geosci,1A Rue Ferollerie, F-41071 Orleans 2, France.	gaillard@cnrs-orleans.fr	Pichavant, Michel cha/C-1371-2012; Scaillet, Bruno/A-5846-2012; Gaillard, Fabrice/H-1308-2012	Pichavant, Michel cha/0000-0001-8346-5302; Gaillard, Fabrice/0000-0001-8079-0476; Gaillard, Fabrice/0000-0002-4443-8253; Iacono Marziano, Giada/0000-0001-7814-0546; Scaillet, Bruno/0000-0003-1561-0226	INSU; Electrovolc; French national agency for research (ANR) [JC05-42707]	INSU(Centre National de la Recherche Scientifique (CNRS)); Electrovolc; French national agency for research (ANR)(French National Research Agency (ANR))	We thank an INSU grant and the Electrovolc project, which is funded by the French national agency for research (ANR): contract JC05-42707 allocated to F. G. We also thank two anonymous reviewers.	Aubaud C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021341; Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; Cartigny P, 2008, EARTH PLANET SC LETT, V265, P672, DOI 10.1016/j.epsl.2007.11.011; Constable S, 2006, GEOPHYS J INT, V166, P435, DOI 10.1111/j.1365-246X.2006.03041.x; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Dasgupta R, 2007, GEOLOGY, V35, P135, DOI 10.1130/G22856A.1; Demouchy S, 2006, GEOLOGY, V34, P429, DOI 10.1130/G22386.1; Dobson DP, 1996, EARTH PLANET SC LETT, V143, P207, DOI 10.1016/0012-821X(96)00139-2; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Gaillard F, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003282; Gaillard F, 2004, EARTH PLANET SC LETT, V218, P215, DOI 10.1016/S0012-821X(03)00639-3; GENGE MJ, 1995, EARTH PLANET SC LETT, V131, P225, DOI 10.1016/0012-821X(95)00020-D; Hammouda T, 2000, GEOLOGY, V28, P283, DOI 10.1130/0091-7613(2000)28<283:UMIBCM>2.0.CO;2; Jones AG, 1999, LITHOS, V48, P57, DOI 10.1016/S0024-4937(99)00022-5; KARATO SI, 2006, REV MINERAL GEOCHEM, V62, pCH15; Kojima T, 2008, J ELECTROCHEM SOC, V155, pF150, DOI 10.1149/1.2917212; Liu Q, 2003, CONTRIB MINERAL PETR, V146, P370, DOI 10.1007/s00410-003-0505-7; Marty B, 1998, CHEM GEOL, V145, P233, DOI 10.1016/S0009-2541(97)00145-9; MINARIK WG, 1995, EARTH PLANET SC LETT, V133, P423, DOI 10.1016/0012-821X(95)00085-Q; Pommier A, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005269; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Shcheka SS, 2006, EARTH PLANET SC LETT, V245, P730, DOI 10.1016/j.epsl.2006.03.036; Simonnet C, 2003, REV SCI INSTRUM, V74, P2805, DOI 10.1063/1.1564272; SWEENEY RJ, 1994, EARTH PLANET SC LETT, V128, P259, DOI 10.1016/0012-821X(94)90149-X; Tarits P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019277; TYBURCZY JA, 1983, J GEOPHYS RES, V88, P2413, DOI 10.1029/JB088iB03p02413; Wang DJ, 2006, NATURE, V443, P977, DOI 10.1038/nature05256; Xu YS, 2000, J GEOPHYS RES-SOL EA, V105, P27865, DOI 10.1029/2000JB900299; Yoshino T, 2006, NATURE, V443, P973, DOI 10.1038/nature05223	30	243	263	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1363	1365		10.1126/science.1164446	http://dx.doi.org/10.1126/science.1164446			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039132	Green Submitted			2022-12-28	WOS:000261170600034
J	Nathan, C				Nathan, Carl			MICROBIOLOGY An Antibiotic Mimics Immunity	SCIENCE			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; NITRIC-OXIDE; IDENTIFICATION; RESISTANCE; SYNTHASE; DEFENSE		[Nathan, Carl] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University	Nathan, C (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	cnathan@med.cornell.edu						Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Chan ED, 2008, NEW ENGL J MED, V359, P657, DOI 10.1056/NEJMc0706556; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Nathan C, 2006, SCIENCE, V312, P1874; Nathan C, 2008, TUBERCULOSIS, V88, pS25, DOI 10.1016/S1472-9792(08)70034-9; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103	16	14	17	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1337	1338		10.1126/science.1167452	http://dx.doi.org/10.1126/science.1167452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039126				2022-12-28	WOS:000261170600025
J	MacMillan, HL; Wathen, CN; Barlow, J; Fergusson, DM; Leventhal, JM; Taussig, HN				MacMillan, Harriet L.; Wathen, C. Nadine; Barlow, Jane; Fergusson, David M.; Leventhal, John M.; Taussig, Heather N.			Child Maltreatment 3 Interventions to prevent child maltreatment and associated impairment	LANCET			English	Article							KINSHIP FOSTER-CARE; INTIMATE PARTNER VIOLENCE; NURSE HOME VISITATION; 15-YEAR FOLLOW-UP; SEXUAL-ABUSE; FAMILY REUNIFICATION; DOMESTIC VIOLENCE; PHYSICAL ABUSE; YOUNG-CHILDREN; PSYCHOLOGICAL INTERVENTIONS	Although a broad range of programmes for prevention of child maltreatment exist, the effectiveness of most of the programmes is unknown. Two specific home-visiting programmes-the Nurse-Family Partnership (best evidence) and Early Start-have been shown to prevent child maltreatment and associated outcomes such as injuries. One population-level parenting programme has shown benefits, but requires further assessment and replication. Additional in-hospital and clinic strategies show promise in preventing physical abuse and neglect. However, whether school-based educational programmes prevent child sexual abuse is unknown, and there are currently no known approaches to prevent emotional abuse or exposure to intimate-partner violence. A specific parent-training programme has shown benefits in preventing recurrence of physical abuse; no intervention has yet been shown to be effective in preventing recurrence of neglect. A few interventions for neglected children and mother-child therapy for families with intimate-partner violence show promise in improving behavioural outcomes. Cognitive-behavioural therapy for sexually abused children with symptoms of post-traumatic stress shows the best evidence for reduction in mental-health conditions. For maltreated children, foster care placement can lead to benefits compared with young people who remain at home or those who reunify from foster care; enhanced foster care shows benefits for children. Future research should ensure that interventions are assessed in controlled trials, using actual outcomes of maltreatment and associated health measures.	[MacMillan, Harriet L.] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada; [MacMillan, Harriet L.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [MacMillan, Harriet L.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Wathen, C. Nadine] Univ Western Ontario, Fac Informat & Media Studies, London, ON, Canada; [Barlow, Jane] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Fergusson, David M.] Christchurch Sch Med & Hlth Sci, Dept Psychol Med, Christchurch, New Zealand; [Leventhal, John M.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Taussig, Heather N.] Univ Colorado, Denver Sch Med, Kempe Ctr, Dept Pediat, Denver, CO 80202 USA; [Taussig, Heather N.] Univ Colorado, Denver Sch Med, Kempe Ctr, Dept Psychiat, Denver, CO 80202 USA	McMaster University; McMaster University; McMaster University; Western University (University of Western Ontario); University of Warwick; University of Otago; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	MacMillan, HL (corresponding author), McMaster Univ, Chedoke Hosp, Offord Ctr Child Studies, Patterson Bldg, Hamilton, ON L8N 3Z5, Canada.	macmilnh@mcmaster.ca	MacMillan, Harriet/B-4530-2016; Barlow, Jane/O-7727-2016	MacMillan, Harriet/0000-0002-1223-706X; Taussig, Heather/0000-0001-7909-2988; Barlow, Jane/0000-0001-8418-4270; Fergusson, David/0000-0002-8117-017X	Canadian Institutes of Health Research-Ontario Women's Health Council New Investigator Award; National Institute of Mental Health [ROI MH076919]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076919] Funding Source: NIH RePORTER	Canadian Institutes of Health Research-Ontario Women's Health Council New Investigator Award(Canadian Institutes of Health Research (CIHR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Ellen Jamieson for her help in editing the manuscript, David Finkelhor for his comments, and the steering group, including Ruth Gilbert, Danya Glaser, Pat Hamilton, Rosalyn Proops, Richard Reading, and June Thoburn for their suggestions on this manuscript. HMacM receives support from the David R (Dan) Offord Chair in Child Studies. NW is supported by a Canadian Institutes of Health Research-Ontario Women's Health Council New Investigator Award. I-IT would like to acknowledge the support of the National Institute of Mental Health Grant (ROI MH076919).	Allin H, 2005, CAN J PSYCHIAT, V50, P497, DOI 10.1177/070674370505000810; [Anonymous], 1998, Pediatrics, V101, P486; [Anonymous], 2003, LANCET, V361, P443; Babcock JC, 2004, CLIN PSYCHOL REV, V23, P1023, DOI 10.1016/j.cpr.2002.07.001; Bakermans-Kranenburg MJ, 1998, INFANT MENT HEALTH J, V19, P202, DOI 10.1002/(SICI)1097-0355(199822)19:2<202::AID-IMHJ8>3.0.CO;2-P; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barlow J, 2006, COCHRANE DATABASE SY, V3; BARLOW J, SYSTEMATIC IN PRESS; Barlow J, 2006, J CHILD SERV, V1, P6, DOI 10.1108/17466660200600020; Barth RP, 1998, CHILD YOUTH SERV REV, V20, P577, DOI 10.1016/S0190-7409(98)00027-9; BARTH RP, 1994, CHILD WELFARE RES RE, V1, P323; Beeman SK, 2000, CHILD YOUTH SERV REV, V22, P37, DOI 10.1016/S0190-7409(99)00072-9; Benedict MI, 1996, CHILD WELFARE, V75, P529; BERLINER L, 1993, J INTERPERS VIOLENCE, V8, P556, DOI 10.1177/088626093008004010; Berrick J. D., 1998, TENDER YEARS DEV SEN; BERRICK JD, 1994, CHILD YOUTH SERV REV, V16, P33, DOI 10.1016/0190-7409(94)90015-9; Bilukha O, 2005, AM J PREV MED, V28, P11, DOI 10.1016/j.amepre.2004.10.004; Boulton S., 2000, CLIN CHILD PSYCHOL P, V5, P439; Brooks D, 1998, CHILD YOUTH SERV REV, V20, P475, DOI 10.1016/S0190-7409(98)00020-6; BRUNK M, 1987, J CONSULT CLIN PSYCH, V55, P171, DOI 10.1037/0022-006X.55.2.171; Bugental DB, 2004, CLIN PSYCHOL-SCI PR, V11, P112, DOI 10.1093/clipsy/bph059; BULL J, 2004, ANTE POST NATAL HOME; Bybee D, 2005, AM J COMMUN PSYCHOL, V36, P85, DOI 10.1007/s10464-005-6234-5; Carpenter SC, 2004, CHILD YOUTH SERV REV, V26, P673, DOI 10.1016/j.childyouth.2004.02.015; Carpenter SC, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e46; Chaffin M, 2004, CHILD ABUSE NEGLECT, V28, P589, DOI 10.1016/j.chiabu.2004.04.004; Chaffin M, 2004, CHILD YOUTH SERV REV, V26, P1097, DOI 10.1016/j.childyouth.2004.08.008; Chaffin M, 2004, J CONSULT CLIN PSYCH, V72, P500, DOI 10.1037/0022-006X.72.3.500; Chaffin M, 2006, CHILD MALTREATMENT, V11, P301, DOI 10.1177/1077559506291261; Chambless DL, 1998, J CONSULT CLIN PSYCH, V66, P7, DOI 10.1037/0022-006X.66.1.7; Chung EK, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e81; Cohen JA, 2004, J AM ACAD CHILD PSY, V43, P393, DOI 10.1097/00004583-200404000-00005; Cohen JA, 2006, J SOC ISSUES, V62, P737, DOI 10.1111/j.1540-4560.2006.00485.x; COLTON M, 1991, SOCIAL WORK SOCIAL S, V2, P177; COURTNEY ME, 1995, SOC SERV REV, V69, P226, DOI 10.1086/604115; COURTNEY ME, 1994, SOC SERV REV, V68, P81, DOI 10.1086/604034; COURTNEY ME, 1997, CHILD WELFARE RES RE, V2, P130; CULP RE, 1991, AM J ORTHOPSYCHIAT, V61, P114, DOI 10.1037/h0079233; Dagenais C, 2004, CHILD YOUTH SERV REV, V26, P249, DOI 10.1016/j.childyouth.2004.01.015; Davidson-Arad B, 2003, CHILD ABUSE NEGLECT, V27, P733, DOI 10.1016/S0145-2134(03)00113-3; Davis MK, 2000, J CLIN CHILD PSYCHOL, V29, P257, DOI 10.1207/S15374424jccp2902_11; De Robertis MT, 2004, CHILD MALTREATMENT, V9, P92, DOI 10.1177/1077559503260402; Deblinger E, 2006, J AM ACAD CHILD PSY, V45, P1474, DOI 10.1097/01.chi.0000240839.56114.bb; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Dodge KA, 2004, CHILD WELFARE, V83, P109; DUBOWITZ H, 1994, CHILD YOUTH SERV REV, V16, P85, DOI 10.1016/0190-7409(94)90017-5; DUBOWITZ H, 1993, J DEV BEHAV PEDIATR, V14, P386; DUBOWITZ H, PEDIATRICS IN PRESS; Eckenrode J, 2000, JAMA-J AM MED ASSOC, V284, P1385, DOI 10.1001/jama.284.11.1385; Edgeworth J, 2000, WHAT WORKS FOR CHILDREN AND ADOLESCENTS?, P17; Ehrle J, 2002, CHILD YOUTH SERV REV, V24, P15, DOI 10.1016/S0190-7409(01)00166-9; Evans SE, 2008, AGGRESS VIOLENT BEH, V13, P131, DOI 10.1016/j.avb.2008.02.005; Fanshel D., 1978, CHILDREN FOSTER CARE; Fantuzzo J, 1996, J CONSULT CLIN PSYCH, V64, P1377, DOI 10.1037/0022-006X.64.6.1377; Fantuzzo J, 2005, J CLIN CHILD ADOLESC, V34, P320, DOI 10.1207/s15374424jccp3402_11; FANTUZZO JW, 1986, PROF PSYCHOL-RES PR, V17, P375, DOI 10.1037/0735-7028.17.5.375; FEIN E, 1992, SOC SERV REV, V66, P335, DOI 10.1086/603926; Fergusson DM, 2005, PEDIATRICS, V116, pE803, DOI 10.1542/peds.2005-0948; Fergusson DM, EARLY START EVALUATI; Festinger T., 1994, RETURNING CARE DISCH; Fraser MW, 1996, CHILD YOUTH SERV REV, V18, P335, DOI 10.1016/0190-7409(96)00009-6; Furniss, 2006, PREVENTING CHILD MAL; Gebel TJ, 1996, CHILD WELFARE, V75, P5; Geeraert L, 2004, CHILD MALTREATMENT, V9, P277, DOI 10.1177/1077559504264265; GELLES RJ, 1993, J INTERPERS VIOLENCE, V8, P557, DOI 10.1177/088626093008004011; Gershater-Molko RM, 2003, J FAM VIOLENCE, V18, P377, DOI 10.1023/A:1026219920902; Gershater-Molko Ronit M, 2002, Child Maltreat, V7, P277, DOI 10.1177/1077559502007003009; GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61706-7; Glaser D., 2001, EMOTIONAL ABUSE EMOT; Gomby DS, 2007, CHILD ABUSE NEGLECT, V31, P793, DOI 10.1016/j.chiabu.2007.07.001; Gomby DS, 1999, FUTURE CHILD, V9, P4, DOI 10.2307/1602719; Graham-Bermann SA, 2007, J CONSULT CLIN PSYCH, V75, P199, DOI 10.1037/0022-006X.75.2.199; Hamby S, 2000, J AM ACAD CHILD PSY, V39, P829, DOI 10.1097/00004583-200007000-00011; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Heneghan AM, 1996, PEDIATRICS, V97, P535; Holt VL, 2002, JAMA-J AM MED ASSOC, V288, P589, DOI 10.1001/jama.288.5.589; Horwitz SM, 2001, ARCH PEDIAT ADOL MED, V155, P1255; Hughes JR, 2004, CHILD ABUSE NEGLECT, V28, P1081, DOI 10.1016/j.chiabu.2004.02.004; IGLEHART AP, 1994, CHILD YOUTH SERV REV, V16, P107, DOI 10.1016/0190-7409(94)90018-3; JACOBS F, 2001, CS70; JONES HB, 2004, CHILD YOUTH SERV REV, V26, P657; Jonson-Reid M, 2000, CHILD YOUTH SERV REV, V22, P493, DOI 10.1016/S0190-7409(00)00100-6; Kahn A.J., 1993, FUTURE CHILD, P39, DOI [10.2307/1602542, DOI 10.2307/1602542]]; Keller TE, 2001, CHILD YOUTH SERV REV, V23, P915, DOI 10.1016/S0190-7409(01)00175-X; Kessler RC, 2008, ARCH GEN PSYCHIAT, V65, P625, DOI 10.1001/archpsyc.65.6.625; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Kolko DJ, 1996, CHILD ABUSE NEGLECT, V20, P23, DOI 10.1016/0145-2134(95)00113-1; Krugman SD, 2007, CURR OPIN PEDIATR, V19, P711, DOI 10.1097/MOP.0b013e3282f1c7e1; LAHTI J, 1982, SOC SERV REV     DEC, P556; Lau AS, 2003, J ABNORM CHILD PSYCH, V31, P345, DOI 10.1023/A:1023816000232; Lawrence CR, 2006, DEV PSYCHOPATHOL, V18, P57, DOI 10.1017/S0954579406060044; Leslie LK, 2000, CHILD ABUSE NEGLECT, V24, P465, DOI 10.1016/S0145-2134(00)00116-2; Lieberman AF, 2005, J AM ACAD CHILD PSY, V44, P1241, DOI 10.1097/01.chi.0000181047.59702.58; Lieberman AF, 2006, J AM ACAD CHILD PSY, V45, P913, DOI 10.1097/01.chi.0000222784.03735.92; Litrownik AJ, 2003, J FAM VIOLENCE, V18, P19, DOI 10.1023/A:1021449330344; Littell J. H., 1995, SYNTHESIS RES FAMILY; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MacLeod J, 2000, CHILD ABUSE NEGLECT, V24, P1127, DOI 10.1016/S0145-2134(00)00178-2; MACMILLAN HL, 1994, J CHILD PSYCHOL PSYC, V35, P857, DOI 10.1111/j.1469-7610.1994.tb02299.x; MacMillan HL, 2005, LANCET, V365, P1786, DOI 10.1016/S0140-6736(05)66388-X; Maluccio AN, 1996, CHILD YOUTH SERV REV, V18, P287, DOI 10.1016/0190-7409(96)00007-2; MALUCCIO AN, 1994, CHILD YOUTH SERV REV, V16, P295, DOI 10.1016/0190-7409(94)90023-X; Melton GR, 2008, FAM COMMUNITY HEALTH, V31, P84, DOI 10.1097/01.FCH.0000314570.20787.c9; *NAT CTR INJ PREV, 2004, US EV BAS PAR PROGR; National Research Council, 1993, UND CHILD AB NEGL; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Nelson HD, 2004, ANN INTERN MED, V140, P387, DOI 10.7326/0003-4819-140-5-200403020-00015; Newton RR, 2000, CHILD ABUSE NEGLECT, V24, P1363, DOI 10.1016/S0145-2134(00)00189-7; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Olds DL, 2007, PEDIATRICS, V120, pE832, DOI 10.1542/peds.2006-2111; Olds DL, 2007, J CHILD PSYCHOL PSYC, V48, P355, DOI 10.1111/j.1469-7610.2006.01702.x; OLDS DL, 1986, PEDIATRICS, V78, P65; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Olds DL, 2004, PEDIATRICS, V114, P1560, DOI 10.1542/peds.2004-0961; OLDS DL, COMMUNITY B IN PRESS; POLIT DF, 1989, FAM PLANN PERSPECT, V21, P203, DOI 10.2307/2135572; PRINZ RJ, PREV SCI IN PRESS; Ramchandani P, 2003, BRIT J PSYCHIAT, V183, P484, DOI 10.1192/bjp.183.6.484; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; READING R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61709-2; Rispens J, 1997, CHILD ABUSE NEGLECT, V21, P975, DOI 10.1016/S0145-2134(97)00058-6; Roberts I, 1996, BRIT MED J, V312, P29, DOI 10.1136/bmj.312.7022.29; RUNYAN DK, 1985, PEDIATRICS, V75, P562; Sanders MR, 2004, BEHAV THER, V35, P513, DOI 10.1016/S0005-7894(04)80030-3; SCHUERMAN J, 1997, BEST INTERESTS FAMIL; Shore N, 2002, CHILD YOUTH SERV REV, V24, P109, DOI 10.1016/S0190-7409(01)00170-0; Silverman WK, 2008, J CLIN CHILD ADOLESC, V37, P156, DOI 10.1080/15374410701818293; Sinclair I, 2005, FOSTER CHILDREN THEY; Singer LT, 2004, JAMA-J AM MED ASSOC, V291, P2448, DOI 10.1001/jama.291.20.2448; Skowron E, 2005, PSYCHOTHERAPY, V42, P52, DOI 10.1037/0033-3204.42.1.52; Stallard P, 2006, CLIN PSYCHOL REV, V26, P895, DOI 10.1016/j.cpr.2005.09.005; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Taussig HN, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e10; TAUSSIG HN, 2002, 15 INT C MENT HLTH S; Terling T, 1999, CHILD ABUSE NEGLECT, V23, P1359, DOI 10.1016/S0145-2134(99)00103-9; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Timmer SG, 2004, CHILD MALTREATMENT, V9, P251, DOI 10.1177/1077559504266998; Toth SL, 2002, DEV PSYCHOPATHOL, V14, P877, DOI 10.1017/S095457940200411X; UDWIN O, 1983, BRIT J EDUC PSYCHOL, V53, P32, DOI 10.1111/j.2044-8279.1983.tb02533.x; WALD MS, 1988, PROTECTING ABUSED NE; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; Wethington HR, 2008, AM J PREV MED, V35, P287, DOI 10.1016/j.amepre.2008.06.024; WIDOM CS, 1991, AM J ORTHOPSYCHIAT, V61, P195, DOI 10.1037/h0079252; WOLFE DA, 1981, J CONSULT CLIN PSYCH, V49, P633, DOI 10.1037/0022-006X.49.5.633; Wulczyn F, 2004, FUTURE CHILD, V14, P95, DOI 10.2307/1602756; Zuravin S. J., 1999, FOSTER CARE CRISIS T, P63; Zuravin SJ, 1997, SOC WORK RES, V21, P34, DOI 10.1093/swr/21.1.34; ZWI KJ, 2007, COCHRANE DB SYST REV, V2	151	359	362	3	151	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2009	373	9659					250	266		10.1016/S0140-6736(08)61708-0	http://dx.doi.org/10.1016/S0140-6736(08)61708-0			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19056113				2022-12-28	WOS:000262537500028
J	Van Voorhis, B				Van Voorhis, Bradley			A 41-Year-Old Woman With Menorrhagia, Anemia, and Fibroids Review of Treatment of Uterine Fibroids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; ARTERY EMBOLIZATION; ABDOMINAL HYSTERECTOMY; PREMENOPAUSAL WOMEN; INTRAUTERINE-DEVICE; CLINICAL-OUTCOMES; PREGNANCY OUTCOMES; RANDOMIZED-TRIAL; RISK FACTOR; BLOOD-LOSS	Uterine fibroids are common tumors that can cause heavy menstrual bleeding, pelvic pressure symptoms, and reproductive disorders. The incidence of fibroids peaks in the fifth decade of age and they are more common in African American women. Often, fibroids are asymptomatic and require no treatment. However, the case of Ms P, a 41-year-old woman with recurrent uterine fibroids, menorrhagia, anemia, and fatigue who wishes to retain fertility, illustrates the symptoms that require treatment. Evaluation usually begins with a pelvic examination and an ultrasound to determine both the size and location of the fibroids within the uterus. Standard treatment of symptomatic fibroids is surgical removal by myomectomy or hysterectomy, depending in part on the desire for future fertility; new treatment options include uterine artery embolization via interventional radiologic techniques as well as various medical interventions. Several new therapies show promise but are still experimental at this time. The evidence for treatment options for Ms P and symptomatic patients with fibroids in general is discussed.	[Van Voorhis, Bradley] Univ Iowa Hosp & Clin, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	University of Iowa	Van Voorhis, B (corresponding author), Univ Iowa Hosp & Clin, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, 200 Hawkins Rd, Iowa City, IA 52242 USA.	brad-van-voorhis@uiowa.edu		Van Voorhis, Brad/0000-0002-1455-0164				Altman D, 2007, LANCET, V370, P1494, DOI 10.1016/S0140-6736(07)61635-3; *AM SOC REPR MED P, 2004, FERTIL STERIL S1, V82, pS111; BRANDON DD, 1995, J CLIN ENDOCR METAB, V80, P1876, DOI 10.1210/jc.80.6.1876; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; CARLSON KJ, 1994, OBSTET GYNECOL, V83, P556, DOI 10.1097/00006250-199404000-00012; Celik H, 2003, FERTIL STERIL, V79, P1207, DOI 10.1016/S0015-0282(03)00076-1; Clevenger-Hoeft M, 1999, OBSTET GYNECOL, V94, P516, DOI 10.1016/S0029-7844(99)00345-2; *CLIN MAN GUID OBS, 2000, MAN AN BLEED ACOG 20, V2, P1049; Dallenbach P, 2007, OBSTET GYNECOL, V110, P625, DOI 10.1097/01.AOG.0000278567.37925.4e; DAYBAIRD D, 2003, AM J OBSTET GYNECOL, V188, P100; DERMAN SG, 1991, OBSTET GYNECOL, V77, P591; DeWaay DJ, 2002, OBSTET GYNECOL, V100, P3, DOI 10.1016/S0029-7844(02)02007-0; Dubuisson JB, 1996, J GYNECOL SURG, V12, P159, DOI 10.1089/gyn.1996.12.159; Dutton S, 2007, BJOG-INT J OBSTET GY, V114, P1340, DOI 10.1111/j.1471-0528.2007.01526.x; Edwards RD, 2007, NEW ENGL J MED, V356, P360; Eisinger SH, 2003, OBSTET GYNECOL, V101, P243, DOI 10.1016/S0029-7844(02)02511-5; EMANUEL MH, 1995, AM J OBSTET GYNECOL, V172, P547, DOI 10.1016/0002-9378(95)90571-5; Falcone T, 2008, OBSTET GYNECOL, V111, P753, DOI 10.1097/AOG.0b013e318165f18c; Farquhar CM, 2005, BJOG-INT J OBSTET GY, V112, P956, DOI 10.1111/j.1471-0528.2005.00696.x; FEDELE L, 1990, BRIT J OBSTET GYNAEC, V97, P393, DOI 10.1111/j.1471-0528.1990.tb01824.x; FEDELE L, 1995, HUM REPROD, V10, P1795, DOI 10.1093/oxfordjournals.humrep.a136176; Fiscella K, 2006, OBSTET GYNECOL, V108, P1381, DOI 10.1097/01.AOG.0000243776.23391.7b; FRASER IS, 1991, AUST NZ J OBSTET GYN, V31, P66, DOI 10.1111/j.1479-828X.1991.tb02769.x; Frederick J, 2002, HUM REPROD, V17, P2967, DOI 10.1093/humrep/17.11.2967; Gabriel-Cox K, 2007, AM J OBSTET GYNECOL, V196, P588, DOI 10.1016/j.ajog.2007.03.014; Garry R, 2004, BRIT MED J, V328, P129, DOI 10.1136/bmj.37984.623889.F6; Garry R, 2004, BRIT MED J, V328, P494; Goldberg J, 2006, CURR OPIN OBSTET GYN, V18, P402, DOI 10.1097/01.gco.0000233934.13684.cb; Goodwin SC, 2008, OBSTET GYNECOL, V111, P22, DOI 10.1097/01.AOG.0000296526.71749.c9; Griffiths A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003857.pub2; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Hartmann KE, 2004, OBSTET GYNECOL, V104, P701, DOI 10.1097/01.AOG.0000140684.37428.48; HAYNES PJ, 1977, BRIT J OBSTET GYNAEC, V84, P763, DOI 10.1111/j.1471-0528.1977.tb12490.x; Hehenkamp WJK, 2008, RADIOLOGY, V246, P823, DOI 10.1148/radiol.2463070260; Hehenkamp WJK, 2007, HUM REPROD, V22, P1996, DOI 10.1093/humrep/dem105; Hesley GK, 2006, MAYO CLIN PROC, V81, P936, DOI 10.4065/81.7.936; HILARIO SG, FERTIL STER IN PRESS; Hodge JC, 2007, HUM MOL GENET, V16, pR7, DOI 10.1093/hmg/ddm043; Holub Z, 2008, FERTIL STERIL, V90, P1886, DOI 10.1016/j.fertnstert.2007.08.033; Hurskainen R, 2004, JAMA-J AM MED ASSOC, V291, P1456, DOI 10.1001/jama.291.12.1456; Hurskainen R, 2001, LANCET, V357, P273, DOI 10.1016/S0140-6736(00)03615-1; Iverson RE, 1996, OBSTET GYNECOL, V88, P415, DOI 10.1016/0029-7844(96)00218-9; Jepson R., 2000, COCHRANE DB SYST REV; Jindabanjerd Kanok, 2006, J Med Assoc Thai, V89 Suppl 4, pS147; Kjerulff KH, 2000, OBSTET GYNECOL, V95, P319, DOI 10.1016/S0029-7844(99)00544-X; LAMORTE AI, 1993, OBSTET GYNECOL, V82, P897; Learman LA, 2004, OBSTET GYNECOL, V103, P824, DOI 10.1097/01.AOG.0000124272.22072.6f; Lethaby A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001016.pub2; Lethaby AE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002126.pub2; Lethaby AE, 2008, BEST PRACT RES CL OB, V22, P307, DOI 10.1016/j.bpobgyn.2007.07.010; Lippman SA, 2003, FERTIL STERIL, V80, P1488, DOI 10.1016/S0015-0282(03)02207-6; Lumbiganon P, 1996, BRIT J OBSTET GYNAEC, V103, P909, DOI 10.1111/j.1471-0528.1996.tb09911.x; Magos A, 2007, LANCET, V370, P1462, DOI 10.1016/S0140-6736(07)61613-4; MAKARAINEN L, 1986, BRIT J OBSTET GYNAEC, V93, P974, DOI 10.1111/j.1471-0528.1986.tb08019.x; Mall A, 2002, OBSTET GYNECOL, V100, P659, DOI 10.1016/S0029-7844(02)02185-3; MALONE LJ, 1969, OBSTET GYNECOL, V34, P200; Mara M, 2008, CARDIOVASC INTER RAD, V31, P73, DOI 10.1007/s00270-007-9195-2; Marino JL, 2004, HUM REPROD, V19, P2350, DOI 10.1093/humrep/deh407; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Mercorio F, 2003, CONTRACEPTION, V67, P277, DOI 10.1016/S0010-7824(02)00522-X; Merrill RM, 2008, MED SCI MONITOR, V14, pCR24; Myers ER, 2002, OBSTET GYNECOL, V100, P8, DOI 10.1016/S0029-7844(02)02019-7; Nezhat FR, 1998, J AM ASSOC GYN LAP, V5, P237, DOI 10.1016/S1074-3804(98)80025-X; Olufowobi O, 2004, J Obstet Gynaecol, V24, P434; Orsini G, 2002, Minerva Ginecol, V54, P253; Palomba S, 1998, FERTIL STERIL, V70, P111, DOI 10.1016/S0015-0282(98)00128-9; PARKER WH, 1994, OBSTET GYNECOL, V83, P414; Pinto I, 2003, RADIOLOGY, V226, P425, DOI 10.1148/radiol.2262011716; Pron G, 2005, OBSTET GYNECOL, V105, P67, DOI 10.1097/01.AOG.0000149156.07061.1f; REIN MS, 1995, AM J OBSTET GYNECOL, V172, P14, DOI 10.1016/0002-9378(95)90077-2; Sardo ADS, 2008, HUM REPROD UPDATE, V14, P101, DOI 10.1093/humupd/dmm041; Schwartz SM, 2000, ENVIRON HEALTH PERSP, V108, P821, DOI 10.2307/3454313; Seracchioli R, 2000, HUM REPROD, V15, P2663, DOI 10.1093/humrep/15.12.2663; Sharp HT, 2006, OBSTET GYNECOL, V108, P990, DOI 10.1097/01.AOG.0000232618.26261.75; Silva JCRE, 2005, J REPROD MED, V50, P613; Somigliana E, 2007, HUM REPROD UPDATE, V13, P465, DOI 10.1093/humupd/dmm013; Soysal S, 2005, GYNECOL OBSTET INVES, V59, P29, DOI 10.1159/000080932; Stewart EA, 2006, FERTIL STERIL, V85, P22, DOI 10.1016/j.fertnstert.2005.04.072; Stewart EA, 2007, OBSTET GYNECOL, V110, P279, DOI 10.1097/01.AOG.0000275283.39475.f6; Stovall DW, 2001, CLIN OBSTET GYNECOL, V44, P364, DOI 10.1097/00003081-200106000-00022; Sumitani H, 2000, ENDOCRINOLOGY, V141, P3852, DOI 10.1210/en.141.10.3852; Tjarks M, 2000, OBSTET GYNECOL, V96, P886, DOI 10.1016/S0029-7844(00)01059-0; Van Voorhis BJ, 2002, J REPROD MED, V47, P663; Van Voorhis BJ, 2008, OBSTET GYNECOL, V112, P101, DOI 10.1097/AOG.0b013e31817d452b; Varelas FK, 2007, OBSTET GYNECOL, V110, P643, DOI 10.1097/01.AOG.0000279151.20878.60; VIKHLYAEVA EM, 1995, INT J GYNECOL OBSTET, V51, P127, DOI 10.1016/0020-7292(95)02533-I; Volkers NA, 2006, J VASC INTERV RADIOL, V17, P471, DOI 10.1097/01.RVI.0000203419.61593.84; Walker WJ, 2006, AM J OBSTET GYNECOL, V195, P1266, DOI 10.1016/j.ajog.2006.04.011; Warner PE, 2004, AM J OBSTET GYNECOL, V190, P1216, DOI 10.1016/j.ajog.2003.11.015; Weber AM, 1999, AM J OBSTET GYNECOL, V181, P530, DOI 10.1016/S0002-9378(99)70488-6; Wegienka G, 2003, OBSTET GYNECOL, V101, P431, DOI 10.1016/S0029-7844(02)03121-6; Wise LA, 2004, AM J EPIDEMIOL, V159, P113, DOI 10.1093/aje/kwh016; Wu T, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005287.pub3, 10.1002/14651858.CD005287.pub2]; Yang CH, 2002, MATURITAS, V43, P35, DOI 10.1016/S0378-5122(02)00159-7	94	27	28	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					82	93		10.1001/jama.2008.791	http://dx.doi.org/10.1001/jama.2008.791			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19050179				2022-12-28	WOS:000262220400023
J	Han, YL; Shokef, Y; Alsayed, AM; Yunker, P; Lubensky, TC; Yodh, AG				Han, Yilong; Shokef, Yair; Alsayed, Ahmed M.; Yunker, Peter; Lubensky, Tom C.; Yodh, Arjun G.			Geometric frustration in buckled colloidal monolayers	NATURE			English	Article							TRIANGULAR LATTICE; GLASSY DYNAMICS; HARD-SPHERES; CRYSTALS; TRANSITION; DEFECTS; ENTROPY; SYSTEM; ARRAYS; ANTIFERROMAGNET	Geometric frustration arises when lattice structure prevents simultaneous minimization of local interaction energies. It leads to highly degenerate ground states and, subsequently, to complex phases of matter, such as water ice, spin ice, and frustrated magnetic materials. Here we report a simple geometrically frustrated system composed of closely packed colloidal spheres confined between parallel walls. Diameter- tunable microgel spheres are self- assembled into a buckled triangular lattice with either up or down displacements, analogous to an antiferromagnetic Ising model on a triangular lattice. Experiment and theory reveal single- particle dynamics governed by in- plane lattice distortions that partially relieve frustration and produce ground states with zigzagging stripes and subextensive entropy, rather than the more random configurations and extensive entropy of the antiferromagnetic Ising model. This tunable soft- matter system provides a means to directly visualize the dynamics of frustration, thermal excitations and defects.	[Han, Yilong; Shokef, Yair; Alsayed, Ahmed M.; Yunker, Peter; Lubensky, Tom C.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Han, Yilong] Hong Kong Univ Sci & Technol, Dept Phys, Kowloon, Hong Kong, Peoples R China	University of Pennsylvania; Hong Kong University of Science & Technology	Shokef, Y (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	yilong@ust.hk; yair.shokef@weizmann.ac.il	Shokef, Yair/C-3452-2009	Shokef, Yair/0000-0002-1195-4614; Yunker, Peter/0000-0001-8471-4171	NSF [DMR-0804881]; MRSEC [DMR-0520020]; NASA [NAG-2939]	NSF(National Science Foundation (NSF)); MRSEC(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	We thank B. Chakraborty, R.D. Kamien, D. Li, A. J. Liu, C. D. Modes, T.- K. Ng, S.A. Rice, Y. Snir, T.A. Witten and Y. Zhou for discussions. This work was supported primarily by the NSF through MRSEC grant DMR-0520020 and partially by DMR-0804881 (NSF) and by NAG-2939 (NASA).	Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Blunt MO, 2008, SCIENCE, V322, P1077, DOI 10.1126/science.1163338; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Chakraborty B, 2000, J PHYS-CONDENS MAT, V12, P6487, DOI 10.1088/0953-8984/12/29/320; CHEN ZY, 1986, J PHYS C SOLID STATE, V19, P6825, DOI 10.1088/0022-3719/19/34/019; CHOU T, 1993, PHYS REV E, V48, P4611, DOI 10.1103/PhysRevE.48.4611; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Davidovic D, 1996, PHYS REV LETT, V76, P815, DOI 10.1103/PhysRevLett.76.815; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; Gu L, 1996, PHYS REV B, V53, P11985, DOI 10.1103/PhysRevB.53.11985; Han Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041406; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Hilgenkamp H, 2003, NATURE, V422, P50, DOI 10.1038/nature01442; HOUTAPPEL RMF, 1950, PHYSICA, V16, P425, DOI 10.1016/0031-8914(50)90130-3; KOSHIKIYA Y, 1982, LECT COLL S JAP; Lee SH, 2000, PHYS REV LETT, V84, P3718, DOI 10.1103/PhysRevLett.84.3718; Libal A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.228302; Liebmann R., 1986, STAT MECH PERIODIC F; Mau SC, 1999, PHYS REV E, V59, P4396, DOI 10.1103/PhysRevE.59.4396; Melby P, 2005, J PHYS-CONDENS MAT, V17, pS2689, DOI 10.1088/0953-8984/17/24/020; METCALF BD, 1974, PHYS LETT A, VA 46, P325, DOI 10.1016/0375-9601(74)90247-3; Millane RP, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.057101; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Moessner R, 2001, CAN J PHYS, V79, P1283, DOI 10.1139/cjp-79-11/12-1283; Moller G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.237202; MURRAY CA, 1987, PHYS REV LETT, V58, P1200, DOI 10.1103/PhysRevLett.58.1200; Nisoli C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.217203; Nussinov Z, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014208; NUSSINOV Z, 2001, COMMENSURATE INCOMME; Ogawa T., 1983, Journal of the Physical Society of Japan, V52, P167; Osterman N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248301; PANSU B, 1984, J PHYS-PARIS, V45, P331, DOI 10.1051/jphys:01984004502033100; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; PIERANSKI P, 1983, PHYS REV LETT, V50, P900, DOI 10.1103/PhysRevLett.50.900; Ramirez AP, 2003, NATURE, V421, P483, DOI 10.1038/421483a; Schmidt M, 1997, PHYS REV E, V55, P7228, DOI 10.1103/PhysRevE.55.7228; Schmidt M, 1996, PHYS REV LETT, V76, P4552, DOI 10.1103/PhysRevLett.76.4552; SHIH WY, 1985, PHYS REV B, V32, P158, DOI 10.1103/PhysRevB.32.158; SHOKEF Y, 2008, STRIPES ZIGZAGS SLOW; VILLAIN J, 1980, J PHYS-PARIS, V41, P1263, DOI 10.1051/jphys:0198000410110126300; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447; WANNIER GH, 1973, PHYS REV B, V7, P5017, DOI 10.1103/PhysRevB.7.5017; WEISS JA, 1995, J CHEM PHYS, V103, P1180, DOI 10.1063/1.469828; Yin H, 2001, PHYS REV LETT, V86, P2058, DOI 10.1103/PhysRevLett86.2058; Zangi R, 1998, PHYS REV E, V58, P7529, DOI 10.1103/PhysRevE.58.7529	46	172	174	3	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					898	903		10.1038/nature07595	http://dx.doi.org/10.1038/nature07595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092926	Green Submitted			2022-12-28	WOS:000261768300034
J	Merritt, WM; Lin, YG; Han, LY; Kamat, AA; Spannuth, WA; Schmandt, R; Urbauer, D; Pennacchio, LA; Cheng, J; Nick, AM; Deavers, MT; Mourad-Zeidan, A; Wang, H; Mueller, P; Lenburg, ME; Gray, JW; Mok, S; Birrer, MJ; Lopez-Berestein, G; Coleman, RL; Bar-Eli, M; Sood, AK				Merritt, William M.; Lin, Yvonne G.; Han, Liz Y.; Kamat, Aparna A.; Spannuth, Whitney A.; Schmandt, Rosemarie; Urbauer, Diana; Pennacchio, Len A.; Cheng, Jan-Fang; Nick, Alpa M.; Deavers, Michael T.; Mourad-Zeidan, Alexandra; Wang, Hua; Mueller, Peter; Lenburg, Marc E.; Gray, Joe W.; Mok, Samuel; Birrer, Michael J.; Lopez-Berestein, Gabriel; Coleman, Robert L.; Bar-Eli, Menashe; Sood, Anil K.			Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERFERING RNA DELIVERY; GENE-EXPRESSION; BREAST-CANCER; MICRORNAS; CARCINOMA; ADENOCARCINOMA; PROLIFERATION; INITIATION; PATHWAYS; ESTROGEN	Background: We studied Dicer and Drosha, components of the RNA-interference machinery, in ovarian cancer. Methods: We measured messenger RNA (mRNA) levels of Dicer and Drosha in specimens of invasive epithelial ovarian cancer from 111 patients, using a quantitative reverse-transcriptase-polymerase-chain-reaction assay, and compared the results with clinical outcomes. Validation was performed with the use of published microarray data from cohorts of patients with ovarian, breast, and lung cancer. Mutational analyses of genomic DNA from the Dicer and Drosha genes were performed in a subgroup of ovarian-cancer specimens. Dicer-dependent functional assays were performed by means of in vitro transfection with small interfering RNA (siRNA) and short hairpin RNA (shRNA). Results: Levels of Dicer and Drosha mRNA correlated with the levels of expression of the corresponding protein and were decreased in 60% and 51% of ovarian-cancer specimens, respectively. Low Dicer expression was significantly associated with advanced tumor stage (P=0.007), and low Drosha expression with suboptimal surgical cytoreduction (P=0.02). Cancer specimens with both high Dicer expression and high Drosha expression were associated with increased median survival (>11 years, vs. 2.66 years for other subgroups; P<0.001). We found three independent predictors of reduced disease-specific survival in multivariate analyses: low Dicer expression (hazard ratio, 2.10; P=0.02), high-grade histologic features (hazard ratio, 2.46; P=0.03), and poor response to chemotherapy (hazard ratio, 3.95; P<0.001). Poor clinical outcomes among patients with low Dicer expression were validated in additional cohorts of patients. Rare missense mutations were found in the Dicer and Drosha genes, but their presence or absence did not correlate with the level of expression. Functional assays indicated that gene silencing with shRNA, but not siRNA, may be impaired in cells with low Dicer expression. Conclusions: Our findings indicate that levels of Dicer and Drosha mRNA in ovarian-cancer cells have associations with outcomes in patients with ovarian cancer.	[Merritt, William M.; Lin, Yvonne G.; Han, Liz Y.; Kamat, Aparna A.; Spannuth, Whitney A.; Schmandt, Rosemarie; Urbauer, Diana; Nick, Alpa M.; Deavers, Michael T.; Mourad-Zeidan, Alexandra; Wang, Hua; Mueller, Peter; Lopez-Berestein, Gabriel; Coleman, Robert L.; Bar-Eli, Menashe; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Unit 1362, Houston, TX 77230 USA; [Pennacchio, Len A.; Cheng, Jan-Fang; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Pennacchio, Len A.; Cheng, Jan-Fang] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Lenburg, Marc E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Mok, Samuel] Brigham & Womens Hosp, Boston, MA 02115 USA; [Birrer, Michael J.] Ctr Canc Res, Bethesda, MD USA	University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Boston University; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Unit 1362, POB 301439, Houston, TX 77230 USA.	asood@mdanderson.org	Lenburg, Marc/B-8027-2008; Gray, Joe/AAX-9549-2020; Coleman, Robert/E-4346-2019	Lenburg, Marc/0000-0002-5760-4708; Pennacchio, Len/0000-0002-8748-3732; Cheng, Jan-Fang/0000-0001-7315-7613	National Cancer Institute [CA101642]; Ovarian Cancer Research Fund Program Project Development; University of Texas M. D. Anderson Cancer Center Ovarian Cancer Specialized Program of Research Excellence [P50 CA083639]; National Institutes of Health [CA110793, CA109298, P50 CA58207, U54 CA112970]; Gynecologic Cancer Foundation; Zarrow Foundation; Betty Ann Asche Murray Distinguished Professorship; Marcus Foundation; U. S. Department of Energy; Office of Science; Office of Biological and Environmental Research [DE-AC03-76SF00098]; NATIONAL CANCER INSTITUTE [ZIASC000165, T32CA101642, R01CA110793, U54CA112970, R01CA109298, P50CA083639, P50CA058207] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund Program Project Development; University of Texas M. D. Anderson Cancer Center Ovarian Cancer Specialized Program of Research Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gynecologic Cancer Foundation; Zarrow Foundation; Betty Ann Asche Murray Distinguished Professorship; Marcus Foundation; U. S. Department of Energy(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Cancer Institute (T32 Training Grant CA101642), the Ovarian Cancer Research Fund Program Project Development Grant, the University of Texas M. D. Anderson Cancer Center Ovarian Cancer Specialized Program of Research Excellence (P50 CA083639), the National Institutes of Health (CA110793, CA109298, P50 CA58207, and U54 CA112970), the Gynecologic Cancer Foundation, the Zarrow Foundation, the Betty Ann Asche Murray Distinguished Professorship, the Marcus Foundation, and the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research (contract DE-AC03-76SF00098).; Dr. Gray reports receiving consulting fees from Agendia and Sirna. No other potential conflict of interest relevant to this article was reported.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; [Anonymous], 2007, R LANG ENV STAT COMP; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chiosea SI, 2008, VIRCHOWS ARCH, V452, P629, DOI 10.1007/s00428-007-0574-5; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Irvin-Wilson CV, 2005, BREAST CANCER RES, V7, pR563, DOI 10.1186/bcr1043; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Singh M, 2007, GYNECOL ONCOL, V106, P325, DOI 10.1016/j.ygyno.2007.03.042; Sood AK, 2001, AM J PATHOL, V158, P1279, DOI 10.1016/S0002-9440(10)64079-5; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang L, 2006, CELL CYCLE, V5, P2216, DOI 10.4161/cc.5.19.3319; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	41	529	570	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2641	2650		10.1056/NEJMoa0803785	http://dx.doi.org/10.1056/NEJMoa0803785			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092150	Green Accepted, Green Submitted			2022-12-28	WOS:000261757300004
J	Goswami, D; Gowrishankar, K; Bilgrami, S; Ghosh, S; Raghupathy, R; Chadda, R; Vishwakarma, R; Rao, M; Mayor, S				Goswami, Debanjan; Gowrishankar, Kripa; Bilgrami, Sameera; Ghosh, Subhasri; Raghupathy, Riya; Chadda, Rahul; Vishwakarma, Ram; Rao, Madan; Mayor, Satyajit			Nanoclusters of GPI-Anchored Proteins Are Formed by Cortical Actin-Driven Activity	CELL			English	Article							LIPID RAFTS; PLASMA-MEMBRANE; CELL; CHOLESTEROL; ACTIVATION; ORGANIZATION; MICROSCOPY; CDC42	Several cell-surface lipid-tethered proteins exhibit a concentration-independent, cholesterol-sensitive organization of nanoscale clusters and monomers. To understand the mechanism of formation of these clusters, we investigate the spatial distribution and steady-state dynamics of fluorescently tagged GPI-anchored protein nanoclusters using high-spatial and temporal resolution FRET microscopy. These studies reveal a nonrandom spatial distribution of nanoclusters, concentrated in optically resolvable domains. Monitoring the dynamics of recovery of fluorescence intensity and anisotropy, we find that nanoclusters are immobile, and the dynamics of inter-conversion between nanoclusters and monomers, over a range of temperatures, is spatially heterogeneous and non-Arrhenius, with a sharp crossover coinciding with a reduction in the activity of cortical actin. Cholesterol depletion perturbs cortical actin and the spatial scale and interconversion dynamics of nanoclusters. Direct perturbations of cortical actin activity also affect the construction, dynamics, and spatial organization of nanoclusters. These results suggest a unique mechanism of complexation of cell-surface molecules regulated by cortical actin activity.	[Goswami, Debanjan; Bilgrami, Sameera; Ghosh, Subhasri; Raghupathy, Riya; Chadda, Rahul; Rao, Madan; Mayor, Satyajit] Nat Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India; [Gowrishankar, Kripa; Rao, Madan] Raman Res Inst, Bangalore 560080, Karnataka, India; [Vishwakarma, Ram] Natl Inst Immunol, New Delhi 110067, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Science & Technology (India); Raman Research Institute (RRI); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Rao, M (corresponding author), Nat Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	madan@ncbs.res.in; mayor@ncbs.res.in	Rao, Madan/E-2927-2012; Chadda, Rahul/AAM-2085-2020	Ghosh, Subhasri/0000-0002-3907-6366	Central Imaging and Flow Facility at NCBS; HFSP [RGP 0050/ 2005)/DST(SR/S5/NM-36/2005)]	Central Imaging and Flow Facility at NCBS; HFSP(Human Frontier Science Program)	We thank M. Thattai, G. V. Shivashankar, and S. Ramaswamy for a critical reading, N. Periasami ( DCS, TIFR, Mumbai) for the help with time-resolved anistropy analysis, and H. Krishnamurthy and the Central Imaging and Flow Facility at NCBS for their help and support. S. M. acknowledges DST for J C Bose fellowship. S. M. and M. R. acknowledge grants from HFSP(RGP 0050/ 2005)/DST(SR/S5/NM-36/2005)/DBT/Wellcome Trust ( NLO-056727/Z/99/B)and HFSP( RGP26/2007)/IFCPAR, respectively.	[Anonymous], 2007, PRINCIPLES CONDENSED; Becker W, 2005, ADV TIME CORRELATED; Bretscher A, 1997, J CELL SCI, V110, P3011; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hatwalne Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118101; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; ISRAELACHVILI JN, 1992, INTERMOLOLECULAR SUR; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Keller H, 2002, EXP CELL RES, V277, P161, DOI 10.1006/excr.2002.5552; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; PETERS R, 1981, P NATL ACAD SCI-BIOL, V78, P962, DOI 10.1073/pnas.78.2.962; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Ramaswamy S, 2001, CR ACAD SCI IV-PHYS, V2, P817, DOI 10.1016/S1296-2147(01)01226-4; Ramaswamy S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/423; Rao M, 2005, BBA-MOL CELL RES, V1746, P221, DOI 10.1016/j.bbamcr.2005.08.002; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHEETZ MP, 1984, J CELL BIOL, V99, P1867, DOI 10.1083/jcb.99.5.1867; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563	36	356	356	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1085	1097		10.1016/j.cell.2008.11.032	http://dx.doi.org/10.1016/j.cell.2008.11.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070578	Bronze			2022-12-28	WOS:000261642800024
J	Cates, W; Feldblum, P				Cates, Willard; Feldblum, Paul			HIV prevention research: the ecstasy and the agony	LANCET			English	Editorial Material							VAGINAL GEL; MALE CIRCUMCISION; CONTROLLED-TRIAL; DOUBLE-BLIND; INFECTION; TRANSMISSION; WOMEN; UGANDA; MEN		[Cates, Willard; Feldblum, Paul] Family Hlth Int, Res Triangle Pk, NC 27709 USA		Cates, W (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	Wcates@fhi.org						Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; CATES W, 1992, NEW ENGL J MED, V327, P492, DOI 10.1056/NEJM199208133270711; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Geary CW, 2003, AIDS EDUC PREV, V15, P499, DOI 10.1521/aeap.15.7.499.24044; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Horton R, 2008, LANCET, V372, P421, DOI 10.1016/S0140-6736(08)60882-X; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Trussell J, 2005, CONTRACEPTION, V72, P408, DOI 10.1016/j.contraception.2005.06.063; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wallace AR, 2007, CONTRACEPTION, V76, P53, DOI 10.1016/j.contraception.2006.10.012	22	9	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1932	1933		10.1016/S0140-6736(08)61824-3	http://dx.doi.org/10.1016/S0140-6736(08)61824-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	19059036				2022-12-28	WOS:000261471600006
J	Roberts, I				Roberts, Ian			Corporate capture and Coca-Cola	LANCET			English	Editorial Material									[Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Ian.Roberts@lshtm.ac.uk						GARCIA P, 2008, COMMUNICATION   1006; KER K, 2003, COCHRANE DB SYST REV, V3; Millstone E, 2008, LANCET, V372, P94, DOI 10.1016/S0140-6736(08)61012-0; PRATS J, 2008, COMMUNICATION   1007; Roberts I, 2007, J ROY SOC MED, V100, P360, DOI 10.1258/jrsm.100.8.360; Yach D, 2008, PUBLIC HEALTH NUTR, V11, P109, DOI 10.1017/S1368980007001619	6	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 6	2008	372	9654					1934	1935		10.1016/S0140-6736(08)61825-5	http://dx.doi.org/10.1016/S0140-6736(08)61825-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	19059037				2022-12-28	WOS:000261471600007
J	Thompson, RJ; Jackson, MF; Olah, ME; Rungta, RL; Hines, DJ; Beazely, MA; MacDonald, JF; MacVicar, BA				Thompson, Roger J.; Jackson, Michael F.; Olah, Michelle E.; Rungta, Ravi L.; Hines, Dustin J.; Beazely, Michael A.; MacDonald, John F.; MacVicar, Brian A.			Activation of Pannexin-1 Hemichannels Augments Aberrant Bursting in the Hippocampus	SCIENCE			English	Article							EPILEPTIFORM ACTIVITY; ENTORHINAL CORTEX; P2X(7) RECEPTOR; IN-VIVO; NEURONS; GAP; SLICES; ATP	Pannexin- 1 ( Px1) is expressed at postsynaptic sites in pyramidal neurons, suggesting that these hemichannels contribute to dendritic signals associated with synaptic function. We found that, in pyramidal neurons, N- methyl- D- aspartate receptor ( NMDAR) activation induced a secondary prolonged current and dye flux that were blocked with a specific inhibitory peptide against Px1 hemichannels; knockdown of Px1 by RNA interference blocked the current in cultured neurons. Enhancing endogenous NMDAR activation in brain slices by removing external magnesium ions (Mg2+) triggered epileptiform activity, which had decreased spike amplitude and prolonged interburst interval during application of the Px1 hemichannel blocking peptide. We conclude that Px1 hemichannel opening is triggered by NMDAR stimulation and can contribute to epileptiform seizure activity.	[Thompson, Roger J.; Rungta, Ravi L.; Hines, Dustin J.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Thompson, Roger J.; Rungta, Ravi L.; Hines, Dustin J.; MacVicar, Brian A.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Jackson, Michael F.; Olah, Michelle E.; Beazely, Michael A.; MacDonald, John F.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada	University of British Columbia; University of British Columbia; Western University (University of Western Ontario)	Thompson, RJ (corresponding author), Univ Calgary, Dept Cell Biol & Anat, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	rj.thompson@ucalgary.ca; bmacvicar@brain.ubc.ca	Thompson, Roger/A-3029-2012; Hines, Dustin/AAC-6394-2021; Thompson, Roger/L-3930-2016; MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015; Jackson, Mike/H-5573-2012	Thompson, Roger/0000-0002-7019-7246; MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Jackson, Mike/0000-0002-4730-201X; Beazely, Michael/0000-0002-8722-460X; Rungta, Ravi/0000-0003-3505-2743	Heart and Stroke Foundation of British Columbia; Canadian Institutes of Health Research; Canadian Stroke Network	Heart and Stroke Foundation of British Columbia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Stroke Network	This work was supported by grants to B. A. M. from the Heart and Stroke Foundation of British Columbia, to B.A.M. or J.F.M. (15514) from the Canadian Institutes of Health Research, and by a grant from the Canadian Stroke Network to B.A.M., J.F.M., and R.J.T. B.A.M. holds a Canada Research Chair (Tier 1) in Neuroscience. The authors kindly acknowledge Y.T. Wang for critical reading of the manuscript and S. Panuela and D. Laird for generously providing the anti-Px1 antibody.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bennett MVL, 2006, BRAIN CELL BIOL, V35, P5, DOI 10.1007/s11068-006-9004-x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chen QX, 1997, J NEUROSCI, V17, P4032; Connor JA, 2000, J NEUROPHYSIOL, V83, P90, DOI 10.1152/jn.2000.83.1.90; DREIER JP, 1990, NEUROSCI LETT, V119, P68, DOI 10.1016/0304-3940(90)90757-Z; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Jagt TAV, 2008, J NEUROSCI, V28, P5029, DOI 10.1523/JNEUROSCI.5069-07.2008; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	18	263	266	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1555	1559		10.1126/science.1165209	http://dx.doi.org/10.1126/science.1165209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056988				2022-12-28	WOS:000261377400052
J	Phillips, KA				Phillips, Kathryn A.			Closing the Evidence Gap in the Use of Emerging Testing Technologies in Clinical Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COST-EFFECTIVENESS ANALYSIS; ADJUVANT TRASTUZUMAB; BREAST-CANCER		[Phillips, Kathryn A.] Univ Calif San Francisco, Ctr Translat & Policy Res Personalized Med, Sch Pharm, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Phillips, Kathryn A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Phillips, KA (corresponding author), Univ Calif San Francisco, Ctr Translat & Policy Res Personalized Med, Sch Pharm, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St,Ste 420, San Francisco, CA 94143 USA.	phillipsk@pharmacy.ucsf.edu	Marshall, Deborah/J-7248-2015	Marshall, Deborah/0000-0002-8467-8008	NATIONAL CANCER INSTITUTE [R01CA101849, P01CA130818] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA130818-01A1, R01 CA101849, R01CA101849, R01 CA101849-01A1, P01 CA130818, P01CA130818] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*CRISP, ERA COMM COMP RETR I; Culliton BJ, 2008, HEALTH AFFAIR, V27, pW41, DOI 10.1377/hlthaff.27.1.w41; DESTEFANO F, 2008, PUBLICATION AGENCY H; Elkin EB, 2004, J CLIN ONCOL, V22, P854, DOI 10.1200/JCO.2004.04.158; Garrison LR, 2007, CANCER-AM CANCER SOC, V110, P489, DOI 10.1002/cncr.22806; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Kurian AW, 2007, J CLIN ONCOL, V25, P634, DOI 10.1200/JCO.2006.06.3081; Liberato NL, 2007, J CLIN ONCOL, V25, P625, DOI 10.1200/JCO.2006.06.4220; Mathews AW, 2008, WALL STREET J   0104, pB1; NASS SJ, 2007, CANC BIOMARKERS PROM; POLLACK A, 2007, NY TIMES        0612; Stark A, 2004, INT J QUAL HEALTH C, V16, P517, DOI 10.1093/intqhc/mzh085; Tong KB, 2007, 2007 BREAST CANC S S; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	14	36	39	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2542	2544		10.1001/jama.2008.754	http://dx.doi.org/10.1001/jama.2008.754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050197	Green Accepted			2022-12-28	WOS:000261286200023
J	Bernards, R				Bernards, Rene			RnAi Delivers Insights into Liver Cancer	CELL			English	Editorial Material								Of the myriad alterations in gene copy number found in cancer cells, which alterations are critical for the cancer phenotype? In this issue of Cell, Zender et al. (2008) describe an integrative genomics approach to identify new tumor suppressor genes involved in hepatocellular carcinoma.	[Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423				Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Moore MAS, 2007, ANN NY ACAD SCI, V1106, P114, DOI 10.1196/annals.1392.019; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	5	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					793	795		10.1016/j.cell.2008.11.001	http://dx.doi.org/10.1016/j.cell.2008.11.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041743	Bronze			2022-12-28	WOS:000261183900010
J	Lavik, G; Stuhrmann, T; Bruchert, V; Van der Plas, A; Mohrholz, V; Lam, P; Mussmann, M; Fuchs, BM; Amann, R; Lass, U; Kuypers, MMM				Lavik, Gaute; Stuehrmann, Torben; Bruechert, Volker; Van der Plas, Anja; Mohrholz, Volker; Lam, Phyllis; Mussmann, Marc; Fuchs, Bernhard M.; Amann, Rudolf; Lass, Ulrich; Kuypers, Marcel M. M.			Detoxification of sulphidic African shelf waters by blooming chemolithotrophs	NATURE			English	Article							SULFIDE; BACTERIA; IDENTIFICATION; HYPOXIA; GAS; PHYTOPLANKTON; COMMUNITIES; REDUCTION; OXIDATION; SEDIMENT	Coastal waters support similar to 90 per cent of global fisheries and are therefore an important food reserve for our planet(1). Eutrophication of these waters, due to human activity, leads to severe oxygen depletion and the episodic occurrence of hydrogen sulphide toxic to multi- cellular life - with disastrous consequences for coastal ecosytems(2-5). Here we show that an area of similar to 7,000 km(2) of African shelf, covered by sulphidic water, was detoxified by blooming bacteria that oxidized the biologically harmful sulphide to environmentally harmless colloidal sulphur and sulphate. Combined chemical analyses, stoichiometric modelling, isotopic incubations, comparative 16S ribosomal RNA, functional gene sequence analyses and fluorescence in situ hybridization indicate that the detoxification proceeded by chemolithotrophic oxidation of sulphide with nitrate and was mainly catalysed by two discrete populations of gamma- and epsilon-proteobacteria. Chemolithotrophic bacteria, accounting for similar to 20 per cent of the bacterioplankton in sulphidic waters, created a buffer zone between the toxic sulphidic subsurface waters and the oxic surface waters, where fish and other nekton live. This is the first time that large- scale detoxification of sulphidic waters by chemolithotrophs has been observed in an open- ocean system. The data suggest that sulphide can be completely consumed by bacteria in the subsurface waters and, thus, can be overlooked by remote sensing or monitoring of shallow coastal waters. Consequently, sulphidic bottom waters on continental shelves may be more common than previously believed, and could therefore have an important but as yet neglected effect on benthic communities.	[Lavik, Gaute; Stuehrmann, Torben; Bruechert, Volker; Lam, Phyllis; Fuchs, Bernhard M.; Amann, Rudolf; Kuypers, Marcel M. M.] Max Planck Inst Microbiol, D-28359 Bremen, Germany; [Van der Plas, Anja] Minist Fisheries & Marine Resources, Natl Marine Informat & Res Ctr, Swakopmund, Namibia; [Mohrholz, Volker; Lass, Ulrich] Balt Sea Res Inst Warnemunde, D-18119 Rostock, Germany; [Mussmann, Marc] Univ Vienna, Dept Microbial Ecol, Vienna Ecol Ctr, A-1090 Vienna, Austria	Max Planck Society; University of Vienna	Kuypers, MMM (corresponding author), Max Planck Inst Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	mkuypers@mpi-bremen.de	Mussmann, Marc/A-8649-2017; Amann, Rudolf I/C-6534-2014; Lavik, Gaute/F-6578-2013; Lam, Phyllis/D-9574-2011; Mussmann, Marc/AAA-6108-2021	Mussmann, Marc/0000-0003-3102-8703; Amann, Rudolf I/0000-0002-0846-7372; Lam, Phyllis/0000-0003-2067-171X; , Marc/0000-0003-2785-2521; Bruchert, Volker/0000-0002-8956-3840; Mohrholz, Volker/0000-0003-0778-9182; Fuchs, Bernhard/0000-0001-9828-1290	MPG; BMBF programme Geotechnologien; NAMIBGAS; DFG; BENEFIT; Namibian Ministry of Fisheries and Natural Resources	MPG(Max Planck Society); BMBF programme Geotechnologien(Federal Ministry of Education & Research (BMBF)); NAMIBGAS; DFG(German Research Foundation (DFG)); BENEFIT; Namibian Ministry of Fisheries and Natural Resources	We thank B. Barker Jorgensen, F. Inagaki, C. Hubert, T. Ferdelman and G. Collins for discussions; the Namibian authorities for access to their national waters; the crew of RV Alexander von Humboldt for assistance onboard; S. Kruger for operating the pump-CTD and oceanographic equipment; T. Heene for assistance with the collection of oceanographic data and generating oceanographic plots; and G. Klockgether, J. Sawicka, J. Wulf, S. Lenk, D. Franzke and K. Nkandi for assistance with the analysis. The investigations were supported by the MPG, the BMBF programme Geotechnologien and the project NAMIBGAS, the DFG, BENEFIT and the Namibian Ministry of Fisheries and Natural Resources.	Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Blazejak A, 2006, APPL ENVIRON MICROB, V72, P5527, DOI 10.1128/AEM.02441-05; Bruchert V, 2006, NATO SCI S SS IV EAR, V64, P161; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Copenhagen, 1953, INVESTIGATIONAL REPO, V14, P1; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Emeis KC, 2004, CONT SHELF RES, V24, P627, DOI 10.1016/j.csr.2004.01.007; Fennel K, 2003, LIMNOL OCEANOGR, V48, P1521, DOI 10.4319/lo.2003.48.4.1521; Gevertz D, 2000, APPL ENVIRON MICROB, V66, P2491, DOI 10.1128/AEM.66.6.2491-2501.2000; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Hart T. J., 1960, Discovery Reports, V31, P123; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kirchman DL, 2001, AQUAT MICROB ECOL, V26, P13, DOI 10.3354/ame026013; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Malakoff D, 1998, SCIENCE, V281, P190, DOI 10.1126/science.281.5374.190; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Ohde T, 2007, CONT SHELF RES, V27, P744, DOI 10.1016/j.csr.2006.11.016; Paerl HW, 2003, ENVIRON MICROBIOL, V5, P1025, DOI 10.1046/j.1462-2920.2003.00504.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	40	237	242	5	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					581	U86		10.1038/nature07588	http://dx.doi.org/10.1038/nature07588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19078958				2022-12-28	WOS:000262852200041
J	Buszczak, M; Paterno, S; Spradling, AC				Buszczak, Michael; Paterno, Shelley; Spradling, Allan C.			Drosophila Stem Cells Share a Common Requirement for the Histone H2B Ubiquitin Protease Scrawny	SCIENCE			English	Article							RNA-POLYMERASE-II; METHYLATION; OVARY; MAINTENANCE; CHROMATIN; DIVISION; COMPASS; COMPLEX; MIDGUT; GENES	Stem cells within diverse tissues share the need for a chromatin configuration that promotes self- renewal, yet few chromatin proteins are known to regulate multiple types of stem cells. We describe a Drosophila gene, scrawny ( scny), encoding a ubiquitin- specific protease, which is required in germline, epithelial, and intestinal stem cells. Like its yeast relative UBP10, Scrawny deubiquitylates histone H2B and functions in gene silencing. Consistent with previous studies of this conserved pathway of chromatin regulation, scny mutant cells have elevated levels of ubiquitinylated H2B and trimethylated H3K4. Our findings suggest that inhibiting H2B ubiquitylation through scny represents a common mechanism within stem cells that is used to repress the premature expression of key differentiation genes, including Notch target genes.	[Buszczak, Michael; Paterno, Shelley; Spradling, Allan C.] Carnegie Inst, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21218 USA	Carnegie Institution for Science	Spradling, AC (corresponding author), Carnegie Inst, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21218 USA.	spradling@ciwemb.edu		Buszczak, Michael/0000-0001-6361-3654	Howard Hughes Medical Institute; American Cancer Society Fellowship [PF-04-022-01-CSM]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society Fellowship(American Cancer Society)	This work was supported by the Howard Hughes Medical Institute. M. B. was supported in part by American Cancer Society Fellowship PF-04-022-01-CSM. We thank D. McKearin, M. Oren, and the Bloomington Stock Center for reagents; B. Ohlstein for helpful advice and for assisting with the initial characterization of the scny midgut phenotype; and T. Nystul for critical reading of the manuscript.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Li Jianduan, 2008, Int J Med Sci, V5, P133; Lin HF, 1997, DEVELOPMENT, V124, P2463; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tenney K, 2006, P NATL ACAD SCI USA, V103, P11970, DOI 10.1073/pnas.0603620103; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	22	93	100	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					248	251		10.1126/science.1165678	http://dx.doi.org/10.1126/science.1165678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19039105	Green Accepted			2022-12-28	WOS:000262290600037
J	[Anonymous]				[Anonymous]			Eyes west	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					838	838		10.1038/456838a	http://dx.doi.org/10.1038/456838a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092874	Bronze			2022-12-28	WOS:000261768300003
J	Burke, FD				Burke, Frank D.			The cult of the conference bag	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Burke, Frank D.] Derbyshire Royal Infirm, Pulvertaft Hand Unit, Derby DE1 2QY, England		Burke, FD (corresponding author), Derbyshire Royal Infirm, Pulvertaft Hand Unit, Derby DE1 2QY, England.	frank.burke@virgin.net							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2677	10.1136/bmj.a2677	http://dx.doi.org/10.1136/bmj.a2677			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088136				2022-12-28	WOS:000262184900001
J	Carter, AP; Garbarino, JE; Wilson-Kubalek, EM; Shipley, WE; Cho, C; Milligan, RA; Vale, RD; Gibbons, IR				Carter, Andrew P.; Garbarino, Joan E.; Wilson-Kubalek, Elizabeth M.; Shipley, Wesley E.; Cho, Carol; Milligan, Ronald A.; Vale, Ronald D.; Gibbons, I. R.			Structure and Functional Role of Dynein's Microtubule-Binding Domain	SCIENCE			English	Article							CYTOPLASMIC DYNEIN; MOTOR PROTEINS; TRANSPORT; RESOLUTION; MUTATIONS; MOTIONS; SITE	Dynein motors move various cargos along microtubules within the cytoplasm and power the beating of cilia and flagella. An unusual feature of dynein is that its microtubule- binding domain ( MTBD) is separated from its ring- shaped AAA+ adenosine triphosphatase ( ATPase) domain by a 15- nanometer coiled- coil stalk. We report the crystal structure of the mouse cytoplasmic dynein MTBD and a portion of the coiled coil, which supports a mechanism by which the ATPase domain and MTBD may communicate through a shift in the heptad registry of the coiled coil. Surprisingly, functional data suggest that the MTBD, and not the ATPase domain, is the main determinant of the direction of dynein motility.	[Carter, Andrew P.; Cho, Carol; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Carter, Andrew P.; Cho, Carol; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Garbarino, Joan E.; Shipley, Wesley E.; Gibbons, I. R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wilson-Kubalek, Elizabeth M.; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Scripps Research Institute	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Cho, Carol/0000-0003-4070-6561; Carter, Andrew/0000-0001-7292-5430	Jane Coffin Childs Foundation; NIH [GM52468-14, P01-AR42895, GM30401-29]; Agouron Institute; Leukemia and Lymphoma Society; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052468, R37GM030401, R01GM052468, R01GM030401, R01GM097312] Funding Source: NIH RePORTER	Jane Coffin Childs Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agouron Institute(Pfizer); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Welburn and E. Nogales for advice and equipment; M. Kikkawa for sending his group's electron density map; and N. Bradshaw, J. Kardon, K. Aathavan, A. Dose, A. Gennerich, A. Roll- Mecak, and S. Reck- Peterson for critically reading the manuscript. Supported by the Jane Coffin Childs Foundation (A.P.C.); NIH grants GM52468-14 (R.A.M.), P01-AR42895 (R.D.V.) and GM30401-29 (I.R.G.)]; the Agouron Institute (A.P.C.); the Leukemia and Lymphoma Society (A.P.C.); and the Howard Hughes Medical Institute. Crystallography data were collected at beamline 8.3.1 of the Advanced Light Source at Lawrence Berkeley National Laboratory. The atomic coordinates and structure factors have been deposited in the Protein Data Bank (code 3ERR). Cryo-EM data were collected in part at the National Resource for Automated Molecular Microscopy at the Scripps Research Institute (NIH P41 RR-17573). Maps were deposited at the EMDataBank (EMD-1581).	Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zuccarello D, 2008, HUM REPROD, V23, P1957, DOI 10.1093/humrep/den193	24	181	183	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1691	1695		10.1126/science.1164424	http://dx.doi.org/10.1126/science.1164424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074350	Green Accepted			2022-12-28	WOS:000261608300045
J	Katikireddi, SV; Cloud, GC				Katikireddi, Srinivasa Vittal; Cloud, Geoffrey Christopher			Planning a patient's discharge from hospital	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSPECTIVE AUDIT; MEDICAL PATIENTS; READMISSION; CARE; RISK		[Katikireddi, Srinivasa Vittal] NHS Lothian, Edinburgh EH8 9RS, Midlothian, Scotland; [Cloud, Geoffrey Christopher] Univ London St Georges Hosp, Dept Clin Neurosci, London SW17 0QT, England	St Georges University London	Katikireddi, SV (corresponding author), NHS Lothian, Edinburgh EH8 9RS, Midlothian, Scotland.	vkatikireddi@yahoo.co.uk		Katikireddi, Srinivasa/0000-0001-6593-9092; Cloud, Geoffrey/0000-0002-8365-6907				Abramson J S, 1993, Health Soc Work, V18, P57; BOULT C, 1993, J AM GERIATR SOC, V41, P811, DOI 10.1111/j.1532-5415.1993.tb06175.x; Brown A, 1999, J SOC ADMIN PHARM, V16, P199; *CAR ENGL, 2002, HOSP DISCH PRACT BRI; Carers UK, 2007, REAL CHANG NOT SHORT; Chu LW, 1999, GERONTOLOGY, V45, P220, DOI 10.1159/000022091; Dawson R, 1998, ANN ROY COLL SURG, V80, P229; *DEP HLTH, 2007, NAT FRAM NHS CONT HE; *DEP HLTH, 2003, DISCH HOSP PATHW PRO; Kwok T, 1999, J ROY COLL PHYS LOND, V33, P153; Macaulay EM, 1996, BRIT J SURG, V83, P788, DOI 10.1002/bjs.1800830619; Melis RJF, 2004, BRIT MED J, V329, P360, DOI 10.1136/bmj.329.7462.360; Nazareth I, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.1.33; SACHS SB, 2000, NURS PRACT FORUM, V11, P65; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; *SIGN, 2003, 65 SIGN; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206	17	12	13	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 12	2008	337								a2694	10.1136/bmj.a2694	http://dx.doi.org/10.1136/bmj.a2694			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CC	19074562				2022-12-28	WOS:000262777000002
J	Zhang, XQ; Chen, SH; Yoo, S; Chakrabarti, S; Zhang, T; Ke, T; Oberti, C; Yong, SL; Fang, F; Li, L; de la Fuente, R; Wang, LJ; Chen, QY; Wang, QK				Zhang, Xianqin; Chen, Shenghan; Yoo, Shin; Chakrabarti, Susmita; Zhang, Teng; Ke, Tie; Oberti, Carlos; Yong, Sandro L.; Fang, Fang; Li, Lin; de la Fuente, Roberto; Wang, Lejin; Chen, Qiuyun; Wang, Qing Kenneth			Mutation in Nuclear Pore Component NUP155 Leads to Atrial Fibrillation and Early Sudden Cardiac Death	CELL			English	Article							NATRIURETIC-PEPTIDE; COMPLEX PROTEIN; SCN5A MUTATION; MESSENGER-RNA; HEAT-SHOCK; GENE; ASSOCIATION; ENVELOPE; GENOME; HEAT-SHOCK-PROTEIN-70	Atrial fibrillation (AF) is the most common form of sustained clinical arrhythmia. We previously mapped an AF locus to chromosome 5p13 in an AF family with sudden death in early childhood. Here we show that the specific AF gene underlying this linkage is NUP155, which encodes a member of the nucleoporins, the components of the nuclear pore complex (NPC). We have identified a homozygous mutation, R391H, in NUP155 that cosegregates with AF, affects nuclear localization of NUP155, and reduces nuclear envelope permeability. Homozygous NUP155(-/-) knockout mice die before E8.5, but heterozygous NUP155(+/-) mice show the AF phenotype. The R391H mutation and reduction of NUP155 are associated with inhibition of both export of Hsp70 mRNA and nuclear import of Hsp70 protein. These human and mouse studies indicate that loss of NUP155 function causes AF by altering mRNA and protein transport and link the NPC to cardiovascular disease.	[Zhang, Xianqin; Chen, Shenghan; Yoo, Shin; Chakrabarti, Susmita; Zhang, Teng; Ke, Tie; Oberti, Carlos; Yong, Sandro L.; Fang, Fang; Li, Lin; Wang, Lejin; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Lerner Coll Med,Ctr Cardiovasc Genet, Cleveland Clin,Lerner Res Inst,Dept Mol Cardiol, Dept Mol Med,Taussig Canc Ctr,Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Zhang, Xianqin; Ke, Tie; Wang, Lejin; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Zhang, Xianqin; Ke, Tie; Wang, Lejin; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Oberti, Carlos; de la Fuente, Roberto] Osped Italiano Umberto I, Dept Cardiol, Montevideo 11600, Uruguay; [Fang, Fang; Wang, Qing Kenneth] Cleveland State Univ, Dept Chem, Cleveland, OH 44107 USA	Case Western Reserve University; Cleveland Clinic Foundation; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Ohio; Cleveland State University	Wang, QK (corresponding author), Case Western Reserve Univ, Lerner Coll Med,Ctr Cardiovasc Genet, Cleveland Clin,Lerner Res Inst,Dept Mol Cardiol, Dept Mol Med,Taussig Canc Ctr,Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wangq2@ccf.org	Chakrabarti, Susmita/CAH-2331-2022; zhang, xianqin/GYE-0638-2022; Ke, Tie/AIC-5771-2022	Chakrabarti, Susmita/0000-0003-1197-2780; Ke, Tie/0000-0002-8888-8424				Afzal AR, 2008, CARDIOLOGY, V110, P45, DOI 10.1159/000109406; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Chou CC, 2008, CONTEMP CARDIOL, P101, DOI 10.1007/978-1-59745-163-5_8; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Ehrlich JR, 2008, CONTEMP CARDIOL, P37, DOI 10.1007/978-1-59745-163-5_4; Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grote P, 2006, NAT PROTOC, V1, P3034, DOI 10.1038/nprot.2006.460; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Kampinga HH, 2007, CELL STRESS CHAPERON, V12, P97, DOI 10.1379/CSC-285.1; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kim YK, 2006, CIRCULATION, V113, P2589, DOI 10.1161/CIRCULATIONAHA.105.598409; Knight BP, 2003, PACE, V26, P1620, DOI 10.1046/j.1460-9592.2003.t01-1-00241.x; Laramie JM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-17; Mandal K, 2005, ANN THORAC SURG, V79, P865, DOI 10.1016/j.athoracsur.2004.08.018; Nattel S, 1999, CARDIOVASC RES, V42, P298, DOI 10.1016/S0008-6363(99)00022-X; Oberti C, 2004, CIRCULATION, V110, P3753, DOI 10.1161/01.CIR.0000150333.87176.C7; Peters NS, 2002, LANCET, V359, P593, DOI 10.1016/S0140-6736(02)07748-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RADU A, 1993, J CELL BIOL, V121, P1, DOI 10.1083/jcb.121.1.1; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Rose RA, 2004, AM J PHYSIOL-HEART C, V286, pH1970, DOI 10.1152/ajpheart.00893.2003; Savelieva I, 2004, EUROPACE, V5, pS5, DOI 10.1016/j.eupc.2004.07.003; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; St Rammos K, 2002, CARDIOVASC SURG, V10, P228; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Van Wagoner DR, 2000, J MOL CELL CARDIOL, V32, P1101, DOI 10.1006/jmcc.2000.1147; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang QK, 2008, CONTEMP CARDIOL, P133, DOI 10.1007/978-1-59745-163-5_10; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yong SRL, 2007, BIOCHEM BIOPH RES CO, V352, P378, DOI 10.1016/j.bbrc.2006.11.019; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhang T, 2007, BIOCHEM BIOPH RES CO, V355, P444, DOI 10.1016/j.bbrc.2007.01.170; Zhang XQ, 2002, GENE, V288, P9, DOI 10.1016/S0378-1119(02)00470-5; Zhang XQ, 1999, GENOMICS, V57, P144, DOI 10.1006/geno.1999.5741	45	204	214	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1017	1027		10.1016/j.cell.2008.10.022	http://dx.doi.org/10.1016/j.cell.2008.10.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070573	Bronze			2022-12-28	WOS:000261642800018
J	Calais, E; d'Oreye, N; Albaric, J; Deschamps, A; Delvaux, D; Deverchere, J; Ebinger, C; Ferdinand, RW; Kervyn, F; Macheyeki, AS; Oyen, A; Perrot, J; Saria, E; Smets, B; Stamps, DS; Wauthier, C				Calais, Eric; d'Oreye, Nicolas; Albaric, Julie; Deschamps, Anne; Delvaux, Damien; Deverchere, Jacques; Ebinger, Cynthia; Ferdinand, Richard W.; Kervyn, Francois; Macheyeki, Athanas S.; Oyen, Anneleen; Perrot, Julie; Saria, Elifuraha; Smets, Benoit; Stamps, D. Sarah; Wauthier, Christelle			Strain accommodation by slow slip and dyking in a youthful continental rift, East Africa	NATURE			English	Article							SOUTHERN KENYA RIFT; MAGMA ACCUMULATION; SURFACE UPLIFT; 1960 COLLAPSE; VOLCANO; DEFORMATION; SUBSIDENCE; VOLUME; MANTLE	Continental rifts begin and develop through repeated episodes of faulting and magmatism, but strain partitioning between faulting and magmatism during discrete rifting episodes remains poorly documented. In highly evolved rifts, tensile stresses from far-field plate motions accumulate over decades before being released during relatively short time intervals by faulting and magmatic intrusions(1-3). These rifting crises are rarely observed in thick lithosphere during the initial stages of rifting. Here we show that most of the strain during the July - August 2007 seismic crisis in the weakly extended Natron rift, Tanzania, was released aseismically. Deformation was achieved by slow slip on a normal fault that promoted subsequent dyke intrusion by stress unclamping. This event provides compelling evidence for strain accommodation by magma intrusion, in addition to slip along normal faults, during the initial stages of continental rifting and before significant crustal thinning.	[Calais, Eric; Stamps, D. Sarah] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47906 USA; [d'Oreye, Nicolas; Oyen, Anneleen] Natl Museum Nat Hist, Dept Geophys Astrophys, L-2160 Luxembourg, Luxembourg; [Albaric, Julie; Deverchere, Jacques; Perrot, Julie] Univ Bretagne Occidentale, Inst Univ Europeen Mer, F-29280 Plouzane, France; [Deschamps, Anne] Geosci Azur, CNRS, UNS, F-06560 Valbonne, France; [Delvaux, Damien; Kervyn, Francois; Smets, Benoit; Wauthier, Christelle] Royal Museum Cent Africa, B-3080 Tervuren, Belgium; [Ebinger, Cynthia] Univ Rochester, Dept Earth & Environm Sci, New York, NY 14627 USA; [Ferdinand, Richard W.] Univ Dar Es Salaam, Dept Geol, Dar Es Salaam, Tanzania; [Macheyeki, Athanas S.] Univ Ghent, Dept Soil Sci & Geol, Renard Ctr Marine Geol, B-9000 Ghent, Belgium; [Macheyeki, Athanas S.] Mineral Resources Madini Inst, Dodoma, Tanzania; [Oyen, Anneleen] Delft Univ Technol, NL-2600 Delft, Netherlands; [Saria, Elifuraha] Ardhi Univ, Dept Geomatics, Dar Es Salaam, Tanzania; [Wauthier, Christelle] Univ Liege, B-4000 Liege, Belgium	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Royal Museum for Central Africa; University of Rochester; University of Dar es Salaam; Ghent University; Delft University of Technology; University of Liege	Calais, E (corresponding author), Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47906 USA.	ecalais@purdue.edu	Déverchère, Jacques/A-8170-2010; d'Oreye, Nicolas/I-6906-2013; Deschamps, Anne/B-9433-2012; Calais, Eric/K-8219-2012; Perrot, Julie/A-7160-2010	d'Oreye, Nicolas/0000-0002-3192-448X; Deschamps, Anne/0000-0002-6209-9814; Calais, Eric/0000-0002-5935-8117; Albaric, Julie/0000-0001-7275-554X; Wauthier, Christelle/0000-0002-3767-8080; Ebinger, Cynthia/0000-0002-6211-3399; Stamps, D. Sarah/0000-0002-3531-1752; Deverchere, Jacques/0000-0001-5138-7821	US National Science Foundation [EAR-0801801, EAR-0538119]; French INSU-CNRS DyETI programme; Belgian Science Policy; SAMAAV and Rukwa; Division Of Earth Sciences [0801801] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); French INSU-CNRS DyETI programme; Belgian Science Policy(Belgian Federal Science Policy Office); SAMAAV and Rukwa; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Envisat/ASAR data were systematically programmed and acquired through the ESA Cat-1 project no. C1P.3224. Interferograms were computed using DORIS software ( Delft University of Technology). Precise orbits were provided by the Delft Institute of Earth Observation and Space Systems and ESA. We thank the Tanzania Survey and Mapping Department for their support of the October field expedition and the Tanzania Commission for Science and Technology. We thank V. Cayol and Y. Fukushima for their contribution in analysing the ground deformations, F. Paganelli, J. Biggs and J. Keller for discussions and K. Feigl and F. Sigmundsson for their comments. We acknowledge support from the US National Science Foundation under grants EAR-0801801 and EAR-0538119, from the French INSU-CNRS DyETI programme and from the Belgian Science Policy under projects SAMAAV and Rukwa.	Amelung F, 2007, SCIENCE, V316, P1026, DOI 10.1126/science.1140035; Baer G, 2008, EARTH PLANET SC LETT, V272, P339, DOI 10.1016/j.epsl.2008.04.052; Birt CS, 1997, TECTONOPHYSICS, V278, P211, DOI 10.1016/S0040-1951(97)00105-4; Buck WR, 2004, MARG THEOR EXP EARTH, P1; Cattin R, 2005, EARTH PLANET SC LETT, V239, P352, DOI 10.1016/j.epsl.2005.07.028; Cayol V, 1998, J GEOPHYS RES-SOL EA, V103, P18025, DOI 10.1029/98JB00201; DAWSON JB, 1968, GEOL RUNDSCH, V57, P865; DELANEY PT, 1994, B VOLCANOL, V56, P417, DOI 10.1007/BF00302823; Ebinger C, 1997, J GEOL SOC LONDON, V154, P947, DOI 10.1144/gsjgs.154.6.0947; GREEN WV, 1991, NATURE, V354, P199, DOI 10.1038/354199a0; HEKI K, 1993, J GEOPHYS RES-SOL EA, V98, P14279, DOI 10.1029/93JB00781; Ibs-von Seht M, 2001, GEOPHYS J INT, V146, P439, DOI 10.1046/j.0956-540x.2001.01464.x; Johnson DJ, 2000, B VOLCANOL, V61, P491, DOI 10.1007/s004450050006; Lienert B. R. E., 1995, SEISMOL RES LETT, V66, P26, DOI DOI 10.1785/GSSRL.66.5.26; Massonnet D, 1998, REV GEOPHYS, V36, P441, DOI 10.1029/97RG03139; Nishimura T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019810; Nyblade A.A., 1996, EOS T AM GEOPHYS UN, V77, P517, DOI [10.1029/96EO00339, DOI 10.1029/96EO00339, DOI 10.1029/96E000339]; Nyblade AA, 2000, GEOLOGY, V28, P599; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; PRODEHL C, 1991, NATURE, V354, P223, DOI 10.1038/354223a0; RUBIN AM, 1992, J GEOPHYS RES-SOL EA, V97, P1839, DOI 10.1029/91JB02170; Stamps DS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032781; TONGUE J, 1994, TECTONOPHYSICS, V236, P151, DOI 10.1016/0040-1951(94)90174-0; Vauchez A, 2005, EARTH PLANET SC LETT, V232, P295, DOI 10.1016/j.epsl.2005.01.024; Vaughan RG, 2008, J VOLCANOL GEOTH RES, V173, P196, DOI 10.1016/j.jvolgeores.2008.01.028; Wright TJ, 2006, NATURE, V442, P291, DOI 10.1038/nature04978	28	154	156	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					783	U67		10.1038/nature07478	http://dx.doi.org/10.1038/nature07478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079058	Green Published			2022-12-28	WOS:000261559900047
J	Donnelly, P				Donnelly, Peter			Progress and challenges in genome-wide association studies in humans	NATURE			English	Article							SUSCEPTIBILITY LOCI; PROSTATE-CANCER; BREAST-CANCER; VARIANTS; DISEASE; RISK; REPLICATION; HEIGHT	After more than a decade of hope and hype, researchers are finally making inroads into understanding the genetic basis of many common human diseases. The use of genome- wide association studies has broken the logjam, enabling genetic variants at specific loci to be associated with particular diseases. Genetic association data are now providing new routes to understanding the aetiology of disease, as well as new footholds on the long and difficult path to better treatment and disease prevention.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	peter.donnelly@well.ox.ac.uk		Donnelly, Peter/0000-0001-9495-3408				Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; ORAHILLY SP, 1986, LANCET, V2, P360; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	20	251	262	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					728	731		10.1038/nature07631	http://dx.doi.org/10.1038/nature07631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079049				2022-12-28	WOS:000261559900036
J	Fallani, L; Inguscio, M				Fallani, L.; Inguscio, M.			PHYSICS Controlling Cold-Atom Conductivity	SCIENCE			English	Editorial Material							ANDERSON LOCALIZATION; MOTT INSULATOR; LATTICES; GASES		[Fallani, L.; Inguscio, M.] Univ Florence, LENS European Lab Nonlinear Spect, Dipartimento Fis, I-50019 Sesto Fiorentino, FI, Italy; [Fallani, L.; Inguscio, M.] CNR, INFM, I-50019 Sesto Fiorentino, FI, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Fallani, L (corresponding author), Univ Florence, LENS European Lab Nonlinear Spect, Dipartimento Fis, Via Nello Carrara 1, I-50019 Sesto Fiorentino, FI, Italy.	fallani@lens.unifi.it; inguscio@lens.unifi.it	Fallani, Leonardo/GXN-0557-2022; Fallani, Leonardo/C-5347-2008	Fallani, Leonardo/0000-0001-5327-3254; Fallani, Leonardo/0000-0001-5327-3254; Inguscio, Massimo/0000-0001-8152-8103				ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Inguscio M., 2008, ULTRA COLD FERMI GAS, V164; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Kleppner D, 2004, PHYS TODAY, V57, P12, DOI 10.1063/1.1801843; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Modugno G, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.011601; Mott N.F., 1990, METAL INSULATOR TRAN; Pezze L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.120401; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449	16	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1480	1481		10.1126/science.1166914	http://dx.doi.org/10.1126/science.1166914			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056966				2022-12-28	WOS:000261377400029
J	Zaret, KS; Grompe, M				Zaret, Kenneth S.; Grompe, Markus			Generation and Regeneration of Cells of the Liver and Pancreas	SCIENCE			English	Review							EPITHELIAL PROGENITOR CELLS; INSULIN GENE-TRANSCRIPTION; EMBRYONIC STEM-CELLS; BETA-CELLS; ALAGILLE-SYNDROME; ENDODERM; DIFFERENTIATION; ENDOCRINE; ZEBRAFISH; SIGNALS	Liver and pancreas progenitors develop from endoderm cells in the embryonic foregut. Shortly after their specification, liver and pancreas progenitors rapidly acquire markedly different cellular functions and regenerative capacities. These changes are elicited by inductive signals and genetic regulatory factors that are highly conserved among vertebrates. Interest in the development and regeneration of the organs has been fueled by the intense need for hepatocytes and pancreatic beta cells in the therapeutic treatment of liver failure and type I diabetes. Studies in diverse model organisms have revealed evolutionarily conserved inductive signals and transcription factor networks that elicit the differentiation of liver and pancreatic cells and provide guidance for how to promote hepatocyte and b cell differentiation from diverse stem and progenitor cell types.	[Zaret, Kenneth S.] Fox Chase Canc Ctr, Epigenet & Progenitor Cells Program, Philadelphia, PA 19111 USA; [Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA; [Grompe, Markus] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA	Fox Chase Cancer Center; Oregon Health & Science University; Oregon Health & Science University	Zaret, KS (corresponding author), Fox Chase Canc Ctr, Epigenet & Progenitor Cells Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	zaret@fccc.edu		Grompe, Markus/0000-0002-6616-4345	NIH [R37 GM36477, U01 DK072503, P30CA06927, U01 DK072477, ROI DK05192]; Juvenile Diabetes Research Foundation [18508680-36749]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051592, U01DK072477, U01DK072503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036477, R37GM036477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to many in the field whose work we could not cite because of space constraints. We thank D. Freedman-Cass for comments and E. Pytko for help in preparing the manuscript. K.S.Z. is supported by NIH grants R37 GM36477, U01 DK072503, and P30CA06927, and M. G. by grants U01 DK072477 and ROI DK05192 and Juvenile Diabetes Research Foundation grant 18508680-36749. The authors have patents pending related to the work in this article. M.G. is a cofounder of DNA Repair Company and the founder of Yecuris and has equities in both. K.S.Z. is on a scientific advisory board for Johnson and Johnson.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Chalmers AD, 2000, DEVELOPMENT, V127, P381; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Chung WS, 2008, DEV CELL, V14, P582, DOI 10.1016/j.devcel.2008.02.012; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dabeva MD, 1997, P NATL ACAD SCI USA, V94, P7356, DOI 10.1073/pnas.94.14.7356; Deutsch G, 2001, DEVELOPMENT, V128, P871; diIorio P, 2007, DEV BIOL, V304, P221, DOI 10.1016/j.ydbio.2006.12.024; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dorrell C, 2008, HEPATOLOGY, V48, P1282, DOI 10.1002/hep.22468; Edsbagge J, 2005, DEVELOPMENT, V132, P1085, DOI 10.1242/dev.01643; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; KVITTINGEN EA, 1994, J CLIN INVEST, V94, P1657, DOI 10.1172/JCI117509; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; LEDOUARIN N, 1964, B BIOL FRANCE BELGIQ, V98, P543; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; Manfroid I, 2007, DEVELOPMENT, V134, P4011, DOI 10.1242/dev.007823; Margagliotti S, 2007, DEV BIOL, V311, P579, DOI 10.1016/j.ydbio.2007.09.013; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; McCright B, 2002, DEVELOPMENT, V129, P1075; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Offield MF, 1996, DEVELOPMENT, V122, P983; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; REDDY JK, 1991, DIGEST DIS SCI, V36, P502, DOI 10.1007/BF01298883; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Roy S, 2001, CURR BIOL, V11, P1358, DOI 10.1016/S0960-9822(01)00402-X; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; SHAPIRO AM, 2000, J NEW ENG MED, V343, P230; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Wells JM, 2000, DEVELOPMENT, V127, P1563; WESSELLS NK, 1967, DEV BIOL, V15, P237, DOI 10.1016/0012-1606(67)90042-5; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yoshitomi H, 2004, DEVELOPMENT, V131, P807, DOI 10.1242/dev.00960; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	80	439	470	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1490	1494		10.1126/science.1161431	http://dx.doi.org/10.1126/science.1161431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056973	Green Accepted			2022-12-28	WOS:000261377400035
J	Gsponer, J; Futschik, ME; Teichmann, SA; Babu, MM				Gsponer, Jorg; Futschik, Matthias E.; Teichmann, Sarah A.; Babu, M. Madan			Tight Regulation of Unstructured Proteins: From Transcript Synthesis to Protein Degradation	SCIENCE			English	Article							INTRINSIC DISORDER; ALPHA-SYNUCLEIN; METABOLISM; P27(KIP1); BINDING; CANCER; P27	Altered abundance of several intrinsically unstructured proteins ( IUPs) has been associated with perturbed cellular signaling that may lead to pathological conditions such as cancer. Therefore, it is important to understand how cells precisely regulate the availability of IUPs. We observed that regulation of transcript clearance, proteolytic degradation, and translational rate contribute to controlling the abundance of IUPs, some of which are present in low amounts and for short periods of time. Abundant phosphorylation and low stochasticity in transcription and translation indicate that the availability of IUPs can be finely tuned. Fidelity in signaling may require that most IUPs be available in appropriate amounts and not present longer than needed.	[Gsponer, Jorg; Futschik, Matthias E.; Teichmann, Sarah A.; Babu, M. Madan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Futschik, Matthias E.] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Futschik, Matthias E.] Univ Algarve, Inst Biotechnol & Bioengn, Ctr Mol & Struct Biomed, P-8005139 Faro, Portugal	MRC Laboratory Molecular Biology; Humboldt University of Berlin; Universidade do Algarve	Gsponer, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	jgsponer@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019; Futschik, Matthias/AAK-8837-2020	Futschik, Matthias/0000-0002-6245-8071; Teichmann, Sarah/0000-0002-6294-6366	Royal Society; MRC Special Training Fellowship; Medical Research Council [G0600158, MC_U105185859, MC_U105161047] Funding Source: researchfish; MRC [MC_U105185859, G0600158, MC_U105161047] Funding Source: UKRI	Royal Society(Royal Society of London); MRC Special Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge MRC for funding and thank the two anonymous referees, the editor, A. Bertolotti, A. Tzakos, A. Wuster, C. Brockmann, C. Chothia, D. Finley, D. Rubinsztein, E. Levy, H. McMahon, I. Schafer, J. Bui, K. Weber, M. Goedert, R. Janky, S. Michnick, and S. Sarkar for providing helpful comments. We apologize for, because of lack of space, not citing the work that describes the datasets and other references. Many can be found in the SOM. M.M.B. acknowledges Darwin College and Schlumberger Ltd, and M.M.B. and M.E.F. acknowledge the Royal Society for support. J.G. is funded by an MRC Special Training Fellowship in computational biology.	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Mathes E, 2008, EMBO J, V27, P1421, DOI 10.1038/emboj.2008.91; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Tambyrajah WS, 2007, ARCH BIOCHEM BIOPHYS, V466, P186, DOI 10.1016/j.abb.2007.07.019; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	29	347	350	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1365	1368		10.1126/science.1163581	http://dx.doi.org/10.1126/science.1163581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039133	Green Submitted, Green Accepted			2022-12-28	WOS:000261170600035
J	Vijg, J; Maslov, AY; Suh, Y				Vijg, Jan; Maslov, Alexander Y.; Suh, Yousin			Aging: A Sirtuin Shake-Up?	CELL			English	Editorial Material							DNA-DAMAGE RESPONSE; TUMORIGENESIS; DEACETYLASE; MICE	The yeast sirtuin (Sir2) is a histone deacetylase that modulates yeast replicative life span by suppressing genome instability through chromatin modification. In this issue, Oberdoerffer et al. (2008) report that SIRT1, the mammalian ortholog of Sir2, is involved in DNA damage-induced chromatin reorganization, which promotes genome stability in mammalian cells.	[Vijg, Jan; Maslov, Alexander Y.; Suh, Yousin] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Suh, Yousin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.	jvijg@aecom.yu.edu	Maslov, Alexander/AAH-3788-2019					Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Polo SE, 2007, CELL CYCLE, V6, P2355, DOI 10.4161/cc.6.19.4756; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Yuan Z, 2007, CELL CYCLE, V6, P2869, DOI 10.4161/cc.6.23.5026	9	17	18	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					797	798		10.1016/j.cell.2008.11.008	http://dx.doi.org/10.1016/j.cell.2008.11.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041745	Bronze			2022-12-28	WOS:000261183900012
J	Hishida, T; Kubota, Y; Carr, AM; Iwasaki, H				Hishida, Takashi; Kubota, Yoshino; Carr, Antony M.; Iwasaki, Hiroshi			RAD6-RAD18-RAD5-pathway-dependent tolerance to chronic low-dose ultraviolet light	NATURE			English	Article							DNA-DAMAGE TOLERANCE; NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; BUDDING YEAST; REPLICATION; CHECKPOINT; PROTEIN; MECHANISMS; UBIQUITIN	In nature, organisms are exposed to chronic low- dose ultraviolet light ( CLUV) as opposed to the acute high doses common to laboratory experiments. Analysis of the cellular response to acute high-dose exposure has delineated the importance of direct DNA repair by the nucleotide excision repair pathway(1) and for checkpoint-induced cell cycle arrest in promoting cell survival(2). Here we examine the response of yeast cells to CLUV and identify a key role for the RAD6-RAD18-RAD5 error- free postreplication repair (RAD6 error-free PRR) pathway(3,4) in promoting cell growth and survival. We show that loss of the RAD6 error- free PRR pathway results in DNA-damage-checkpoint- induced G2 arrest in CLUV-exposed cells, whereas wild-type and nucleotide-excision-repair-deficient cells are largely unaffected. Cell cycle arrest in the absence of the RAD6 error- free PRR pathway was not caused by a repair defect or by the accumulation of ultraviolet-induced photoproducts. Notably, we observed increased replication protein A (RPA) and Rad52 - yellow fluorescent protein foci(5) in the CLUV- exposed rad18 Delta cells and demonstrated that Rad52- mediated homologous recombination is required for the viability of the rad18 Delta cells after release from CLUV- induced G2 arrest. These and other data presented suggest that, in response to environmental levels of ultraviolet exposure, the RAD6 error- free PRR pathway promotes replication of damaged templates without the generation of extensive single- stranded DNA regions. Thus, the error- free PRR pathway is specifically important during chronic low- dose ultraviolet exposure to prevent counter- productive DNA checkpoint activation and allow cells to proliferate normally.	[Hishida, Takashi; Kubota, Yoshino] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Carr, Antony M.] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Iwasaki, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan	Osaka University; University of Sussex; Yokohama City University	Hishida, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hishida@biken.osaka-u.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873; Carr, Antony Michael/0000-0002-2028-2389; Hishida, Takashi/0000-0002-9752-6599	Sumitomo foundation; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; MRC (UK) [G0600233]; MRC [G0600233] Funding Source: UKRI; Medical Research Council [G0600233, G0300662B] Funding Source: researchfish	Sumitomo foundation; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Rothstein and H. Araki for strains; T. Matsunaga for anti- thymine dimer monoclonal antibody (designated TDM2 antibody); and T. Ohya for technical assistance. This work was supported by the Sumitomo foundation, by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the MRC (UK) grant G0600233.	Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; HARM W, 1969, RADIAT RES, V40, P63, DOI 10.2307/3572983; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Paciotti V, 2000, GENE DEV, V14, P2046; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Schepers A, 2001, J MOL BIOL, V308, P597, DOI 10.1006/jmbi.2001.4637; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	34	64	66	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					612	U124		10.1038/nature07580	http://dx.doi.org/10.1038/nature07580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19079240	Green Accepted			2022-12-28	WOS:000262852200048
J	Duckworth, W; Abraira, C; Moritz, T; Reda, D; Emanuele, N; Reaven, PD; Zieve, FJ; Marks, J; Davis, SN; Hayward, R; Warren, SR; Goldman, S; McCarren, M; Vitek, ME; Henderson, WG; Huang, GD				Duckworth, William; Abraira, Carlos; Moritz, Thomas; Reda, Domenic; Emanuele, Nicholas; Reaven, Peter D.; Zieve, Franklin J.; Marks, Jennifer; Davis, Stephen N.; Hayward, Rodney; Warren, Stuart R.; Goldman, Steven; McCarren, Madeline; Vitek, Mary Ellen; Henderson, William G.; Huang, Grant D.		VADT Investigators	Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; MACROVASCULAR DISEASE; ASSOCIATION; MELLITUS	Background The effects of intensive glucose control on cardiovascular events in patients with long-standing type 2 diabetes mellitus remain uncertain. Methods We randomly assigned 1791 military veterans ( mean age, 60.4 years) who had a suboptimal response to therapy for type 2 diabetes to receive either intensive or standard glucose control. Other cardiovascular risk factors were treated uniformly. The mean number of years since the diagnosis of diabetes was 11.5, and 40% of the patients had already had a cardiovascular event. The goal in the intensive- therapy group was an absolute reduction of 1.5 percentage points in the glycated hemoglobin level, as compared with the standard- therapy group. The primary outcome was the time from randomization to the first occurrence of a major cardiovascular event, a composite of myocardial infarction, stroke, death from cardiovascular causes, congestive heart failure, surgery for vascular disease, inoperable coronary disease, and amputation for ischemic gangrene. Results The median follow- up was 5.6 years. Median glycated hemoglobin levels were 8.4% in the standard- therapy group and 6.9% in the intensive- therapy group. The primary outcome occurred in 264 patients in the standard- therapy group and 235 patients in the intensive- therapy group (hazard ratio in the intensive- therapy group, 0.88; 95% confidence interval [CI], 0.74 to 1.05; P = 0.14). There was no significant difference between the two groups in any component of the primary outcome or in the rate of death from any cause ( hazard ratio, 1.07; 95% CI, 0.81 to 1.42; P = 0.62). No differences between the two groups were observed for microvascular complications. The rates of adverse events, predominantly hypoglycemia, were 17.6% in the standard- therapy group and 24.1% in the intensive- therapy group. Conclusions Intensive glucose control in patients with poorly controlled type 2 diabetes had no significant effect on the rates of major cardiovascular events, death, or microvascular complications. (ClinicalTrials. gov number, NCT00032487.).	[Duckworth, William; Reaven, Peter D.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ 85012 USA; [Abraira, Carlos; Marks, Jennifer] Vet Affairs Med Ctr, Miami, FL 33125 USA; [Moritz, Thomas; Reda, Domenic; McCarren, Madeline; Vitek, Mary Ellen; Henderson, William G.] Hines VA Cooperat Studies Program Coordinating Ct, Hines, IL USA; [Emanuele, Nicholas] Edward Hines Jr VA Hosp, Hines, IL 60141 USA; [Zieve, Franklin J.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Davis, Stephen N.] Tennessee Valley Hlth Care Syst, Nashville, TN USA; [Hayward, Rodney] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Warren, Stuart R.] VA Cooperat Studies Program Clin Res Pharm Coordi, Albuquerque, NM USA; [Goldman, Steven] So Arizona VA Hlth Care Syst, Tucson, AZ USA; [Huang, Grant D.] VA Off Res & Dev, Cooperat Studies Program Cent Off, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Hunter Holmes McGuire Veterinary Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System	Duckworth, W (corresponding author), Phoenix Vet Affairs Hlth Care Syst, 650 E Indian Sch Rd, Phoenix, AZ 85012 USA.	william.duckworth@va.gov	Greiver, Michelle/N-8764-2015; Bajaj, Mandeep/B-6060-2009	Greiver, Michelle/0000-0001-8957-0285; , Domenic/0000-0003-1831-4270	Veterans Affairs Cooperative Studies Program; Department of Veterans Affairs Office of Research and Development; American Diabetes Association; National Eye Institute; GlaxoSmithKline; Novo Nordisk; Roche Diagnostics; Sanofi-Aventis; Amylin; Kos Pharmaceuticals; Caremark; Takeda; Takeda Pharmaceuticals; Merck; Pfizer; Eli Lilly; Johnson Johnson; Hoffmann-La Roche; Mannkind; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Veterans Affairs Cooperative Studies Program(US Department of Veterans Affairs); Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); American Diabetes Association(American Diabetes Association); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Roche Diagnostics; Sanofi-Aventis(Sanofi-Aventis); Amylin; Kos Pharmaceuticals; Caremark; Takeda(Takeda Pharmaceutical Company Ltd); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Merck(Merck & Company); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Hoffmann-La Roche(Hoffmann-La Roche); Mannkind; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Veterans Affairs Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development; the American Diabetes Association; and the National Eye Institute. Pharmaceutical and other supplies and financial assistance were provided by GlaxoSmithKline, Novo Nordisk, Roche Diagnostics, Sanofi-Aventis, Amylin, and Kos Pharmaceuticals.; Dr. Duckworth reports receiving consulting fees from Novo Nordisk, GlaxoSmithKline, and Caremark and lecture fees from Sanofi-Aventis; Dr. Abraira, receiving lecture fees from SanofiAventis and Takeda; Dr. Reaven, receiving consulting and lecture fees from Takeda Pharmaceuticals and grant support from Takeda Pharmaceuticals and Amylin and having an equity interest in Merck, Pfizer, Eli Lilly, and Johnson & Johnson; Dr. Zieve, receiving lecture fees from GlaxoSmithKline and Kos Pharmaceuticals and grant support from Kos Pharmaceuticals, GlaxoSmithKline, Hoffmann-La Roche, Amylin Pharmaceuticals, and Novo Nordisk; Dr. Marks, receiving consulting fees from Eli Lilly and Novo Nordisk, lecture fees from Pfizer, Merck, and Takeda, and grant support from Eli Lilly, Mannkind, Merck, and Pfizer; and Dr. Davis, receiving consulting fees and grant support from Sanofi- Aventis and Amylin and lecture fees from Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.; We thank coordinators Susan Collier and Christina Paul for their help in the preparation of the manuscript and Rebecca Miller for assistance in the preparation of the final draft and for her consistent support throughout the study.	Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; Abraira C, 2003, J DIABETES COMPLICAT, V17, P314, DOI 10.1016/S1056-8727(02)00277-5; ABRAIRA C, 2008, DIABETES OBES METAB; Abraira C, 2003, CLIN DIABETES, V21, P107, DOI [DOI 10.2337/DIACLIN.21.3.107, 10.2337/diaclin.21.3.107]; American Diabetes Association, 2002, DIABETES CARE S1, V25, pS33, DOI DOI 10.2337/DIACARE.25.2007.S33; Duckworth William C, 2006, Endocr Pract, V12 Suppl 1, P85; Emanuele N, 2005, DIABETES CARE, V28, P1954, DOI 10.2337/diacare.28.8.1954; EMANUELE N, 2008, J DIABETES COMP 0410; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; HALPERN J, 1987, CONTROL CLIN TRIALS, V8, P177, DOI 10.1016/0197-2456(87)90043-2; HENDERSON WG, 1991, CONTROL CLIN TRIALS, V12, P304, DOI 10.1016/0197-2456(91)90027-J; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kirkman MS, 2006, J DIABETES COMPLICAT, V20, P75, DOI 10.1016/j.jdiacomp.2005.06.013; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; SHAMOON H, 1995, ARCH OPHTHALMOL-CHIC, V113, P36; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shichiri M, 2000, DIABETES CARE, V23, pB21; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UKPDS GROUP, 1999, BMJ-BRIT MED J, V318, P29; 1985, ARCH OPHTHALMOL-CHIC, V103, P1796	28	3358	3552	3	191	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					129	U62		10.1056/NEJMoa0808431	http://dx.doi.org/10.1056/NEJMoa0808431			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19092145	Bronze			2022-12-28	WOS:000262258300006
J	Nickel, JC; Krieger, JN; McNaughton-Collins, M; Anderson, RU; Pontari, M; Shoskes, DA; Litwin, MS; Alexander, RB; White, PC; Berger, R; Nadler, R; O'Leary, M; Liong, ML; Zeitlin, S; Chuai, S; Landis, JR; Kusek, JW; Nyberg, LM; Schaeffer, AJ				Nickel, J. Curtis; Krieger, John N.; McNaughton-Collins, Mary; Anderson, Rodney U.; Pontari, Michel; Shoskes, Daniel A.; Litwin, Mark S.; Alexander, Richard B.; White, Paige C.; Berger, Richard; Nadler, Robert; O'Leary, Michael; Liong, Men Long; Zeitlin, Scott; Chuai, Shannon; Landis, J. Richard; Kusek, John W.; Nyberg, Leroy M.; Schaeffer, Anthony J.		Chronic Prostatitis Collaborative	Alfuzosin and Symptoms of Chronic Prostatitis-Chronic Pelvic Pain Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; DOUBLE-BLIND; ALPHA-BLOCKERS; MEN; MULTICENTER; THERAPY; INDEX; ANTAGONISTS; TAMSULOSIN; IMPACT	Background: In men with chronic prostatitis-chronic pelvic pain syndrome, treatment with alpha-adrenergic receptor blockers early in the course of the disorder has been reported to be effective in some, but not all, relatively small randomized trials. Methods: We conducted a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of alfuzosin, an alpha-adrenergic receptor blocker, in reducing symptoms in men with chronic prostatitis-chronic pelvic pain syndrome. Participation in the study required diagnosis of the condition within the preceding 2 years and no previous treatment with an alpha-adrenergic receptor blocker. Men were randomly assigned to treatment for 12 weeks with either 10 mg of alfuzosin per day or placebo. The primary outcome was a reduction of at least 4 points (from baseline to 12 weeks) in the score on the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) (range, 0 to 43; higher scores indicate more severe symptoms). A 4-point decrease is the minimal clinically significant difference in the score. Results: A total of 272 eligible participants underwent randomization, and in both study groups, 49.3% of participants had a decrease of at least 4 points in their total NIH-CPSI score (rate difference associated with alfuzosin, 0.1%; 95% confidence interval, -11.2 to 11.0; P=0.99). In addition, a global response assessment showed similar response rates at 12 weeks: 33.6% in the placebo group and 34.8% in the alfuzosin group (P=0.90). The rates of adverse events in the two groups were also similar. Conclusions: Our findings do not support the use of alfuzosin to reduce the symptoms of chronic prostatitis-chronic pelvic pain syndrome in men who have not received prior treatment with an alpha-blocker. (ClinicalTrials.gov number, NCT00103402.).	[Nickel, J. Curtis] Queens Univ, Kingston Gen Hosp, Dept Urol, Kingston, ON K7L 2V7, Canada; [Nickel, J. Curtis] Queens Univ, Dept Urol, Kingston, ON, Canada; [Krieger, John N.; Berger, Richard] Univ Washington, Dept Urol, Seattle, WA USA; [McNaughton-Collins, Mary] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Anderson, Rodney U.] Stanford Univ, Med Ctr, Dept Urol, Stanford, CA 94305 USA; [Pontari, Michel] Temple Univ, Dept Urol, Philadelphia, PA 19122 USA; [Shoskes, Daniel A.] Cleveland Clin, Glickman Urol Inst, Cleveland, OH 44106 USA; [Litwin, Mark S.; Chuai, Shannon] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Litwin, Mark S.; Chuai, Shannon] Univ Calif Los Angeles, David Geffen Sch Med, Dept Hlth Serv, Los Angeles, CA 90095 USA; [Litwin, Mark S.; Chuai, Shannon] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; [Alexander, Richard B.] Univ Maryland, Dept Urol, Baltimore, MD 21201 USA; [White, Paige C.] Univ Mississippi, Dept Surg, Jackson, MS 39216 USA; [Nadler, Robert; Schaeffer, Anthony J.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [O'Leary, Michael] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Liong, Men Long] Univ Sci Malaysia, George Town, Malaysia; [Zeitlin, Scott; Landis, J. Richard] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kusek, John W.; Nyberg, Leroy M.] NIDDKD, Bethesda, MD 20892 USA	Queens University - Canada; Queens University - Canada; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University System of Maryland; University of Maryland Baltimore; University of Mississippi; Northwestern University; Harvard University; Brigham & Women's Hospital; Universiti Sains Malaysia; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Nickel, JC (corresponding author), Queens Univ, Kingston Gen Hosp, Dept Urol, Kingston, ON K7L 2V7, Canada.	jcn@queensu.ca	mao, renxiang/H-3360-2013; Landis, J. Richard/A-9330-2010	Cheah, Phaik Yeong/0000-0001-6327-3266; Landis, J Richard/0000-0001-8099-0988; Litwin, Mark/0000-0002-2318-344X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK065186, U01DK065189, U01DK065187, U01DK065268, U01DK065297, U01DK065257, U01DK065174, U01DK065266, U01DK065287, U01DK065277, U01DK065209] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK065186-05, U01 DK065209-05, U01 DK065209-04S2, U01 DK065277-05, U01 DK065209-03S1, U01 DK065187, U01 DK065277, U01 DK065209, U01 DK65209, U01 DK065209-06, U01 DK065266, U01 DK65187, U01 DK65287, U01 DK065209-03S2, U01 DK65266, U01 DK65186, U01 DK065209-02, U01 DK65277, U01 DK065186, U01 DK065209-05S1, U01 DK065287-03, U01 DK65189, U01 DK065297-05, U01 DK065209-04S1, U01 DK065268, U01 DK065287, U01 DK065189, U01 DK065257, U01 DK65297, U01 DK65257, U01 DK065209-03, U01 DK065187-05, U01 DK065209-04, U01 DK065174-05, U01 DK065209-01, U01 DK65268, U01 DK65174, U01 DK065268-05, U01 DK065209-02S1, U01 DK065266-05, U01 DK065257-05, U01 DK065189-06, U01 DK065174, U01 DK065297] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander RB, 2004, ANN INTERN MED, V141, P581, DOI 10.7326/0003-4819-141-8-200410190-00005; Andersson KE, 2007, NAT CLIN PRACT UROL, V4, P368, DOI 10.1038/ncpuro0836; AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calhoun EA, 2004, ARCH INTERN MED, V164, P1231; Cheah PY, 2003, J UROLOGY, V169, P592, DOI 10.1016/S0022-5347(05)63960-2; CLEMENS JQ, 2007, J UROL S4, V177, P30; Collins MM, 2001, J GEN INTERN MED, V16, P656; COLLINS MM, 2004, UROLOGIC DIS AM, P9; Cox D. R., 1984, ANAL SURVIVAL DATA; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Mehik A, 2003, UROLOGY, V62, P425, DOI 10.1016/S0090-4295(03)00466-7; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mishra VC, 2007, J UROLOGY, V177, P25, DOI 10.1016/j.juro.2006.08.090; NCI, 2006, COMM TERM CRIT ADV E; Nickel JC, 2008, BJU INT, V101, P59, DOI 10.1111/j.1464-410X.2007.07196.x; Nickel JC, 2004, BJU INT, V94, P1230, DOI 10.1111/j.1464-410X.2004.05148.x; Nickel JC, 2004, J UROLOGY, V171, P1594, DOI 10.1097/01.ju.0000117811.40279.19; Nickel JC, 2003, UROLOGY, V62, P614, DOI 10.1016/S0090-4295(03)00583-1; Nickel JC, 2003, J UROLOGY, V169, P1401, DOI 10.1097/01.ju.0000054983.45096.16; Propert KJ, 2006, QUAL LIFE RES, V15, P299, DOI 10.1007/s11136-005-1317-1; Propert KJ, 2002, UROLOGY, V59, P870, DOI 10.1016/S0090-4295(02)01601-1; Roberts RO, 1998, UROLOGY, V51, P578, DOI 10.1016/S0090-4295(98)00034-X; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 2004, UROLOGY, V64, P777, DOI 10.1016/j.urology.2004.04.056; Schaeffer AJ, 2002, J UROLOGY, V168, P593, DOI 10.1016/S0022-5347(05)64686-1; Schaeffer AJ, 2006, NEW ENGL J MED, V355, P1690, DOI 10.1056/NEJMcp060423; Shaeffer AJ, 2006, MALE LOWER URINARY T, P341; Tugcu V, 2007, EUR UROL, V51, P1113, DOI 10.1016/j.eururo.2006.09.036; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Wenninger K, 1996, J UROLOGY, V155, P965, DOI 10.1016/S0022-5347(01)66359-6; Yang G, 2006, J ANDROL, V27, P847, DOI 10.2164/jandrol.106.000661; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	110	122	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2663	2673		10.1056/NEJMoa0803240	http://dx.doi.org/10.1056/NEJMoa0803240			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092152	Green Accepted			2022-12-28	WOS:000261757300006
J	Wellbery, C				Wellbery, Caroline			A Testy Experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												wellberc@georgetown.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2708	2708		10.1001/jama.2008.833	http://dx.doi.org/10.1001/jama.2008.833			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088340				2022-12-28	WOS:000261730400001
J	Chan, CE; Odde, DJ				Chan, Clarence E.; Odde, David J.			Traction Dynamics of Filopodia on Compliant Substrates	SCIENCE			English	Article							FOCAL ADHESIONS; GROWTH; ACTIN; FORCE; CELLS	Cells sense the environment's mechanical stiffness to control their own shape, migration, and fate. To better understand stiffness sensing, we constructed a stochastic model of the "motor-clutch" force transmission system, where molecular clutches link F-actin to the substrate and mechanically resist myosin- driven F- actin retrograde flow. The model predicts two distinct regimes: ( i) "frictional slippage," with fast retrograde flow and low traction forces on stiff substrates and ( ii) oscillatory "load-and-fail" dynamics, with slower retrograde flow and higher traction forces on soft substrates. We experimentally confirmed these model predictions in embryonic chick forebrain neurons by measuring the nanoscale dynamics of single- growth- cone filopodia. Furthermore, we experimentally observed a model- predicted switch in F- actin dynamics around an elastic modulus of 1 kilopascal. Thus, a motor- clutch system inherently senses and responds to the mechanical stiffness of the local environment.	[Chan, Clarence E.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Odde, DJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/AAY-1720-2020; Odde, David/H-4925-2011; Ladoux, Benoit/A-9879-2013	Odde, David/0000-0001-7731-2799; 	Institute for Engineering in Medicine at the University of Minnesota; NSF [MCB-0615568]; National Institute of General Medical Sciences [R01-GM-76177]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076177] Funding Source: NIH RePORTER	Institute for Engineering in Medicine at the University of Minnesota(University of Minnesota System); NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Institute for Engineering in Medicine at the University of Minnesota, NSF (grant MCB-0615568), and the National Institute of General Medical Sciences (grant R01-GM-76177). We thank P. Letourneau, D. Bray, and E. Tuzel for stimulating discussions; N. Simha for helpful discussions on gel mechanics; N. Koyano for assistance with in ovo electroporation; and members of the Odde Lab, D. Seetapun, A. Bicek, M. Gardner, and T. Dahl for technical assistance.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fass JN, 2003, BIOPHYS J, V85, P623, DOI 10.1016/S0006-3495(03)74506-8; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Howard J., 2002, APPL MECH REV, V55, pB39; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	19	549	568	11	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1687	1691		10.1126/science.1163595	http://dx.doi.org/10.1126/science.1163595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074349				2022-12-28	WOS:000261608300044
J	Taylor, JS; Nicholson, S				Taylor, James S.; Nicholson, Simon			They don't train 'em like they used to	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Taylor, James S.] Steyning Hlth Ctr, Steyning BN44 3RJ, England; [Nicholson, Simon] Maidstone Gen Hosp, Maidstone ME16 9QQ, Kent, England		Taylor, JS (corresponding author), Steyning Hlth Ctr, Steyning BN44 3RJ, England.	dr.jstaylor@hotmail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 12	2008	337								a2895	10.1136/bmj.a2895	http://dx.doi.org/10.1136/bmj.a2895			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CC	19074564				2022-12-28	WOS:000262777000004
J	Greenhalgh, T				Greenhalgh, Trisha			Selecting the next generation	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Greenhalgh, Trisha] UCL, London, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 10	2008	337								a2963	10.1136/bmj.a2963	http://dx.doi.org/10.1136/bmj.a2963			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CA	19073690				2022-12-28	WOS:000262776800031
J	Reddy, M; Gill, SS; Kalkar, SR; Wu, W; Anderson, PJ; Rochon, PA				Reddy, Madhuri; Gill, Sudeep S.; Kalkar, Sunila R.; Wu, Wei; Anderson, Peter J.; Rochon, Paula A.			Treatment of Pressure Ulcers A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GROWTH FACTOR-BB; DOUBLE-BLIND; DECUBITUS ULCERS; RANDOMIZED-TRIAL; TOPICAL APPLICATION; SPINAL-CORD; HYDROCOLLOID DRESSINGS; COLLAGENASE OINTMENT; SEMELIL ANGIPARS(TM); COST-EFFECTIVENESS	Context Many treatments for pressure ulcers are promoted, but their relative efficacy is unclear. Objective To systematically review published randomized controlled trials ( RCTs) evaluating therapies for pressure ulcers. Data Sources and Study Selection The databases of MEDLINE, EMBASE, and CINAHL were searched ( from inception through August 23, 2008) to identify relevant RCTs published in the English language. Data Extraction Methodological characteristics and outcomes were extracted by 3 investigators. Data Synthesis A total of 103 RCTs met inclusion criteria. Of these, 83 did not provide sufficient information about authors' potential financial conflicts of interest. Methodological quality was variable. Most trials were conducted in acute care ( 38 [ 37%]), mixed care ( 25 [ 24%]), or long- term care ( 22 [ 21%]) settings. Among 12 RCTs evaluating support surfaces, no clear evidence favored one support surface over another. No trials compared a specialized support surface with a standard mattress and repositioning. Among 7 RCTs evaluating nutritional supplements, 1 higher- quality trial found that protein supplementation of long- term care residents improved wound healing compared with placebo ( improvement in Pressure Ulcer Scale for Healing mean [ SD] score of 3.55 [ 4.66] vs 3.22 [ 4.11], respectively; P <. 05). Other nutritional supplement RCTs showed mixed results. Among 54 RCTs evaluating absorbent wound dressings, 1 found calcium alginate dressings improved healing compared with dextranomer paste ( mean wound surface area reduction per week, 2.39 cm(2) vs 0.27 cm(2), respectively; P <. 001). No other dressing was superior to alternatives. Among 9 RCTs evaluating biological agents, several trials reported benefits with different topical growth factors. However, the incremental benefit of these biological agents over less expensive standard wound care remains uncertain. No clear benefit was identified in 21 RCTs evaluating adjunctive therapies including electric current, ultrasound, light therapy, and vacuum therapy. Conclusions Little evidence supports the use of a specific support surface or dressing over other alternatives. Similarly, there is little evidence to support routine nutritional supplementation or adjunctive therapies compared with standard care.	[Reddy, Madhuri] Harvard Univ, Beth Israel Deaconess Med Ctr, Hebrew Rehabil Ctr Aged, Dept Med,Div Gerontol,Sch Med, Boston, MA 02131 USA; [Gill, Sudeep S.] Queens Univ, Div Geriatr Med, Dept Med, Kingston, ON, Canada; [Gill, Sudeep S.] Queens Univ, Div Geriatr Med, Dept Community Hlth, Kingston, ON, Canada; [Gill, Sudeep S.] Queens Univ, Div Geriatr Med, Dept Epidemiol, Kingston, ON, Canada; [Kalkar, Sunila R.; Wu, Wei; Anderson, Peter J.; Rochon, Paula A.] Kunin Lunenfeld Appl Res Unit Baycrest, Toronto, ON, Canada; [Rochon, Paula A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Rochon, Paula A.] Inst Clin Evaluat Sci, Toronto, ON, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Reddy, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Hebrew Rehabil Ctr Aged, Dept Med,Div Gerontol,Sch Med, 1200 Center St, Boston, MA 02131 USA.	Madhuri.Reddy@hrca.harvard.edu	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151; Wu, Wei/0000-0002-9633-4122	Canadian Institutes of Health Research Interdisciplinary Capacity Enhancement [H0A-80075]; Ontario Ministry of Health and Long-Term Care Career Scientist Award	Canadian Institutes of Health Research Interdisciplinary Capacity Enhancement(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care Career Scientist Award(Ministry of Health and Long-Term Care, Ontario)	This work was supported by Canadian Institutes of Health Research Interdisciplinary Capacity Enhancement grant H0A-80075. Dr Gill was supported by an Ontario Ministry of Health and Long-Term Care Career Scientist Award.	Adderley U., 2007, COCHRANE DB SYST REV, V2; Adegoke B O, 2001, Afr J Med Med Sci, V30, P195; Adunsky A, 2005, ARCH GERONTOL GERIAT, V41, P261, DOI 10.1016/j.archger.2005.04.004; AGREN MS, 1985, SCAND J PLAST RECONS, V19, P97, DOI 10.3109/02844318509052871; ALLMAN RM, 1987, ANN INTERN MED, V107, P641, DOI 10.7326/0003-4819-107-5-641; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Alvarez OM, 2002, WOUNDS, V14, P293; Amione P, 2005, J Wound Care, V14, P365; ASBJORNSEN G, 1990, J CLIN EXP GERONTOL, V12, P209; Ayello Elizabeth A, 2002, Adv Skin Wound Care, V15, P125, DOI 10.1097/00129334-200205000-00008; Banwell H, 2006, DERMATOLOGY, V212, P66, DOI 10.1159/000089202; Bates-Jensen B M, 1992, Decubitus, V5, P20; Belmin J, 2002, J AM GERIATR SOC, V50, P269, DOI 10.1046/j.1532-5415.2002.50058.x; Benati G, 2001, ARCH GERONTOL GERIAT, P43, DOI 10.1016/S0167-4943(01)00120-0; Boutron I, 2005, J CLIN EPIDEMIOL, V58, P1233, DOI 10.1016/j.jclinepi.2005.05.004; Brandeis G H, 2001, Adv Skin Wound Care, V14, P245, DOI 10.1097/00129334-200109000-00011; Branom R, 2001, Ostomy Wound Manage, V47, P38; BROD M, 1990, ARCH DERMATOL, V126, P969, DOI 10.1001/archderm.126.7.969; Brown-Etris M, 2008, ADV SKIN WOUND CARE, V21, P160; Burgos A, 2000, CLIN DRUG INVEST, V19, P399, DOI 10.2165/00044011-200019060-00002; Burgos A, 2000, CLIN DRUG INVEST, V19, P357, DOI 10.2165/00044011-200019050-00006; Burke DT, 1998, AM J PHYS MED REHAB, V77, P394, DOI 10.1097/00002060-199809000-00006; Chang K W, 1998, Med J Malaysia, V53, P428; Colin D, 1996, J Wound Care, V5, P444; COLWELL S, 1993, NEW STATESMAN SOC, V6, P28; Comorosan S, 1993, Rom J Physiol, V30, P41; Cuddigan J, 1998, Adv Wound Care, V11, P294; Cullum N, 2001, Health Technol Assess, V5, P1; Darkovich S L, 1990, Ostomy Wound Manage, V29, P47; Day A, 1995, Ostomy Wound Manage, V41, P52; Day A, 1993, Decubitus, V6, P32; De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398; Dehlin O, 2003, AGING CLIN EXP RES, V15, P259; Desneves KJ, 2005, CLIN NUTR, V24, P979, DOI 10.1016/j.clnu.2005.06.011; Di Giulio Paola, 2004, Assist Inferm Ric, V23, P201; ENGDAHL E, 1980, CURR THER RES CLIN E, V28, P377; *EUR PRESS ULC ADV, EUR GUID PRESS ULC T; Evans D, 2000, J Wound Care, V9, P181; FERRELL BA, 1993, JAMA-J AM MED ASSOC, V269, P494, DOI 10.1001/jama.269.4.494; Ferrell BA, 2000, J AM GERIATR SOC, V48, P1042, DOI 10.1111/j.1532-5415.2000.tb04778.x; Flanagan Madeleine, 2003, Ostomy Wound Manage, V49, P28; Ford CN, 2002, ANN PLAS SURG, V49, P55, DOI 10.1097/00000637-200207000-00009; GERBER RM, 1979, NURS RES, V28, P16; Gerding G A, 1992, Dermatol Nurs, V4, P389; Graumlich JF, 2003, J AM GERIATR SOC, V51, P147, DOI 10.1046/j.1532-5415.2003.51051.x; Gregor S, 2008, ARCH SURG-CHICAGO, V143, P189, DOI 10.1001/archsurg.2007.54; GRIFFIN JW, 1991, PHYS THER, V71, P433, DOI 10.1093/ptj/71.6.433; Groen H W, 1999, J Wound Care, V8, P333; Gunes UY, 2007, J WOUND OSTOMY CONT, V34, P184, DOI 10.1097/01.WON.0000264833.11108.35; GUTHRIE M, 1988, WOUNDS, V1, P142; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Hirshberg J, 2001, Adv Skin Wound Care, V14, P91, DOI 10.1097/00129334-200103000-00013; Hollisaz Mohammad Taghi, 2004, BMC Dermatol, V4, P18; HONDE C, 1994, J AM GERIATR SOC, V42, P1180, DOI 10.1111/j.1532-5415.1994.tb06985.x; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Iordanou Pangiota, 2002, Int J Nurs Pract, V8, P49, DOI 10.1046/j.1440-172x.2002.00338.x; Kaya A Z, 2005, J Wound Care, V14, P42; KIM YC, 1996, YONSEI MED J, V37, P181; KLOTH LC, 1988, PHYS THER, V68, P503, DOI 10.1093/ptj/68.4.503; Kloth Luther C, 2002, Adv Skin Wound Care, V15, P270, DOI 10.1097/00129334-200211000-00008; KNUDSEN L, 1982, CURR THER RES CLIN E, V32, P498; Kraft M R, 1993, Decubitus, V6, P42; KRANKE P, 2004, COCHRANE DB SYST REV, V2; Kuflik A, 2001, Ostomy Wound Manage, V47, P52; Kuhn B A, 1992, Nurs Econ, V10, P353; Land L, 2000, J Tissue Viability, V10, P6; Landi F, 2003, ANN INTERN MED, V139, P635, DOI 10.7326/0003-4819-139-8-200310210-00006; Lassere MN, 2007, J RHEUMATOL, V34, P607; Lee S Kwon, 2006, Adv Skin Wound Care, V19, P92, DOI 10.1097/00129334-200603000-00011; LEVASSEUR SA, 1991, J ADV NURS, V16, P952; Lucas C, 2003, LASER MED SCI, V18, P72, DOI 10.1007/s10103-003-0259-5; Matzen S, 1999, SCAND J PLAST RECONS, V33, P13, DOI 10.1080/02844319950159578; Maume Sylive, 2003, Ostomy Wound Manage, V49, P44; McDiarmid T, 1985, PHYSIOTHERAPY, V71, P66; *MED HEALTHC PROD, WE REG; MOBERG S, 1983, J AM GERIATR SOC, V31, P462, DOI 10.1111/j.1532-5415.1983.tb05117.x; Motta G, 1999, Ostomy Wound Manage, V45, P44; Mulder GD, 1994, J GERIATRIC DERMATOL, V2, P87; Mulder Gerit D., 1993, Wound Repair and Regeneration, V1, P213, DOI 10.1046/j.1524-475X.1993.10406.x; Muller E, 2001, PHARMACOECONOMICS, V19, P1209; MUSTOE TA, 1994, ARCH SURG-CHICAGO, V129, P213; Myers S A, 1990, Decubitus, V3, P16; *NAT PRESS ULC ADV, TERMS DEF REL SUPP S; NELSON EA, 2003, COCHRANE DB SYST REV, V1; Niedner R, 1997, DERMATOLOGY, V195, P89, DOI 10.1159/000246038; Nisi Giuseppe, 2005, Chir Ital, V57, P465; Nixon J, 2006, BMJ-BRIT MED J, V332, P1413, DOI 10.1136/bmj.38849.478299.7C; NORRIS JR, 1971, J AM GERIATR SOC, V19, P793, DOI 10.1111/j.1532-5415.1971.tb02430.x; NUSSBAUM EL, 1994, PHYS THER, V74, P812, DOI 10.1093/ptj/74.9.812; Oleske D M, 1986, J Enterostomal Ther, V13, P90; Palfreyman SJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001103.pub2; PARISH LC, 1979, CUTIS, V23, P106; Payne WG, 2004, J APPL RES HIGH EDUC, V4, P12; Price P, 2000, J Wound Care, V9, P201; Pullen R, 2002, AGE AGEING, V31, P126, DOI 10.1093/ageing/31.2.126; REDDY M, 2005, CAN J GERIATR, V8, P50; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Rees RS, 1999, WOUND REPAIR REGEN, V7, P141, DOI 10.1046/j.1524-475X.1999.00141.x; Reichert-Penetrat S, 1999, ANN DERMATOL VENER, V126, P131; Rhodes RS, 2001, ANN PHARMACOTHER, V35, P675; ROBSON MC, 1992, LANCET, V339, P23, DOI 10.1016/0140-6736(92)90143-Q; ROBSON MC, 1992, ANN SURG, V216, P401, DOI 10.1097/00000658-199210000-00002; Robson MC, 2000, ANN SURG, V231, P600, DOI 10.1097/00000658-200004000-00020; Roeckl-Wiedmann I, 2005, BRIT J SURG, V92, P24, DOI 10.1002/bjs.4863; Rosenthal MJ, 2003, ARCH PHYS MED REHAB, V84, P1733, DOI 10.1016/S0003-9993(03)00435-0; Russell L, 2003, Br J Nurs, V12, P256; Russell L, 2000, J Wound Care, V9, P52; Russell L, 2003, BRIT J NURSING, V12, P256; Saap L, 2004, ARCH DERMATOL, V140, P1241, DOI 10.1001/archderm.140.10.1241; Salzberg C A, 1995, Ostomy Wound Manage, V41, P42; Sayag J., 1996, J WOUND CARE, V5, P357, DOI 10.12968/jowc.1996.5.8.357; Schaum KD, 2005, OSTOMY WOUND MANAG, V51, P36; SCHAUM KD, 2005, OSTOMY WOUND MANAG, V51, P96; Schubert V, 2001, PHOTODERMATOL PHOTO, V17, P32, DOI 10.1034/j.1600-0781.2001.017001032.x; Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x; Seaman S, 2000, Ostomy Wound Manage, V46, P18; SEBERN MD, 1986, ARCH PHYS MED REHAB, V67, P726, DOI 10.1016/0003-9993(86)90004-3; Seeley J, 1999, Ostomy Wound Manage, V45, P39; Shamimi NK, 2008, DARU, V16, P54; Shamimi NK, 2008, DARU, V16, P49; Sibbald R G, 2000, Ostomy Wound Manage, V46, P14; Sipponen A, 2008, BRIT J DERMATOL, V158, P1055, DOI 10.1111/j.1365-2133.2008.08461.x; Small N, 2002, Curationis, V25, P74; Sopata M, 2002, J Wound Care, V11, P107; Stotts NA, 2001, J GERONTOL A-BIOL, V56, pM795, DOI 10.1093/gerona/56.12.M795; Subbanna PK, 2007, SPINAL CORD, V45, P739, DOI 10.1038/sj.sc.3102029; Taly AB, 2004, ARCH PHYS MED REHAB, V85, P1657, DOI 10.1016/j.apmr.2004.03.028; TAYLOR TV, 1974, LANCET, V2, P544; terRiet G, 1995, J CLIN EPIDEMIOL, V48, P1453, DOI 10.1016/0895-4356(95)00053-4; TERRIET G, 1995, BMJ-BRIT MED J, V310, P1040, DOI 10.1136/bmj.310.6986.1040; Thomas D R, 1997, Adv Wound Care, V10, P96; Thomas D R, 1998, Adv Wound Care, V11, P273; Thomas DR, 2006, J AM MED DIR ASSOC, V7, P46, DOI 10.1016/j.jamda.2005.10.004; Toba K, 1997, Nihon Ronen Igakkai Zasshi, V34, P577; *US FDA, INF FDA DRESS DRUGS; van Rijswijk L, 2006, J Wound Care, V15, P11; VANORT SR, 1976, NURS RES, V25, P9; VANRIJSWIJK L, 1993, J FAM PRACTICE, V36, P625; Vermeulen H, 2004, COCHRANE DB SYST REV, V2, pCD003554; Wanner MB, 2003, SCAND J PLAST RECONS, V37, P28; Whitney J D, 2001, J Wound Ostomy Continence Nurs, V28, P244, DOI 10.1067/mjw.2001.117564; Whitney J, 2006, WOUND REPAIR REGEN, V14, P663, DOI 10.1111/j.1524-475X.2006.00175.x; WILLS EE, 1983, J AM GERIATR SOC, V31, P131, DOI 10.1111/j.1532-5415.1983.tb04850.x; WOOD JM, 1993, ARCH DERMATOL, V129, P999, DOI 10.1001/archderm.129.8.999; Woodbury M, 2004, OSTOMY WOUND MANAG, V50, P34; Woodbury M, 2004, OSTOMY WOUND MANAG, V50, P30; Woodbury M, 2004, OSTOMY WOUND MANAG, V50, P32; Woodbury M, 2004, OSTOMY WOUND MANAG, V50, P26; Woodbury M Gail, 2004, Ostomy Wound Manage, V50, P22; Woodbury MG, 2004, OSTOMY WOUND MANAG, V50, P22; Woodbury MG, 2004, OSTOMY WOUND MANAG, V50, P28; XAKELLIS GC, 1992, ARCH PHYS MED REHAB, V73, P463; Yastrub Diane J, 2004, Care Manag J, V5, P213, DOI 10.1891/cmaj.2004.5.4.213	153	156	160	1	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2647	2662		10.1001/jama.2008.778	http://dx.doi.org/10.1001/jama.2008.778			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066385				2022-12-28	WOS:000261503000024
J	Sabio, G; Das, M; Mora, A; Zhang, ZY; Jun, JY; Ko, HJ; Barrett, T; Kim, JK; Davis, RJ				Sabio, Guadalupe; Das, Madhumita; Mora, Alfonso; Zhang, Zhiyou; Jun, John Y.; Ko, Hwi Jin; Barrett, Tamera; Kim, Jason K.; Davis, Roger J.			A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; IN-VIVO; INTERLEUKIN-6 DOES/DOES; GLUCOSE-HOMEOSTASIS; BENEFICIAL ROLE; OBESITY; SOCS-3; MICE; INFLAMMATION; HEPATOCYTES	A high-fat diet causes activation of the regulatory protein c-Jun NH(2)-terminal kinase 1 (JNK1) and triggers development of insulin resistance. JNK1 is therefore a potential target for therapeutic treatment of metabolic syndrome. We explored the mechanism of JNK1 signaling by engineering mice in which the Jnk1 gene was ablated selectively in adipose tissue. JNK1 deficiency in adipose tissue suppressed high- fat diet- induced insulin resistance in the liver. JNK1- dependent secretion of the inflammatory cytokine interleukin- 6 by adipose tissue caused increased expression of liver SOCS3, a protein that induces hepatic insulin resistance. Thus, JNK1 activation in adipose tissue can cause insulin resistance in the liver.	[Sabio, Guadalupe; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Sabio, Guadalupe; Das, Madhumita; Mora, Alfonso; Barrett, Tamera; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Jun, John Y.] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Mora, Alfonso/D-2759-2017; Sabio, Guadalupe/H-9733-2015	Mora, Alfonso/0000-0002-6397-4836; Sabio, Guadalupe/0000-0002-2822-0625; Davis, Roger/0000-0002-0130-1652; Kim, Jason/0000-0002-7185-042X	NIH; American Diabetes Association [1-04-RA-47]; Pennsylvania State Department of Health; Core facilities at the University of Massachusetts; National Institute of Diabetes and Digestive and Kidney Diseases; Diabetes and Endocrinology Research Center [DK52530]; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080756, R01DK052530] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Pennsylvania State Department of Health; Core facilities at the University of Massachusetts; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes and Endocrinology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank V. Benoit, J. Cavanagh- Kyros, K. Gemme, N. Kennedy, J. Liu, and J. Reilly for expert assistance. These studies were supported by grants from NIH (to R.J.D.), the American Diabetes Association (1-04-RA-47 to J.K.K.), and the Pennsylvania State Department of Health (to J.K.K.). Core facilities at the University of Massachusetts used by these studies were supported by the National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes and Endocrinology Research Center (DK52530). R.J.D. is an Investigator of the Howard Hughes Medical Institute.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Mauvais-Jarvis F, 2002, CLIN ENDOCRINOL, V57, P1, DOI 10.1046/j.1365-2265.2002.01563.x; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mooney RA, 2007, J APPL PHYSIOL, V102, P816, DOI 10.1152/japplphysiol.01208a.2006; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2001, CURR OPIN HEMATOL, V8, P137, DOI 10.1097/00062752-200105000-00002; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001	26	434	451	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1539	1543		10.1126/science.1160794	http://dx.doi.org/10.1126/science.1160794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056984	Green Accepted			2022-12-28	WOS:000261377400048
J	Windsor, JS				Windsor, Jeremy S.			Voices in the air	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Windsor, Jeremy S.] UCL, Inst Human Hlth & Performance, London N19 5LW, England	University of London; University College London	Windsor, JS (corresponding author), UCL, Inst Human Hlth & Performance, London N19 5LW, England.	jswindsor@doctors.org.uk						BONINGTON C, 1997, EVEREST HARD WAY, P186; HABELER P, 1979, EVEREST IMPOSSIBLE V, P167; POTTERFIELD P, 2004, MOUNTAINEERS ANTHOLO, P52; VENABLES S, 2000, EVEREST ALONE AUMMIT, P184	4	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 5	2008	337								a2667	10.1136/bmj.a2667	http://dx.doi.org/10.1136/bmj.a2667			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NY	19060106				2022-12-28	WOS:000261891100005
J	Morgan, DO				Morgan, David O.			SnapShot: Cell-Cycle Regulators II	CELL			English	Editorial Material							MACHINE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Morgan, David/0000-0001-8753-4416				Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606	5	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					974	U14		10.1016/j.cell.2008.10.040	http://dx.doi.org/10.1016/j.cell.2008.10.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041757	Bronze			2022-12-28	WOS:000261183900026
J	Ekelund, CK; Jorgensen, FS; Petersen, OB; Sundberg, K; Tabor, A				Ekelund, Charlotte K.; Jorgensen, Finn Stener; Petersen, Olav Bjorn; Sundberg, Karin; Tabor, Ann		Danish Fetal Med Res Grp	Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL SERUM BIOCHEMISTRY; ROUTINE CLINICAL-PRACTICE; 1ST-TRIMESTER; TRISOMY-21; ULTRASOUND; RISK; AGE; MULTICENTER; EXPERIENCE	Objectives To evaluate the impact of a screening strategy in the first trimester, introduced in Denmark during 2004-6, on the number of infants born with Down's syndrome and the number of chorionic villus samplings and amniocenteses, and to determine detection and false positive rates in the screened population in 2005 and 2006. Design Population based cohort study. Setting 19 Danish departments of gynaecology and obstetrics and a central cytogenetic registry 2000-7. Participants 65 000 pregnancies per year. Main outcome measures The primary outcomes measured were number of fetuses and newborn infants with Down's syndrome diagnosed prenatally and postnatally and number of chorionic villus samplings and amniocenteses carried out. Secondary outcomes measured were number of women screened in 2005 and 2006, screen positive rate, and information on screening in 2005 and 2006 for infants with a postnatal diagnosis of Down's syndrome. Results The number of infants born with Down's syndrome decreased from 55-65 per year during 2000-4 to 31 in 2005 and 32 in 2006. The total number of chorionic villus samplings and amniocenteses carried out decreased from 7524 in 2000 to 3510 in 2006. The detection rate in the screened population in 2005 was 86% (95% confidence interval 79% to 92%) and in 2006 was 93% (87% to 97%). The corresponding false positive rates were 3.9% (3.7% to 4.1%) and 3.3% (3.1% to 3.4%). Conclusion The introduction of a combined risk assessment during the first trimester at a national level in Denmark halved the number of infants born with Down's syndrome. The strategy also resulted in a sharp decline in the number of chorionic villus samplings and amniocenteses carried out, even before full implementation of the policy.	[Ekelund, Charlotte K.; Sundberg, Karin; Tabor, Ann] Univ Copenhagen Hosp, Dept Fetal Med, Rigshosp, DK-2100 Copenhagen, Denmark; [Jorgensen, Finn Stener] Hvidovre Univ Hosp, Fetal Med Unit, Dept Obstet & Gynaecol, DK-2650 Hvidovre, Denmark; [Petersen, Olav Bjorn] Skejby Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark; [Tabor, Ann] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; University of Copenhagen	Tabor, A (corresponding author), Univ Copenhagen Hosp, Dept Fetal Med, Rigshosp, DK-2100 Copenhagen, Denmark.	ann.tabor@rh.regionh.dk	ekelund, charlotte/AFQ-9414-2022; Ekelund, Charlotte Kvist/I-4187-2018; Petersen, Olav Bjørn/A-1081-2013	ekelund, charlotte/0000-0002-8337-5101; Ekelund, Charlotte Kvist/0000-0002-8337-5101; Petersen, Olav Bjørn/0000-0001-8517-4082; Christensen, Jeanette Reffstrup/0000-0002-2412-5989; Tabor, Ann/0000-0001-7450-1543; Jorgensen, Finn Stener/0000-0002-1592-5407; Olesen, Annette Wind/0000-0002-0586-4815; Farlie, Richard/0000-0001-5286-3244				Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; Chang TC, 2006, AUST NZ J OBSTET GYN, V46, P92, DOI 10.1111/j.1479-828X.2006.00534.x; *DAN NAT BOARD HLT, 2003, REP WORK COMM PREN D; Hadlow NC, 2005, BJOG-INT J OBSTET GY, V112, P1561, DOI 10.1111/j.1471-0528.2005.00722.x; Jorgensen Maiken Thyregod, 2003, Ugeskr Laeger, V165, P447; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Nicolaides KH, 2005, ULTRASOUND OBST GYN, V25, P221, DOI 10.1002/uog.1860; O'Leary P, 2006, OBSTET GYNECOL, V107, P869, DOI 10.1097/01.AOG.0000207562.09858.16; O'Leary P, 2006, AUST NZ J OBSTET GYN, V46, P427, DOI 10.1111/j.1479-828X.2006.00629.x; Reddy UM, 2006, OBSTET GYNECOL, V107, P167, DOI 10.1097/01.AOG.0000194186.34664.a9; Schielen PCJI, 2006, PRENATAL DIAG, V26, P711, DOI 10.1002/pd.1486; Snijders RJM, 1999, ULTRASOUND OBST GYN, V13, P167, DOI 10.1046/j.1469-0705.1999.13030167.x; Soergel P, 2006, FETAL DIAGN THER, V21, P264, DOI 10.1159/000091353; Spencer K, 2003, BJOG-INT J OBSTET GY, V110, P281, DOI 10.1016/S1470-0328(03)02946-X; Stenhouse EJ, 2004, PRENATAL DIAG, V24, P774, DOI 10.1002/pd.980; Tabor A., 2007, ULTRASOUND OBST GYN, V30, P376; Torring Niels, 2008, Ugeskr Laeger, V170, P50; Wojdemann KR, 2005, ULTRASOUND OBST GYN, V25, P227, DOI 10.1002/uog.1834	18	164	165	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2008	337								a2547	10.1136/bmj.a2547	http://dx.doi.org/10.1136/bmj.a2547			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QC	19039015	Green Published, hybrid			2022-12-28	WOS:000261827700001
J	Grabowski, GA				Grabowski, Gregory A.			Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease	LANCET			English	Review							ENZYME REPLACEMENT THERAPY; UNFOLDED PROTEIN RESPONSE; MACROPHAGE-TARGETED GLUCOCEREBROSIDASE; ACID BETA-GLUCOSIDASE; PARKINSONS-DISEASE; N-BUTYLDEOXYNOJIRIMYCIN; ENDOPLASMIC-RETICULUM; GENE-THERAPY; GLUCOSYLCERAMIDE SYNTHASE; CHITOTRIOSIDASE ACTIVITY	Gaucher's disease continues to be a model for applications of molecular medicine to clinical delineation, diagnosis, and treatment. Analyses of several thousand affected individuals have broadened the range of the pan-ethnic disease variants, provided initial genotype and phenotype correlations, and established the effectiveness of enzyme therapy. Large numbers of affected individuals worldwide have provided insight into the effect of disease variation related to ethnic origin, prognosis, and outcome. The ability to safely and effectively use enzyme therapy to inhibit or reverse visceral-disease progression and involvement has provided impetus for design of new enzyme therapies, and creation of substrate depletion and pharmacological chaperone strategies. Such innovations could provide interventions that are effective for neuronopathic variants and, potentially, could be more cost effective than other treatments. These developments are novel, clinically important, advancements for patients with other lysosomal storage diseases and genetic diseases.	[Grabowski, Gregory A.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Grabowski, GA (corresponding author), Childrens Hosp Res Fdn, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	greg.grabowski@cchmc.org			NIDDK NIH HHS [DK36729] Funding Source: Medline; NINDS NIH HHS [NS36681, NS45911] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036681, U01NS045911] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE A, 1992, EUR J BIOCHEM, V210, P765, DOI 10.1111/j.1432-1033.1992.tb17479.x; ABRAHAMOV A, 1995, LANCET, V346, P1000, DOI 10.1016/S0140-6736(95)91688-1; Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Beutler E, 2000, BLOOD CELL MOL DIS, V26, P303, DOI 10.1006/bcmd.2000.0311; BEUTLER E, 1993, BRIT J HAEMATOL, V85, P401, DOI 10.1111/j.1365-2141.1993.tb03185.x; Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; BEUTLER E, 1993, AM J HUM GENET, V52, P85; BEUTLER E, 1991, BLOOD, V78, P1183; Beutler E, 2000, ACTA HAEMATOL-BASEL, V104, P103, DOI 10.1159/000039760; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bieberich E, 1999, J NEUROCHEM, V72, P1040, DOI 10.1046/j.1471-4159.1999.0721040.x; Bonetta L, 2002, NAT MED, V8, P1189, DOI 10.1038/nm1102-1189; Boven LA, 2004, AM J CLIN PATHOL, V122, P359, DOI 10.1309/BG5VA8JRDQH1M7HN; Brady RO, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.6.e11; Brinkman J, 2005, J INHERIT METAB DIS, V28, P13, DOI 10.1007/s10545-005-4416-9; Clark LN, 2005, MOVEMENT DISORD, V20, P100, DOI 10.1002/mds.20320; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Cox TM, 2003, J INHERIT METAB DIS, V26, P513, DOI 10.1023/A:1025902113005; Czartoryska B, 1998, CLIN BIOCHEM, V31, P417, DOI 10.1016/S0009-9120(98)00030-7; de Fost M, 2006, BLOOD, V108, P830, DOI 10.1182/blood-2005-12-5072; DESNICK RJ, 1982, GAUCHER DIS CENTURY; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; Elstein D, 2004, J INHERIT METAB DIS, V27, P757, DOI 10.1023/B:BOLI.0000045756.54006.17; Enquist IB, 2006, P NATL ACAD SCI USA, V103, P13819, DOI 10.1073/pnas.0606016103; ERIKSON A, 1990, ACTA PAEDIATR SCAND, V79, P680, DOI 10.1111/j.1651-2227.1990.tb11535.x; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Filocamo M, 2000, BLOOD CELL MOL DIS, V26, P611, DOI 10.1006/bcmd.2000.0341; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; Fredman P, 1998, J INHERIT METAB DIS, V21, P472, DOI 10.1023/A:1005454602454; FUTERMAN T, 2006, GAUCHER DIS; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gaucher PCE, 1882, THESIS PARIS; Ginzburg L, 2004, SEMIN CELL DEV BIOL, V15, P417, DOI 10.1016/j.semcdb.2004.03.003; Giraldo P, 2006, HAEMATOLOGICA, V91, P703; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRABOWSKI GA, 2006, AM J HUM GENET, P427; GRABOWSKI GA, 2006, GAUCHER DIS, P49; Grabowski GA, 2006, METABOLIC MOL BASES; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; HOLLAK CEM, 1995, LANCET, V345, P1474, DOI 10.1016/S0140-6736(95)91037-9; Hruska KS, 2006, GAUCHER DIS, P13; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; Kaplan P, 2006, ARCH PEDIAT ADOL MED, V160, P603, DOI 10.1001/archpedi.160.6.603; Kelly JW, 2005, NEW ENGL J MED, V352, P722, DOI 10.1056/NEJMcibr044231; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Luberto C, 2002, NEUROCHEM RES, V27, P609, DOI 10.1023/A:1020267831851; Marshall E, 2003, SCIENCE, V299, P320, DOI 10.1126/science.299.5605.320; MCEACHERN K, 2006, AM J HUM GENET, P424; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; McEachern KA, 2006, J GENE MED, V8, P719, DOI 10.1002/jgm.901; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mignot C, 2003, AM J MED GENET A, V120A, P338, DOI 10.1002/ajmg.a.20117; Moran MT, 2000, BLOOD, V96, P1969, DOI 10.1182/blood.V96.5.1969.h8001969_1969_1978; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Pastores GM, 2005, CLIN THER, V27, P1215, DOI 10.1016/j.clinthera.2005.08.004; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Pastores GM, 2003, J INHERIT METAB DIS, V26, P641, DOI 10.1023/B:BOLI.0000005623.60471.51; PASTORES GM, 1993, BLOOD, V82, P408; PATTERSON MC, 1993, NEUROLOGY, V43, P1993, DOI 10.1212/WNL.43.10.1993; Platt FM, 2001, J INHERIT METAB DIS, V24, P275, DOI 10.1023/A:1010335505357; POLLACK A, 2003, NY TIMES, pA17; Pollack Andrew, 2003, N Y Times Web, pA17; Rappeport J M, 1986, Birth Defects Orig Artic Ser, V22, P101; RICHARDS SM, 1993, BLOOD, V82, P1402; RINGDEN O, 1988, TRANSPLANTATION, V46, P66, DOI 10.1097/00007890-198807000-00011; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Rosenberg M, 1999, BLOOD, V93, P2081, DOI 10.1182/blood.V93.6.2081.406k07_2081_2088; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Sato C, 2005, MOVEMENT DISORD, V20, P367, DOI 10.1002/mds.20319; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shayman JA, 2003, GLYCOCONJUGATE J, V20, P25, DOI 10.1023/B:GLYC.0000016739.32089.55; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; SHUKLA GS, 1991, J NEUROCHEM, V56, P2125, DOI 10.1111/j.1471-4159.1991.tb03475.x; Sidransky E, 2005, MOL GENET METAB, V84, P302, DOI 10.1016/j.ymgme.2004.11.007; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; Sobreira E, 2007, MOL GENET METAB, V90, P81, DOI 10.1016/j.ymgme.2006.08.009; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Stone DL, 1999, EUR J HUM GENET, V7, P505, DOI 10.1038/sj.ejhg.5200315; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tylki-Szymanska A, 2006, GENET MED, V8, P8, DOI 10.1097/01.gim.0000196443.42899.25; Weinreb NJ, 2004, SEMIN HEMATOL, V41, P15, DOI 10.1053/j.seminhematol.2004.07.010; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wenstrup RJ, 2007, J BONE MINER RES, V22, P119, DOI 10.1359/JBMR.061004; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; XU YH, 2005, AM J HUM GENET, V207, P1413; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhao HQ, 2003, BLOOD CELL MOL DIS, V30, P90, DOI 10.1016/S1079-9796(03)00012-3; Zimmer KP, 1999, J PATHOL, V188, P407; ZIMRAN A, 2006, AM J HUM GENET, P428	105	357	409	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1263	1271		10.1016/S0140-6736(08)61522-6	http://dx.doi.org/10.1016/S0140-6736(08)61522-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357YB	19094956				2022-12-28	WOS:000259882000032
J	Oshima, S; Turer, EE; Callahan, JA; Chai, S; Advincula, R; Barrera, J; Shifrin, N; Lee, B; Yen, B; Woo, T; Malynn, BA; Ma, A				Oshima, Shigeru; Turer, Emre E.; Callahan, Joseph A.; Chai, Sophia; Advincula, Rommel; Barrera, Julio; Shifrin, Nataliya; Lee, Bettina; Yen, Benjamin; Woo, Tammy; Malynn, Barbara A.; Ma, Averil			ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development	NATURE			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; JNK ACTIVATION; MICE; A20; INDUCTION; LETHALITY; APOPTOSIS; RESPONSES; REQUIRES	Proteins that directly regulate tumour necrosis factor receptor ( TNFR) signalling have critical roles in regulating cellular activation and survival. ABIN-1 (A20 binding and inhibitor of NF-kappa B) is a novel protein that is thought to inhibit NF-kappa B signalling(1,2). Here we show that mice deficient for ABIN-1 die during embryogenesis with fetal liver apoptosis, anaemia and hypoplasia. ABIN-1 deficient cells are hypersensitive to tumour necrosis factor (TNF)induced programmed cell death, and TNF deficiency rescues ABIN-1 deficient embryos. ABIN-1 inhibits caspase 8 recruitment to FADD (Fas-associated death domain-containing protein) in TNF-induced signalling complexes, preventing caspase 8 cleavage and programmed cell death. Moreover, ABIN-1 directly binds polyubiquitin chains and this ubiquitin sensing activity is required for ABIN-1's anti-apoptotic activity. These studies provide insights into how ubiquitination and ubiquitin sensing proteins regulate cellular and organismal survival.	[Oshima, Shigeru; Turer, Emre E.; Callahan, Joseph A.; Chai, Sophia; Advincula, Rommel; Barrera, Julio; Shifrin, Nataliya; Lee, Bettina; Yen, Benjamin; Woo, Tammy; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, 513 Parnassus Ave,S-1057, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu	Oshima, Shigeru/C-9865-2015	Oshima, Shigeru/0000-0003-1186-9177	NIH; UCSF Liver Center Pathology and Flow Cytometry Facilities; UCSF Transgenic and Targeted Mutagenesis Core Facility; Crohn's and Colitis Foundation of America; NSF fellowship; Rainin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Liver Center Pathology and Flow Cytometry Facilities; UCSF Transgenic and Targeted Mutagenesis Core Facility; Crohn's and Colitis Foundation of America; NSF fellowship(National Science Foundation (NSF)); Rainin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH (A.M.), UCSF Liver Center Pathology and Flow Cytometry Facilities, UCSF Transgenic and Targeted Mutagenesis Core Facility, a fellowship from the Crohn's and Colitis Foundation of America (S.O.), a pre-doctoral NSF fellowship (J.A.C.) and the Rainin Foundation.	Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; VAN AD, 1996, SCIENCE, V274, P787; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wullaert A, 2005, HEPATOLOGY, V42, P381, DOI 10.1002/hep.20785	24	127	133	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					906	909		10.1038/nature07575	http://dx.doi.org/10.1038/nature07575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19060883	Green Accepted			2022-12-28	WOS:000263266700050
J	Hockel, M; Dornhofer, N				Hoeckel, Michael; Dornhoefer, Nadja			Treatment of early endometrial carcinoma: is less more?	LANCET			English	Editorial Material							SURGERY; SPREAD; CANCER		[Hoeckel, Michael; Dornhoefer, Nadja] Univ Leipzig, Dept Obstet & Gynaecol, Womens & Childrens Ctr, D-04103 Leipzig, Germany	Leipzig University	Hockel, M (corresponding author), Univ Leipzig, Dept Obstet & Gynaecol, Womens & Childrens Ctr, D-04103 Leipzig, Germany.	michael.hoeckel@uni-klinik.leipzig.de						Abu-Rustum NR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.010; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Chan JK, 2006, CANCER, V107, P1823, DOI 10.1002/cncr.22185; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Hockel A, 2005, CANCER RES, V65, P2997; Hockel M, 2005, LANCET ONCOL, V6, P751, DOI 10.1016/S1470-2045(05)70324-7; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Kodama J, 2007, CURR OPIN OBSTET GYN, V19, P42, DOI 10.1097/GCO.0b013e32801127b7; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; MILAS L, 1988, CANCER RES, V48, P2116; Niikura H, 2004, GYNECOL ONCOL, V92, P669, DOI 10.1016/j.ygyno.2003.10.039; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Rose Carsten, LANCET, V325, P16, DOI [10.1016/s0140-6736(85)90966-3, DOI 10.1016/S0140-6736(85)90966-3, DOI 10.1016/S0140-6736(08)61766-3]; 2008, LANCET          1213, DOI DOI 10.1016/S0140-6736(08)61767-5	15	17	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					97	99		10.1016/S0140-6736(08)61768-7	http://dx.doi.org/10.1016/S0140-6736(08)61768-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19070890				2022-12-28	WOS:000262340900004
J	Williams, K				Williams, Keith			Reappraising Florence Nightingale	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Williams, Keith] UCL, Wellcome Trust Ctr Hist Med, London NW1 2BE, England	University of London; University College London	Williams, K (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London NW1 2BE, England.	kcwilliams@ic24.net						CANTLIE N, 1974, HIST ARMY MED DEP, V2, P179; COOK E, 1913, F NIGHTINGALE; LANKFORD ND, 1980, B HIST MED, V54, P511; ROYLE T, 1999, CRIMEA GREAT CRIMEAN, P254; SHEPHERD J, 1991, CRIMEAN DOCTORS; SMITH A, 1955, COMMUNICATION   1206; SMITH F, 1929, SHORT HIST ROYAL ARM, P13; SMITH FB, 1982, F NIGHTINGALE REPUTA; Woodham-Smith Cecil, 1950, F NIGHTINGALE 1820 1; 1856, PARLIAMENTARY PAPERS, V13, P287	10	8	8	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2889	10.1136/bmj.a2889	http://dx.doi.org/10.1136/bmj.a2889			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SV	19088144				2022-12-28	WOS:000262184900007
J	Rogers, H; Maher, L; Plsek, PE				Rogers, Hugh; Maher, Lynne; Plsek, Paul E.			New design rules for driving innovation in access to secondary care in the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPLEXITY SCIENCE; HEALTH-CARE		[Rogers, Hugh; Maher, Lynne] NHS Inst Innovat & Improvement, Coventry CV4 7AL, W Midlands, England; [Plsek, Paul E.] Paul E Plsek & Assoc, Roswell, GA 30075 USA	University of Warwick	Rogers, H (corresponding author), NHS Inst Innovat & Improvement, Coventry CV4 7AL, W Midlands, England.	hugh.rogers@institute.nhs.uk						[Anonymous], 2007, 10 HIGH IMP CHANG SE; Bar-yam Y., 2004, UNIFYING THEMES COMP, VII; Bate P, 2006, QUAL SAF HEALTH CARE, V15, P307, DOI 10.1136/qshc.2005.016527; Cancer Services Collaborative Improvement Partnership, 2005, APPL HIGH IMP CHANG; CAPRA F, 1996, WEB LIFE NEW SCI UND; Darzi A., 2008, HIGH QUALITY CARE AL; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2001, EXP PAT NEW APPR CHR; Institute of Medicine, 2001, CROSSING QUALITY CHA; Johnson-Laird P. N., 1983, MENTAL MODELS; *NHS I INN IMPR, 2006, HIGH IMP CHANG PRACT; NHS Institute for Innovation and Improvement, 2007, THINK DIFF; Pickles J, 2008, CLIN GOVERNANCE, V13, P51; Plsek P, 1999, ANN INTERN MED, V131, P438, DOI 10.7326/0003-4819-131-6-199909210-00009; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; ROSENHEAD J, 2001, STUDYING ORG DELIVER; Simon H.A., 1996, SCI ARTIFICIAL, V3rd ed; Spurgeon P, 2000, BRIT MED J, V320, P838, DOI 10.1136/bmj.320.7238.838; UK Government, 2021, GP IT FUTURES SYSTEM	22	8	8	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 15	2008	337								a2321	10.1136/bmj.a2321	http://dx.doi.org/10.1136/bmj.a2321			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SS	19074942				2022-12-28	WOS:000262184600010
J	Singh, SK; Piscitelli, CL; Yamashita, A; Gouaux, E				Singh, Satinder K.; Piscitelli, Chayne L.; Yamashita, Atsuko; Gouaux, Eric			A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation	SCIENCE			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; HUMAN SEROTONIN TRANSPORTERS; TRANSMEMBRANE DOMAIN-I; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; GABA TRANSPORTER; BINDING-SITE; MECHANISM; ANTIDEPRESSANTS; DEFICIENCY	Secondary transporters are workhorses of cellular membranes, catalyzing the movement of small molecules and ions across the bilayer and coupling substrate passage to ion gradients. However, the conformational changes that accompany substrate transport, the mechanism by which a substrate moves through the transporter, and principles of competitive inhibition remain unclear. We used crystallographic and functional studies on the leucine transporter ( LeuT), a model for neurotransmitter sodium symporters, to show that various amino acid substrates induce the same occluded conformational state and that a competitive inhibitor, tryptophan ( Trp), traps LeuT in an open- to- out conformation. In the Trp complex, the extracellular gate residues arginine 30 and aspartic acid 404 define a second weak binding site for substrates or inhibitors as they permeate from the extracellular solution to the primary substrate site, which demonstrates how residues that participate in gating also mediate permeation.	[Singh, Satinder K.; Piscitelli, Chayne L.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; [Piscitelli, Chayne L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Yamashita, Atsuko] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Columbia University	Singh, SK (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.		Yamashita, Atsuko/H-5566-2017; Gouaux, Eric/Y-4370-2019	Yamashita, Atsuko/0000-0002-8001-4642; Gouaux, Eric/0000-0002-8549-2360	NIH/National Institute of Neurological Disorders and Stroke National Research Service Award; NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award; NIH Multidisciplinary Training in Neuroendocrinology; NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH083050, R01MH070039] Funding Source: NIH RePORTER	NIH/National Institute of Neurological Disorders and Stroke National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Multidisciplinary Training in Neuroendocrinology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the staff of National Synchrotron Light Source beamline X29A and Advanced Light Source beamlines 8.2.1 and 8.2.2 for assistance with data collection. S. K. S. was supported by an individual NIH/National Institute of Neurological Disorders and Stroke National Research Service Award postdoctoral fellowship and a NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award. C. L. P. was supported by an institutional NIH Multidisciplinary Training in Neuroendocrinology grant. A. Y. was on leave from the Laboratory for Structural Biochemistry, RIKEN Harima Institute at SPring-8, Japan. This work was supported by NIH (E.G.). E.G. is an investigator with the Howard Hughes Medical Institute. Coordinates and structure factors of the LeuT complexes have been deposited in the Protein Data Bank with the following accession codes: glycine (3F4J), alanine (3F48), 30 mM Leu (3F3E), methionine (3F3D), selenomethionine (3F4I), 4-fluorophenylalanine (3F3C) and Trp (3F3A).	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; BARKER EL, 2000, PSYCHOPHARMACOLOGY 4, P321; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; KIMELBERG HK, 1983, J NEUROCHEM, V40, P1265, DOI 10.1111/j.1471-4159.1983.tb13565.x; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Masson J, 1999, PHARMACOL REV, V51, P439; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	36	338	340	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1655	1661		10.1126/science.1166777	http://dx.doi.org/10.1126/science.1166777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074341	Green Accepted			2022-12-28	WOS:000261608300035
J	Gervas, J; Starfield, B; Heath, I				Gervas, Juan; Starfield, Barbara; Heath, Iona			Is clinical prevention better than cure?	LANCET			English	Editorial Material							HEALTH; CARE		[Gervas, Juan] Equipo CESCA, Med Canencia Sierra Garganta Montes & El Cuadron, Madrid, Spain; [Starfield, Barbara] Johns Hopkins Univ, Baltimore, MD USA; [Heath, Iona] Royal Coll Gen Practitioners, London, England	Novartis; Johns Hopkins University	Gervas, J (corresponding author), Equipo CESCA, Med Canencia Sierra Garganta Montes & El Cuadron, Madrid, Spain.	jgervasc@meditex.es						BARSKY AJ, 1988, NEW ENGL J MED, V318, P414, DOI 10.1056/NEJM198802183180705; Bentzen N, 2003, WONCA DICT GEN FAMIL; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Canadian Health Services Research Foundation, 2004, J Health Serv Res Policy, V9, P191; COCHRANE A L, 1955, R Soc Health J, V75, P584; Fleetcroft Robert, 2006, J Health Serv Res Policy, V11, P27, DOI 10.1258/135581906775094316; Fugelli P, 2006, PATIENT EDUC COUNS, V60, P267, DOI 10.1016/j.pec.2005.11.002; GERVAS J, 2002, EUR J GEN PRACT, V8, P47; Gervas Juan, 2006, Gac Sanit, V20 Suppl 1, P127, DOI 10.1157/13086036; Gray JAM, 1999, LANCET, V354, P1550, DOI 10.1016/S0140-6736(98)08482-7; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Heath I, 2007, BRIT MED J, V334, P19, DOI 10.1136/bmj.39066.541678.B7; HOLTZMAN NA, 1979, INT J HEALTH SERV, V9, P25, DOI 10.2190/9PJP-8R5C-JKJP-LK7A; Ilich I., 1976, MED NEMESIS EXPROPRI; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Richens J, 2000, LANCET, V355, P400, DOI 10.1016/S0140-6736(99)09109-6; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Steinberg EP, 2005, HEALTH AFFAIR, V24, P80, DOI 10.1377/hlthaff.24.1.80; StewartBrown S, 1997, BRIT MED J, V314, P533, DOI 10.1136/bmj.314.7080.533; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101	22	52	56	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1997	1999		10.1016/S0140-6736(08)61843-7	http://dx.doi.org/10.1016/S0140-6736(08)61843-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380NE	19059049				2022-12-28	WOS:000261471600026
J	Ogawa, W; Kasuga, M				Ogawa, Wataru; Kasuga, Masato			CELL SIGNALING Fat Stress and Liver Resistance	SCIENCE			English	Editorial Material							INSULIN-RESISTANCE; INFLAMMATION; SENSITIVITY; OBESITY; ACTIVATION		[Ogawa, Wataru; Kasuga, Masato] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan; [Kasuga, Masato] Int Med Ctr Japan, Res Inst, Tokyo 1628655, Japan	Kobe University; National Center for Global Health & Medicine - Japan	Ogawa, W (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan.	kasuga@med.kobe-u.ac.jp	OGAWA, Wataru/AAQ-9586-2020					Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sebba A, 2008, AM J HEALTH-SYST PH, V65, P1413, DOI 10.2146/ajhp070449; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151	15	31	33	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1483	1484		10.1126/science.1167571	http://dx.doi.org/10.1126/science.1167571			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056968				2022-12-28	WOS:000261377400031
J	Katz, IT; Wright, AA				Katz, Ingrid T.; Wright, Alexi A.			Circumcision - A Surgical Strategy for HIV Prevention in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEN						Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007433-19, T32 AI007433] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2006, PLOS MED, V3, P705, DOI 10.1371/journal.pmed.0030226; Bailey RC, 2008, B WORLD HEALTH ORGAN, V86, P669, DOI 10.2471/BLT.08.051482; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; WAWER M, 2008, 15 C RETR OPP INF BO	6	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2412	2415		10.1056/NEJMp0805791	http://dx.doi.org/10.1056/NEJMp0805791			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	378MT	19052123	Green Accepted			2022-12-28	WOS:000261325900002
J	Okie, S				Okie, Susan			Home Delivery - Bringing Primary Care to the Housebound Elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Institute of Medicine, 2008, RET AG AM BUILD HLTH; MASTER RJ, 1980, NEW ENGL J MED, V302, P1434, DOI 10.1056/NEJM198006263022602; Yaggy SD, 2006, GERONTOLOGIST, V46, P271, DOI 10.1093/geront/46.2.271	3	6	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2409	2412		10.1056/NEJMp0808067	http://dx.doi.org/10.1056/NEJMp0808067			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	378MT	19052122				2022-12-28	WOS:000261325900001
J	Gostin, LO; Hankins, CA				Gostin, Lawrence O.; Hankins, Catherine A.			Male Circumcision as an HIV Prevention Strategy in Sub-Saharan Africa Sociolegal Barriers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION; PARTNERS; HEALTH; RISK		[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS UNAIDS, Dept Evidence Monitoring & Policy, Geneva, Switzerland	Georgetown University; UNAIDS	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Hankins, Catherine/0000-0002-1642-8592				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2046, DOI 10.1001/jama.2008.588; Gostin LO, 2006, JAMA-J AM MED ASSOC, V296, P2023, DOI 10.1001/jama.296.16.2023; Hankins C, 2007, REPROD HEALTH MATTER, V15, P62, DOI 10.1016/S0968-8080(07)29311-5; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; SERWADDA D, 2008, 15 C RETR OPP INF FE; *UN EC SOC COUNC, 2000, 122004 UN EC UN COMM; UNAIDS, 2007, MAL CIRC GLOB TRENDS; *UNAIDS, 2007, SAF VOL INF MAL CIRC; *UNAIDS, 2008, LEG REG SELF ASS TOO; World Health Organization, 2007, NEW DAT MAL CIRC HIV	15	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2539	2541		10.1001/jama.2008.752	http://dx.doi.org/10.1001/jama.2008.752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050196				2022-12-28	WOS:000261286200022
J	Machin, S; Pekkarinen, T				Machin, Stephen; Pekkarinen, Tuomas			ASSESSMENT Global Sex Differences in Test Score Variability	SCIENCE			English	Editorial Material							GENDER; PERFORMANCE; HYPOTHESIS; DIVERSITY; MATH		[Pekkarinen, Tuomas] Helsinki Sch Econ, Dept Econ, Helsinki 00101, Finland; [Pekkarinen, Tuomas] Govt Inst Econ Res VATT, Helsinki 00101, Finland; [Pekkarinen, Tuomas] Abo Akad Univ, Dept Econ & Stat, SF-20500 Turku, Finland; [Machin, Stephen] UCL, Dept Econ, London WC1E 6BT, England	Aalto University; VATT Institute for Economic Research; Abo Akademi University; University of London; University College London	Pekkarinen, T (corresponding author), Helsinki Sch Econ, Dept Econ, Helsinki 00101, Finland.	tuomas.pekkarinen@hse.fi			Economic and Social Research Council [RES-107-28-1001] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], PIRLS 2001 USER GUID; Arulampalam W, 2007, IND LABOR RELAT REV, V60, P163, DOI 10.1177/001979390706000201; Bayard K, 2003, J LABOR ECON, V21, P887, DOI 10.1086/377026; Ellis H., 1894, MAN WOMAN STUDY SECO; FEINGOLD A, 1992, REV ED RE, V59, P185; Galton Francis, 1869, HEREDITARY GENIUS; Guiso L, 2008, SCIENCE, V320, P1164, DOI 10.1126/science.1154094; Hausmann R., 2006, GLOBAL GENDER GAP RE; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; JENSEN AR, 1971, INTELLIGENCE GENETIC; Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67; Leuven E, 2004, ECON J, V114, P466, DOI 10.1111/j.1468-0297.2004.00217.x; Maccoby E.E., 1974, PSYCHOL SEX DIFFEREN; Machin S, 2005, OXFORD REV ECON POL, V21, P357, DOI 10.1093/oxrep/gri021; MARTIN MO, 2005, TIMMS 2003 USER GUID; McGrayne S., 2001, NOBEL PRIZE WOMEN SC, Vsecond edition).; Muller CB, 2005, SCIENCE, V307, P1043; NODDINGS N, 1992, REV EDUC RES, V62, P85, DOI 10.3102/00346543062001085; *PISA, 2003, 2003 ASS FRAM MATH R	21	106	108	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1331	1332		10.1126/science.1162573	http://dx.doi.org/10.1126/science.1162573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	376FX	19039123				2022-12-28	WOS:000261170600021
J	Meng, W; Mushika, Y; Ichii, T; Takeichi, M				Meng, Wenxiang; Mushika, Yoshimi; Ichii, Tetsuo; Takeichi, Masatoshi			Anchorage of Microtubule Minus Ends to Adherens Junctions Regulates Epithelial Cell-Cell Contacts	CELL			English	Article							TRACKING PROTEINS; CADHERIN FUNCTION; N-CADHERIN; CATENIN; COMPLEX; DYNAMICS; KINESIN; BINDING; LOCALIZATION; P120-CATENIN	Epithelial cells contain noncentrosomal microtubules (MTs), whose minus ends are oriented apically. In contrast with the well-known interactions of the minus ends with the centrosome, little is known about the termination site of the noncentrosomal minus ends. Here we show that a population of MT minus ends is anchored at the zonula adherens (ZA), the apical-most part of the cadherin-based adherens junction, via a protein that we have termed Nezha. We initially identified PLEKHA7 as a ZA component and subsequently detected Nezha as a partner for PLEKHA7. Nezha bound MTs at their minus ends and tethered them to the ZA. Furthermore, we found that a minus end-directed motor, KIFC3, was concentrated at the ZA in a PLEKHA7/Nezha/MT-dependent manner; and depletion of any of these proteins resulted in disorganization of the ZA. We propose that the PLEKHA7/Nezha/MT complex regulates the ZA integrity by recruiting KIFC3 to this junctional site.	[Meng, Wenxiang; Mushika, Yoshimi; Ichii, Tetsuo; Takeichi, Masatoshi] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Mushika, Yoshimi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Kyoto University	Takeichi, M (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Meng, Wenxiang/0000-0003-0060-0535	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Mimori-Kiyosue for advice, N. Hirokawa for KIFC3 antibody and cDNA, and K. Shinmyozu for mass spectrometric analysis. We are also grateful to C. Yoshii, H. Abe-Ishigami, and M. Nomura-Harata for their technical support, as well as other members of our laboratory for discussion. This work was supported by a grant from the program Grants-in-Aid for Specially Promoted Research of the Ministry of Education, Science, Sports, and Culture of Japan.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Chartier NT, 2007, CANCER RES, V67, P9781, DOI 10.1158/0008-5472.CAN-07-0233; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Ichii T, 2007, GENES CELLS, V12, P827, DOI 10.1111/j.1365-2443.2007.01095.x; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kaufmann U, 1999, J CELL SCI, V112, P55; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu H, 2007, CELL STRUCT FUNCT, V32, P127, DOI 10.1247/csf.07023; Maekawa S, 2001, J BIOCHEM-TOKYO, V129, P691, DOI 10.1093/oxfordjournals.jbchem.a002908; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mogensen MM, 2000, J CELL SCI, V113, P3013; MOGENSEN MM, 1987, J CELL SCI, V88, P95; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SHIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245, DOI 10.1247/csf.11.245; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SU LK, 1995, CANCER RES, V55, P2972; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Troxell ML, 1999, AM J PHYSIOL-CELL PH, V276, pC404, DOI 10.1152/ajpcell.1999.276.2.C404; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Vogelmann R, 2005, MOL BIOL CELL, V16, P701, DOI 10.1091/mbc.E04-09-0827; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yang ZH, 1997, GENOMICS, V45, P123, DOI 10.1006/geno.1997.4901; Yvon AMC, 1997, J CELL SCI, V110, P2391	40	298	313	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					948	959		10.1016/j.cell.2008.09.040	http://dx.doi.org/10.1016/j.cell.2008.09.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041755	Bronze			2022-12-28	WOS:000261183900024
J	Coleman, R				Coleman, Robert			Commentary: Controversies in NICE guidance on metastatic spinal cord compression	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Coleman, Robert] Weston Park Hosp, Acad Unit Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England	Weston Park Hospital	Coleman, R (corresponding author), Weston Park Hosp, Acad Unit Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England.	r.e.coleman@sheffield.ac.uk						Levack P, 2002, CLIN ONCOL-UK, V14, P472, DOI 10.1053/clon.2002.0098; Levack P, 2001, 9708 CRAG; Loblaw DA, 2003, CLIN ONCOL-UK, V15, P211, DOI 10.1016/S0936-6555(02)00400-4; *NAT I HLTH CLIN E, 2008, 75 NICE NAT I HLTH C; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1	5	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 27	2008	337								a2555	10.1136/bmj.a2555	http://dx.doi.org/10.1136/bmj.a2555			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QC	19039018				2022-12-28	WOS:000261827700005
J	Kraemer, JD; Bhattacharya, D; Gostin, LO				Kraemer, John D.; Bhattacharya, Dhrubajyoti; Gostin, Lawrence O.			Blocking humanitarian assistance: a crime against humanity?	LANCET			English	Editorial Material									[Kraemer, John D.; Bhattacharya, Dhrubajyoti; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, Oneill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, Oneill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu						HUTCHINSON MR, 1993, HARVARD INT LAW J, V34, P624; MERTUS J, 2000, ILSA J INT COMP L, V6, P527; OHMAR K, 2008, UPI ASIA        0626; ROTBERG RI, 2008, BOSTON GLOBE    0625, pA15; Saechao T. R., 2007, BROOKLYN J INT LAW, V32, P663; TERRY JP, 2004, ARMY LAWYER, V8, P36; U.N. General Assembly, 2005, WORLD SUMMIT OUTCOME; *UN, 1945, CHART; UN Economic and Social Council, 2000, RIGHT HIGH ATT STAND; WHO World Health Organization, 2006, CONST WHO	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 4	2008	372	9645					1203	1205		10.1016/S0140-6736(08)61499-3	http://dx.doi.org/10.1016/S0140-6736(08)61499-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19094941				2022-12-28	WOS:000259882000008
J	Trompette, A; Divanovic, S; Visintin, A; Blanchard, C; Hegde, RS; Madan, R; Thorne, PS; Wills-Karp, M; Gioannini, TL; Weiss, JP; Karp, CL				Trompette, Aurelien; Divanovic, Senad; Visintin, Alberto; Blanchard, Carine; Hegde, Rashmi S.; Madan, Rajat; Thorne, Peter S.; Wills-Karp, Marsha; Gioannini, Theresa L.; Weiss, Jerry P.; Karp, Christopher L.			Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein	NATURE			English	Article							TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; ALLERGIC DISEASE; CELL ACTIVATION; ENDOTOXIN; MD-2; ASTHMA; LIPOPOLYSACCHARIDE; RESPONSES; EXPOSURE	Aeroallergy results from maladaptive immune responses to ubiquitous, otherwise innocuous environmental proteins(1). Although the proteins targeted by aeroallergic responses represent a tiny fraction of the airborne proteins humans are exposed to, allergenicity is a quite public phenomenon - the same proteins typically behave as aeroallergens across the human population. Why particular proteins tend to act as allergens in susceptible hosts is a fundamental mechanistic question that remains largely unanswered. The main house- dust- mite allergen, Der p 2, has structural homology with MD- 2 ( also known as LY96), the lipopolysaccharide ( LPS)- binding component of the Toll- like receptor ( TLR) 4 signalling complex(2-4). Here we show that Der p 2 also has functional homology, facilitating signalling through direct interactions with the TLR4 complex, and reconstituting LPS- driven TLR4 signalling in the absence of MD- 2. Mirroring this, airway sensitization and challenge with Der p 2 led to experimental allergic asthma in wild type and MD- 2- deficient, but not TLR4- deficient, mice. Our results indicate that Der p 2 tends to be targeted by adaptive immune responses because of its auto-adjuvant properties. The fact that other members of the MD- 2- like lipid- binding family are allergens, and that most defined major allergens are thought to be lipid- binding proteins(5), suggests that intrinsic adjuvant activity by such proteins and their accompanying lipid cargo may have some generality as a mechanism underlying the phenomenon of allergenicity.	[Trompette, Aurelien; Divanovic, Senad; Madan, Rajat; Karp, Christopher L.] Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA; [Blanchard, Carine] Childrens Hosp, Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Hegde, Rashmi S.] Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Wills-Karp, Marsha] Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Visintin, Alberto] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01606 USA; [Thorne, Peter S.] Univ Iowa, Dept Occupat & Environm Med, Iowa City, IA 52241 USA; [Gioannini, Theresa L.; Weiss, Jerry P.] Univ Iowa, Inflammat Program, Dept Internal Med, Iowa City, IA 52241 USA; [Gioannini, Theresa L.; Weiss, Jerry P.] Vet Affairs Med Ctr, Iowa City, IA 52247 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Karp, CL (corresponding author), Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA.	chris.karp@chmcc.org	Madan, Rajat/V-6168-2019	Madan, Rajat/0000-0002-9821-1257; Karp, Christopher/0000-0002-0832-2659; Thorne, Peter/0000-0002-5045-0929	Sandler Foundation for Asthma Research; National Institute of Allergy and Infectious Diseases; Veteran's Administration; NATIONAL EYE INSTITUTE [R01EY014648] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075159] Funding Source: NIH RePORTER	Sandler Foundation for Asthma Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veteran's Administration(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Vogel for re-purified LPS; E. Kurt-Jones and R. Finberg for HEK293 cells expressing TLR4 complex proteins, N.J. Gay for discussions, and L. Flick and J. Bohnert for technical assistance. This work was funded by grants from the Sandler Foundation for Asthma Research (C.L.K.), the National Institute of Allergy and Infectious Diseases (C.L.K., J.P.W.), and the Veteran's Administration (T.L.G.).	Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Gehring U, 2002, AM J RESP CRIT CARE, V166, P939, DOI 10.1164/rccm.200203-256OC; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; HEYMANN PW, 1989, J ALLERGY CLIN IMMUN, V83, P1055, DOI 10.1016/0091-6749(89)90447-8; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; MAUNSELL K, 1968, LANCET, V1, P1267; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park GM, 2000, CLIN EXP ALLERGY, V30, P1293, DOI 10.1046/j.1365-2222.2000.00883.x; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Teghanemt A, 2007, J BIOL CHEM, V282, P36250, DOI 10.1074/jbc.M705995200; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579	30	537	548	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					585	U91		10.1038/nature07548	http://dx.doi.org/10.1038/nature07548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19060881	Green Accepted			2022-12-28	WOS:000262852200042
J	Bindman, AB; Chattopadhyay, A; Auerback, GM				Bindman, Andrew B.; Chattopadhyay, Arpita; Auerback, Glenna M.			Interruptions in Medicaid Coverage and Risk for Hospitalization for Ambulatory Care-Sensitive Conditions	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-INSURANCE; MANAGED CARE; ENROLLMENT; CANCER	Background: Many low-income U.S. citizens experience interruptions in health insurance coverage. Objective: To determine the rate of hospitalization for ambulatory care-sensitive conditions among Medicaid beneficiaries with interruptions in coverage. Design: Retrospective cohort study. Setting: California Medicaid population. Patients: 4 735 797 adults in California age 18 to 64 years who received a minimum of 1 month of Medicaid coverage between 1998 to 2002. Measurement: Time to hospitalization for an ambulatory care sensitive condition. Results: Sixty-two percent of Medicaid beneficiaries experienced at least 1 interruption in coverage during the study period. The 3 most common ambulatory care-sensitive conditions resulting in a hospitalization were heart failure, diabetes, and chronic obstructive pulmonary disease. Interruptions in coverage were associated with a higher risk for hospitalization for an ambulatory care-sensitive condition (adjusted hazard ratio, 3.66 [95% CI, 3.59 to 3.72]; P < 0.001). In subgroup analyses, the association between interrupted coverage and hospitalization was stronger for beneficiaries eligible through the Temporary Aid to Needy Families program (adjusted hazard ratio, 8.56 [CI, 8.06 to 9.08]) than for beneficiaries eligible through the Supplemental Security Income program (adjusted hazard ratio, 1.72 [CI, 1.67 to 1.76]), who typically retain Medicare coverage even when their Medicaid coverage is interrupted. Limitation: The study lacked information on why interruptions occurred and whether beneficiaries with interruptions transitioned to other insurance coverage. Conclusion: Interruptions in Medicaid coverage are associated with a higher rate of hospitalization for ambulatory care-sensitive conditions. Policies that reduce the frequency of interruptions in Medicaid coverage might prevent some of the health events that trigger hospitalization and high-cost health care spending.	[Bindman, Andrew B.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Bindman, AB (corresponding author), San Francisco Gen Hosp, Bldg 10,Ward 13,1001 Potrero Ave, San Francisco, CA 94110 USA.	abindman@medsfgh.ucsf.edu	Dalla Zuanna, Teresa/G-3133-2015		The Commonwealth Fund; national, private foundation	The Commonwealth Fund; national, private foundation	By The Commonwealth Fund, a national, private foundation that supports independent research on health and social issues.	Agency for Healthcare Research and Quality, 2002, AHRQ QUAL IND GUID P; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Bindman AB, 2005, HEALTH SERV RES, V40, P19, DOI 10.1111/j.1475-6773.2005.00340.x; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Bradley CJ, 2005, CANCER-AM CANCER SOC, V103, P1712, DOI 10.1002/cncr.20954; Carrasquillo O, 1998, AM J PUBLIC HEALTH, V88, P464, DOI 10.2105/AJPH.88.3.464; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; *ER MARD ASS, 2002, US MARK RES IMPR ENR; FLEMING ST, 1995, MED CARE RES REV, V52, P88, DOI 10.1177/107755879505200106; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Harman JS, 2003, PSYCHIAT SERV, V54, P999, DOI 10.1176/appi.ps.54.7.999; *I MED, 2004, INS AM HLTH; *KAIS COMM, 2001, STAT NAT MED ENR SPE; *KAIS COMM MED UN, 2006, WHO NEEDS MED AID; KLEIN J, 2002, MED CARE STAT SECTIO; Klein K, 2005, ENTRANCES EXITS HLTH, V855, P1; Kruzikas DT, 2004, PREVENTABLE HOSPITAL; PAGE C, 1999, GUIDE MEDICAL PROGRA; Perkins CI, 2001, MED CARE, V39, P1224, DOI 10.1097/00005650-200111000-00009; RAINS J, 2001, OSHPD MEDICAL MATCH; Short PF, 2003, HEALTH AFFAIR, V22, P244, DOI 10.1377/hlthaff.22.6.244; SHORT PF, 2003, CHURN CHURN CHURN IN, V688, P1; *US GOV ACC OFF, 2007, MED STAT REP CIT DOC; YAMAGUCHI K, 1991, EVENT HIST ANAL, P182	24	73	74	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					854	+		10.7326/0003-4819-149-12-200812160-00004	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384VI	19075204				2022-12-28	WOS:000261771900002
J	Lin, YF; Gill, ME; Koubova, J; Page, DC				Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.			Germ Cell-Intrinsic and -Extrinsic Factors Govern Meiotic Initiation in Mouse Embryos	SCIENCE			English	Article							MEIOSIS; PROTEIN; FEMALE; GENE; EXPRESSION; HOMOLOG; PATHWAY; GONADS; ARREST	Retinoic acid ( RA) is an essential extrinsic inducer of meiotic initiation in mammalian germ cells. However, RA acts too widely in mammalian development to account, by itself, for the cell- type and temporal specificity of meiotic initiation. We considered parallels to yeast, in which extrinsic and intrinsic factors combine to restrict meiotic initiation. We demonstrate that, in mouse embryos, extrinsic and intrinsic factors together regulate meiotic initiation. The mouse RNA- binding protein DAZL, which is expressed by postmigratory germ cells, is a key intrinsic factor, enabling those cells to initiate meiosis in response to RA. Within a brief developmental window, Dazl- expressing germ cells in both XX and XY embryos actively acquire the ability to interpret RA as a meiosis- inducing signal.	[Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Whitehead Inst, Cambridge, MA 02142 USA; [Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lin, YF (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA.			Gill, Mark/0000-0002-2069-958X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank H. Cooke for mice carrying the Dazl<SUP>Tm1Hgu</SUP> allele; C. Heyting for SYCP3 antisera; T. Noce for MVH antisera; and A. Amon, E. Anderson, A. Baltus, A. Bortvin, M. Carmell, G. Fink, A. Hochwagen, Y. Hu, J. Lange, J. Mueller, L. Okumura, and T. Orr-Weaver for advice and comments on the manuscript. Microscopy and image capture were conducted at the W. M. Keck Foundation Biological Imaging Facility at the Whitehead Institute. This work was supported by the Howard Hughes Medical Institute.	Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bannister LA, 2004, CYTOGENET GENOME RES, V107, P191, DOI 10.1159/000080597; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BYSKOV AG, 1976, DEV BIOL, V52, P193, DOI 10.1016/0012-1606(76)90239-6; BYSKOV AGS, 1974, NATURE, V252, P396, DOI 10.1038/252396a0; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Di Carlo A, 2000, INT J DEV BIOL, V44, P241; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; HOPPER AK, 1975, GENETICS, V80, P41; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MCLAREN A, 1983, J EXP ZOOL, V228, P167, DOI 10.1002/jez.1402280203; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Scherthan H, 2003, CYTOGENET GENOME RES, V103, P235, DOI 10.1159/000076809; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; UPADHYAY S, 1982, P NATL ACAD SCI-BIOL, V79, P6584, DOI 10.1073/pnas.79.21.6584	25	186	193	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1685	1687		10.1126/science.1166340	http://dx.doi.org/10.1126/science.1166340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074348				2022-12-28	WOS:000261608300043
J	Tsai, AG; Lu, HH; Raghavan, SC; Muschen, M; Hsieh, CL; Lieber, MR				Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Muschen, Markus; Hsieh, Chih-Lin; Lieber, Michael R.			Human Chromosomal Translocations at CpG Sites and a Theoretical Basis for Their Lineage and Stage Specificity	CELL			English	Article							SINGLE-STRANDED-DNA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CLASS SWITCH RECOMBINATION; MAJOR BREAKPOINT REGION; V(D)J RECOMBINATION; CYTOSINE DEAMINATION; TRANSGENIC MICE; EXCISION-REPAIR; RAG COMPLEX; B-CELLS	We have assembled, annotated, and analyzed a database of over 1700 breakpoints from the most common chromosomal rearrangements in human leukemias and lymphomas. Using this database, we show that although the CpG dinucleotide constitutes only 1% of the human genome, it accounts for 40%-70% of breakpoints at pro-B/pre-B stage translocation regions-specifically, those near the bcl-2, bcl-1, and E2A genes. We do not observe CpG hotspots in rearrangements involving lymphoid-myeloid progenitors, mature B cells, or T cells. The stage specificity, lineage specificity, CpG targeting, and unique breakpoint distributions at these cluster regions may be explained by a lesion-specific double-strand breakage mechanism involving the RAG complex acting at AID-deaminated methyl-CpGs.	[Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Urol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA; [Muschen, Markus] Univ So Calif, Childrens Hosp Los Angeles, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pediat, Los Angeles, CA 90027 USA; [Muschen, Markus] Univ So Calif, Childrens Hosp Los Angeles, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Room 5428,1441 Eastlake Ave,MC9176, Los Angeles, CA 90089 USA.	lieber@usc.edu		Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345; Tsai, Albert/0000-0002-6607-3347	NATIONAL CANCER INSTITUTE [R01CA137060, R21CA152497, R01CA139032, R37CA051105, R01CA100504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043236, R01GM056984] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA051105-18, R01 CA139032-01, R01 CA137060, R01 CA100504-06, R01 CA100504, R37 CA051105-20, R21 CA152497, R37 CA051105, R37 CA051105-19, R01 CA139032, R37 CA051105-21] Funding Source: Medline; NIGMS NIH HHS [R01 GM043236-14, R01 GM043236, R01 GM056984, R01 GM056984-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALT FW, 1982, NATURE, V296, P325, DOI 10.1038/296325a0; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Barreto V, 2001, EUR J IMMUNOL, V31, P3763, DOI 10.1002/1521-4141(200112)31:12<3763::AID-IMMU3763>3.0.CO;2-Y; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bassing CH, 2008, BLOOD, V111, P2163, DOI 10.1182/blood-2007-08-104760; Bertoni F, 2004, BRIT J HAEMATOL, V124, P130, DOI 10.1046/j.1365-2141.2003.04761.x; Bestor TH, 2003, ANN NY ACAD SCI, V983, P22, DOI 10.1111/j.1749-6632.2003.tb05959.x; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; BURROWS PD, 1983, NATURE, V306, P243, DOI 10.1038/306243a0; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hotfilder M, 2005, CANCER RES, V65, P1442, DOI 10.1158/0008-5472.CAN-04-1356; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; LOVEC H, 1994, EMBO J, V13, P3487, DOI 10.1002/j.1460-2075.1994.tb06655.x; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; MULLER JR, 1995, CANCER RES, V55, P5012; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pine SR, 2003, LEUKEMIA RES, V27, P155, DOI 10.1016/S0145-2126(02)00183-2; Raghavan SC, 2007, DNA REPAIR, V6, P751, DOI 10.1016/j.dnarep.2006.12.016; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Schlissel MS, 2006, GENE DEV, V20, P1539, DOI 10.1101/gad.1446506; SCHMUTTE C, 1995, CANCER RES, V55, P3742; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Smith DP, 2005, ONCOGENE, V24, P3544, DOI 10.1038/sj.onc.1208399; Takai Daiya, 2003, In Silico Biology, V3, P235; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Unniraman S, 2006, DNA REPAIR, V5, P1259, DOI 10.1016/j.dnarep.2006.05.019; WADA M, 1993, BLOOD, V82, P3163; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Weinberg OK, 2007, J MOL DIAGN, V9, P530, DOI 10.2353/jmoldx.2007.070038; Welzel N, 2001, CANCER RES, V61, P1629; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Yang AS, 1996, J MOL BIOL, V258, P240, DOI 10.1006/jmbi.1996.0246; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zhang M, 2008, J BIOL CHEM, V283, P6717, DOI 10.1074/jbc.M710301200	71	176	184	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1130	1142		10.1016/j.cell.2008.10.035	http://dx.doi.org/10.1016/j.cell.2008.10.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070581	Bronze, Green Accepted			2022-12-28	WOS:000261642800028
J	Abdulla, S; Oberholzer, R; Juma, O; Kubhoja, S; Machera, F; Membi, C; Omari, S; Urassa, A; Mshinda, H; Jumanne, A; Salim, N; Shomari, M; Aebi, T; Schellenberg, DM; Carter, T; Villafana, T; Demoitie, MA; Dubois, MC; Leach, A; Lievens, M; Vekemans, J; Cohen, J; Ballou, WR; Tanner, M				Abdulla, Salim; Oberholzer, Rolf; Juma, Omar; Kubhoja, Sulende; Machera, Francisca; Membi, Christopher; Omari, Said; Urassa, Alwisa; Mshinda, Hassan; Jumanne, Ajuza; Salim, Nahya; Shomari, Mwanjaa; Aebi, Thomas; Schellenberg, David M.; Carter, Terrell; Villafana, Tonya; Demoitie, Marie-Ange; Dubois, Marie-Claude; Leach, Amanda; Lievens, Marc; Vekemans, Johan; Cohen, Joe; Ballou, W. Ripley; Tanner, Marcel			Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM-FALCIPARUM INFECTION; MOZAMBIQUE; EFFICACY; CHILDREN; DISEASE	Background: The RTS,S/AS malaria vaccine is being developed for delivery through the World Health Organization's Expanded Program on Immunization (EPI). We assessed the feasibility of integrating RTS,S/AS02D into a standard EPI schedule for infants. Methods: In this phase 2B, single-center, double-blind, controlled trial involving 340 infants in Bagamoyo, Tanzania, we randomly assigned 340 infants to receive three doses of either the RTS,S/AS02D vaccine or the hepatitis B vaccine at 8, 12, and 16 weeks of age. All infants also received a vaccine containing diphtheria and tetanus toxoids, whole-cell pertussis vaccine, and conjugated Haemophilus influenzae type b vaccine (DTPw/Hib). The primary objectives were the occurrence of serious adverse events during a 9-month surveillance period and a demonstration of noninferiority of the responses to the EPI vaccines (DTPw/Hib and hepatitis B surface antigen) with coadministration of the RTS,S/AS02D vaccine, as compared with the hepatitis B vaccine. The detection of antibodies against Plasmodium falciparum circumsporozoite and efficacy against malaria infection were secondary objectives. Results: At least one serious adverse event was reported in 31 of 170 infants who received the RTS,S/AS02D vaccine (18.2%; 95% confidence interval [CI], 12.7 to 24.9) and in 42 of 170 infants who received the hepatitis B vaccine (24.7%; 95% CI, 18.4 to 31.9). The results showed the noninferiority of the RTS,S/AS02D vaccine in terms of antibody responses to EPI antigens. One month after vaccination, 98.6% of infants receiving the RTS,S/AS02D vaccine had seropositive titers for anticircumsporozoite antibodies on enzyme-linked immunosorbent assay (ELISA). During the 6-month period after the third dose of vaccine, the efficacy of the RTS,S/AS02D vaccine against first infection with P. falciparum malaria was 65.2% (95% CI, 20.7 to 84.7; P=0.01). Conclusions: The use of the RTS,S/AS02D vaccine in infants had a promising safety profile, did not interfere with the immunologic responses to coadministered EPI antigens, and reduced the incidence of malaria infection. (ClinicalTrials.gov number, NCT00289185.).	[Abdulla, Salim; Oberholzer, Rolf; Juma, Omar; Machera, Francisca; Membi, Christopher; Omari, Said; Urassa, Alwisa; Mshinda, Hassan; Jumanne, Ajuza; Salim, Nahya; Shomari, Mwanjaa; Aebi, Thomas; Schellenberg, David M.; Tanner, Marcel] Ifakara Hlth Inst, Bagamoyo Res & Training Ctr, Bagamoyo, Tanzania; [Oberholzer, Rolf; Aebi, Thomas; Tanner, Marcel] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Kubhoja, Sulende] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Schellenberg, David M.] London Sch Hyg & Trop Med, London WC1, England; [Carter, Terrell; Villafana, Tonya] Malaria Vaccine Initiat, Program Appropriate Technol Hlth, Bethesda, MD USA; [Demoitie, Marie-Ange; Dubois, Marie-Claude; Leach, Amanda; Lievens, Marc; Vekemans, Johan; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Ballou, W. Ripley] Bill & Melinda Gates Fdn, Seattle, WA USA	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; Muhimbili University of Health & Allied Sciences; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; Bill & Melinda Gates Foundation	Abdulla, S (corresponding author), Ifakara Hlth Inst, Bagamoyo Res & Training Ctr, Box 74, Bagamoyo, Tanzania.	sabdulla@ihi.or.tz	Leach, Amanda/AAS-1120-2020	Leach, Amanda/0000-0002-7114-9967; Schellenberg, David/0000-0001-8222-0186; masoud, nahya salim/0000-0002-3784-6478	Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative; GlaxoSmithKline Biologicals; Malaria Vaccine Initiative; Bill and Melinda Gates Foundation	Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative; GlaxoSmithKline Biologicals(GlaxoSmithKline); Malaria Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported by the Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative and by GlaxoSmithKline Biologicals.; Ms. Carter and Dr. Villafana report being employees of the Malaria Vaccine Initiative, which supports the development and testing of several malaria vaccines; Drs. Demoitie, Dubois, Leach, Lievens, Vekemans, Cohen, and Ballou, being employees of GlaxoSmithKline Biologicals at the time the study was performed; Drs. Dubois, Leach, Cohen, and Ballou, having an equity interest in GlaxoSmithKline; Drs. Cohen and Ballou, being listed as inventors of patented malaria vaccines, although neither reports holding a patent for a malaria vaccine. No other potential conflict of interest relevant to this article was reported. We thank all the children and parents who participated in this study; the Bagamoyo communities and their leaders; the entire staff at Bagamoyo Research and Training Centre of Ifakara Health Institute, Bagamoyo District Hospital, and the dispensaries in the study area; Zaria Said and Richard Kamata, study counselors at the Swiss Tropical Institute, Basel, for providing key support to this trial and acting as site partners; Christoph Hatz for serving as a liaison between the trial team and the Swiss institutional review boards; Christine Walliser and Christian Wirz for their administrative and logistic support; Hans-Peter Marti for providing assistance with laboratory procedures; Rahiya Shariff for her coordination of the communications team; our colleagues in other trial sites supported by the Malaria Vaccine Initiative through the Bill and Melinda Gates Foundation, particularly the team from Centro de Investigacao em Saude de Manhica at Manhica, Mozambique, which provided support and advice for the implementation of the trial; the staff of the Malaria Project Team at GlaxoSmithKline Biologicals, particularly Nathalie Annez, Delphine Beauport, Sarah Benns, Philippe Dehottay, Issam Jaimai, Isabelle Ramboer, Shantala Rao, Christine Swysen, Joelle Thonnard, Marie Chantal Uwamwezi, Wendy Valinski, and Laurence Vigneron; Christian Loucq, Melinda Moree, and Regina Rabinovich for their hard work and dedication to the project; Karim Manji for providing continuous support and guidance; Malcolm Molyneux, chair of the data and safety monitoring board, for his instruction and support; Andrew Kitua, director of the National Institute of Health at the Ministry of Health and Social Welfare; and the staff of the Contract Laboratory Services of South Africa for providing invaluable support.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; *SADC MIN HLTH, 2007, STRAT PLAN FIGHT MAL; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; *UNICEF, 2007, IMM SUMM 2007 ED	12	170	180	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2533	2544		10.1056/NEJMoa0807773	http://dx.doi.org/10.1056/NEJMoa0807773			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19064623	Green Accepted			2022-12-28	WOS:000261534200005
J	Chapman, S				Chapman, Simon			Should smoking in outside public spaces be banned? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTHY-YOUNG ADULTS; PASSIVE SMOKING		[Chapman, Simon] Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.	sc@med.usyd.edu.au	Chapman, Simon/D-4114-2009					Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; COLE P, 1995, EPIDEMIOLOGY, V6, P78, DOI 10.1097/00001648-199501000-00016; DOLL R, 1992, BMJ-BRIT MED J, V305, P1521, DOI 10.1136/bmj.305.6868.1521; Fowles J, 2003, TOB CONTROL, V12, P424, DOI 10.1136/tc.12.4.424; Klepeis NE, 2007, J AIR WASTE MANAGE, V57, P522, DOI 10.3155/1047-3289.57.5.522; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; Staudenmayer Herman, 2003, Toxicological Reviews, V22, P235, DOI 10.2165/00139709-200322040-00005; Staudenmayer Herman, 2003, Toxicological Reviews, V22, P247, DOI 10.2165/00139709-200322040-00006; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO	10	29	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2008	337								a2804	10.1136/bmj.a2804	http://dx.doi.org/10.1136/bmj.a2804			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CB	19074219				2022-12-28	WOS:000262776900006
J	Hauser, RG; Almquist, AK				Hauser, Robert G.; Almquist, Adrian K.			Learning from Our Mistakes? Testing New ICD Technology.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIOVERTER-DEFIBRILLATOR LEAD; FAILURE		[Hauser, Robert G.; Almquist, Adrian K.] Minneapolis Heart Inst, Minneapolis, MN USA	Minneapolis Heart Institute Foundation	Hauser, RG (corresponding author), Minneapolis Heart Inst, Minneapolis, MN USA.		Hauser, Robert/AAP-1653-2020					[Anonymous], 2007, URG MED DEV INF SPRI; Gornick CC, 2005, HEART RHYTHM, V2, P681, DOI 10.1016/j.hrthm.2005.05.014; Hauser RG, 2007, HEART RHYTHM, V4, P892, DOI 10.1016/j.hrthm.2007.03.041; Kallinen LM, 2008, HEART RHYTHM, V5, P775, DOI 10.1016/j.hrthm.2008.02.039; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495	5	27	28	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2517	2519		10.1056/NEJMp0805359	http://dx.doi.org/10.1056/NEJMp0805359			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073974				2022-12-28	WOS:000261534200003
J	Tam, MDBS				Tam, Matthew D. B. S.			A to Z of radiology	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tam, Matthew D. B. S.] Norfolk & Norwich Hosp, Radiol Acad, Norwich NR4 7UB, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Tam, MDBS (corresponding author), Norfolk & Norwich Hosp, Radiol Acad, Norwich NR4 7UB, Norfolk, England.	matthewtam2005@gmail.com	Tam, Matthew/T-9812-2019						0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2008	337								a2590	10.1136/bmj.a2590	http://dx.doi.org/10.1136/bmj.a2590			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CB	19074221				2022-12-28	WOS:000262776900003
J	Fiscella, K; Tancredi, D				Fiscella, Kevin; Tancredi, Daniel			Socioeconomic Status and Coronary Heart Disease Risk Prediction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALL-CAUSE MORTALITY; CARDIOVASCULAR RISK; VALIDATION; PROJECT; SCORE		[Fiscella, Kevin] Univ Rochester, Dept Family Med, Rochester, NY USA; [Fiscella, Kevin] Univ Rochester, Dept Community & Prevent Med, Rochester, NY USA; [Fiscella, Kevin] Univ Rochester, Dept Oncol, Rochester, NY USA; [Tancredi, Daniel] Univ Calif Davis, Dept Pediat, Ctr Healthcare Policy & Res, Davis, CA 95616 USA	University of Rochester; University of Rochester; University of Rochester; University of California System; University of California Davis	Fiscella, K (corresponding author), 1381 South Ave, Rochester, NY 14620 USA.	Kevin_Fiscella@URMC.rochester.edu	Fiscella, Kevin Anthony/AFO-3350-2022; Tancredi, Daniel J/O-3381-2013	Fiscella, Kevin Anthony/0000-0003-3613-8012; Tancredi, Daniel J/0000-0002-3884-7907	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081066] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081066-01A2, R01 HL081066, 1R01 HL081066-01A2] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brindle PM, 2005, BRIT J GEN PRACT, V55, P838; *C BUDG OFF, 2008, GROW DSP LIF EXP; Claussen B, 2003, J EPIDEMIOL COMMUN H, V57, P40, DOI 10.1136/jech.57.1.40; Commission on Social Determinants of Health, 2008, CSDH FIN REP CLOS GA; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Fiscella K, 2004, ANN FAM MED, V2, P469, DOI 10.1370/afm.88; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	15	54	57	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2666	2668		10.1001/jama.2008.792	http://dx.doi.org/10.1001/jama.2008.792			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066387	Green Accepted			2022-12-28	WOS:000261503000026
J	Giraud-Roufast, A; Chabot, JM				Giraud-Roufast, Alexandra; Chabot, Jean Michel			Medical Acceptance of Quality Assurance in Health Care The French Experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Giraud-Roufast, Alexandra] Hop Hotel Dieu, Dept Publ Hlth, F-63058 Clermont Ferrand 1, France; [Chabot, Jean Michel] French Natl Author Hlth, Paris, France	CHU Clermont Ferrand	Giraud-Roufast, A (corresponding author), Hop Hotel Dieu, Dept Publ Hlth, Bd Leon Malfreyt, F-63058 Clermont Ferrand 1, France.	agiraud-roufast@chu-clermontferrand.fr						BRENNAN TA, 1996, NEW RULES; DONABEDIAN A, 1982, EXPLORATIONS QUALITY, V1; *FRENCH NAT AUTH H, 2007, ACCR MAN HOSP HLTH C; *FRENCH NAT SCH AD, 2003, PUBL HLTH POL SEM GR; Giraud A, 2001, QUAL HEALTH CARE, V10, P111, DOI 10.1136/qhc.10.2.111; *HAUT AUT SANT, RAPP ACT 2007; Holmboe ES, 2008, JAMA-J AM MED ASSOC, V299, P338, DOI 10.1001/jama.299.3.338; Lieberman D, 2006, NEW ENGL J MED, V355, P2588, DOI 10.1056/NEJMe068254; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; TANENBAUM SJ, 1993, NEW ENGL J MED, V329, P1268, DOI 10.1056/NEJM199310213291713	10	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2663	2665		10.1001/jama.2008.805	http://dx.doi.org/10.1001/jama.2008.805			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066386				2022-12-28	WOS:000261503000025
J	Volpp, KG; John, LK; Troxel, AB; Norton, L; Fassbender, J; Loewenstein, G				Volpp, Kevin G.; John, Leslie K.; Troxel, Andrea B.; Norton, Laurie; Fassbender, Jennifer; Loewenstein, George			Financial Incentive-Based Approaches for Weight Loss A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MONETARY CONTRACTS; LOSS AVERSION; OBESITY; HEALTH; OVERWEIGHT; PREVALENCE; REDUCTION; REGRET; CHOICE; ADULTS	Context Identifying effective obesity treatment is both a clinical challenge and a public health priority due to the health consequences of obesity. Objective To determine whether common decision errors identified by behavioral economists such as prospect theory, loss aversion, and regret could be used to design an effective weight loss intervention. Design, Setting, and Participants Fifty- seven healthy participants aged 30- 70 years with a body mass index of 30- 40 were randomized to 3 weight loss plans: monthly weigh- ins, a lottery incentive program, or a deposit contract that allowed for participant matching, with a weight loss goal of 1 lb ( 0.45 kg) a week for 16 weeks. Participants were recruited May- August 2007 at the Philadelphia VA Medical Center in Pennsylvania and were followed up through June 2008. Main Outcome Measures Weight loss after 16 weeks. Results The incentive groups lost significantly more weight than the control group ( mean, 3.9 lb). Compared with the control group, the lottery group lost a mean of 13.1 lb ( 95% confidence interval [ CI] of the difference in means, 1.95- 16.40; P=. 02) and the deposit contract group lost a mean of 14.0 lb ( 95% CI of the difference in means, 3.69- 16.43; P =. 006). About half of those in both incentive groups met the 16- lb target weight loss: 47.4% ( 95% CI, 24.5%- 71.1%) in the deposit contract group and 52.6% ( 95% CI, 28.9%- 75.6%) in the lottery group, whereas 10.5% ( 95% CI, 1.3%- 33.1%; P=. 01) in the control group met the 16- lb target. Although the net weight loss between enrollment in the study and at the end of 7 months was larger in the incentive groups ( 9.2 lb; t= 1.21; 95% CI, - 3.20 to 12.66; P=. 23, in the lottery group and 6.2 lb; t= 0.52; 95% CI, - 5.17 to 8.75; P=. 61 in the deposit contract group) than in the control group ( 4.4 lb), these differences were not statistically significant. However, incentive participants weighed significantly less at 7 months than at the study start ( P=. 01 for the lottery group; P=. 03 for the deposit contract group) whereas controls did not. Conclusions The use of economic incentives produced significant weight loss during the 16 weeks of intervention that was not fully sustained. The longer- term use of incentives should be evaluated. Trial Registration clinicaltrials. gov Identifier: NCT00520611.	[Volpp, Kevin G.; Troxel, Andrea B.; Norton, Laurie; Loewenstein, George] Univ Penn, Sch Med, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Norton, Laurie] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Wharton Sch, Philadelphia, PA USA; [Volpp, Kevin G.; Norton, Laurie] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Univ Penn, Sch Med, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Troxel, Andrea B.; Fassbender, Jennifer] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Troxel, Andrea B.; Fassbender, Jennifer] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [John, Leslie K.; Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Carnegie Mellon University	Volpp, KG (corresponding author), Univ Penn, Sch Med, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent, 1232 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Volpp, Kevin/0000-0003-1423-4599; Troxel, Andrea/0000-0002-1393-3075	National Institute on Aging [P30 AG12836]; Boettner Center for Pensions and Retirement Security at the University of Pennsylvania; National Institute of Child Health and Development Population Research Infrastructure Program [R24 HD-044964]; University of Pennsylvania [58-4000-70058]; S Department of Agriculture; Economic Research Service; Hewlett Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD044964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG012836] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Boettner Center for Pensions and Retirement Security at the University of Pennsylvania; National Institute of Child Health and Development Population Research Infrastructure Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Pennsylvania; S Department of Agriculture; Economic Research Service; Hewlett Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant P30 AG12836 from the National Institute on Aging, the Boettner Center for Pensions and Retirement Security at the University of Pennsylvania, grant R24 HD-044964 from National Institute of Child Health and Development Population Research Infrastructure Program, all at the University of Pennsylvania, and grant 58-4000-70058 from the US Department of Agriculture, Economic Research Service, and the Hewlett Foundation.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; [Anonymous], 2006, STRATEGIC PLAN NIH O; [Anonymous], 1988, BRIT J PSYCHIAT, DOI DOI 10.1192/S0007125000223416; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Camerer C, 2005, J MARKETING RES, V42, P129, DOI 10.1509/jmkr.42.2.129.62286; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; *COMM DEV CRIT EV, 1995, WEIGH OPT CRIT EV WE; Connolly T, 2006, J BEHAV DECIS MAKING, V19, P139, DOI 10.1002/bdm.510; Encinosa WE, 2006, MED CARE, V44, P706, DOI 10.1097/01.mlr.0000220833.89050.ed; Finkelstein EA, 2007, J OCCUP ENVIRON MED, V49, P981, DOI 10.1097/JOM.0b013e31813c6dcb; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Higgins ST, 2000, J CONSULT CLIN PSYCH, V68, P64, DOI 10.1037/0022-006X.68.1.64; Higgins ST, 1999, NBER CONF R, P157; JEFFERY RW, 1978, BEHAV RES THER, V16, P363, DOI 10.1016/0005-7967(78)90005-0; JEFFERY RW, 1983, J CONSULT CLIN PSYCH, V51, P242, DOI 10.1037/0022-006X.51.2.242; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kirby KN, 1997, J EXP PSYCHOL GEN, V126, P54, DOI 10.1037/0096-3445.126.1.54; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; LOEWENSTEIN G, 1992, Q J ECON, V107, P573, DOI 10.2307/2118482; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; McTigue KM, 2003, ANN INTERN MED, V139, P933, DOI 10.7326/0003-4819-139-11-200312020-00013; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; *NIH, 1998, OBES RES, V6, P464; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Organization WH, 1998, WELLB MEAS PRIM HLTH; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Read D, 1999, J RISK UNCERTAINTY, V19, P171, DOI 10.1023/A:1007879411489; Rizzo JA, 2003, REV ECON STAT, V85, P909, DOI 10.1162/003465303772815817; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Sindelar JL, 2008, HEALTH ECON, V17, P449, DOI 10.1002/hec.1350; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; Thaler RH, 1997, Q J ECON, V112, P647, DOI 10.1162/003355397555226; VOLPP KG, HLTH AFF MI IN PRESS	39	561	563	2	95	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2631	2637		10.1001/jama.2008.804	http://dx.doi.org/10.1001/jama.2008.804			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380YW	19066383	Green Accepted			2022-12-28	WOS:000261503000022
J	Driver, JA; Djousse, L; Logroscino, G; Gaziano, JM; Kurth, T				Driver, Jane A.; Djousse, Luc; Logroscino, Giancarlo; Gaziano, J. Michael; Kurth, Tobias			Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; LIFETIME RISK; PHYSICIANS HEALTH; ALZHEIMERS-DISEASE; BETA-CAROTENE; MORTALITY; BURDEN; STROKE; CHOLESTEROL; POPULATION	Objective To investigate the influence of increasing age on the incidence and remaining lifetime risk of cardiovascular disease and cancer in a cohort of older men. Design Prospective cohort study. Setting United States. Participants 22 048 male doctors aged 40- 84 who were free of major disease in 1982. Main outcome measures Incidence and remaining lifetime risk of major cardiovascular disease ( myocardial infarction, stroke, and death from cardiovascular disease) and cancer. Results 3252 major cardiovascular events and 5400 incident cancers were confirmed over 23 years of follow-up. The incidence of major cardiovascular disease continued to increase to age 100. Beginning at age 80, however, major cardiovascular disease was more likely to be diagnosed at death. The incidence of cancer peaked in those aged 80- 89 and then declined. Cancers detected by screening accounted for most of the decline, whereas most cancers for which there was no screening continued to increase to age 100. Unadjusted cumulative incidence overestimated the risk of cardiovascular disease by 16% and cancer by 8.5%. The remaining lifetime risk of cancer at age 40 was 45.1% ( 95% confidence interval 43.8% to 46.3%) and at age 90 was 9.6% ( 7.2% to 11.9%). The remaining lifetime risk of major cardiovascular disease at age 40 was 34.8% ( 33.1% to 36.5%) and at age 90 was 16.7% ( 12.9% to 20.6%). Conclusions In this prospective cohort of men, the incidence of new cardiovascular disease continued to increase after age 80 but was most often diagnosed at death. The decrease in incidence of cancer late in life seemed largely due to a decline in cancers usually detected by screening. These findings suggest that people aged 80 and older have a substantial amount of undiagnosed disease. The remaining lifetime risk of both diseases approached a plateau in the 10th decade. This may be due to decreased detection of disease and reporting of symptoms and increased resistance to disease in those who survive to old age. Accurate estimates of disease risk in an aging population require adjustment for competing risks of mortality.	[Driver, Jane A.; Djousse, Luc; Gaziano, J. Michael; Kurth, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02215 USA; [Logroscino, Giancarlo] Univ Bari, Sch Med, Dept Neurol & Psychiat, Bari, Italy; [Gaziano, J. Michael; Kurth, Tobias] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res Informat Ctr, Boston, MA USA; [Kurth, Tobias] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universita degli Studi di Bari Aldo Moro; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Driver, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02215 USA.	jdriver@partners.org	Djousse, Luc/F-5033-2017; Kurth, Tobias/A-9243-2012; LOGROSCINO, GIANCARLO/K-5148-2016	Djousse, Luc/0000-0002-9902-3047; Kurth, Tobias/0000-0001-7169-2620; LOGROSCINO, GIANCARLO/0000-0003-0423-3242	Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School; Eleanor and the Miles Shore 50th anniversary fellowship programme; Harvard Medical School; National Cancer Institute [CA-34944, CA-40360, CA-097193]; National Heart, Lung, and Blood Institute, Bethesda, Maryland [HL-26490, HL-34595]; NATIONAL CANCER INSTITUTE [R01CA040360, R01CA097193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School; Eleanor and the Miles Shore 50th anniversary fellowship programme; Harvard Medical School; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors' work was independent of the funders. JAD received support for this research from the Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School and the Eleanor and the Miles Shore 50th anniversary fellowship programme for scholars in medicine at Harvard Medical School. The Physicians' Health Study is supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute, and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.	Arias HR, 2003, INT REV NEUROBIOL, V54, P1, DOI 10.1016/S0074-7742(03)54002-8; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; BRODY JA, 1986, J CHRON DIS, V39, P871, DOI 10.1016/0021-9681(86)90035-4; CASTELLI WP, 1989, AM J CARDIOL, V63, P12; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Cook NR, 2000, ARCH INTERN MED, V160, P921, DOI 10.1001/archinte.160.7.921; de Rijke JM, 2000, CANCER, V89, P1121, DOI 10.1002/1097-0142(20000901)89:5<1121::AID-CNCR22>3.3.CO;2-7; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Merrill RM, 2001, ANN EPIDEMIOL, V11, P547, DOI 10.1016/S1047-2797(01)00254-X; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Saltzstein SL, 1998, J AM GERIATR SOC, V46, P994, DOI 10.1111/j.1532-5415.1998.tb02755.x; SCHOUTEN LJ, 1994, J EPIDEMIOL COMMUN H, V48, P596, DOI 10.1136/jech.48.6.596; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; UN Population Division, 2002, WORLD POP AG 1950 20; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; *WHO, 1971, ISCH HEART DIS REG R; *WHO, 2007, TOP 10 CAUS DEATH; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	30	108	112	1	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2008	337								a2467	10.1136/bmj.a2467	http://dx.doi.org/10.1136/bmj.a2467			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399BZ	19066258	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000262776700003
J	Soligard, T; Myklebust, G; Steffen, K; Holme, I; Silvers, H; Bizzini, M; Junge, A; Dvorak, J; Bahr, R; Andersen, TE				Soligard, Torbjorn; Myklebust, Grethe; Steffen, Kathrin; Holme, Ingar; Silvers, Holly; Bizzini, Mario; Junge, Astrid; Dvorak, Jiri; Bahr, Roald; Andersen, Thor Einar			Comprehensive warm-up programme to prevent injuries in young female footballers: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CRUCIATE LIGAMENT INJURY; SOCCER PLAYERS; TEAM HANDBALL; PROSPECTIVE INTERVENTION; EUROPEAN FOOTBALL; TRAINING-PROGRAM; HIGH PREVALENCE; VIDEO ANALYSIS; ELITE SOCCER; RISK-FACTORS	Objective To examine the effect of a comprehensive warm-up programme designed to reduce the risk of injuries in female youth football. Design Cluster randomised controlled trial with clubs as the unit of randomisation. Setting 125 football clubs from the south, east, and middle of Norway ( 65 clusters in the intervention group; 60 in the control group) followed for one league season ( eight months). Participants 1892 female players aged 13- 17 ( 1055 players in the intervention group; 837 players in the control group). Intervention A comprehensive warm- up programme to improve strength, awareness, and neuromuscular control during static and dynamic movements. Main outcome measure Injuries to the lower extremity ( foot, ankle, lower leg, knee, thigh, groin, and hip). Results During one season, 264 players had relevant injuries: 121 players in the intervention group and 143 in the control group ( rate ratio 0.71, 95% confidence interval 0.49 to 1.03). In the intervention group there was a significantly lower risk of injuries overall ( 0.68, 0.48 to 0.98), overuse injuries ( 0.47, 0.26 to 0.85), and severe injuries ( 0.55, 0.36 to 0.83). Conclusion Though the primary outcome of reduction in lower extremity injury did not reach significance, the risk of severe injuries, overuse injuries, and injuries overall was reduced. This indicates that a structured warm- up programme can prevent injuries in young female football players. Trial registration ISRCTN10306290.	[Soligard, Torbjorn; Myklebust, Grethe; Steffen, Kathrin; Holme, Ingar; Bahr, Roald; Andersen, Thor Einar] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway; [Silvers, Holly] Santa Monica Orthopaed & Sports Med Res Fdn, Santa Monica, CA 90404 USA; [Bizzini, Mario; Junge, Astrid; Dvorak, Jiri] Schulthess Clin, FIFA Med Assessment & Res Ctr, CH-8008 Zurich, Switzerland	Norwegian School of Sport Sciences; Schulthess Clinic	Soligard, T (corresponding author), Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, POB 4014,Ullevaal Stad, N-0806 Oslo, Norway.	torbjorn.soligard@nih.no	Silvers-Granelli, Holly/D-4467-2014; Bahr, Roald/B-6964-2014	Silvers-Granelli, Holly/0000-0002-8959-9448; Andersen, Thor Einar/0000-0003-4172-4518; Soligard, Torbjorn/0000-0001-8863-4574; Junge, Astrid/0000-0002-6815-9793; Bahr, Roald/0000-0001-5725-4237	FIFA Medical Assessment and Research Centre; Royal Norwegian Ministry of Culture and Church Affairs; South-Eastern Norway Regional Health Authority; Norwegian Olympic Committee and Confederation of Sport; Norsk Tipping AS	FIFA Medical Assessment and Research Centre; Royal Norwegian Ministry of Culture and Church Affairs; South-Eastern Norway Regional Health Authority; Norwegian Olympic Committee and Confederation of Sport; Norsk Tipping AS	This study was supported by grants from the FIFA Medical Assessment and Research Centre. The Oslo Sports Trauma Research Center has been established at the Norwegian School of Sport Sciences through grants from the Royal Norwegian Ministry of Culture and Church Affairs, the South-Eastern Norway Regional Health Authority, the Norwegian Olympic Committee and Confederation of Sport, and Norsk Tipping AS. No author or related institution has received any financial benefit from research in this study.	Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P172, DOI 10.1111/j.1600-0838.1997.tb00135.x; Bahr R, 2003, BRIT J SPORT MED, V37, P384, DOI 10.1136/bjsm.37.5.384; Becker A, 2006, SPORTVERLETZ SPORTSC, V20, P196, DOI 10.1055/s-2006-927193; BEYNNON BD, 1995, AM J SPORT MED, V23, P24, DOI 10.1177/036354659502300105; Bjordal JM, 1997, AM J SPORT MED, V25, P341, DOI 10.1177/036354659702500312; Boden BP, 2000, ORTHOPEDICS, V23, P573, DOI 10.3928/0147-7447-20000601-15; Caraffa A, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P19, DOI 10.1007/BF01565992; Chappell JD, 2002, AM J SPORT MED, V30, P261, DOI 10.1177/03635465020300021901; Dvorak J., 2005, FOOTBALL MED MANUAL, P81; Ebstrup JF, 2000, SCAND J MED SCI SPOR, V10, P114, DOI 10.1034/j.1600-0838.2000.010002114.x; Emery CA, 2005, CAN MED ASSOC J, V172, P749, DOI 10.1503/cmaj.1040805; ENGSTROM B, 1991, AM J SPORT MED, V19, P372, DOI 10.1177/036354659101900408; Fagenbaum R, 2003, AM J SPORT MED, V31, P233, DOI 10.1177/03635465030310021301; Faude O, 2005, AM J SPORT MED, V33, P1694, DOI 10.1177/0363546505275011; FIFA, FIFA BIG COUNT 2006; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Heidt RS, 2000, AM J SPORT MED, V28, P659, DOI 10.1177/03635465000280050601; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hewett TE, 1996, AM J SPORT MED, V24, P765, DOI 10.1177/036354659602400611; Jacobson I, 2007, SCAND J MED SCI SPOR, V17, P84, DOI 10.1111/j.1600-0838.2006.00524.x; Jacobsson I, 2006, ADV PHYSIOTHER, V8, P66; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Junge A, 2007, BRIT J SPORT MED, V41, pI3, DOI 10.1136/bjsm.2007.036020; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Li G, 1999, J BIOMECH, V32, P395, DOI 10.1016/S0021-9290(98)00181-X; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; Mjolsnes R, 2004, SCAND J MED SCI SPOR, V14, P311, DOI 10.1046/j.1600-0838.2003.367.x; Myklebust G, 2005, BRIT J SPORT MED, V39, P127, DOI 10.1136/bjsm.2004.010900; Myklebust G, 2003, CLIN J SPORT MED, V13, P71, DOI 10.1097/00042752-200303000-00002; Olsen OE, 2006, SCAND J MED SCI SPOR, V16, P426, DOI 10.1111/j.1600-0838.2005.00484.x; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Ostenberg A, 2000, SCAND J MED SCI SPOR, V10, P279, DOI 10.1034/j.1600-0838.2000.010005279.x; Powell JW, 2000, AM J SPORT MED, V28, P385, DOI 10.1177/03635465000280031801; Soderman K, 2000, KNEE SURG SPORT TR A, V8, P356, DOI 10.1007/s001670000147; Soderman K, 2001, SCAND J MED SCI SPOR, V11, P299, DOI 10.1034/j.1600-0838.2001.110508.x; STEFFEN K, 2008, SCAND J MED SCI 0114; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; Tegnander A, 2008, KNEE SURG SPORT TR A, V16, P194, DOI 10.1007/s00167-007-0403-z; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Withrow TJ, 2008, J BONE JOINT SURG AM, V90A, P815, DOI 10.2106/JBJS.F.01352	46	446	460	1	90	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2008	337								a2469	10.1136/bmj.a2469	http://dx.doi.org/10.1136/bmj.a2469			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399BZ	19066253	Green Published, hybrid			2022-12-28	WOS:000262776700004
J	Kao, DP				Kao, David P.			What can we learn from drug marketing efficiency?	BRITISH MEDICAL JOURNAL			English	Editorial Material							FDA; RATES		[Kao, David P.] Univ Colorado, Ctr Hlth Sci, Acad Off 1, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Kao, DP (corresponding author), Univ Colorado, Ctr Hlth Sci, Acad Off 1, 12631 E 17th Ave,Suite 7102, Aurora, CO 80045 USA.	dkao42@yahoo.com	Kao, David P/K-3288-2013	Kao, David P/0000-0002-2832-9348	NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER; NLM NIH HHS [2 T15 LM007033-24] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BERKROT B, 2006, REUTERS         1121; Berndt ER, 2005, NAT REV DRUG DISCOV, V4, P545, DOI 10.1038/nrd1774; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; DiMasi JA, 2004, PHARMACOECONOMICS, V22, P1, DOI 10.2165/00019053-200422002-00002; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P286, DOI 10.1067/mcp.2001.115132; Hong Song Hee, 2005, J Manag Care Pharm, V11, P746; Horton R, 2001, LANCET, V357, P1544, DOI 10.1016/S0140-6736(00)04776-0; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; McClellan M, 2007, NEW ENGL J MED, V356, P1700, DOI 10.1056/NEJMp078057; *MED HEALTHC PROD, CORP PLAN 2008 2013; Okie S, 2005, NEW ENGL J MED, V352, P1063, DOI 10.1056/NEJMp058003; *PFIZ, 2006 FIN REP; PLATT R, 2007, USING HLTH PLAN DATA; Union of Concerned Scientists, 2006, VOIC SCI FDA PROT PU; *UPPS MON CTR, REP WHO COLL CTR INT; *US DEP HHS, 2007, BUDG BRIEF FY 2007; Vilas-Boas I, 1997, J MANAGE CARE PHARM, V3, P459	18	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 2	2008	337								a2591	10.1136/bmj.a2591	http://dx.doi.org/10.1136/bmj.a2591			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NV	19050331	Green Published			2022-12-28	WOS:000261890800018
J	Long, FX				Long, Fanxin			When the Gut Talks to Bone	CELL			English	Editorial Material							RECEPTOR-RELATED PROTEIN-5; OSTEOBLAST; DIFFERENTIATION; PROGENITORS; MUTATION; HEDGEHOG; ROLES; LRP5	Mutations in LRP5, a coreceptor for Wnt proteins, cause the disease osteoporosis pseudoglioma. A new study by Yadav et al. (2008) now challenges the view that LRP5 controls bone mass through Wnt signaling in bone and argues instead that LRP5 regulates bone mass indirectly through its effects on serotonin synthesis in the gut.	[Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63131 USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63131 USA	Washington University (WUSTL); Washington University (WUSTL)	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63131 USA.	flong@wustl.edu						Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259	10	13	14	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					795	796		10.1016/j.cell.2008.11.007	http://dx.doi.org/10.1016/j.cell.2008.11.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041744	Bronze			2022-12-28	WOS:000261183900011
J	White, BD; Stirling, AJ; Paterson, E; Asquith-Coe, K; Melder, A				White, B. D.; Stirling, A. J.; Paterson, E.; Asquith-Coe, K.; Melder, A.		Guideline Dev Grp	Diagnosis and management of patients at risk of or with metastatic spinal cord compression: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							ONTARIO		[White, B. D.] Queens Med Ctr, Univ Nottingham Hosp NHS Trust, Nottingham NG7 2UH, England; [Stirling, A. J.] Royal Orthopaed Hosp NHS Fdn Trust, Dept Spinal Surg, Birmingham B31 2AP, W Midlands, England; [Paterson, E.] Govan Hlth Ctr, Glasgow G51 4BJ, Lanark, Scotland; [Asquith-Coe, K.; Melder, A.] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, Wales	Nottingham University Hospital NHS Trust; University of Nottingham; Royal Orthopaedic Hospital	White, BD (corresponding author), Queens Med Ctr, Univ Nottingham Hosp NHS Trust, Nottingham NG7 2UH, England.	barrie.white@nuh.nhs.uk			National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Cancer was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	*DEV WORK GROUP, 2007, W SCOTL MAL SPIN COR; EVAN G, 2003, EUR J PALLIAT CARE, V10, P148; Levack P, 2002, CLIN ONCOL-UK, V14, P472, DOI 10.1053/clon.2002.0098; Levack P, 2001, 9708 CRAG; Loblaw DA, 2005, J CLIN ONCOL, V23, P2028, DOI 10.1200/JCO.2005.00.067; Loblaw DA, 2003, CLIN ONCOL-UK, V15, P211, DOI 10.1016/S0936-6555(02)00400-4; *NAT I HLTH CLIN E, 2008, LOW BACK PAIN AC MAN; *NAT I HLTH CLIN E, 2007, 49 NICE NAT I HLTH C; *NAT I HLTH CLIN E, 2003, 7 NICE NAT I HLTH CL; *NAT I HLTH CLIN E, 2008, 75 NICE NAT I HLTH C; *NAT I HLTH CLIN E, 2005, 29 NICE NAT I HLTH C; *NAT I HLTH CLIN E, 2007, 46 NICE NAT I HLTH C; National Institute for Health and Clinical Excellence, 2007, GUID MAN	13	40	42	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 27	2008	337								a2538	10.1136/bmj.a2538	http://dx.doi.org/10.1136/bmj.a2538			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QC	19039017				2022-12-28	WOS:000261827700002
J	Bray, GA				Bray, George A.			Is new hope on the horizon for obesity?	LANCET			English	Editorial Material							PHARMACOTHERAPY; METAANALYSIS; RIMONABANT; OVERWEIGHT; TRIALS		[Bray, George A.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bray, GA (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	george.Bray@PBRC.edu						Astrup A, 2008, LANCET, V372, P1906, DOI 10.1016/S0140-6736(08)61525-1; Bray GA, 1999, ENDOCR REV, V20, P805, DOI 10.1210/er.20.6.805; Bray GA., 2007, BATTLE BULGE; Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; European Medicines Agency, 2008, PUBL STAT BEXTR VALD; Galuska D. A., 2008, Morbidity and Mortality Weekly Report, V57, P765; Haddock CK, 2002, INT J OBESITY, V26, P262, DOI 10.1038/sj.ijo.0801889; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P586, DOI 10.1038/clpt.1992.69	12	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1859	1860		10.1016/S0140-6736(08)61792-4	http://dx.doi.org/10.1016/S0140-6736(08)61792-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041787				2022-12-28	WOS:000261388700005
J	Qaseem, A; Snow, V; Shekelle, P; Hopkins, R; Owens, DK				Qaseem, Amir; Snow, Vincenza; Shekelle, Paul; Hopkins, Robert, Jr.; Owens, Douglas K.		Clinical Efficacy Assessment Subco	Screening for HIV in Health Care Settings: A Guidance Statement From the American College of Physicians and HIV Medicine Association	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; UNITED-STATES; COST-EFFECTIVENESS; RECOMMENDATIONS; TRANSMISSION; INFECTION	Description: The American College of Physicians (ACP) developed this guidance statement to present the available evidence on screening for HIV in health care settings. Methods: This guidance statement is derived from an appraisal of available guidelines on screening for HIV. Authors searched the National Guideline Clearinghouse to identify guidelines on screening for HIV in the United States and used the AGREE ( Appraisal of Guidelines Research and Evaluation) instrument to evaluate guidelines from the U. S. Preventive Services Task Force and the Centers for Disease Control and Prevention. Guidance Statement 1: ACP recommends that clinicians adopt routine screening for HIV and encourage patients to be tested. Guidance Statement 2: ACP recommends that clinicians determine the need for repeat screening on an individual basis.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Santa Monica, CA USA; RAND Corp, Santa Monica, CA USA; Univ Arkansas, Little Rock, AR 72204 USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA	American College of Physicians; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Adams K., 2003, PRIORITY AREAS NATL; *AM COLL OBST GYN, 2008, OBSTET GYNECOL, V112, P413; American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V112, P401, DOI 10.1097/AOG.0b013e318183fbc2; [Anonymous], 2006, MMWR RECOMM REP; [Anonymous], NAT HIV PREV C ATL G; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P1145; *CDCP, 2008, CAS HIV INF AIDS US, V18; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P538; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P380; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US C; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; CHOU R, 2007, AHRQ PUBLICATION; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Cummiskey J., 2008, Morbidity and Mortality Weekly Report, V57, P660; Department of Health and Human Services, 2008, GUID US ANT AG HIV 1, P1; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Holtgrave DR, 2007, PLOS MED, V4, P1011, DOI 10.1371/journal.pmed.0040194; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Liddicoat RV, 2006, AIDS PATIENT CARE ST, V20, P84, DOI 10.1089/apc.2006.20.84; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; ORSULICJERAS S, 2005, J MENTAL HLTH COUNSE, V25, P233; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; Owens DK, 2007, J GEN INTERN MED, V22, P315, DOI 10.1007/s11606-006-0028-9; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; ROTHERAMBORUS MJ, 1997, AIDS BEHAV, V1, P43, DOI DOI 10.1023/A:1026213905034; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Schuman Paula, 2004, MedGenMed, V6, P52; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; *US PREV SERV TASK, 2007, US PREV SERV TASK FO; *US PREV SERV TASK, 2007, AHRQ PUBL; Walensky R. P., 2004, Morbidity and Mortality Weekly Report, V53, P523; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; Walensky RP, 2002, ARCH INTERN MED, V162, P887, DOI 10.1001/archinte.162.8.887; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Webster RD, 2003, JAIDS-J ACQ IMM DEF, V33, P223, DOI 10.1097/00126334-200306010-00018	42	105	105	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					125	U86		10.7326/0003-4819-150-2-200901200-00300	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00300			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19047022				2022-12-28	WOS:000262655200007
J	Sasaki, S; Mello, CC; Shimada, A; Nakatani, Y; Hashimoto, SI; Ogawa, M; Matsushima, K; Gu, SGP; Kasahara, M; Ahsan, B; Sasaki, A; Saito, T; Suzuki, Y; Sugano, S; Kohara, Y; Takeda, H; Fire, A; Morishita, S				Sasaki, Shin; Mello, Cecilia C.; Shimada, Atsuko; Nakatani, Yoichiro; Hashimoto, Shin-ichi; Ogawa, Masako; Matsushima, Kouji; Gu, Sam Guoping; Kasahara, Masahiro; Ahsan, Budrul; Sasaki, Atsushi; Saito, Taro; Suzuki, Yutaka; Sugano, Sumio; Kohara, Yuji; Takeda, Hiroyuki; Fire, Andrew; Morishita, Shinichi			Chromatin-Associated Periodicity in Genetic Variation Downstream of Transcriptional Start Sites	SCIENCE			English	Article							NUCLEOSOME POSITIONS; HIGH-RESOLUTION; HUMAN GENOME; DNA-REPAIR; EVOLUTION; YEAST; PROMOTERS; STRAND	Might DNA sequence variation reflect germline genetic activity and underlying chromatin structure? We investigated this question using medaka (Japanese killifish, Oryzias latipes), by comparing the genomic sequences of two strains (Hd-rR and HNI) and by mapping similar to 37.3 million nucleosome cores from Hd-rR blastulae and 11,654 representative transcription start sites from six embryonic stages. We observed a distinctive similar to 200-base pair (bp) periodic pattern of genetic variation downstream of transcription start sites; the rate of insertions and deletions longer than 1 bp peaked at positions of approximately +200, +400, and +600 bp, whereas the point mutation rate showed corresponding valleys. This similar to 200-bp periodicity was correlated with the chromatin structure, with nucleosome occupancy minimized at positions 0, +200, +400, and +600 bp. These data exemplify the potential for genetic activity (transcription) and chromatin structure to contribute to molding the DNA sequence on an evolutionary time scale.	[Mello, Cecilia C.; Gu, Sam Guoping; Fire, Andrew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Mello, Cecilia C.; Gu, Sam Guoping; Fire, Andrew] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Sasaki, Shin; Nakatani, Yoichiro; Kasahara, Masahiro; Ahsan, Budrul; Sasaki, Atsushi; Saito, Taro; Morishita, Shinichi] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan; [Shimada, Atsuko; Takeda, Hiroyuki] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Hashimoto, Shin-ichi; Ogawa, Masako; Matsushima, Kouji] Univ Tokyo, Dept Mol Prevent Med, Sch Med, Tokyo 1130033, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Kohara, Yuji] Res Org Informat & Syst, Ctr Genet Resources Informat, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Morishita, Shinichi] Japan Sci & Technol Agcy, Tokyo 1028666, Japan	Stanford University; Stanford University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Fire, A (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	afire@stanford.edu; moris@cb.k.u-tokyo.ac.jp	TAKEDA, HIROYUKI/G-4950-2014; Pillay, Nischalan/F-9536-2012	Kasahara, Masahiro/0000-0001-8430-1414; Fire, Andrew/0000-0001-6217-8312; Nakatani, Yoichiro/0000-0001-7604-0242; Morishita, Shinichi/0000-0002-6201-8885	Monbukagakusho; Japan Science and Technology Agency; NIH [T32 CA09151, R01 GM37706]; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (C) from the Monbukagakusho: MEXT, by the Japan Science and Technology Agency, and by the NIH (T32 CA09151 to C. C. M.; R01 GM37706 to A. F.). Computational time was provided by the Human Genome Center and the Information Technology Center, the University of Tokyo. We thank A. Sidow, A. Valouev, S. Johnson, J. Ford, and J. Cai for specific advice over the course of this work, and our colleagues at each institution for their help and suggestions. All sequence data are deposited at NCBI Short Read Archive (accession number SRA002449).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Higasa K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-66; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Suter B, 1997, EMBO J, V16, P2150, DOI 10.1093/emboj/16.8.2150; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Tijsterman M, 1999, MOL CELL BIOL, V19, P934; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Washietl S, 2008, TRENDS GENET, V24, P583, DOI 10.1016/j.tig.2008.09.003; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391	23	100	102	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					401	404		10.1126/science.1163183	http://dx.doi.org/10.1126/science.1163183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074313	Green Accepted			2022-12-28	WOS:000262481400044
J	Imambekov, A; Glazman, LI				Imambekov, Adilet; Glazman, Leonid I.			Universal Theory of Nonlinear Luttinger Liquids	SCIENCE			English	Article							DIMENSIONAL QUANTUM FLUIDS; MANY-FERMION SYSTEM; EXCITATIONS; MODEL	One- dimensional quantum fluids are conventionally described by using an effective hydrodynamic approach known as Luttinger liquid theory. As the principal simplification, a generic spectrum of the constituent particles is replaced by a linear one, which leads to a linear hydrodynamic theory. We show that to describe the measurable dynamic response functions one needs to take into account the nonlinearity of the generic spectrum and thus of the resulting quantum hydrodynamic theory. This nonlinearity leads, for example, to a qualitative change in the behavior of the spectral function. The universal theory developed in this article is applicable to a wide class of one-dimensional fermionic, bosonic, and spin systems.	[Imambekov, Adilet; Glazman, Leonid I.] Yale Univ, Dept Phys, New Haven, CT 06520 USA	Yale University	Glazman, LI (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.	Leonid.Glazman@yale.edu	Imambekov, Adilet/D-1687-2009		U.S. Department of Energy [DE-FG02-08ER46482]	U.S. Department of Energy(United States Department of Energy (DOE))	We thank A. Kamenev and D. Abanin for useful discussions. This work was supported by U.S. Department of Energy grant no. DE-FG02-08ER46482.	Abanin DA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.186803; ALBANIN DA, 2004, PHYS REV LETT, V93; Auslaender OM, 2002, SCIENCE, V295, P825, DOI 10.1126/science.1066266; Bettelheim E, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/39/392003; Cheianov VV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.126403; Dao TL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.240402; Duan LM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.103201; Dzyaloshinskii I. E., 1974, SOV PHYS JETP, V38, P202; GIAMARCHI T, 2004, QUANTUM PHYS 1 DMENS; HALDANE FDM, 1981, PHYS REV LETT, V47, P1840, DOI 10.1103/PhysRevLett.47.1840; HALDANE FDM, 1981, J PHYS C SOLID STATE, V14, P2585, DOI 10.1088/0022-3719/14/19/010; Imambekov A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206805; LUTHER A, 1974, PHYS REV B, V9, P2911, DOI 10.1103/PhysRevB.9.2911; MATTIS DC, 1965, J MATH PHYS, V6, P304, DOI 10.1063/1.1704281; Pereira RG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.027206; Pustilnik M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.196405; Pustilnik M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126805; Rozhkov AV, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.245123; Rozhkov AV, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125109; Rozhkov AV, 2005, EUR PHYS J B, V47, P193, DOI 10.1140/epjb/e2005-00312-3; Schollwock U, 2005, REV MOD PHYS, V77, P259, DOI 10.1103/RevModPhys.77.259; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863	28	184	187	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					228	231		10.1126/science.1165403	http://dx.doi.org/10.1126/science.1165403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19039106	Green Submitted			2022-12-28	WOS:000262290600031
J	Lee, HN; Paeng, K; Swallen, SF; Ediger, MD				Lee, Hau-Nan; Paeng, Keewook; Swallen, Stephen F.; Ediger, M. D.			Direct Measurement of Molecular Mobility in Actively Deformed Polymer Glasses	SCIENCE			English	Article							SPATIALLY HETEROGENEOUS DYNAMICS; CONSTITUTIVE MODEL; AMORPHOUS POLYMERS; DEFORMATION; RELAXATION; STRAIN; PLASTICITY; TRANSITION; FLOW; PMMA	When sufficient force is applied to a glassy polymer, it begins to deform through movement of the polymer chains. We used an optical photobleaching technique to quantitatively measure changes in molecular mobility during the active deformation of a polymer glass [ poly( methyl methacrylate)]. Segmental mobility increases by up to a factor of 1000 during uniaxial tensile creep. Although the Eyring model can describe the increase in mobility at low stress, it fails to describe mobility after flow onset. In this regime, mobility is strongly accelerated and the distribution of relaxation times narrows substantially, indicating a more homogeneous ensemble of local environments. At even larger stresses, in the strain- hardening regime, mobility decreases with increasing stress. Consistent with the view that stress- induced mobility allows plastic flow in polymer glasses, we observed a strong correlation between strain rate and segmental mobility during creep.	[Lee, Hau-Nan; Paeng, Keewook; Swallen, Stephen F.; Ediger, M. D.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lee, HN (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.		Ediger, Mark/AGZ-4130-2022	Ediger, Mark/0000-0003-4715-8473	NSF [NIRT0506840]	NSF(National Science Foundation (NSF))	This work was supported by NSF through grant NIRT0506840. We thank K. Schweizer, J. Caruthers, G. Medvedev, J. de Pablo, and R. Riggleman for helpful discussions.	Bergman R, 1998, J NON-CRYST SOLIDS, V235, P580, DOI 10.1016/S0022-3093(98)00639-5; BOYCE MC, 1988, MECH MATER, V7, P15, DOI 10.1016/0167-6636(88)90003-8; BUCKLEY CP, 1995, POLYMER, V36, P3301, DOI 10.1016/0032-3861(95)99429-X; Capaldi FM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.175505; Caruthers JM, 2004, POLYMER, V45, P4577, DOI 10.1016/j.polymer.2004.04.021; Casas F, 2008, MACROMOLECULES, V41, P860, DOI 10.1021/ma0714969; Chen K, 2008, MACROMOLECULES, V41, P5908, DOI 10.1021/ma800778v; Chen K, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/26006; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; Eyring H, 1936, J CHEM PHYS, V4, P283, DOI 10.1063/1.1749836; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; Haxton TK, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.195701; Kramer EJ, 2005, J POLYM SCI POL PHYS, V43, P3369, DOI 10.1002/polb.20639; Lee HN, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2868774; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Loo LS, 2000, SCIENCE, V288, P116, DOI 10.1126/science.288.5463.116; Lyulin AV, 2005, EUROPHYS LETT, V71, P618, DOI 10.1209/epl/i2005-10133-0; Martinez-Vega JJ, 2002, POLYMER, V43, P4979, DOI 10.1016/S0032-3861(02)00332-4; McKenna GB, 2003, J PHYS-CONDENS MAT, V15, pS737, DOI 10.1088/0953-8984/15/11/301; Meijer HEH, 2005, PROG POLYM SCI, V30, P915, DOI 10.1016/j.progpolymsci.2005.06.009; Riggleman RA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.215501; Riggleman RA, 2008, MACROMOLECULES, V41, P4969, DOI 10.1021/ma8001214; ROBERTSON RE, 1966, J CHEM PHYS, V44, P3950, DOI 10.1063/1.1726558; Schall P, 2007, SCIENCE, V318, P1895, DOI 10.1126/science.1149308; Struik L. C. E., 1978, PHYS AGING AMORPHOUS; Thurau CT, 2002, J CHEM PHYS, V116, P9089, DOI 10.1063/1.1472508; van Melick HGH, 2003, POLYMER, V44, P2493, DOI 10.1016/S0032-3861(03)00112-5; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; YEE AF, 1988, J POLYM SCI POL PHYS, V26, P2463, DOI 10.1002/polb.1988.090261206	29	231	237	7	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					231	234		10.1126/science.1165995	http://dx.doi.org/10.1126/science.1165995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19039104				2022-12-28	WOS:000262290600032
J	Berkoff, MC; Zolotor, AJ; Makoroff, KL; Thackeray, JD; Shapiro, RA; Runyan, DK				Berkoff, Molly Curtin; Zolotor, Adam J.; Makoroff, Kathi L.; Thackeray, Jonathan D.; Shapiro, Robert A.; Runyan, Desmond K.			Has This Prepubertal Girl Been Sexually Abused?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADOLESCENT GIRLS; GENITAL INJURIES; CHILDREN; APPEARANCE; HYMEN; ANATOMY; LIFE; CARE; AGE	Context The legal and social sequelae of interpreting genital findings as indicative of sexual abuse are significant. While the absence of genital trauma does not rule out sexual abuse, the physical examination can identify genital findings compatible with sexual abuse. Objectives To determine the diagnostic utility of the genital examination in prepubertal girls for identifying nonacute sexual abuse. Data Sources Published articles ( 1966- October 2008) that appeared in the MEDLINE database and were indexed under the search terms of child abuse, sexual or child abuse and either physical examination; genitalia; female, diagnosis; or sensitivity and specificity; and bibliographies of retrieved articles and textbooks. Study Selection Three of the authors independently reviewed titles of articles obtained from MEDLINE and selected articles for full- text review. Data Extraction Two authors independently abstracted data to calculate sensitivity, specificity, and likelihood ratios for the diagnosis of nonacute genital trauma caused by sexual abuse in prepubertal girls. Results Data were not pooled due to study heterogeneity. The presence of vaginal discharge ( positive likelihood ratio, 2.7; 95% confidence interval, 1.2- 6.0) indicates an increased likelihood of sexual abuse. In the posterior hymen, hymenal transections, deep notches, and perforations prompt concerns for genital trauma from sexual abuse, but the sensitivity is unknown. Without a history of genital trauma from sexual abuse, the majority of prepubertal girls will not have a hymenal transection ( specificity close to 100%). Conclusions Vaginal discharge as well as posterior hymenal transections, deep notches, and perforations raise the suspicion for sexual abuse in a prepubertal girl, but the findings do not independently confirm the diagnosis. Given the broad 95% confidence intervals around the likelihood ratios for the presence of findings along with the low or unknown sensitivity of all physical examination findings evaluated, the physical examination cannot independently confirm or exclude nonacute sexual abuse as the cause of genital trauma in prepubertal girls.	[Berkoff, Molly Curtin; Runyan, Desmond K.] Univ N Carolina, Div Gen Pediat, Chapel Hill, NC 27599 USA; [Zolotor, Adam J.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA; [Makoroff, Kathi L.; Shapiro, Robert A.] Cincinnati Childrens Hosp Med Ctr, Ctr Safe & Healthy Children, Cincinnati, OH USA; [Thackeray, Jonathan D.] Nationwide Childrens Hosp, Ctr Child & Family Advocacy, Columbus, OH USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Cincinnati Children's Hospital Medical Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Berkoff, MC (corresponding author), Univ N Carolina, Div Gen Pediat, 231 MacNider,CB 7225, Chapel Hill, NC 27599 USA.	molly_berkoff@med.unc.edu	Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029; Zolotor, Adam/0000-0002-9007-223X	Robert Wood Johnson Clinical Scholars Program	Robert Wood Johnson Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF))	Dr Berkoff was supported in part by the Robert Wood Johnson Clinical Scholars Program.	Adams JA, 2003, ACTA PAEDIATR, V92, P1378, DOI 10.1080/08035250310006449; ADAMS JA, 1994, PEDIATRICS, V94, P310; Adams JA, 2007, J PEDIATR ADOL GYNEC, V20, P163, DOI 10.1016/j.jpag.2006.10.001; Adams Joyce A, 2004, J Pediatr Adolesc Gynecol, V17, P191; Adams JA, 2008, CURR OPIN OBSTET GYN, V20, P435, DOI 10.1097/GCO.0b013e32830866f4; *AM PHARM ASS, 1997, PREV MAG APHA, P1; BERENSON A, 1991, PEDIATRICS, V87, P458; Berenson AB, 2002, J PEDIATR-US, V140, P600, DOI 10.1067/mpd.2002.123101; Berenson AB, 2002, PEDIATRICS, V109, P228, DOI 10.1542/peds.109.2.228; BERENSON AB, 1992, PEDIATRICS, V89, P387; BERENSON AB, 1995, PEDIATRICS, V95, P490; Berenson AB, 2000, AM J OBSTET GYNECOL, V182, P820, DOI 10.1016/S0002-9378(00)70331-0; BERENSON AB, 1993, PEDIATRICS, V91, P820; Bernet W, 1997, J AM ACAD CHILD PSY, V36, pS37, DOI 10.1097/00004583-199710001-00004; *CDCP, 2006, SEX TRANSM DIS TREAT; *CHILD MED EV PROG, N CAR CHILD MED EV P; Christian CW, 2000, PEDIATRICS, V106, P100, DOI 10.1542/peds.106.1.100; De Jong AR, 1998, CHILD ABUSE NEGLECT, V22, P645, DOI 10.1016/S0145-2134(98)00041-6; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Friedrich W N, 2001, Child Maltreat, V6, P37, DOI 10.1177/1077559501006001004; *GALL POLL ORG, 1995, DISC CHILDR AM GALL; GARDNER JJ, 1992, J PEDIATR-US, V120, P251, DOI 10.1016/S0022-3476(05)80436-6; Heger A, 2002, CHILD ABUSE NEGLECT, V26, P645, DOI 10.1016/S0145-2134(02)00339-3; Heger Astrid H, 2002, J Pediatr Adolesc Gynecol, V15, P27, DOI 10.1016/S1083-3188(01)00136-X; Kellogg N, 2005, PEDIATRICS, V116, P506, DOI 10.1542/peds.2005-1336; Kellogg ND, 2004, PEDIATRICS, V113, pE67, DOI 10.1542/peds.113.1.e67; Makoroff KL, 2002, CHILD ABUSE NEGLECT, V26, P1235, DOI 10.1016/S0145-2134(02)00419-2; MCCANN J, 1990, PEDIATRICS, V85, P182; MCCANN J, 1990, PEDIATRICS, V86, P428; MCCANN J, 1992, PEDIATRICS, V89, P307; MCCANN J, 1993, PEDIATRICS, V91, P390; McCann J, 2007, PEDIATRICS, V120, P1000, DOI 10.1542/peds.2006-0230; McCann J, 2007, PEDIATRICS, V119, pE1094, DOI 10.1542/peds.2006-0964; Myhre AK, 2003, ACTA PAEDIATR, V92, P1453, DOI 10.1080/08035250310007574; Rosen DS, 2004, PEDIATR REV, V25, P194, DOI 10.1542/pir.25-6-194; Simms MD, 2000, PEDIATRICS, V106, P909; Sinal SH, 1997, ARCH PEDIAT ADOL MED, V151, P497, DOI 10.1001/archpedi.1997.02170420067011; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; *US DEP HHS, 2007, CHILD MALTR 2005	39	35	37	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2779	2792		10.1001/jama.2008.827	http://dx.doi.org/10.1001/jama.2008.827			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088355				2022-12-28	WOS:000261730400024
J	Jenny, C				Jenny, Carole			Medicine Discovers Child Abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRAUMATIC BRAIN-INJURY; SEXUAL-ABUSE; MALTREATMENT		[Jenny, Carole] Brown Univ, Dept Pediat, Albert Med Sch, Providence, RI 02903 USA	Brown University	Jenny, C (corresponding author), Brown Univ, Dept Pediat, Albert Med Sch, 593 Eddy St,Potter 005, Providence, RI 02903 USA.	cjenny@lifespan.org						Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Block RW, 2006, J PEDIATR-US, V148, P711, DOI 10.1016/j.jpeds.2006.01.033; Bolen RM, 1999, SOC SERV REV, V73, P281, DOI 10.1086/514425; Cicchetti D, 2007, DEV PSYCHOPATHOL, V19, P1161, DOI 10.1017/S0954579407000600; COOK A, 2003, NETWORK NCTS; Eckenrode J, 2001, DEV PSYCHOPATHOL, V13, P873, DOI 10.1017/S0954579401004072; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; GAUDIOSI JA, 2008, US DEP HLTH HUMAN SE; KEMPE A, 2007, GOOD KNIGHT CHILDREN; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; KEMPE CH, 1978, PEDIATRICS, V62, P382; Mathews B, 2008, CHILD MALTREATMENT, V13, P50, DOI 10.1177/1077559507310613; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Templeton David J, 2006, Sex Health, V3, P5, DOI 10.1071/SH05028	15	16	16	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2796	2797		10.1001/jama.2008.842	http://dx.doi.org/10.1001/jama.2008.842			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088357	Bronze			2022-12-28	WOS:000261730400026
J	Shama, G				Shama, Gilbert			Auntibiotics: the BBC, penicillin, and the second world war	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shama, Gilbert] Loughborough Univ Technol, Dept Chem Engn, Loughborough LE11 3TU, Leics, England	Loughborough University	Shama, G (corresponding author), Loughborough Univ Technol, Dept Chem Engn, Loughborough LE11 3TU, Leics, England.	g.shama@lboro.ac.uk	Shama, Gilbert/E-9008-2011					Burns M, 2002, ADV APPL MICROBIOL, V51, P185, DOI 10.1016/S0065-2164(02)51006-6; Quirke, 2008, COLLABORATION PHARM, P85; RICHARDS PS, 1994, SCI INFORM WARTIME A; Shama G, 2002, HIST STUD PHYS BIOL, V32, P347, DOI 10.1525/hsps.2002.32.2.347; SHAMA G, 2008, MICROBE, V3, P511	5	3	3	1	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 12	2008	337								a2746	10.1136/bmj.a2746	http://dx.doi.org/10.1136/bmj.a2746			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CC	19074563	Green Published, Green Accepted			2022-12-28	WOS:000262777000003
J	Lu, PF; Werb, Z				Lu, Pengfei; Werb, Zena			Patterning Mechanisms of Branched Organs	SCIENCE			English	Review							MAMMARY-GLAND; STEM-CELL; SALIVARY-GLAND; AXON GUIDANCE; MORPHOGENESIS; DROSOPHILA; CUES; BEHAVIOR; SIGNALS; KIDNEY	Branching morphogenesis is one of the earliest events essential for the success of metazoans. By branching out and forming cellular or tissue extensions, cells can maximize their surface area and overcome space constraints posed by organ size. Over the past decade, tremendous progress has been made toward understanding the branching mechanisms of various invertebrate and vertebrate organ systems. Despite their distinct origins, morphologies and functions, different cell and tissue types use a remarkably conserved set of tools to undergo branching morphogenesis. Recent studies have shed important light on the basis of molecular conservation in the formation of branched structures in diverse organs.	[Lu, Pengfei; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Lu, Pengfei; Werb, Zena] Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu			NIH [ES012801, CA057621]; NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES012801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank G. Dijkgraaf for taking the photograph of the fluorescent mammary gland and M. Chan, O. Klein, J. Phillips, and M. Zeiger for helpful discussions and insightful comments. We regret that many authors' work could not be cited because of space limitations. This work was supported by grants ES012801 and CA057621 from NIH.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Bahary N, 2001, SCIENCE, V294, P530, DOI 10.1126/science.1066282; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Chung L, 2007, DEVELOPMENT, V134, P2935, DOI 10.1242/dev.005066; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Davies JA, 2002, BIOESSAYS, V24, P937, DOI 10.1002/bies.10161; Englund C, 2002, DEVELOPMENT, V129, P4941; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Jones CA, 2007, CURR OPIN GENET DEV, V17, P332, DOI 10.1016/j.gde.2007.07.004; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Silberstein GB, 2001, MICROSC RES TECHNIQ, V52, P155, DOI 10.1002/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Smith GH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1856; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tufro A, 2008, MECH DEVELOP, V125, P558, DOI 10.1016/j.mod.2007.12.003; Wagner KU, 2005, J MAMMARY GLAND BIOL, V10, P25, DOI 10.1007/s10911-005-2538-1; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	34	134	137	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1506	1509		10.1126/science.1162783	http://dx.doi.org/10.1126/science.1162783			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056977	Green Accepted			2022-12-28	WOS:000261377400039
J	Thomas, MP; Wang, A				Thomas, Michael P.; Wang, Andrew			Taken Out of Context	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THROMBOTIC THROMBOCYTOPENIC PURPURA; INFECTIVE ENDOCARDITIS; CRITERIA; CLASSIFICATION; VASCULITIS; DIAGNOSIS		[Thomas, Michael P.] Univ Michigan Hlth Syst, Dept Med, Ann Arbor, MI USA; [Wang, Andrew] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Michigan System; University of Michigan; Duke University	Wang, A (corresponding author), DUMC 3428, Durham, NC 27710 USA.	a.wang@duke.edu		Wang, Andrew/0000-0001-8729-0933				BLOCH DA, 1990, ARTHRITIS RHEUM, V33, P1068; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; George JN, 2006, NEW ENGL J MED, V354, P1927, DOI 10.1056/NEJMcp053024; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Rao JK, 1998, ANN INTERN MED, V129, P345, DOI 10.7326/0003-4819-129-5-199809010-00001; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Saleh A, 2005, BEST PRACT RES CL RH, V19, P209, DOI 10.1016/j.berh.2004.09.001	9	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2478	2482		10.1056/NEJMcps0801308	http://dx.doi.org/10.1056/NEJMcps0801308			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378MT	19052129				2022-12-28	WOS:000261325900010
J	Kesselheim, AS; Misono, AS; Lee, JL; Stedman, MR; Brookhart, MA; Choudhry, NK; Shrank, WH				Kesselheim, Aaron S.; Misono, Alexander S.; Lee, Joy L.; Stedman, Margaret R.; Brookhart, M. Alan; Choudhry, Niteesh K.; Shrank, William H.			Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							COMPARATIVE BIOEQUIVALENCE; FORMULATION SUBSTITUTION; MEDICATION ADHERENCE; AMLODIPINE BESYLATE; BETA-BLOCKER; DOUBLE-BLIND; OF-INTEREST; OPEN-LABEL; WARFARIN; CROSSOVER	Context Use of generic drugs, which are bioequivalent to brand- name drugs, can help contain prescription drug spending. However, there is concern among patients and physicians that brand- name drugs may be clinically superior to generic drugs. Objectives To summarize clinical evidence comparing generic and brand- name drugs used in cardiovascular disease and to assess the perspectives of editorialists on this issue. Data Sources Systematic searches of peer- reviewed publications in MEDLINE, EMBASE, and International Pharmaceutical Abstracts from January 1984 to August 2008. Study Selection Studies compared generic and brand- name cardiovascular drugs using clinical efficacy and safety end points. We separately identified editorials addressing generic substitution. Data Extraction We extracted variables related to the study design, setting, participants, clinical end points, and funding. Methodological quality of the trials was assessed by Jadad and Newcastle- Ottawa scores, and a meta- analysis was performed to determine an aggregate effect size. For editorials, we categorized authors' positions on generic substitution as negative, positive, or neutral. Results We identified 47 articles covering 9 subclasses of cardiovascular medications, of which 38 ( 81%) were randomized controlled trials ( RCTs). Clinical equivalence was noted in 7 of 7 RCTs ( 100%) of beta - blockers, 10 of 11 RCTs ( 91%) of diuretics, 5 of 7 RCTs ( 71%) of calcium channel blockers, 3 of 3 RCTs ( 100%) of antiplatelet agents, 2 of 2 RCTs ( 100%) of statins, 1 of 1 RCT ( 100%) of angiotensin- converting enzyme inhibitors, and 1 of 1 RCT ( 100%) of alpha - blockers. Among narrow therapeutic index drugs, clinical equivalence was reported in 1 of 1 RCT ( 100%) of class 1 antiarrhythmic agents and 5 of 5 RCTs ( 100%) of warfarin. Aggregate effect size ( n= 837) was - 0.03 ( 95% confidence interval, - 0.15 to 0.08), indicating no evidence of superiority of brand- name to generic drugs. Among 43 editorials, 23 ( 53%) expressed a negative view of generic drug substitution. Conclusions Whereas evidence does not support the notion that brand- name drugs used in cardiovascular disease are superior to generic drugs, a substantial number of editorials counsel against the interchangeability of generic drugs.	[Kesselheim, Aaron S.; Misono, Alexander S.; Lee, Joy L.; Stedman, Margaret R.; Brookhart, M. Alan; Choudhry, Niteesh K.; Shrank, William H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Lee, Joy/0000-0003-2589-8200	Attorney General Prescriber and Consumer Education Grant Program; Agency for Healthcare Research and Quality Post-Doctoral Fellowship in Health Services Research at the Harvard School of Public Health; National Institute on Aging [AG027400)]; National Heart, Lung, and Blood Institute [K23HL090505-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL090505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG027400] Funding Source: NIH RePORTER	Attorney General Prescriber and Consumer Education Grant Program; Agency for Healthcare Research and Quality Post-Doctoral Fellowship in Health Services Research at the Harvard School of Public Health(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported in part by a grant from the Attorney General Prescriber and Consumer Education Grant Program. Dr Kesselheim's work was supported by an Agency for Healthcare Research and Quality Post- Doctoral Fellowship in Health Services Research at the Harvard School of Public Health. Dr Brookhart is supported by a career development award from the National Institute on Aging (AG027400). Dr Shrank is supported by a career development award from the National Heart, Lung, and Blood Institute (K23HL090505-01).	ABELLI C, 2001, STP PHARMA PRATIQUES, V11, P102; Ahrens W, 2007, PHARMACOEPIDEM DR S, V16, P1298, DOI 10.1002/pds.1494; AI-Jazairi AS, 2008, ANN SAUDI MED, V28, P33; Amit G, 2004, AM J CARDIOL, V93, P1558, DOI 10.1016/j.amjcard.2004.02.071; Ashraf Tariq, 2005, JPMA Journal of the Pakistan Medical Association, V55, P443; Assawawitoontip Surin, 2002, Journal of the Medical Association of Thailand, V85, pS118; AWAD R, 1992, INT J CLIN PHARM TH, V30, P18; BALLIN J, 1988, NEW YORK STATE J MED, V88, P121; Banahan BF, 1998, FORMULARY, V33, P1082; BECK M, 2008, WALL STREET J   0422, pD1; Benditt DG, 1999, J INTERV CARD ELECTR, V3, P145, DOI 10.1023/A:1009817413845; Benet LZ, 1999, TRANSPLANT P, V31, P1642, DOI 10.1016/S0041-1345(99)00083-4; Benson SR, 1998, AM J HEALTH-SYST PH, V55, P727, DOI 10.1093/ajhp/55.7.727; Bongers V, 1999, CLIN DRUG INVEST, V17, P103, DOI 10.2165/00044011-199917020-00004; Burns M, 1999, J THROMB THROMBOLYS, V7, P137, DOI 10.1023/A:1008829403320; Calvert RT, 1996, J PHARM PHARMACOL, V48, P9, DOI 10.1111/j.2042-7158.1996.tb05867.x; Canan B, 2007, J ENVIRON ENG GEOPH, V12, P255, DOI 10.2113/JEEG12.3.255; CARTER BL, 1993, PHARMACOTHERAPY, V13, P359; CARTER BL, 1989, PHARMACOTHERAPY, V9, P17; Chiang H T, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V55, P366; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COLAIZZI JL, 1986, CLIN THER, V8, P370; *CONS ASS, 1997, DRUG THER B, V35, P9; DeCara JM, 1998, CHEST, V113, P261, DOI 10.1378/chest.113.2.261; Deeks J J, 2003, Health Technol Assess, V7, piii; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; ELSAYED MS, 1989, MED SCI SPORT EXER, V21, P369; Fischer MA, 2004, PHARMACOEPIDEM DR S, V13, P207, DOI 10.1002/pds.872; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850; Gaither CA, 2001, J AM PHARM ASS, V41, P729, DOI [10.1016/S1086-5802(16)31308-0, DOI 10.1016/S1086-5802(16)31308-0]; GARG SK, 1984, INT J CLIN PHARM TH, V22, P618; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; GRAHNEN A, 1984, EUR J CLIN PHARMACOL, V27, P595, DOI 10.1007/BF00556898; Haines ST, 1998, AM J HEALTH-SYST PH, V55, P729, DOI 10.1093/ajhp/55.7.729; Halkin H, 2003, CLIN PHARMACOL THER, V74, P215, DOI 10.1016/S0009-9236(03)00166-8; HANDLER J, 1998, PREV CARDIOL, V4, P13; Hedges LV, 2014, STAT METHODS META AN; HENDELES L, 1993, AM J HOSP PHARM, V50, P323, DOI 10.1093/ajhp/50.2.323; Henderson JD, 2001, SOUTHERN MED J, V94, P16; Hope KA, 2001, ANN PHARMACOTHER, V35, P183, DOI 10.1345/aph.10207; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KAOJARERN S, 1990, Journal of the Medical Association of Thailand, V73, P191; KASMER RJ, 1987, DRUG INTEL CLIN PHAR, V21, P183; Keith LG, 1998, INT J FERTIL WOMEN M, V43, P139; Kesselheim AS, 2006, HEALTH AFFAIR, V25, P1637, DOI 10.1377/hlthaff.25.6.1637; Kim SH, 2007, CLIN THER, V29, P1924, DOI 10.1016/j.clinthera.2007.09.018; KOWEY PR, 1990, INTERN MED SPECIALIS, V11, P151; KOWEY PR, 1990, INTERN MED SPECIALIS, V11, P146; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Lee HL, 2005, CLIN THER, V27, P309, DOI 10.1016/j.clinthera.2005.03.004; LOFHOLM PW, 1991, US PHARM, V16, P44; LOFHOLM PW, 1991, US PHARM, V16, P46; LOFHOLM PW, 1991, US PHARM, V16, P51; MAITAI CK, 1984, E AFR MED J, V61, P6; MARTIN BK, 1984, J PHARM SCI, V73, P437, DOI 10.1002/jps.2600730404; MARZO A, 1995, ARZNEIMITTEL-FORSCH, V45-1, P109; MCCUE JD, 1991, P T, V16, P770; McGavock H, 2001, PHARMACOEPIDEM DR S, V10, P555, DOI 10.1002/pds.626; McLachlan AJ, 2007, AUST PRESCR, V30, P41, DOI 10.18773/austprescr.2007.021; MERALI RM, 1996, CAN J CLIN PHARM, V3, P29; Meredith P, 2003, CLIN THER, V25, P2875, DOI 10.1016/S0149-2918(03)80340-5; Meredith PA, 1996, DRUG SAFETY, V15, P233, DOI 10.2165/00002018-199615040-00001; MEYER BH, 1985, S AFR MED J, V68, P645; Meyer GF, 1999, TRANSPLANT P, V31, p10S, DOI 10.1016/S0041-1345(99)00105-0; Meyer M, 1998, PHARMACOTHERAPY, V18, P884; Meyer MC, 1998, AM J MANAG CARE, V4, P1183; Mignini F, 2007, CLIN EXP HYPERTENS, V29, P539, DOI 10.1080/10641960701744046; Milligan PE, 2002, ANN PHARMACOTHER, V36, P764, DOI 10.1345/aph.1A327; Mirfazaelian Ahmad, 2003, Daru, V11, P95; Murphy JE, 1999, ARCH INTERN MED, V159, P429, DOI 10.1001/archinte.159.5.429; Murray MD, 1997, PHARMACOTHERAPY, V17, P98; NEUTEL JM, 1998, CARDIOVASC REV REP, V19, P49; NOLANPE, 1989, AM J CARDIOL, V64, P1371; PAN HYM, 1984, MED J AUSTRALIA, V140, P221, DOI 10.5694/j.1326-5377.1984.tb104001.x; Park JY, 2004, CLIN THER, V26, P715, DOI 10.1016/S0149-2918(04)90071-9; Paterson JM, 2006, JAMA-J AM MED ASSOC, V296, P1969, DOI 10.1001/jama.296.16.1969-b; Pereira JA, 2005, ANN PHARMACOTHER, V39, P1188, DOI 10.1345/aph.1G003; Portoles A, 2005, ARZNEIMITTELFORSCH, V55, P212; Portoles Antonio, 2004, Current Therapeutic Research, V65, P34, DOI 10.1016/S0011-393X(04)90003-3; Rao TRK, 2003, CURR THER RES CLIN E, V64, P685, DOI 10.1016/j.curtheres.2003.09.014; Reiffel JA, 2004, PROG CARDIOVASC DIS, V47, P3, DOI 10.1016/j.pcad.2004.04.002; Reiffel JA, 2001, CURR OPIN CARDIOL, V16, P23, DOI 10.1097/00001573-200101000-00004; Reiffel JA, 2000, AM J CARDIOL, V85, p46D; RENN E, 2000, P T, V25, P487; RHEINSTEIN PH, 1990, DRUG SAFETY, V5, P114, DOI 10.2165/00002018-199000051-00018; RICHTONHEWETT S, 1988, ARCH INTERN MED, V148, P806, DOI 10.1001/archinte.148.4.806; Riechelmann RP, 2007, J CLIN ONCOL, V25, P4642, DOI 10.1200/JCO.2007.11.2482; ROCKOFF J, 2008, BALTIMORE SUN, pA1; ROSENTHAL R, 1982, PSYCHOL BULL, V92, P500, DOI 10.1037/0033-2909.92.2.500; ROSS MB, 1989, HOSP FORMUL, V24, P441; SANDERSON JH, 1986, LANCET, V1, P967; Sarkar Mohamadi A., 1995, Clinical Research and Regulatory Affairs, V12, P47, DOI 10.3109/10601339509079576; Saseen JJ, 1997, J CLIN PHARMACOL, V37, P526, DOI 10.1002/j.1552-4604.1997.tb04331.x; SAUL S, 2007, NY TIMES        1103, pA1; SAWONIAK AE, 2002, CAN J HOSP PHARM, V55, P215; SCHEIDT S, 1998, CARDIOVASC REV REP, V19, P46; SCHWARTZ LL, 1985, AM J MED, V79, P38, DOI 10.1016/0002-9343(85)90584-4; SHAROKY M, 1989, CLIN PHARMACY, V8, P496; SHRANK W, IN PRESS HLTH AFF; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; SINGH A, 1987, INT J CLIN PHARM TH, V25, P136; SOMBERG J, 1985, CARDIOVASC REV REP, V6, P1010; STAGNITTI M, 2004, TOP 5 THERAPEUTIC CL; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; STROM BL, 1987, NEW ENGL J MED, V316, P1456, DOI 10.1056/NEJM198706043162306; Swenson CN, 2000, AM J HEALTH-SYST PH, V57, P452, DOI 10.1093/ajhp/57.5.452; Tsai YS, 2007, CLIN THER, V29, P670, DOI 10.1016/j.clinthera.2007.04.013; Usha PR, 1997, CLIN DRUG INVEST, V14, P482, DOI 10.2165/00044011-199714060-00006; Verbeeck RK, 2006, EUR J PHARM SCI, V28, P1, DOI 10.1016/j.ejps.2005.12.001; WALDMAN SA, 1995, J CLIN PHARMACOL, V35, P163, DOI 10.1002/j.1552-4604.1995.tb05006.x; Weibert RT, 2000, ANN PHARMACOTHER, V34, P981, DOI 10.1345/aph.10068; Witt DM, 2003, PHARMACOTHERAPY, V23, P360, DOI 10.1592/phco.23.3.360.32103; Wittkowsky AK, 1997, PHARMACOTHERAPY, V17, P640; Wiwanitkit Viroj, 2002, BMC Clin Pharmacol, V2, P1, DOI 10.1186/1472-6904-2-1; 1995, GUIDANCE IND IMMEDIA	115	325	336	1	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2514	2526		10.1001/jama.2008.758	http://dx.doi.org/10.1001/jama.2008.758			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050195	Green Accepted			2022-12-28	WOS:000261286200020
J	Fromme, EK; Farber, NJ; Babbott, SF; Pickett, ME; Beasley, BW				Fromme, Erik K.; Farber, Neil J.; Babbott, Stewart F.; Pickett, Mary E.; Beasley, Brent W.			What Do You Do When Your Loved One Is Ill? The Line between Physician and Family Member	ANNALS OF INTERNAL MEDICINE			English	Article							DOCTOR; CARE	Conventional wisdom and professional ethics generally dictate that physicians should avoid doctoring family members because of potential conflicts of interest. Nevertheless, cross-sectional surveys find that the practice is commonplace. Physicians have unique opportunities to influence their family member's care because they possess knowledge and status within the health care system; however, when physicians participate in the care of family members, they must not lose objectivity and confuse their personal and professional roles. Because health care systems are complicated, medical information is difficult to understand, and medical errors are common, it can be a great relief for families to have someone "on the inside" who is accessible and trustworthy. Yet, the benefits of becoming involved in a loved one's care are accompanied by risks, especially when a physician takes action that a nonphysician would be incapable of performing. Except for convenience, most if not all of the benefits of getting involved can be realized by physician-family members acting as a family member or an advocate rather than as a physician. Rules about what is or what is not appropriate for physician family members are important but insufficient to guide physicians in every circumstance. Physician-family members can ask themselves, "What could I do in this situation if I did not have a medical degree?" and consider avoiding acts that require a medical license.	[Fromme, Erik K.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA	Oregon Health & Science University	Fromme, EK (corresponding author), Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	frommee@ohsu.edu	Beasley, Brent/AAE-9466-2021	Beasley, Brent/0000-0002-0997-9636	National Cancer Institute [K07CA109511-01A1]; NATIONAL CANCER INSTITUTE [K07CA109511] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Fromme is supported by a Career Development Award from the National Cancer Institute (K07CA109511-01A1).	*AM MED ASS, 2006, COD MED ETH CURR OP; DUSDIEKER LB, 1993, AM J DIS CHILD, V147, P146, DOI 10.1001/archpedi.1993.02160260036018; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Fromme E, 2003, JAMA-J AM MED ASSOC, V290, P2048, DOI 10.1001/jama.290.15.2048; Fromme EK, 2004, J FAM PRACTICE, V53, P299; GOLDMAN L, 2000, HDB PHYS HLTH ESSENT; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; LAPUMA J, 1991, NEW ENGL J MED, V325, P1290, DOI 10.1056/NEJM199110313251806; LAPUMA J, 1992, JAMA-J AM MED ASSOC, V267, P1810, DOI 10.1001/jama.267.13.1810; MARZUK PM, 1987, NEW ENGL J MED, V317, P1409, DOI 10.1056/NEJM198711263172209; SCHMALL V, 2000, CAREGIVER HELPBOOK P; Schneck SA, 1998, JAMA-J AM MED ASSOC, V280, P2039, DOI 10.1001/jama.280.23.2039; Spiro HM, 1998, ANN INTERN MED, V128, P152, DOI 10.7326/0003-4819-128-2-199801150-00014; STOUDEMIRE A, 1983, ANN INTERN MED, V98, P654, DOI 10.7326/0003-4819-98-5-654; WASSERMAN RC, 1989, PEDIATRICS, V83, P319; Wolff JL, 2008, ARCH INTERN MED, V168, P1409, DOI 10.1001/archinte.168.13.1409	16	18	18	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					825	W170		10.7326/0003-4819-149-11-200812020-00011	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047031				2022-12-28	WOS:000261645300008
J	Mendenhall, GS				Mendenhall, G. Stuart			Death and Taxes	ANNALS OF INTERNAL MEDICINE			English	Article							POSTPONEMENT; OCCASIONS	Tax incentives can provide a large financial impetus to change behavior. Current U. S. law establishes a substantial discontinuity in the amount of estate tax that many patients will have to pay in 2010: During this year only, the tax rate drops to zero. This article discusses concerns regarding the sharp change in tax rate and the incentives it creates for persons who are nearing the end of life and provides estimates of the number of people affected by this issue.	Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mendenhall, GS (corresponding author), Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Scaife Hall S-553,200 Lothrop St, Pittsburgh, PA 15213 USA.	gsmenden@post.harvard.edu						*CBO CTR BUDG POL, 2006, STAT EST TAX 2006; *CDC NAT CTR HLTH, 2007, BIRTHS MARR DIV DEAT; Clotfelter CT., 1990, W3273 NBER; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; *US CENS BUR, 2006, S1101 US CENS BUR AM; Young DC, 2004, JAMA-J AM MED ASSOC, V292, P3012, DOI 10.1001/jama.292.24.3012; [No title captured]	9	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					822	824		10.7326/0003-4819-149-11-200812020-00010	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047030				2022-12-28	WOS:000261645300007
J	Binder, PM				Binder, P. -M.			PHYSICS Reflections on a Wall of Light	SCIENCE			English	Editorial Material							MAXWELLS DEMON		[Binder, P. -M.] Univ Hawaii, Dept Phys & Astron, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo	Binder, PM (corresponding author), Univ Hawaii, Dept Phys & Astron, Hilo, HI 96720 USA.	pbinder@hawaii.edu	Binder, P. -M./L-9889-2015					BENNETT CH, 1987, SCI AM, V257, P108, DOI 10.1038/scientificamerican1187-108; LANDAUER R, 1961, IBM J RES DEV, V5, P182; Leff HS., 2003, MAXWELLS DEMON, V2; Lloyd S, 1997, PHYS REV A, V56, P3374, DOI 10.1103/PhysRevA.56.3374; Marian A, 2008, NAT PHOTONICS, V2, P463, DOI 10.1038/nphoton.2008.145; Narevicius E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093003; PRICE GN, 2008, PHYS REV LETT, V100; Ruan XL, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.214304; Ruschhaupt A, 2006, J PHYS B-AT MOL OPT, V39, P3833, DOI 10.1088/0953-4075/39/18/012; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; Thorn JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240407	11	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1334	1335		10.1126/science.1166681	http://dx.doi.org/10.1126/science.1166681			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039125				2022-12-28	WOS:000261170600023
J	Vale, RD				Vale, Ronald D.			Microscopes for Fluorimeters: The Era of Single Molecule Measurements	CELL			English	Article							LOCALIZATION MICROSCOPY; DYNAMIC INSTABILITY; RNA-POLYMERASE; LIVING CELLS; PROTEIN; MICROTUBULES; F-1-ATPASE; COMPLEXES; FILAMENT; MOVEMENT	As transforming as the first atomic resolution view of myoglobin in the late 1950s, scientists can now use a suite of single molecule technologies to watch protein macromolecular machines executing their functions "in real time." This Essay highlights applications and challenges of single molecule studies in structural biology, cell biology, and biotechnology.	[Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	vale@cmp.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM038499-17, R01 GM038499] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Greenleaf WJ, 2006, SCIENCE, V313, P801, DOI 10.1126/science.1130105; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	33	17	19	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					779	785		10.1016/j.cell.2008.11.009	http://dx.doi.org/10.1016/j.cell.2008.11.009			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041739	Bronze, Green Accepted			2022-12-28	WOS:000261183900006
J	Werdin, F; Tenenhaus, M; Rennekampff, HO				Werdin, Frank; Tenenhaus, Mayer; Rennekampff, Hans-Oliver			Chronic wound care	LANCET			English	Editorial Material							PERIPHERAL ARTERIAL-DISEASE; THERAPY		[Werdin, Frank] Univ Tubingen, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-72076 Tubingen, Germany; [Tenenhaus, Mayer] Univ Calif San Diego, Sch Med, Div Plast Surg, San Diego, CA 92103 USA; [Rennekampff, Hans-Oliver] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany	Eberhard Karls University of Tubingen; University of California System; University of California San Diego; Hannover Medical School	Werdin, F (corresponding author), Univ Tubingen, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-72076 Tubingen, Germany.	fwerdin@gmx.de						Ayello EA, 2004, NURSING, V34, P26; Chaby G, 2007, ARCH DERMATOL, V143, P1297, DOI 10.1001/archderm.143.10.1297; Dissemond J., 2007, HAUTARZT, V12, P1; Gohel MS, 2007, BMJ-BRIT MED J, V335, P83, DOI 10.1136/bmj.39216.542442.BE; Hiatt WR, 2002, J VASC SURG, V36, P1283, DOI 10.1067/mva.2002.129654; JULL A, 2007, COCHRANE DB SYST REV, V1; McInnes E, 1998, Nurs Stand, V13, P61; MIELL JM, 1999, WOUND REPAIR REGEN, V7, P335; Norman PE, 2004, MED J AUSTRALIA, V181, P150, DOI 10.5694/j.1326-5377.2004.tb06206.x; Padberg FT, 2004, J VASC SURG, V39, P79, DOI 10.1016/j.jvs.2003.09.036; Press E, 2010, CLIN PRACTICE GUIDEL; Royal College of Nursing (RCN), 2006, CLIN PRACTICE GUIDEL; Steed DL, 2004, AM J SURG, V187, p71S, DOI 10.1016/S0002-9610(03)00307-6; Vaneau M, 2007, ARCH DERMATOL, V143, P1291, DOI 10.1001/archderm.143.10.1291; Wraight PR, 2005, DIABETIC MED, V22, P127, DOI 10.1111/j.1464-5491.2004.01363.x	15	74	82	2	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1860	1862		10.1016/S0140-6736(08)61793-6	http://dx.doi.org/10.1016/S0140-6736(08)61793-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041788				2022-12-28	WOS:000261388700006
J	Pincock, S				Pincock, Stephen			Lunch with The Lancet	LANCET			English	Editorial Material												stephen.pincock@journalist.co.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 4	2008	372	9645					1213	1213		10.1016/S0140-6736(08)61506-8	http://dx.doi.org/10.1016/S0140-6736(08)61506-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19094943				2022-12-28	WOS:000259882000012
J	Core, LJ; Waterfall, JJ; Lis, JT				Core, Leighton J.; Waterfall, Joshua J.; Lis, John T.			Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters	SCIENCE			English	Article							HUMAN GENOME; POLYMERASE-II; HUMAN-CELLS; TRANSCRIPTION; ARCHITECTURE; BINDING; GENES; MAPS	RNA polymerases are highly regulated molecular machines. We present a method ( global run-on sequencing, GRO-seq) that maps the position, amount, and orientation of transcriptionally engaged RNA polymerases genome- wide. In this method, nuclear run- on RNA molecules are subjected to large- scale parallel sequencing and mapped to the genome. We show that peaks of promoter- proximal polymerase reside on similar to 30% of human genes, transcription extends beyond pre-messenger RNA 3 ' cleavage, and antisense transcription is prevalent. Additionally, most promoters have an engaged polymerase upstream and in an orientation opposite to the annotated gene. This divergent polymerase is associated with active genes but does not elongate effectively beyond the promoter. These results imply that the interplay between polymerases and regulators over broad promoter regions dictates the orientation and efficiency of productive transcription.	[Core, Leighton J.; Waterfall, Joshua J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jtl10@cornell.edu		Waterfall, Joshua/0000-0002-3762-5050	NIH [GM25232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully thank C. Haudenschild for advice on construction of our libraries and for performing the initial alignments, Q. Sun and L. Ponnala for aligning the trimmed reads, A. Siepel for computational and statistical discussion, and the members of the Lis lab for suggestions regarding this work. The work was funded by NIH grant GM25232 to J.T.L. The data discussed in this publication have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus under accession number GSE13518. The authors are filing a patent based on the work in this paper.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	22	1356	1391	8	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1845	1848		10.1126/science.1162228	http://dx.doi.org/10.1126/science.1162228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056941	Green Accepted			2022-12-28	WOS:000261799400055
J	Brown, C; Lilford, R				Brown, Celia; Lilford, Richard			Evaluating service delivery interventions to enhance patient safety	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPISTEMOLOGY; FRAMEWORK; DESIGN; CARE; QUALITY		[Brown, Celia; Lilford, Richard] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Brown, C (corresponding author), Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham B15 2TT, W Midlands, England.	c.a.brown@bham.ac.uk	Taylor, Celia/E-3494-2010	Brown, Celia/0000-0002-7526-0793	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brown C, 2008, QUAL SAF HEALTH CARE, V17, P158, DOI 10.1136/qshc.2007.023630; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P170, DOI 10.1136/qshc.2007.023655; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P163, DOI 10.1136/qshc.2007.023648; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P178, DOI 10.1136/qshc.2007.023663; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Donabedian A., 1980, DEFINITION QUALITY A, P4; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; Lilford R, 2006, QUAL SAF HEALTH CARE, V15, P311, DOI 10.1136/qshc.2005.017178; Lilford Richard, 2007, J Health Serv Res Policy, V12, P173, DOI 10.1258/135581907781543012; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; Lilford RJ, 1996, BRIT MED J, V313, P603; Lowe DB, 2007, AGE AGEING, V36, P83, DOI 10.1093/ageing/afl145; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Medical Research Council, 2008, DEV EV COMPL INT NEW; Murray DM, 2003, EVALUATION REV, V27, P79, DOI 10.1177/0193841X02239019; OVRETVEIT J, 2005, WHICH INTERVENTIONS; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Wilson B, 2002, INT J QUAL HEALTH C, V14, P175, DOI 10.1093/oxfordjournals.intqhc.a002609	21	33	33	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2008	337								a2764	10.1136/bmj.a2764	http://dx.doi.org/10.1136/bmj.a2764			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091764	hybrid			2022-12-28	WOS:000262185000002
J	Rubin, P				Rubin, Peter			Not what we used to be?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rubin, Peter] Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England	University of Nottingham	Rubin, P (corresponding author), Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England.	peter.rubin@nottingham.ac.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2905	10.1136/bmj.a2905	http://dx.doi.org/10.1136/bmj.a2905			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088146				2022-12-28	WOS:000262184900009
J	Greer, SL				Greer, Scott L.			Devolution and divergence in UK health policies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENGLISH NHS		[Greer, Scott L.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Greer, SL (corresponding author), Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA.	slgreer@umich.edu		Greer, Scott Edward Lennarson/0000-0002-5288-0471				Bevan G, 2006, BMJ-BRIT MED J, V332, P419, DOI 10.1136/bmj.332.7538.419; GREER SL, 2008, HLTH INTERGOVERNMENT; Greer SL, 2004, TERRITORIAL POLITICS; KLEIN R, 2008, BRIT MED J, P337; MCLEAN I, IN PRESS DEVOLUTION; *NAT ASS WAL, 2001, IMPR HLTH WAL PLAN N; Scottish Executive Health Department, 2003, PARTN CAR SCOTL HLTH; Scottish Office, 1997, DES CAR REN NAT HLTH; Stevens S, 2004, HEALTH AFFAIR, V23, P37, DOI 10.1377/hlthaff.23.3.37	9	19	19	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2008	337								a2616	10.1136/bmj.a2616	http://dx.doi.org/10.1136/bmj.a2616			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SS	19074939				2022-12-28	WOS:000262184600012
J	Bejon, P; Lusingu, J; Olotu, A; Leach, A; Lievens, M; Vekemans, J; Mshamu, S; Lang, T; Gould, J; Dubois, M; Demoitie, M; Stallaert, JF; Vansadia, P; Carter, T; Njuguna, P; Awuondo, KO; Malabeja, A; Abdul, O; Gesase, S; Mturi, N; Drakeley, CJ; Savarese, B; Villafana, T; Ballou, WR; Cohen, J; Riley, EM; Lemnge, MM; Marsh, K; von Seidlein, L				Bejon, Philip; Lusingu, John; Olotu, Ally; Leach, Amanda; Lievens, Marc; Vekemans, Johan; Mshamu, Salum; Lang, Trudie; Gould, Jayne; Dubois, Marie-Claude; Demoitie, Marie-Ange; Stallaert, Jean-Francois; Vansadia, Preeti; Carter, Terrell; Njuguna, Patricia; Awuondo, Ken O.; Malabeja, Anangisye; Abdul, Omar; Gesase, Samwel; Mturi, Neema; Drakeley, Chris J.; Savarese, Barbara; Villafana, Tonya; Ballou, W. Ripley; Cohen, Joe; Riley, Eleanor M.; Lemnge, Martha M.; Marsh, Kevin; von Seidlein, Lorenz			Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; RANDOMIZED CONTROLLED-TRIAL; CIRCUMSPOROZOITE PROTEIN; GLOBAL DISTRIBUTION; FOLLOW-UP; MORTALITY; COMBINATION; PROTECTION; MORBIDITY; DISEASE	Background: Plasmodium falciparum malaria is a pressing global health problem. A previous study of the malaria vaccine RTS,S (which targets the circumsporozoite protein), given with an adjuvant system (AS02A), showed a 30% rate of protection against clinical malaria in children 1 to 4 years of age. We evaluated the efficacy of RTS,S given with a more immunogenic adjuvant system (AS01E) in children 5 to 17 months of age, a target population for vaccine licensure. Methods: We conducted a double-blind, randomized trial of RTS,S/AS01E vaccine as compared with rabies vaccine in children in Kilifi, Kenya, and Korogwe, Tanzania. The primary end point was fever with a falciparum parasitemia density of more than 2500 parasites per microliter, and the mean duration of follow-up was 7.9 months (range, 4.5 to 10.5). Results: A total of 894 children were randomly assigned to receive the RTS,S/AS01E vaccine or the control (rabies) vaccine. Among the 809 children who completed the study procedures according to the protocol, the cumulative number in whom clinical malaria developed was 32 of 402 assigned to receive RTS,S/AS01E and 66 of 407 assigned to receive the rabies vaccine; the adjusted efficacy rate for RTS,S/AS01E was 53% (95% confidence interval [CI], 28 to 69; P<0.001) on the basis of Cox regression. Overall, there were 38 episodes of clinical malaria among recipients of RTS,S/AS01E, as compared with 86 episodes among recipients of the rabies vaccine, with an adjusted rate of efficacy against all malarial episodes of 56% (95% CI, 31 to 72; P<0.001). All 894 children were included in the intention-to-treat analysis, which showed an unadjusted efficacy rate of 49% (95% CI, 26 to 65; P<0.001). There were fewer serious adverse events among recipients of RTS,S/AS01E, and this reduction was not only due to a difference in the number of admissions directly attributable to malaria. Conclusions: RTS,S/AS01E shows promise as a candidate malaria vaccine. (ClinicalTrials.gov number, NCT00380393.).	[Bejon, Philip; Olotu, Ally; Lang, Trudie; Njuguna, Patricia; Awuondo, Ken O.; Mturi, Neema; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Bejon, Philip; Marsh, Kevin] Univ Oxford, Nuffield Dept Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Lusingu, John; Mshamu, Salum; Malabeja, Anangisye; Abdul, Omar; Gesase, Samwel; Lemnge, Martha M.] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [Lusingu, John; Mshamu, Salum; Gould, Jayne; Malabeja, Anangisye; Abdul, Omar; Gesase, Samwel; Drakeley, Chris J.; Riley, Eleanor M.; Lemnge, Martha M.; von Seidlein, Lorenz] Joint Malaria Programme, Korogwe, Tanzania; [Lusingu, John] Univ Copenhagen, Ctr Med Parasitol, DK-1168 Copenhagen, Denmark; [Leach, Amanda; Lievens, Marc; Vekemans, Johan; Dubois, Marie-Claude; Demoitie, Marie-Ange; Stallaert, Jean-Francois; Ballou, W. Ripley; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Gould, Jayne; Drakeley, Chris J.; Riley, Eleanor M.; von Seidlein, Lorenz] London Sch Hyg & Trop Med, London WC1, England; [Vansadia, Preeti; Carter, Terrell; Savarese, Barbara; Villafana, Tonya] Malaria Vaccine Initiat, Program Appropriate Technol Hlth, Bethesda, MD USA; [von Seidlein, Lorenz] Int Vaccine Inst, Seoul, South Korea; [von Seidlein, Lorenz] Mahidol Oxford Res Inst, Bangkok, Thailand	Kenya Medical Research Institute; University of Oxford; National Institute of Medical Research; University of Copenhagen; GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; International Vaccine Institute; Mahidol University	Bejon, P (corresponding author), KEMRI, POB 230, Mombasa, Kenya.	pbejon@kilifi.kemri-wellcome.org	Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020; Lusingu, John P. A./GSJ-3228-2022; Leach, Amanda/AAS-1120-2020	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Leach, Amanda/0000-0002-7114-9967; Lusingu, John P. A./0000-0002-9407-0602	Wellcome Trust [077092] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2008, INT C HARM TECHN REQ; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Snow RW, 2004, AM J TROP MED HYG, V71, P16, DOI 10.4269/ajtmh.2004.71.16; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961	26	306	324	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2521	2532		10.1056/NEJMoa0807381	http://dx.doi.org/10.1056/NEJMoa0807381			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19064627	Green Accepted			2022-12-28	WOS:000261534200004
J	Glezen, WP				Glezen, W. Paul			Prevention and Treatment of Seasonal Influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARTICLE AEROSOL TREATMENT; VACCINE CAIV-T; VIRUS VACCINE; WORKING ADULTS; LIVE; TRIVALENT; RIBAVIRIN; CHILDREN; HEALTHY; INTRANASAL		[Glezen, W. Paul] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Glezen, W. Paul] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Glezen, WP (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza,MS-BCM-280, Houston, TX 77030 USA.	wglezen@bcm.edu			Sanofi Pasteur; GlaxoSmithKline; Roche; Novartis; MedImmune; Merck	Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Novartis(Novartis); MedImmune(AstraZenecaMedimmune); Merck(Merck & Company)	Dr. Glezen reports receiving consulting fees from Sanofi Pasteur, GlaxoSmithKline, Roche, Novartis, MedImmune, and Merck and research support from MedImmune. No other potential conflict of interest relevant to this article was reported.	Ambrose CS, 2008, PEDIATR INFECT DIS J, V27, P744, DOI 10.1097/INF.0b013e318174e0f8; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Bocchini JA, 2007, PEDIATRICS, V119, P852, DOI 10.1542/peds.2007-0224; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Gaglani MJ, 2004, ARCH PEDIAT ADOL MED, V158, P65, DOI 10.1001/archpedi.158.1.65; GILBERT BE, 1985, ANTIMICROB AGENTS CH, V27, P309, DOI 10.1128/AAC.27.3.309; Glezen WP, 2008, PEDIATR INFECT DIS J, V27, pS104, DOI 10.1097/INF.0b013e318168b729; Glezen WP, 2006, J CLIN VIROL, V37, P237, DOI 10.1016/j.jcv.2006.08.020; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Halloran ME, 2007, VACCINE, V25, P4038, DOI 10.1016/j.vaccine.2007.02.060; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Halloran ME, 2003, AM J EPIDEMIOL, V158, P305, DOI 10.1093/aje/kwg163; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Keitel WA, 2006, ARCH INTERN MED, V166, P1121, DOI 10.1001/archinte.166.10.1121; KIRSHON B, 1988, J REPROD MED, V33, P399; KNIGHT V, 1981, LANCET, V2, P945; Kwong Jeff C, 2007, Health Rep, V18, P9; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; MCCLUNG HW, 1983, JAMA-J AM MED ASSOC, V249, P2671, DOI 10.1001/jama.249.19.2671; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McElhaney JE, 2008, J INFECT DIS, V198, P632, DOI 10.1086/590435; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Nyquist Ann-Christine, 2007, Manag Care, V16, P6; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Piedra PA, 2007, PEDIATRICS, V120, pE553, DOI 10.1542/peds.2006-2836; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Strikas RA, 2002, CLIN INFECT DIS, V35, P590, DOI 10.1086/342200; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; WHITAKERDOWLING P, 1991, J INFECT DIS, V164, P1200, DOI 10.1093/infdis/164.6.1200; Whitley RJ, 2006, J INFECT DIS, V194, pS133, DOI 10.1086/507548; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650; YOUNGNER JS, 1994, J CLIN MICROBIOL, V32, P750, DOI 10.1128/JCM.32.3.750-754.1994; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; 2007, MMWR MORB MORTAL WKL, V56, P118; 2008, MMWR MORB MORTAL WKL, V57, P1046	47	73	79	4	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2579	2585		10.1056/NEJMcp0807498	http://dx.doi.org/10.1056/NEJMcp0807498			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073977				2022-12-28	WOS:000261534200009
J	Stymiest, JL; Bagutski, V; French, RM; Aggarwal, VK				Stymiest, Jake L.; Bagutski, Viktor; French, Rosalind M.; Aggarwal, Varinder K.			Enantiodivergent conversion of chiral secondary alcohols into tertiary alcohols	NATURE			English	Article							ASYMMETRIC TRANSFER HYDROGENATION; ELECTROPHILIC SUBSTITUTION; CARBONYL-COMPOUNDS; BORONIC ESTERS; KETONES; ADDITIONS; REAGENTS; CATALYST; CONSTRUCTION; THALIDOMIDE	From receptors in the nose to supramolecular biopolymers, nature shows a remarkable degree of specificity in the recognition of chiral molecules, resulting in the mirror image arrangements of the two forms eliciting quite different biological responses(1,2). It is thus critically important that during a chemical synthesis of chiral molecules only one of the two three- dimensional arrangements is created. Although certain classes of chiral molecules ( for example secondary alcohols(3,4)) are now easy to make selectively in the single mirror image form, one class - those containing quaternary stereogenic centres ( a carbon atom with four different non- hydrogen substituents) - remains a great challenge(5-8). Here we present a general solution to this problem which takes easily obtainable secondary alcohols in their single mirror image form and in a two- step sequence converts them into tertiary alcohols ( quaternary stereogenic centres). The overall process involves removing the hydrogen atom ( attached to carbon) of the secondary alcohol and effectively replacing it with an alkyl, alkenyl or aryl group. Furthermore, starting from a single mirror image form of the secondary alcohol, either mirror image form of the tertiary alcohol can be made with high levels of stereo control. Thus, a broad range of tertiary alcohols can now be easily made by this method with very high levels of selectivity. We expect that this methodology could find widespread application, as the intermediate tertiary boronic esters can potentially be converted into a range of functional groups with retention of configuration.	[Stymiest, Jake L.; Bagutski, Viktor; French, Rosalind M.; Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Aggarwal, VK (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	v.aggarwal@bristol.ac.uk	Bagutski, Viktor V/A-3207-2013; Aggarwal, Varinder/AAG-8504-2019	Bagutski, Viktor V/0000-0002-7514-2455; Aggarwal, Varinder/0000-0003-0344-6430	EPSRC; Merck; Royal Society for a Wolfson Research Merit Award; Senior Research Fellowship	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Merck(Merck & Company); Royal Society for a Wolfson Research Merit Award(Royal Society of London); Senior Research Fellowship	We thank EPSRC for financial support and Frontier Scientific for their donation of boronic esters. We also thank Merck for unrestricted research support. V. K. A. thanks the Royal Society for a Wolfson Research Merit Award and EPSRC for a Senior Research Fellowship.	Aggarwal VK, 2006, PURE APPL CHEM, V78, P215, DOI 10.1351/pac200678020215; Betancort JM, 2004, SYNLETT, P749, DOI 10.1055/s-2004-817779; CARSTENS A, 1994, TETRAHEDRON, V50, P6097, DOI 10.1016/S0040-4020(01)90461-2; Chen CA, 2007, ANGEW CHEM INT EDIT, V46, P5373, DOI 10.1002/anie.200701201; Christoffers J, 2005, QUATERNARY STEREOCENTERS: CHALLENGES AND SOLUTIONS FOR ORGANIC SYNTHESIS, P1, DOI 10.1002/3527606858; Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P388, DOI 10.1002/(SICI)1521-3773(19980302)37:4<388::AID-ANIE388>3.0.CO;2-V; CROSSLEY R, 1992, TETRAHEDRON, V48, P8155, DOI 10.1016/S0040-4020(01)80486-5; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Derwing C, 1999, EUR J ORG CHEM, V1999, P3519; Fang GY, 2007, J AM CHEM SOC, V129, P14632, DOI 10.1021/ja074110i; Forrat VJ, 2005, TETRAHEDRON-ASYMMETR, V16, P3341, DOI 10.1016/j.tetasy.2005.08.031; Fujii A, 1996, J AM CHEM SOC, V118, P2521, DOI 10.1021/ja954126l; HOPPE D, 1990, ANGEW CHEM INT EDIT, V29, P1424, DOI 10.1002/anie.199014241; Hoppe D., 1997, ANGEW CHEM INT EDIT, V36, P2282, DOI DOI 10.1002/ANIE.199722821; Hurst, 1990, HETEROATOM CHEM, V1, P65; Jeon SJ, 2005, J AM CHEM SOC, V127, P16416, DOI 10.1021/ja052200m; Jeon SJ, 2005, J ORG CHEM, V70, P448, DOI 10.1021/jo048683e; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; Krasovskiy A, 2006, ANGEW CHEM INT EDIT, V45, P497, DOI 10.1002/anie.200502485; LEVIN GB, 2006, DETECTING LIFE BIOL; Matteson DS, 1998, TETRAHEDRON, V54, P10555, DOI 10.1016/S0040-4020(98)00321-4; Noyori R, 1997, ACCOUNTS CHEM RES, V30, P97, DOI 10.1021/ar9502341; Pu L, 2001, CHEM REV, V101, P757, DOI 10.1021/cr000411y; Ramon DJ, 1998, TETRAHEDRON LETT, V39, P1239, DOI 10.1016/S0040-4039(97)10765-1; Riant O, 2007, ORG BIOMOL CHEM, V5, P873, DOI 10.1039/b617746h; Rouhi M, 2005, CHEM ENG NEWS, V83, P122, DOI 10.1021/cen-v083n025.p122; Shibasaki M, 2008, CHEM REV, V108, P2853, DOI 10.1021/cr078340r; Stymiest JL, 2007, ANGEW CHEM INT EDIT, V46, P7491, DOI 10.1002/anie.200702146; Thayer AM, 2007, CHEM ENG NEWS, V85, P11, DOI 10.1021/cen-v085n032.p011; Thiemann W H, 1998, Biol Sci Space, V12, P73	30	293	293	5	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					778	U61		10.1038/nature07592	http://dx.doi.org/10.1038/nature07592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	381TX	19079057				2022-12-28	WOS:000261559900046
J	Fishman, L; Saunders, A				Fishman, Lila; Saunders, Arpiar			Centromere-Associated Female Meiotic Drive Entails Male Fitness Costs in Monkeyflowers	SCIENCE			English	Article							TRANSMISSION RATIO DISTORTION; SEGREGATION; SELECTION; MEIOSIS; LOCUS	Female meiotic drive, in which paired chromosomes compete for access to the egg, is a potentially powerful but rarely documented evolutionary force. In interspecific monkeyflower ( Mimulus) hybrids, a driving M. guttatus allele ( D) exhibits a 98: 2 transmission advantage via female meiosis. We show that extreme interspecific drive is most likely caused by divergence in centromere- associated repeat domains and document cytogenetic and functional polymorphism for drive within a population of M. guttatus. In conspecific crosses, D had a 58: 42 transmission advantage over nondriving alternative alleles. However, individuals homozygous for the driving allele suffered reduced pollen viability. These fitness effects and molecular population genetic data suggest that balancing selection prevents the fixation or loss of D and that selfish chromosomal transmission may affect both individual fitness and population genetic load.	[Fishman, Lila; Saunders, Arpiar] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Fishman, L (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	lila.fishman@mso.umt.edu			NSF [DEB-0316786, BIO-0328326]	NSF(National Science Foundation (NSF))	We thank J. H. Willis, J. K. Kelly, J. Birchler, D. Charlesworth, H. Malik, C. Barr, V. Ezenwa, D. Emlen, and S. Miller for critical comments; J. H. Willis, C. Wu, T. J. Vision, E. Ganko, L. Bridges, and J. K. Kelly for materials and communicatingunpublished results; and D. Pedersen, D. Carvey, T. Huggins, E. Peters, and B. Utgaard for lab, greenhouse, and field assistance. D. Rokhsar and J. Schmutz of DOE Joint Genome Institute provided the M. guttatus draft whole-genome sequence. Supported by NSF grants DEB-0316786 (L.F.) and BIO-0328326 (J.H. Willis, L.F., et al.). Sequences have been deposited in GenBank, with the accession numbers FJ147360 to FJ147465.	Ardlie KG, 1998, TRENDS GENET, V14, P189, DOI 10.1016/S0168-9525(98)01455-3; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Birchler JA, 2003, GENETICS, V164, P835; Buckler ES, 1999, GENETICS, V153, P415; Charlesworth B, 2007, GENET RES, V89, P85, DOI 10.1017/S001667230700866X; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Daniel A, 2002, AM J MED GENET, V111, P450, DOI 10.1002/ajmg.10618; Dawe RK, 2004, CHROMOSOME RES, V12, P655, DOI 10.1023/B:CHRO.0000036607.74671.db; de Villena FPM, 2001, GENETICS, V159, P1179; de Villena FPM, 2001, MAMM GENOME, V12, P331, DOI 10.1007/s003350040003; Dyer KA, 2007, P NATL ACAD SCI USA, V104, P1587, DOI 10.1073/pnas.0605578104; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Fishman L, 2001, GENETICS, V159, P1701; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Johnson T, 2005, PHILOS T R SOC B, V360, P1411, DOI 10.1098/rstb.2005.1667; Kelly JK, 2003, GENETICS, V164, P1071; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lamb JC, 2007, CURR OPIN PLANT BIOL, V10, P116, DOI 10.1016/j.pbi.2007.01.008; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Malik HS, 2005, TRENDS ECOL EVOL, V20, P151, DOI 10.1016/j.tree.2005.01.014; Mroczek RJ, 2006, GENETICS, V174, P145, DOI 10.1534/genetics.105.048322; Wu GM, 2005, GENETICS, V170, P327, DOI 10.1534/genetics.104.039479; Zwick ME, 1999, GENETICS, V152, P1605	24	183	183	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1559	1562		10.1126/science.1161406	http://dx.doi.org/10.1126/science.1161406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056989				2022-12-28	WOS:000261377400053
J	Gachter, S; Renner, E; Sefton, M				Gachter, Simon; Renner, Elke; Sefton, Martin			The Long-Run Benefits of Punishment	SCIENCE			English	Article							ALTRUISTIC PUNISHMENT		[Gachter, Simon; Renner, Elke; Sefton, Martin] Univ Nottingham, Sch Econ, Ctr Decis Res & Expt Econ, Nottingham NG7 2RD, England	University of Nottingham	Gachter, S (corresponding author), Univ Nottingham, Sch Econ, Ctr Decis Res & Expt Econ, Sir Clive Granger Bldg,Univ Pk, Nottingham NG7 2RD, England.	simon.gaechter@nottingham.ac.uk	Gachter, Simon/C-9787-2009	Gachter, Simon/0000-0002-7182-8505; Renner, Elke/0000-0001-5858-9872; Sefton, Martin/0000-0002-1327-7311	University of Nottingham; British Academy	University of Nottingham; British Academy	This work was supported by the University of Nottingham and the British Academy.	Bowles S., 2003, MICROECONOMICS BEHAV; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012	8	348	353	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1510	1510		10.1126/science.1164744	http://dx.doi.org/10.1126/science.1164744			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056978				2022-12-28	WOS:000261377400040
J	Schneider, U; Hackermuller, L; Will, S; Best, T; Bloch, I; Costi, TA; Helmes, RW; Rasch, D; Rosch, A				Schneider, U.; Hackermueller, L.; Will, S.; Best, Th.; Bloch, I.; Costi, T. A.; Helmes, R. W.; Rasch, D.; Rosch, A.			Metallic and Insulating Phases of Repulsively Interacting Fermions in a 3D Optical Lattice	SCIENCE			English	Article							ANDERSON LOCALIZATION; MOTT INSULATOR; ATOMS	The fermionic Hubbard model plays a fundamental role in the description of strongly correlated materials. We have realized this Hamiltonian in a repulsively interacting spin mixture of ultracold K-40 atoms in a three- dimensional ( 3D) optical lattice. Using in situ imaging and independent control of external confinement and lattice depth, we were able to directly measure the compressibility of the quantum gas in the trap. Together with a comparison to ab initio dynamical mean field theory calculations, we show how the system evolves for increasing confinement from a compressible dilute metal over a strongly interacting Fermi liquid into a band- insulating state. For strong interactions, we find evidence for an emergent incompressible Mott insulating phase. This demonstrates the potential to model interacting condensed- matter systems using ultracold fermionic atoms.	[Schneider, U.; Hackermueller, L.; Will, S.; Best, Th.; Bloch, I.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Bloch, I.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Costi, T. A.] Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany; [Costi, T. A.] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Helmes, R. W.; Rasch, D.; Rosch, A.] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany	Johannes Gutenberg University of Mainz; Max Planck Society; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; University of Cologne	Bloch, I (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany.	bloch@uni-mainz.de	Costi, Theo A/C-5113-2011; Will, Sebastian/B-8933-2011; Costi, Theodoulos/AAY-1846-2021; Rosch, Achim/A-2962-2009; Rosch, Achim/AAY-7730-2020; Bloch, Immanuel/G-3174-2010; Bloch, Immanuel/N-9169-2019; Schneider, Ulrich/N-4820-2015	Costi, Theo A/0000-0003-0815-5237; Will, Sebastian/0000-0003-2672-5264; Costi, Theodoulos/0000-0003-0815-5237; Rosch, Achim/0000-0002-6586-5721; Rosch, Achim/0000-0002-6586-5721; Bloch, Immanuel/0000-0002-0679-4759; Schneider, Ulrich/0000-0003-4345-9498; Hackermueller, Lucia/0000-0001-9880-2914	Deutsche Forschungsgemeinschaft [FOR801, SFB608, SFB TR 12]; European Union (Scalable Quantum Computing with Light and Atoms); Air Force Office of Scientific Research; Defense Advanced Research Projects Agency (Optical Lattice Emulator); John von Neumann Institute for Computing (Julich); MATCOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (Scalable Quantum Computing with Light and Atoms)(European Commission); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency (Optical Lattice Emulator)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); John von Neumann Institute for Computing (Julich)(Helmholtz Association); MATCOR	We thank E. Demler for fruitful discussions; T. Rom, D. van Oosten, and S. Braun for help during the setup of the experiment; and the Leibniz Institute of Surface Modification (IOM Leipzig) for providing the phase masks used in phase-contrast imaging. We acknowledge funding by the Deutsche Forschungsgemeinschaft (grants FOR801, SFB608, and SFB TR 12), European Union (Scalable Quantum Computing with Light and Atoms), Air Force Office of Scientific Research, and Defense Advanced Research Projects Agency (Optical Lattice Emulator), as well as supercomputer support by the John von Neumann Institute for Computing (Julich). S. W. acknowledges additional support by MATCOR.	ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Andrews MR, 1996, SCIENCE, V273, P84, DOI 10.1126/science.273.5271.84; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Bulla R, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.045103; Bulla R, 2008, REV MOD PHYS, V80, P395, DOI 10.1103/RevModPhys.80.395; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Folling S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.060403; Gebhard F., 1997, MOTT METAL INSULATOR; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Gerbier F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090401; Gerbier F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120405; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Helmes RW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.066802; Helmes RW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.056403; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; KASTBERG A, 1995, PHYS REV LETT, V74, P1542, DOI 10.1103/PhysRevLett.74.1542; Koetsier A, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.023623; Kohl M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.080403; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; LOCH I, 2008, REV MOD PHYS, V80, P885; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; SNOCK M, 2008, N J PHYS, V10; Spielman IB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080404; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; Trebst S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.250402; Werner F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.056401; Winkler K, 2006, NATURE, V441, P853, DOI 10.1038/nature04918	34	588	590	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1520	1525		10.1126/science.1165449	http://dx.doi.org/10.1126/science.1165449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056980	Green Submitted			2022-12-28	WOS:000261377400043
J	Krause, O; Tanaka, M; Usuda, T; Hattori, T; Goto, M; Birkmann, S; Nomoto, K				Krause, Oliver; Tanaka, Masaomi; Usuda, Tomonori; Hattori, Takashi; Goto, Miwa; Birkmann, Stephan; Nomoto, Ken'ichi			Tycho Brahe's 1572 supernova as a standard type Ia as revealed by its light-echo spectrum	NATURE			English	Article							HIGH-VELOCITY FEATURES; CASSIOPEIA-A; WHITE-DWARF; SN 2001EL; MODELS; PROGENITOR; CONSTANT; REMNANT	Type Ia supernovae are thermonuclear explosions of white dwarf stars in close binary systems(1). They play an important role as cosmological distance indicators and have led to the discovery of the accelerated expansion of the Universe(2,3). Among the most important unsolved questions(4) about supernovae are how the explosion actually proceeds and whether accretion occurs from a companion or by the merging of two white dwarfs. Tycho Brahe's supernova of 1572 ( SN 1572) is thought to be one of the best candidates for a type Ia supernova in the Milky Way(5). The proximity of the SN 1572 remnant has allowed detailed studies, such as the possible identification of the binary companion(6), and provides a unique opportunity to test theories of the explosion mechanism and the nature of the progenitor. The determination of the hitherto unknown(7-9) spectroscopic type of this supernova is crucial in relating these results to the diverse population of type Ia supernovae(10). Here we report an optical spectrum of Tycho's supernova near maximum brightness, obtained from a scattered- light echo more than four centuries after the direct light from the explosion swept past the Earth. We find that SN 1572 belongs to the majority class of normal type Ia supernovae.	[Krause, Oliver; Goto, Miwa; Birkmann, Stephan] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Tanaka, Masaomi; Nomoto, Ken'ichi] Univ Tokyo, Inst Phys & Math Universe, Chiba 2778568, Japan; [Tanaka, Masaomi; Nomoto, Ken'ichi] Univ Tokyo, Dept Astron, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Usuda, Tomonori; Hattori, Takashi] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Birkmann, Stephan] European Space Agcy, Dept Space Sci, NL-2200 AG Noordwijk, Netherlands	Max Planck Society; University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); European Space Agency	Krause, O (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	krause@mpia.de; nomoto@astron.s.u-tokyo.ac.jp	Tanaka, Masaomi/A-4354-2011		Japan Society for the Promotion of Science Research Fellowship for Young Scientists; World Premier International Research Center Initiative, MEXT, Japan	Japan Society for the Promotion of Science Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Premier International Research Center Initiative, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is based on data collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan, and the German-Spanish Astronomical Center, Calar Alto, jointly operated by the Max-Planck-Institut fur Astronomie Heidelberg and the Instituto de Astrofisica de Andalucia. We thank U. Thiele and the Calar Alto observers for their support. M. T. is supported by the Japan Society for the Promotion of Science Research Fellowship for Young Scientists. This research has been supported in part by the World Premier International Research Center Initiative, MEXT, Japan.	BAADE W, 1945, ASTROPHYS J, V102, P309, DOI 10.1086/144761; BRAHE T, 1972, OPERA OMNIA, V2, P307; Branch D, 2006, PUBL ASTRON SOC PAC, V118, P560, DOI 10.1086/502778; Decourchelle A, 2001, ASTRON ASTROPHYS, V365, pL218, DOI 10.1051/0004-6361:20000115; DOGGETT JB, 1985, ASTRON J, V90, P2303, DOI 10.1086/113934; FILIPPENKO AV, 1992, ASTRON J, V104, P1543, DOI 10.1086/116339; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; FILIPPENKO AV, 1992, ASTROPHYS J, V384, pL15, DOI 10.1086/186252; HERNANDEZ JG, 2008, ASTROPHYS J IN PRESS; Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; Kasen D, 2003, ASTROPHYS J, V593, P788, DOI 10.1086/376601; Krause O, 2005, SCIENCE, V308, P1604, DOI 10.1126/science.1112035; Krause O, 2008, SCIENCE, V320, P1195, DOI 10.1126/science.1155788; Mattila S, 2005, ASTRON ASTROPHYS, V443, P649, DOI 10.1051/0004-6361:20052731; Mazzali PA, 2005, ASTROPHYS J, V623, pL37, DOI 10.1086/429874; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Nugent P, 2002, PUBL ASTRON SOC PAC, V114, P803, DOI 10.1086/341707; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Rest A, 2008, ASTROPHYS J LETT, V681, pL81, DOI 10.1086/590427; Rest A, 2008, ASTROPHYS J, V680, P1137, DOI 10.1086/587158; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Ruiz-Lapuente P, 2004, ASTROPHYS J, V612, P357, DOI 10.1086/422419; Ruiz-Lapuente P, 2004, NATURE, V431, P1069, DOI 10.1038/nature03006; Schaefer BE, 1996, ASTROPHYS J, V459, P438, DOI 10.1086/176906; Sparks WB, 2008, ASTRON J, V135, P605, DOI 10.1088/0004-6256/135/2/605; Tanaka M, 2006, ASTROPHYS J, V645, P470, DOI 10.1086/504102; VANDENBERGH S, 1993, ASTROPHYS J, V413, P67, DOI 10.1086/172977; Voelk HJ, 2008, ASTRON ASTROPHYS, V483, P529, DOI 10.1051/0004-6361:20079337; Wang LF, 2003, ASTROPHYS J, V591, P1110, DOI 10.1086/375444	30	130	132	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					617	619		10.1038/nature07608	http://dx.doi.org/10.1038/nature07608			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052622	Green Submitted			2022-12-28	WOS:000261340000035
J	Fontelo, P; Liu, F; Zhang, K; Ackerman, M				Fontelo, Paul; Liu, Fang; Zhang, Kai; Ackerman, Michael			Extending the benefits of One Laptop per Child to health	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fontelo, Paul; Liu, Fang; Zhang, Kai; Ackerman, Michael] Natl Lib Med, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Fontelo, P (corresponding author), Natl Lib Med, Bethesda, MD 20894 USA.	fontelo@nlm.nih.gov			NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		*INDIVOHEALTH, IND DOSS; *NAT LIB MED, VIRT SLID NLM; *NAT LIB MED, BABELMESH; *NAT LIB MED, NEWS PODC WEBC; *NAT LIB MED, PUBMED HANDH	5	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2008	337								a2459	10.1136/bmj.a2459	http://dx.doi.org/10.1136/bmj.a2459			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386NU	19047193	Green Published, hybrid			2022-12-28	WOS:000261890700012
J	Singh, R; Manjunatha, U; Boshoff, HIM; Ha, YH; Niyomrattanakit, P; Ledwidge, R; Dowd, CS; Lee, IY; Kim, P; Zhang, L; Kang, SH; Keller, TH; Jiricek, J; Barry, CE				Singh, Ramandeep; Manjunatha, Ujjini; Boshoff, Helena I. M.; Ha, Young Hwan; Niyomrattanakit, Pornwaratt; Ledwidge, Richard; Dowd, Cynthia S.; Lee, Ill Young; Kim, Pilho; Zhang, Liang; Kang, Sunhee; Keller, Thomas H.; Jiricek, Jan; Barry, Clifton E., III			PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release	SCIENCE			English	Article							NITRIC-OXIDE; COENZYME F-420; BOVIS BCG; METABOLISM; IDENTIFICATION; BIOSYNTHESIS; RESISTANCE	Bicyclic nitroimidazoles, including PA- 824, are exciting candidates for the treatment of tuberculosis. These prodrugs require intracellular activation for their biological function. We found that Rv3547 is a deazaflavin- dependent nitroreductase ( Ddn) that converts PA- 824 into three primary metabolites; the major one is the corresponding des- nitroimidazole ( des- nitro). When derivatives of PA- 824 were used, the amount of des- nitro metabolite formed was highly correlated with anaerobic killing of Mycobacterium tuberculosis ( Mtb). Des- nitro metabolite formation generated reactive nitrogen species, including nitric oxide ( NO), which are the major effectors of the anaerobic activity of these compounds. Furthermore, NO scavengers protected the bacilli from the lethal effects of the drug. Thus, these compounds may act as intracellular NO donors and could augment a killing mechanism intrinsic to the innate immune system.	[Singh, Ramandeep; Manjunatha, Ujjini; Boshoff, Helena I. M.; Ha, Young Hwan; Ledwidge, Richard; Dowd, Cynthia S.; Lee, Ill Young; Kim, Pilho; Zhang, Liang; Kang, Sunhee; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Manjunatha, Ujjini; Niyomrattanakit, Pornwaratt; Keller, Thomas H.; Jiricek, Jan] Novartis Inst Trop Dis, Singapore 138670, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis	Barry, CE (corresponding author), NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@mail.nih.gov	Barry, Clifton E/ABE-7992-2020; Jiricek, Jan/AAA-4701-2021; kang, sunhee/AAM-9148-2020; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X; Keller, Thomas/0000-0002-7553-6235	National Institute of Allergy and Infectious Diseases; NIH; Bill and Melinda Gates Foundation; Wellcome Trust; Grand Challenges in Global Health Initiative; Korea Foundation for International Cooperation of Science and Technology; Korean Ministry of Education, Science and Technology ( MEST) [No. K20501000001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000693] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome Trust); Grand Challenges in Global Health Initiative; Korea Foundation for International Cooperation of Science and Technology; Korean Ministry of Education, Science and Technology ( MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Nathan ( Cornell University) and T. P. Begley ( Cornell University) for insightful comments, S. Ehrt ( Cornell University) for proteosome mutants, L. Daniels ( Texas A& M University) for F420 and M. Goodwin ( Tuberculosis Research Section) for analytical support. This work was funded ( in part) by the intramural research program of National Institute of Allergy and Infectious Diseases, NIH, and ( in part) by a grant from the Bill and Melinda Gates Foundation and the Wellcome Trust through the Grand Challenges in Global Health Initiative. This work was also supported by the Korea Foundation for International Cooperation of Science and Technology ( KICOS) through a grant provided by the Korean Ministry of Education, Science and Technology ( MEST) ( No. K20501000001).	Anderson RF, 2008, ORG BIOMOL CHEM, V6, P1973, DOI 10.1039/b801859f; Ballini R, 2004, TETRAHEDRON, V60, P1017, DOI 10.1016/j.tet.2003.11.016; Barry CE, 2004, CURR PHARM DESIGN, V10, P3239, DOI 10.2174/1381612043383214; BEAULIEU BB, 1981, ANTIMICROB AGENTS CH, V20, P410, DOI 10.1128/AAC.20.3.410; Boshoff H.I., 2006, DRUG DISCOV TOD DIS, V3, P237, DOI 10.1016/j.ddmec.2006.06.002; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Fitzpatrick PF, 2005, ARCH BIOCHEM BIOPHYS, V433, P157, DOI 10.1016/j.abb.2004.08.021; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hofmann KW, 2004, APPL ENVIRON MICROB, V70, P2854, DOI 10.1128/AEM.70.5.2854-2860.2004; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Rigas B, 2008, NITRIC OXIDE-BIOL CH, V19, P199, DOI 10.1016/j.niox.2008.04.022; Smets BF, 2007, APPL MICROBIOL BIOT, V76, P267, DOI 10.1007/s00253-007-1008-7; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004	23	450	483	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1392	1395		10.1126/science.1164571	http://dx.doi.org/10.1126/science.1164571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039139	Green Accepted			2022-12-28	WOS:000261170600042
J	Blumenthal, D; Morone, J				Blumenthal, David; Morone, James			The Lessons of Success - Revisiting the Medicare Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blumenthal, David] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; [Morone, James] Brown Univ, Dept Polit Sci, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Brown University	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA.							Bator Francis M., 2007, NO GOOD CHOICES LBJ; BLUMENTHAL D, HEART POWER IN PRESS; Califano J, 2000, TRIUMPH TRAGEDY L JO; Clinton Bill, 2004, MY LIFE; COHEN W, 1969, COMMUNICATION   0302; Dallek Robert, 2004, LB JOHNSON PORTRAIT; HACKER J, 1997, ROAD NOWHERE; Harris Richard, 1966, SACRED TRUST; JACOBS L, 2000, PRESIDENTS DONT PAND; Jacobs Lawrence R., 1993, HLTH NATIONS PUBLIC; JOHNSON H, 1996, SYSTEM AM WAY POLITI; Johnson L. B., 1971, VANTAGE POINT PERSPE; JOHNSON LB, 1964, COMMUNICATION   0609; JOHNSON LB, 1965, COMMUNICATION   0323; JOHNSON LB, 1964, COMMUNICATION   0611; JOHNSON LB, 1965, COMMUNICATION   0306; Kearns Goodwin Doris., 1991, L JOHNSON AM DREAM; Lawrence F.O'Brien, 1986, COMMUNICATION   0724; MARMOR TR, 2000, POLITICS MED; Mills Wilbur, 1987, COMMUNICATION   0325; Oberlander Jonathan, 2003, POLITICAL LIFE MED; PETERSON MA, 2005, HLTH WEALTHY FAIR, P2005; Skocpol T., 1996, BOOMERANG CLINTONS H; STEINMO S, 1995, J HEALTH POLIT POLIC, V20, P329, DOI 10.1215/03616878-20-2-329	24	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2384	2389		10.1056/NEJMhpr0806879	http://dx.doi.org/10.1056/NEJMhpr0806879			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377SG	19038885				2022-12-28	WOS:000261270300013
J	Bressler, C; Milne, C; Pham, VT; ElNahhas, A; van der Veen, RM; Gawelda, W; Johnson, S; Beaud, P; Grolimund, D; Kaiser, M; Borca, CN; Ingold, G; Abela, R; Chergui, M				Bressler, Ch.; Milne, C.; Pham, V. -T.; ElNahhas, A.; van der Veen, R. M.; Gawelda, W.; Johnson, S.; Beaud, P.; Grolimund, D.; Kaiser, M.; Borca, C. N.; Ingold, G.; Abela, R.; Chergui, M.			Femtosecond XANES Study of the Light-Induced Spin Crossover Dynamics in an Iron(II) Complex	SCIENCE			English	Article							RAY-ABSORPTION SPECTROSCOPY; X-RAYS; EXCITED-STATES; SPECTRA; RELAXATION; SCATTERING; SYSTEMS	X- ray absorption spectroscopy is a powerful probe of molecular structure, but it has previously been too slow to track the earliest dynamics after photoexcitation. We investigated the ultrafast formation of the lowest quintet state of aqueous iron(II) tris( bipyridine) upon excitation of the singlet metal- to- ligand- charge- transfer ((MLCT)-M-1) state by femtosecond optical pump/ x- ray probe techniques based on x- ray absorption near- edge structure ( XANES). By recording the intensity of a characteristic XANES feature as a function of laser pump/ x- ray probe time delay, we find that the quintet state is populated in about 150 femtoseconds. The quintet state is further evidenced by its full XANES spectrum recorded at a 300- femtosecond time delay. These results resolve a long- standing issue about the population mechanism of quintet states in iron( II)- based complexes, which we identify as a simple (MLCT)-M-1-->(MLCT)-M-3-->T-5 cascade from the initially excited state. The time scale of the (MLCT)-M-3-->T-5 relaxation corresponds to the period of the iron- nitrogen stretch vibration.	[Bressler, Ch.; Milne, C.; Pham, V. -T.; ElNahhas, A.; van der Veen, R. M.; Gawelda, W.; Kaiser, M.; Chergui, M.] Ecole Polytech Fed Lausanne, Lab Spect Ultrarapide, ISIC, FSB BSP, CH-1015 Lausanne, Switzerland; [van der Veen, R. M.; Gawelda, W.; Johnson, S.; Beaud, P.; Grolimund, D.; Kaiser, M.; Borca, C. N.; Ingold, G.; Abela, R.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Chergui, M (corresponding author), Ecole Polytech Fed Lausanne, Lab Spect Ultrarapide, ISIC, FSB BSP, CH-1015 Lausanne, Switzerland.	Majed.chergui@epfl.ch	Milne, Christopher/C-6883-2008; Bressler, Christian/G-1864-2010; Grolimund, Daniel/O-3127-2017; MS-Powder+MS-Surfdiff+Micro-XAS+Super-XAS, SLS/M-1551-2019; van der Veen, Renske M/A-1834-2011; Beaud, Paul Alexandre/A-8178-2008; Johnson, Steven Lee/B-3252-2008; Gawelda, Wojciech M/B-7878-2014	Milne, Christopher/0000-0003-4714-9139; Grolimund, Daniel/0000-0001-9721-7940; van der Veen, Renske M/0000-0003-0584-4045; Beaud, Paul Alexandre/0000-0001-5028-9138; Johnson, Steven Lee/0000-0001-6074-4894; Gawelda, Wojciech M/0000-0001-7824-9197; , C/0000-0001-9694-5495	Swiss National Science Foundation (FNRS) [110464, 107956, 620-066145, 105239]; Staatssekretariat fur Bildung und Forschungcontract [COST D35 C06.0016]	Swiss National Science Foundation (FNRS)(Swiss National Science Foundation (SNSF)); Staatssekretariat fur Bildung und Forschungcontract	This work was funded by the Swiss National Science Foundation (FNRS), 110464, 107956, 620-066145, and 105239, and by Staatssekretariat fur Bildung und Forschungcontract COST D35 C06.0016. We are very grateful to A. Hauser ( Geneva) for providing us with the samples, as well as for many useful discussions. We also thank M. Benfatto (Rome) for providing us with the MXAN code and for useful discussions.	Bargheer M, 2006, CHEMPHYSCHEM, V7, P783, DOI 10.1002/cphc.200500591; Beaud P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.174801; Benfatto M, 2001, J SYNCHROTRON RADIAT, V8, P267, DOI 10.1107/S0909049500015338; BERGKAMP MA, 1983, J PHYS CHEM-US, V87, P4441, DOI 10.1021/j100245a024; Bianconi A., 1988, XRAY ABSORPTION PRIN, P573; Brady C, 2004, TOP CURR CHEM, V235, P1, DOI 10.1007/b95420; Bressler C, 2004, CHEM REV, V104, P1781, DOI 10.1021/cr0206667; Bressler C, 2008, Z KRISTALLOGR, V223, P307, DOI 10.1524/zkri.2008.0030; Briois V, 2001, INORG CHEM, V40, P912, DOI 10.1021/ic0007153; Cavalleri A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067405; Cavalleri A, 2004, TOP APPL PHYS, V92, P309; Chen LX, 2004, ANGEW CHEM INT EDIT, V43, P2886, DOI 10.1002/anie.200300596; CREUTZ C, 1980, J AM CHEM SOC, V102, P1309, DOI 10.1021/ja00524a014; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dick S, 1998, Z KRIST-NEW CRYST ST, V213, P356; Gaffney KJ, 2007, SCIENCE, V316, P1444, DOI 10.1126/science.1135923; Gawelda W, 2006, J AM CHEM SOC, V128, P5001, DOI 10.1021/ja054932k; Gawelda W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057401; Gawelda W, 2007, J AM CHEM SOC, V129, P8199, DOI 10.1021/ja070454x; Gutlich P, 2004, TOP CURR CHEM, V233, P1, DOI 10.1007/b13527; Hauser A, 2004, TOP CURR CHEM, V234, P155, DOI 10.1007/b95416; Khalil M, 2006, J PHYS CHEM A, V110, P38, DOI 10.1021/jp055002q; Lee T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1852455; MCCUSKER JK, 1993, J AM CHEM SOC, V115, P298, DOI 10.1021/ja00054a043; Monat JE, 2000, J AM CHEM SOC, V122, P4092, DOI 10.1021/ja992436o; Ordejon B, 2008, J AM CHEM SOC, V130, P13961, DOI 10.1021/ja804506h; Raksi F, 1996, J CHEM PHYS, V104, P6066, DOI 10.1063/1.471305; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; Stamm C, 2007, NAT MATER, V6, P740, DOI 10.1038/nmat1985; Tomov IV, 2004, CHEM PHYS LETT, V389, P363, DOI 10.1016/j.cplett.2004.03.087; Tuchagues JP, 2004, TOP CURR CHEM, V235, P85, DOI 10.1007/b95423	31	435	438	3	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					489	492		10.1126/science.1165733	http://dx.doi.org/10.1126/science.1165733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19074309				2022-12-28	WOS:000262587900038
J	Heimberg, H				Heimberg, Harry			Boosting Beta-Cell Numbers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heimberg, Harry] Vrije Univ Brussels, Ctr Diabet Res, Brussels, Belgium; [Heimberg, Harry] Juvenile Diabet Res Fdn Ctr Beta Cell Therapy Dia, Brussels, Belgium	Vrije Universiteit Brussel	Heimberg, H (corresponding author), Vrije Univ Brussels, Ctr Diabet Res, Brussels, Belgium.			Heimberg, Harry/0000-0003-1954-7375				Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2723	2724		10.1056/NEJMcibr0807675	http://dx.doi.org/10.1056/NEJMcibr0807675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092158	Green Published			2022-12-28	WOS:000261757300014
J	Sarewitz, D; Nelson, R				Sarewitz, Daniel; Nelson, Richard			Three rules for technological fixes	NATURE			English	Editorial Material							CAPTURE; ENERGY		[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA; [Nelson, Richard] Columbia Univ, New York, NY 10027 USA	Arizona State University; Arizona State University-Tempe; Columbia University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	daniel.sarewitz@asu.edu; rrn2@columbia.edu						Baciocchi R, 2006, CHEM ENG PROCESS, V45, P1047, DOI 10.1016/j.cep.2006.03.015; Foray D., 2003, LONDON REV ED, V1, P7, DOI DOI 10.1080/14748460306689; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; MURNANE R, 2004, EC INNOVATION NEW TE, V16, P307; National Research Council, 2003, STRATEGIC ED RES PAR; Prins G, 2007, NATURE, V449, P973, DOI 10.1038/449973a; Sarewitz D, 2008, CONTROVERSIES IN SCIENCE & TECHNOLOGY, VOL 2, P329; Stolaroff J.K., 2006, THESIS CARNEGIE MELL	10	62	62	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					871	872		10.1038/456871a	http://dx.doi.org/10.1038/456871a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	384TY	19092910	Bronze			2022-12-28	WOS:000261768300015
J	MacDonald, R				MacDonald, Rhona			Profile Gunilla Backman: putting the right to health into practice	LANCET			English	Biographical-Item												rhona.macdonald@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2015	2015		10.1016/S0140-6736(08)61857-7	http://dx.doi.org/10.1016/S0140-6736(08)61857-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19070730	Bronze			2022-12-28	WOS:000261746900011
J	Anbar, AD				Anbar, Ariel D.			OCEANS Elements and Evolution	SCIENCE			English	Editorial Material							CHEMISTRY; STOICHIOMETRY; OXYGENATION; COEVOLUTION; CYCLES		[Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Anbar, AD (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	anbar@asu.edu						Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Buesseler KO, 2008, SCIENCE, V319, P162, DOI 10.1126/science.1154305; Buick R, 2007, GEOBIOLOGY, V5, P97, DOI 10.1111/j.1472-4669.2007.00110.x; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Elser J, 2006, AM NAT, V168, pS25, DOI 10.1086/509048; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Konhauser KO, 2007, SCIENCE, V315, P1234, DOI 10.1126/science.1136328; Lyons TW, 2008, SCIENCE, V321, P923, DOI 10.1126/science.1162870; Morel FMM, 2008, GEOBIOLOGY, V6, P318, DOI 10.1111/j.1472-4669.2008.00144.x; PECOITS E, 2008, ASTROBIOLOGY, V8, P412; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Williams RJP, 2003, J THEOR BIOL, V220, P323, DOI 10.1006/jtbi.2003.3152; WOLFESIMON F, INT J ASTRO IN PRESS; Zerkle AL, 2005, AM J SCI, V305, P467, DOI 10.2475/ajs.305.6-8.467; ZERKLE AL, 2006, GEOBIOLOGY, V4, P285	26	212	225	7	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1481	1483		10.1126/science.1163100	http://dx.doi.org/10.1126/science.1163100			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056967				2022-12-28	WOS:000261377400030
J	Fragner, A; Goppl, M; Fink, JM; Baur, M; Bianchetti, R; Leek, PJ; Blais, A; Wallraff, A				Fragner, A.; Goeppl, M.; Fink, J. M.; Baur, M.; Bianchetti, R.; Leek, P. J.; Blais, A.; Wallraff, A.			Resolving Vacuum Fluctuations in an Electrical Circuit by Measuring the Lamb Shift	SCIENCE			English	Article							QUANTUM; PHOTON; FIELDS	Quantum theory predicts that empty space is not truly empty. Even in the absence of any particles or radiation, in pure vacuum, virtual particles are constantly created and annihilated. In an electromagnetic field, the presence of virtual photons manifests itself as a small renormalization of the energy of a quantum system, known as the Lamb shift. We present an experimental observation of the Lamb shift in a solid- state system. The strong dispersive coupling of a superconducting electronic circuit acting as a quantum bit ( qubit) to the vacuum field in a transmission- line resonator leads to measurable Lamb shifts of up to 1.4% of the qubit transition frequency. The qubit is also observed to couple more strongly to the vacuum field than to a single photon inside the cavity, an effect that is explained by taking into account the limited anharmonicity of the higher excited qubit states.	[Fragner, A.; Goeppl, M.; Fink, J. M.; Baur, M.; Bianchetti, R.; Leek, P. J.; Wallraff, A.] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Blais, A.] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Sherbrooke	Wallraff, A (corresponding author), ETH, Dept Phys, CH-8093 Zurich, Switzerland.	andreas.wallraff@phys.ethz.ch	Wallraff, Andreas J/C-2130-2009; Blais, Alexandre/E-3315-2010; Leek, Peter/C-7252-2016; Bianchetti, Romeo/D-6836-2016; Baur, Matthias/E-6479-2013; Fink, Johannes M/C-1919-2008	Wallraff, Andreas J/0000-0002-3476-4485; Blais, Alexandre/0000-0002-0591-2012; Leek, Peter/0000-0002-1410-5642; Fink, Johannes M/0000-0001-8112-028X	Swiss National Science Foundation; ETHZ; European Commission with a Marie Curie Intra-European Fellowship; Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research; Fonds Quebecois de la Recherche sur la Nature et les Technologies	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETHZ(ETH Zurich); European Commission with a Marie Curie Intra-European Fellowship(European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	We thank G. Blatter for stimulating discussions and L. Bishop, P. Studer, J. Koch, and R. Schoelkopf for their support in analyzing vacuum Rabi- mode spectra in the presence of thermal photons. This work was supported by the Swiss National Science Foundation and ETHZ. P.J.L. was supported by the European Commission with a Marie Curie Intra-European Fellowship. A.B. was supported by the Natural Sciences and Engineering Research Council of Canada, Canadian Institute for Advanced Research, and Fonds Quebecois de la Recherche sur la Nature et les Technologies.	BETHE HA, 1947, PHYS REV, V72, P339, DOI 10.1103/PhysRev.72.339; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bloch F, 1940, PHYS REV, V57, P522, DOI 10.1103/PhysRev.57.522; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; BRUNE M, 1994, PHYS REV LETT, V72, P3339, DOI 10.1103/PhysRevLett.72.3339; CASIMIR HBG, 1948, PHYS REV, V73, P360, DOI 10.1103/PhysRev.73.360; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Clarke J., 2006, SQUID HDB; Gambetta J, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042318; Haroche S., 2006, EXPLORING QUANTUM; HEINZEN DJ, 1987, PHYS REV LETT, V59, P2623, DOI 10.1103/PhysRevLett.59.2623; Houck AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080502; Irish EK, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155311; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; Marrocco M, 1998, PHYS REV LETT, V81, P5784, DOI 10.1103/PhysRevLett.81.5784; Milonni P. W., 1994, QUANTUM VACUUM INTRO; Niering M, 2000, PHYS REV LETT, V84, P5496, DOI 10.1103/PhysRevLett.84.5496; PURCELL EM, 1946, PHYS REV, V69, P681; Rau I, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.054521; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Schreier JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180502; Schuster DI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.049902; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Schwinger J., 1958, SELECTED PAPERS QUAN; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Walls D. F., 1994, QUANTUM OPT; Ye J, 2008, SCIENCE, V320, P1734, DOI 10.1126/science.1148259	30	82	83	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1357	1360		10.1126/science.1164482	http://dx.doi.org/10.1126/science.1164482			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039130				2022-12-28	WOS:000261170600032
J	Kamper, L; Haage, P				Kamper, Lars; Haage, Patrick			Prepatellar Bursitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kamper, Lars; Haage, Patrick] Helios Clin Wuppertal, D-42283 Wuppertal, Germany		Kamper, L (corresponding author), Helios Clin Wuppertal, D-42283 Wuppertal, Germany.		Kamper, Lars/AAB-6005-2020	Kamper, Lars/0000-0002-1989-7976					0	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2366	2366		10.1056/NEJMicm074304	http://dx.doi.org/10.1056/NEJMicm074304			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377SG	19038882				2022-12-28	WOS:000261270300008
J	Theilen, U; Johnston, ED; Robinson, PA				Theilen, U.; Johnston, E. D.; Robinson, P. A.			Lesson of the Week Rapidly fatal invasive pertussis in young infants - how can we change the outcome?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; BORDETELLA-PERTUSSIS; CONTROLLED-TRIAL; ADOLESCENTS; STRATEGIES; VACCINE; DEATHS; ADULTS		[Theilen, U.; Johnston, E. D.; Robinson, P. A.] Royal Hosp Sick Children, Paediat Intens Care Unit, Edinburgh EH9 1LF, Midlothian, Scotland		Theilen, U (corresponding author), Royal Hosp Sick Children, Paediat Intens Care Unit, Edinburgh EH9 1LF, Midlothian, Scotland.	ulf.theilen@luht.scot.nhs.uk						BONMARIN I, 2002, RENACOQ SURVEILLANCE; BRECHLER V, 1992, J BIOL CHEM, V267, P15496; Cherry JD, 2005, PEDIATRICS, V116, P755, DOI 10.1542/peds.2005-0960; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; *EMPF STAEN IMPFK, 2005, EPIDEMIL B, V30, P257; Forsyth KD, 2004, CLIN INFECT DIS, V39, P1802, DOI 10.1086/426020; Halasa NB, 2003, PEDIATRICS, V112, P1274, DOI 10.1542/peds.112.6.1274; Halperin SA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e42; Hethcote HW, 1999, MATH BIOSCI, V158, P47, DOI 10.1016/S0025-5564(99)00004-8; Hoppe JE, 2000, PEDIATR INFECT DIS J, V19, P244, DOI 10.1097/00006454-200003000-00014; Liese J, 2005, MONATSSCHR KINDERH, V153, P845, DOI 10.1007/s00112-005-1218-y; MEHTA DK, 2006, 289 BMA RPS; Pierce C, 2000, INTENS CARE MED, V26, P1512, DOI 10.1007/s001340000587; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Van der Wielen M, 2000, VACCINE, V18, P2075, DOI 10.1016/S0264-410X(99)00568-X; Van Rie Annelies, 2005, Pediatr Infect Dis J, V24, pS62, DOI 10.1097/01.inf.0000160915.93979.8f; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Vranken P, 2006, AM J INFECT CONTROL, V34, P550, DOI 10.1016/j.ajic.2006.01.008; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; *WHO, 1999, INF CONS CONTR PERT	24	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2008	337								a343	10.1136/bmj.39575.715787.80	http://dx.doi.org/10.1136/bmj.39575.715787.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QC	19039016				2022-12-28	WOS:000261827700004
J	Chan, FKL				Chan, Francis K. L.			Proton-pump inhibitors in peptic ulcer disease	LANCET			English	Editorial Material							INDUCED GASTROINTESTINAL TOXICITY; COST-EFFECTIVENESS; DOUBLE-BLIND; HIGH-RISK; OMEPRAZOLE; ENDOSCOPY; PREVENTION; STRATEGIES; CELECOXIB		[Chan, Francis K. L.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Chan, Francis K. L.] Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, FKL (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China.	fklchan@cuhk.edu.hk	Chan, Francis K. L./F-4851-2010	Chan, Francis K. L./0000-0001-7388-2436				Al-Sabah S, 2008, CLIN GASTROENTEROL H, V6, P418, DOI 10.1016/j.cgh.2007.12.037; Barkun A, 2003, ANN INTERN MED, V139, P843, DOI 10.7326/0003-4819-139-10-200311180-00012; Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1; CHAN FK, AM J GASTRO IN PRESS; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Dorward S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005415.pub2; Elliott RA, 2006, RHEUMATOLOGY, V45, P606, DOI 10.1093/rheumatology/kei241; Lau JY, 2007, NEW ENGL J MED, V356, P1631, DOI 10.1056/NEJMoa065703; Lau JYW, 2000, NEW ENGL J MED, V343, P310, DOI 10.1056/NEJM200008033430501; Leontiadis GI, 2007, HEALTH TECHNOL ASSES, V11, P1; Leontiadis GI, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002094.pub3; ROSTOM A, 2002, COCHRANE DB SYST REV, V2002, DOI [DOI 10.1002/14651858.CD002296, 10.1002/14651858.CD002296]; Rostom A, 2007, CLIN GASTROENTEROL H, V5, P818, DOI 10.1016/j.cgh.2007.03.011; Tsoi KKF, 2008, GASTROINTEST ENDOSC, V67, P1056, DOI 10.1016/j.gie.2007.11.056	16	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1198	1200		10.1016/S0140-6736(08)61497-X	http://dx.doi.org/10.1016/S0140-6736(08)61497-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19094939				2022-12-28	WOS:000259882000006
J	Cooper, RA; Wang, Y; Vignolle, B; Lipscombe, OJ; Hayden, SM; Tanabe, Y; Adachi, T; Koike, Y; Nohara, M; Takagi, H; Proust, C; Hussey, NE				Cooper, R. A.; Wang, Y.; Vignolle, B.; Lipscombe, O. J.; Hayden, S. M.; Tanabe, Y.; Adachi, T.; Koike, Y.; Nohara, M.; Takagi, H.; Proust, Cyril; Hussey, N. E.			Anomalous Criticality in the Electrical Resistivity of La2-xSrxCuO4	SCIENCE			English	Article							T-C SUPERCONDUCTOR; NORMAL-STATE; QUANTUM CRITICALITY; FERMI-SURFACE; TEMPERATURE; PSEUDOGAP; PHASE; DEPENDENCE; SCATTERING; LIQUID	The presence or absence of a quantum critical point and its location in the phase diagram of high-temperature superconductors have been subjects of intense scrutiny. Clear evidence for quantum criticality, particularly in the transport properties, has proved elusive because the important low-temperature region is masked by the onset of superconductivity. We present measurements of the low- temperature in- plane resistivity of several highly doped La2-xSrxCuO4 single crystals in which the superconductivity had been stripped away by using high magnetic fields. In contrast to other quantum critical systems, the resistivity varies linearly with temperature over a wide doping range with a gradient that scales monotonically with the superconducting transition temperature. It is maximal at a critical doping level (p(c)) similar to 0.19 at which superconductivity is most robust. Moreover, its value at pc corresponds to the onset of quasi- particle incoherence along specific momentum directions, implying that the interaction that first promotes high- temperature superconductivity may ultimately destroy the very quasi- particle states involved in the superconducting pairing.	[Cooper, R. A.; Wang, Y.; Lipscombe, O. J.; Hayden, S. M.; Hussey, N. E.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Vignolle, B.; Proust, Cyril] CNRS UPS INSA, LNCMP, UMR 5147, F-31400 Toulouse, France; [Tanabe, Y.; Adachi, T.; Koike, Y.] Tohoku Univ, Dept Appl Phys, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Nohara, M.; Takagi, H.] Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, Chiba 2778651, Japan	University of Bristol; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Tohoku University; University of Tokyo	Hussey, NE (corresponding author), Univ Bristol, HH Wills Phys Lab, Tyndall Ave, Bristol BS8 1TL, Avon, England.	n.e.hussey@bristol.ac.uk	NOHARA, Minoru/B-1476-2011; Hayden, Stephen M/F-4162-2011; TAKAGI, HIDENORI/Q-1041-2019; Takagi, Hidenori/B-2935-2010; Tanabe, Yoichi/A-4864-2010; Wang, Yue/E-9002-2010; Hussey, Nigel E/F-9699-2015	NOHARA, Minoru/0000-0003-1931-9903; Hayden, Stephen M/0000-0002-3209-027X; TAKAGI, HIDENORI/0000-0001-5700-3761; Tanabe, Yoichi/0000-0003-3136-1469; Hussey, Nigel/0000-0002-8590-8979	Engineering and Physical Sciences Research Council (UK); Royal Society, Laboratoire National des Champs Magnetiques Pulses; French Agence Nationale de la Recherche IceNET; EuroMagNET; Engineering and Physical Sciences Research Council [EP/F038836/1, EP/C511778/1] Funding Source: researchfish; EPSRC [EP/F038836/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society, Laboratoire National des Champs Magnetiques Pulses(Royal Society of London); French Agence Nationale de la Recherche IceNET(French National Research Agency (ANR)); EuroMagNET; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge technical and scientific assistance from S.L. Kearns, J. Levallois, and N. Mangkorntang and collaborative support from H.H. Wen. This work was supported by Engineering and Physical Sciences Research Council ( UK), the Royal Society, Laboratoire National des Champs Magnetiques Pulses, the French Agence Nationale de la Recherche IceNET, and EuroMagNET.	Abdel-Jawad M, 2006, NAT PHYS, V2, P821, DOI 10.1038/nphys449; Abdel-Jawad M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.107002; Ando Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267001; Balakirev FF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017004; Boebinger GS, 1996, PHYS REV LETT, V77, P5417, DOI 10.1103/PhysRevLett.77.5417; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Dagan Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.167001; Daou R, 2009, NAT PHYS, V5, P31, DOI [10.1038/nphys1109, 10.1038/NPHYS1109]; Doiron-Leyraud N, 2003, NATURE, V425, P595, DOI 10.1038/nature01968; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Grigera SA, 2001, SCIENCE, V294, P329, DOI 10.1126/science.1063539; GURVITCH M, 1987, PHYS REV LETT, V59, P1337, DOI 10.1103/PhysRevLett.59.1337; Hussey NE, 2003, EUR PHYS J B, V31, P495, DOI 10.1140/epjb/e2003-00059-9; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; Loram JW, 1998, J PHYS CHEM SOLIDS, V59, P2091, DOI 10.1016/S0022-3697(98)00180-2; Loram JW, 2001, J PHYS CHEM SOLIDS, V62, P59, DOI 10.1016/S0022-3697(00)00101-3; Mackenzie AP, 1996, PHYS REV B, V53, P5848, DOI 10.1103/PhysRevB.53.5848; Molegraaf HJA, 2002, SCIENCE, V295, P2239, DOI 10.1126/science.1069947; Moriya T, 2000, ADV PHYS, V49, P555, DOI 10.1080/000187300412248; Nakamae S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.100502; Nakatsuji S, 2008, NAT PHYS, V4, P603, DOI 10.1038/nphys1002; Naqib SH, 2003, PHYSICA C, V387, P365, DOI 10.1016/S0921-4534(02)02330-4; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Paglione J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.246405; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Panagopoulos C, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.220502; Phillips P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107002; Proust C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.147003; Rullier-Albenque F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.027003; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035103; TAKAGI H, 1992, PHYS REV LETT, V69, P297; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Tanabe Y, 2005, J PHYS SOC JPN, V74, P2893, DOI 10.1143/JPSJ.74.2893; Tanabe Y, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.113706; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; WIESMANN H, 1977, PHYS REV LETT, V38, P782, DOI 10.1103/PhysRevLett.38.782; Yoshida T, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/12/125209; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a	39	288	289	6	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					603	607		10.1126/science.1165015	http://dx.doi.org/10.1126/science.1165015			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19074310				2022-12-28	WOS:000262862800034
J	Cameron, A; Ewen, M; Ross-Degnan, D; Ball, D; Laing, R				Cameron, A.; Ewen, M.; Ross-Degnan, D.; Ball, D.; Laing, R.			Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis	LANCET			English	Article							DRUGS	Background WHO and Health Action International (HAI) have developed a standardised method for surveying medicine prices, availability, affordability, and price components in low-income and middle-income countries. Here, we present a secondary analysis of medicine availability in 45 national and subnational surveys done using the WHO/HAI methodology. Methods Data from 45 WHO/HAI surveys in 36 countries were adjusted for inflation or deflation and purchasing power parity. international reference prices from open international procurements for generic products were used as comparators. Results are presented for 15 medicines included in at least 80% of surveys and four individual medicines. Findings Average public sector availability of generic medicines ranged from 29.4% to 54.4% across WHO regions. Median government procurement prices for 15 generic medicines were 1.11 times corresponding international reference prices, although purchasing efficiency ranged from 0 . 09 to 5 . 37 times international reference prices. Low procurement prices did not always translate into low patient prices. Private sector patients paid 9-25 times international reference prices for lowest-priced generic products and over 20 times international reference prices for originator products across WHO regions. Treatments for acute and chronic illness were largely unaffordable in many countries. In the private sector, wholesale mark-ups ranged from 2% to 380%, whereas retail mark-ups ranged from 10% to 552%. In countries where value added tax was applied to medicines, the amount charged varied from 4% to 15%. Interpretation Overall, public and private sector prices for originator and generic medicines were substantially higher than would be expected if purchasing and distribution were efficient and mark-ups were reasonable. Policy options such as promoting generic medicines and alternative financing mechanisms are needed to increase availability reduce prices, and improve affordability. Funding None.	[Cameron, A.; Laing, R.] WHO, CH-1211 Geneva 27, Switzerland; [Ewen, M.] Hlth Act Int, Amsterdam, Netherlands; [Ross-Degnan, D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ross-Degnan, D.] Harvard Pilgrim Hlth Care, Boston, MA USA	World Health Organization; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Cameron, A (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	camerona@who.int			Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development; Open Society Institute; Finnish International Development Agency	Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development(European Commission); Open Society Institute; Finnish International Development Agency	We thank Jean-Marc Guimier, Edson Meza, and Peter Stephens for providing information and data used in the paper, and Kirsten Myhr for providing input into an early draft. We also thank the country teams who undertook surveys of medicine prices and availability, as well as the consultants who provided technical support for data collection, analysis, and interpretation. We also appreciate the support of the WHO Regional Office for Africa and the WHO Department of Technical Cooperation for Essential Drugs and Traditional Medicine for surveys done in Africa. Financial support for the WHO/HAI Project on Medicine Prices and Availability has been provided by: Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development; Open Society Institute; and Finnish International Development Agency.	ANDERSSON F, 1993, PHARMACOECONOMICS, V4, P247, DOI 10.2165/00019053-199304040-00003; [Anonymous], INT DRUG PRIC IND GU; [Anonymous], 2004, WORLD MED SIT; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; BALA K, 1998, HAINEWS          APR, V100, P2; BALA K, 1998, HAINEWS          APR, V100, P13; BALA K, 2000, HAINEWS          APR, V112, P1; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Danzon PM, 1998, PHARMACOECONOMICS, V14, P115, DOI 10.2165/00019053-199814001-00014; Gelders S., 2006, PRICE AVAILABILITY A; *HLTH ACT INT, 2007, HLTH ACT INT MED PRI; *HLTH ACT INT, 2006, COMP PRIC DAT DIFF S; *INT FED PHARM MAN, ACC ACC IN AAI; International Monetary Fund, 2007, WORLD EC OUTL DAT; Laing R., 2005, PHARM TARIFFS WHAT I; MADDEN J, 2003, ESSENTIAL DRUGS MONI, V33, P19; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; MYHR K, COMP PRICES ESSENTIA; *NOV, COART AFR GAIN MOM G; *NOV NORD, SUST REP 2003 WHAT D; Organisation for Economic Co-operation and Development, DRUG SPEND OECD COUN; Ridley DB, 2005, PHARMACOECONOMICS, V23, P651, DOI 10.2165/00019053-200523070-00002; SAGOO K, 2000, HAINEWS          DEC, V110, P1; Vasan A, 2006, B WORLD HEALTH ORGAN, V84, P393, DOI 10.2471/BLT.05.025684; *WHO, 1997, PUBL PRIV ROL PHARM; *WHO, 2001, 54 WORLD HLTH ASS GE, V1; *WHO, 2007, REP REG COMM E MED 5; WHO, 2004, WORLD HLTH REP 2004, P126; *WHO HLTH ACT INT, 2003, MED PRIC NE IN PRESS; *WHO HLTH ACT INT, 2008, SYR AR REP MED PRIC; *WORLD BANK, 2007, COUNTR CLASS; World Health Organization, 2004, EQ ACC ESS MED FRAM; World Health Organization and Health Action International, MEAS MED PRIC AV AFF	33	490	506	6	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					240	249		10.1016/S0140-6736(08)61762-6	http://dx.doi.org/10.1016/S0140-6736(08)61762-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QB	19042012				2022-12-28	WOS:000262537500027
J	Gilbert, R; Widom, CS; Browne, K; Fergusson, D; Webb, E; Janson, S				Gilbert, Ruth; Widom, Cathy Spatz; Browne, Kevin; Fergusson, David; Webb, Elspeth; Janson, Staffan			Child Maltreatment 1 Burden and consequences of child maltreatment in high-income countries	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HEALTH-CARE UTILIZATION; QUALITY-OF-LIFE; SEXUAL-ABUSE; PHYSICAL ABUSE; RISK-FACTORS; MULTIPLE FORMS; MENTAL-HEALTH; LONGITUDINAL ANALYSIS; SOCIOECONOMIC-STATUS	Child maltreatment remains a major public-health and social-welfare problem in high-income countries. Every year, about 4-16% of children are physicafly abused and one in ten is neglected or psychologically abused. During childhood, between 5% and 10% of girls and up to 5% of boys are exposed to penetrative sexual abuse, and up to three times this number are exposed to any type of sexual abuse. However, official rates for substantiated child maltreatment indicate less than a tenth of this burden. Exposure to multiple types and repeated episodes of maltreatment is associated with increased risks of severe maltreatment and psychological consequences. Child maltreatment substantially contributes to child mortality and morbidity and has longlasting effects on mental health, drug and alcohol misuse (especially in girls), risky sexual behaviour, obesity, and criminal behaviour, which persist into adulthood. Neglect is at least as damaging as physical or sexual abuse in the long term but has received the least scientific and public attention. The high burden and serious and long-term consequences of child maltreatment warrant increased investment in preventive and therapeutic strategies from early childhood.	[Gilbert, Ruth] UCL, Inst Child Hlth, Ctr Evidence Based Child Hlth, London WC1N 1EH, England; [Gilbert, Ruth] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London WC1N 1EH, England; [Widom, Cathy Spatz] CUNY John Jay Coll Criminal Justice, Dept Psychol, New York, NY 10019 USA; [Browne, Kevin] Univ Nottingham, Inst Work Hlth & Org, Nottingham NG7 2RD, England; [Browne, Kevin] Univ Birmingham, WHO Collaborating Ctr Child Care & Protect, Birmingham, W Midlands, England; [Fergusson, David] Christchurch Sch Med & Hlth Sci, Christchurch Hlth & Dev Study, Dept Psychol Med, Christchurch, New Zealand; [Webb, Elspeth] Cardiff Univ, Dept Child Hlth, Sch Med, Cardiff, Wales; [Janson, Staffan] Karlstad Univ, Dept Publ Hlth, Karlstad, Sweden	University of London; University College London; University of London; University College London; City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY); University of Nottingham; University of Birmingham; University of Otago; Cardiff University; Karlstad University	Gilbert, R (corresponding author), UCL, Inst Child Hlth, Ctr Evidence Based Child Hlth, 30 Guilford St, London WC1N 1EH, England.	r.gilbert@ich.ucl.ac.uk		Fergusson, David/0000-0002-8117-017X; Gilbert, Ruth/0000-0001-9347-2709				Afifi TO, 2008, AM J PUBLIC HEALTH, V98, P946, DOI 10.2105/AJPH.2007.120253; Amand AS, 2008, CHILD MALTREATMENT, V13, P145, DOI 10.1177/1077559508315353; Andrews GJ, 2004, CHILD SEXUAL ABUSE C; [Anonymous], [No title captured]; Appel AE, 1998, J FAM PSYCHOL, V12, P578, DOI 10.1037/0893-3200.12.4.578; Appleyard K, 2005, J CHILD PSYCHOL PSYC, V46, P235, DOI 10.1111/j.1469-7610.2004.00351.x; Ards SD, 2001, CHILD ABUSE NEGLECT, V25, P7, DOI 10.1016/S0145-2134(00)00221-0; Arriola KRJ, 2005, CHILD ABUSE NEGLECT, V29, P725, DOI 10.1016/j.chiabu.2004.10.014; *AUSTR I HLTH WELF, 2004, AUSTR HLTH 2004; Bae HO, 2007, CHILD YOUTH SERV REV, V29, P856, DOI 10.1016/j.childyouth.2007.01.002; Banyard VL, 2001, J TRAUMA STRESS, V14, P697, DOI 10.1023/A:1013085904337; Behl LE, 2003, CHILD ABUSE NEGLECT, V27, P215, DOI 10.1016/S0145-2134(02)00535-5; Berger LM, 2005, CHILD ABUSE NEGLECT, V29, P107, DOI 10.1016/j.chiabu.2004.02.006; BERRIEN FB, 1995, CHILD ABUSE NEGLECT, V19, P261, DOI 10.1016/0145-2134(94)00124-D; Bifulco A, 1997, J CHILD PSYCHOL PSYC, V38, P365, DOI 10.1111/j.1469-7610.1997.tb01520.x; Boden JM, 2007, CHILD ABUSE NEGLECT, V31, P1101, DOI 10.1016/j.chiabu.2007.03.022; Bonomi AE, 2008, J GEN INTERN MED, V23, P294, DOI 10.1007/s11606-008-0516-1; Brewerton Timothy D, 2007, Eat Disord, V15, P285, DOI 10.1080/10640260701454311; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brookman F, 2006, J INTERPERS VIOLENCE, V21, P869, DOI 10.1177/0886260506288935; Brown J, 2005, CLIN J PAIN, V21, P374, DOI 10.1097/01.ajp.0000149797.16370.dc; Brown J, 1999, J AM ACAD CHILD PSY, V38, P1490, DOI 10.1097/00004583-199912000-00009; Brown J, 2004, J DEV BEHAV PEDIATR, V25, P77, DOI 10.1097/00004703-200404000-00001; Carlson B.E., 2000, TRAUMA VIOLENCE ABUS, V1, P321, DOI DOI 10.1177/1524838000001004002; Carter R., 2005, FAMILY MATTERS STUDY; Chartier MJ, 2007, AM J EPIDEMIOL, V165, P1031, DOI 10.1093/aje/kwk113; Classen CC, 2005, TRAUMA VIOLENCE ABUS, V6, P103, DOI 10.1177/1524838005275087; CLEAVER H, 2004, ASSESSING CHILDRENS; Clemmons JC, 2007, CHILD MALTREATMENT, V12, P172, DOI 10.1177/1077559506298248; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; CREIGHTON S, 2004, PREVALENCE INCIDENCE; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; *DEP CHILDR SCH FA, 2008, REF ASS CHILDR YOUNG; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; Drake B, 2006, CHILD ABUSE NEGLECT, V30, P1201, DOI 10.1016/j.chiabu.2006.05.008; Draper B, 2008, J AM GERIATR SOC, V56, P262, DOI 10.1111/j.1532-5415.2007.01537.x; Dube Shanta R, 2002, Violence Vict, V17, P3, DOI 10.1891/vivi.17.1.3.33635; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Egeland B., 2002, CHILDRENS SERVICES S, V5, P249, DOI [DOI 10.1207/S15326918CS0504_2, 10.1207/S15326918CS0504_2]; Evans E, 2005, CHILD ABUSE NEGLECT, V29, P45, DOI 10.1016/j.chiabu.2004.06.014; Everson MD, 2008, CHILD MALTREATMENT, V13, P14, DOI 10.1177/1077559507307837; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fergusson D., 1999, CHILDHOOD SEXUAL ABU; Fergusson DM, 2008, CHILD ABUSE NEGLECT, V32, P607, DOI 10.1016/j.chiabu.2006.12.018; Fergusson DM, 1996, J AM ACAD CHILD PSY, V35, P1365, DOI 10.1097/00004583-199610000-00024; Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111; Fergusson DM, 1997, CHILD ABUSE NEGLECT, V21, P789, DOI 10.1016/S0145-2134(97)00039-2; Finkelhor D, 2005, CHILD MALTREATMENT, V10, P5, DOI 10.1177/1077559504271287; Finkelhor D., 2008, CHILDHOOD VICTIMIZAT; Finkelhor D, 2007, CHILD ABUSE NEGLECT, V31, P479, DOI 10.1016/j.chiabu.2006.03.012; Fisher MH, 2008, INT REV RES MENT RET, V35, P251, DOI 10.1016/S0074-7750(07)35007-6; Flaherty EG, 2008, PEDIATRICS, V122, P611, DOI 10.1542/peds.2007-2311; Fluke JD, 2008, CHILD MALTREATMENT, V13, P76, DOI 10.1177/1077559507311517; Furniss, 2006, PREVENTING CHILD MAL; GELLES RJ, 1986, CHILD ABUSE NEGLECT, V10, P501, DOI 10.1016/0145-2134(86)90055-4; GHATE D, 2002, NATL STUDY PARENTS C; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Govindshenoy M, 2007, CHILD CARE HLTH DEV, V33, P552, DOI 10.1111/j.1365-2214.2006.00693.x; Hamilton C. E., 1999, CHILD MALTREATMENT, V4, P275, DOI [DOI 10.1177/1077559599004004001, 10.1177/1077559599004004001]; Hamilton-Giachritsis CE, 2005, J FAM PSYCHOL, V19, P619, DOI 10.1037/0893-3200.19.4.619; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; HERCZOG M, 2002, CHILD SEXUAL ABUSE E; HERRENKOHL EC, 1995, CHILD ABUSE NEGLECT, V19, P191, DOI 10.1016/0145-2134(94)00116-C; Herrenkohl RC, 1997, AM J ORTHOPSYCHIAT, V67, P422, DOI 10.1037/h0080244; Herrenkohl TI, 2008, TRAUMA VIOLENCE ABUS, V9, P84, DOI 10.1177/1524838008314797; Herrenkohl TI, 2007, J FAM VIOLENCE, V22, P553, DOI 10.1007/s10896-007-9107-x; Hillis SD, 2004, PEDIATRICS, V113, P320, DOI 10.1542/peds.113.2.320; Hindley N, 2006, ARCH DIS CHILD, V91, P744, DOI 10.1136/adc.2005.085639; HM Government, 2018, WORKING TOGETHER SAF; Hubbard D.J., 2002, J OFFENDER REHABIL, V34, P1, DOI [10.1300/J076v34n03_, DOI 10.1300/J076V34N03_01]; Hunnicutt G, 2008, HOMICIDE STUD, V12, P46, DOI 10.1177/1088767907311245; Hunt K., 1998, ABANDONED STATE CRUE; Hussey JM, 2006, PEDIATRICS, V118, P933, DOI 10.1542/peds.2005-2452; Jaffee SR, 2007, CHILD ABUSE NEGLECT, V31, P231, DOI 10.1016/j.chiabu.2006.03.011; Janson S., 2007, VIOLENCE CHILDREN SW; Johnson JG, 2002, AM J PSYCHIAT, V159, P394, DOI 10.1176/appi.ajp.159.3.394; Johnson JG, 2001, COMPR PSYCHIAT, V42, P16, DOI 10.1053/comp.2001.19755; Jones L., 2001, DECLINE CHILD SEXUAL; Jonson-Reid M, 2004, CHILD MALTREATMENT, V9, P382, DOI 10.1177/1077559504269192; Kalichman Seth C, 2004, J Child Sex Abus, V13, P1, DOI 10.1300/J070v13n01_01; Kendall-Tackett K, 2004, CHILD ABUSE NEGLECT, V28, P723, DOI 10.1016/j.chiabu.2004.02.002; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Klonsky ED, 2008, BRIT J PSYCHIAT, V192, P166, DOI 10.1192/bjp.bp.106.030650; Kotch JB, 2008, PEDIATRICS, V121, P725, DOI 10.1542/peds.2006-3622; Lansford JE, 2002, ARCH PEDIAT ADOL MED, V156, P824, DOI 10.1001/archpedi.156.8.824; Lansford JE, 2007, CHILD MALTREATMENT, V12, P233, DOI 10.1177/1077559507301841; Lau AS, 2005, CHILD ABUSE NEGLECT, V29, P533, DOI 10.1016/j.chiabu.2003.05.005; Lee V, 2007, CHILD MALTREATMENT, V12, P281, DOI 10.1177/1077559507303778; Leeb RebeccaT., 2008, CHILD MALTREATMENT; Leiter J, 1997, AM EDUC RES J, V34, P563, DOI 10.3102/00028312034003563; Lewis T, 2007, CHILD MALTREATMENT, V12, P259, DOI 10.1177/1077559507303402; Linton SJ, 2002, PAIN, V96, P347, DOI 10.1016/S0304-3959(01)00480-8; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Maas C, 2008, TRAUMA VIOLENCE ABUS, V9, P56, DOI 10.1177/1524838007311105; Machado C, 2007, CHILD ABUSE NEGLECT, V31, P657, DOI 10.1016/j.chiabu.2006.11.002; MacMillan HL, 2003, CHILD ABUSE NEGLECT, V27, P1397, DOI 10.1016/j.chiabu.2003.06.003; MacMillan HL, 1997, JAMA-J AM MED ASSOC, V278, P131, DOI 10.1001/jama.278.2.131; MACMILLAN HL, 2008, LANCET          1203, DOI [DOI 10.1016/S0140-6736(08)61708-0, 10.1016/S0140-6736(21)02844-0, DOI 10.1016/S0140-6736(21)02844-0]; Manly JT, 2001, DEV PSYCHOPATHOL, V13, P759, DOI 10.1017/S0954579401004023; Maxfield MG, 1996, ARCH PEDIAT ADOL MED, V150, P390, DOI 10.1001/archpedi.1996.02170290056009; May-Chahal C, 2005, CHILD ABUSE NEGLECT, V29, P969, DOI 10.1016/j.chiabu.2004.05.009; May-Chahal C., 2006, EUROPEAN J SOCIAL WO, V9, P3, DOI DOI 10.1080/13691450500480706; McHolm AE, 2003, AM J PSYCHIAT, V160, P933, DOI 10.1176/appi.ajp.160.5.933; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; Melchert TP, 1997, CHILD ABUSE NEGLECT, V21, P125, DOI 10.1016/S0145-2134(96)00138-X; Merrick MT, 2008, CHILD MALTREATMENT, V13, P122, DOI 10.1177/1077559507306715; Merrill LL, 2003, J CONSULT CLIN PSYCH, V71, P987, DOI 10.1037/0022-006X.71.6.987; Merritt MHB, 2006, PEDIATRICS, V117, pE278, DOI 10.1154/peds.2005-1473; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Mullen PE, 1996, CHILD ABUSE NEGLECT, V20, P7, DOI 10.1016/0145-2134(95)00112-3; Nelson EC, 2002, ARCH GEN PSYCHIAT, V59, P139, DOI 10.1001/archpsyc.59.2.139; Noll JG, 2007, PEDIATRICS, V120, pE61, DOI 10.1542/peds.2006-3058; Noll JG, 2006, J PEDIATR PSYCHOL, V31, P469, DOI 10.1093/jpepsy/jsj040; Ondersma SJ, 2007, CHILD MALTREATMENT, V12, P111, DOI 10.1177/1077559507300622; OSTERGREN M, 2003, IMPROVING MATERNAL I; Paolucci EO, 2001, J PSYCHOL, V135, P17, DOI 10.1080/00223980109603677; PEREZ CM, 1994, CHILD ABUSE NEGLECT, V18, P617, DOI 10.1016/0145-2134(94)90012-4; Pinheiro P.S., 2006, WORLD REPORT VIOLENC; Prosser LA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-42; Raphael Karen G, 2004, Curr Pain Headache Rep, V8, P99, DOI 10.1007/s11916-004-0023-y; Raphael KG, 2005, CLIN J PAIN, V21, P371, DOI 10.1097/01.ajp.0000149794.70627.18; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; READING R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61709-2; Rind B, 1998, PSYCHOL BULL, V124, P22, DOI 10.1037/0033-2909.124.1.22; Roberts I, 1998, J PUBLIC HEALTH MED, V20, P463, DOI 10.1093/oxfordjournals.pubmed.a024803; Sebre S, 2004, CHILD ABUSE NEGLECT, V28, P113, DOI 10.1016/j.chiabu.2003.06.004; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; Senn TE, 2007, ARCH SEX BEHAV, V36, P637, DOI 10.1007/s10508-006-9109-4; Shevlin M, 2008, SCHIZOPHRENIA BULL, V34, P193, DOI 10.1093/schbul/sbm069; Sidebotham P, 2002, CHILD ABUSE NEGLECT, V26, P1243, DOI 10.1016/S0145-2134(02)00415-5; Sidebotham P., 2001, CHILD ABUSE REV, V10, P97, DOI [DOI 10.1002/CAR.643, 10.1002/car.643]; Simpson TL, 2002, CLIN PSYCHOL REV, V22, P27, DOI 10.1016/S0272-7358(00)00088-X; SMITH C, 1995, CRIMINOLOGY, V33, P451, DOI 10.1111/j.1745-9125.1995.tb01186.x; Spataro J, 2004, BRIT J PSYCHIAT, V184, P416, DOI 10.1192/bjp.184.5.416; Sternberg KJ, 2006, CHILD ABUSE NEGLECT, V30, P283, DOI 10.1016/j.chiabu.2005.10.008; Stouthamer-Loeber M, 2001, DEV PSYCHOPATHOL, V13, P941, DOI 10.1017/S0954579401004102; Straus MA, 2005, CHILD ABUSE NEGLECT, V29, P19, DOI 10.1016/j.chiabu.2004.08.005; Streissguth Ann P, 1994, Alcohol Health Res World, V18, P74; Sullivan PM, 2000, CHILD ABUSE NEGLECT, V24, P1257, DOI 10.1016/S0145-2134(00)00190-3; Theodore A, 2007, CHILD MALTREATMENT, V12, P96, DOI 10.1177/1077559506296904; Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403; Thornberry TP, 2001, DEV PSYCHOPATHOL, V13, P957, DOI 10.1017/S0954579401004114; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Tomeo ME, 2001, ARCH SEX BEHAV, V30, P535, DOI 10.1023/A:1010243318426; Trocme N, 2003, CAN MED ASSOC J, V169, P911, DOI 10.1016/j.chiabu.2006.02.015; U.S. Department of Health and Human Services Administration on Children Youth and Families, 2008, CHILD MALTR 2006; *UNICEF, 2001, CHILD AB RES CAR I R; UNICEF, 2003, LEAG TABL CHILD MALT; *US DEP HHS, 2006, 3 NAT INC STUD CHILD; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Walsh CA, 2007, J INTERPERS VIOLENCE, V22, P1536, DOI 10.1177/0886260507306484; Whiffen VE, 2005, TRAUMA VIOLENCE ABUS, V6, P24, DOI 10.1177/1524838004272543; *WHO REG OFF EUR, 2008, HLTH ALL DAT HFA DB; Widom CS, 2008, CHILD ABUSE NEGLECT, V32, P785, DOI 10.1016/j.chiabu.2007.12.006; Widom CS, 2007, J STUD ALCOHOL DRUGS, V68, P317, DOI 10.15288/jsad.2007.68.317; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; Widom CS, 2006, PSYCHOL ADDICT BEHAV, V20, P394, DOI 10.1037/0893-164X.20.4.394; Widom CS, 1999, AM J PSYCHIAT, V156, P1223; Widom CS, 2004, CHILD ABUSE NEGLECT, V28, P715, DOI 10.1016/j.chiabu.2004.03.009; Widom CS, 1999, J CONSULT CLIN PSYCH, V67, P867, DOI 10.1037/0022-006X.67.6.867; Widom CS, 1997, PSYCHOL ASSESSMENT, V9, P34, DOI 10.1037/1040-3590.9.1.34; WIDOM CS, 1995, J STUD ALCOHOL, V56, P207, DOI 10.15288/jsa.1995.56.207; Widom CS, 2001, ALCOHOL RES HEALTH, V25, P52; WIDOM CS, 1989, SCIENCE, V244, P160, DOI 10.1126/science.2704995; Widom CS, 1998, ADVERSITY, STRESS AND PSYCHOPATHOLOGY, P81; Wilson HW, 2008, HEALTH PSYCHOL, V27, P149, DOI 10.1037/0278-6133.27.2.149; Woodman J, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12330; Yates TM, 2003, DEV PSYCHOPATHOL, V15, P199, DOI 10.1017/S0954579403000117; Yates TM, 2008, DEV PSYCHOPATHOL, V20, P651, DOI 10.1017/S0954579408000321; Zawitz M.W, 2007, HOMICIDE TRENDS US; ZINGRAFF MT, 1993, CRIMINOLOGY, V31, P173, DOI 10.1111/j.1745-9125.1993.tb01127.x	172	2207	2238	14	215	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					68	81		10.1016/S0140-6736(08)61706-7	http://dx.doi.org/10.1016/S0140-6736(08)61706-7			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19056114				2022-12-28	WOS:000262183800033
J	Steinbrook, R				Steinbrook, Robert			Medical Student Debt - Is There a Limit?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FUTURE					rsteinbrook@attglobal.net						Ebell MH, 2008, JAMA-J AM MED ASSOC, V300, P1131, DOI 10.1001/jama.300.10.1131; Jolly P, 2007, MED SCH TUITION YOUN; JOLLY P, 2008, DIVERSITY US MED STU, V8; Morrison G, 2005, NEW ENGL J MED, V352, P117, DOI 10.1056/NEJMp048089; 2008, US NEWS WORLD R 1120	5	40	40	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2629	2632		10.1056/NEJMp0808520	http://dx.doi.org/10.1056/NEJMp0808520			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092148				2022-12-28	WOS:000261757300001
J	Stotland, NE				Stotland, Naomi E.			Obesity and pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL WEIGHT-GAIN; BODY-MASS INDEX; CESAREAN DELIVERY; MATERNAL OBESITY; BARIATRIC SURGERY; VAGINAL BIRTH; FETAL; OUTCOMES; WOMEN; VISUALIZATION		[Stotland, Naomi E.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Stotland, NE (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 1001 Potrero Ave 6D-1, San Francisco, CA 94110 USA.	stotlandn@obgyn.ucsf.edu						Abodeely A, 2008, SURG OBES RELAT DIS, V4, P464, DOI 10.1016/j.soard.2007.08.018; American College of Obstetricians and Gynecologists (ACOG), 2005, OBSTET GYNECOL, V106, P671, DOI [10.1097/00006250-200509000-00054, DOI 10.1097/00006250-200509000-00054]; Artal R, 2007, APPL PHYSIOL NUTR ME, V32, P596, DOI 10.1139/H07-024; Boulvain M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000451.pub2; Carroll CS, 2003, AM J OBSTET GYNECOL, V188, P1516, DOI 10.1067/mob.2003.472; Catalano PM, 2007, OBSTET GYNECOL, V109, P419, DOI 10.1097/01.AOG.0000253311.44696.85; Chelmow D, 2004, OBSTET GYNECOL, V103, P974, DOI 10.1097/01.AOG.0000124807.76451.47; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a; Durnwald CP, 2004, AM J OBSTET GYNECOL, V191, P954, DOI 10.1016/j.ajog.2004.05.051; Goffman D, 2007, J PERINATOL, V27, P597, DOI 10.1038/sj.jp.7211810; Grimes DA, 2005, CONTRACEPTION, V72, P1, DOI 10.1016/j.contraception.2005.04.002; Gunderson EP, 2001, INT J OBESITY, V25, P853, DOI 10.1038/sj.ijo.0801631; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hendler I, 2005, J ULTRAS MED, V24, P1205, DOI 10.7863/jum.2005.24.9.1205; Hendler I, 2004, AM J OBSTET GYNECOL, V190, P1616, DOI 10.1016/j.ajog.2004.03.064; Hendler I, 2004, INT J OBESITY, V28, P1607, DOI 10.1038/sj.ijo.0802759; Huber LRB, 2007, AM J EPIDEMIOL, V166, P1306, DOI 10.1093/aje/kwm221; Huber LRB, 2005, MATERN CHILD HLTH J, V9, P413, DOI 10.1007/s10995-005-0015-5; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Oddy WH, 2006, J PEDIATR-US, V149, P185, DOI 10.1016/j.jpeds.2006.04.005; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Patel JA, 2008, SURG OBES RELAT DIS, V4, P39, DOI 10.1016/j.soard.2007.10.008; Smaill Fiona M, 2019, Cochrane Database Syst Rev, V2019, DOI 10.1002/14651858.CD000490.pub4; Soens MA, 2008, ACTA ANAESTH SCAND, V52, P6, DOI 10.1111/j.1399-6576.2007.01483.x; Stotland NE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.048; Stotland NE, 2005, OBSTET GYNECOL, V105, P633, DOI 10.1097/01.AOG.0000152349.84025.35; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Wax JR, 2007, OBSTET GYNECOL SURV, V62, P595, DOI 10.1097/01.ogx.0000279291.86611.46; Wing RR, 2003, PRIMARY CARE, V30, P375, DOI 10.1016/S0095-4543(03)00009-5; World Health Organization, 2021, OB OV FACT SHEETS	32	9	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2008	337								a2450	10.1136/bmj.a2450	http://dx.doi.org/10.1136/bmj.a2450			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SS	19074938				2022-12-28	WOS:000262184600004
J	de Riedmatten, H; Afzelius, M; Staudt, MU; Simon, C; Gisin, N				de Riedmatten, Hugues; Afzelius, Mikael; Staudt, Matthias U.; Simon, Christoph; Gisin, Nicolas			A solid-state light-matter interface at the single-photon level	NATURE			English	Article								Coherent and reversible mapping of quantum information between light and matter is an important experimental challenge in quantum information science. In particular, it is an essential requirement for the implementation of quantum networks and quantum repeaters(1-3). So far, quantum interfaces between light and atoms have been demonstrated with atomic gases(4-9), and with single trapped atoms in cavities(10). Here we demonstrate the coherent and reversible mapping of a light field with less than one photon per pulse onto an ensemble of similar to 10(7) atoms naturally trapped in a solid. This is achieved by coherently absorbing the light field in a suitably prepared solid- state atomic medium(11). The state of the light is mapped onto collective atomic excitations at an optical transition and stored for a pre- determined time of up to 1 mu s before being released in a well- defined spatio- temporal mode as a result of a collective interference. The coherence of the process is verified by performing an interference experiment with two stored weak pulses with a variable phase relation. Visibilities of more than 95 per cent are obtained, demonstrating the high coherence of the mapping process at the single- photon level. In addition, we show experimentally that our interface makes it possible to store and retrieve light fields in multiple temporal modes. Our results open the way to multimode solid- state quantum memories as a promising alternative to atomic gases.	[de Riedmatten, Hugues; Afzelius, Mikael; Staudt, Matthias U.; Simon, Christoph; Gisin, Nicolas] Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland	University of Geneva	de Riedmatten, H (corresponding author), Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland.	hugues.deriedmatten@unige.ch	Simon, Christoph/F-8163-2010; Afzelius, Mikael/N-5825-2016; de Riedmatten, Hugues/P-7563-2017	Simon, Christoph/0000-0003-0747-8800; Afzelius, Mikael/0000-0001-8367-6820; de Riedmatten, Hugues/0000-0002-4418-0723	Swiss NCCR Quantum Photonics; European Commission	Swiss NCCR Quantum Photonics(Swiss National Science Foundation (SNSF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank E. Cavalli and M. Bettinelli for kindly lending us the Nd:YVO<INF>4</INF> crystal. This work was supported by the Swiss NCCR Quantum Photonics and by the European Commission under the Integrated Project Qubit Applications.	AFZELIUS M, MULTIMODE QUANTUM ME; Alexander AL, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043602; Appel J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093602; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Bottger T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.075101; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; de Seze E, 2003, OPT COMMUN, V223, P321, DOI 10.1016/S0030-4018(03)01677-8; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Fraval E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030506; Gorshkov AV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.123601; HASEGAWA Y, 1995, PHYS REV LETT, V75, P2216, DOI 10.1103/PhysRevLett.75.2216; Hastings-Simon SR, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125111; HESSELINK WH, 1979, PHYS REV LETT, V43, P1991, DOI 10.1103/PhysRevLett.43.1991; Hetet G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.023601; Honda K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093601; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Kraus B, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.020302; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; MITSUNAGA M, 1991, OPT LETT, V16, P264, DOI 10.1364/OL.16.000264; Moiseev SA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.173601; Nunn J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.011401; Ohlsson N, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.063812; Rippe L, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022307; Simon C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190503; Staudt MU, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.113601; Staudt MU, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.173602	30	356	361	6	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					773	777		10.1038/nature07607	http://dx.doi.org/10.1038/nature07607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079056	Green Accepted, Green Submitted			2022-12-28	WOS:000261559900045
J	Kwiatkowski, D				Kwiatkowski, Dominic		Malaria Genomic Epidemiology	A global network for investigating the genomic epidemiology of malaria	NATURE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; WIDE ASSOCIATION; INSECTICIDE RESISTANCE; GENETIC-ASSOCIATION; ANOPHELES-GAMBIAE; AFRICAN CHILDREN; SEQUENCE; COLLABORATION; POPULATION; DIVERSITY	Large-scale studies of genomic variation could assist efforts to eliminate malaria. But there are scientific, ethical and practical challenges to carrying out such studies in developing countries, where the burden of disease is greatest. The Malaria Genomic Epidemiology Network (MalariaGEN) is now working to overcome these obstacles, using a consortial approach that brings together researchers from 21 countries.				dominic@sanger.ac.uk	Makani, Julie/E-8525-2017; Deloukas, Panos/B-2922-2013; mangano, valentina/I-2456-2012; Mead, Daniel/AAE-6629-2019; Dunstan, Sarah/AAO-9597-2020; Clark, Taane G./AAM-2570-2020; Makani, Julie/N-9370-2013; Troye-Blomberg, Marita/B-9210-2016	Makani, Julie/0000-0002-4801-6250; Deloukas, Panos/0000-0001-9251-070X; Mead, Daniel/0000-0001-7717-4330; Clark, Taane G./0000-0001-8985-9265; Makani, Julie/0000-0002-4801-6250; Troye-Blomberg, Marita/0000-0002-2804-0325; Kwiatkowski, Dominic/0000-0002-5023-0176; Small, Kerrin/0000-0003-4566-0005; Mangano, Valentina D/0000-0002-2021-6162; Lin, Enmoore/0000-0002-8584-7627; Thera, Mahamadou A/0000-0002-2679-035X; Manske, Magnus/0000-0001-5916-0947; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Ishengoma, Deus/0000-0003-2040-3416; Bull, Susan/0000-0002-9730-091X; Oluoch, Tom/0000-0001-9621-5900; Farrar, Jeremy/0000-0002-2700-623X; Reeder, John/0000-0003-1395-1289; Ragoussis, Ioannis/0000-0002-8515-0934; Apinjoh, Tobias/0000-0001-9889-7271; Allen, Stephen/0000-0001-6675-249X; Dunstan, Sarah/0000-0001-7873-933X; Singhasivanon, Pratap/0000-0002-9759-1702; Conway, David/0000-0002-8711-3037; Hart, Lee/0000-0002-6473-0964; Karunaweera, Nadira/0000-0003-3985-1817; Amodu, Olukemi/0000-0003-1477-4229; Kivinen, Katja/0000-0002-1135-7625; Moyes, Catherine/0000-0002-8028-4079; Bojang, Kalifa/0000-0001-7506-0938; Maslen, Gareth/0000-0001-7318-3678	Medical Research Council [G19/9, G0600718, G0600230(77610), G0200454, G0200454(62635), G0600230] Funding Source: Medline; Wellcome Trust [077383/Z/05/Z, 076934, 077383] Funding Source: Medline; MRC [G19/9, G0200454, G0600718, G0600230] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chokshi DA, 2005, GENOMICS SOC POLICY, V1, P1; Chokshi DA, 2007, PLOS MED, V4, P636, DOI 10.1371/journal.pmed.0040095; Chokshi DA, 2006, B WORLD HEALTH ORGAN, V84, P382, DOI 10.2471/BLT.06.029843; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Teo YY, 2008, NAT METHODS, V5, P279, DOI 10.1038/nmeth0408-279; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	34	112	115	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					732	U39		10.1038/nature07632	http://dx.doi.org/10.1038/nature07632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TX	19079050	Green Accepted, Bronze			2022-12-28	WOS:000261559900037
J	Muehlstaedt, M				Muehlstaedt, Michael			Periungual Tungiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Munich, D-80377 Munich, Germany	University of Munich	Muehlstaedt, M (corresponding author), Univ Munich, D-80377 Munich, Germany.	mmuehlst@med.lmu.de	Mühlstädt, Michael/J-7047-2012; Mühlstädt, Michael/AAN-2158-2021						0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					E30	E30		10.1056/NEJMicm074290	http://dx.doi.org/10.1056/NEJMicm074290			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073971				2022-12-28	WOS:000261534200011
J	Tyler, RH				Tyler, Robert H.			Strong ocean tidal flow and heating on moons of the outer planets	NATURE			English	Article							HOT JUPITERS; GALILEAN SATELLITES; SUBSURFACE OCEAN; OBLIQUITY TIDES; DISSIPATION; EUROPA; TITAN	Data from recent space missions have added strong support for the idea that there are liquid oceans on several moons of the outer planets, with Jupiter's moon Europa having received the most attention(1-4). But given the extremely cold surface temperatures and meagre radiogenic heat sources of these moons, it is still unclear how these oceans remain liquid. The prevailing conjecture is that these oceans are heated by tidal forces that flex the solid moon ( rock plus ice) during its eccentric orbit, and that this heat entering the ocean does not rapidly escape because of the insulating layer of ice over the ocean surface. Here, however, I describe strong tidal dissipation ( and heating) in the liquid oceans; I show that a subdominant and previously unconsidered tidal force due to obliquity ( axial tilt of the moon with respect to its orbital plane) has the right form and frequency to resonantly excite large- amplitude Rossby waves in these oceans. In the specific case of Europa, the minimumkinetic energy of the flow associated with this resonance ( 7.3x10(18) J) is two thousand times larger than that of the flow excited by the dominant tidal forces, and dissipation of this energy seems large enough to be a primary ocean heat source.	[Tyler, Robert H.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Tyler, Robert H.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tyler, RH (corresponding author), Univ Washington, Appl Phys Lab, 1013 NE 40th St, Seattle, WA 98105 USA.	tyler@apl.washington.edu			NASA Outer Planets Research	NASA Outer Planets Research	K. Khurana provided helpful comments during the preparation of this manuscript. This work has been supported by the NASA Outer Planets Research program.	Bills BG, 2005, ICARUS, V175, P233, DOI 10.1016/j.icarus.2004.10.028; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; Egbert GD, 2001, J GEOPHYS RES-OCEANS, V106, P22475, DOI 10.1029/2000JC000699; Fabrycky DC, 2007, ASTROPHYS J, V665, P754, DOI 10.1086/519075; Jayne SR, 2001, GEOPHYS RES LETT, V28, P811, DOI 10.1029/2000GL012044; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; Levrard B, 2007, ASTRON ASTROPHYS, V462, pL5, DOI 10.1051/0004-6361:20066487; LONGUETH.MS, 1968, PHILOS TR R SOC S-A, V262, P511, DOI 10.1098/rsta.1968.0003; Moore WB, 2000, ICARUS, V147, P317, DOI 10.1006/icar.2000.6460; OJAKANGAS GW, 1986, ICARUS, V66, P9459; SAGAN C, 1982, NATURE, V300, P731, DOI 10.1038/300731a0; SEARS WD, 1995, ICARUS, V113, P39, DOI 10.1006/icar.1995.1004; Spohn T, 2003, ICARUS, V161, P456, DOI 10.1016/S0019-1035(02)00048-9; SQUYRES SW, 1983, ICARUS, V53, P319, DOI 10.1016/0019-1035(83)90152-5; Stevenson D, 2000, SCIENCE, V289, P1305, DOI 10.1126/science.289.5483.1305; WADHAMS P, 1973, J GEOPHYS RES, V78, P3552, DOI 10.1029/JC078i018p03552; Winn JN, 2005, ASTROPHYS J, V628, pL159, DOI 10.1086/432834	17	85	86	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					770	U55		10.1038/nature07571	http://dx.doi.org/10.1038/nature07571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079055				2022-12-28	WOS:000261559900044
J	Kato, GJ; Gladwin, MT				Kato, Gregory J.; Gladwin, Mark T.			Evolution of Novel Small-Molecule Therapeutics Targeting Sickle Cell Vasculopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OXIDE SYNTHASE INHIBITOR; NITRIC-OXIDE; PULMONARY-HYPERTENSION; ADHESION MOLECULES; PLATELET ACTIVATION; ENDOTHELIAL-CELLS; HEME OXYGENASE-1; ASYMMETRIC DIMETHYLARGININE; ISCHEMIA-REPERFUSION; ARGININE METABOLISM	A 34- year- old African American woman with sickle cell disease and history of relatively severe hemolysis, chronic leg ulcers, and mild pulmonary hypertension presented with a new ischemic stroke. Recent research has suggested a syndrome of hemolysis- associated vasculopathy in patients with sickle cell disease, which features severe hemolytic anemia and leads to scavenging of nitric oxide and its biochemical precursor L- arginine. This diminished bioavailability of nitric oxide promotes a hemolysis-vascular dysfunction syndrome, which includes pulmonary hypertension, cutaneous leg ulceration, priapism, and ischemic stroke. Additional correlates of this vasculopathy include activation of endothelial cell adhesion molecules, platelets, and the vascular protectant hemeoxygenase- 1. Some known risk factors for atherosclerosis are also associated with sickle cell vasculopathy, including low levels of apolipoprotein AI and high levels of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase. Identification of dysregulated vascular biology pathways in sickle vasculopathy has provided a focus for new clinical trials for therapeutic intervention, including inhaled nitric oxide, sodium nitrite, L- arginine, phosphodiesterase- 5 inhibitors, niacin, inhaled carbon monoxide, and endothelin receptor antagonists. This article reviews the pathophysiology of sickle vasculopathy and the results of preliminary clinical trials of novel small- molecule therapeutics directed at abnormal vascular biology in patients with sickle cell disease.	[Kato, Gregory J.] NHLBI, Dept Crit Care Med, Ctr Clin, NIH, Bethesda, MD 20892 USA; [Kato, Gregory J.] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Gladwin, Mark T.] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA USA; [Gladwin, Mark T.] Hemostasis & Vasc Biol Res Inst, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kato, GJ (corresponding author), NHLBI, Dept Crit Care Med, Ctr Clin, NIH, 10 Ctr Dr,MSC 1476,Bldg 10 CRC,Room 5-5140, Bethesda, MD 20892 USA.	gkato@mail.nih.gov	Kato, Gregory J/I-7615-2014	Kato, Gregory J/0000-0003-4465-3217	Department of Intramural Research of the NIH Clinical Center; National Heart, Lung, and Blood Institute; Institute of Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NIH Collaborative Research and Development Agreement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006014] Funding Source: NIH RePORTER; CLINICAL CENTER [Z01CL008070] Funding Source: NIH RePORTER	Department of Intramural Research of the NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institute of Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NIH Collaborative Research and Development Agreement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	Drs Kato and Gladwin have been supported by intramural funds from the Department of Intramural Research of the NIH Clinical Center and the National Heart, Lung, and Blood Institute (NHLBI). Dr Gladwin currently receives support from the Institute of Transfusion Medicine, the Hemophilia Center of Western Pennsylvania, and grant support through an NIH Collaborative Research and Development Agreement of inhaled nitric oxide gas with Ikaria.	Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Ataga KI, 2004, AM J MED, V117, P665, DOI 10.1016/j.amjmed.2004.03.034; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Bialecki ES, 2002, AM J MED, V113, P252, DOI 10.1016/S0002-9343(02)01165-8; Bryan NS, 2008, FREE RADICAL BIO MED, V45, P468, DOI 10.1016/j.freeradbiomed.2008.04.040; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; Burnett AL, 2006, J SEX MED, V3, P1077, DOI 10.1111/j.1743-6109.2006.00333.x; Cartwright JE, 1997, EXP CELL RES, V235, P431, DOI 10.1006/excr.1997.3723; Conran N, 2004, AM J HEMATOL, V76, P343, DOI 10.1002/ajh.20129; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dasgupta T, 2006, FREE RADICAL BIO MED, V41, P1771, DOI 10.1016/j.freeradbiomed.2006.08.025; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Derchi G, 2005, HAEMATOLOGICA, V90, P452; Dessap AM, 2008, AM J RESP CRIT CARE, V177, P646, DOI 10.1164/rccm.200710-1606OC; Duits AJ, 2003, ANN HEMATOL, V82, P171, DOI 10.1007/S00277-003-0610-8; Duits AJ, 1996, CLIN IMMUNOL IMMUNOP, V81, P96, DOI 10.1006/clin.1996.0163; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gonzalez FM, 2008, CIRCULATION, V117, P2986, DOI 10.1161/CIRCULATIONAHA.107.748814; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2005, BRIT J HAEMATOL, V130, P943, DOI 10.1111/j.1365-2141.2005.05701.x; KATO GJ, DISORDERS H IN PRESS; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kaul DK, 2006, AM J PHYSIOL-CELL PH, V291, pC922, DOI 10.1152/ajpcell.00639.2005; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Kaul DK, 2000, AM J PHYSIOL-HEART C, V278, pH1799, DOI 10.1152/ajpheart.2000.278.6.H1799; Klings ES, 2008, AM J HEMATOL, V83, P547, DOI 10.1002/ajh.21187; Landburg PP, 2008, AM J HEMATOL, V83, P577, DOI 10.1002/ajh.21184; Lee SK, 2002, NEPHRON, V90, P447, DOI 10.1159/000054733; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Machado RF, 2005, BRIT J HAEMATOL, V129, P449, DOI 10.1111/j.1365-2141.2005.05432.x; Machado RF, 2007, BRIT J HAEMATOL, V136, P319, DOI 10.1111/j.1365-2141.2006.06417.x; Machado RF, 2006, JAMA-J AM MED ASSOC, V296, P310, DOI 10.1001/jama.296.3.310; Mack AK, 2008, BRIT J HAEMATOL, V142, P971, DOI 10.1111/j.1365-2141.2008.07259.x; Mathews MK, 2002, BRIT J OPHTHALMOL, V86, P684, DOI 10.1136/bjo.86.6.684; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Minneci PC, 2008, AM J PHYSIOL-HEART C, V295, pH743, DOI 10.1152/ajpheart.00151.2008; Mitchell BL, 2007, J NATL MED ASSOC, V99, P300; Mohan JS, 2005, BLOOD COAGUL FIBRIN, V16, P209, DOI 10.1097/01.mbc.0000164431.98169.8f; Monnet D, 1996, ANN BIOL CLIN-PARIS, V54, P285; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris CR, 2003, AM J RESP CRIT CARE, V168, P63, DOI 10.1164/rccm.200208-967OC; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; OHENEFREMPONG K, 1991, SEMIN HEMATOL, V28, P213; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; Pluta RM, 2005, JAMA-J AM MED ASSOC, V293, P1477, DOI 10.1001/jama.293.12.1477; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Romero JR, 2002, BLOOD, V99, P1103, DOI 10.1182/blood.V99.4.1103; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; Saleh AW, 1998, ACTA HAEMATOL-BASEL, V100, P26, DOI 10.1159/000040859; SASAKI J, 1983, CLIN LAB HAEMATOL, V5, P35; SASAKI J, 1986, CLIN CHEM, V32, P226; Schnog JB, 2005, ANN HEMATOL, V84, P282, DOI 10.1007/s00277-004-0983-3; Schnog JB, 2003, ANN HEMATOL, V82, P109, DOI 10.1007/s00277-003-0609-1; Schnog JJB, 2004, ANN HEMATOL, V83, P371, DOI 10.1007/s00277-004-0856-9; Setty BNY, 2008, BLOOD, V111, P905, DOI 10.1182/blood-2007-07-099465; Setty BNY, 2003, LANCET, V362, P1450, DOI 10.1016/S0140-6736(03)14689-2; Setty BNY, 1996, BLOOD, V88, P2311, DOI 10.1182/blood.V88.6.2311.bloodjournal8862311; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; Space SL, 2000, AM J HEMATOL, V63, P200, DOI 10.1002/(SICI)1096-8652(200004)63:4<200::AID-AJH7>3.0.CO;2-Q; Spiecker M, 1998, J LEUKOCYTE BIOL, V63, P732, DOI 10.1002/jlb.63.6.732; Takahashi M, 1996, CYTOKINE, V8, P817, DOI 10.1006/cyto.1996.0109; van Beers EJ, 2008, HAEMATOLOGICA, V93, pE42, DOI 10.3324/haematol.12632; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Walmet PS, 2003, AM J HEMATOL, V73, P215, DOI 10.1002/ajh.10360; Weiner DL, 2003, JAMA-J AM MED ASSOC, V289, P1136, DOI 10.1001/jama.289.9.1136; WESTWICK J, 1983, J MED, V14, P17; Wun T, 1998, BRIT J HAEMATOL, V100, P741, DOI 10.1046/j.1365-2141.1998.00627.x; YUDITSKAYA S, BLOOD IN PRESS	82	56	60	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2638	2646		10.1001/jama.2008.598	http://dx.doi.org/10.1001/jama.2008.598			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066384	Green Accepted			2022-12-28	WOS:000261503000023
J	Lewis, D				Lewis, Deborah			Legacy A Conversation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												deborahjlewis@starpower.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2588	2589		10.1001/jama.2008.807	http://dx.doi.org/10.1001/jama.2008.807			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066372				2022-12-28	WOS:000261503000001
J	Di Bisceglie, AM; Shiffman, ML; Everson, GT; Lindsay, KL; Everhart, JE; Wright, EC; Lee, WM; Lok, AS; Bonkovsky, HL; Morgan, TR; Ghany, MG; Morishima, C; Snow, KK; Dienstag, JL				Di Bisceglie, Adrian M.; Shiffman, Mitchell L.; Everson, Gregory T.; Lindsay, Karen L.; Everhart, James E.; Wright, Elizabeth C.; Lee, William M.; Lok, Anna S.; Bonkovsky, Herbert L.; Morgan, Timothy R.; Ghany, Marc G.; Morishima, Chihiro; Snow, Kristin K.; Dienstag, Jules L.		HALT-C Trial Investigators	Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; INTERFERON THERAPY; VIRUS-INFECTION; TRIAL; RIBAVIRIN; NONRESPONDERS; INHIBITOR; CIRRHOSIS; ALPHA-2A; RISK	Background: In patients with chronic hepatitis C who do not have a response to antiviral treatment, the disease may progress to cirrhosis, liver failure, hepatocellular carcinoma, and death. Whether long-term antiviral therapy can prevent progressive liver disease in such patients remains uncertain. Methods: We conducted a randomized, controlled trial of peginterferon alfa-2a at a dosage of 90 microg per week for 3.5 years, as compared with no treatment, in 1050 patients with chronic hepatitis C and advanced fibrosis who had not had a response to previous therapy with peginterferon and ribavirin. The patients, who were stratified according to stage of fibrosis (622 with noncirrhotic fibrosis and 428 with cirrhosis), were seen at 3-month intervals and underwent liver biopsy at 1.5 and 3.5 years after randomization. The primary end point was progression of liver disease, as indicated by death, hepatocellular carcinoma, hepatic decompensation, or, for those with bridging fibrosis at baseline, an increase in the Ishak fibrosis score of 2 or more points. Results: We randomly assigned the patients to receive peginterferon (517 patients) or no therapy (533 patients) for 3.5 years. The level of serum aminotransferases, the level of serum hepatitis C virus RNA, and histologic necroinflammatory scores all decreased significantly (P<0.001) with treatment, but there was no significant difference between the groups in the rate of any primary outcome (34.1% in the treatment group and 33.8% in the control group; hazard ratio, 1.01; 95% confidence interval, 0.81 to 1.27; P=0.90). The percentage of patients with at least one serious adverse event was 38.6% in the treatment group and 31.8% in the control group (P=0.07). Conclusions: Long-term therapy with peginterferon did not reduce the rate of disease progression in patients with chronic hepatitis C and advanced fibrosis, with or without cirrhosis, who had not had a response to initial treatment with peginterferon and ribavirin. (ClinicalTrials.gov number, NCT00006164.).	[Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, St Louis, MO 63110 USA; [Shiffman, Mitchell L.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA; [Everson, Gregory T.] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Lindsay, Karen L.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Everhart, James E.; Wright, Elizabeth C.; Ghany, Marc G.] NIDDKD, Bethesda, MD 20892 USA; [Lee, William M.] Univ Texas Dallas, SW Med Ctr, Dallas, TX USA; [Lok, Anna S.] Univ Michigan, Med Ctr, Ann Arbor, MI USA; [Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Farmington, CT USA; [Morgan, Timothy R.] Univ Calif Irvine, Irvine, CA USA; [Morgan, Timothy R.] Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA; [Morishima, Chihiro] Univ Washington, Seattle, WA 98195 USA; [Snow, Kristin K.] New England Res Inst, Watertown, MA 02172 USA; [Dienstag, Jules L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Dienstag, Jules L.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Saint Louis University; Virginia Commonwealth University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of Connecticut; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of Washington; University of Washington Seattle; HealthCore, Inc; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Di Bisceglie, AM (corresponding author), St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, 3635 Vista Ave, St Louis, MO 63110 USA.	dibiscam@slu.edu	Bonkovsky, Herbert L./AAH-1892-2021; Ghany, Marc/AAU-4238-2021; Lok, Anna/B-8292-2009	Bonkovsky, Herbert L./0000-0001-7387-3230; Ghany, Marc/0000-0003-2837-0188; Yang, Shuman/0000-0002-9638-0890; Dienstag, Jules/0000-0001-7024-0980; Morishima, Chihiro/0000-0001-5330-9464	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute,; National Center for Minority Health and Health Disparities; National Center for Research Resources; National Institute on Alcohol Abuse and Alcoholism [K24 AA13736]; Hoffmann-La Roche; Idenix Pharmaceuticals; Novartis; Vertex Pharmaceuticals; Bristol- Myers Squibb; Abbott; Schering-Plough; Anadys; GlobeImmune; Pharmasset; SciClone Pharmaceuticals; Clinical Care Options; Gilead; Geneva Foundation; Hoffmann La Roche; Biolex; Valeant Pharmaceuticals; GlaxoSmithKline; Novartis/Human Genome Sciences; King Pharmaceuticals; Peregrine Pharmaceuticals; Roche Diagnostics; ZymoGenetics; Wyeth Pharmaceuticals; Eli Lilly; FibroGen; AstraZeneca; Siemens; Ovation Pharmaceuticals; Boehringer-Ingelheim; Cardax Pharmaceuticals; Achillion Pharmaceuticals; Avant Immunotherapeutics; CombinatoRx; Cubist Pharmaceuticals; Nucleonics; Oxxon; Metabasis; Amgen; Biogen; EnablEd and Clinical Care Options; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827, M01RR000051, M01RR000065, M01RR006192, M01RR000043, M01RR001066, M01RR000633, M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092328, N01DK092321, N01DK092319, N01DK092323, N01DK092318, N01DK092327, ZIADK075009, N01DK092325, N01DK092320, N01DK092322, N01DK092326, N01DK092324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA013736] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Hoffmann-La Roche(Hoffmann-La Roche); Idenix Pharmaceuticals; Novartis(Novartis); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Bristol- Myers Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Schering-Plough(Merck & CompanySchering Plough Corporation); Anadys; GlobeImmune; Pharmasset; SciClone Pharmaceuticals; Clinical Care Options; Gilead(Gilead Sciences); Geneva Foundation; Hoffmann La Roche(Hoffmann-La Roche); Biolex; Valeant Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Novartis/Human Genome Sciences; King Pharmaceuticals; Peregrine Pharmaceuticals; Roche Diagnostics; ZymoGenetics; Wyeth Pharmaceuticals(Wyeth); Eli Lilly(Eli Lilly); FibroGen; AstraZeneca(AstraZeneca); Siemens(Siemens AG); Ovation Pharmaceuticals; Boehringer-Ingelheim(Boehringer Ingelheim); Cardax Pharmaceuticals; Achillion Pharmaceuticals; Avant Immunotherapeutics; CombinatoRx; Cubist Pharmaceuticals; Nucleonics; Oxxon; Metabasis; Amgen(Amgen); Biogen(Biogen); EnablEd and Clinical Care Options; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by contracts from the National Institute of Diabetes and Digestive and Kidney Diseases, with additional support from the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, the National Center for Minority Health and Health Disparities, the National Center for Research Resources, and the National Institute on Alcohol Abuse and Alcoholism (K24 AA13736); and by Hoffmann-La Roche through a Cooperative Research and Development Agreement with the National Institutes of Health.; Dr. Di Bisceglie reports receiving consulting fees from Hoffmann-La Roche, Idenix Pharmaceuticals, Novartis, Vertex Pharmaceuticals, Bristol- Myers Squibb, Abbott, Schering-Plough, Anadys, GlobeImmune, Pharmasset, and SciClone Pharmaceuticals; lecture fees from Novartis and Clinical Care Options; and grant support from Hoffmann- La Roche, Idenix Pharmaceuticals, Vertex Pharmaceuticals, Bristol-Myers Squibb, GlobeImmune, Pharmasset, Gilead, Geneva Foundation, and SciClone Pharmaceuticals; Dr. Shiffman, receiving consulting fees from Hoffmann La Roche, Biolex, Valeant Pharmaceuticals, and GlaxoSmithKline; lecture fees from Hoffmann-La Roche; and grant support from Schering-Plough, Valeant Pharmaceuticals, Vertex Pharmaceuticals, and Hoffmann-La Roche; Dr. Everson, receiving consulting fees from Hoffmann-La Roche and Vertex Pharmaceuticals, lecture fees from Hoffmann-La Roche, and grant support from Hoffmann-La Roche, Schering- Plough, Vertex Pharmaceuticals, Pharmasset, and Novartis/Human Genome Sciences; Dr. Lindsay, receiving consulting fees from Hoffmann-La Roche, Bristol-Myers Squibb, Human Genome Sciences, Idenix Pharmaceuticals, King Pharmaceuticals, Peregrine Pharmaceuticals, Roche Diagnostics, Valeant Pharmaceuticals, and ZymoGenetics; grant support from Hoffmann-La Roche, Idenix Pharmaceuticals, Human Genome Sciences, Schering- Plough, Valeant Pharmaceuticals, Vertex Pharmaceuticals, and Wyeth Pharmaceuticals; and lecture fees from Clinical Care Options; Dr. Lee, receiving consulting fees from Eli Lilly, FibroGen, and AstraZeneca and grant support from Hoffmann-La Roche, Schering-Plough, Vertex Pharmaceuticals, GlaxoSmithKline, Siemens, GlobeImmune, and Bristol- Myers Squibb; Dr. Lok, receiving consulting fees and grant support from Hoffmann-La Roche and Schering-Plough; Dr. Bonkovsky, receiving consulting fees from Novartis, Ovation Pharmaceuticals, and Boehringer- Ingelheim; lecture fees from Ovation Pharmaceuticals; and grant support from Novartis, Vertex Pharmaceuticals, and Hoffmann-La Roche; Dr. Morgan, receiving consulting fees from Hoffmann-La Roche, Vertex Pharmaceuticals, Cardax Pharmaceuticals, and Valeant Pharmaceuticals and lecture fees and grant support from Hoffmann-La Roche and Schering- Plough; and Dr. Dienstag, receiving consulting fees from Achillion Pharmaceuticals, Avant Immunotherapeutics, CombinatoRx, Bristol- Myers Squibb, Cubist Pharmaceuticals, Nucleonics, Pharmasset, SciClone Pharmaceuticals, Human Genome Sciences, Oxxon, Metabasis, Schering- Plough, Amgen, AstraZeneca, Biogen, Vertex Pharmaceuticals, Wyeth Pharmaceuticals, and Gilead; receiving lecture fees from EnablEd and Clinical Care Options; receiving grant support from Vertex Pharmaceuticals; and holding stock options in Metabasis, Achillion Pharmaceuticals, and Nucleonics. No other potential conflict of interest relevant to this article was reported.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Di Bisceglie AM, 2005, J HEPATOL, V43, P434, DOI 10.1016/j.jhep.2005.03.019; Fartoux L, 2007, CLIN GASTROENTEROL H, V5, P502, DOI 10.1016/j.cgh.2006.10.016; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; ISHAK KG, 1994, MODERN PATHOL, V7, P690; Lee WM, 2004, CONTROL CLIN TRIALS, V25, P472, DOI 10.1016/j.cct.2004.08.003; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Shiffman ML, 1999, GASTROENTEROLOGY, V117, P1164, DOI 10.1016/S0016-5085(99)70402-6; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	20	333	347	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2429	2441		10.1056/NEJMoa0707615	http://dx.doi.org/10.1056/NEJMoa0707615			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378MT	19052125	Green Accepted, Green Published			2022-12-28	WOS:000261325900004
J	Mastepanov, M; Sigsgaard, C; Dlugokencky, EJ; Houweling, S; Strom, L; Tamstorf, MP; Christensen, TR				Mastepanov, Mikhail; Sigsgaard, Charlotte; Dlugokencky, Edward J.; Houweling, Sander; Strom, Lena; Tamstorf, Mikkel P.; Christensen, Torben R.			Large tundra methane burst during onset of freezing	NATURE			English	Article							TRACE GAS-EXCHANGE; ATMOSPHERIC METHANE; NORTHEAST GREENLAND; ARCTIC TUNDRA; CH4; EMISSION; CLIMATE; THAW; CO2	Terrestrial wetland emissions are the largest single source of the greenhouse gas methane(1). Northern high- latitude wetlands contribute significantly to the overall methane emissions from wetlands, but the relative source distribution between tropical and high- latitude wetlands remains uncertain(2,3). As a result, not all the observed spatial and seasonal patterns of atmospheric methane concentrations can be satisfactorily explained, particularly for high northern latitudes. For example, a late- autumn shoulder is consistently observed in the seasonal cycles of atmospheric methane at high- latitude sites(4), but the sources responsible for these increased methane concentrations remain uncertain. Here we report a data set that extends hourly methane flux measurements from a high Arctic setting into the late autumn and early winter, during the onset of soil freezing. We find that emissions fall to a low steady level after the growing season but then increase significantly during the freeze- in period. The integral of emissions during the freeze- in period is approximately equal to the amount of methane emitted during the entire summer season. Three- dimensional atmospheric chemistry and transport model simulations of global atmospheric methane concentrations indicate that the observed early winter emission burst improves the agreement between the simulated seasonal cycle and atmospheric data from latitudes north of 60 degrees N. Our findings suggest that permafrost- associated freeze- in bursts of methane emissions from tundra regions could be an important and so far unrecognized component of the seasonal distribution of methane emissions from high latitudes.	[Mastepanov, Mikhail; Strom, Lena; Christensen, Torben R.] Lund Univ, Geobiosphere Sci Ctr, S-22362 Lund, Sweden; [Sigsgaard, Charlotte] Univ Copenhagen, Inst Geog & Geol, DK-1350 Copenhagen, Denmark; [Dlugokencky, Edward J.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Houweling, Sander] SRON, Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Houweling, Sander] Univ Utrecht, Inst Marine & Atmospher Res Utrecht IMAU, NL-3584 CC Utrecht, Netherlands; [Tamstorf, Mikkel P.] Univ Aarhus, Natl Environm Res Inst, DK-4000 Roskilde, Denmark	Lund University; University of Copenhagen; National Oceanic Atmospheric Admin (NOAA) - USA; Utrecht University; Aarhus University	Christensen, TR (corresponding author), Lund Univ, Geobiosphere Sci Ctr, Solvegatan 12, S-22362 Lund, Sweden.	Torben.Christensen@nateko.lu.se	Tamstorf, Mikkel/I-7101-2013; Tamstorf, Mikkel/ACU-7592-2022; Tamstorf, Mikkel/AAB-6627-2020; Dlugokencky, Edward/AAN-8746-2020; Mastepanov, Mikhail/G-1235-2016	Tamstorf, Mikkel/0000-0002-2811-331X; Tamstorf, Mikkel/0000-0002-2811-331X; Dlugokencky, Edward/0000-0003-0612-6985; Mastepanov, Mikhail/0000-0002-5543-0302	Danish Ministry of the Environment; Commission for Scientific Research in Greenland (KVUG); Swedish Research Councils VR; FORMAS	Danish Ministry of the Environment; Commission for Scientific Research in Greenland (KVUG); Swedish Research Councils VR(Swedish Research Council); FORMAS(Swedish Research Council Formas)	This work was carried out under the auspices of the GeoBasis programme and part of the Zackenberg Ecological Research Operations funded by the Danish Ministry of the Environment and the ISICaB project funded by the Commission for Scientific Research in Greenland (KVUG). ASIAQ-Greenland Survey provided climate data. The work was also supported by the Swedish Research Councils VR and FORMAS. We thank P. Bergamachi (JRC) and J.-F. Meirink (KNMI) for providing the TM5 model setup. T. Tagesson helped with the field work in Zackenberg. We are grateful for comments on earlier versions of this manuscript from A. Lindroth and B. Christensen.	Bergamaschi P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007268; Bliss L.C., 1992, ARCTIC ECOSYSTEMS CH, V59, P89; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Christensen TR, 2000, GLOBAL BIOGEOCHEM CY, V14, P701, DOI 10.1029/1999GB001134; CHRISTENSEN TR, 1993, BIOGEOCHEMISTRY, V21, P117, DOI 10.1007/BF00000874; Christiansen HH, 2002, J QUATERNARY SCI, V17, P145, DOI 10.1002/jqs.665; Corradi C, 2005, GLOBAL CHANGE BIOL, V11, P1910, DOI 10.1111/j.1365-2486.2005.01023.x; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; DLUGOKENCKY EJ, 1994, J GEOPHYS RES-ATMOS, V99, P17021, DOI 10.1029/94JD01245; FAN SM, 1992, J GEOPHYS RES-ATMOS, V97, P16627, DOI 10.1029/91JD02531; Fletcher SEM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002223; Friborg T, 2000, GLOBAL BIOGEOCHEM CY, V14, P715, DOI 10.1029/1999GB001136; Gedney N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020919; Hargreaves KJ, 2001, THEOR APPL CLIMATOL, V70, P203, DOI 10.1007/s007040170015; Krol M, 2005, ATMOS CHEM PHYS, V5, P417, DOI 10.5194/acp-5-417-2005; Meltofte H, 2008, ADV ECOL RES, V40, P1, DOI 10.1016/S0065-2504(07)00001-3; Miller JB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029213; Reeburgh WS, 1998, J GEOPHYS RES-ATMOS, V103, P29005, DOI 10.1029/98JD00993; Tokida T, 2007, CHEMOSPHERE, V70, P165, DOI 10.1016/j.chemosphere.2007.06.042; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34207, DOI 10.1029/2001JD900164; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; Whalen SC, 1988, GLOBAL BIOGEOCHEM CY, V2, P399, DOI 10.1029/GB002i004p00399	22	219	247	4	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					628	U58		10.1038/nature07464	http://dx.doi.org/10.1038/nature07464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052625	Green Published			2022-12-28	WOS:000261340000038
J	Kannel, WB; Wolf, PA				Kannel, William B.; Wolf, Phillip A.			Framingham Study Insights on the Hazards of Elevated Blood Pressure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; RISK; STROKE; AGE		[Kannel, William B.; Wolf, Phillip A.] Boston Univ, Sch Med, Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA	Boston University; Framingham Heart Study	Kannel, WB (corresponding author), Boston Univ, Sch Med, Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave, Framingham, MA 01702 USA.	billkannel@yahoo.com		Wolf, Philip/0000-0002-3628-301X	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Kannel W B, 1995, Hypertens Res, V18, P181, DOI 10.1291/hypres.18.181; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1980, CIRCULATION, V61, P1179, DOI 10.1161/01.CIR.61.6.1179; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kannel WB, 2003, HYPERTENSION, V42, P453, DOI 10.1161/01.HYP.0000093382.69464.C4; Kannel WB, 2000, J HUM HYPERTENS, V14, P83, DOI 10.1038/sj.jhh.1000949; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; *NAT HEART LUNG BL, FRAM STUD DAT; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417	15	35	37	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2545	2547		10.1001/jama.2008.759	http://dx.doi.org/10.1001/jama.2008.759			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050198	Bronze			2022-12-28	WOS:000261286200024
J	Bryson, CL; Au, DH; Sun, HL; Williams, EC; Kivlahan, DR; Bradley, KA				Bryson, Chris L.; Au, David H.; Sun, Haili; Williams, Emily C.; Kivlahan, Daniel R.; Bradley, Katharine A.			Alcohol Screening Scores and Medication Nonadherence	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; CONSUMPTION QUESTIONS; OBJECTIVE ASSESSMENT; PREVENTIVE-SERVICES; MENTAL-HEALTH; AUDIT-C; VETERANS; IMPACT	Background: Medication nonadherence is common and is associated with adverse outcomes. Alcohol misuse may be a risk factor for nonadherence; however, evidence is limited. Objective: To identify whether alcohol misuse, as identified by a simple screening tool, is associated in a dose-response manner with increased risk for medication nonadherence in veterans attending primary care clinics. Design: Secondary analysis of cohort data collected prospectively from 1997 to 2000 as part of a randomized, controlled trial. Setting: 7 Veterans Affairs primary care clinics. Participants: 5473 patients taking a statin, 3468 patients taking oral hypoglycemic agents, and 13 729 patients taking antihypertensive medications. Measurements: Patients completed the Alcohol Use Disorder Identification Test-Consumption (AUDIT-C) questionnaire, a validated 3-question alcohol misuse screening test. Their scores were categorized into nondrinkers; low-level alcohol use; and mild, moderate, and severe alcohol misuse. Medication adherence, defined as having medications available for at least 80% of the observation days, was measured from pharmacy records for either 90 days or 1 year after the alcohol screening date. Logistic regression was used to estimate the predicted proportions of adherent patients in each AUDIT-C group and adjusted for demographic and clinical covariates. Results: The proportion of patients treated for hypertension and hyperlipidemia who were nonadherent increased with higher AUDIT-C scores. For 1-year adherence to statins, the percentage of adherent patients was lower in the 2 highest alcohol misuse groups ( adjusted percentage of adherent patients, 58% [95% CI, 52% to 65%] and 55% [ CI, 47% to 63%]) than in the nondrinker group (66% [ CI, 64% to 68%]). For 1-year adherence to antihypertensive regimens, the percentage of adherent patients was lower in the 3 highest alcohol misuse groups ( adjusted percentage of adherent patients, 61% [ CI, 58% to 64%]; 60% [ CI, 56% to 63%]; and 56% [ CI, 52% to 60%]) than in the nondrinker group ( 64% [ CI, 63% to 65%]). No statistically significant differences were observed for oral hypoglycemics in adjusted analyses. Limitation: This observational study cannot address whether changes in drinking lead to changes in adherence and may not be generalizable to other populations. Conclusion: Alcohol misuse, as measured by a brief screening questionnaire, was associated with increased risk for medication nonadherence.	[Bryson, Chris L.] Vet Affairs Puget Sound Healthcare Syst, Hlth Serv Res & Dev Serv, Hlth Serv Res & Dev NW Ctr Excellence, Seattle, WA 98101 USA; Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Bryson, CL (corresponding author), Vet Affairs Puget Sound Healthcare Syst, Hlth Serv Res & Dev Serv, Hlth Serv Res & Dev NW Ctr Excellence, 1100 Olive Way,Suite 1400, Seattle, WA 98101 USA.	christopher.bryson@va.gov; haili.sun@va.gov		Williams, Emily/0000-0002-8210-6137	Department of Veterans Affairs [SDR 96-002, IIR 99-376]; Veterans Health Administration; Health Services Research & Development Service; AUDIT-C as a Scaled Marker for Health Risks in VA Medical Outpatients [IAC 05-206]; Development Service Career Development Awards [RCD 03-177, RCD 00-018]	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Health Services Research & Development Service(US Department of Veterans Affairs); AUDIT-C as a Scaled Marker for Health Risks in VA Medical Outpatients; Development Service Career Development Awards	By the Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service (AUDIT-C as a Scaled Marker for Health Risks in VA Medical Outpatients; IAC 05-206). The ACQUIP was funded by Department of Veterans Affairs grants SDR 96-002 and IIR 99-376. Drs. Bryson and Au were supported by Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service Career Development Awards (RCD 03-177 and RCD 00-018).	Ahmed AT, 2006, DIABETIC MED, V23, P795, DOI 10.1111/j.1464-5491.2006.01878.x; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Au DH, 2007, ALCOHOL CLIN EXP RES, V31, P443, DOI 10.1111/j.1530-0277.2006.00325.x; Au DH, 2001, MED CARE, V39, P879, DOI 10.1097/00005650-200108000-00013; Balkrishnan R, 2003, CLIN THER, V25, P2958, DOI 10.1016/S0149-2918(03)80347-8; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1111/j.1530-0277.1998.tb03991.x; Bradley KA, 2001, J STUD ALCOHOL, V62, P826, DOI 10.15288/jsa.2001.62.826; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bradley KA, 2006, AM J MANAG CARE, V12, P597; Braithwaite RS, 2005, ALCOHOL CLIN EXP RES, V29, P1190, DOI 10.1097/01.ALC.0000171937.87731.28; Bryson CL, 2007, MED CARE, V45, P497, DOI 10.1097/MLR.0b013e3180329368; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cook RL, 2001, J GEN INTERN MED, V16, P83, DOI 10.1111/j.1525-1497.2001.00122.x; Cooper C, 2005, AM J GERIAT PSYCHIAT, V13, P1067, DOI 10.1097/00019442-200512000-00006; Copeland LA, 2008, J NERV MENT DIS, V196, P16, DOI 10.1097/NMD.0b013e318160ea00; Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x; Fihn SD, 2004, AM J MED, V116, P241, DOI 10.1016/j.amjmed.2003.10.026; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; Golin CE, 2002, J GEN INTERN MED, V17, P756, DOI 10.1046/j.1525-1497.2002.11214.x; HARRIS AH, SUBST USE M IN PRESS; Haskard KB, 2008, J ASTHMA, V45, P369, DOI 10.1080/02770900801971776; Hawkins Eric J, 2007, Subst Abus, V28, P53, DOI 10.1300/J465v28n03_06; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Johnson KH, 2000, ARCH FAM MED, V9, P964, DOI 10.1001/archfami.9.10.964; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kinder LS, 2008, PSYCHOSOM MED, V70, P20, DOI 10.1097/PSY.0b013e31815aac93; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Palepu A, 2004, ADDICTION, V99, P361, DOI 10.1111/j.1360-0443.2003.00670.x; Parsons JT, 2007, JAIDS-J ACQ IMM DEF, V46, P443, DOI 10.1097/QAI.0b013e318158a461; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Rose HL, 2008, ADDICTION, V103, P1271, DOI 10.1111/j.1360-0443.2008.02199.x; Samet JH, 2005, ANTIVIR THER, V10, P83; Smith MW, 2003, MED CARE RES REV, V60, p92S, DOI 10.1177/1077558703256726; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; StataCorp, 2005, STAT STAT SOFTW REL; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Zaghloul SS, 2004, ARCH DERMATOL, V140, P408, DOI 10.1001/archderm.140.4.408; Zaghloul SS, 2005, BRIT J DERMATOL, V152, P1015, DOI 10.1111/j.1365-2133.2005.06357.x	43	101	102	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					795	W165		10.7326/0003-4819-149-11-200812020-00004	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	383AA	19047026				2022-12-28	WOS:000261645300003
J	Gardner, MK; Bouck, DC; Paliulis, LV; Meehl, JB; O'Toole, ET; Haase, J; Soubry, A; Joglekar, AP; Winey, M; Salmon, ED; Bloom, K; Odde, DJ				Gardner, Melissa K.; Bouck, David C.; Paliulis, Leocadia V.; Meehl, Janet B.; O'Toole, Eileen T.; Haase, Julian; Soubry, Adelheid; Joglekar, Ajit P.; Winey, Mark; Salmon, Edward D.; Bloom, Kerry; Odde, David J.			Chromosome Congression by Kinesin-5 Motor-Mediated Disassembly of Longer Kinetochore Microtubules	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; NUCLEAR MIGRATION; YEAST; DYNAMICS; PROTEINS; ORIENTATION; REQUIRES; MITOSIS; KIF18A	During mitosis, sister chromatids congress to the spindle equator and are subsequently segregated via attachment to dynamic kinetochore microtubule (kMT) plus ends. A major question is how kMT plus-end assembly is spatially regulated to achieve chromosome congression. Here we find in budding yeast that the widely conserved kinesin-5 sliding motor proteins, Cin8p and Kip1p, mediate chromosome congression by suppressing kMT plus-end assembly of longer kMTs. Of the two, Cin8p is the major effector and its activity requires a functional motor domain. In contrast, the depolymerizing kinesin-8 motor Kip3p plays a minor role in spatial regulation of yeast kMT assembly. Our analysis identified a model where kinesin-5 motors bind to kMTs, move to kMT plus ends, and upon arrival at a growing plus end promote net kMT plus-end disassembly. In conclusion, we find that length-dependent control of net kMT assembly by kinesin-5 motors yields a simple and stable self-organizing mechanism for chromosome congression.	[Gardner, Melissa K.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Bouck, David C.; Paliulis, Leocadia V.; Haase, Julian; Soubry, Adelheid; Joglekar, Ajit P.; Salmon, Edward D.; Bloom, Kerry] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Meehl, Janet B.; O'Toole, Eileen T.; Winey, Mark] Univ Colorado, MCD Biol, Boulder, CO 80301 USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Boulder	Odde, DJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/AAY-1720-2020; Odde, David/H-4925-2011; Bloom, Kerry/AAE-5336-2019	Odde, David/0000-0001-7731-2799; Bloom, Kerry/0000-0002-3457-004X; Joglekar, Ajit/0000-0002-0607-5332; Bouck, David/0000-0002-6281-2544; Haase, Julian/0000-0001-5891-4241	NIH [GM071522, GM32238]; NIH NRSA [EB005568]; SPIRE [GM00678]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB005568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024364, K12GM000678, R37GM032238, R01GM071522, R01GM032238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPIRE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dominique Seetapun for providing matlab kymograph code, Drs. Tom Hays and Leah Gheber for helpful discussions, Dr. Jeff Molk for comments on the manuscript, and Marybeth Anderson for assistance with bim1 Delta images. Plasmids and strains were kindly provided by Drs. S. Reed, B. Errede, M. A. Hoyt, L. Gheber, and D. Pellman. This work was supported by NIH grant GM071522 to D. J. O. K. B. is supported by NIH grant GM32238 and M. K. G. is supported by NIH NRSA grant EB005568. E. T. O. is supported in part by grant RR-00592 from the National Center for Research Resources of the NIH to A. Hoenger. L. V. P. is supported by a SPIRE fellowship (GM00678).	Bouck DC, 2007, CURR BIOL, V17, P741, DOI 10.1016/j.cub.2007.03.033; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; de Gramont A, 2007, CELL CYCLE, V6, P1231, DOI 10.4161/cc.6.10.4181; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gardner MK, 2008, TRENDS CELL BIOL, V18, P307, DOI 10.1016/j.tcb.2008.05.003; Gardner MK, 2007, METHODS, V41, P232, DOI 10.1016/j.ymeth.2006.08.002; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Huang BY, 2006, J CELL BIOL, V175, P17, DOI 10.1083/jcb.200606021; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; O'Toole ET, 2002, METHOD ENZYMOL, V351, P81; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Tao L, 2006, CURR BIOL, V16, P2293, DOI 10.1016/j.cub.2006.09.064; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	43	131	131	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					894	906		10.1016/j.cell.2008.09.046	http://dx.doi.org/10.1016/j.cell.2008.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041752	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000261183900020
J	Zhan, LX; Rosenberg, A; Bergami, KC; Yu, M; Xuan, ZY; Jaffe, AB; Allred, C; Muthuswamy, SK				Zhan, Lixing; Rosenberg, Avi; Bergami, Kenneth C.; Yu, Min; Xuan, Zhenyu; Jaffe, Aron B.; Allred, Craig; Muthuswamy, Senthil K.			Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma	CELL			English	Article							PAPILLOMAVIRUS E6 PROTEINS; TUMOR-SUPPRESSOR SCRIBBLE; MYC-INDUCED TUMORIGENESIS; GROWTH-FACTOR-ALPHA; C-MYC; TRANSGENIC MICE; MOUSE MAMMARY; EPITHELIAL-CELLS; BREAST-CANCER; PROLIFERATION CONTROL	Loss of cell polarity proteins such as Scribble induces neoplasia in Drosophila by promoting uncontrolled proliferation. In mammals, the role that polarity proteins play during tumorigenesis is not well understood. Here, we demonstrate that depletion of Scribble in mammary epithelia disrupts cell polarity, blocks three-dimensional morphogenesis, inhibits apoptosis, and induces dysplasia in vivo that progress to tumors after long latency. Loss of Scribble cooperates with oncogenes such as c-myc to transform epithelial cells and induce tumors in vivo by blocking activation of an apoptosis pathway. Like depletion, mislocalization of Scribble from cell-cell junction was sufficient to promote cell transformation. Interestingly, spontaneous mammary tumors in mice and humans possess both downregulated and mislocalized Scribble. Thus, we demonstrate that scribble inhibits breast cancer formation and that deregulation of polarity pathways promotes dysplastic and neoplastic growth in mammals by disrupting morphogenesis and inhibiting cell death.	[Zhan, Lixing; Rosenberg, Avi; Bergami, Kenneth C.; Yu, Min; Xuan, Zhenyu; Muthuswamy, Senthil K.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Rosenberg, Avi] SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; [Jaffe, Aron B.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Allred, Craig] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Washington University (WUSTL)	Muthuswamy, SK (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	muthuswa@cshl.edu	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634; Zhan, Lixing/0000-0003-4949-4358; Yu, Min/0000-0002-3969-8720; Jaffe, Aron/0000-0002-6220-0476; Rosenberg, Avi/0000-0003-2356-950X; Xuan, Zhenyu/0000-0001-9344-8493	NCI [CA098830, DOD BC075024, CA105388]; Rita Allen Foundation; FACT foundation; Glen Cove Cares; Long Islanders Against Breast Cancer; NATIONAL CANCER INSTITUTE [R01CA098830, U01CA105388, R56CA098830] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rita Allen Foundation; FACT foundation; Glen Cove Cares; Long Islanders Against Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dan Medina (Baylor College of Medicine) for the COMMA-1D cells and for his continued support and guidance during the course of the experiments. We thank Lewis Chodosh for providing tumor samples from MMTV-Myc transgenics and Patrick Humbert for the Scribble cDNA. We also wish to thank Alan Hall and members of the Muthuswamy laboratory for their critical discussions and comments regarding the manuscript, Jim Duffy for his assistance with art work, and Bill Tansey for the reagents and helpful discussions. This work was supported by CA098830, DOD BC075024, and CA105388 grants from NCI, Rita Allen Foundation, FACT foundation, Glen Cove Cares, and Long Islanders Against Breast Cancer.	AGUILARCORDOVA E, 1991, ONCOGENE, V6, P1601; ALLRED CA, 2004, DIS BREAST, P507; Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737; Amundadottir LT, 1996, ONCOGENE, V13, P757; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bryant PJ, 1997, DEV GENET, V20, P75, DOI 10.1002/(SICI)1520-6408(1997)20:2<75::AID-DVG1>3.3.CO;2-G; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Edwards P A, 1996, Cancer Treat Res, V83, P23; EHMANN UK, 1987, JNCI-J NATL CANCER I, V78, P751; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Jager R, 1997, ONCOGENE, V15, P1787, DOI 10.1038/sj.onc.1201353; Jamerson MH, 2004, BRIT J CANCER, V91, P1372, DOI 10.1038/sj.bjc.6602137; JERRY DJ, 1994, IN VITRO CELL DEV-AN, V30A, P87; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Lane MA, 1999, ONCOL REP, V6, P507; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; LORENZO C, 1999, CANC METASTASIS REV, V18, P295; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Murtagh J, 2004, J CELL BIOL, V166, P133, DOI 10.1083/jcb.200403020; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nass SJ, 1997, BREAST CANCER RES TR, V44, P1, DOI 10.1023/A:1005858611585; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Ramljak D, 2003, EXP CELL RES, V287, P397, DOI 10.1016/S0014-4827(03)00135-6; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; SANDGREN EP, 1995, CANCER RES, V55, P3915; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; SPANDIDOS DA, 1987, ANTICANCER RES, V7, P1299; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tilli Maddalena T, 2003, Breast Cancer Res, V5, P202, DOI 10.1186/bcr614; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Yu K, 1997, CELL GROWTH DIFFER, V8, P731; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158	64	308	322	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					865	878		10.1016/j.cell.2008.09.045	http://dx.doi.org/10.1016/j.cell.2008.09.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041750	Bronze, Green Accepted			2022-12-28	WOS:000261183900018
J	David, R				David, Rosalie			The art of healing in ancient Egypt: a scientific reappraisal	LANCET			English	Editorial Material									[David, Rosalie] Univ Manchester, KNH Ctr Biomed Egyptol, Manchester M13 9PL, Lancs, England	University of Manchester	David, R (corresponding author), Univ Manchester, KNH Ctr Biomed Egyptol, Manchester M13 9PL, Lancs, England.							Campbell J, 2007, PHARM J, P735; Daumas F., 1957, B I FRANCAIS ARCHEOL, V56, P35; David AR, 2008, EGYPTIAN MUMMIES AND MODERN SCIENCE, P1, DOI 10.1017/CBO9780511499654; David R., 2004, MAGIC RATIONALITY AN; GHALIOUNGUI P, 1963, MED SCI ANCIENT EGYP; Nunn JF, 1996, ANCIENT EGYPTIAN MED	6	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1802	1803		10.1016/S0140-6736(08)61749-3	http://dx.doi.org/10.1016/S0140-6736(08)61749-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	375KG	19048654				2022-12-28	WOS:000261112000014
J	Smyth, DJ; Plagnol, V; Walker, NM; Cooper, JD; Downes, K; Yang, JHM; Howson, JMM; Stevens, H; McManus, R; Wijmenga, C; Heap, GA; Dubois, PC; Clayton, DG; Hunt, KA; van Heel, DA; Todd, JA				Smyth, Deborah J.; Plagnol, Vincent; Walker, Neil M.; Cooper, Jason D.; Downes, Kate; Yang, Jennie H. M.; Howson, Joanna M. M.; Stevens, Helen; McManus, Ross; Wijmenga, Cisca; Heap, Graham A.; Dubois, Patrick C.; Clayton, David G.; Hunt, Karen A.; van Heel, David A.; Todd, John A.			Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL MICROBIOTA; RISK VARIANTS; CHEMOKINE; SUSCEPTIBILITY; ASSOCIATION; POLYMORPHISMS; PREVALENCE; MULTIPLE; CHILDREN; LOCUS	Background: Two inflammatory disorders, type 1 diabetes and celiac disease, cosegregate in populations, suggesting a common genetic origin. Since both diseases are associated with the HLA class II genes on chromosome 6p21, we tested whether non-HLA loci are shared. Methods: We evaluated the association between type 1 diabetes and eight loci related to the risk of celiac disease by genotyping and statistical analyses of DNA samples from 8064 patients with type 1 diabetes, 9339 control subjects, and 2828 families providing 3064 parent-child trios (consisting of an affected child and both biologic parents). We also investigated 18 loci associated with type 1 diabetes in 2560 patients with celiac disease and 9339 control subjects. Results: Three celiac disease loci - RGS1 on chromosome 1q31, IL18RAP on chromosome 2q12, and TAGAP on chromosome 6q25 - were associated with type 1 diabetes (P<1.00 x 10(-4)). The 32-bp insertion-deletion variant on chromosome 3p21 was newly identified as a type 1 diabetes locus (P=1.81 x 10(-8)) and was also associated with celiac disease, along with PTPN2 on chromosome 18p11 and CTLA4 on chromosome 2q33, bringing the total number of loci with evidence of a shared association to seven, including SH2B3 on chromosome 12q24. The effects of the IL18RAP and TAGAP alleles confer protection in type 1 diabetes and susceptibility in celiac disease. Loci with distinct effects in the two diseases included INS on chromosome 11p15, IL2RA on chromosome 10p15, and PTPN22 on chromosome 1p13 in type 1 diabetes and IL12A on 3q25 and LPP on 3q28 in celiac disease. Conclusions: A genetic susceptibility to both type 1 diabetes and celiac disease shares common alleles. These data suggest that common biologic mechanisms, such as autoimmunity-related tissue damage and intolerance to dietary antigens, may be etiologic features of both diseases.	[Smyth, Deborah J.; Plagnol, Vincent; Walker, Neil M.; Cooper, Jason D.; Downes, Kate; Yang, Jennie H. M.; Howson, Joanna M. M.; Stevens, Helen; Clayton, David G.; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; [McManus, Ross] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Heap, Graham A.; Dubois, Patrick C.; Hunt, Karen A.; van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; University of Groningen; University of Groningen; University of London; Queen Mary University London	Todd, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Wijmenga, Cisca/AAE-7719-2019; McManus, Ross/AAE-9236-2020; Todd, John A/A-3542-2010; Plagnol, Vincent/A-5667-2011; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; Todd, John A/0000-0003-2740-8148; Plagnol, Vincent/0000-0002-5597-9215; Heap, Graham/0000-0003-4131-6792; van Heel, David/0000-0002-0637-2265; Howson, Joanna/0000-0001-7618-0050; smyth, deborah/0000-0002-6330-2669; McManus, Ross/0000-0002-0529-9617; Walker, Neil/0000-0001-9796-7688	Juvenile Diabetes Research Foundation International; Wellcome Trust; National Institute for Health Research's Cambridge Biomedical Research Centre; Celiac UK; Celiac Disease Consortium; European Union; Netherlands Organization for Scientific Research; Science Foundation Ireland; Irish Health Research Board; Hitachi Europe; NexPep; MRC [G0000934, G0700545] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0000934, G0700545] Funding Source: researchfish	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research's Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Celiac UK; Celiac Disease Consortium; European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board; Hitachi Europe; NexPep; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Juvenile Diabetes Research Foundation International, the Wellcome Trust, the National Institute for Health Research's Cambridge Biomedical Research Centre, Celiac UK, the Celiac Disease Consortium (an innovative cluster approved by the Netherlands Genomics Initiative and partly funded by the Dutch Government), the European Union, the Netherlands Organization for Scientific Research, the Science Foundation Ireland, and the Irish Health Research Board.; Dr. McManus reports receiving grant support from Hitachi Europe; and Dr. van Heel, having an equity interest in and receiving consulting fees from NexPep. No other potential conflict of interest relevant to this article was reported.; We thank all the patients and control subjects for their participation in the study; the Avon Longitudinal Study of Parents and Children Laboratory in Bristol and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan, and P. Burton for preparing and providing the control DNA samples; the Human Biological Data Interchange and Diabetes UK for data on multiplex families; the Norwegian Study Group for Childhood Diabetes for the collection of the Norwegian families, especially D. Undlien and K. Ronningen; D. Savage, C. Patterson, D. Carson, and P. Maxwell for the Northern Irish samples; J. Tuomilehto, L. Kinnunen, E. TuomilehtoWolf, V. Harjutsalo, and T. Valle of Genetics of Type 1 Diabetes in Finland for the Finnish family samples; C. Guja and C. IonescuTirgoviste for the Romanian family samples; the Irish Blood Transfusion Service - Trinity College Dublin Biobank for DNA from Irish control subjects; the Barts and the London Genome Centre for genotyping support; J. Swift, R. Crimmins, P. Kumar, D. P. Jewell, L. Dinesen, S. P. L. Travis, K. Moriarty, P. Howdle, D. S. Sanders, G. K. T. Holmes, S. Sleet, and Celiac UK for the collection of British celiac samples; A. Monsuur, C. J. Mulder, M. L. Mearin, and W. H. M. Verbeek, for the recruitment of patients; G. Meijer and J. Meijer for their review of histologic analyses; K. Duran for DNA extraction; H. van Someren and F. Mulder for clinical database management; L. Franke, A. Zhernakova, M. Plateel, and the genotyping facilities at University Medical Center Groningen and University Medical Center Utrecht in the Netherlands for their technical assistance; F. M. Stevens, C. O'Morain, N. P. Kennedy, M. Abuzakouk, R. McLoughlin, K. Brophy, C. Feighery, J. McPartlin, D. Kelleher, A. W. Ryan, and G. Turner for sample collection and genotyping; and L. Wicker for comments on the manuscript.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Barrett R, 2008, J MOTOR BEHAV, V40, P62, DOI 10.3200/JMBR.40.1.62-70; Buhler MM, 2002, AUTOIMMUNITY, V35, P457, DOI 10.1080/0891693021000041088; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; COOPER JD, 2008, NAT GENET       1102; Frisk G, 2008, MED HYPOTHESES, V70, P1207, DOI 10.1016/j.mehy.2007.05.058; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; HAFLER JP, 2008, GENES IMMUN     1030; Hanifi-Moghaddam P, 2006, DIABETIC MED, V23, P156, DOI 10.1111/j.1464-5491.2005.01743.x; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Kalev I, 2003, J DIABETES COMPLICAT, V17, P387, DOI 10.1016/S1056-8727(02)00242-8; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Meagher C, 2007, DIABETES, V56, P809, DOI 10.2337/db06-0619; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Prahalad S, 2006, GENES IMMUN, V7, P264, DOI 10.1038/sj.gene.6364298; Rioux JD, 2004, AM J MED GENET A, V130A, P345, DOI 10.1002/ajmg.a.30072; Santin I, 2008, TISSUE ANTIGENS, V71, P247, DOI 10.1111/j.1399-0039.2007.01002.x; Szalai C, 1999, PEDIATR RES, V46, P82, DOI 10.1203/00006450-199907000-00014; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weber F, 2008, GENES IMMUN, V9, P259, DOI 10.1038/gene.2008.14; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang B, 2004, CYTOKINE, V26, P114, DOI 10.1016/j.cyto.2004.01.005	35	521	536	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2767	2777		10.1056/NEJMoa0807917	http://dx.doi.org/10.1056/NEJMoa0807917			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19073967	Green Accepted			2022-12-28	WOS:000261950800004
J	Meldrum, FC; Sear, RP				Meldrum, Fiona C.; Sear, Richard P.			MATERIALS SCIENCE Now You See Them	SCIENCE			English	Editorial Material							CALCIUM-CARBONATE; STRUCTURAL-PROPERTIES; CHEMISTRY		[Meldrum, Fiona C.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Sear, Richard P.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England	University of Bristol; University of Surrey	Meldrum, FC (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	fiona.meldrum@bristol.ac.uk; r.sear@surrey.ac.uk	Meldrum, Fiona C/E-2726-2014	Meldrum, Fiona/0000-0001-9243-8517				Baletto F, 2005, REV MOD PHYS, V77, P371, DOI 10.1103/RevModPhys.77.371; Burton RC, 2008, CRYST GROWTH DES, V8, P1559, DOI 10.1021/cg700829r; Chiarella RA, 2007, FARADAY DISCUSS, V136, P179, DOI 10.1039/b616164m; CLARKSON JR, 1992, J CHEM SOC FARADAY T, V88, P243, DOI 10.1039/ft9928800243; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; Dusek U, 2006, SCIENCE, V312, P1375, DOI 10.1126/science.1125261; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Hassan SA, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031501; Hughes CE, 2007, FARADAY DISCUSS, V136, P71, DOI 10.1039/b616611c; Lam RSK, 2007, CRYSTENGCOMM, V9, P1226, DOI 10.1039/b710895h; Sear RP, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/3/033101; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Wolf SE, 2008, J AM CHEM SOC, V130, P12342, DOI 10.1021/ja800984y	13	88	91	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1802	1803		10.1126/science.1167221	http://dx.doi.org/10.1126/science.1167221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095931				2022-12-28	WOS:000261799400042
J	Botteri, E; Iodice, S; Bagnardi, V; Raimondi, S; Lowenfels, AB; Maisonneuve, P				Botteri, Edoardo; Iodice, Simona; Bagnardi, Vincenzo; Raimondi, Sara; Lowenfels, Albert B.; Maisonneuve, Patrick			Smoking and Colorectal Cancer A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SINGAPORE-CHINESE HEALTH; MALE BRITISH DOCTORS; 26-YEAR FOLLOW-UP; CIGARETTE-SMOKING; RISK-FACTORS; COLON-CANCER; RECTAL-CANCER; LIFE-STYLE; ALCOHOL-CONSUMPTION; JAPANESE MEN	Context Colorectal cancer is the third most common form of cancer and the fourth most frequent cause of cancer deaths worldwide. The association between cigarette smoking and colorectal cancer has been inconsistent among studies. Objective To clarify the association of cigarette smoking and colorectal cancer, we performed a comprehensive literature search and a meta- analysis of observational studies considering both incidence and mortality. Data Sources We performed a literature search using PubMed, ISI Web of Science ( Science Citation Index Expanded), and EMBASE to May 2008, with no restrictions. We also reviewed references from all retrieved articles. Study Selection All articles that were independent and contained the minimum information necessary to estimate the colorectal cancer risk associated with cigarette smoking and a corresponding measure of uncertainty. Data Extraction Articles were reviewed and data were extracted and crosschecked independently by 3 investigators, and any disagreement was resolved by consensus among all 3. Results One hundred six observational studies were included in the analysis of incidence. Twenty- six studies provided adjusted risk estimates for ever smokers vs never smokers, leading to a pooled relative risk of 1.18 ( 95% confidence interval [CI], 1.11-1.25). Smoking was associated with an absolute risk increase of 10.8 cases per 100 000 person- years ( 95% CI, 7.9- 13.6). We found a statistically significant dose-relationship with an increasing number of pack- years and cigarettes per day. However, the association was statistically significant only after 30 years of smoking. Seventeen cohort studies were included in the analysis of mortality. The pooled risk estimate for ever vs never smokers was 1.25 ( 95% CI, 1.14- 1.37). Smoking was associated with an absolute risk increase of 6.0 deaths per 100 000 person- years ( 95% CI, 4.2-7.6). For both incidence and mortality, the association was stronger for cancer of the rectum than of the colon. Conclusion Cigarette smoking is significantly associated with colorectal cancer incidence and mortality.	[Botteri, Edoardo; Iodice, Simona; Bagnardi, Vincenzo; Raimondi, Sara; Maisonneuve, Patrick] European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy; [Bagnardi, Vincenzo] Univ Milano Bicocca, Dept Stat, Milan, Italy; [Lowenfels, Albert B.] New York Med Coll, Dept Surg, Valhalla, NY 10595 USA; [Lowenfels, Albert B.] New York Med Coll, Dept Community & Prevent Med, Valhalla, NY 10595 USA	IRCCS European Institute of Oncology (IEO); University of Milano-Bicocca; New York Medical College; New York Medical College	Botteri, E (corresponding author), European Inst Oncol, Div Epidemiol & Biostat, Via Ripamonti 435, I-20141 Milan, Italy.	edoardo.botteri@ieo.it	Raimondi, Sara/J-5236-2016; Maisonneuve, Patrick/U-9789-2018; Lowenfels, Albert/ABD-8388-2021	Raimondi, Sara/0000-0003-4673-9049; Maisonneuve, Patrick/0000-0002-5309-4704; Botteri, Edoardo/0000-0002-9023-8068				Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Akhter M, 2007, EUR J CANCER, V43, P383, DOI 10.1016/j.ejca.2006.09.020; AKIBA S, 1990, ENVIRON HEALTH PERSP, V87, P19, DOI 10.2307/3431001; AKIBA S, 1994, ENVIRON HEALTH PERSP, V102, P15, DOI 10.1289/ehp.94102s815; ANTONCULVER H, 1991, CANCER DETECT PREV, V15, P345; Ates NA, 2005, BIOCHEM GENET, V43, P149, DOI 10.1007/s10528-005-1508-z; BARON JA, 1994, CANCER EPIDEM BIOMAR, V3, P565; Batty GD, 2008, ANN ONCOL, V19, P996, DOI 10.1093/annonc/mdm578; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berndt SI, 2006, CANCER EPIDEM BIOMAR, V15, P2263, DOI 10.1158/1055-9965.EPI-06-0449; Bongaerts BWC, 2006, ALCOHOL, V38, P147, DOI 10.1016/j.alcohol.2006.06.003; Botteri E, 2008, GASTROENTEROLOGY, V134, P388, DOI 10.1053/j.gastro.2007.11.007; Buc E, 2006, DIS COLON RECTUM, V49, P1893, DOI 10.1007/s10350-006-0704-1; Campbell RJ, 2001, CANCER DETECT PREV, V25, P430; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500; Chia VM, 2006, CANCER RES, V66, P6877, DOI 10.1158/0008-5472.CAN-06-1535; Chiu BCH, 2001, ANN EPIDEMIOL, V11, P28, DOI 10.1016/S1047-2797(00)00175-7; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; CHOI SY, 1991, INT J EPIDEMIOL, V20, P878, DOI 10.1093/ije/20.4.878; CHUTE CG, 1991, CANCER CAUSE CONTROL, V2, P117, DOI 10.1007/BF00053131; Chyou PH, 1996, ANN EPIDEMIOL, V6, P276, DOI 10.1016/S1047-2797(96)00047-6; Colangelo LA, 2004, CANCER-AM CANCER SOC, V100, P288, DOI 10.1002/cncr.11923; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; DANIELL HW, 1986, CANCER, V58, P784, DOI 10.1002/1097-0142(19860801)58:3<784::AID-CNCR2820580328>3.0.CO;2-N; DAVANZO B, 1995, PREV MED, V24, P571, DOI 10.1006/pmed.1995.1091; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diergaarde B, 2003, CARCINOGENESIS, V24, P565, DOI 10.1093/carcin/24.3.565; Diergaarde B, 2007, CLIN GASTROENTEROL H, V5, P736, DOI 10.1016/j.cgh.2007.02.019; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; DORN HF, 1960, ACTA UNION INT CONTR, V16, P1653; Driver JA, 2007, AM J MED, V120, P257, DOI 10.1016/j.amjmed.2006.05.055; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engeland A, 1996, CANCER CAUSE CONTROL, V7, P497, DOI 10.1007/BF00051881; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Freedman AN, 1996, BRIT J CANCER, V73, P902, DOI 10.1038/bjc.1996.180; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Gao CM, 2007, WORLD J GASTROENTERO, V13, P5725, DOI 10.3748/wjg.v13.i43.5725; Ghadirian P, 1998, CANCER DETECT PREV, V22, P396, DOI 10.1046/j.1525-1500.1998.00058.x; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P192, DOI 10.1093/jnci/86.3.192; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P183, DOI 10.1093/jnci/86.3.183; Goy J, 2008, ANN EPIDEMIOL, V18, P156, DOI 10.1016/j.annepidem.2007.09.004; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HEINEMAN EF, 1994, INT J CANCER, V59, P728, DOI 10.1002/ijc.2910590603; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho JWC, 2004, INT J CANCER, V109, P587, DOI 10.1002/ijc.20018; Hsing AW, 1998, INT J CANCER, V77, P549, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;549::AID-IJC13&gt;3.0.CO;2-1; Hu JF, 2007, EUR J CANCER PREV, V16, P275, DOI 10.1097/01.cej.0000228411.21719.25; IARC, 2004, IARC MON EV CARC RIS, V83, P1; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; INOUE M, 1995, CANCER CAUSE CONTROL, V6, P14, DOI 10.1007/BF00051676; Jass JR, 2001, J PATHOL, V193, P283, DOI 10.1002/1096-9896(200103)193:3<283::AID-PATH799>3.0.CO;2-9; Jee SH, 2004, CANCER CAUSE CONTROL, V15, P341, DOI 10.1023/B:CACO.0000027481.48153.97; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji BT, 2002, EUR J CANCER PREV, V11, P237, DOI 10.1097/00008469-200206000-00007; Jin MJ, 2005, CANCER GENET CYTOGEN, V163, P38, DOI 10.1016/j.cancergencyto.2005.05.001; KAHN HAROLD A., 1966, NAT CANCER INST MONOGR, V19, P1; KATO I, 1990, JPN J CANCER RES, V81, P115, DOI 10.1111/j.1349-7006.1990.tb02536.x; Kato I, 1997, NUTR CANCER, V28, P276, DOI 10.1080/01635589709514588; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Kim Hwa Jung, 2006, J Prev Med Public Health, V39, P123; Kim JI, 2003, WORLD J GASTROENTERO, V9, P956; KLATSKY AL, 1988, AM J EPIDEMIOL, V128, P1007; Knekt P, 1998, BRIT J CANCER, V78, P136, DOI 10.1038/bjc.1998.455; KOTAKE K, 1995, JPN J CLIN ONCOL, V25, P195; LeMarchand L, 1997, CANCER RES, V57, P4787; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Liaw KM, 1998, TOB CONTROL, V7, P141, DOI 10.1136/tc.7.2.141; Limburg PJ, 2003, CLIN GASTROENTEROL H, V1, P202, DOI 10.1053/jcgh.2003.50030; LONGACRE TA, 1990, AM J SURG PATHOL, V14, P524, DOI 10.1097/00000478-199006000-00003; LONGNECKER MP, 1989, CANCER, V64, P1372, DOI 10.1002/1097-0142(19890915)64:6<1372::AID-CNCR2820640633>3.0.CO;2-I; Luchtenborg M, 2005, AM J EPIDEMIOL, V161, P806, DOI 10.1093/aje/kwi114; Luchtenborg M, 2007, CANCER EPIDEM BIOMAR, V16, P1341, DOI 10.1158/1055-9965.EPI-06-0519; Makinen MJ, 2001, J PATHOL, V193, P286, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2; Minami Y, 2003, CANCER SCI, V94, P540, DOI 10.1111/j.1349-7006.2003.tb01480.x; Neugut AI, 2000, J NATL CANCER I, V92, P1791, DOI 10.1093/jnci/92.22.1791; NEWCOMB PA, 1995, CANCER RES, V55, P4906; Nkondjock A, 2004, INT J CANCER, V110, P110, DOI 10.1002/ijc.20066; Nordlund LA, 1997, INT J CANCER, V73, P625, DOI 10.1002/(SICI)1097-0215(19971127)73:5<625::AID-IJC2>3.0.CO;2-Z; Nyren O, 1996, JNCI-J NATL CANCER I, V88, P1302, DOI 10.1093/jnci/88.18.1302; Okayama A, 2007, ASIAN PAC J CANCER P, V8, P191; OLSEN J, 1993, INT J EPIDEMIOL, V22, P398, DOI 10.1093/ije/22.3.398; Otani T, 2003, CANCER EPIDEM BIOMAR, V12, P1492; Otori K, 1997, GUT, V40, P660, DOI 10.1136/gut.40.5.660; Ozasa K, 2007, ASIAN PAC J CANCER P, V8, P89; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paskett ED, 2007, JNCI-J NATL CANCER I, V99, P1729, DOI 10.1093/jnci/djm176; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Peppone LJ, 2008, J CANCER RES CLIN, V134, P743, DOI 10.1007/s00432-007-0332-8; PETERS RK, 1989, CANCER RES, V49, P5459; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; ROGOT E, 1980, PUBLIC HEALTH REP, V95, P213; ROHAN TE, 2000, COLORECTAL DIS, V2, P298; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; SANDLER RS, 1988, JNCI-J NATL CANCER I, V80, P1329, DOI 10.1093/jnci/80.16.1329; Sanjoaquin MA, 2004, BRIT J CANCER, V90, P118, DOI 10.1038/sj.bjc.6601441; Sauerbrei W, 1999, BRIT J CANCER, V79, P1752, DOI 10.1038/sj.bjc.6690279; Shankar A, 2008, EUR J CANCER, V44, P100, DOI 10.1016/j.ejca.2007.10.015; Sharpe CR, 2002, DIS COLON RECTUM, V45, P1041, DOI 10.1007/s10350-004-6357-z; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; Slattery M L, 1990, Epidemiology, V1, P141, DOI 10.1097/00001648-199003000-00010; Slattery ML, 2004, AM J EPIDEMIOL, V160, P842, DOI 10.1093/aje/kwh298; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Slattery ML, 1997, INT J CANCER, V70, P259, DOI 10.1002/(SICI)1097-0215(19970127)70:3<259::AID-IJC2>3.3.CO;2-9; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; Sparks R, 2004, INT J EPIDEMIOL, V33, P955, DOI 10.1093/ije/dyh102; Steindorf K, 2000, EUR J CANCER PREV, V9, P309, DOI 10.1097/00008469-200010000-00004; Steinmetz J, 2007, PRESSE MED, V36, P1174, DOI 10.1016/j.lpm.2007.02.012; Sturmer T, 2000, J NATL CANCER I, V92, P1178, DOI 10.1093/jnci/92.14.1178; Tavani A, 1998, EUR J EPIDEMIOL, V14, P675, DOI 10.1023/A:1007545607059; Terry MB, 1998, AM J EPIDEMIOL, V147, P903; Terry P, 2001, INT J CANCER, V91, P585, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1086>3.0.CO;2-H; Terry PD, 2002, INT J CANCER, V99, P480, DOI 10.1002/ijc.10364; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Tiemersma E W, 2002, IARC Sci Publ, V156, P491; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; TUYNS AJ, 1982, INT J CANCER, V30, P9, DOI 10.1002/ijc.2910300103; TVERDAL A, 1993, J CLIN EPIDEMIOL, V46, P475, DOI 10.1016/0895-4356(93)90025-V; van der Hel OL, 2003, CANCER CAUSE CONTROL, V14, P293, DOI 10.1023/A:1023601922106; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; van Wayenburg CAM, 2000, EPIDEMIOLOGY, V11, P304, DOI 10.1097/00001648-200005000-00013; Verla-Tebit E, 2006, INT J CANCER, V119, P630, DOI 10.1002/ijc.21875; Wakai K, 2003, J EPIDEMIOL, V13, P323, DOI 10.2188/jea.13.323; Watson P, 2004, ARCH INTERN MED, V164, P2429, DOI 10.1001/archinte.164.22.2429; Wen CP, 2004, PREV MED, V39, P528, DOI 10.1016/j.ypmed.2004.02.010; WESTON AP, 1995, AM J GASTROENTEROL, V90, P24; World Health Organization, 2008, WHO REP GLOB TOB EP; WU AH, 1987, BRIT J CANCER, V55, P687, DOI 10.1038/bjc.1987.140; Yamada K, 1997, CANCER CAUSE CONTROL, V8, P780, DOI 10.1023/A:1018491607454; Yang P, 2000, MOL GENET METAB, V71, P639, DOI 10.1006/mgme.2000.3089; Yoshioka Makoto, 1999, Journal of UOEH, V21, P133; Yun YH, 2004, CANCER DETECT PREV, V29, P15, DOI 10.1016/j.cdp.2004.08.006; Zisman AL, 2006, ARCH INTERN MED, V166, P629, DOI 10.1001/archinte.166.6.629	137	514	530	4	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2765	2778		10.1001/jama.2008.839	http://dx.doi.org/10.1001/jama.2008.839			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088354				2022-12-28	WOS:000261730400023
J	Smith, L; Thornton, SJ; Reinarz, J; Williams, AN				Smith, L.; Thornton, S. J.; Reinarz, J.; Williams, A. N.			Please, sir, I want some more	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Williams, A. N.] Northampton Gen Hosp, Dept Dietet, Northampton NN1 5BD, England; Univ Birmingham Sch Med, Ctr Hist Med, Birmingham B15 2TT, W Midlands, England; Northampton Gen Hosp, Virtual Acad Unit, CDC, Northampton NN1 5BD, England	University of Birmingham	Williams, AN (corresponding author), Northampton Gen Hosp, Dept Dietet, Northampton NN1 5BD, England.	anw@doctors.org.uk						ACKROYD P, 1990, VINTAGE GREAT BRITAI; Brennan PO, 2001, ARCH DIS CHILD, V85, P504, DOI 10.1136/adc.85.6.504; CROWTHER MA, 1983, WORKHOUSE SYSTEM 183, P216; Department of Health, 1991, REP HLTH SOC SUBJ; DICKENS C, 1837, O TIWST PARISH BOYS, P12; Digby A, 1978, PAUPER PALACES; King Steven, 2000, POVERTY WELFARE ENGL; MATTERER JL, 2002, 17 CENTURY ENGLISH R; PEREIRA J, 1843, TREATISE FOOD DIET O; Roberts David, 1963, HIST J, V6, P97	10	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2008	337								a2722	10.1136/bmj.a2722	http://dx.doi.org/10.1136/bmj.a2722			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091756				2022-12-28	WOS:000262185000001
J	Toman, E				Toman, Elizabeth			Family Doctor	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM 87108 USA		Toman, E (corresponding author), New Mexico Vet Affairs Hlth Care Syst, 1501 San Pedro Dr SE, Albuquerque, NM 87108 USA.	elizabethtoman@msn.com							0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					907	908		10.7326/0003-4819-149-12-200812160-00012	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075212				2022-12-28	WOS:000261771900010
J	Karkazis, K; Feder, EK				Karkazis, Katrina; Feder, Ellen K.			Naming the problem: disorders and their meanings	LANCET			English	Editorial Material									[Karkazis, Katrina] Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA; [Feder, Ellen K.] American Univ, Dept Philosophy & Relig, Washington, DC 20016 USA	Stanford University; American University	Karkazis, K (corresponding author), Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA.	karkazis@stanford.edu	Karkazis, Katrina/AAE-7276-2019	Karkazis, Katrina/0000-0001-9103-2881; Feder, Ellen K./0000-0002-8014-2804				Aronowitz Robert, 1998, MAKING SENSE ILLNESS; Frank AW., 2013, WOUNDED STORYTELLER; KARKAZIS 9KATRINA, 2008, MEDICAL AUTHORITY LI; Kleinman A., 1988, ILLNESS NARRATIVES; Rosenberg Charles, 1992, FRAMING DIS STUDIES; Sontag S., 1978, ILLNESS METAPHOR	6	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2016	2017		10.1016/S0140-6736(08)61858-9	http://dx.doi.org/10.1016/S0140-6736(08)61858-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19090028				2022-12-28	WOS:000261746900012
J	Labouriau, R; Amorim, A				Labouriau, Rodrigo; Amorim, Antonio			Comment on "An Association Between the Kinship and Fertility of Human Couples"	SCIENCE			English	Editorial Material							INBREEDING DEPRESSION; OUTBREEDING DEPRESSION; DISTANCE		[Labouriau, Rodrigo] Aarhus Univ, Dept Genet & Biotechnol, Fac Agr Sci, DK-8830 Tjele, Denmark; [Amorim, Antonio] Univ Porto, Fac Sci, P-4200465 Oporto, Portugal; [Amorim, Antonio] Univ Porto, Inst Mol Pathol & Immunol IPATIMUP, P-4200465 Oporto, Portugal	Aarhus University; Universidade do Porto; Universidade do Porto	Labouriau, R (corresponding author), Aarhus Univ, Dept Genet & Biotechnol, Fac Agr Sci, DK-8830 Tjele, Denmark.	rodrigo.labouriau@agrsci.dk	Labouriau, Rodrigo/H-3890-2014; Amorim, Antonio/A-7938-2008; Labouriau, Rodrigo/AAD-2576-2020	Labouriau, Rodrigo/0000-0001-8713-6864; Amorim, Antonio/0000-0002-7518-6247; 				Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Grindeland JM, 2008, J EVOLUTION BIOL, V21, P716, DOI 10.1111/j.1420-9101.2008.01519.x; Helgason A, 2008, SCIENCE, V319, P813, DOI 10.1126/science.1150232; KIMURA M, 1964, GENETICS, V49, P561; Labouriau R, 2001, COLLOQ INRA, V96, P99; Labouriau R, 2008, GENETICS, V178, P601, DOI 10.1534/genetics.107.072454; Lauritzen L.S., 1999, COMPLEX STOCHASTIC S; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Malecot Gustave, 1959, PUBL I STAT U PARIS, V8, P173; MORTON NE, 1977, ANN HUM GENET, V40, P361, DOI 10.1111/j.1469-1809.1977.tb00200.x; MORTON NE, 1969, ANNU REV GENET, V3, P53, DOI 10.1146/annurev.ge.03.120169.000413; Schierup MH, 1996, HEREDITY, V77, P461, DOI 10.1038/hdy.1996.172; Whittaker J., 1990, GRAPHICAL MODELS APP	13	12	13	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908								10.1126/science.1161907	http://dx.doi.org/10.1126/science.1161907			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074330				2022-12-28	WOS:000261608300021
J	Dzik, WH; Laposata, M; Hertl, M; Sandberg, WS; Chatterji, M; Misdraji, J				Dzik, Walter H.; Laposata, Michael; Hertl, Martin; Sandberg, Warren S.; Chatterji, Manjil; Misdraji, Joseph			A Man with Hemophilia, Hepatocellular Carcinoma, and Intractable Bleeding Factor VIII deficiency with factor VIII inhibitor, hepatitis C with bridging fibrosis, and hepatocellular carcinoma (stage pT1N0MX).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIVER-TRANSPLANTATION; NATURAL-HISTORY; RITUXIMAB; FIBRINOLYSIS; DISEASE; BIOPSY; DEATH		[Dzik, Walter H.] Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA; [Laposata, Michael; Misdraji, Joseph] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hertl, Martin] Massachusetts Gen Hosp, Dept Transplant Surg, Boston, MA 02114 USA; [Sandberg, Warren S.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Chatterji, Manjil] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Dzik, Walter H.; Misdraji, Joseph] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Hertl, Martin] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Sandberg, Warren S.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Chatterji, Manjil] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Dzik, WH (corresponding author), Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA.		Misdraji, Joseph/AAD-4588-2019; Misdraji, Joseph/AGX-4779-2022		Instrumentation Laboratory; BD Diagnostics Preanalytical Systems; Cedars-Sinai Medical Center; Trinity Laboratories; Catalyst Oncology; Cubist Pharmaceuticals; Cystic Fibrosis Foundation	Instrumentation Laboratory; BD Diagnostics Preanalytical Systems; Cedars-Sinai Medical Center; Trinity Laboratories; Catalyst Oncology; Cubist Pharmaceuticals; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	Dr. Laposata reports receiving consulting fees from Instrumentation Laboratory, BD Diagnostics Preanalytical Systems, Cedars-Sinai Medical Center, Trinity Laboratories, Catalyst Oncology, and Cubist Pharmaceuticals; having an equity interest in American Medical Diagnostics, Medpacks, PocketMedicine, and T2 Biosystems; receiving lecture fees from GlaxoSmithKline and G-2 Reports; and receiving grant support from the Cystic Fibrosis Foundation for one-time instrument purchase. No other potential	ARONSON DL, 1988, AM J HEMATOL, V27, P7, DOI 10.1002/ajh.2830270103; Ashrani AA, 2004, HAEMOPHILIA, V10, P735, DOI 10.1111/j.1365-2516.2004.01030.x; Carcao M, 2006, HAEMOPHILIA, V12, P7, DOI 10.1111/j.1365-2516.2005.01170.x; Drummond J C, 2001, Anesthesiol Clin North Am, V19, P633; DZIK WH, 1988, BLOOD, V71, P1090; EYSTER ME, 1992, BLOOD, V79, P2494; Field JJ, 2007, HAEMOPHILIA, V13, P46, DOI 10.1111/j.1365-2516.2006.01342.x; Fox RA, 2006, HAEMOPHILIA, V12, P218, DOI 10.1111/j.1365-2516.2006.01215.x; Franchini M, 2004, THROMB HAEMOSTASIS, V92, P1259, DOI 10.1160/TH04-08-0510; Franchini M, 2006, AM J HEMATOL, V81, P696, DOI 10.1002/ajh.20701; Gordon FH, 1998, GUT, V42, P744, DOI 10.1136/gut.42.5.744; Goudemand J, 1997, THROMB HAEMOSTASIS, V77, P336; Khakhar AK, 2005, HAEMOPHILIA, V11, P623, DOI 10.1111/j.1365-2516.2005.01145.x; Lethagen S, 2001, BRIT J HAEMATOL, V113, P87, DOI 10.1046/j.1365-2141.2001.02700.x; LEWIS JH, 1985, NEW ENGL J MED, V312, P1189; Makris M, 1996, BRIT J HAEMATOL, V94, P746, DOI 10.1046/j.1365-2141.1996.02343.x; Mannucci PM, 2001, NEW ENGL J MED, V345, P1067; Moschovi M, 2006, HAEMOPHILIA, V12, P95, DOI 10.1111/j.1365-2516.2006.01185.x; PORTE RJ, 1989, TRANSPLANTATION, V47, P978, DOI 10.1097/00007890-198906000-00012; SANDBERGS WS, 2008, ANESTHESIOLOGY, P1338; Steadman Randolph H, 2004, Anesthesiol Clin North Am, V22, P687, DOI 10.1016/j.atc.2004.06.009; Stieltjes N, 2004, BRIT J HAEMATOL, V125, P769, DOI 10.1111/j.1365-2141.2004.04968.x; Tradati F, 1998, BLOOD, V91, P1173; Wong VS, 1997, BRIT J HAEMATOL, V97, P343; Yee TT, 2000, GUT, V47, P845, DOI 10.1136/gut.47.6.845	25	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2587	2597		10.1056/NEJMcpc0807506	http://dx.doi.org/10.1056/NEJMcpc0807506			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073979				2022-12-28	WOS:000261534200012
J	Loxterkamp, D				Loxterkamp, David			The headwaters of family medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Loxterkamp, David] Seaport Family Practice, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Family Practice, 41 Wight St, Belfast, ME 04915 USA.	mclobster@verizon.net							0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2008	337								a2575	10.1136/bmj.a2575	http://dx.doi.org/10.1136/bmj.a2575			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399BZ	19066259				2022-12-28	WOS:000262776700005
J	Gilmore, G				Gilmore, Gerard			ASTRONOMY How Cold Is Cold Dark Matter?	SCIENCE			English	Editorial Material							MILKY-WAY; GALAXY		[Gilmore, Gerard] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	University of Cambridge	Gilmore, G (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	gil@ast.cam.ac.uk						Belokurov V, 2007, ASTROPHYS J, V654, P897, DOI 10.1086/509718; Freeman K, 2002, ANNU REV ASTRON ASTR, V40, P487, DOI 10.1146/annurev.astro.40.060401.093840; GILMORE G, 1989, ANNU REV ASTRON ASTR, V27, P555; Gilmore G, 2007, ASTROPHYS J, V663, P948, DOI 10.1086/518025; MAJEWSKI SR, 1993, ANNU REV ASTRON ASTR, V31, P575; Springel V, 2006, NATURE, V440, P1137, DOI 10.1038/nature04805; Walker MG, 2007, ASTROPHYS J, V667, pL53, DOI 10.1086/521998	7	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1476	1477		10.1126/science.1165790	http://dx.doi.org/10.1126/science.1165790			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056963				2022-12-28	WOS:000261377400026
J	Macara, IG; Mili, S				Macara, Ian G.; Mili, Stavroula			Polarity and Differential Inheritance-Universal Attributes of Life?	CELL			English	Review							ASYMMETRIC CELL-DIVISION; EXTRACHROMOSOMAL CIRCULAR DNA; IMMORTAL STRAND HYPOTHESIS; MESSENGER-RNA LOCALIZATION; SENSORY ORGAN PRECURSORS; INTESTINAL STEM-CELLS; SACCHAROMYCES-CEREVISIAE; DAMAGED PROTEINS; INTRACELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM	When and why did cell polarization arise? Recent work in bacteria and yeast suggests that polarization may have evolved to restrict senescence to one daughter during division by enabling the differential segregation of damaged material. In more complex organisms, polarity functions have diversified to permit the differential inheritance of centrosomes, RNAs, proteins, and membranes, which is essential for the generation of diverse cell types from stem cells and for morphogenesis.	[Macara, Ian G.; Mili, Stavroula] Univ Virginia, Sch Med, Ctr Cell Signaling, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Macara, IG (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Dept Microbiol, Charlottesville, VA 22908 USA.	igm9c@virginia.edu	Mili, Stavroula/AAI-7076-2021	Mili, Stavroula/0000-0002-9161-8660	Leukemia and Lymphoma Society [5028-06];  [GM 070902]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Lannigan, A. Spang, the reviewers, and members of the Macara lab for critical reading of the manuscript and many helpful suggestions. This work was supported by grant GM 070902 (to I. M.) and Leukemia and Lymphoma Society fellowship 5028-06 (to S. M.).	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bornens M, 2002, CURR BIOL, V12, pR71, DOI 10.1016/S0960-9822(01)00678-9; Brennwald P, 2007, FEBS LETT, V581, P2119, DOI 10.1016/j.febslet.2007.03.043; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cairns J, 2006, GENETICS, V174, P1069, DOI 10.1534/genetics.104.66886; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; Cerutti L, 1999, J CELL SCI, V112, P2313; CHENG J, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07386; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; Cohen S, 1999, MOL CELL BIOL, V19, P6682; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; DHONUKSHE P, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07409; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Feng W, 2007, EMBO J, V26, P2786, DOI 10.1038/sj.emboj.7601702; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gerst JE, 2008, TRENDS CELL BIOL, V18, P68, DOI 10.1016/j.tcb.2007.11.005; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gonsalvez GB, 2005, BIOL CELL, V97, P75; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanamori T, 2008, EMBO J, V27, P1647, DOI 10.1038/emboj.2008.102; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; King ML, 2005, BIOL CELL, V97, P19; Kingsley EP, 2007, EVOL DEV, V9, P527, DOI 10.1111/j.1525-142X.2007.00194.x; Kloc M, 2005, DEVELOPMENT, V132, P3445, DOI 10.1242/dev.01919; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; LARK KG, 1966, SCIENCE, V154, P1202, DOI 10.1126/science.154.3753.1202; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; Nystrom T, 2007, PLOS GENET, V3, P2355, DOI 10.1371/journal.pgen.0030224; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pederson T, 2006, NAT CELL BIOL, V8, P652, DOI 10.1038/ncb0706-652; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Potten CS, 2002, J CELL SCI, V115, P2381; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; VANLOON N, 1994, NUCLEIC ACIDS RES, V22, P2447, DOI 10.1093/nar/22.13.2447; Wang H, 2006, DEV CELL, V10, P117, DOI 10.1016/j.devcel.2005.11.004; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2008, J CELL BIOL, V180, P261, DOI 10.1083/jcb.200707083; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	94	99	100	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					801	812		10.1016/j.cell.2008.11.006	http://dx.doi.org/10.1016/j.cell.2008.11.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041746	Bronze, Green Accepted			2022-12-28	WOS:000261183900013
J	Rando, OJ				Rando, Oliver J.			Evolution in a Test Tube: The Hatchet before the Scalpel	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; DUPLICATION; ANEUPLOIDY; POLYPLOIDY; YEAST	Gene duplication provides an organism with a rich source of genetic material for tinkering by selection during evolution. In this issue, Rancati et al. (2008) report that extensive polyploidy and aneuploidy are the initial evolutionary changes in yeast selected in vitro to overcome defects resulting from the loss of a myosin II protein crucial for normal cytokinesis.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu		Rando, Oliver/0000-0003-1516-9397				DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Ohno S., 1970, EVOLUTION GENE DUPLI; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107	10	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					789	791		10.1016/j.cell.2008.11.005	http://dx.doi.org/10.1016/j.cell.2008.11.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041741	Bronze			2022-12-28	WOS:000261183900008
J	Ballardie, FW; Cowley, R; Cox, A; Curry, A; Denley, H; Denton, J; Dick, J; Guerquin-Kern, JL; Redmond, A				Ballardie, Francis W.; Cowley, Richard; Cox, Alan; Curry, Alan; Denley, Helen; Denton, John; Dick, Jeremy; Guerquin-Kern, Jean-Luc; Redmond, Anthony			A man who brought the war home with him	LANCET			English	Editorial Material									[Ballardie, Francis W.; Cowley, Richard; Curry, Alan; Denley, Helen; Denton, John] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; [Ballardie, Francis W.; Cowley, Richard] Univ Manchester, Dept Gen Internal Med & Nephrol, Manchester, Lancs, England; [Curry, Alan; Denley, Helen] Univ Manchester, Dept Pathol, Manchester, Lancs, England; [Denton, John] Univ Manchester, Dept Lab Med, Manchester, Lancs, England; [Dick, Jeremy] Hope Hosp, Dept Neurosci, Manchester, Lancs, England; [Redmond, Anthony] Hope Hosp, Dept Undergrad Med Educ, Manchester, Lancs, England; [Cox, Alan] Univ Sheffield, Ctr Analyt Sci, Sheffield, S Yorkshire, England; [Guerquin-Kern, Jean-Luc] Curie Res Inst, Paris, France	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Sheffield; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Ballardie, FW (corresponding author), Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, Lancs, England.	francisballardie@mail.com	Redmond, Anthony C/E-2452-2018; Guerquin-Kern, Jean-Luc/M-5000-2018	Guerquin-Kern, Jean-Luc/0000-0002-8610-0146				Bertell R, 2006, INT J HEALTH SERV, V36, P503, DOI 10.2190/13JL-9LHM-FMR4-0V7B; Dalakas MC, 2001, NEUROLOGY, V57, P780, DOI 10.1212/WNL.57.5.780; Hemdan NYA, 2007, ANN NY ACAD SCI, V1109, P129, DOI 10.1196/annals.1398.015; *UN ENV PROGR, 2001, DEPL UR SIT KOS DET	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1926	1926		10.1016/S0140-6736(08)61811-5	http://dx.doi.org/10.1016/S0140-6736(08)61811-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041801				2022-12-28	WOS:000261388700028
J	Korennykh, AV; Egea, PF; Korostelev, AA; Finer-Moore, J; Zhang, C; Shokat, KM; Stroud, RM; Walter, P				Korennykh, Alexei V.; Egea, Pascal F.; Korostelev, Andrei A.; Finer-Moore, Janet; Zhang, Chao; Shokat, Kevan M.; Stroud, Robert M.; Walter, Peter			The unfolded protein response signals through high-order assembly of Ire1	NATURE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER-STRESS; KINASE; MECHANISM; AUTOPHOSPHORYLATION; ACTIVATION; SOFTWARE	Aberrant folding of proteins in the endoplasmic reticulum activates the bifunctional transmembrane kinase/ endoribonuclease Ire1. Ire1 excises an intron from HAC1 messenger RNA in yeasts and Xbp1 messenger RNA in metozoans encoding homologous transcription factors. This non- conventional mRNA splicing event initiates the unfolded protein response, a transcriptional program that relieves the endoplasmic reticulum stress. Here we show that oligomerization is central to Ire1 function and is an intrinsic attribute of its cytosolic domains. We obtained the 3.2- A crystal structure of the oligomer of the Ire1 cytosolic domains in complex with a kinase inhibitor that acts as a potent activator of the Ire1 RNase. The structure reveals a rod- shaped assembly that has no known precedence among kinases. This assembly positions the kinase domain for trans- autophosphorylation, orders the RNase domain, and creates an interaction surface for binding of the mRNA substrate. Activation of Ire1 through oligomerization expands the mechanistic repertoire of kinase- based signalling receptors.	[Korennykh, Alexei V.; Egea, Pascal F.; Finer-Moore, Janet; Stroud, Robert M.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Korennykh, Alexei V.; Zhang, Chao; Shokat, Kevan M.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Korostelev, Andrei A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Korennykh, AV (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	alexei.korennykh@ucsf.edu	Longo, Kenneth A/A-5631-2010; egea, pascal/V-7662-2019; Egea, Pascal Francois/AAI-2759-2020	egea, pascal/0000-0003-4432-8625; Korostelev, Andrei/0000-0003-1588-717X	Jane Coffin Childs; National Parkinson Foundation; NIH [RO1 GM60641]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060641] Funding Source: NIH RePORTER	Jane Coffin Childs; National Parkinson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Krutchinsky for the help with MALDI instruments and for the tryptic digest analysis of Ire1KR32, F. Gruswitz for useful discussions, C. Waddling for managing the protein crystallization facility of the molecular structure group (MSG) at UCSF, and to the staff of the beamline 8.3.1 at the Advanced Light Source (Berkeley). We thank members of the Walter laboratory for critical review of the manuscript. A.V.K. is a recipient of Jane Coffin Childs fellowship. C.Z. was supported by a grant from the National Parkinson Foundation. R.M.S., J.F.-M. and P.F.E. were supported by an NIH grant RO1 GM60641. P. W. and K.M.S. are Investigators of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabiola F, 2006, ACTA CRYSTALLOGR D, V62, P227, DOI 10.1107/S0907444905040680; Goffin L, 2006, MOL BIOL CELL, V17, P5309, DOI 10.1091/mbc.E06-04-0292; Gonzalez TN, 2000, METH MOL B, V160, P25; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Kudo T, 2002, ANN NY ACAD SCI, V977, P349, DOI 10.1111/j.1749-6632.2002.tb04837.x; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naidoo N, 2005, J NEUROCHEM, V92, P1150, DOI 10.1111/j.1471-4159.2004.02952.x; Nock S, 2001, METHOD ENZYMOL, V342, P3, DOI 10.1016/S0076-6879(01)42530-4; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Yonemoto W, 1997, PROTEIN ENG, V10, P915, DOI 10.1093/protein/10.8.915; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zheng Y, 2005, J MICROBIOL, V43, P529	35	445	464	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					687	U2		10.1038/nature07661	http://dx.doi.org/10.1038/nature07661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079236	Green Accepted			2022-12-28	WOS:000263064700033
J	Turnbaugh, PJ; Hamady, M; Yatsunenko, T; Cantarel, BL; Duncan, A; Ley, RE; Sogin, ML; Jones, WJ; Roe, BA; Affourtit, JP; Egholm, M; Henrissat, B; Heath, AC; Knight, R; Gordon, JI				Turnbaugh, Peter J.; Hamady, Micah; Yatsunenko, Tanya; Cantarel, Brandi L.; Duncan, Alexis; Ley, Ruth E.; Sogin, Mitchell L.; Jones, William J.; Roe, Bruce A.; Affourtit, Jason P.; Egholm, Michael; Henrissat, Bernard; Heath, Andrew C.; Knight, Rob; Gordon, Jeffrey I.			A core gut microbiome in obese and lean twins	NATURE			English	Article							COMPARATIVE METAGENOMICS; DNA-SEQUENCES; DIVERSITY; PROTEIN; ECOLOGY; SETS	The human distal gut harbours a vast ensemble of microbes ( the microbiota) that provide important metabolic capabilities, including the ability to extract energy from otherwise indigestible dietary polysaccharides(1-6). Studies of a few unrelated, healthy adults have revealed substantial diversity in their gut communities, as measured by sequencing 16S rRNA genes(6-8), yet how this diversity relates to function and to the rest of the genes in the collective genomes of the microbiota ( the gut microbiome) remains obscure. Studies of lean and obese mice suggest that the gut microbiota affects energy balance by influencing the efficiency of calorie harvest from the diet, and how this harvested energy is used and stored(3-5). Here we characterize the faecal microbial communities of adult female monozygotic and dizygotic twin pairs concordant for leanness or obesity, and their mothers, to address how host genotype, environmental exposure and host adiposity influence the gut microbiome. Analysis of 154 individuals yielded 9,920 near full- length and 1,937,461 partial bacterial 16S rRNA sequences, plus 2.14 gigabases from their microbiomes. The results reveal that the human gut microbiome is shared among family members, but that each person's gut microbial community varies in the specific bacterial lineages present, with a comparable degree of co- variation between adult monozygotic and dizygotic twin pairs. However, there was a wide array of shared microbial genes among sampled individuals, comprising an extensive, identifiable 'core microbiome' at the gene, rather than at the organismal lineage, level. Obesity is associated with phylum- level changes in the microbiota, reduced bacterial diversity and altered representation of bacterial genes and metabolic pathways. These results demonstrate that a diversity of organismal assemblages can nonetheless yield a core microbiome at a functional level, and that deviations from his core are associated with different physiological states (obese compared with lean).	[Turnbaugh, Peter J.; Yatsunenko, Tanya; Ley, Ruth E.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Duncan, Alexis; Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63108 USA; [Hamady, Micah] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Cantarel, Brandi L.; Henrissat, Bernard] CNRS, UMR6098, Marseille, France; [Sogin, Mitchell L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; [Jones, William J.] Univ S Carolina, Environm Genome Core Facil, Columbia, SC 29208 USA; [Roe, Bruce A.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Roe, Bruce A.] Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA; [Affourtit, Jason P.; Egholm, Michael] 454 Life Sci, Branford, CT 06405 USA	Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); Marine Biological Laboratory - Woods Hole; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu	Sogin, Mitchell/AAE-7186-2019; Knight, Rob/D-1299-2010; Eckhardt, Erik/G-1567-2010; Henrissat, Bernard/J-2475-2012; Ley, Ruth E/M-8542-2014; Cantarel, Brandi/ABF-5756-2020	Henrissat, Bernard/0000-0002-3434-8588; Ley, Ruth E/0000-0002-9087-1672; Cantarel, Brandi/0000-0003-4126-4478; Knight, Rob/0000-0002-0975-9019; Turnbaugh, Peter/0000-0002-0888-2875	National Institutes of Health [DK78669, ES012742, AA09022, HD049024]; National Science Foundation [OCE0430724]; W.M. Keck Foundation; Crohn's and Colitis Foundation of America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049024] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009022, K05AA017688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); W.M. Keck Foundation(W.M. Keck Foundation); Crohn's and Colitis Foundation of America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank: S. Wagoner and J. Manchester for technical support; S. Marion and D. Hopper for recruitment of participants and sample collection; A. Goodman, B. Muegge, and M. Mahowald for suggestions; S. Huse (Marine Biological Laboratory), F. Niazi and S. Attiya ( 454 Life Sciences), C. Markovic, L. Fulton, B. Fulton, E. Mardis and R. Wilson (Washington University Genome Sequencing Center) and S. Macmil, G. Wiley, C. Qu, and P. Wang ( University of Oklahoma) for their assistance with sequencing; and P. M. Coutinho ( Universite de Provence, France) for help with the CAZy analysis. Deep draft assemblies of reference gut genomes were generated as part of a National Human Genome Research Institute (NHGRI)-sponsored human gut microbiome initiative (http://genome.wustl.edu/pub/organism/Microbes/Human_Gut_Microbiome/). This work was supported in part by the National Institutes of Health (DK78669/ ES012742/AA09022/HD049024), the National Science Foundation (OCE0430724), the W.M. Keck Foundation, and the Crohn's and Colitis Foundation of America.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Heath AC, 2002, TWIN RES, V5, P107, DOI 10.1375/twin.5.2.107; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Watson SB, 1997, LIMNOL OCEANOGR, V42, P487, DOI 10.4319/lo.1997.42.3.0487; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	34	5197	5537	46	1977	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					480	U7		10.1038/nature07540	http://dx.doi.org/10.1038/nature07540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19043404	Green Accepted, Green Submitted			2022-12-28	WOS:000262519200047
J	Scott, DA				Scott, Dorothy A.			The landscape of child maltreatment	LANCET			English	Editorial Material							ABUSE; RISK		[Scott, Dorothy A.] Univ S Australia, Australian Ctr Child Protect, Magill, SA 5072, Australia	University of South Australia	Scott, DA (corresponding author), Univ S Australia, Australian Ctr Child Protect, Magill Campus, Magill, SA 5072, Australia.	Dorothy.A.Scott@unisa.edu.au						DAWE S, 2008, 29 AUSTR I FAM STUD; Doyle JJ, 2007, AM ECON REV, V97, P1583, DOI 10.1257/aer.97.5.1583; GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61707-9; GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61706-7; HIRTE C, 2008, RES REPORT CONTACT S; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; MACMILLAN HL, 2008, LANCET          1203, DOI [DOI 10.1016/S0140-6736(08)61708-0, 10.1016/S0140-6736(21)02844-0, DOI 10.1016/S0140-6736(21)02844-0]; O'Donnell M, 2008, AUST NZ J PUBL HEAL, V32, P325, DOI 10.1111/j.1753-6405.2008.00249.x; READING R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61709-2; Rubin DM, 2007, PEDIATRICS, V119, P336, DOI 10.1542/peds.2006-1995; Sabol W, 2004, CHILD ABUSE NEGLECT, V28, P967, DOI 10.1016/j.chiabu.2004.03.014; Sebre S, 2004, CHILD ABUSE NEGLECT, V28, P113, DOI 10.1016/j.chiabu.2003.06.004; TAYLOR J, 2004, CHIDL NEGLECT PRACTI	13	13	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					101	102		10.1016/S0140-6736(08)61702-X	http://dx.doi.org/10.1016/S0140-6736(08)61702-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19056116				2022-12-28	WOS:000262340900006
J	Ren, H; Sigman, DM; Meckler, AN; Plessen, B; Robinson, RS; Rosenthal, Y; Haug, GH				Ren, H.; Sigman, D. M.; Meckler, A. N.; Plessen, B.; Robinson, R. S.; Rosenthal, Y.; Haug, G. H.			Foraminiferal Isotope Evidence of Reduced Nitrogen Fixation in the Ice Age Atlantic Ocean	SCIENCE			English	Article							PLANKTONIC-FORAMINIFERA; SEDIMENT N-15/N-14; PARTICLE DYNAMICS; ATMOSPHERIC CO2; NORTH-ATLANTIC; ARABIAN SEA; DENITRIFICATION; PACIFIC; CARBON; FRACTIONATION	Fixed nitrogen ( N) is a limiting nutrient for algae in the low- latitude ocean, and its oceanic inventory may have been higher during ice ages, thus helping to lower atmospheric CO(2) during those intervals. In organic matter within planktonic foraminifera shells in Caribbean Sea sediments, we found that the (15)N/(14)N ratio from the last ice age is higher than that from the current interglacial, indicating a higher nitrate (15)N/(14)N ratio in the Caribbean thermocline. This change and other species- specific differences are best explained by less N fixation in the Atlantic during the last ice age. The fixation decrease was most likely a response to a known ice age reduction in ocean N loss, and it would have worked to balance the ocean N budget and to curb ice age- interglacial change in the N inventory.	[Ren, H.; Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Meckler, A. N.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Plessen, B.] Deutsch Geoforschungszentrum, Helmholtz Zentrum Potsdam, D-14473 Potsdam, Germany; [Robinson, R. S.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Rosenthal, Y.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Y.] Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; [Haug, G. H.] ETH, Dept Earth Sci, Inst Geol, CH-8092 Zurich, Switzerland; [Haug, G. H.] Univ Potsdam, DFG Leibniz Ctr Earth Surface Proc & Climate Stud, Inst Geosci, D-14476 Potsdam, Germany	Princeton University; California Institute of Technology; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Rhode Island; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Potsdam	Ren, H (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.	hren@princeton.edu	Sigman, Daniel M/A-2649-2008; Meckler, Anna Nele/AAC-2490-2020	Sigman, Daniel M/0000-0002-7923-1973; Meckler, Anna Nele/0000-0002-7225-8276; Robinson, Rebecca/0000-0002-8072-1603; REN, HAO-JIA/0000-0002-1769-4243	NSF [ANT-0453680, OCE- 9981479, OCE- 0447570, OCE-0220776, OCE-0341412, OCE-0502504, OCE-0437366, OCE-0350794]; Schlanger Ocean Drilling Fellowship; Princeton Carbon Mitigation Initiative; Deutsche Forschungsgemeinschaft	NSF(National Science Foundation (NSF)); Schlanger Ocean Drilling Fellowship; Princeton Carbon Mitigation Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Bernhard and D. McCorkle for supplying surface sediment samples; Y. Wang, M. Coray, and S. Bishop for technical assistance; B. Brunelle for advice; and two anonymous reviewers for comments. Supported by NSF grants ANT-0453680, OCE- 9981479, and OCE- 0447570 (D.M.S.), OCE-0220776, OCE-0341412, and OCE-0502504 (Y.R.), and OCE-0437366 and OCE-0350794 (J. Bernhard), a Schlanger Ocean Drilling Fellowship (H.R.), BP through the Princeton Carbon Mitigation Initiative, and Deutsche Forschungsgemeinschaft grants (G.H.H.). This research used samples provided by the ODP, which is sponsored by NSF and participating countries under the management of Joint Oceanographic Institutions.	ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; ALTABET MA, 1989, LIMNOL OCEANOGR, V34, P1185, DOI 10.4319/lo.1989.34.7.1185; Altabet MA, 1989, GLOBAL BIOGEOCHEM CY, V3, P107, DOI 10.1029/GB003i002p00107; Barford CC, 1999, APPL ENVIRON MICROB, V65, P989; Brandes JA, 1997, GEOCHIM COSMOCHIM AC, V61, P1793, DOI 10.1016/S0016-7037(97)00041-0; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CHECKLEY DM, 1989, DEEP-SEA RES, V36, P1449, DOI 10.1016/0198-0149(89)90050-2; CHRISTENSEN JP, 1994, CONT SHELF RES, V14, P547, DOI 10.1016/0278-4343(94)90103-1; De Pol-Holz R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024477; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; DiFiore PJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003216; Emmer E, 2000, PALEOCEANOGRAPHY, V15, P377, DOI 10.1029/1999PA000417; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Hastings MG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003789; Haug GH, 1998, PALEOCEANOGRAPHY, V13, P427, DOI 10.1029/98PA01976; JASPER JP, 1990, NATURE, V347, P462, DOI 10.1038/347462a0; KAO SJ, 2008, ATMOS CHEM PHYS DISC, V5, P1017; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; KING K JR, 1972, Micropaleontology (New York), V18, P285, DOI 10.2307/1485009; Knapp AN, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002320; Knapp AN, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003107; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Meckler AN, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002893; Mintenbeck K, 2007, DEEP-SEA RES PT I, V54, P1015, DOI 10.1016/j.dsr.2007.03.005; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Mora G, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001132; NAKATSUKA T, 1995, GEOPHYS RES LETT, V22, P2525, DOI 10.1029/95GL02544; Ravelo AC, 1992, PALEOCEANOGRAPHY, V7, P815, DOI 10.1029/92PA02092; REDFIELD AC, 1958, AM SCI, V46, P205; ROBBINS LL, 1990, GEOCHIM COSMOCHIM AC, V54, P2285, DOI 10.1016/0016-7037(90)90052-M; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; SWEENEY RE, 1980, MAR CHEM, V9, P145, DOI 10.1016/0304-4203(80)90064-X; Thunell RC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2002GB002028, 10.1029/2003GB002185]; Uhle ME, 1997, ORG GEOCHEM, V27, P103, DOI 10.1016/S0146-6380(97)00075-2; UHLE ME, 1990, LIMNOL OCEANOGR, V44, P1968; WADA E, 1976, GEOCHIM COSMOCHIM AC, V40, P249, DOI 10.1016/0016-7037(76)90183-6	41	109	112	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					244	248		10.1126/science.1165787	http://dx.doi.org/10.1126/science.1165787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19095896				2022-12-28	WOS:000262290600036
J	Lippman, SM; Klein, EA; Goodman, PJ; Lucia, MS; Thompson, IM; Ford, LG; Parnes, HL; Minasian, LM; Gaziano, JM; Hartline, JA; Parsons, JK; Bearden, JD; Crawford, ED; Goodman, GE; Claudio, J; Winquist, E; Cook, ED; Karp, DD; Walther, P; Lieber, MM; Kristal, AR; Darke, AK; Arnold, KB; Ganz, PA; Santella, RM; Albanes, D; Taylor, PR; Probstfield, JL; Jagpal, TJ; Crowley, JJ; Meyskens, FL; Baker, LH; Coltman, CA				Lippman, Scott M.; Klein, Eric A.; Goodman, Phyllis J.; Lucia, M. Scott; Thompson, Ian M.; Ford, Leslie G.; Parnes, Howard L.; Minasian, Lori M.; Gaziano, J. Michael; Hartline, Jo Ann; Parsons, J. Kellogg; Bearden, James D., III; Crawford, E. David; Goodman, Gary E.; Claudio, Jaime; Winquist, Eric; Cook, Elise D.; Karp, Daniel D.; Walther, Philip; Lieber, Michael M.; Kristal, Alan R.; Darke, Amy K.; Arnold, Kathryn B.; Ganz, Patricia A.; Santella, Regina M.; Albanes, Demetrius; Taylor, Philip R.; Probstfield, Jeffrey L.; Jagpal, T. J.; Crowley, John J.; Meyskens, Frank L., Jr.; Baker, Laurence H.; Coltman, Charles A., Jr.			Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers The Selenium and Vitamin E Cancer Prevention Trial ( SELECT)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; NUTRITIONAL PREVENTION; ALPHA-TOCOPHEROL; BREAST-CANCER; BETA-CAROTENE; CELL-CYCLE; SUPPLEMENTATION; CARCINOMA; FINASTERIDE; MORTALITY	Context Secondary analyses of 2 randomized controlled trials and supportive epidemiologic and preclinical data indicated the potential of selenium and vitamin E for preventing prostate cancer. Objective To determine whether selenium, vitamin E, or both could prevent prostate cancer and other diseases with little or no toxicity in relatively healthy men. Design, Setting, and Participants A randomized, placebo- controlled trial ( Selenium and Vitamin E Cancer Prevention Trial [ SELECT]) of 35 533 men from 427 participating sites in the United States, Canada, and Puerto Rico randomly assigned to 4 groups ( selenium, vitamin E, selenium + vitamin E, and placebo) in a double- blind fashion between August 22, 2001, and June 24, 2004. Baseline eligibility included age 50 years or older ( African American men) or 55 years or older ( all other men), a serum prostate- specific antigen level of 4 ng/ mL or less, and a digital rectal examination not suspicious for prostate cancer. Interventions Oral selenium ( 200 mu g/d from L- selenomethionine) and matched vitamin E placebo, vitamin E ( 400 IU/ d of all rac-alpha-tocopheryl acetate) and matched selenium placebo, selenium + vitamin E, or placebo + placebo for a planned follow-up of minimum of 7 years and a maximum of 12 years. Main Outcome Measures Prostate cancer and prespecified secondary outcomes, including lung, colorectal, and overall primary cancer. Results As of October 23, 2008, median overall follow- up was 5.46 years ( range, 4.17- 7.33 years). Hazard ratios ( 99% confidence intervals [ CIs]) for prostate cancer were 1.13 ( 99% CI, 0.95- 1.35; n= 473) for vitamin E, 1.04 ( 99% CI, 0.87- 1.24; n= 432) for selenium, and 1.05 ( 99% CI, 0.88- 1.25; n= 437) for selenium + vitamin E vs 1.00 ( n= 416) for placebo. There were no significant differences ( all P >. 15) in any other prespecified cancer end points. There were statistically nonsignificant increased risks of prostate cancer in the vitamin E group ( P=. 06) and type 2 diabetes mellitus in the selenium group ( relative risk, 1.07; 99% CI, 0.94- 1.22; P=. 16) but not in the selenium + vitamin E group. Conclusion Selenium or vitamin E, alone or in combination at the doses and formulations used, did not prevent prostate cancer in this population of relatively healthy men. Trial Registration clinicaltrials. gov identifier: NCT00006392.	[Lippman, Scott M.; Karp, Daniel D.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac & Head & Neck Med Oncol, Div Canc Med,Unit 432, Houston, TX 77030 USA; [Lippman, Scott M.; Cook, Elise D.] Univ Texas Houston, MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Klein, Eric A.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Goodman, Phyllis J.; Hartline, Jo Ann; Darke, Amy K.; Arnold, Kathryn B.; Crowley, John J.] SW Oncol Grp, Ctr Stat, Seattle, WA USA; [Lucia, M. Scott] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO USA; [Crawford, E. David] Univ Colorado, Hlth Sci Ctr, Div Urol Oncol, Denver, CO USA; [Thompson, Ian M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX USA; [Coltman, Charles A., Jr.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med Hematol, San Antonio, TX USA; [Coltman, Charles A., Jr.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med Oncol, San Antonio, TX USA; [Ford, Leslie G.; Parnes, Howard L.; Minasian, Lori M.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Albanes, Demetrius; Taylor, Philip R.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gaziano, J. Michael] Boston VA Healthcare Ctr, Vet Affairs Cooperat Studies Program, Boston, MA USA; [Gaziano, J. Michael] Boston VA Healthcare Ctr, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Parsons, J. Kellogg] Moores Canc Ctr, La Jolla, CA USA; [Bearden, James D., III] Upstate Carolina CCOP, Spartanburg, SC USA; [Goodman, Phyllis J.] Swedish Canc Inst, Div Hematol & Oncol, Seattle, WA USA; [Claudio, Jaime] Altamira Family Med, Rio Piedras, PR USA; [Winquist, Eric] London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada; [Walther, Philip] Duke Univ, Med Ctr, Dept Urol Surg, Durham, NC USA; [Lieber, Michael M.] Mayo Clin, Dept Urol, Rochester, MN USA; [Kristal, Alan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Probstfield, Jeffrey L.] Univ Washington, Dept Med & Cardiol, Seattle, WA 98195 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90024 USA; [Santella, Regina M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Jagpal, T. J.] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC V5Z 1M9, Canada; [Meyskens, Frank L., Jr.] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA; [Baker, Laurence H.] Univ Michigan, Div Hematol & Oncol, Ann Arbor, MI 48109 USA; [Baker, Laurence H.; Coltman, Charles A., Jr.] SW Oncol Grp, Ann Arbor, MI USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Southwest Oncology Group; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Swedish Cancer Institute; Swedish Medical Center; London Health Sciences Centre; Western University (University of Western Ontario); Duke University; Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Columbia University; University of British Columbia; University of California System; University of California Irvine; University of Michigan System; University of Michigan; Southwest Oncology Group	Lippman, SM (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac & Head & Neck Med Oncol, Div Canc Med,Unit 432, 1515 Holcombe Blvd, Houston, TX 77030 USA.	slippman@mdanderson.org; kleine@ccf.org	Albanes, Demetrius/B-9749-2015	Kristal, Alan/0000-0002-7329-1617	Public Health Service Cooperative Agreement [CA37429]; National Cancer Institute; National Institutes of Health; Department of Health and Human Services; National Center for Complementary and Alternative Medicine; NATIONAL CANCER INSTITUTE [P30CA062203, U10CA037429] Funding Source: NIH RePORTER	Public Health Service Cooperative Agreement(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Public Health Service Cooperative Agreement grant CA37429 awarded by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, and in part by the National Center for Complementary and Alternative Medicine (National Institutes of Health). Study agents and packaging were provided by Perrigo Company ( Allegan, Michigan), Sabinsa Corporation ( Piscataway, NewJersey), Tishcon Corporation (Westbury, New York), and DSM Nutritional Products Inc ( Parsipanny, New Jersey).	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bleys J, 2007, DIABETES CARE, V30, P829, DOI 10.2337/dc06-1726; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fleshner N, 1999, J UROLOGY, V161, P1651, DOI 10.1016/S0022-5347(05)68998-7; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Harlan SR, 2003, J UROLOGY, V170, P1804, DOI 10.1097/01.ju.0000091641.34674.11; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Hoffman RM, 2004, CANCER, V101, P2011, DOI 10.1002/cncr.20608; Ip C, 2000, CANCER RES, V60, P2882; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang C, 2001, CANCER RES, V61, P3062; Kirsh VA, 2006, JNCI-J NATL CANCER I, V98, P245, DOI 10.1093/jnci/djj050; Lee IM, 2006, J NATL CANCER I, V98, P225, DOI 10.1093/jnci/djj066; Li HJ, 2004, JNCI-J NATL CANCER I, V96, P696, DOI 10.1093/jnci/djh125; Lippman SM, 2005, JNCI-J NATL CANCER I, V97, P94, DOI 10.1093/jnci/dji009; Lippman SM, 1998, JNCI-J NATL CANCER I, V90, P1514, DOI 10.1093/jnci/90.20.1514; Logothetis CJ, 2008, CANCER PREV RES, V1, P151, DOI 10.1158/1940-6207.CAPR-08-0085; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Lucia MS, 2007, JNCI-J NATL CANCER I, V99, P1375, DOI 10.1093/jnci/djm117; Lucia MS, 2008, CANCER PREV RES, V1, P167, DOI 10.1158/1940-6207.CAPR-08-0078; Menter DG, 2000, CANCER EPIDEM BIOMAR, V9, P1171; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; Rajpathak S, 2005, J AM COLL NUTR, V24, P250, DOI 10.1080/07315724.2005.10719472; Redman C, 1998, CANCER LETT, V125, P103, DOI 10.1016/S0304-3835(97)00497-7; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; Scardino PT, 2003, NEW ENGL J MED, V349, P297, DOI 10.1056/NEJMe038109; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Taylor PR, 1998, J NATL CANCER I, V90, P1184, DOI 10.1093/jnci/90.16.1184; Taylor PR, 2004, JNCI-J NATL CANCER I, V96, P645, DOI 10.1093/jnci/djh147; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Traber MG, 2006, AM J CLIN NUTR, V84, P959, DOI 10.1093/ajcn/84.5.959; Venkateswaran V, 2002, J UROLOGY, V168, P1578, DOI 10.1016/S0022-5347(05)64524-7; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045; Yoshizawa K, 1998, JNCI-J NATL CANCER I, V90, P1219, DOI 10.1093/jnci/90.16.1219; Zhong WX, 2001, CANCER RES, V61, P7071	48	1479	1530	3	187	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					39	51		10.1001/jama.2008.864	http://dx.doi.org/10.1001/jama.2008.864			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19066370	Green Accepted			2022-12-28	WOS:000262220400019
J	Subramanian, V; Hawkey, CJ				Subramanian, Venkataraman; Hawkey, Christopher J.			Assessing bleeds clinically: what's the score?	LANCET			English	Editorial Material							UPPER GASTROINTESTINAL HEMORRHAGE; OUTPATIENT MANAGEMENT; PREDICT NEED; ENDOSCOPY; SYSTEM		[Subramanian, Venkataraman; Hawkey, Christopher J.] Univ Nottingham, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England	University of Nottingham	Hawkey, CJ (corresponding author), Univ Nottingham, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England.	cj.hawkey@nottingham.ac.uk	Subramanian, Venkataraman/B-8274-2011	Subramanian, Venkataraman/0000-0003-3603-0861				Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; *BRIT SOC GASTR NH, 2007, UK COMP AUD UPP GAST; Chen GC, 2007, AM J EMERG MED, V25, P774, DOI 10.1016/j.ajem.2006.12.024; Cipolletta L, 2002, GASTROINTEST ENDOSC, V55, P1, DOI 10.1067/mge.2002.119219; Das A, 2008, GASTROENTEROLOGY, V134, P65, DOI 10.1053/j.gastro.2007.10.037; *DEP HLTH HOM OFF, 2007, SAF SENS SOC NEXT ST; Gralnek IM, 2004, GASTROINTEST ENDOSC, V60, P9, DOI 10.1016/S0016-5107(04)01524-X; Hay JA, 1996, AM J MED, V100, P313, DOI 10.1016/S0002-9343(97)89490-9; Longstreth GF, 1998, GASTROINTEST ENDOSC, V47, P219, DOI 10.1016/S0016-5107(98)70316-5; Masaoka T, 2007, J GASTROEN HEPATOL, V22, P1404, DOI 10.1111/j.1440-1746.2006.04762.x; NETTEN A, 2006, UNIT COSTS HLTH SOCI; Okazaki K, 2002, GUT, V51, P1, DOI 10.1136/gut.51.1.1; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Romagnuolo J, 2007, ARCH INTERN MED, V167, P265, DOI 10.1001/archinte.167.3.265; SAEED ZA, 1993, AM J GASTROENTEROL, V88, P1842; STANLEY AJ, 2008, LANCET          1215, DOI DOI 10.1016/S0140-6736(08)61769-9	16	3	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					5	7		10.1016/S0140-6736(08)61770-5	http://dx.doi.org/10.1016/S0140-6736(08)61770-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19091391				2022-12-28	WOS:000262183800006
J	Lo Celso, C; Fleming, HE; Wu, JWW; Zhao, CX; Miake-Lye, S; Fujisaki, J; Cote, D; Rowe, DW; Lin, CP; Scadden, DT				Lo Celso, Cristina; Fleming, Heather E.; Wu, Juwell W.; Zhao, Cher X.; Miake-Lye, Sam; Fujisaki, Joji; Cote, Daniel; Rowe, David W.; Lin, Charles P.; Scadden, David T.			Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche	NATURE			English	Article							STEM-CELL; IDENTIFICATION; OSTEOPONTIN; EXPRESSION; COMPONENT	Stem cells reside in a specialized, regulatory environment termed the niche that dictates how they generate, maintain and repair tissues(1,2). We have previously documented that transplanted haematopoietic stem and progenitor cell populations localize to subdomains of bone- marrow microvessels where the chemokine CXCL12 is particularly abundant(3). Using a combination of high-resolution confocal microscopy and two- photon video imaging of individual haematopoietic cells in the calvarium bone marrow of living mice over time, we examine the relationship of haematopoietic stem and progenitor cells to blood vessels, osteoblasts and endosteal surface as they home and engraft in irradiated and c-Kit-receptor-deficient recipient mice. Osteoblasts were enmeshed in microvessels and relative positioning of stem/ progenitor cells within this complex tissue was nonrandom and dynamic. Both cell autonomous and non- autonomous factors influenced primitive cell localization. Different haematopoietic cell subsets localized to distinct locations according to the stage of differentiation. When physiological challenges drove either engraftment or expansion, bone- marrow stem/ progenitor cells assumed positions in close proximity to bone and osteoblasts. Our analysis permits observing in real time, at a single cell level, processes that previously have been studied only by their long- term outcome at the organismal level.	[Lo Celso, Cristina; Fleming, Heather E.; Zhao, Cher X.; Miake-Lye, Sam; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Wu, Juwell W.; Fujisaki, Joji; Cote, Daniel; Lin, Charles P.] Massachusetts Gen Hosp, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02114 USA; [Wu, Juwell W.; Fujisaki, Joji; Cote, Daniel; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Lo Celso, Cristina; Fleming, Heather E.; Wu, Juwell W.; Zhao, Cher X.; Fujisaki, Joji; Lin, Charles P.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Rowe, David W.] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Connecticut; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	lin@helix.mgh.harvard.edu; dscadden@mgh.harvard.edu	Côté, Daniel/D-5185-2011; Fang, Zhijun/L-9620-2013	Lo Celso, Cristina/0000-0002-1163-4207	EMBO; HFSP; National Institutes of Health; Harvard Stem Cell Institute; NATIONAL EYE INSTITUTE [R01EY014106] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Schipani for providing the PPR mice. We are grateful for help and advice from A. Catic, L. Purton, V. Janzen, G. Adams, J. Spencer, J. Runnels and P. O'Donovan. We thank Y. Tang for the mice husbandry care; D. Dombkowski, L. Prickett and K. Folz-Donahue for cell sorting expertise; R. Klein and K. Chomsky-Higgins for technical assistance; and C. Pasker, V. Shannon, M. Indico Miklosik and D. Machon for administrative assistance. C. L. C. was funded by EMBO and HFSP. The project was funded by the National Institutes of Health (to D.T.S. and C.P.L.), the Harvard Stem Cell Institute (to C.P.L.) and philanthropic sources (to D.T.S. and C.L.C.).	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CROCK HW, 1967, BLOOD SUPPLY LOWER L; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; LORD BI, 1975, BLOOD, V46, P65; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Migliaccio AR, 1999, EXP HEMATOL, V27, P1655, DOI 10.1016/S0301-472X(99)00110-1; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 1997, BLOOD, V90, P4646; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Taichman RUSSELL S., 2000, Hematology, V4, P421; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhong JF, 2002, BLOOD, V100, P3521, DOI 10.1182/blood-2002-04-1256; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	33	659	667	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					92	U96		10.1038/nature07434	http://dx.doi.org/10.1038/nature07434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19052546	Green Accepted			2022-12-28	WOS:000262104900037
J	Bush, SD; Pelaez, NJ; Rudd, JA; Stevens, MT; Tanner, KD; Williams, KS				Bush, S. D.; Pelaez, N. J.; Rudd, J. A.; Stevens, M. T.; Tanner, K. D.; Williams, K. S.			THE PIPELINE Science Faculty with Education Specialties	SCIENCE			English	Editorial Material									[Rudd, J. A.] Calif State Univ Los Angeles, Los Angeles, CA 90032 USA; [Bush, S. D.] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Pelaez, N. J.] Purdue Univ, W Lafayette, IN 47907 USA; [Stevens, M. T.] Calif State Univ Stanislaus, Turlock, CA 95382 USA; [Tanner, K. D.] San Francisco State Univ, San Francisco, CA 94132 USA; [Williams, K. S.] San Diego State Univ, San Diego, CA 92182 USA	California State University System; California State University Los Angeles; California State University System; California Polytechnic State University San Luis Obispo; Purdue University System; Purdue University; Purdue University West Lafayette Campus; California State University System; California State University Stanislaus; California State University System; San Francisco State University; California State University System; San Diego State University	Rudd, JA (corresponding author), Calif State Univ Los Angeles, Los Angeles, CA 90032 USA.	jrudd@calstatela.edu	Stevens, Michael/AAC-4660-2021; Pelaez, Nancy/U-2883-2019	Stevens, Michael/0000-0003-3267-2285; Pelaez, Nancy/0000-0002-6328-5010				Bush S D, 2006, CBE Life Sci Educ, V5, P297, DOI 10.1187/cbe.06-09-0189; *CAL STAT U, 2008 FACTS 23 CAMPS; *NAT AC CTR ED, 2005, WORKSH ED RES POS ST; National Academy of Sciences National Academy of Engineering and Institute of Medicine, 2007, RIS GATH STORM EN EM; OECD, 2007, OECD PUBL; Seymour E., 1997, TALKING LEAVING WHY	6	28	28	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1795	1796		10.1126/science.1162072	http://dx.doi.org/10.1126/science.1162072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095927				2022-12-28	WOS:000261799400038
J	Patton, D; McIntosh, A				Patton, Declan; McIntosh, Andrew			Head and neck injury risks in heavy metal: head bangers stuck between rock and a hard bass	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To investigate the risks of mild traumatic brain injury and neck injury associated with head banging, a popular dance form accompanying heavy metal music. Design Observational studies, focus group, and biomechanical analysis. Participants Head bangers. Main outcome measures Head Injury Criterion and Neck Injury Criterion were derived for head banging styles and both popular heavy metal songs and easy listening music controls. Results An average head banging song has a tempo of about 146 beats per minute, which is predicted to cause mild head injury when the range of motion is greater than 75 degrees. At higher tempos and greater ranges of motion there is a risk of neck injury. Conclusion To minimise the risk of head and neck injury, head bangers should decrease their range of head and neck motion, head bang to slower tempo songs by replacing heavy metal with adult oriented rock, only head bang to every second beat, or use personal protective equipment.	[Patton, Declan; McIntosh, Andrew] Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	McIntosh, A (corresponding author), Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia.	a.mcintosh@unsw.edu.au						BALSAMO T, 2006, EVANESCENCE GUITARIS; BASHAM D, 2001, BASSIST J NEWSTED LE; BENNETT J, 2008, SKY NEWS; BOSTROM O, 1996, INT RES COUNC BIOM I; BRANDLE L, 2003, BILLBOARD B; Brault JR, 1998, ARCH PHYS MED REHAB, V79, P72, DOI 10.1016/S0003-9993(98)90212-X; Clauser C. E., 1969, WEIGHT VOLUME CTR MA, P1; DANENBERG MA, 1987, LANG SPEECH HEAR SER, V8, P267; EGNOR M R, 1991, Pediatric Neurosurgery, V17, P135, DOI 10.1159/000120583; Ferrario VF, 2002, J ORTHOPAED RES, V20, P122, DOI 10.1016/S0736-0266(01)00079-1; FINE M, 2008, NIELSEN SOUNDSCAN; JAKOBSSON L, 1999, INT RES COUNC BIOM I; KIMPTON P, 2008, OBSERVER; Kunin M, 2007, J NEUROPHYSIOL, V98, P3095, DOI 10.1152/jn.00764.2007; LEWIS D, 1997, L ZEPPELIN CONCERT F; McConville J. T., 1980, ANTHROPOMETRIC RELAT; Neyaz Z, 2006, NEUROL INDIA, V54, P319; Panjabi MM, 2005, J BIOMECH, V38, P1694, DOI 10.1016/j.jbiomech.2004.07.015; Spheeris P., 1988, DECLINE W CIVILIZA 2; Spheeris Penelope, 1992, WAYNES WORLD; THOMPSON B, 2008, DAILY TELEGRAPH; TYRELL D, 1998, CRASHWORTHINESS PASS	22	8	8	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2008	337								a2825	10.1136/bmj.a2825	http://dx.doi.org/10.1136/bmj.a2825			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091761	hybrid, Green Published			2022-12-28	WOS:000262185000007
J	Park, MP; Park, RHR				Park, M. P.; Park, R. H. R.			Fantastic feeding funnels	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Park, M. P.] Univ Glasgow, Dept Adult & Continuing Educ, Glasgow G3 6NH, Lanark, Scotland; [Park, R. H. R.] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow; University of Glasgow	Park, MP (corresponding author), Univ Glasgow, Dept Adult & Continuing Educ, Glasgow G3 6NH, Lanark, Scotland.	mpark@educ.gla.ac.uk						ANKORI G, 1993, JEWISH ART, V19, P224; AWEKOTUKU NT, 2006, SENSIBLE OBJECTS COL, P121; Budrys V, 2006, EUR NEUROL, V55, P4, DOI 10.1159/000091136; CAWTHORNE T, 1962, P ROY SOC MED, V55, P213, DOI 10.1177/003591576205500308; De Tolnay Charles, 1966, HIERONYMUS BOSCH; Herrera H., 1983, FRIDA BIOGRAPHY F KA; KLINGENDER FD, 1966, GOYA DEMOCRATIC TRAD; LINFERT C, 1972, HIERONYMUS BOSCH; MUNDOR H, 1965, DOCTORS MED WORKS DA; PRICE R, 1981, MED HIST, V25, P269, DOI 10.1017/S002572730003458X; ZAMUDIOTAYLOR V, 2007, F KAHLO, P14	11	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2888	10.1136/bmj.a2888	http://dx.doi.org/10.1136/bmj.a2888			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088143				2022-12-28	WOS:000262184900006
J	Hori, T; Amano, M; Suzuki, A; Backer, CB; Welburn, JP; Dong, YM; McEwen, BF; Shang, WH; Suzuki, E; Okawa, K; Cheeseman, IM; Fukagawa, T				Hori, Tetsuya; Amano, Miho; Suzuki, Aussie; Backer, Chelsea B.; Welburn, Julie P.; Dong, Yimin; McEwen, Bruce F.; Shang, Wei-Hao; Suzuki, Emiko; Okawa, Katsuya; Cheeseman, Iain M.; Fukagawa, Tatsuo			CCAN Makes Multiple Contacts with Centromeric DNA to Provide Distinct Pathways to the Outer Kinetochore	CELL			English	Article							CENP-A CHROMATIN; CHROMOSOME SEGREGATION; MOLECULAR ARCHITECTURE; MITOTIC CHECKPOINT; HUMAN-CELLS; COMPLEX; COMPONENT; ORGANIZATION; INTERPHASE; PROTEINS	Kinetochore specification and assembly requires the targeted deposition of specialized nucleosomes containing the histone H3 variant CENP-A at centromeres. However, CENP-A is not sufficient to drive full-kinetochore assembly, and it is not clear how centromeric chromatin is established. Here, we identify CENP-W as a component of the DNA-proximal constitutive centromere-associated network (CCAN) of proteins. We demonstrate that CENP-W forms a DNA-binding complex together with the CCAN component CENP-T. This complex directly associates with nucleosomal DNA and with canonical histone H3, but not with CENP-A, in centromeric regions. CENP-T/CENP-W functions upstream of other CCAN components with the exception of CENP-C, an additional putative DNA-binding protein. Our analysis indicates that CENP-T/CENP-W and CENP-C provide distinct pathways to connect the centromere with outer kinetochore assembly. In total, our results suggest that the CENP-T/CENP-W complex is directly involved in establishment of centromere chromatin structure coordinately with CENP-A.	[Hori, Tetsuya; Amano, Miho; Suzuki, Aussie; Shang, Wei-Hao; Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Suzuki, Emiko] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, SOKENDAI, Mishima, Shizuoka 4118540, Japan; [Backer, Chelsea B.; Welburn, Julie P.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Backer, Chelsea B.; Welburn, Julie P.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA; [Dong, Yimin; McEwen, Bruce F.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; Wadsworth Center; Kyoto University	Fukagawa, T (corresponding author), Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan.	tfukagaw@lab.nig.ac.jp	Suzuki, Aussie/ABF-4170-2021; Fukagawa, Tatsuo/AAK-3922-2021	Suzuki, Emiko/0000-0002-4005-0542; Welburn, Julie/0000-0002-5440-6060; Cheeseman, Iain/0000-0002-3829-5612; Suzuki, Aussie/0000-0001-7390-5116	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Smith Family Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smith Family Foundation	The authors are very grateful to K. Suzuki, M. Takahashi, and K. Kita for technical assistance. We also thank H. Kimura and V. Regnier for reagents. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to T. F. and a Smith Family Foundation New Investigator Award and Thomas D. and Virginia W. Cabot Career Development Professorship to I. M. C.	Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Krasikova A, 2006, CHROMOSOME RES, V14, P777, DOI 10.1007/s10577-006-1085-y; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Yang CH, 1996, MOL CELL BIOL, V16, P3576	41	293	301	4	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 12	2008	135	6					1039	1052		10.1016/j.cell.2008.10.019	http://dx.doi.org/10.1016/j.cell.2008.10.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070575	Bronze			2022-12-28	WOS:000261642800020
J	Mahowald, GK; Baron, JM; Sleckman, BP				Mahowald, Grace K.; Baron, Jason M.; Sleckman, Barry P.			Collateral Damage from Antigen Receptor Gene Diversification	CELL			English	Review							SOMATIC HYPERMUTATION; V(D)J RECOMBINATION; TRANSPOSITION; TRANSLOCATIONS; MECHANISMS; CELLS; ENDS; AID	Chromosomal translocations that juxtapose antigen receptor genes and oncogenes are frequently associated with lymphoid malignancies. In this issue, Robbiani et al. ( 2008) show that activation-induced deaminase ( AID), an enzyme involved in antigen receptor gene diversification, generates DNA double-strand breaks (DSBs) in oncogenes, and Tsai et al. ( 2008) propose that AID and the recombinase-activating gene ( RAG) endonuclease may collaborate to generate off-target DSBs.	[Mahowald, Grace K.; Baron, Jason M.; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	sleckman@immunology.wustl.edu		Mahowald, Grace/0000-0003-4541-4920				Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Curry JD, 2007, J EXP MED, V204, P2293, DOI 10.1084/jem.20070583; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Messier TL, 2003, EMBO J, V22, P1381, DOI 10.1093/emboj/cdg137; Raghavan SC, 2006, BIOESSAYS, V28, P480, DOI 10.1002/bies.20353; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; Sekiguchi J, 2001, MOL CELL, V8, P1383, DOI 10.1016/S1097-2765(01)00423-3; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386	18	22	23	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1009	1012		10.1016/j.cell.2008.11.024	http://dx.doi.org/10.1016/j.cell.2008.11.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070571	Bronze			2022-12-28	WOS:000261642800016
J	Shubeita, GT; Tran, SL; Xu, J; Vershinin, M; Cermelli, S; Cotton, SL; Welte, MA; Gross, SP				Shubeita, George T.; Tran, Susan L.; Xu, Jing; Vershinin, Michael; Cermelli, Silvia; Cotton, Sean L.; Welte, Michael A.; Gross, Steven P.			Consequences of Motor Copy Number on the Intracellular Transport of Kinesin-1-Driven Lipid Droplets	CELL			English	Article							KINESIN-HEAVY-CHAIN; TUG-OF-WAR; CARGO TRANSPORT; IN-VIVO; ORGANELLE TRANSPORT; DROSOPHILA EMBRYOS; CYTOPLASMIC DYNEIN; VESICLE TRANSPORT; MOLECULAR MOTORS; PROTEIN	The microtubule motor kinesin-1 plays central roles in intracellular transport. It has been widely assumed that many cellular cargos are moved by multiple kinesins and that cargos with more motors move faster and for longer distances; concrete evidence, however, is sparse. Here we rigorously test these notions using lipid droplets in Drosophila embryos. We first employ antibody inhibition, genetics, biochemistry, and particle tracking to demonstrate that kinesin-1 mediates plus-end droplet motion. We then measure how variation in kinesin-1 expression affects the forces driving individual droplets and estimate the number of kinesins actively engaged per droplet. Unlike in vitro, increased motor number results in neither longer travel distances nor higher velocities. Our data suggest that cargos in vivo can simultaneously engage multiple kinesins and that transport properties are largely unaffected by variation in motor number. Apparently, higher-order regulatory mechanisms rather than motor number per se dominate cargo transport in vivo.	[Shubeita, George T.; Xu, Jing; Vershinin, Michael; Cermelli, Silvia; Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Tran, Susan L.; Welte, Michael A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Tran, Susan L.; Cotton, Sean L.; Welte, Michael A.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Tran, Susan L.; Cotton, Sean L.; Welte, Michael A.] Brandeis Univ, Rosenstiel Med Res Ctr, Waltham, MA 02454 USA	University of California System; University of California Irvine; University of Rochester; Brandeis University; Brandeis University	Welte, MA (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.	michael.welte@rochester.edu; sgross@uci.edu	Welte, Michael/AAH-5589-2019	Welte, Michael/0000-0001-5741-4720; Vershinin, Michael/0000-0002-8207-1376; Shubeita, George/0000-0003-4889-7542	NIGMS [GM64624, GM64687]; University of Rochester; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064624, T32GM007122, R01GM064687] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Rochester; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Stock Center, B. Saxton, and I. Palacios for fly stocks, B. Theurkauf and B. Cha for advice on antibody microinjections, N. Rizzo for help with western analysis, and A. Mu r ller and D. Lambert for comments on the manuscript. This work was supported by NIGMS grantGM64624 ( to S. P. G.) and NIGMS grant GM64687 and start- up support from the University of Rochester ( to M. A. W). G. T. S. was a Paul Sigler/Agouron Fellow of the Helen Hay Whitney Foundation.	Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Carter BC, 2005, PHYS BIOL, V2, P60, DOI 10.1088/1478-3967/2/1/008; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Foe Victoria E., 1993, P149; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Guo Y, 2005, MOL BIOL CELL, V16, P1406, DOI 10.1091/mbc.E04-10-0920; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Snider J, 2004, P NATL ACAD SCI USA, V101, P13204, DOI 10.1073/pnas.0403092101; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045	33	271	273	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1098	1107		10.1016/j.cell.2008.10.021	http://dx.doi.org/10.1016/j.cell.2008.10.021			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070579	Bronze, Green Accepted			2022-12-28	WOS:000261642800025
J	Greely, H; Sahakian, B; Harris, J; Kessler, RC; Gazzaniga, M; Campbell, P; Farah, MJ				Greely, Henry; Sahakian, Barbara; Harris, John; Kessler, Ronald C.; Gazzaniga, Michael; Campbell, Philip; Farah, Martha J.			Towards responsible use of cognitive-enhancing drugs by the healthy	NATURE			English	Editorial Material							BRAIN; MODAFINIL; SLEEP		[Greely, Henry] Stanford Univ, Sch Law, Stanford, CA 94305 USA; [Sahakian, Barbara] Univ Cambridge, Dept Psychiat, Cambridge, England; [Sahakian, Barbara] MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England; [Harris, John] Univ Manchester, Inst Sci Eth & Innovat, Manchester M13 9PL, Lancs, England; [Harris, John] Univ Manchester, Wellcome Strateg Programme Human Body Its Scope L, Manchester M13 9PL, Lancs, England; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Gazzaniga, Michael] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA; [Campbell, Philip] Nature, London N1 9XW, England; [Farah, Martha J.] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	Stanford University; University of Cambridge; University of Cambridge; University of Manchester; University of Manchester; Harvard University; Harvard Medical School; University of California System; University of California Santa Barbara; University of Pennsylvania; Pennsylvania Medicine	Greely, H (corresponding author), Stanford Univ, Sch Law, Crown Quadrangle,559 Nathan Abbott Way, Stanford, CA 94305 USA.	hgreely@stanford.edu; jenny.hall@cpft.nhs.uk; john.harris@manchester.ac.uk; kessler@hcp.med.harvard.edu; m.gazzaniga@psych.ucsb.edu; nature@nature.com; mfarah@psych.upenn.edu	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745	Medical Research Council [G0001354B] Funding Source: researchfish; Medical Research Council [G0001354] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Almeida SS, 2002, NUTR NEUROSCI, V5, P311, DOI 10.1080/1028415021000033776; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; Chatterjee A, 2004, NEUROLOGY, V63, P968, DOI 10.1212/01.WNL.0000138438.88589.7C; Diller LD, 1996, HASTINGS CENT REP, V26, P12, DOI 10.2307/3528571; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Fukuyama Francis, 2002, OUR POSTHUMAN FUTURE; Gron G, 2005, PSYCHOPHARMACOLOGY, V182, P170, DOI 10.1007/s00213-005-0043-2; Harris J., 2007, ENHANCING EVOLUTION; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Kass L, 2003, THER BIOT PURS HAPP; Lynch G, 2006, TRENDS NEUROSCI, V29, P554, DOI 10.1016/j.tins.2006.07.007; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Moreno J. D., 2006, MIND WARS BRAIN RES; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Schacter D., 2002, 7 SINS MEMORY; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; Vastag B, 2004, JAMA-J AM MED ASSOC, V291, P167, DOI 10.1001/jama.291.2.167; Weyandt Lisa L, 2006, J Atten Disord, V10, P9	23	472	485	1	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					702	705		10.1038/456702a	http://dx.doi.org/10.1038/456702a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19060880	Green Submitted			2022-12-28	WOS:000261559900020
J	Riebesell, U; Bellerby, RGJ; Engel, A; Fabry, VJ; Hutchins, DA; Reusch, TBH; Schulz, KG; Morel, FMM				Riebesell, Ulf; Bellerby, Richard G. J.; Engel, Anja; Fabry, Victoria J.; Hutchins, David A.; Reusch, Thorsten B. H.; Schulz, Kai G.; Morel, Francois M. M.			Comment on "Phytoplankton Calcification in a High-CO(2) World"	SCIENCE			English	Editorial Material							COCCOLITHOPHORID EMILIANIA-HUXLEYI; CO2; PCO(2)		[Riebesell, Ulf; Reusch, Thorsten B. H.; Schulz, Kai G.] Leibniz Inst Marine Sci, IFM GEOMAR, D-24105 Kiel, Germany; [Bellerby, Richard G. J.] Univ Bergen, Bjerknes Ctr Climate Res, N-5020 Bergen, Norway; [Engel, Anja] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Fabry, Victoria J.] Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA; [Hutchins, David A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Morel, Francois M. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Bjerknes Centre for Climate Research; University of Bergen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; California State University System; California State University San Marcos; University of Southern California; Princeton University	Riebesell, U (corresponding author), Leibniz Inst Marine Sci, IFM GEOMAR, Dusternbrooker Weg 20, D-24105 Kiel, Germany.	uriebesell@ifm-geomar.de	Riebesell, Ulf/AAC-9717-2020; Bellerby, Richard/ABD-6590-2021; Reusch, Thorsten B. H./B-9311-2019; Schulz, Kai G./Q-5608-2017; Schulz, Kai/AEZ-9073-2022; Reusch, Thorsten B.H./G-4141-2011; Hutchins, David A/D-3301-2013	Bellerby, Richard/0000-0003-3598-4006; Schulz, Kai G./0000-0002-8481-4639; Schulz, Kai/0000-0002-8481-4639; Hutchins, David A/0000-0002-6637-756X; Engel, Anja/0000-0002-1042-1955; Reusch, Thorsten B. H./0000-0002-8961-4337; Riebesell, Ulf/0000-0002-9442-452X				Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; IGLESIASRODRIGU.MD, 2001, PHYCOLOGIA, V40, P503; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Leonardos N, 2005, J PHYCOL, V41, P1196, DOI 10.1111/j.1529-8817.2005.00152.x; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Sciandra A, 2003, MAR ECOL PROG SER, V261, P111, DOI 10.3354/meps261111; Spijkerman E, 2008, PHYSIOL PLANTARUM, V133, P41, DOI 10.1111/j.1399-3054.2008.01062.x; The Royal Society, 2005, 1205 ROYAL SOC; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321	13	47	53	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907								10.1126/science.1161096	http://dx.doi.org/10.1126/science.1161096			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056960	Green Accepted			2022-12-28	WOS:000261377400021
J	Rozema, J; Flowers, T				Rozema, Jelte; Flowers, Timothy			ECOLOGY Crops for a Salinized World	SCIENCE			English	Editorial Material							SALT TOLERANCE; WATER RELATIONS; HALOPHYTES; IRRIGATION; GROWTH		[Rozema, Jelte] Vrije Univ Amsterdam, Dept Syst Ecol, Amsterdam, Netherlands; [Flowers, Timothy] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Flowers, Timothy] Univ Western Australia, Sch Plant Biol, Fac Nat & Agr Sci, Crawley, WA 6009, Australia	Vrije Universiteit Amsterdam; University of Sussex; University of Western Australia	Rozema, J (corresponding author), Vrije Univ Amsterdam, Dept Syst Ecol, Amsterdam, Netherlands.	jelte.rozema@falw.vu.nl	Flowers, Timothy/AAI-7078-2020	Flowers, Timothy/0000-0002-2712-9504				AHMAD R, 2002, PROSPECTS SALINE AGR; Brown JJ, 1999, AQUACULTURE, V175, P255, DOI 10.1016/S0044-8486(99)00084-8; FAO, GLOB NETW INT SOIL M; FAO, TERR DAT; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; GLENN EP, 1991, SCIENCE, V251, P1065, DOI 10.1126/science.251.4997.1065; Koyro HW, 2006, ENVIRON EXP BOT, V56, P136, DOI 10.1016/j.envexpbot.2005.02.001; Malash NM, 2008, IRRIGATION SCI, V26, P313, DOI 10.1007/s00271-007-0095-7; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Niazi BH, 2000, J AGRON CROP SCI, V184, P101, DOI 10.1046/j.1439-037x.2000.00353.x; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rozema J, 1996, HALOPHYTES AND BIOSALINE AGRICULTURE, P17; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; *UN POP DIV, CHART PROGR POP; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002	17	417	479	11	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1478	1480		10.1126/science.1168572	http://dx.doi.org/10.1126/science.1168572			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056965	Green Submitted			2022-12-28	WOS:000261377400028
J	Fowler, JH; Christakis, NA				Fowler, James H.; Christakis, Nicholas A.			Dynamic spread of happiness in a large social network: longitudinal analysis over 20 years in the Framingham Heart Study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; HAPPY; ALGORITHM; EVOLUTION; LAUGHTER	Objectives To evaluate whether happiness can spread from person to person and whether niches of happiness form within social networks. Design Longitudinal social network analysis. Setting Framingham Heart Study social network. Participants 4739 individuals followed from 1983 to 2003. Main outcome measures Happiness measured with validated four item scale; broad array of attributes of social networks and diverse social ties. Results Clusters of happy and unhappy people are visible in the network, and the relationship between people's happiness extends up to three degrees of separation ( for example, to the friends of one's friends' friends). People whoare surrounded by many happy people and thosewho are central in the network are more likely to become happy in the future. Longitudinal statistical models suggest that clusters of happiness result from the spread of happiness and not just a tendency for people to associate with similar individuals. A friend who lives within a mile ( about 1.6 km) and who becomes happy increases the probability that a person is happy by 25% ( 95% confidence interval 1% to 57%). Similar effects are seen in coresident spouses ( 8%, 0.2% to 16%), siblings who live within a mile ( 14%, 1% to 28%), and next door neighbours ( 34%, 7% to 70%). Effects are not seen between coworkers. The effect decays with time and with geographical separation. Conclusions People's happiness depends on the happiness of others with whom they are connected. This provides further justification for seeing happiness, like health, as a collective phenomenon.	[Christakis, Nicholas A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	Harvard University; Harvard University; University of California System; University of California San Diego	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Fowler, James H/C-2750-2008; Christakis, Nicholas A/C-3205-2009	Fowler, James H/0000-0001-7795-1638; 	NIH [R-01 AG24448, P-01 AG031093]; Robert Wood Johnson Foundation; NHLBI's Framingham Heart Study [N01-HC-25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024448, P01AG031093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NHLBI's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This was work was supported by NIH (R-01 AG24448, P-01 AG031093) and by the Pioneer Portfolio of the Robert Wood Johnson Foundation; NHLBI's Framingham Heart Study is supported by contract number N01-HC-25195. Neither author has a dependent relationship with any of the funding agencies.	BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; CAMPBELL KE, 1991, SOC NETWORKS, V13, P203, DOI 10.1016/0378-8733(91)90006-F; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Carrington PJ, 2005, MODELS METHODS SOCIA, V28; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; CLARK AE, 1994, ECON J, V104, P648, DOI 10.2307/2234639; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; Csikszentmihalyi M., 1991, FLOW PSYCHOL OPTIMAL; Dawber TR., 1980, FRAMINGHAM STUDY EPI, DOI DOI 10.4159/HARVARD.9780674492097; DEGARGINO JP, 2004, CHILDRENS HLTH ENV G; Delamothe T, 2005, BRIT MED J, V331, P1489, DOI 10.1136/bmj.331.7531.1489; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fowler JH, 2008, J HEALTH ECON, V27, P1400, DOI 10.1016/j.jhealeco.2008.07.001; Gardner J, 2007, J HEALTH ECON, V26, P49, DOI 10.1016/j.jhealeco.2006.08.004; Gervais M, 2005, Q REV BIOL, V80, P395, DOI 10.1086/498281; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Goodall J., 1968, ANIM BEHAV MONOGR, V1, P165; Graham C., 2006, J ECON INEQUAL, V4, P107, DOI [10.1007/s10888-005-9009-1, DOI 10.1007/S10888-005-9009-1, DOI 10.1007/s10888-005-9009-1]; Hatfield E., 1994, REV PERSONALITY SOCI; HOWES MJ, 1985, J PERS SOC PSYCHOL, V49, P1110, DOI 10.1037/0022-3514.49.4.1110; JOSEPH S, 1995, PSYCHOL REP, V76, P40, DOI 10.2466/pr0.1995.76.1.40; Kahneman D, 2006, SCIENCE, V312, P1908, DOI 10.1126/science.1129688; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Keltner D, 1997, J PERS SOC PSYCHOL, V73, P687, DOI 10.1037/0022-3514.73.4.687; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Larson R., 1994, DIVERGENT REALITIES; Laurenceau JP, 2005, J FAM PSYCHOL, V19, P86, DOI 10.1037/0893-3200.19.1.86; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lykken D, 1996, PSYCHOL SCI, V7, P186, DOI 10.1111/j.1467-9280.1996.tb00355.x; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Papa A, 2008, EMOTION, V8, P1, DOI 10.1037/1528-3542.8.1.1; Pescosolido BA, 1998, SOC SCI MED, V46, P275, DOI 10.1016/S0277-9536(97)00160-3; Pugh SD, 2001, ACAD MANAGE J, V44, P1018, DOI 10.2307/3069445; Ross N, 2005, J EPIDEMIOL COMMUN H, V59, P614, DOI 10.1136/jech.2004.031732; Schildcrout JS, 2005, BIOSTATISTICS, V6, P633, DOI 10.1093/biostatistics/kxi033; Scollon CN., 2003, J HAPPINESS STUD, V4, P5, DOI [10.1023/A:1023605205115, DOI 10.1023/A:1023605205115]; SHEEHAN TJ, 1995, J PERS ASSESS, V64, P507, DOI 10.1207/s15327752jpa6403_9; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Subramanian SV, 2005, J EPIDEMIOL COMMUN H, V59, P664, DOI 10.1136/jech.2004.025742; Surakka V, 1998, INT J PSYCHOPHYSIOL, V29, P23, DOI 10.1016/S0167-8760(97)00088-3; SZABO G, NETWORK EFFECTS SERV; THORSON JA, 1993, B PSYCHONOMIC SOC, V31, P577, DOI 10.3758/BF03337359; Tsai WC, 2002, J APPL PSYCHOL, V87, P1001, DOI 10.1037//0021-9010.87.5.1001; Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010; Wilson TD, 2003, SOC COGNITION, V21, P421, DOI 10.1521/soco.21.6.421.28688; ZAJONC RB, 1985, SCIENCE, V228, P15, DOI 10.1126/science.3883492; Zivin K, 2007, AM J GERIAT PSYCHIAT, V15, P772, DOI 10.1097/JGP.0b013e318050c9ae	59	913	933	8	209	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2008	337								a2338	10.1136/bmj.a2338	http://dx.doi.org/10.1136/bmj.a2338			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386NX	19056788	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000261891000003
J	Quintana, E; Shackleton, M; Sabel, MS; Fullen, DR; Johnson, TM; Morrison, SJ				Quintana, Elsa; Shackleton, Mark; Sabel, Michael S.; Fullen, Douglas R.; Johnson, Timothy M.; Morrison, Sean J.			Efficient tumour formation by single human melanoma cells	NATURE			English	Article							CANCER STEM-CELLS; ACUTE MYELOID-LEUKEMIA; NOD/SCID MICE; LYMPHOBLASTIC-LEUKEMIA; MALIGNANT-MELANOMA; BASEMENT-MEMBRANE; INITIATING CELLS; LIVER METASTASIS; PROGENITOR CELLS; CD122(+) CELLS	A fundamental question in cancer biology is whether cells with tumorigenic potential are common or rare within human cancers. Studies on diverse cancers, including melanoma, have indicated that only rare human cancer cells ( 0.1 - 0.0001%) form tumours when transplanted into non- obese diabetic/ severe combined immunodeficiency ( NOD/ SCID) mice. However, the extent to which NOD/ SCID mice underestimate the frequency of tumorigenic human cancer cells has been uncertain. Here we show that modified xenotransplantation assay conditions, including the use of more highly immunocompromised NOD/ SCID interleukin- 2 receptor gamma chain null (Il2rg(-/-)) mice, can increase the detection of tumorigenic melanoma cells by several orders of magnitude. In limiting dilution assays, approximately 25% of unselected melanoma cells from 12 different patients, including cells from primary and metastatic melanomas obtained directly from patients, formed tumours under these more permissive conditions. In single- cell transplants, an average of 27% of unselected melanoma cells from four different patients formed tumours. Modifications to xenotransplantation assays can therefore dramatically increase the detectable frequency of tumorigenic cells, demonstrating that they are common in some human cancers.	[Quintana, Elsa; Shackleton, Mark; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; [Quintana, Elsa; Shackleton, Mark; Morrison, Sean J.] Univ Michigan, Ctr Cell Biol, Ann Arbor, MI 48109 USA; [Sabel, Michael S.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Fullen, Douglas R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Johnson, Timothy M.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; Sabel, Michael S/A-7521-2009	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; Allen H. Blondy Research Fellowship; Lewis and Lillian Becker; University of Michigan Comprehensive Cancer Center; National Institutes of Health [CA46592]; University of Michigan Flow Cytometry Core Facility; N. McAnsh and the University of Michigan Cancer Centre Histology Core; National Institute of Diabetes, Digestive, and Kidney Diseases [NIH5P60- DK20572]; Michigan Diabetes Research and Training Center; Spanish Ministry of Education; Marie Curie Outgoing International Fellowship from the European Commission; Australian National Health and Medical Research Council; Human Frontiers Science Program and Australia Post; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Allen H. Blondy Research Fellowship; Lewis and Lillian Becker; University of Michigan Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Flow Cytometry Core Facility(University of Michigan System); N. McAnsh and the University of Michigan Cancer Centre Histology Core; National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Diabetes Research and Training Center; Spanish Ministry of Education(Spanish Government); Marie Curie Outgoing International Fellowship from the European Commission(European Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Human Frontiers Science Program and Australia Post(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Howard Hughes Medical Institute and by the Allen H. Blondy Research Fellowship. The University of Michigan Melanoma Bank was supported by a gift from Lewis and Lillian Becker. Flow cytometry was partly supported by the University of Michigan Comprehensive Cancer Center grant from the National Institutes of Health CA46592. We thank: D. Adams, M. White and the University of Michigan Flow Cytometry Core Facility for support; N. McAnsh and the University of Michigan Cancer Centre Histology Core for histological studies; G. K. Smyth for assistance with statistics; and Z. Azizan for support with tissue collection. Antibody production was supported in part by the National Institute of Diabetes, Digestive, and Kidney Diseases, grant NIH5P60- DK20572 to the Michigan Diabetes Research and Training Center. Some antibodies were provided by Caltag or by eBioscience to screen for cancer stem- cell markers. Human primary melanocyte cultures were provided by M. Soengas. Human mesenchymal stem cells were provided by Z. Wang and P. Krebsbach. E. Q. was supported by the Spanish Ministry of Education and the Marie Curie Outgoing International Fellowship from the European Commission. M. S. was supported by the Australian National Health and Medical Research Council, the Human Frontiers Science Program and Australia Post.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bancroft JD, 1990, THEORY PRACTICE HIST; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Cox CV, 2004, BLOOD, V104, P2919, DOI 10.1182/blood-2004-03-0901; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; FRIDMAN R, 1991, JNCI-J NATL CANCER I, V83, P769, DOI 10.1093/jnci/83.11.769; Hamada K, 2008, INT J ONCOL, V32, P153; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; NAKAJIMA T, 1982, CANCER, V50, P912, DOI 10.1002/1097-0142(19820901)50:5<912::AID-CNCR2820500519>3.0.CO;2-U; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; PRETLOW TG, 1991, CANCER RES, V51, P3814; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2003, EXP HEMATOL, V31, P551, DOI 10.1016/S0301-472X(03)00076-6; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Suemizu H, 2007, INT J ONCOL, V31, P741; SWEENEY TM, 1991, CANCER METAST REV, V10, P245, DOI 10.1007/BF00050795; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wang Z, 2006, STEM CELLS, V24, P1573, DOI 10.1634/stemcells.2005-0399; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	43	1350	1404	5	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					593	U33		10.1038/nature07567	http://dx.doi.org/10.1038/nature07567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052619	Green Accepted, Green Published			2022-12-28	WOS:000261340000031
J	Conen, D; Tedrow, UB; Cook, NR; Moorthy, MV; Buring, JE; Albert, CM				Conen, David; Tedrow, Usha B.; Cook, Nancy R.; Moorthy, M. V.; Buring, Julie E.; Albert, Christine M.			Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; ADRENERGIC ACTIVITY; PRIMARY PREVENTION; CARDIAC-RHYTHM; HEART-FAILURE; OLDER-ADULTS; FOLLOW-UP; HEALTH; MEN; DRINKING		[Conen, David] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland; [Conen, David; Tedrow, Usha B.; Moorthy, M. V.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Ctr Arrhythmia Prevent, Boston, MA USA; [Conen, David; Cook, Nancy R.; Moorthy, M. V.; Buring, Julie E.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA USA; [Tedrow, Usha B.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Boston, MA USA; [Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Aging, Boston, MA USA; [Cook, Nancy R.; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA	University of Basel; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Conen, D (corresponding author), Univ Basel Hosp, Div Cardiol, Petersgraben 4, CH-4031 Basel, Switzerland.	conend@uhbs.ch	Tedrow, Usha/AFV-2528-2022	Albert, Christine/0000-0002-2081-1121	Swiss National Science Foundation [PASMA 118586/1]; National Heart, Lung, and Blood Institute [HL-043851, HL-080467]; National Cancer Institute [CA-047988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Conen was supported by grant PASMA 118586/1 from the Swiss National Science Foundation. The Women's Health Study was supported by grants HL-043851 and HL-080467 from the National Heart, Lung, and Blood Institute and CA-047988 from the National Cancer Institute.	BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; COX DR, 1972, J R STAT SOC B, V34, P187; DENISON H, 1994, BRIT HEART J, V72, P554; Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004; Djousse L, 2007, CIRCULATION, V115, P34, DOI 10.1161/CIRCULATIONAHA.106.661868; ETTINGER PO, 1978, AM HEART J, V95, P555, DOI 10.1016/0002-8703(78)90296-X; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Gavazzi A, 2000, AM J CARDIOL, V85, P1114, DOI 10.1016/S0002-9149(00)00706-2; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; HANSAGI H, 1995, STROKE, V26, P1768, DOI 10.1161/01.STR.26.10.1768; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; KOSKINEN P, 1987, BRIT HEART J, V57, P468, DOI 10.1136/hrt.57.5.468; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lazarevic AM, 2000, J AM COLL CARDIOL, V35, P1599, DOI 10.1016/S0735-1097(00)00565-9; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Maki T, 1998, AM J CARDIOL, V82, P317, DOI 10.1016/S0002-9149(98)00299-9; Marcus GM, 2008, PACE, V31, P266, DOI 10.1111/j.1540-8159.2008.00985.x; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; Mukamal KJ, 2007, AM HEART J, V153, P260, DOI 10.1016/j.ahj.2006.10.039; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Psaty BM, 1997, CIRCULATION, V96, P2455; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; THORNTON JR, 1984, LANCET, V2, P1013; Tolstrup J, 2006, BMJ-BRIT MED J, V332, P1244, DOI 10.1136/bmj.38831.503113.7C; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Walsh CR, 2002, ANN INTERN MED, V136, P181, DOI 10.7326/0003-4819-136-3-200202050-00005; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054	32	144	143	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2489	2496		10.1001/jama.2008.755	http://dx.doi.org/10.1001/jama.2008.755			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050192	Green Accepted, Bronze			2022-12-28	WOS:000261286200017
J	Venkatachalam, K; Long, AA; Elsaesser, R; Nikolaeva, D; Broadie, K; Montell, C				Venkatachalam, Kartik; Long, A. Ashleigh; Elsaesser, Rebecca; Nikolaeva, Daria; Broadie, Kendal; Montell, Craig			Motor Deficit in a Drosophila Model of Mucolipidosis Type IV due to Defective Clearance of Apoptotic Cells	CELL			English	Article							RETINAL DEGENERATION; MEMBRANE-PROTEIN; DEATH; NEURODEGENERATION; MUTATIONS; AUTOPHAGY; IDENTIFICATION; SUPPRESSION; ENDOCYTOSIS; CROQUEMORT	Disruption of the Transient Receptor Potential (TRP) mucolipin 1 (TRPML1) channel results in the neurodegenerative disorder mucolipidosis type IV (MLIV), a lysosomal storage disease with severe motor impairments. The mechanisms underlying MLIV are poorly understood and there is no treatment. Here, we report a Drosophila MLIV model, which recapitulates the key disease features, including abnormal intracellular accumulation of macromolecules, motor defects, and neurodegeneration. The basis for the buildup of macromolecules was defective autophagy, which resulted in oxidative stress and impaired synaptic transmission. Late-apoptotic cells accumulated in trpml mutant brains, suggesting diminished cell clearance. The accumulation of late-apoptotic cells and motor deficits were suppressed by expression of trpml(+) in neurons, glia, or hematopoietic cells. We conclude that the neurodegeneration and motor defects result primarily from decreased clearance of apoptotic cells. Since hematopoietic cells in humans are involved in clearance of apoptotic cells, our results raise the possibility that bone marrow transplantation may limit the progression of MLIV.	[Venkatachalam, Kartik; Elsaesser, Rebecca; Nikolaeva, Daria; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Venkatachalam, Kartik; Elsaesser, Rebecca; Nikolaeva, Daria; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA; [Long, A. Ashleigh; Broadie, Kendal] Vanderbilt Univ, Vanderbilt Brain Inst, Kennedy Ctr Res Human Dev, Dept Biol Sci, Nashville, TN 37232 USA	Johns Hopkins University; Johns Hopkins University; Vanderbilt University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Long, Ashleigh/AAE-7365-2022; Montell, Craig/AAH-3357-2021	Long, Ashleigh/0000-0002-0190-6707; Montell, Craig/0000-0001-5637-1482	MLIV Foundation; National Institute of Neurological Disorders and Stroke [NS41740]; March of Dimes; National Eye Institute [EY08117]; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041740] Funding Source: NIH RePORTER	MLIV Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); March of Dimes(March of Dimes); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Bloomington Stock Center for fly stocks, T. Neufeld for the hsGFP-ATG8 flies, N. Franc for the UAS-crq flies, J. Corden, J. Lorsch, R. Rao, and S. Muend for use of equipment, and M. Sepanski for preparing sections of fly heads. We thank S. J. Moon, Y. Jiao, and X. Wang for technical advice, and M. Kottgen, Y. Kwon, and D. Wasserman for helpful discussions. We also thank the Microscopy Facility at the Cell Biology Department, the Johns Hopkins University School of Medicine, for use of their equipment. K. V. was supported in part by an MLIV Foundation postdoctoral fellowship. The work in the K. B. laboratory was supported by the National Institute of Neurological Disorders and Stroke (NS41740), and that in the C. M. laboratory was supported by grants from the March of Dimes and the National Eye Institute (EY08117). The authors declare no conflicts of interest.	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Badre NH, 2005, COMP BIOCHEM PHYS A, V140, P363, DOI 10.1016/j.cbpb.2005.01.019; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Brunell AB, 2007, J SOC CLIN PSYCHOL, V26, P92, DOI 10.1521/jscp.2007.26.1.92; Cooper JD, 2003, CURR OPIN NEUROL, V16, P121, DOI 10.1097/00019052-200304000-00001; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Fergestad T, 2001, J NEUROSCI, V21, P1218; FLETCHER BL, 1973, ANAL BIOCHEM, V52, P1, DOI 10.1016/0003-2697(73)90327-8; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; GOLDIN E, 1995, PEDIATR RES, V37, P687, DOI 10.1203/00006450-199506000-00003; Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Lee CY, 2001, DEVELOPMENT, V128, P1443; Li J, 2000, CELL BIOL INT, V24, P9, DOI 10.1006/cbir.1999.0438; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Menoret A, 2002, INT J HYPERTHER, V18, P490, DOI 10.1080/02656730210146926; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Pang Z, 1997, J NEUROSCI, V17, P3064; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Trotta N, 2004, J NEUROBIOL, V60, P328, DOI 10.1002/neu.20017; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112	52	169	171	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					838	851		10.1016/j.cell.2008.09.041	http://dx.doi.org/10.1016/j.cell.2008.09.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041749	Green Accepted, Bronze			2022-12-28	WOS:000261183900016
J	Venters, HD				Venters, Homer Drae			Who is Jack Bauer?	LANCET			English	Editorial Material									[Venters, Homer Drae] NYU, New York, NY 10016 USA	New York University	Venters, HD (corresponding author), NYU, 550 1St Ave, New York, NY 10016 USA.	homer.venters@med.nyu.edu						Abed RT, 2005, BRIT MED BULL, V72, P1, DOI 10.1093/bmb/ldh037; Brecher Robert, 2007, TORTURE TICKING BOMB; British Medical Association, 1992, MED BETR PART DOCT H; BUDIANSKY S, 2005, ATLANTIC MONTHLY JUN, P32; Fischer David Hackett, 2004, WASHINGTONS CROSSING; Jones Adam, 2004, GENOCIDE WAR CRIMES; McCoy A., 2006, QUESTION TORTURE CIA; NAGOURNEY A, 2007, NY TIMES        0627, pA1; *US INT SCI BOARD, 2006, ED INF INT SCI ART F; WORSNIP P, 2008, INT HERALD TRIB 0626; Yawar A, 2004, J ROY SOC MED, V97, P366, DOI 10.1258/jrsm.97.8.366	11	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1924	1925		10.1016/S0140-6736(08)61810-3	http://dx.doi.org/10.1016/S0140-6736(08)61810-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	379IA	19041800				2022-12-28	WOS:000261388700027
J	Aragon, T; van Anken, E; Pincus, D; Serafimova, IM; Korennykh, AV; Rubio, CA; Walter, P				Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter			Messenger RNA targeting to endoplasmic reticulum stress signalling sites	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; TRANSLATION; YEAST; KINASE; LOCALIZATION; DEGRADATION; EXPRESSION; MECHANISM; TRANSPORT	Deficiencies in the protein- folding capacity of the endoplasmic reticulum (ER) in all eukaryotic cells lead to ER stress and trigger the unfolded protein response (UPR)(1-3). ER stress is sensed by Ire1, a transmembrane kinase/ endoribonuclease, which initiates the non- conventional splicing of the messenger RNA encoding a key transcription activator, Hac1 in yeast or XBP1 in metazoans. In the absence of ER stress, ribosomes are stalled on unspliced HAC1 mRNA. The translational control is imposed by a base- pairing interaction between the HAC1 intron and the HAC1 5' untranslated region(4). After excision of the intron, transfer RNA ligase joins the severed exons(5,6), lifting the translational block and allowing synthesis of Hac1 from the spliced HAC1 mRNA to ensue(4). Hac1 in turn drives the UPR gene expression program comprising 7-8% of the yeast genome(7) to counteract ER stress. Here we show that, on activation, Ire1 molecules cluster in the ER membrane into discrete foci of higher- order oligomers, to which unspliced HAC1 mRNA is recruited by means of a conserved bipartite targeting element contained in the 3' untranslated region. Disruption of either Ire1 clustering or HAC1 mRNA recruitment impairs UPR signalling. The HAC1 3' untranslated region element is sufficient to target other mRNAs to Ire1 foci, as long as their translation is repressed. Translational repression afforded by the intron fulfils this requirement for HAC1 mRNA. Recruitment of mRNA to signalling centres provides a new paradigm for the control of eukaryotic gene expression.	[Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Aragon, T (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	Tomas.Aragon@ucsf.edu	van Anken, Eelco/AAN-9015-2020; Aragon, Tomas/ABH-4616-2020; Longo, Kenneth A/A-5631-2010	Aragon, Tomas/0000-0002-1700-2729; van Anken, Eelco/0000-0001-9529-2701	Basque Foundation for Science; Howard Hughes Medical Institute; Netherlands Organization for Scientific Research (NWO); National Science Foundation; President's Dissertation Year Fellowship; Jane Childs Memorial Fund for Medical Research	Basque Foundation for Science; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); President's Dissertation Year Fellowship; Jane Childs Memorial Fund for Medical Research	We thank M. Jonikas and B. Kornmann for their help with the MatLab scripts; R. Parker for the pPS2037 and pRP1187 plasmids; K. Thorn for the pKT127 plasmid and for his assistance with microscopy at the Nikon Imaging Center at UCSF; and C. Guthrie, R. Andino, J. Gross and members of the Walter laboratory for discussion and comments on the manuscript. T. A. was supported by the Basque Foundation for Science and the Howard Hughes Medical Institute; E. v. A. by the Netherlands Organization for Scientific Research (NWO); D. P. and C. A. R. by the National Science Foundation; C.A.R. by the President's Dissertation Year Fellowship; and A.V.K. by the Jane Childs Memorial Fund for Medical Research. P. W. is an Investigator of the Howard Hughes Medical Institute.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Choi SB, 2000, NATURE, V407, P765, DOI 10.1038/35037633; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Guthrie C., 2002, GUIDE YEAST GENETICS; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MADDOCK JR, 1993, SCIENCE, V259, P1717; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pollock R, 1999, METHOD ENZYMOL, V306, P263; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352	33	229	249	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2009	457	7230					736	U9		10.1038/nature07641	http://dx.doi.org/10.1038/nature07641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079237	Green Accepted, Green Submitted			2022-12-28	WOS:000263064700044
J	Aynsley-Green, A; Hall, D				Aynsley-Green, Albert; Hall, David			Safeguarding children: a call to action	LANCET			English	Editorial Material									[Hall, David] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7700 Cape Town, South Africa; [Aynsley-Green, Albert] 11MILLION, London, England	University of Cape Town	Hall, D (corresponding author), Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7700 Cape Town, South Africa.	David.Hall@uct.ac.za						Andersson N, 2004, BMJ-BRIT MED J, V329, P952, DOI 10.1136/bmj.38226.617454.7C; Coulton CJ, 1999, CHILD ABUSE NEGLECT, V23, P1019, DOI 10.1016/S0145-2134(99)00076-9; Frick PJ, 2008, J CHILD PSYCHOL PSYC, V49, P359, DOI 10.1111/j.1469-7610.2007.01862.x; Goldstein S., 2004, HLTH PROMOTION J AUS, V15, P114, DOI [10.1071/HE04114, DOI 10.1071/HE04114]; Guillebaud J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.39575.691343.80; JARFVIS H, 1999, TALKING RIGHTS TAKIN; MACMILLAN HL, 2008, LANCET          1203, DOI [DOI 10.1016/S0140-6736(08)61708-0, 10.1016/S0140-6736(21)02844-0, DOI 10.1016/S0140-6736(21)02844-0]; Olds David L, 2002, Prev Sci, V3, P153, DOI 10.1023/A:1019990432161; READING R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61709-2; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; United Nations, 2006, REP IND EXP UN STUD	11	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					280	281		10.1016/S0140-6736(08)61705-5	http://dx.doi.org/10.1016/S0140-6736(08)61705-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19056118				2022-12-28	WOS:000262728100008
J	Gaziano, JM; Glynn, RJ; Christen, WG; Kurth, T; Belanger, C; MacFadyen, J; Bubes, V; Manson, JE; Sesso, HD; Buring, JE				Gaziano, J. Michael; Glynn, Robert J.; Christen, William G.; Kurth, Tobias; Belanger, Charlene; MacFadyen, Jean; Bubes, Vadim; Manson, Joann E.; Sesso, Howard D.; Buring, Julie E.			Vitamins E and C in the Prevention of Prostate and Total Cancer in Men The Physicians' Health Study II Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BETA-CAROTENE SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; ALPHA-TOCOPHEROL; ANTIOXIDANT VITAMINS; COLORECTAL-CANCER; MORTALITY; SELENIUM; RISK	Context Many individuals take vitamins in the hopes of preventing chronic diseases such as cancer, and vitamins E and C are among the most common individual supplements. A large- scale randomized trial suggested that vitamin E may reduce risk of prostate cancer; however, few trials have been powered to address this relationship. No previous trial in men at usual risk has examined vitamin C alone in the prevention of cancer. Objective To evaluate whether long- term vitamin E or C supplementation decreases risk of prostate and total cancer events among men. Design, Setting, and Participants The Physicians' Health Study II is a randomized, double- blind, placebo- controlled factorial trial of vitamins E and C that began in 1997 and continued until its scheduled completion on August 31, 2007. A total of 14 641 male physicians in the United States initially aged 50 years or older, including 1307 men with a history of prior cancer at randomization, were enrolled. Intervention Individual supplements of 400 IU of vitamin E every other day and 500 mg of vitamin C daily. Main Outcome Measures Prostate and total cancer. Results During a mean follow- up of 8.0 years, there were 1008 confirmed incident cases of prostate cancer and 1943 total cancers. Compared with placebo, vitamin E had no effect on the incidence of prostate cancer ( active and placebo vitamin E groups, 9.1 and 9.5 events per 1000 person- years; hazard ratio [ HR], 0.97; 95% confidence interval [ CI], 0.85- 1.09; P=. 58) or total cancer ( active and placebo vitamin E groups, 17.8 and 17.3 cases per 1000 person- years; HR, 1.04; 95% CI, 0.95- 1.13; P=. 41). There was also no significant effect of vitamin C on total cancer ( active and placebo vitamin C groups, 17.6 and 17.5 events per 1000 person- years; HR, 1.01; 95% CI, 0.92- 1.10; P=. 86) or prostate cancer ( active and placebo vitamin C groups, 9.4 and 9.2 cases per 1000 person- years; HR, 1.02; 95% CI, 0.90- 1.15; P=. 80). Neither vitamin E nor vitamin C had a significant effect on colorectal, lung, or other site- specific cancers. Adjustment for adherence and exclusion of the first 4 or 6 years of follow- up did not alter the results. Stratification by various cancer risk factors demonstrated no significant modification of the effect of vitamin E on prostate cancer risk or either agent on total cancer risk. Conclusions In this large, long- term trial of male physicians, neither vitamin E nor C supplementation reduced the risk of prostate or total cancer. These data provide no support for the use of these supplements for the prevention of cancer in middle- aged and older men. Trial Registration clinicaltrials. gov Identifier: NCT00270647.	[Gaziano, J. Michael; Glynn, Robert J.; Christen, William G.; Kurth, Tobias; Belanger, Charlene; MacFadyen, Jean; Bubes, Vadim; Manson, Joann E.; Sesso, Howard D.; Buring, Julie E.] Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02120 USA; [Gaziano, J. Michael; Kurth, Tobias; Sesso, Howard D.; Buring, Julie E.] Brigham & Womens Hosp, Div Aging, Dept Med, Boston, MA 02120 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Cardiovasc Dis, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; [Glynn, Robert J.; Kurth, Tobias; Manson, Joann E.; Sesso, Howard D.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Gaziano, JM (corresponding author), Brigham & Womens Hosp, Div Prevent Med, Dept Med, 1620 Tremont St, Boston, MA 02120 USA.	jmgaziano@partners.org	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620	National Institutes of Health (Bethesda, Maryland) [CA 97193, CA 34944, CA 40360, HL 26490, HL 34595]; BASF Corporation (Florham Park, New Jersey); NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF Corporation (Florham Park, New Jersey)(BASF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants CA 97193, CA 34944, CA 40360, HL 26490, and HL 34595 from the National Institutes of Health (Bethesda, Maryland) and an investigator-initiated grant from BASF Corporation (Florham Park, New Jersey). Study agents and packaging were provided by BASF Corporation, Wyeth Pharmaceuticals (Madison, New Jersey), and DSM Nutritional Products Inc (formerly Roche Vitamins) (Parsippany, New Jersey).	Albanes D, 2000, CANCER CAUSE CONTROL, V11, P197, DOI 10.1023/A:1008936214087; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; BLOCK G, 1991, AM J CLIN NUTR, V53, pS270, DOI 10.1093/ajcn/53.1.270S; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; BYERS T, 1995, AM J CLIN NUTR, V62, P1385, DOI 10.1093/ajcn/62.6.1385S; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Dusinska M, 2003, MUTAGENESIS, V18, P371, DOI 10.1093/mutage/geg002; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; HEILBRUN LK, 1989, INT J CANCER, V44, P1, DOI 10.1002/ijc.2910440102; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Helzlsouer KJ, 2000, J NATL CANCER I, V92, P2018, DOI 10.1093/jnci/92.24.2018; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; HOWE GR, 1990, JNCI-J NATL CANCER I, V82, P561, DOI 10.1093/jnci/82.7.561; Klein EA, 2000, PROSTATE CANCER P D, V3, P145, DOI 10.1038/sj.pcan.4500412; KNEKT P, 1991, AM J EPIDEMIOL, V134, P471, DOI 10.1093/oxfordjournals.aje.a116118; KROMHOUT D, 1987, AM J CLIN NUTR, V45, P1361, DOI 10.1093/ajcn/45.5.1361; LANG JM, 1991, STAT MED, V10, P1585, DOI 10.1002/sim.4780101010; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; LONN E, 2005, JAMA-J AM MED ASSOC, V293, P1138; Manson Joann E., 1995, Annals of Epidemiology, V5, P261, DOI 10.1016/1047-2797(94)00091-7; MCKEOWNEYSSEN G, 1988, CANCER RES, V48, P4701; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Virtamo J, 2003, JAMA-J AM MED ASSOC, V290, P476, DOI 10.1001/jama.290.4.476; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	34	347	365	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					52	62		10.1001/jama.2008.862	http://dx.doi.org/10.1001/jama.2008.862			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19066368	Bronze, Green Accepted			2022-12-28	WOS:000262220400020
J	Hegde, D; Mowery, DC				Hegde, Deepak; Mowery, David C.			RESEARCH FUNDING Politics and Funding in the U. S. Public Biomedical R&D System	SCIENCE			English	Editorial Material									[Hegde, Deepak; Mowery, David C.] Univ Calif Berkeley, Walter A Haas Sch Business, Berkeley, CA 94720 USA; [Mowery, David C.] Natl Bur Econ Res, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; National Bureau of Economic Research	Hegde, D (corresponding author), Univ Calif Berkeley, Walter A Haas Sch Business, 350 Barrows Hall, Berkeley, CA 94720 USA.	hegde@haas.berkeley.edu						*AAAS, 2008, HIST DAT FED R D FY; Fenno R.F, 1965, POWER PURSE APPROPRI; HEGDE D, J LAW EC IN PRESS; *NAT SCI FDN DIV S, 2006, SURV RES DEV EXP U C; *NIH, 2007, ACT COD ORG COD DEF	5	25	25	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1797	1798		10.1126/science.1158562	http://dx.doi.org/10.1126/science.1158562			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	385FF	19095928				2022-12-28	WOS:000261799400039
J	Preker, P; Nielsen, J; Kammler, S; Lykke-Andersen, S; Christensen, MS; Mapendano, CK; Schierup, MH; Jensen, TH				Preker, Pascal; Nielsen, Jesper; Kammler, Susanne; Lykke-Andersen, Soren; Christensen, Marianne S.; Mapendano, Christophe K.; Schierup, Mikkel H.; Jensen, Torben Heick			RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters	SCIENCE			English	Article							HUMAN GENOME; DNA DEMETHYLATION; POLYMERASE; CHROMATIN; HISTORY; ENCODE; WIDE	Studies have shown that the bulk of eukaryotic genomes is transcribed. Transcriptome maps are frequently updated, but low- abundant transcripts have probably gone unnoticed. To eliminate RNA degradation, we depleted the exonucleolytic RNA exosome from human cells and then subjected the RNA to tiling microarray analysis. This revealed a class of short, polyadenylated and highly unstable RNAs. These promoter upstream transcripts ( PROMPTs) are produced similar to 0.5 to 2.5 kilobases upstream of active transcription start sites. PROMPT transcription occurs in both sense and antisense directions with respect to the downstream gene. In addition, it requires the presence of the gene promoter and is positively correlated with gene activity. We propose that PROMPT transcription is a common characteristic of RNA polymerase II ( RNAPII) transcribed genes with a possible regulatory potential.	[Preker, Pascal; Kammler, Susanne; Lykke-Andersen, Soren; Christensen, Marianne S.; Mapendano, Christophe K.; Jensen, Torben Heick] Univ Aarhus, Ctr mRNP Biogenesis & Metab, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Nielsen, Jesper; Schierup, Mikkel H.] Univ Aarhus, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Jensen, TH (corresponding author), Univ Aarhus, Ctr mRNP Biogenesis & Metab, Dept Mol Biol, CF Mollers Alle,Bldg 1130, DK-8000 Aarhus C, Denmark.	thj@mb.au.dk	Lykke-Andersen, Søren/B-1553-2013; Jensen, Torben H/G-2954-2017; Schierup, Mikkel H/F-1675-2010; Schierup, Mikkel Heide/AAM-4997-2020	Schierup, Mikkel H/0000-0002-5028-1790; Schierup, Mikkel Heide/0000-0002-5028-1790; Lykke-Andersen, Soren/0000-0001-9357-2910; Jensen, Torben Heick/0000-0001-5127-1239	Danish National Research Foundation; Danish Natural Science Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council(Danish Natural Science Research Council)	We thank G. Pruijn for antibodies, D. Libri, A. Sandelin, and D. Schubeler for comments on the manuscript, and D. Riishoj and K. Jorgensen for technical assistance. This work was supported by the Danish National Research Foundation and the Danish Natural Science Research Council. Microarray data have been submitted to gene expression omnibus (GEO) at the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/) under accession number GSE12431.	Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	13	541	565	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1851	1854		10.1126/science.1164096	http://dx.doi.org/10.1126/science.1164096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056938				2022-12-28	WOS:000261799400057
J	Prum, RO				Prum, Richard O.			EVOLUTION Who's Your Daddy?	SCIENCE			English	Editorial Material							PARENTAL-CARE; ORIGIN; DINOSAUR; BIRDS		[Prum, Richard O.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Prum, Richard O.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA	Yale University; Yale University	Prum, RO (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, POB 208105, New Haven, CT 06520 USA.	richard.prum@yale.edu		Prum, Richard/0000-0002-4741-7132				Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; DAVIES SJJ, 2001, RATITES TINAMOUS; Ligon JD, 1999, EVOLUTION AVIAN BREE; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Prum RO, 2002, AUK, V119, P1, DOI 10.1642/0004-8038(2002)119[0001:WOSCAT]2.0.CO;2; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; Tullberg BS, 2002, PHILOS T R SOC B, V357, P251, DOI 10.1098/rstb.2001.0932; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; Wesolowski T, 2004, BEHAV ECOL, V15, P520, DOI 10.1093/beheco/arh039; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342	16	7	7	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1799	1800		10.1126/science.1168808	http://dx.doi.org/10.1126/science.1168808			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095929				2022-12-28	WOS:000261799400040
J	Lieske, B				Lieske, B.			The left handed surgical trainee	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lieske, B.] Royal Berkshire Hosp NHS Fdn Trust, Reading RG1 5AN, Berks, England	Royal Berkshire Hospital	Lieske, B (corresponding author), Royal Berkshire Hosp NHS Fdn Trust, Reading RG1 5AN, Berks, England.	Bettina_Lieske@yahoo.co.uk						Adusumilli Prasad S, 2004, Curr Surg, V61, P587, DOI 10.1016/j.cursur.2004.05.022; McManus C, 2003, RIGHT HAND LEFT HAND; SCHOTT J, 1995, BRIT MED J, V310, P739, DOI 10.1136/bmj.310.6981.739b	3	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2883	10.1136/bmj.a2883	http://dx.doi.org/10.1136/bmj.a2883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088142				2022-12-28	WOS:000262184900005
J	Bache, S; Edenborough, F				Bache, Sarah; Edenborough, Frank			A symphony of maladies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WIND INSTRUMENT PLAYERS; EMBOUCHURE DYSTONIA; MUSICIANS DYSTONIA; BRASS MUSICIANS; FOCAL DYSTONIA; PREVALENCE; HAND; DERMATITIS; FLAUTISTS; PRESSURE		[Bache, Sarah; Edenborough, Frank] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Bache, S (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.	sarahbache@doctors.org.uk						Aydin P, 2000, J GLAUCOMA, V9, P322; Bejjani FJ, 1996, ARCH PHYS MED REHAB, V77, P406, DOI 10.1016/S0003-9993(96)90093-3; BRAMLEY S, 2004, STAGE NEWS      0601; Byl NN, 2003, ARCH PHYS MED REHAB, V84, P1505, DOI 10.1016/S0003-9993(03)00276-4; Chesky KS, 2000, J OCCUP ENVIRON MED, V42, P775, DOI 10.1097/00043764-200008000-00001; COUGHLAN S, 2007, BBC NEWS        0515; CURTIS P, 1974, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.5912.226-a; DAHL MGC, 1978, BRIT MED J, V2, P1023, DOI 10.1136/bmj.2.6143.1023; David S, 1997, AM J EMERG MED, V15, P73, DOI 10.1016/S0735-6757(97)90054-1; Dawson WJ, 1997, MED PROBL PERFORM AR, V12, P107; Deniz O, 2006, ARCH MED RES, V37, P506, DOI 10.1016/j.arcmed.2005.09.015; Elghozi JL, 2008, CLIN AUTON RES, V18, P96, DOI 10.1007/s10286-008-0462-3; Evers S, 2000, NEUROLOGY, V55, P865, DOI 10.1212/WNL.55.6.865; EVERS S, 1998, NEUROLOGY, V104, P1203; Fetter D, 1993, Md Med J, V42, P289; Foxman Irina, 2006, AAOHN J, V54, P309; Frucht SJ, 2001, MOVEMENT DISORD, V16, P899, DOI 10.1002/mds.1167; Fry HJH, 1998, NEUROLOGY, V51, P512, DOI 10.1212/WNL.51.2.512; Gambichler T, 2008, CONTACT DERMATITIS, V58, P217, DOI 10.1111/j.1600-0536.2007.01310.x; Gambichler Thilo, 2004, BMC Dermatol, V4, P3, DOI 10.1186/1471-5945-4-3; Gilbert T B, 1998, Md Med J, V47, P23; HANSFORD R, 2007, BMJ CAREERS, V335, P159; Hirata Y, 2004, NEUROREPORT, V15, P815, DOI 10.1097/00001756-200404090-00015; Inesta C., 2008, J OCCUP MED TOXICOL, V3, P16, DOI [10.1186/1745-6673-3-16, DOI 10.1186/1745-6673-3-16]; Inoue A, 1998, CONTACT DERMATITIS, V39, P37, DOI 10.1111/j.1600-0536.1998.tb05816.x; Isaacson G, 2000, Ear Nose Throat J, V79, P272; Jabusch HC, 2005, MOVEMENT DISORD, V20, P1623, DOI 10.1002/mds.20631; Jabusch HC, 2006, ADV COGN PSYCHOL, P207, DOI DOI 10.2478/V10053-008-0056-6; Klotz DA, 2001, LARYNGOSCOPE, V111, P2157, DOI 10.1097/00005537-200112000-00015; Koppejan S, 2006, ERGONOMICS, V49, P316, DOI 10.1080/00140130500436213; Kumar G, 1998, BRIT J RADIOL, V71, P799, DOI 10.1259/bjr.71.847.9771394; Liu S, 2002, SOUTH MED J, V95, P727; Lombardi C, 2003, Eur Ann Allergy Clin Immunol, V35, P52; Lozano FJR, 2008, MED PROBL PERFORM AR, V23, P12; LUCIA R, 1994, J ASTHMA, V31, P375, DOI 10.3109/02770909409061317; Malick D, 2007, CLEFT PALATE-CRAN J, V44, P424, DOI 10.1597/06-176.1; MANDELL HN, 1962, NEW ENGL J MED, V266, P348, DOI 10.1056/NEJM196202152660708; MARSHMAN G, 1992, CONTACT DERMATITIS, V26, P134, DOI 10.1111/j.1600-0536.1992.tb00902.x; MENCIMER S, 2003, WASHINGTON POST 0325; Morais D, 2007, ACTA OTORRINOLAR ESP, V58, P401, DOI 10.1016/S0001-6519(07)74956-7; Moreno J C, 1997, Am J Contact Dermat, V8, P39, DOI 10.1016/S1046-199X(97)90035-X; MULCAHY D, 1990, BRIT HEART J, V64, P388; Murphy J, 1999, CONTACT DERMATITIS, V40, P334, DOI 10.1111/j.1600-0536.1999.tb06092.x; MURPHY JM, 1974, BMJ-BRIT MED J, V2, P335, DOI 10.1136/bmj.2.5914.335-a; Nakamura M, 1999, CONTACT DERMATITIS, V40, P219, DOI 10.1111/j.1600-0536.1999.tb06044.x; NIZET PM, 1976, J ELECTROCARDIOL, V9, P51, DOI 10.1016/S0022-0736(76)80010-6; Papsin BC, 1996, LARYNGOSCOPE, V106, P757, DOI 10.1097/00005537-199606000-00017; PETERS C, NOISE HEARING LOSS M; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Sakai N, 2002, MED PROBL PERFORM AR, V17, P178; SCHAFERCRANE G, 2006, PHYS MED REH CLIN N, V17, P827; Schuele S, 2005, NEUROLOGY, V64, P341, DOI 10.1212/01.WNL.0000149768.36634.92; Schuele S, 2004, MOVEMENT DISORD, V19, P43, DOI 10.1002/mds.10647; Schuman JS, 2001, OPHTHALMOLOGY, V108, P635, DOI 10.1016/S0161-6420(00)00559-5; SHARIPO P, 1991, J AM ACAD DERMATOL, V24, P665; SOLOMON JW, 2007, GUITAR REV, V133, P2; Stasney CR, 2003, MED PROBL PERFORM AR, V18, P153; Sternbach D, 1993, Md Med J, V42, P283; TADDEY JJ, 1992, CRANIO, V10, P241, DOI 10.1080/08869634.1992.11677916; Thayer JF, 2000, BIOMED SCI INSTRUM, V395, P301; Yeo DKL, 2002, AUST DENT J, V47, P2, DOI 10.1111/j.1834-7819.2002.tb00296.x; 1990, ART HAZARDS NEWS, V13	62	6	6	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2008	337								a2646	10.1136/bmj.a2646	http://dx.doi.org/10.1136/bmj.a2646			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CC	19074561				2022-12-28	WOS:000262777000001
J	Barbash, DA				Barbash, Daniel A.			Clash of the Genomes	CELL			English	Editorial Material							DROSOPHILA; HYBRIDS; SYSTEM	Full-genome sequences of multiple yeast species offer exciting possibilities for the functional analysis of yeast evolution and speciation. Lee et al. ( 2008) now report that hybrid sterility between two yeast species is caused by incompatibility between a nuclear-encoded mitochondrial regulatory protein and its mitochondrial-encoded target gene.	Cornell Univ, Dept Genet & Mol Biol, Ithaca, NY 14853 USA	Cornell University	Barbash, DA (corresponding author), Cornell Univ, Dept Genet & Mol Biol, 401 Biotechnol Bldg, Ithaca, NY 14853 USA.	dab87@cornell.edu			NIGMS NIH HHS [R01 GM074737] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074737] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Costanzo MC, 2000, GENETICS, V154, P999; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Greig D, 2009, HEREDITY, V102, P39, DOI 10.1038/hdy.2008.73; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698; Rawson PD, 2002, P NATL ACAD SCI USA, V99, P12955, DOI 10.1073/pnas.202335899; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x	9	3	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1002	1003		10.1016/j.cell.2008.11.019	http://dx.doi.org/10.1016/j.cell.2008.11.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070568	Bronze			2022-12-28	WOS:000261642800013
J	Grirrane, A; Corma, A; Garcia, H				Grirrane, Abdessamad; Corma, Avelino; Garcia, Hermenegildo			Gold-Catalyzed Synthesis of Aromatic Azo Compounds from Anilines and Nitroaromatics	SCIENCE			English	Article							STILBENE AMINE EXCIPLEXES; CATION RADICAL FORMATION; NITRO-COMPOUNDS; SUPPORTED GOLD; OXIDATION; MOLECULE; ALCOHOLS	The selective formation of aromatic azo compounds at preparative or industrial levels requires stoichiometric amounts of environmentally unfriendly transition metals or nitrites. Here, we show that gold nanoparticles supported on titanium dioxide (TiO(2)) and nanoparticulated cerium dioxide (CeO(2)) catalyze the aerobic oxidation of aromatic anilines to aromatic azo compounds with yields above 98% under mild reaction conditions. Gold on TiO(2) can also act as a reductive catalyst to access the compound directly from nitroaromatics through a two- step, one- pot reaction. The catalytic process shows promise for efficient synthesis of symmetric aromatic azo compounds, and even a range of asymmetric aromatic azo compounds.	[Grirrane, Abdessamad; Corma, Avelino; Garcia, Hermenegildo] Univ Politecn Valencia, Inst Tecnol Quim, CSIC, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Corma, A (corresponding author), Univ Politecn Valencia, Inst Tecnol Quim, CSIC, Valencia 46022, Spain.	acorma@itq.upv.es; hgarcia@qim.upv.es	Grirrane, Abdessamad/G-9792-2015; Garcia, Hermenegildo/E-3296-2010; CANOS, AVELINO CORMA/A-3040-2013	Grirrane, Abdessamad/0000-0001-5388-3554; Garcia, Hermenegildo/0000-0002-9664-493X; CANOS, AVELINO CORMA/0000-0002-2232-3527	Spanish DGI [MAT06-14274C02-01, CTQ2006-0658]	Spanish DGI(Spanish Government)	Financial support by the Spanish DGI (MAT06-14274C02-01 and CTQ2006-0658) is gratefully acknowledged. A. G. thanks the Spanish CSIC for a JAE research associate contract. A patent covering the use of these catalysts for the aerobic synthesis of benzenes has been filed at the Spanish Patent Office.	Abad A, 2005, ANGEW CHEM INT EDIT, V44, P4066, DOI 10.1002/anie.200500382; Brede O, 2005, J PHYS CHEM A, V109, P8081, DOI 10.1021/jp053172x; Carrettin S, 2007, CHEM-EUR J, V13, P7771, DOI 10.1002/chem.200700472; Catino S. C, 1985, CONCISE ENCY CHEM TE; Clark JH., 1995, CHEM WASTE MINIMIZAT; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Dabbagh HA, 2007, DYES PIGMENTS, V73, P239, DOI 10.1016/j.dyepig.2005.12.002; Egli R., 1991, COLOUR CHEM DESIGN S; Enache DI, 2006, SCIENCE, V311, P362, DOI 10.1126/science.1120560; FIROUZABADI H, 1983, B CHEM SOC JPN, V56, P914, DOI 10.1246/bcsj.56.914; GONTIER S, 1994, APPL CATAL A-GEN, V118, P173, DOI 10.1016/0926-860X(94)80312-9; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; HUB W, 1983, J PHYS CHEM-US, V87, P4351, DOI 10.1021/j100245a005; HUB W, 1984, J AM CHEM SOC, V106, P701, DOI 10.1021/ja00315a040; Lamy-Pitara E, 1999, J MOL CATAL A-CHEM, V142, P39, DOI 10.1016/S1381-1169(98)00273-8; OHE K, 1989, J ORG CHEM, V54, P4169, DOI 10.1021/jo00278a034; OSUKA A, 1983, CHEM LETT, P1373, DOI 10.1246/cl.1983.1373; Oyama M, 2003, INDIAN J CHEM A, V42, P733; Scaiano JC, 1997, TETRAHEDRON LETT, V38, P5929, DOI 10.1016/S0040-4039(97)01324-5; SMITH MB, 2001, ADV ORGANIC CHEM, V1; Venkataraman K., 1970, CHEM SYNTHETIC DYES	21	544	552	10	384	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1661	1664		10.1126/science.1166401	http://dx.doi.org/10.1126/science.1166401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	382LU	19074342				2022-12-28	WOS:000261608300036
J	von Braun, J				von Braun, Joachim			The food crisis isn't over	NATURE			English	Editorial Material									Int Food Policy Res Inst, Washington, DC 20036 USA	CGIAR; International Food Policy Research Institute (IFPRI)	von Braun, J (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	j.vonbraun@cgiar.org	von Braun, Joachim/AAA-7044-2020	von Braun, Joachim/0000-0001-6571-4838				BEINTEMA NM, 2008, MEASURING AGR RES IN; Fan SG, 2008, AGR ECON-BLACKWELL, V39, P163, DOI 10.1111/j.1574-0862.2008.00328.x; *FAO, 2008, HUNG RIS SOAR PRIC A; von Braun J., 2008, FOOD FINANCIAL CRISE; VONBRAUN J, 2008, 4 IFPRI; *WORLD BANK, 2007, WORLD DEV REP 2008 A	6	46	47	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					701	701		10.1038/456701a	http://dx.doi.org/10.1038/456701a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TX	19079033	Bronze			2022-12-28	WOS:000261559900019
J	Sabir, H; Mayatepek, E; Schaper, J; Tibussek, D				Sabir, Hemmen; Mayatepek, Ertan; Schaper, Jorg; Tibussek, Daniel			Baby-walkers: an avoidable source of hazard	LANCET			English	Editorial Material							SPINAL-CORD-INJURY		[Sabir, Hemmen; Mayatepek, Ertan; Tibussek, Daniel] Univ Dusseldorf, Dept Gen Paediat, Dusseldorf, Germany; [Schaper, Jorg] Univ Dusseldorf, Dept Diagnost Radiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Tibussek, D (corresponding author), Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat, Moorenstr 5, D-40225 Dusseldorf, Germany.	daniel.tibussek@med.uni-duesseldorf.de	tibussek, daniel/AFT-8377-2022	tibussek, daniel/0000-0001-5114-3173				Buldini B, 2006, EUR J PEDIATR, V165, P108, DOI 10.1007/s00431-005-0004-0; Garrett M, 2002, BRIT MED J, V324, P1494, DOI 10.1136/bmj.324.7352.1494; GRABB PA, 1994, NEUROSURGERY, V35, P406, DOI 10.1227/00006123-199409000-00007; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; Shields BJ, 2006, PEDIATRICS, V117, pE452, DOI 10.1542/peds.2005-1916	5	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					2000	2000		10.1016/S0140-6736(08)61844-9	http://dx.doi.org/10.1016/S0140-6736(08)61844-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	19059050				2022-12-28	WOS:000261471600027
J	Skoler-Karpoff, S; Ramjee, G; Ahmed, K; Altini, L; Plagianos, MG; Friedland, B; Govender, S; De Kock, A; Cassim, N; Palanee, T; Dozier, G; Maguire, R; Lahteenmaki, P				Skoler-Karpoff, Stephanie; Ramjee, Gita; Ahmed, Khatija; Altini, Lydia; Plagianos, Marlena Gehret; Friedland, Barbara; Govender, Sumen; De Kock, Alana; Cassim, Nazira; Palanee, Thesla; Dozier, Gregory; Maguire, Robin; Lahteenmaki, Pekka			Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							VAGINAL GEL; TOPICAL MICROBICIDES; SAFETY; ACCEPTABILITY; TRANSMISSION; FORMULATIONS; FEASIBILITY; APPLICATORS; ASSAY; MICE	Background Female-initiated HIV prevention options, such as microbicides, are urgently needed. We assessed Carraguard, a carrageenan-based compound developed by the Population Council, for its efficacy and long-term safety in prevention of HIV infection in women. Methods We undertook a randomised, placebo-controlled, double-blind trial in three South African sites in sexually-active, HIV-negative women, aged 7.6 years and older. 6202 participants, who were randomly assigned by a block randomisation scheme to Carraguard (n=3103) or placebo (methylcellulose [n=3099]), were instructed to use one applicator of gel plus a condom during each vaginal sex act. Participants were followed up for up to 2 years. Visits every 3 months included testing for HIV presence and pregnancy, pelvic examinations, risk reduction counselling, and treatment for curable sexually transmitted infections and symptomatic vaginal infections. The primary outcome was time to HIV seroconversion. Analysis was in the efficacy population (a subset of the intention-to-treat population, excluding participants for whom efficacy could not be assessed). This study is registered with ClinicalTrials.gov, number NCT00213083. Findings For the primary outcome (time to HIV seroconversion) we analysed 3011 women in the Carraguard group and 2994 in the placebo group. HIV incidence was 3.3 per 100 woman-years (95% CI 2.8-3-9) in the Carraguard group (134 events) and 3.8 per 100 woman-years (95% CI 3.2-4.4) in the placebo group (151 events), with no significant difference in the distribution of time to seroconversion (p=0.30). The covariate-adjusted hazard ratio was 0.87 (95% CI 0.69-1.09). Rates of self-reported gel use (96.2% Carragntard, 95.9% placebo) and condom use (64. 1% in both groups) at last sex acts were similar in both groups. On the basis of applicator testing, however, gel was estimated to have been used in only 42.1% of sex acts, on average (41.1% Carraguard, 43-1% placebo). 1420 (23%) women in the intention-to-treat population had adverse events (713 Carraguard, 707 placebo), and 95 (2%) women had adverse events that were related to gel use (48 Carraguard, 47 placebo). Serious adverse events occurred in 72 (2%) women in the Carraguard group and 78 (3%) in the placebo group, only one of which was considered possibly related to gel use (placebo group). Interpretation This study did not show Carraguard's efficacy in prevention of vaginal transmission of HIV. No safety concerns were recorded. Funding US Agency for International Development, Bill & Melinda Gates Foundation.	[Skoler-Karpoff, Stephanie; Plagianos, Marlena Gehret; Friedland, Barbara; Maguire, Robin] Populat Council, New York, NY 10017 USA; [Ramjee, Gita; Palanee, Thesla] MRC, Durban, South Africa; [Ahmed, Khatija; Cassim, Nazira] Univ Limpopo, Garankuwa, South Africa; [Altini, Lydia; De Kock, Alana] Univ Cape Town, Infect Dis Epidemiol Unit, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Govender, Sumen; Lahteenmaki, Pekka] Populat Council, Johannesburg, South Africa; [Dozier, Gregory] PharmaLink FHI, Durham, NC USA; [Lahteenmaki, Pekka] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland	Population Council; University of Limpopo; University of Cape Town; University of Helsinki	Friedland, B (corresponding author), Populat Council, 1 Dag Hammarskjold Plaza, New York, NY 10017 USA.	bfriedland@popcouncil.org	Palanee-Phillips, Thesla/ABD-2449-2020	ahmed, khatija/0000-0003-0309-1641	US Agency for International Development [HRN-A-00-99-00010, GPO-A-00-04-00019]; Bill & Melinda Gates Foundation [#18057]	US Agency for International Development(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the US Agency for International Development, HRN-A-00-99-00010 and GPO-A-00-04-00019 and the Bill & Melinda Gates Foundation. Grant #18057 We thank the participants; the study teams at the MRC, University of Limpopo, Medunsa Campus, University of Cape Town. and the Population Council: the monitors from ClinDev; the laboratory staff at Bio Analytic Research Corporation. MRP Solutions; the members of the data safety and monitoring board and seroconversion review board, David Phillips, Elof Johansson, Neetha Morar, Manuela M Williams, Joseph Skhosana, Smruti Pates. Stephen Eghan. Victoria L Johnson, Lauren Katzen, Sarah Littlefield. Arran D Sharma, and Liping Zhou, without whom this trial could not have been implemented; Rosalie Doninik and Janneke van de Wijgert for their contributions to the development of the protocol and analysis plan: Douglas Taylor, Louise Pedneatlh. Salim Abdool Karim, Sheena McCormack, and Naomi Rutenberg for their invaluable review of the report; and the members of the Clinical Trials "Quick" Working Group for Microbicides for their guidance and support.	BELL RJ, 1993, OBSTET GYNECOL, V82, P328; Coetzee N, 2001, AIDS, V15, P1837, DOI 10.1097/00002030-200109280-00013; COETZEE N, 2002, P 2002 MICR C ANTW B; Coggins C, 2000, SEX TRANSM INFECT, V76, P480, DOI 10.1136/sti.76.6.480; COX DR, 1972, J R STAT SOC B, V34, P187; Elias CJ, 1997, CONTRACEPTION, V56, P387, DOI 10.1016/S0010-7824(97)00176-5; ELLIOTT JP, 1992, J REPROD MED, V37, P713; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Grijsen ML, 2008, SEX TRANSM INFECT, V84, P364, DOI 10.1136/sti.2007.028852; Johnson Kristine E, 2008, Curr Infect Dis Rep, V10, P243, DOI 10.1007/s11908-008-0040-9; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Kilmarx PH, 2006, JAIDS-J ACQ IMM DEF, V43, P327, DOI 10.1097/01.qai.0000243056.59860.c1; Kilmarx PH, 2003, LANCET, V361, P785, DOI 10.1016/S0140-6736(03)12645-1; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Maguire RA, 2001, SEX TRANSM DIS, V28, P259, DOI 10.1097/00007435-200105000-00003; Maguire RA, 1998, SEX TRANSM DIS, V25, P494, DOI 10.1097/00007435-199810000-00010; Mauck C, 2001, AIDS, V15, P857, DOI 10.1097/00002030-200105040-00006; *NAT DEP HLTH S AF, 2003, S AFR STAND TREATM G; Ndinda C, 2008, CULT HEALTH SEX, V10, P205, DOI 10.1080/13691050600988416; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PearcePratt R, 1996, BIOL REPROD, V54, P173, DOI 10.1095/biolreprod54.1.173; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Phillips DM, 1996, PERSPECT DRUG DISCOV, V5, P213, DOI 10.1007/BF02174016; PHILLIPS DM, 1993, P 2 INT S AIDS REPR; *POP COUNC, 1999, LAMBD KAPP CARR PC 5; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Spencer SE, 2004, J INFECT DIS, V189, P410, DOI 10.1086/381125; Sudol KM, 2004, SEX TRANSM DIS, V31, P346, DOI 10.1097/00007435-200406000-00005; Trussell J, 2005, CONTRACEPTION, V72, P408, DOI 10.1016/j.contraception.2005.06.063; *UNAIDS WHO, 2007, AIDS EP UPD; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; van de Wiigert JHHM, 2007, JAIDS-J ACQ IMM DEF, V46, P538, DOI 10.1097/QAI.0b013e318159d5a8; van de Wijgert JHHM, 2007, AIDS, V21, P2369, DOI 10.1097/QAD.0b013e3282ef83fd; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Wallace A, 2004, SEX TRANSM DIS, V31, P465, DOI 10.1097/01.olq.0000135986.35216.ba; Wallace AR, 2007, CONTRACEPTION, V76, P53, DOI 10.1016/j.contraception.2006.10.012; Zacharopoulos VR, 1997, CLIN DIAGN LAB IMMUN, V4, P465, DOI 10.1128/CDLI.4.4.465-468.1997	41	407	419	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1977	1987		10.1016/S0140-6736(08)61842-5	http://dx.doi.org/10.1016/S0140-6736(08)61842-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	19059048				2022-12-28	WOS:000261471600024
J	Eckle, P; Pfeiffer, AN; Cirelli, C; Staudte, A; Dorner, R; Muller, HG; Buttiker, M; Keller, U				Eckle, P.; Pfeiffer, A. N.; Cirelli, C.; Staudte, A.; Doerner, R.; Muller, H. G.; Buettiker, M.; Keller, U.			Attosecond Ionization and Tunneling Delay Time Measurements in Helium	SCIENCE			English	Article							PHASE-CONTROL; FIELD; PROPAGATION; GENERATION; PULSES; LASERS; MEDIA; LIGHT; WAVE	It is well established that electrons can escape from atoms through tunneling under the influence of strong laser fields, but the timing of the process has been controversial and far too rapid to probe in detail. We used attosecond angular streaking to place an upper limit of 34 attoseconds and an intensity- averaged upper limit of 12 attoseconds on the tunneling delay time in strong field ionization of a helium atom. The ionization field derives from 5.5- femtosecond- long near- infrared laser pulses with peak intensities ranging from 2.3 x 10(14) to 3.5 x 10(14) watts per square centimeter ( corresponding to a Keldysh parameter variation from 1.45 to 1.17, associated with the onset of efficient tunneling). The technique relies on establishing an absolute reference point in the laboratory frame by elliptical polarization of the laser pulse, from which field- induced momentum shifts of the emergent electron can be assigned to a temporal delay on the basis of the known oscillation of the field vector.	[Eckle, P.; Pfeiffer, A. N.; Cirelli, C.; Keller, U.] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Staudte, A.] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; [Doerner, R.] Univ Frankfurt, Inst Kernphys, D-60438 Frankfurt, Germany; [Muller, H. G.] FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands; [Buettiker, M.] Univ Geneva, Dept Phys, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; National Research Council Canada; Goethe University Frankfurt; AMOLF; University of Geneva	Eckle, P (corresponding author), ETH, Dept Phys, CH-8093 Zurich, Switzerland.		Cirelli, Claudio/W-4804-2019; Doerner, Reinhard/A-5340-2008; Cirelli, Claudio/C-4293-2012; Pfeiffer, Adrian N/J-7671-2016; Eckle, Petrissa/B-8447-2009; Keller, Ursula/N-2437-2016	Doerner, Reinhard/0000-0002-3728-4268; Pfeiffer, Adrian N/0000-0003-2975-8715; Keller, Ursula/0000-0002-1689-8041; Staudte, Andre/0000-0002-8284-3831	Natural Center of Competence in Research Quantum Photonics (NCCR QP); Swiss National Science Foundation; Alexander-von-Humboldt Stiftung; Deutsche Forschungsgemeinschaft; FOM (Fundamental Research on Matter)	Natural Center of Competence in Research Quantum Photonics (NCCR QP)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Alexander-von-Humboldt Stiftung(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FOM (Fundamental Research on Matter)(FOM (The Netherlands))	This work was supported by Natural Center of Competence in Research Quantum Photonics (NCCR QP), research instrument of the Swiss National Science Foundation, the Alexander-von-Humboldt Stiftung, and the Deutsche Forschungsgemeinschaft. H.G.M. was supported by FOM (Fundamental Research on Matter), which is subsidized by NWO (Netherlands Organization for the Advancement of Research).	Ammosov M. V., 1986, Soviet Physics - JETP, V64, P1191; Apolonski A, 2000, PHYS REV LETT, V85, P740, DOI 10.1103/PhysRevLett.85.740; Brillouin L, 1914, ANN PHYS-BERLIN, V44, P203; BUTTIKER M, 1982, PHYS REV LETT, V49, P1739, DOI 10.1103/PhysRevLett.49.1739; Buttiker M, 1998, ANN PHYS-BERLIN, V7, P602, DOI [10.1002/(SICI)1521-3889(199812)7:7/8<602::AID-ANDP602>3.0.CO;2-G, 10.1002/andp.199851007-802]; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Eckle P, 2008, NAT PHYS, V4, P565, DOI 10.1038/nphys982; Hauri CP, 2004, APPL PHYS B-LASERS O, V79, P673, DOI 10.1007/s00340-004-1650-z; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; LANDAUER R, 1994, REV MOD PHYS, V66, P217, DOI 10.1103/RevModPhys.66.217; MacColl LA, 1932, PHYS REV, V40, P0621, DOI 10.1103/PhysRev.40.621; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; MUGA HG, 2008, LECT NOTES PHYS, V734; Paulus GG, 1998, PHYS REV LETT, V80, P484, DOI 10.1103/PhysRevLett.80.484; Protopapas M, 1997, REP PROG PHYS, V60, P389, DOI 10.1088/0034-4885/60/4/001; Ruseckas J, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.052107; SOMMERFELD A, 1907, PHYS Z, V8, P841; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; WIGNER EP, 1955, PHYS REV, V98, P145, DOI 10.1103/PhysRev.98.145; Winful HG, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/6/101; Yudin GL, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.033404; Zair A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143902	25	581	585	9	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1525	1529		10.1126/science.1163439	http://dx.doi.org/10.1126/science.1163439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056981				2022-12-28	WOS:000261377400044
J	Ker, J; Cantillon, P; Ambrose, L				Ker, Jean; Cantillon, Peter; Ambrose, Lucy			Teaching on a ward round	BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE; MEDICINE		[Ker, Jean; Ambrose, Lucy] Univ Dundee, Ninewells Hosp, Clin Skills Ctr, Dundee DD1 9SY, Scotland; [Cantillon, Peter] Natl Univ Ireland Univ Coll Galway, Dept Gen Practice, Galway, Ireland	University of Dundee; Ollscoil na Gaillimhe-University of Galway	Ker, J (corresponding author), Univ Dundee, Ninewells Hosp, Clin Skills Ctr, Dundee DD1 9SY, Scotland.	j.s.ker@dundee.ac.uk; peter.cantillon@nuigalway.ie						Bleakley A, 2002, MED EDUC, V36, P9, DOI 10.1046/j.1365-2923.2002.01128.x; Brown JS., 1989, ED RES, V18, P32, DOI [DOI 10.3102/0013189X018001032, 10.3102/0013189X018001032]; Bruner J.S., 1966, THEORY INSTRUCTION; Caldwell G, 2006, CLIN TEACH, V3, P185, DOI 10.1111/j.1743-498X.2006.00100.x; Cope P, 2000, J ADV NURS, V31, P850, DOI 10.1046/j.1365-2648.2000.01343.x; CREUSS SR, 2008, BRIT MED J, V336, P718; Dyrbye LN, 2007, ACAD MED, V82, P979, DOI 10.1097/ACM.0b013e318149e29c; Fertleman M, 2005, QUAL SAF HEALTH CARE, V14, P207, DOI 10.1136/qshc.2004.011759; KOHN L, 2000, TO ERR IS HUMAN BUIL; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Morey JC, 2002, HEALTH SERV RES, V37, P1553, DOI 10.1111/1475-6773.01104; Norgaard K, 2004, MED EDUC, V38, P700, DOI 10.1111/j.1365-2929.2004.01840.x; Paice E, 2002, BMJ-BRIT MED J, V325, P707, DOI 10.1136/bmj.325.7366.707; Regehr G, 1996, ACAD MED, V71, P988, DOI 10.1097/00001888-199609000-00015; Rogers A., 1996, TEACHING ADULTS; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; Tolli AP, 2008, J APPL PSYCHOL, V93, P692, DOI 10.1037/0021-9010.93.3.692; WRAY NP, 1986, J MED EDUC, V61, P893; ZWARENSTEIN M, 2007, COCHRANE DB SYST REV; [No title captured]	20	19	19	1	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 2	2008	337								a1930	10.1136/bmj.a1930	http://dx.doi.org/10.1136/bmj.a1930			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386NV	19050018				2022-12-28	WOS:000261890800002
J	Hartl, TA; Smith, HF; Bosco, G				Hartl, Tom A.; Smith, Helen F.; Bosco, Giovanni			Chromosome Alignment and Transvection Are Antagonized by Condensin II	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; BITHORAX-COMPLEX; TRANS; GENE; EXPRESSION; PROTEINS; CIS	Polytene chromosome structure is a characteristic of some polyploid cells where several to thousands of chromatids are closely associated with perfect alignment of homologous DNA sequences. Here, we show that Drosophila condensin II promotes disassembly of polytene structure into chromosomal components. Condensin II also negatively regulates transvection, a process whereby certain alleles are influenced transcriptionally via interallelic physical associations. We propose that condensin II restricts trans- chromosomal interactions that affect transcription through its ability to spatially separate aligned interphase chromosomes.	[Hartl, Tom A.; Smith, Helen F.; Bosco, Giovanni] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Bosco, G (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, 1007 E Lowell St, Tucson, AZ 85721 USA.	gbosco@email.arizona.edu		Bosco, Giovanni/0000-0002-8889-9895	NIH [GM069462]; University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics; Graduate Training in Biochemistry and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics(National Science Foundation (NSF)); Graduate Training in Biochemistry and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge T. Orr-Weaver for supporting the initial screen. We are grateful to the following individuals: C. Boswell ( microscopy), V. Lien ( UAS- Cap- H2- mCherry transgenics), M. Hart ( mitotic index), P. Jansma ( fly imaging), and J. Blumenstiel ( FISH). We thank S. Hawley, T. Orr- Weaver, M. Lilly, E. Kelleher, and the JMST student forum for critical reading of the manuscript and, especially, C.- T. Wu for exceptional guidance with transvection studies. We are grateful to J. Sedat, J. Vazquez, C. Zuker, P. O'Farrell, and C.- T. Wu for fly stocks. Support was from NIH (GM069462) grant to G. B., and T. H. was funded by the University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics and NIH Grant for Graduate Training in Biochemistry and Molecular Biology.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; CABRERA CV, 1985, NATURE, V318, P569, DOI 10.1038/318569a0; CASTELLIGAIR JE, 1990, GENETICS, V126, P177; Dej KJ, 1999, DEVELOPMENT, V126, P293; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Gemkow MJ, 1998, DEVELOPMENT, V125, P4541; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; Golic MM, 1996, GENETICS, V143, P385; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; LEWIS EB, 1955, AM NAT, V89, P73, DOI 10.1086/281867; Morris JR, 1998, P NATL ACAD SCI USA, V95, P10740, DOI 10.1073/pnas.95.18.10740; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Savarese F, 2006, CELL, V126, P248, DOI 10.1016/j.cell.2006.07.008; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049; WHITE RAH, 1985, NATURE, V318, P567, DOI 10.1038/318567a0; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032	20	94	96	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1384	1387		10.1126/science.1164216	http://dx.doi.org/10.1126/science.1164216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039137				2022-12-28	WOS:000261170600040
J	Croskerry, P; Abbass, AA; Wu, AW				Croskerry, Pat; Abbass, Allan A.; Wu, Albert W.			How doctors feel: affective issues in patients' safety	LANCET			English	Editorial Material									[Croskerry, Pat] Dalhousie Univ, Dept Emergency Med, Halifax, NS B3H 2Y9, Canada; [Croskerry, Pat] Dalhousie Univ, Dept Med Educ, Halifax, NS B3H 2Y9, Canada; [Abbass, Allan A.] Dalhousie Univ, Ctr Emot & Hlth, Halifax, NS, Canada; [Wu, Albert W.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Dalhousie University; Dalhousie University; Dalhousie University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Croskerry, P (corresponding author), Dalhousie Univ, Dept Emergency Med, Halifax, NS B3H 2Y9, Canada.	xkerry@ns.sympatico.ca	Wu, Albert/AAJ-4780-2021	Abbass, Allan/0000-0003-1285-5770				*AM MED INF ASS, 2008, DIAGN ERR MED NAT C; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Croskerry P., 2005, CAN J ANAESTH, V52, pR1, DOI [10.1007/BF03023077, DOI 10.1007/BF03023077]; Glassman NS, 1999, COGNITIVE THER RES, V23, P75, DOI 10.1023/A:1018762724798; Graber M, 2005, JT COMM J QUAL PATIE, V31, P106, DOI 10.1016/S1553-7250(05)31015-4; GRABER ML, 2008, AM J MED, V121, pR7; Groopman J, 2007, DOCTORS THINK; GROVES JE, 1978, NEW ENGL J MED, V298, P883, DOI 10.1056/NEJM197804202981605; Ittelson W.H., 1973, ENV COGNITION, P141; Montgomery K, 2006, DOCTORS THINK CLIN J; OLSON SC, 1996, EMERGENCY MED COMPRE; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]	12	75	76	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1205	1206		10.1016/S0140-6736(08)61500-7	http://dx.doi.org/10.1016/S0140-6736(08)61500-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19094942				2022-12-28	WOS:000259882000009
J	Velu, V; Titanji, K; Zhu, BG; Husain, S; Pladevega, A; Lai, LL; Vanderford, TH; Chennareddi, L; Silvestri, G; Freeman, GJ; Ahmed, R; Amara, RR				Velu, Vijayakumar; Titanji, Kehmia; Zhu, Baogong; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Vanderford, Thomas H.; Chennareddi, Lakshmi; Silvestri, Guido; Freeman, Gordon J.; Ahmed, Rafi; Amara, Rama Rao			Enhancing SIV-specific immunity in vivo by PD-1 blockade	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD8 T-CELLS; CHRONIC VIRAL-INFECTION; PROGRAMMED DEATH-1; EFFECTOR FUNCTION; EXPRESSION; LYMPHOCYTES; PERSISTENCE; EXHAUSTION; MECHANISMS	Chronic immunodeficiency virus infections are characterized by dysfunctional cellular and humoral antiviral immune responses(1-3). As such, immune modulatory therapies that enhance and/or restore the function of virus-specific immunity may protect from disease progression. Here we investigate the safety and immune restoration potential of blockade of the co-inhibitory receptor programmed death 1 (PD-1) 4,5 during chronic simian immunodeficiency virus (SIV) infection in macaques. We demonstrate that PD-1 blockade using an antibody to PD-1 is well tolerated and results in rapid expansion of virus-specific CD8 T cells with improved functional quality. This enhanced T-cell immunity was seen in the blood and also in the gut, a major reservoir of SIV infection. PD-1 blockade also resulted in proliferation of memory B cells and increases in SIV envelope-specific antibody. These improved immune responses were associated with significant reductions in plasma viral load and also prolonged the survival of SIV-infected macaques. Blockade was effective during the early (week 10) as well as late (similar to week 90) phases of chronic infection even under conditions of severe lymphopenia. These results demonstrate enhancement of both cellular and humoral immune responses during a pathogenic immunodeficiency virus infection by blocking a single inhibitory pathway and identify a novel therapeutic approach for control of human immunodeficiency virus infections.	[Velu, Vijayakumar; Titanji, Kehmia; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Chennareddi, Lakshmi; Ahmed, Rafi; Amara, Rama Rao] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Velu, Vijayakumar; Titanji, Kehmia; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Chennareddi, Lakshmi; Amara, Rama Rao] Emory Univ, Div Microbiol & Immunol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Zhu, Baogong; Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhu, Baogong; Freeman, Gordon J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Vanderford, Thomas H.; Silvestri, Guido] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Emory University; Emory University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Pennsylvania	Amara, RR (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ramara@emory.edu	Freeman, Gordon/AAC-5380-2019; Amara, Rama/AAO-8136-2021; Velu, Vijayakumar/I-7585-2019	Freeman, Gordon/0000-0002-7210-5616; Velu, Vijayakumar/0000-0003-4238-1924; Lai, Lilin/0000-0002-9528-6990	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165, R24RR016038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057029, R01AI074417, R01AI071852, P30AI050409] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000165, R24 RR16038, P51 RR00165, R24 RR016038] Funding Source: Medline; NIAID NIH HHS [R01 AI057029-05, R01 AI057029-02, R01 AI057029-03, R01 AI071852, R01 AI074417, R01 AI074417-02, P30 AI050409, R01 AI057029-01, R01 AI074417-01A1, R01 AI057029, R01 AI057029-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 1998, J IMMUNOL, V160, P6062; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lai L, 2007, VIROLOGY, V369, P153, DOI 10.1016/j.virol.2007.07.017; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Malley R, 1998, J INFECT DIS, V178, P1555, DOI 10.1086/314523; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	30	576	618	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					206	U5		10.1038/nature07662	http://dx.doi.org/10.1038/nature07662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19078956	Green Accepted			2022-12-28	WOS:000264059700044
J	Gomes, MF; Faiz, MA; Gyapong, JO; Warsame, M; Agbenyega, T; Babiker, A; Baiden, F; Yunus, EB; Binka, F; Clerk, C; Folb, P; Hassan, R; Hossain, MA; Kimbute, O; Kitua, A; Krishna, S; Makasi, C; Mensah, N; Mrango, Z; Olliaro, P; Peto, R; Peto, TJ; Rahman, MR; Ribeiro, I; Samad, R; White, NJ				Gomes, M. F.; Faiz, M. A.; Gyapong, J. O.; Warsame, M.; Agbenyega, T.; Babiker, A.; Baiden, F.; Yunus, E. B.; Binka, F.; Clerk, C.; Folb, P.; Hassan, R.; Hossain, M. A.; Kimbute, O.; Kitua, A.; Krishna, S.; Makasi, C.; Mensah, N.; Mrango, Z.; Olliaro, P.; Peto, R.; Peto, T. J.; Rahman, M. R.; Ribeiro, I.; Samad, R.; White, N. J.		Study 13 Res Grp	Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial	LANCET			English	Article							SEVERE FALCIPARUM-MALARIA; ANTIMALARIAL-DRUG RESISTANCE; CEREBRAL MALARIA; CHILDREN; EFFICACY; QUININE	Background Most malaria deaths occur in rural areas. Rapid progression from illness to death can be interrupted by prompt, effective medication. Antimalarial treatment cannot rescue terminally ill patients but could be effective if given earlier. If patients who cannot be treated orally are several hours from facilities for injections, rectal artesunate can be given before referral and acts rapidly on parasites. We investigated whether this intervention reduced mortality and permanent disability. Methods In Bangladesh, Ghana, and Tanzania, patients with suspected severe malaria who could not be treated orally were allocated randomly to a single artesunate (n=8954) or placebo (n=8872) suppository by taking the next numbered box, then referred to clinics at which injections could be given. Those with antimalarial injections or negative blood smears before randomisation were excluded, leaving 12068 patients (6072 artesunate, 5996 placebo) for analysis. Primary endpoints were mortality, assessed 7-30 days later, and permanent disability, reassessed periodically. All investigators were masked to group assignment. Analysis was by intention to treat. This study is registered in all three countries, numbers ISRCTN83979018, 46343627, and 76987662. Results Mortality was 154 of 6072 artesunate versus 177 of 5996 placebo (2.5% vs 3 . 0%, p=0 . 1). Two versus 13 (0 . 03% vs 0 . 22%, p=0 . 0020) were permanently disabled; total dead or disabled: 156 versus 190 (2 . 6% vs 3.2%, p=0 . 0484). There was no reduction in early mortality (56 vs 51 deaths within 6 h; median 2 h). In patients reaching clinic within 6 h (median 3 h), pre-referral artesunate had no significant effect on death after 6 h or permanent disability (71/4450 [1.6%] vs 82/4426 [1.9%], risk ratio 0.86 [95% Cl 0.63-1.18], p=0.35). In patients still not in clinic after more than 6 h, however, half were still not there after more than 15 h, and pre-referral rectal artesurate significantly reduced death or permanent disability (29/1566 [1.9%] vs 57/1519 [3.8%], risk ratio 0.49 [95% CI 0.32-0.77], p=0 . 0013). Interpretation If patients with severe malaria cannot be treated orally and access to injections will take several hours, a single inexpensive artesunate suppository at the time of referral substantially reduces the risk of death or permanent disability. Funding UNICEF/UNDP/World Bank Special Programme for Research and Training in Tropical Diseases (WHO/TDR); WHO Global Malaria Programme (WHO/GMP); Sall Family Poundation; the European Union (QLRT-2000-01430); the UK Medical Research Council; USAID; Irish Aid; the Karolinska Institute; and the University of Oxford Clinical Trial Service Unit (CTSU).	[Gomes, M. F.; Olliaro, P.] WHO, UNICEF UNDP World Bank, Special Programme Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland; [Faiz, M. A.] Govt Peoples Repub Bangladesh, Minist Hlth & Family Welf, Dhaka, Bangladesh; [Gyapong, J. O.] Ghana Hlth Serv, Hlth Res Unit, Accra, Ghana; [Warsame, M.] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Agbenyega, T.] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Babiker, A.] MRC, HIV Clin Trials Ctr, London, England; [Baiden, F.] WHO, Representat Off, Dar Es Salaam, Tanzania; [Yunus, E. B.; Hassan, R.; Hossain, M. A.; Samad, R.] Chittagong Med Coll, Malaria Res Grp, Chittagong, Bangladesh; [Binka, F.] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Clerk, C.] Dodowa Hlth Res Ctr, Dodowa, Ghana; [Folb, P.] MRC, Cape Town, South Africa; [Kimbute, O.; Kitua, A.; Makasi, C.; Mrango, Z.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Krishna, S.] Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; [Mensah, N.] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Peto, R.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Peto, T. J.] MRC Labs, Banjul, Gambia; [Rahman, M. R.] Begum Khaleda Zia Med Coll, Dhaka, Bangladesh; [Ribeiro, I.] DNDi, Rio De Janeiro, Brazil; [White, N. J.] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand	The World Bank; World Health Organization; Ghana Health Service; World Health Organization; Kwame Nkrumah University Science & Technology; Medical Research Council Clinical Trials Unit; World Health Organization; Chittagong Medical College; University of Ghana; National Institute of Medical Research; St Georges University London; Navrongo Health Research Center; University of Oxford; MRC Laboratory Molecular Biology; Mahidol University	Gomes, MF (corresponding author), WHO, UNICEF UNDP World Bank, Special Programme Res & Training Trop Dis, 1211 Ave Appia, CH-1211 Geneva 27, Switzerland.	gomesm@who.int	White, Nick/AAC-6527-2019; Baiden, Frank/AAF-7309-2020; Rahman, Ridwanur/K-2637-2019; White, Nicholas J/I-4629-2012; Mensah, Nathan/GYR-0802-2022; Baiden, Frank/Q-2018-2019	White, Nick/0000-0002-1897-1978; Baiden, Frank/0000-0003-0141-6561; Kimbute, Omari/0000-0002-0067-5783; Peto, Thomas/0000-0003-3197-9891; Gyapong, John/0000-0002-8415-1468; Krishna, Sanjeev/0000-0003-0066-0634; Owusu-Agyei, Seth/0000-0002-0807-1781	UNICEF/UNDP/World Bank Special Programme for Research and Training in Tropical Diseases (WHO/TDR); Global Malaria Programme (WHO/GMP); Sall Family Foundation, the European Union [QLRT-2000-01430]; UK Medical Research Council; USAID; Irish Aid; Karolinska Institute; University of Oxford Clinical Trial Service Unit (CTSU); NJW is Wellcome Trust Principal Fellow; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	UNICEF/UNDP/World Bank Special Programme for Research and Training in Tropical Diseases (WHO/TDR)(World Health Organization); Global Malaria Programme (WHO/GMP)(World Health Organization); Sall Family Foundation, the European Union; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); USAID(United States Agency for International Development (USAID)); Irish Aid(CGIAR); Karolinska Institute(Karolinska Institutet); University of Oxford Clinical Trial Service Unit (CTSU); NJW is Wellcome Trust Principal Fellow(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the hundreds of villages and thousands of parents or guardians who agreed to take part in this trial; the 417 village recruiters and 74 field supervisors; the local clinics and hospitals in Bangladesh, Ghana, and Tanzania; and the facilities of the Bangladesh Institute of Tropical and Infectious Diseases, the Ghanaian Ministry of Health, and the Tanzanian National Institute of Medical Research. The study was supported financially by the UNICEF/UNDP/World Bank Special Programme for Research and Training in Tropical Diseases (WHO/TDR), the Global Malaria Programme (WHO/GMP), the Sall Family Foundation, the European Union (QLRT-2000-01430), the UK Medical Research Council, USAID, Irish Aid, the Karolinska Institute, and the University of Oxford Clinical Trial Service Unit (CTSU). NJW is Wellcome Trust Principal Fellow.	Al Fadil SM, 2003, B WORLD HEALTH ORGAN, V81, P708; ARROW KJ, 2004, SAVING LIVES BUYTING; Barnes KI, 2004, LANCET, V363, P1598, DOI 10.1016/S0140-6736(04)16203-X; BREWER TG, 1994, T ROY SOC TROP MED H, V88, P33, DOI 10.1016/0035-9203(94)90469-3; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Faiz MA, 2005, LANCET, V366, P717; Krishna S, 2001, ANTIMICROB AGENTS CH, V45, P509, DOI 10.1128/AAC.45.2.509-516.2001; Lopez AD, 2006, DIS CONTROL PRIORITI; MOLYNEUX ME, 1989, Q J MED, V71, P441; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Ngoungou EB, 2006, EPILEPSIA, V47, P873, DOI 10.1111/j.1528-1167.2006.00524.x; Peterson S, 2004, LANCET, V363, P1955, DOI 10.1016/S0140-6736(04)16411-8; Simpson JA, 2006, PLOS MED, V3, P2113, DOI 10.1371/journal.pmed.0030444; White N, 1999, TROP MED INT HEALTH, V4, P469, DOI 10.1046/j.1365-3156.1999.00435.x; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; YUNUS EB, 2004, J BANG COLL PHYS SUR, V22, P83	18	136	140	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					557	566		10.1016/S0140-6736(08)61734-1	http://dx.doi.org/10.1016/S0140-6736(08)61734-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19059639	Green Published, Green Accepted			2022-12-28	WOS:000263333600034
J	van Mameren, J; Modesti, M; Kanaar, R; Wyman, C; Peterman, EJG; Wuite, GJL				van Mameren, Joost; Modesti, Mauro; Kanaar, Roland; Wyman, Claire; Peterman, Erwin J. G.; Wuite, Gijs J. L.			Counting RAD51 proteins disassembling from nucleoprotein filaments under tension	NATURE			English	Article							DNA STRAND-EXCHANGE; ATP HYDROLYSIS; BIOCHEMICAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION; RAD51-DSDNA FILAMENT; RECA FILAMENTS; MOLECULES; DYNAMICS; BINDING; RESOLUTION	The central catalyst in eukaryotic ATP- dependent homologous recombination consists of RAD51 proteins, polymerized around single- stranded DNA. This nucleoprotein filament recognizes and invades a homologous duplex DNA segment(1,2). After strand exchange, the nucleoprotein filament should disassemble so that the recombination process can be completed(3). The molecular mechanism of RAD51 filament disassembly is poorly understood. Here we show, by combining optical tweezers with single- molecule fluorescence microscopy and microfluidics(4,5), that disassembly of human RAD51 nucleoprotein filaments results from the interplay between ATP hydrolysis and the release of the tension stored in the filament. By applying external tension to the DNA, we found that disassembly slows down and can even be stalled. We quantified the fluorescence of RAD51 patches and found that disassembly occurs in bursts interspersed by long pauses. After relaxation of a stalled complex, pauses were suppressed resulting in a large burst. These results indicate that tension- dependent disassembly takes place only from filament ends, after tension- independent ATP hydrolysis. This integrative single-molecule approach allowed us to dissect the mechanism of this principal homologous recombination reaction step, which in turn clarifies how disassembly can be influenced by accessory proteins.	[van Mameren, Joost; Peterman, Erwin J. G.; Wuite, Gijs J. L.] Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands; [van Mameren, Joost; Peterman, Erwin J. G.; Wuite, Gijs J. L.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Modesti, Mauro; Kanaar, Roland; Wyman, Claire] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; [Modesti, Mauro] Univ Aix Marseille 2, CNRS, Unite Propre Rech 3081, F-13402 Marseille 20, France; [Kanaar, Roland; Wyman, Claire] Erasmus MC, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Erasmus University Rotterdam; Erasmus MC	Peterman, EJG (corresponding author), Vrije Univ Amsterdam, Ctr Laser, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	erwinp@few.vu.nl; gwuite@few.vu.nl	Modesti, Mauro/D-6258-2017; Classen, Scott/AAY-8176-2020; Peterman, Erwin/G-5529-2010	Modesti, Mauro/0000-0002-4964-331X; Peterman, Erwin/0000-0003-1058-249X; van Mameren, Joost/0000-0002-0582-6173; wuite, gijs/0000-0002-5706-043X	Biomolecular Physics; Dutch organization for Fundamental Research of Matter (FOM); Dutch Cancer Society; Netherlands Organization for Scientific Research; Netherlands Genomics Initiative/NWO; Association for International Cancer Research; European Commission Integrated Projects Molecular Imaging; DNA Repair; National Cancer Institute-National Institutes of Health USA; NWO Vidi; NWO Vici; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	Biomolecular Physics; Dutch organization for Fundamental Research of Matter (FOM)(FOM (The Netherlands)); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO)); Association for International Cancer Research; European Commission Integrated Projects Molecular Imaging(European CommissionEuropean Commission Joint Research Centre); DNA Repair; National Cancer Institute-National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NWO Vidi(Netherlands Organization for Scientific Research (NWO)); NWO Vici(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. van den Broek and R. T. Dame for discussions and a critical reading of the manuscript and J. Kerssemakers for kindly providing his step fitting algorithm. This work was supported by the Biomolecular Physics program of the Dutch organization for Fundamental Research of Matter (FOM) ( to R.K., C.W., E.J. G.P. and G.J.L.W.), and grants from the Dutch Cancer Society (KWF), the Netherlands Organization for Scientific Research (NWO), the Netherlands Genomics Initiative/NWO, the Association for International Cancer Research and the European Commission Integrated Projects Molecular Imaging and DNA Repair and a National Cancer Institute-National Institutes of Health USA program project (to C.W. and R.K.). E.J.G.P. and G.J.L.W. are recipients of NWO Vidi grants; C.W. of an NWO Vici grant.	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco P R, 1998, Front Biosci, V3, pD570; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Noom MC, 2007, NAT METHODS, V4, P1031, DOI 10.1038/nmeth1126; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Shim KS, 2006, DNA REPAIR, V5, P704, DOI 10.1016/j.dnarep.2006.03.004; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Tombline G, 2002, J BIOL CHEM, V277, P14426, DOI 10.1074/jbc.M109916200; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; van Mameren J, 2006, BIOPHYS J, V91, pL78, DOI 10.1529/biophysj.106.089466; Wyman C, 2006, STRUCTURE, V14, P949, DOI 10.1016/j.str.2006.05.008; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	30	127	128	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					745	748		10.1038/nature07581	http://dx.doi.org/10.1038/nature07581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19060884	Green Accepted			2022-12-28	WOS:000263064700046
J	Reading, R; Bissell, S; Goldhagen, J; Harwin, J; Masson, J; Moynihan, S; Parton, N; Pais, MS; Thoburn, J; Webb, E				Reading, Richard; Bissell, Susan; Goldhagen, Jeffrey; Harwin, Judith; Masson, Judith; Moynihan, Sian; Parton, Nigel; Pais, Marta Santos; Thoburn, June; Webb, Elspeth			Child Maltreatment 4 Promotion of children's rights and prevention of child maltreatment	LANCET			English	Article							CORPORAL PUNISHMENT BAN; PUBLIC-HEALTH; DEVELOPING-COUNTRIES; DEATH STATISTICS; WELFARE SYSTEM; SWEDISH MYTH; PROTECTION; ABUSE; 21ST-CENTURY; PERSPECTIVE	In medical literature, child maltreatment is considered as a public-health problem or an issue of harm to individuals, but less frequently as a violation of children's human rights. Public-health approaches emphasise monitoring, prevention, cost-effectiveness, and population strategies; protective approaches concentrate on the legal and professional response to cases of maltreatment. Both approaches have been associated with improvement in outcomes for children, yet maltreatment remains a major global problem. We describe how children's rights provide a different perspective on child maltreatment, and contribute to both public-health and protective responses. Children's rights as laid out in the UN convention on the rights of the child (UNCRC) provide a framework for understanding child maltreatment as part of a range of violence, harm, and exploitation of children at the individual, institutional, and societal levels. Rights of participation and provision are as important as rights of protection. The principles embodied in the UNCRC are concordant with those of medical ethics. The greatest strength of an approach based on the UNCRC is that it provides a legal instrument for implementing policy, accountability, and social justice, all of which enhance public-health responses. incorporation of the principles of the UNCRC into laws, research, public-health policy, and professional training and practice will result in further progress in the area of child maltreatment.	[Reading, Richard] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Bissell, Susan; Pais, Marta Santos] UNICEF Innocenti Res Ctr, Implementing Int Stand Unit, Florence, Italy; [Goldhagen, Jeffrey] Univ Florida, Div Community Pediat, Jacksonville, FL USA; [Harwin, Judith] Brunel Univ, Sch Hlth Sci & Social Care, London, England; [Masson, Judith] Univ Bristol, Bristol, Avon, England; [Moynihan, Sian] Welsh Deanery, Cardiff, Wales; [Parton, Nigel] Univ Huddersfield, Huddersfield HD1 3DH, W Yorkshire, England; [Thoburn, June] Univ E Anglia, Sch Social Work, Norwich NR4 7TJ, Norfolk, England; [Webb, Elspeth] Cardiff Univ, Coll Med, Cardiff, Wales	University of East Anglia; State University System of Florida; University of Florida; Brunel University; University of Bristol; University of Huddersfield; University of East Anglia; Cardiff University	Reading, R (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	r.reading@uea.ac.uk		Harwin, Judith/0000-0002-0992-5769; Parton, Nigel/0000-0002-0317-7237				Advisory Council on the Misuse of Drugs, 2003, HIDD HARM RESP NEEDS; AHMADU F, 1995, PRIDE            APR, P43; Ajayi A.O., 2004, EARLY CHILD DEV CARE, V174, P183; Anderson P., 2006, ALCOHOL EUROPE; [Anonymous], 2002, WORLD REPORT VIOLENC; [Anonymous], 1992, AIDS WORLD; BANARD M, 2006, DRUG ADDICTION FAMIL; Beckett C, 2005, BRIT J SOC WORK, V35, P125, DOI 10.1093/bjsw/bch166; Bell M, 1999, BRIT J SOC WORK, V29, P437; Bell M, 2007, CHILD PROTECTION HDB, P283; Browne K, 2006, BRIT MED J, V332, P485, DOI 10.1136/bmj.332.7539.485; Browne K, 2005, ADOPT FOSTER, V29, P23, DOI 10.1177/030857590502900405; Butchart A., 2008, MANNUAL ESTIMATING E; Butchart A, 2008, AM J PREV MED, V34, pS103, DOI 10.1016/j.amepre.2008.01.006; Chand, 2000, CHILD FAMILY SOCIAL, V5, P67, DOI 10.1046/j.1365-2206.2000.00144.x; *CHILDR RIGHTS ALL, 2008, NGO REP UN COMM RIGH; Cleaver H., 1999, CHILDRENS NEEDS PARE; Corso PS, 2006, CHILD ABUSE NEGLECT, V30, P727, DOI 10.1016/j.chiabu.2005.12.006; Council of Europe, 1950, EUR CONV HUM RIGHTS; Crampton D, 2007, CHILD FAM SOC WORK, V12, P202, DOI 10.1111/j.1365-2206.2006.00442.x; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; DOEK J, 2002, CHILD ABUSE NEGL, V26, P605; Durrant JE, 1999, CHILD ABUSE NEGLECT, V23, P435, DOI 10.1016/S0145-2134(99)00021-6; Durrant JE, 2005, INT REV VICT, V12, P139, DOI 10.1177/026975800501200203; Ertem IO, 2002, CHILD ABUSE NEGLECT, V26, P751, DOI 10.1016/S0145-2134(02)00349-6; FARRINGTON DP, 1995, J CHILD PSYCHOL PSYC, V36, P929, DOI 10.1111/j.1469-7610.1995.tb01342.x; Fee E, 2008, J PUBLIC HEALTH POL, V29, P54, DOI 10.1057/palgrave.jphp.3200160; Fergusson DM, 1997, CHILD ABUSE NEGLECT, V21, P617, DOI 10.1016/S0145-2134(97)00021-5; Forrester D., 2006, CHILD FAMILY SOCIAL, V11, P325, DOI DOI 10.1111/J.1365-2206.2006.00415.X; Forrester D, 2008, BRIT J SOC WORK, V38, P1518, DOI 10.1093/bjsw/bcm051; Furniss, 2006, PREVENTING CHILD MAL; *GEN ASS UN, 2007, A62214 UN GEN ASS; General Assembly of the United Nations, 1948, UN DECL HUM RIGHTS; GIL DG, 1975, AM J ORTHOPSYCHIAT, V45, P346, DOI 10.1111/j.1939-0025.1975.tb02545.x; GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61707-9; GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)67106-7; Goldhagen J, 2005, PEDIATRICS, V115, P1202, DOI 10.1542/peds.2004-2825U; Goldhagen J, 2003, PEDIATRICS, V112, P742; Green BL, 2007, CHILD MALTREATMENT, V12, P43, DOI 10.1177/1077559506296317; GREENLAND C, 1987, PREVENTING CAN DEATH; Gruskin S., 2003, HLTH HUM RIGHTS, V6, P1; Gruskin S, 2008, B WORLD HEALTH ORGAN, V86, P589, DOI 10.2471/BLT.07.050500; Gruskin S, 2007, LANCET, V370, P449, DOI 10.1016/S0140-6736(07)61200-8; Haapasalo J, 1999, AGGRESS VIOLENT BEH, V4, P107, DOI 10.1016/S1359-1789(97)00027-X; Hart D., 2006, ADULT DRUG PROBLEMS; Harwin J, 2008, J SOC WELF FAM LAW, V29, P277, DOI 10.1080/09649060701752299; Harwin Judith, 1996, CHILDREN RUSSIAN STA; Heath I, 2002, BRIT MED J, V325, P726, DOI 10.1136/bmj.325.7367.726; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; HODGKIN R, 2008, IMPL HDB CONV RIGHTS; Hornor G, 2008, J PEDIATR HEALTH CAR, V22, P35, DOI 10.1016/j.pedhc.2007.01.008; Hunt P, 2007, LANCET, V370, P369, DOI 10.1016/S0140-6736(07)61173-8; Hunt Paul, 2008, Health Hum Rights, V10, P81; Janson S, 2005, BRIT J SOC WORK, V35, P1411, DOI 10.1093/bjsw/bch369; Kamerman SB, 2001, SOC POLICY ADMIN, V35, P69, DOI 10.1111/1467-9515.00220; Kamerman SB, 1997, CHILD POVERTY DEPRIV, P91; KARLSSON L, 2008, UNICEF INNOCENTI RES; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Kemper C.M., 1978, Congressus Theriologicus Internationalis, V2, P261, DOI 10.1016/0145-2134(78)90024-8; Killeen D., 2008, IS POVERTY UK DENIAL; Klevens J, 2007, CHILD MALTREATMENT, V12, P364, DOI 10.1177/1077559507305995; Knutson JF, 2004, AGGRESSIVE BEHAV, V30, P187, DOI 10.1002/ab.20016; KORBIN JE, 1991, CHILD ABUSE NEGLECT, V15, P67, DOI 10.1016/0145-2134(91)90010-B; Kroll B., 2003, PARENTAL SUBSTANCE M; Krug EG, 2002, WORLD REPORT VIOLENC, P241; Kydd J. W, 2003, HLTH HUMAN RIGHTS, V6, P34, DOI DOI 10.2307/4065429; Lachman P, 2002, CHILD ABUSE NEGLECT, V26, P587, DOI 10.1016/S0145-2134(02)00336-8; LAMING H, 2003, CM5730; LANSDOWN G, 2000, CHILD ABUSE REV, V9, P416, DOI DOI 10.1002/1099-0852(200011/12)9:6; Lansdown G., 2005, EVOLVING CAPACITIES; Leeb RebeccaT., 2008, CHILD MALTREATMENT; MACMILLAN HL, 2008, LANCET          1203, DOI [DOI 10.1016/S0140-6736(08)61708-0, 10.1016/S0140-6736(21)02844-0, DOI 10.1016/S0140-6736(21)02844-0]; MANN JM, 1992, J INFECT DIS, V165, P245, DOI 10.1093/infdis/165.2.245; Marsh P., 1998, FAM GROUP C CHILD WE; Masson JM., 2008, CARE PROFILING STUDY; MOFFIT TE, 1994, DUNEDIN STUDY BIRTH; MORRIS Z, 2005, EVIDENCE BASED PRACT; Newman BS, 2005, CHILD ADOLESC SOC WO, V22, P165, DOI 10.1007/s10560-005-3416-9; Onyango P, 2006, LANCET, V367, P693, DOI 10.1016/S0140-6736(06)68269-X; Organisation of African Unity, 1999, AFR CHART RIGHTS WEL; Pais MS, 2006, LANCET, V367, P689; PAIS MS, 2005, UN HUMAN RIGHTS STAN; Parton N., 1991, GOVERNING FAMILY CHI; Parton Nigel, 2006, SAFEGUARDING CHILDHO; Pemberton S, 2007, PLOS MED, V4, P1567, DOI 10.1371/journal.pmed.0040307; Phinney A., 2003, HEALTH HUM RIGHTS, V6, P64, DOI [10.2307/4065430, DOI 10.2307/4065430]; Pinheiro P.S., 2006, WORLD REPORT VIOLENC; Polnay J, 2007, CHILD PROTECTION REA; *ROYAL COLL PAED C, 2008, ADV CHILDR; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Satcher D, 2005, PEDIATRICS, V115, P1124, DOI 10.1542/peds.2004-2825C; SCHOFIELD G, 2004, HEARING CHILDREN COL, P33; Schofield G., 1996, CHILD PROTECTION VOI; *SECR GEN UN, 2007, REP IND EXP UN STUD; SEN A, 1991, DEV FREEDOM; Sethi D, 2006, INJURIES VIOLENCE EU; Silverman JG, 2004, AM J PUBLIC HEALTH, V94, P951, DOI 10.2105/AJPH.94.6.951; Singh JA, 2007, LANCET, V370, P521, DOI 10.1016/S0140-6736(07)61236-7; Smith DW, 2006, CHILD MALTREATMENT, V11, P354, DOI 10.1177/1077559506292277; Spencer N, 2018, POVERTY CHILD HLTH, DOI [10.1201/9781315385297, DOI 10.1201/9781315385297]; Thoburn J., 1995, PATERNALISM OR PARTN; U.S. Department of Health and Human Services, 2006, CHILD MALTR 2004; UK Children's Commissioners, 2008, UK CHILDR COMM REP U; *UN COMM RIGHTS CH, GEN COMM NUMB 5 GEN; *UN COMM RIGHTS CH, 2002, CONCL OBS UK GREAT B; *UN COMM RIGHTS CH, 2003, GEN COMM NUMB 3 HIV; *UN EUR CENTR AS D, 2005, REG CONS EUR CENTR A; *UNCIEF, 2006, GEN MEAS CONV RIGHTS; UNHCR, 2014, COUNTR CHAPT UNHCR R; UNICEF, 2007, PROTECTING THE WORLD'S CHILDREN: IMPACT OF THE CONVENTION ON THE RIGHTS OF THE CHILD IN DIVERSE LEGAL SYSTEMS, P1; UNICEF, 2007, CHILD POV PERSP OV C; *UNICEF, 2008, UNICEF APPL UK COMM; UNICEF, 2003, LEAG TABL CHILD MALT; *UNICEF, 1997, 4 UNICEF INN RES CTR; *UNICEF, 2000, DEC TRANS; *UNICEF, 2002, CHILD AB RES CAR I R; VESNESKI W, 2008, CHILD FAM SOC W 0911, DOI DOI 10.1111/J.1365-2206.2008.00573; Waldfogel J, 2004, CHILD YOUTH SERV REV, V26, P919, DOI 10.1016/j.childyouth.2004.04.002; Waldfogel J., 1998, FUTURE CHILD PROTECT; Walsh C, 2003, CHILD ABUSE NEGLECT, V27, P1409, DOI 10.1016/j.chiabu.2003.07.002; Waters HR, 2005, HEALTH POLICY, V73, P303, DOI 10.1016/j.healthpol.2004.11.022; Waterston T, 2007, ARCH DIS CHILD, V92, P176, DOI 10.1136/adc.2006.098228; Waterston T, 2006, LANCET, V367, P635, DOI 10.1016/S0140-6736(06)68242-1; Waterston T, 2005, ARCH DIS CHILD, V90, P178, DOI 10.1136/adc.2004.064014; Waterston T, 2001, ARCH DIS CHILD, V85, P180, DOI 10.1136/adc.85.3.180; WEBB E, 1994, ARCH DIS CHILD, V70, P441, DOI 10.1136/adc.70.5.441; WEBB E, 2006, ETHICS LAW SOC, V2; Webb E., 2002, CHILD ABUSE REV, V11, P394, DOI [10.1002/car.760, DOI 10.1002/CAR.760]; Wells K, 2006, CHILD ABUSE NEGLECT, V30, P1175, DOI 10.1016/j.chiabu.2006.09.001; *WHO, 1987, GLOB STRAT PREV CONT; *WHO REG OFF EUR, 2007, VIOL INJ PREV PROGR; Wiklund S., 2006, EUROPEAN J SOCIAL WO, V9, P39, DOI [DOI 10.1080/13691450500480615, 10.1080/13691450500480615]; WORCEL SD, CHILD ABUSE IN PRESS; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization (WHO), 2006, INT VIOL ALC RUSS FE; Wright CJ, 2004, CURR OPIN PEDIATR, V16, P281, DOI 10.1097/01.mop.0000126603.31572.03; Yamin Alicia Ely, 2008, Health Hum Rights, V10, P45; Zambrana RE, 2003, CHILD YOUTH SERV REV, V25, P755, DOI 10.1016/S0190-7409(03)00078-1; [No title captured]	140	102	102	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					332	343		10.1016/S0140-6736(08)61709-2	http://dx.doi.org/10.1016/S0140-6736(08)61709-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19056117				2022-12-28	WOS:000262728100029
J	Leucht, S; Corves, C; Arbter, D; Engel, RR; Li, CB; Davis, JM				Leucht, Stefan; Corves, Caroline; Arbter, Dieter; Engel, Rolf R.; Li, Chunbo; Davis, John M.			Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; COST-EFFECTIVENESS; HALOPERIDOL; RISPERIDONE; QUETIAPINE; EFFICACY; OLANZAPINE; CLOZAPINE; ARIPIPRAZOLE	Background Because of the debate about whether second-generation antipsychotic drugs are better than first-generation antipsychotic drugs, we did a meta-analysis of randomised controlled trials to compare the effects of these two types of drugs in patients with schizophrenia. Methods We compared nine second-generation antipsychotic drugs with first-generation drugs for overall efficacy (main outcome), positive, negative and depressive symptoms, relapse, quality of life, extrapyramidal side-effects, weight gain, and sedation. Findings We included 150 double-blind, mostly short-term, studies, with 21533 participants. We excluded open studies because they systematically favoured second-generation drugs. Four of these drugs were better than first-generation antipsychotic drugs for overall efficacy, with small to medium effect sizes (amisulpride -0.31 [95% Cl -0.44 to -0.19, p<0.0001], clozapine -0.52 [-0.75 to -0.29, p<0.0001], olanzapine -0.28 [-0.38 to -0.18, p<0.0001], and risperidone -0.13 [-0.22 to -0.05, p=0.002]). The other second-generation drugs were not more efficacious than the first-generation drugs, even for negative symptoms. Therefore efficacy on negative symptoms cannot be a core component of atypicality. Second-generation antipsychotic drugs induced fewer extrapyramidal side-effects than did haloperidol (even at low doses). Only a few have been shown to induce fewer extrapyramidal side-effects than low-potency first-generation antipsychotic drugs. With the exception of aripiprazole and ziprasidone, second-generation antipsychotic drugs induced more weight gain, in various degrees, than did haloperidol but not than low-potency first-generation drugs. The second-generation drugs also differed in their sedating properties. We did not note any consistent effects of moderator variables, such as industry sponsorship, comparator dose, or prophylactic antiparkinsonian medication. Interpretation Second-generation antipsychotic drugs differ in many properties and are not a homogeneous class. This meta-analysis provides data for individualised treatment based on efficacy, side-effects, and cost. Funding National Institute of Mental Health.	[Leucht, Stefan; Corves, Caroline; Arbter, Dieter] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherapie, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany; [Corves, Caroline; Engel, Rolf R.] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Li, Chunbo] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Dept Biol Psychiat, Shanghai 200030, Peoples R China; [Li, Chunbo] Tongji Univ, Sch Med, Dept Psychiat, Shanghai 200092, Peoples R China; [Davis, John M.] Univ Illinois, Inst Psychiat, Chicago, IL USA; [Davis, John M.] Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA	Technical University of Munich; University of Munich; University of Munich; Shanghai Jiao Tong University; Tongji University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Leucht, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherapie, Dept Psychiat & Psychotherapy, Ismaningerstr 22, D-81675 Munich, Germany.	Stefan.Leucht@lrz.tum.de	Leucht, Stefan/Y-2408-2019; Young, Alexander/A-1523-2009	Leucht, Stefan/0000-0002-4934-4352; Young, Alexander/0000-0002-9367-9213; Corves, Caroline/0000-0002-3324-7953; Engel, Rolf/0000-0001-8022-3228	National Institute of Mental Health [1-P01M H68580-01-CFDA-#93.242]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH068580] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	A small proportion of JMD's work was supported by a National Institute of Mental Health grant (1-P01M H68580-01-CFDA-#93.242); the authors did most of the work in their own time. We are greatly indebted to the Cochrane Schizophrenia Group; without access to their register of randomised controlled trials, this review would not have been possible. We thank Koksal Alptekin, Michael Berk, Robert Buchanan, Chen Jindong, Robert Conley, Nancy Covell, Lieuwe de Haan, Eduardo Ponde de Sena, Robin Emsley, Susan Essock, Bernd Gallhofer, Alan Gelenberg, Jes Gerlach, Donald Goff, Adolph Heck, Chen-Jee Hong, Matti Huttumen, Marek Jarema, Jeanette Jerrell, Deanna Kelly, Eckhard Klieser, Li Zhongyi, Nicolai Malykhin, Sung Kil Min, Ann Mortimer, Robert Rosenheck, Ronald See, Bilgen Taneli, Donna Wirshing, and Zhang Hong Yan for sending us further information on their studies; AstraZeneca, Astellas, Bristol-Myers Squibb, Eli Lilly, Lundbeck, and Sanofi-Aventis for providing unpublished data: and Michiaki Taniguchi, Makoto Wada, Toshiyuki Watanabe, and Rong Xie for translating Japanese and Chinese articles.	ADAMS CE, 2006, COCHRANE SCHIZOPHREN; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; [Anonymous], 2000, Am J Psychiatry, V157, P1; [Anonymous], 1990, Br J Psychiatry, V156, P412; Arvanitis LA, 1997, BIOL PSYCHIAT, V42, P233, DOI 10.1016/S0006-3223(97)00190-X; Berman RM, 2007, J CLIN PSYCHIAT, V68, P843, DOI 10.4088/JCP.v68n0604; Borenstein M, 2009, INTRO META ANAL; Calabrese JR, 2005, AM J PSYCHIAT, V162, P1351, DOI 10.1176/appi.ajp.162.7.1351; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Davies LM, 2007, BRIT J PSYCHIAT, V191, P14, DOI 10.1192/bjp.bp.106.028654; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; DAVIS JM, 1989, COMPREHENSIVE TXB PS, P1591; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Hartung B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003443.pub2; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Higgins J., 2005, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOYBERG OJ, 1993, ACTA PSYCHIAT SCAND, V88, P395, DOI 10.1111/j.1600-0447.1993.tb03480.x; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; Kane JM, 2007, J CLIN PSYCHIAT, V68, P213, DOI 10.4088/JCP.v68n0206; Kaye JA, 2003, BRIT J CLIN PHARMACO, V56, P569, DOI 10.1046/j.1365-2125.2003.01905.x; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Kemmler G, 2005, ARCH GEN PSYCHIAT, V62, P1305, DOI 10.1001/archpsyc.62.12.1305; Klein DF, 1969, DIAGNOSIS DRUG TREAT; Leucht S, 2002, AM J PSYCHIAT, V159, P180, DOI 10.1176/appi.ajp.159.2.180; Leucht S, 2003, LANCET, V361, P1581, DOI 10.1016/S0140-6736(03)13306-5; LEUCHT S, 2008, MOL PSYCHIATR, DOI DOI 10.1038/SJ.MP.4002136; Leucht S, 2007, NEUROPSYCHOPHARMACOL, V32, P1903, DOI 10.1038/sj.npp.1301325; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; LOHSE MJ, 2005, ARZNEIMITTELVERORDNU, P820; McEvoy JP, 2006, AM J PSYCHIAT, V163, P600, DOI 10.1176/appi.ajp.163.4.600; MCEVOY JP, 1991, ARCH GEN PSYCHIAT, V48, P739; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; MOSHOLDER AD, 1997, 20639 NDA FOOD DRUG; Paton C, 2003, J PSYCHOPHARMACOL, V17, P223, DOI 10.1177/0269881103017002012; Polsky D, 2006, AM J PSYCHIAT, V163, P2047, DOI 10.1176/appi.ajp.163.12.2047; Rosenheck R, 2003, JAMA-J AM MED ASSOC, V290, P2693, DOI 10.1001/jama.290.20.2693; Rosenheck R, 1997, NEW ENGL J MED, V337, P809, DOI 10.1056/NEJM199709183371202; Rosenheck RA, 2005, PSYCHIAT SERV, V56, P85, DOI 10.1176/appi.ps.56.1.85; Rosenheck RA, 2006, AM J PSYCHIAT, V163, P2080, DOI 10.1176/appi.ajp.163.12.2080; SARAI K, 1987, PHARMACOPSYCHIATRY, V20, P38, DOI 10.1055/s-2007-1017128; Schooler N, 2005, AM J PSYCHIAT, V162, P947, DOI 10.1176/appi.ajp.162.5.947; Sernyak M, 2007, PSYCHIAT SERV, V58, P1292, DOI 10.1176/appi.ps.58.10.1292; SOARES BGO, 1999, COCHRANE DB SYST REV, V1; Swartz MS, 2007, AM J PSYCHIAT, V164, P428, DOI 10.1176/appi.ajp.164.3.428; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; VANPUTTEN T, 1990, ARCH GEN PSYCHIAT, V47, P754; WARAICH P, 2002, COCHRANE DB SYST REV, V2; Woodward ND, 2005, INT J NEUROPSYCHOPH, V8, P457, DOI 10.1017/S146114570500516X; Zimbroff DL, 1997, AM J PSYCHIAT, V154, P782	51	1293	1366	5	278	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					31	41		10.1016/S0140-6736(08)61764-X	http://dx.doi.org/10.1016/S0140-6736(08)61764-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19058842				2022-12-28	WOS:000262183800029
J	Sharkey, N				Sharkey, Noel			COMPUTER SCIENCE The Ethical Frontiers of Robotics	SCIENCE			English	Editorial Material									[Sharkey, Noel] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England	University of Sheffield	Sharkey, N (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England.	noel@dcs.shef.ac.uk						Blum D, 2003, LOVE GOON PARK H HAR; Breazeal C, 2003, ROBOT AUTON SYST, V42, P167, DOI 10.1016/S0921-8890(02)00373-1; BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; Fong T, 2003, ROBOT AUTON SYST, V42, P143, DOI 10.1016/S0921-8890(02)00372-X; Forlizzi J, 2004, HUM-COMPUT INTERACT, V19, P25, DOI 10.1207/s15327051hci1901&2_3; *IFR STAT DEP, WORLD ROB REP 2008; *NAT RES COUNC COM, 2005, AUT VEH SUPP NAV OP; Sharkey N, 2008, IEEE INTELL SYST, V23, P14, DOI 10.1109/MIS.2008.60; Sharkey N, 2006, ARTIF INTELL REV, V25, P9, DOI 10.1007/s10462-007-9048-z; Sparrow R., 2002, Ethics and Information Technology, V4, P305, DOI 10.1023/A:1021386708994; SPARROW R, 2004, MIND MACH, V16, P141; TANAKA F, 2007, P NATL ACAD SCI USA, V194, P46; *UN PRESS INT, 2008, BAE SYST TECH BOOSTS; *US DEP DEF, 2005, LSD AT L DEF SYST WA; US Department of Defense, 2007, UNM SYST ROADM 2007	15	82	84	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1800	1801		10.1126/science.1164582	http://dx.doi.org/10.1126/science.1164582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	385FF	19095930				2022-12-28	WOS:000261799400041
J	Blossom, DB; Kallen, AJ; Patel, PR; Elward, A; Robinson, L; Gao, GP; Langer, R; Perkins, KM; Jaeger, JL; Kurkjian, KM; Jones, M; Schillie, SF; Shehab, N; Ketterer, D; Venkataraman, G; Kishimoto, TK; Shriver, Z; McMahon, AW; Austen, KF; Kozlowski, S; Srinivasan, A; Turabelidze, G; Gould, CV; Arduino, MJ; Sasisekharan, R				Blossom, David B.; Kallen, Alexander J.; Patel, Priti R.; Elward, Alexis; Robinson, Luke; Gao, Ganpan; Langer, Robert; Perkins, Kiran M.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Jones, Marilyn; Schillie, Sarah F.; Shehab, Nadine; Ketterer, Daniel; Venkataraman, Ganesh; Kishimoto, Takashi Kei; Shriver, Zachary; McMahon, Ann W.; Austen, K. Frank; Kozlowski, Steven; Srinivasan, Arjun; Turabelidze, George; Gould, Carolyn V.; Arduino, Matthew J.; Sasisekharan, Ram			Outbreak of Adverse Reactions Associated with Contaminated Heparin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANAPHYLACTOID REACTIONS; CLINICAL EVENTS; HEMODIALYSIS	Background: In January 2008, the Centers for Disease Control and Prevention began a nationwide investigation of severe adverse reactions that were first detected in a single hemodialysis facility. Preliminary findings suggested that heparin was a possible cause of the reactions. Methods: Information on clinical manifestations and on exposure was collected for patients who had signs and symptoms that were consistent with an allergic-type reaction after November 1, 2007. Twenty-one dialysis facilities that reported reactions and 23 facilities that reported no reactions were included in a case-control study to identify facility-level risk factors. Unopened heparin vials from facilities that reported reactions were tested for contaminants. Results: A total of 152 adverse reactions associated with heparin were identified in 113 patients from 13 states from November 19, 2007, through January 31, 2008. The use of heparin manufactured by Baxter Healthcare was the factor most strongly associated with reactions (present in 100.0% of case facilities vs. 4.3% of control facilities, P<0.001). Vials of heparin manufactured by Baxter from facilities that reported reactions contained a contaminant identified as oversulfated chondroitin sulfate (OSCS). Adverse reactions to the OSCS-contaminated heparin were often characterized by hypotension, nausea, and shortness of breath occurring within 30 minutes after administration. Of 130 reactions for which information on the heparin lot was available, 128 (98.5%) occurred in a facility that had OSCS-contaminated heparin on the premises. Of 54 reactions for which the lot number of administered heparin was known, 52 (96.3%) occurred after the administration of OSCS-contaminated heparin. Conclusions: Heparin contaminated with OSCS was epidemiologically linked to adverse reactions in this nationwide outbreak. The reported clinical features of many of the cases further support the conclusion that contamination of heparin with OSCS was the cause of the outbreak.	[Blossom, David B.; Kallen, Alexander J.; Patel, Priti R.; Schillie, Sarah F.; Shehab, Nadine; Srinivasan, Arjun; Gould, Carolyn V.; Arduino, Matthew J.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Blossom, David B.; Kallen, Alexander J.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Schillie, Sarah F.] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA 30333 USA; [Blossom, David B.; Kallen, Alexander J.; Perkins, Kiran M.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Schillie, Sarah F.; Ketterer, Daniel] Ctr Dis Control & Prevent, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Elward, Alexis] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Jones, Marilyn] BJC Healthcare, St Louis, MO USA; [Turabelidze, George] Missouri Dept Hlth & Senior Serv, St Louis, MO USA; [Robinson, Luke; Gao, Ganpan; Langer, Robert; Sasisekharan, Ram] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Robinson, Luke; Gao, Ganpan; Langer, Robert; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Venkataraman, Ganesh; Kishimoto, Takashi Kei; Shriver, Zachary] Momenta Pharmaceut, Cambridge, MA USA; [McMahon, Ann W.; Kozlowski, Steven] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Austen, K. Frank] Brigham & Womens Hosp, Boston, MA 02115 USA; [Austen, K. Frank] Harvard Univ, Sch Med, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; St. Louis Children's Hospital; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); US Food & Drug Administration (FDA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Patel, PR (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS-A31, Atlanta, GA 30333 USA.	ppatel@cdc.gov	Arduino, Matthew/C-1461-2012; Moore, Jeff/W-5653-2019	Arduino, Matthew/0000-0001-7072-538X; Shehab, Nadine/0000-0001-8700-8539	National Institutes of Health [GM57073, HL080279]; Momenta Pharmaceuticals and Scientific Protein; Momenta Pharmaceuticals; SAGE Products; Pfizer; Lilly; Monsanto; Walgreens; General Electric; Abbott; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057073, R37GM057073, T32GM008334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Momenta Pharmaceuticals and Scientific Protein; Momenta Pharmaceuticals; SAGE Products(General Electric); Pfizer(Pfizer); Lilly(Eli Lilly); Monsanto; Walgreens; General Electric(General Electric); Abbott(Abbott Laboratories); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The CDC investigation had no external funding. The laboratory analysis was supported in part by grants from the National Institutes of Health (GM57073 and HL080279, to Dr. Sasisekharan).; Dr. Venkataraman reports being an employee of Momenta Pharmaceuticals and holding equity in the company, which performs the analysis and characterization of complex mixtures, including heparin, and being an inventor on patent applications for Momenta Pharmaceuticals; Dr. Kishimoto, being an employee of, holding equity in, and being an inventor on patent applications for Momenta Pharmaceuticals; Dr. Langer, receiving consulting fees from Momenta Pharmaceuticals and Scientific Protein, having equity in Momenta Pharmaceuticals, and serving on a paid board of Momenta Pharmaceuticals; Dr. Shriver, being an employee of Momenta Pharmaceuticals and holding equity in the company; Dr. Sasisekharan, holding equity in Momenta Pharmaceuticals and receiving consulting fees or serving on a paid board of Momenta Pharmaceuticals and Scientific Protein Labs; Dr. Austen, receiving consulting fees from Momenta Pharmaceuticals; Dr. Elward, receiving consulting fees or serving on a paid advisory board for Trinity and receiving grant support from SAGE Products; and Dr. Schillie, holding equity in Pfizer, Lilly, Monsanto, Walgreens, General Electric, and Abbott. No other potential conflict of interest relevant to this article was reported.; The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U. S. Department of Health and Human Services.; We thank the many health care professionals at facilities at which adverse events occurred for reporting to public health authorities and for sending heparin vials for laboratory testing; the state epidemiologists and representatives of the End Stage Renal Disease Network for their assistance in facilitating contact between facilities with adverse events and the CDC; Laura Governale ( IMS Health), Gary Warns ( Gambro), and Bill Singley ( Minntech) for the timely information they provided; and representatives of the FDA for their close collaboration, especially in the early stages of this outbreak investigation, in particular, Karen Deasy and Tarun Mallick, who served as important links between the FDA and the CDC and furthered our collective efforts.	Arduino MJ, 2000, SEMIN DIALYSIS, V13, P86, DOI 10.1046/j.1525-139x.2000.00025.x; Berkun Y, 2004, CLIN EXP ALLERGY, V34, P1916, DOI 10.1111/j.1365-2222.2004.02129.x; Bircher AJ, 2006, ALLERGY, V61, P1432, DOI 10.1111/j.1398-9995.2006.01227.x; Bishu K, 2006, CLIN J AM SOC NEPHRO, V1, P820, DOI 10.2215/CJN.00060106; Bottio T, 2003, J THORAC CARDIOV SUR, V126, P1194, DOI 10.1016/S0022-5223(03)00813-4; *CTR MED MED SERV, 2008, INF DIAL FAC COMP; Dias MBS, 2008, INFECT CONT HOSP EP, V29, P125, DOI 10.1086/526440; Ebo DG, 2006, ALLERGY, V61, P211, DOI 10.1111/j.1398-9995.2006.00982.x; *FDA, 2008, INF ADV EV REP HEP; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Leypoldt JK, 2002, KIDNEY INT, V61, P266, DOI 10.1046/j.1523-1755.2002.00099.x; Ludwig RJ, 2006, MINI-REV MED CHEM, V6, P1009, DOI 10.2174/138955706778195180; Maharaj Chris, 2004, Curr Opin Anaesthesiol, V17, P35, DOI 10.1097/00001503-200402000-00007; PEGUES DA, 1992, KIDNEY INT, V42, P1232, DOI 10.1038/ki.1992.409; Schwartz LB, 2008, NEW ENGL J MED, V358, P2505, DOI 10.1056/NEJMe0803599; Vonberg RP, 2007, J HOSP INFECT, V65, P15, DOI 10.1016/j.jhin.2006.09.018; Walenga Jeanine M, 2007, Clin Adv Hematol Oncol, V5, P759; Wan S, 1999, ANN THORAC SURG, V68, P1230, DOI 10.1016/S0003-4975(99)00701-8; ZAKKAR M, 2007, CARDIOPULMONARY BYPA, P321; 2008, MMWR MORB MORTAL WKL, V57, P124; 2005, MMWR MORB MORTAL WKL, V54, P269	22	188	196	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2674	2684		10.1056/NEJMoa0806450	http://dx.doi.org/10.1056/NEJMoa0806450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19052120	Green Accepted			2022-12-28	WOS:000261757300007
J	Godderis, Y; Donnadieu, Y				Godderis, Yves; Donnadieu, Yannick			Carbon cycling and snowball Earth	NATURE			English	Letter							FEEDBACK		[Godderis, Yves] Observ Midi Pyrenees, CNRS, LMTG, F-31400 Toulouse, France; [Donnadieu, Yannick] CEA, CNRS, LSCE, F-91191 Gif Sur Yvette, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Godderis, Y (corresponding author), Observ Midi Pyrenees, CNRS, LMTG, F-31400 Toulouse, France.	godderis@lmtg.obs-mip.fr	Donnadieu, Yannick/G-7546-2016	Donnadieu, Yannick/0000-0002-7315-2684				Berner RA, 1997, GEOLOGY, V25, P955, DOI 10.1130/0091-7613(1997)025<0955:TNFMBA>2.3.CO;2; Donnadieu Y, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001278; Donnadieu Y, 2004, NATURE, V428, P303, DOI 10.1038/nature02408; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; Peltier WR, 2007, NATURE, V450, P813, DOI 10.1038/nature06354; Ridgwell AJ, 2003, SCIENCE, V302, P859, DOI 10.1126/science.1088342; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776	7	6	6	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224								10.1038/nature07653	http://dx.doi.org/10.1038/nature07653			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092867	Bronze			2022-12-28	WOS:000261768300031
J	Gormley, GJ; Dempster, M; Best, R				Gormley, Gerard J.; Dempster, Martin; Best, Rachael			Right-left discrimination among medical students: questionnaire and psychometric study	BRITISH MEDICAL JOURNAL			English	Article							SPATIAL ABILITY; MENTAL ROTATION; SEX-DIFFERENCES; HANDEDNESS; SITE	Objective To determine medical students' self awareness and ability to discriminate right from left; to identify characteristics associated with this ability; and to identify any techniques used to aid discrimination. Design Questionnaire and psychometric study. Setting Undergraduate medical school, Northern Ireland. Participants 290 first year undergraduate students. Main outcome measure Medical students' ability to discriminate right from left using the Bergen right- left discrimination test. Results Test scores ranged from 31 to 143 on a scale of 0144 ( mean 112 ( standard deviation 22.2)). Male students significantly outperformed female students ( 117.18 ( 26.96) v 110.80 ( 28.94)). Students who wanted to be surgeons performed significantly better than those who wanted to be general practitioners or medical doctors ( 119.87 ( 25.15) v 110.55 ( 27.36) v 112.50 ( 26.88)). The interaction effect for sex and career wishes was not significant ( P= 0.370). Students who used learnt techniques to help them discriminate scored significantly less than those who did not ( P< 0.001). Students had greater difficulty in discriminating right from left when looking at the forward view rather than the back view ( P< 0.001). Conclusions Male students were better than female students at distinguishing right from left, and aspiring surgeons were better than aspiring general practitioners or medical doctors. Students had more difficulty with the forward view than the back view. The ability to discriminate right from left calls on several higher functions including memory, visuospatial processing, language, integration of sensory information, and sometimes mental rotation.(1) Some people have difficulty in distinguishing right from left in themselves and in others.(23) Correctly discriminating right from left is important in the practice of medicine. Confusing a patient's right side from their left can result in surgery, procedures, and investigations being carried out on the wrong side.(4) Such mistakes may occur more frequently than is reported,(4) and prevention should start at undergraduate level.(5) Medical students perform better than psychology or law students in right- left discrimination tests, but data are limited.(6) We aimed to assess medical students' perceived and actual right- left discriminatory ability; to identify characteristics associated with this ability; and to identify any techniques used to aid discrimination.	[Gormley, Gerard J.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Med Educ, Belfast, Antrim, North Ireland; [Dempster, Martin; Best, Rachael] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Gormley, GJ (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Med Educ, Belfast, Antrim, North Ireland.	g.gormley@qub.ac.uk	Dempster, Martin/D-7188-2013	Dempster, Martin/0000-0001-9499-3186	Association for the Study of Medical Education	Association for the Study of Medical Education	Association for the Study of Medical Education (small project grant).	Auer T, 2008, LATERALITY, V13, P427, DOI 10.1080/13576500802114120; Benton AL, 1979, CLIN NEUROPSYCHOLOGY; *GEN MED COUNC, 1993, TOM DOCT REC CHANG U; Gibbs VC, 2005, SURG CLIN N AM, V85, P1307, DOI 10.1016/j.suc.2005.09.007; Gibson J B, 1973, Nature, V243, P482, DOI 10.1038/243482b0; GOLDSTEIN D, 1990, MEM COGNITION, V18, P546, DOI 10.3758/BF03198487; HANNAY HJ, 1990, PERCEPT MOTOR SKILL, V70, P451, DOI 10.2466/PMS.70.2.451-457; Johnson BW, 2002, NEUROREPORT, V13, P1929, DOI 10.1097/00001756-200210280-00020; KOHN L, 2000, TO ERR IS HUMAN BUIL; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; MARTINO G, 1995, BRAIN COGNITION, V29, P66, DOI 10.1006/brcg.1995.1268; MCKEEVER WF, 1986, CORTEX, V22, P521, DOI 10.1016/S0010-9452(86)80013-2; Ofte SH, 2002, J CLIN EXP NEUROPSYC, V24, P82, DOI 10.1076/jcen.24.1.82.966; Ofte SH, 2002, SCAND J PSYCHOL, V43, P213, DOI 10.1111/1467-9450.00289; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Seiden SC, 2006, ARCH SURG-CHICAGO, V141, P931, DOI 10.1001/archsurg.141.9.931; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; SILVERMAN AJ, 1966, J PSYCHOSOM RES, V10, P151, DOI 10.1016/0022-3999(66)90058-4; SNYDER TJ, 1991, DEV NEUROPSYCHOL, V7, P219, DOI 10.1080/87565649109540489	19	16	16	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2826	10.1136/bmj.a2826	http://dx.doi.org/10.1136/bmj.a2826			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SV	19088140	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000262184900002
J	Shore, GC; Nguyen, M				Shore, Gordon C.; Nguyen, Mai			Bcl-2 Proteins and Apoptosis: Choose Your Partner	CELL			English	Editorial Material							BAX	The Bcl-2 family protein Bax is a key effector of apoptosis. Lovell et al. ( 2008) now describe the reconstitution and regulation in liposomes of tBid-mediated membrane penetration and oligomerization of Bax. These and other recent studies shed new light on the control of permeabilization of the mitochondrial outer membrane during apoptosis.	[Shore, Gordon C.; Nguyen, Mai] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Shore, Gordon C.; Nguyen, Mai] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Shore, GC (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	gordon.shore@mcgill.ca						Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	9	44	47	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 12	2008	135	6					1004	1006		10.1016/j.cell.2008.11.029	http://dx.doi.org/10.1016/j.cell.2008.11.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070569	Bronze			2022-12-28	WOS:000261642800014
J	Blow, N				Blow, Nathan			Cell imaging: New ways to see a smaller world	NATURE			English	Editorial Material							MICROSCOPY											Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Lord SJ, 2008, J AM CHEM SOC, V130, P9204, DOI 10.1021/ja802883k; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929	6	20	22	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					825	830		10.1038/456825a	http://dx.doi.org/10.1038/456825a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079061	Bronze			2022-12-28	WOS:000261559900058
J	Thomson, G; Wilson, N; Edwards, R; Woodward, A				Thomson, George; Wilson, Nick; Edwards, Richard; Woodward, Alistair			Should smoking in outside public spaces be banned? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCHOOL; HOME		[Thomson, George; Wilson, Nick; Edwards, Richard] Univ Otago, Wellington, New Zealand; [Woodward, Alistair] Univ Auckland, Auckland 1, New Zealand	University of Otago; University of Auckland	Thomson, G (corresponding author), Univ Otago, Box 7343, Wellington, New Zealand.	george.thomson@otago.ac.nz	Edwards, Richard/O-4771-2017	Edwards, Richard/0000-0003-2264-9823; Woodward, Alistair/0000-0001-5425-6018				Alesci NL, 2003, PREV MED, V36, P272, DOI 10.1016/S0091-7435(02)00029-4; *DEP ED, 1995, DRUG PREV SCH ANN 8; Fong GT, 2004, NICOTINE TOB RES, V6, P341, DOI 10.1080/14622200412331320743; Gilpin EA, 2004, TOB CONTROL, V13, P96, DOI 10.1136/tc.2003.007054; Griffiths J, 2005, SMOKE FREE SCOTLAND; *HLTH SPONS COUNC, 2008, ACC SMOK OUTD PUBL P; Klein EG, 2007, NICOTINE TOB RES, V9, pS49, DOI 10.1080/14622200601083467; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Levy DT, 2004, TOB CONTROL, V13, P258, DOI 10.1136/tc.2003.006056; Mackay J, 2006, TOBACCO ATLAS; McCaul KD, 2006, ADDICT BEHAV, V31, P42, DOI 10.1016/j.addbeh.2005.04.004; Milton B, 2004, PUBLIC HEALTH, V118, P247, DOI 10.1016/j.puhe.2003.10.006; *NAT CHILDC ACCR C, 2006, SMOK FREE ENV POL; New Zealand Government, 2003, SMOK FREE ENV AM ACT; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; *POP, 2007, BBC DAIL POL SHOW PO; *QUIT VICT, 2007, QUIT GETS SMOK PLAYG; Repace J., 2008, W MITCHELL LAW, V34, P1621; Stewart-Knox BJ, 2005, BRIT J SOC PSYCHOL, V44, P397, DOI 10.1348/014466604X18073; Tyas SL, 1998, TOB CONTROL, V7, P409, DOI 10.1136/tc.7.4.409; United Nations Office of the High Commissioner, 1990, CONV RIGHTS CHILD; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Wilson Nick, 2007, N Z Med J, V120, pU2624	23	41	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2008	337								a2806	10.1136/bmj.a2806	http://dx.doi.org/10.1136/bmj.a2806			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CB	19074220				2022-12-28	WOS:000262776900007
J	Hopwood, N				Hopwood, Nick			Model politics	LANCET			English	Editorial Material									[Hopwood, Nick] Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge CB2 3RH, England	University of Cambridge	Hopwood, N (corresponding author), Univ Cambridge, Dept Hist & Philosophy Sci, Free School Lane, Cambridge CB2 3RH, England.	ndh12@cam.ac.uk		Hopwood, Nick/0000-0001-7069-7497				de Chadarevian Soraya, 2004, MODELS 3 DIMENSION S; Hopwood N., 2002, EMBRYOS WAX MODELS Z; Hopwood N, 2007, MED HIST, V51, P279, DOI 10.1017/S0025727300000144; SCHNALKE T, 1995, DIS WAX HIST MED MOU	4	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1946	1947		10.1016/S0140-6736(08)61832-2	http://dx.doi.org/10.1016/S0140-6736(08)61832-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380NE	19068512				2022-12-28	WOS:000261471600012
J	Lewis, KW; Aharonson, O; Grotzinger, JP; Kirk, RL; McEwen, AS; Suer, TA				Lewis, Kevin W.; Aharonson, Oded; Grotzinger, John P.; Kirk, Randolph L.; McEwen, Alfred S.; Suer, Terry-Ann			Quasi-Periodic Bedding in the Sedimentary Rock Record of Mars	SCIENCE			English	Article							ARABIA TERRA; ATMOSPHERE; EVOLUTION; CRATERS; CYCLES	Widespread sedimentary rocks on Mars preserve evidence of surface conditions different from the modern cold and dry environment, although it is unknown how long conditions favorable to deposition persisted. We used 1- meter stereo topographic maps to demonstrate the presence of rhythmic bedding at several outcrops in the Arabia Terra region. Repeating beds are similar to 10 meters thick, and one site contains hundreds of meters of strata bundled into larger units at a similar to 10: 1 thickness ratio. This repetition likely points to cyclicity in environmental conditions, possibly as a result of astronomical forcing. If deposition were forced by orbital variation, the rocks may have been deposited over tens of millions of years.	[Lewis, Kevin W.; Aharonson, Oded; Grotzinger, John P.; Suer, Terry-Ann] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Kirk, Randolph L.] US Geol Survey, Flagstaff, AZ 86004 USA; [McEwen, Alfred S.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	California Institute of Technology; United States Department of the Interior; United States Geological Survey; University of Arizona	Lewis, KW (corresponding author), CALTECH, Div Geol & Planetary Sci, 150-21, Pasadena, CA 91125 USA.	klewis@gps.caltech.edu	Lewis, Kevin/E-5557-2012	Aharonson, Oded/0000-0001-9930-2495	NASA's Mars Data Analysis Program; NASA Earth and Space Science Fellowship	NASA's Mars Data Analysis Program(National Aeronautics & Space Administration (NASA)); NASA Earth and Space Science Fellowship	Supported by NASA's Mars Data Analysis Program and by the NASA Earth and Space Science Fellowship program. We thank two anonymous reviewers for helpful comments and suggestions.	Carlson J, 2001, SEDIMENTOLOGY, V48, P1331, DOI 10.1046/j.1365-3091.2001.00426.x; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; Christensen, 1992, MARS, P686; CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; Edgett KS, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001587; Edgett KS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016515; FANALE FP, 1994, ICARUS, V111, P305, DOI 10.1006/icar.1994.1147; FISCHER AG, 1986, ANNU REV EARTH PL SC, V14, P351; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Hinnov LA, 2000, ANNU REV EARTH PL SC, V28, P419, DOI 10.1146/annurev.earth.28.1.419; HOUSE MR, 1995, GEOL SOC SP, P1, DOI 10.1144/GSL.SP.1995.085.01.01; Hynek BM, 2003, GEOLOGY, V31, P757, DOI 10.1130/G19607.1; Kahn R. A., 1992, MARS, P1017; Kieffer H. H., 1992, MARS, P1180; Kirk RL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003000; Landis GA, 2000, J GEOPHYS RES-PLANET, V105, P1855, DOI 10.1029/1999JE001029; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Malamud BD, 2006, J HYDROL, V322, P168, DOI 10.1016/j.jhydrol.2005.02.032; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; Milkovich SM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002349; Schwarzacher W, 2000, EARTH-SCI REV, V50, P51, DOI 10.1016/S0012-8252(99)00070-7; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WAITT RB, 1980, J GEOL, V88, P653, DOI 10.1086/628553; Ward W. R., 1992, MARS, P298; WARD WR, 1974, J GEOPHYS RES, V79, P3387, DOI 10.1029/JC079i024p03387; WEEDOM GP, 2003, TIME SERIES ANAL CYC; Wilkinson BH, 1998, GEOL SOC AM BULL, V110, P1075, DOI 10.1130/0016-7606(1998)110<1075:MHMPAR>2.3.CO;2	30	100	101	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1532	1535		10.1126/science.1161870	http://dx.doi.org/10.1126/science.1161870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056983				2022-12-28	WOS:000261377400046
J	McMahon, A; Supatto, W; Fraser, SE; Stathopoulos, A				McMahon, Amy; Supatto, Willy; Fraser, Scott E.; Stathopoulos, Angelike			Dynamic Analyses of Drosophila Gastrulation Provide Insights into Collective Cell Migration	SCIENCE			English	Article							MORPHOGENESIS; FGF; HEARTLESS; MOVEMENTS; MESODERM; INTERCALATION; ZEBRAFISH; BEHAVIOR; EMBRYOS	The concerted movement of cells from different germ layers contributes to morphogenesis during early embryonic development. Using an optimized imaging approach and quantitative methods, we analyzed the trajectories of hundreds of ectodermal cells and internalized mesodermal cells within Drosophila embryos over 2 hours during gastrulation. We found a high level of cellular organization, with mesoderm cell movements correlating with some but not all ectoderm movements. During migration, the mesoderm population underwent two ordered waves of cell division and synchronous cell intercalation, and cells at the leading edge stably maintained position. Fibroblast growth factor ( FGF) signaling guides mesodermal cell migration; however, we found some directed dorsal migration in an FGF receptor mutant, which suggests that additional signals are involved. Thus, decomposing complex cellular movements can provide detailed insights into collective cell migration.	[McMahon, Amy; Stathopoulos, Angelike] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Supatto, Willy; Fraser, Scott E.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Stathopoulos, A (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	angelike@caltech.edu	Fraser, Scott/Y-3406-2019; Supatto, Willy/B-3720-2013	Fraser, Scott/0000-0002-5377-0223; Supatto, Willy/0000-0002-4562-9166	NIH [R01 GM078542]; Searle Scholars Program; March of Dimes; Basil O'Conner Starter Scholar Award [5-FY06-12]; Caltech Beckman Institute; NIH Center for Excellence in Genomic Science [P50 HG004071]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; March of Dimes(March of Dimes); Basil O'Conner Starter Scholar Award(March of Dimes); Caltech Beckman Institute; NIH Center for Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Levine and E. Meyerowiz for comments on the manuscript, M. Liebling for advice on Imaris and Matlab, and the Caltech Biological Imaging Center for sharing equipment. This work was supported by grants to A. S. from NIH (R01 GM078542), the Searle Scholars Program, and the March of Dimes (Basil O'Conner Starter Scholar Award, 5-FY06-12), and grants to S. F. from the Caltech Beckman Institute and NIH (Center for Excellence in Genomic Science grant P50 HG004071).	Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; Montell DJ, 2006, CURR OPIN GENET DEV, V16, P374, DOI 10.1016/j.gde.2006.06.010; Murray MJ, 2007, DEVELOPMENT, V134, P3975, DOI 10.1242/dev.005389; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schumacher S, 2004, DEVELOPMENT, V131, P2631, DOI 10.1242/dev.01149; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Stern C.D., 2004, GASTRULATION CELLS E; Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wilson R, 2005, DEVELOPMENT, V132, P491, DOI 10.1242/dev.01603; Wilson R, 2000, PHILOS T ROY SOC B, V355, P891, DOI 10.1098/rstb.2000.0625; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005	22	115	118	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1546	1550		10.1126/science.1167094	http://dx.doi.org/10.1126/science.1167094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056986	Green Accepted			2022-12-28	WOS:000261377400050
J	Schweitzer, GE				Schweitzer, Glenn E.			POLICY Science Policy in Kazakhstan	SCIENCE			English	Editorial Material												gschweitzer@nas.edu						National Research Council, 2007, SCI TECHNOLOGY KAZAK, DOI [10.17226/11808, DOI 10.17226/11808]; NAZARBAYER N, 2006, 60 ANN M NAT AC SCI; Nazarbayev NursultanA., 2008, KAZAKHSTAN WAY; *OECD PUBL WORLD B, 2007, HIGH ED KAZ REV NAT	4	3	4	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1474	1475		10.1126/science.1165164	http://dx.doi.org/10.1126/science.1165164			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	379DU	19056962				2022-12-28	WOS:000261377400025
J	Jamerson, K; Weber, MA; Bakris, GL; Dahlof, B; Pitt, B; Shi, V; Hester, A; Gupte, J; Gatlin, M; Velazquez, EJ				Jamerson, Kenneth; Weber, Michael A.; Bakris, George L.; Dahlof, Bjorn; Pitt, Bertram; Shi, Victor; Hester, Allen; Gupte, Jitendra; Gatlin, Marjorie; Velazquez, Eric J.		ACCOMPLISH Trial Investigators	Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AVOIDING CARDIOVASCULAR EVENTS; COMBINATION THERAPY; SYSTOLIC HYPERTENSION; ACCOMPLISH TRIAL; ACE-INHIBITORS; BLOOD-PRESSURE; NITRIC-OXIDE	Background: The optimal combination drug therapy for hypertension is not established, although current U.S. guidelines recommend inclusion of a diuretic. We hypothesized that treatment with the combination of an angiotensin-converting-enzyme (ACE) inhibitor and a dihydropyridine calcium-channel blocker would be more effective in reducing the rate of cardiovascular events than treatment with an ACE inhibitor plus a thiazide diuretic. Methods: In a randomized, double-blind trial, we assigned 11,506 patients with hypertension who were at high risk for cardiovascular events to receive treatment with either benazepril plus amlodipine or benazepril plus hydrochlorothiazide. The primary end point was the composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, hospitalization for angina, resuscitation after sudden cardiac arrest, and coronary revascularization. Results: The baseline characteristics of the two groups were similar. The trial was terminated early after a mean follow-up of 36 months, when the boundary of the prespecified stopping rule was exceeded. Mean blood pressures after dose adjustment were 131.6/73.3 mm Hg in the benazepril-amlodipine group and 132.5/74.4 mm Hg in the benazepril-hydrochlorothiazide group. There were 552 primary-outcome events in the benazepril-amlodipine group (9.6%) and 679 in the benazepril-hydrochlorothiazide group (11.8%), representing an absolute risk reduction with benazepril-amlodipine therapy of 2.2% and a relative risk reduction of 19.6% (hazard ratio, 0.80, 95% confidence interval [CI], 0.72 to 0.90; P<0.001). For the secondary end point of death from cardiovascular causes, nonfatal myocardial infarction, and nonfatal stroke, the hazard ratio was 0.79 (95% CI, 0.67 to 0.92; P=0.002). Rates of adverse events were consistent with those observed from clinical experience with the study drugs. Conclusions: The benazepril-amlodipine combination was superior to the benazepril-hydrochlorothiazide combination in reducing cardiovascular events in patients with hypertension who were at high risk for such events. (ClinicalTrials.gov number, NCT00170950.).	[Jamerson, Kenneth; Pitt, Bertram] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI 48106 USA; [Weber, Michael A.] SUNY Downstate Med Coll, Brooklyn, NY 11203 USA; [Bakris, George L.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Dahlof, Bjorn] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden; [Shi, Victor; Hester, Allen; Gupte, Jitendra; Gatlin, Marjorie] Novartis Pharmaceut, E Hanover, NJ USA; [Velazquez, Eric J.] Duke Univ, Sch Med, Durham, NC USA	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Chicago; Sahlgrenska University Hospital; Novartis; Duke University	Jamerson, K (corresponding author), Univ Michigan Hlth Syst, Div Cardiovasc Med, 24 Frank Lloyd Wright Dr,Lobby M, Ann Arbor, MI 48106 USA.	emarshal@umich.edu		Palomaki, Ari/0000-0001-9759-4332	Novartis; Merck; Daiichi Sankyo; Abbott; Bristol-Myers Squibb; GlaxoSmithKline; King Pharmaceuticals; Boehringer Ingelheim; Forest Pharmaceuticals; Sanofi-Aventis; Gilead; Takeda Pharmaceuticals North America; Pfizer; Cardiokinetix; NovaCardia; Medtronic Foundation; AstraZeneca	Novartis(Novartis); Merck(Merck & Company); Daiichi Sankyo(Daiichi Sankyo Company Limited); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); King Pharmaceuticals; Boehringer Ingelheim(Boehringer Ingelheim); Forest Pharmaceuticals; Sanofi-Aventis(Sanofi-Aventis); Gilead(Gilead Sciences); Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); Pfizer(Pfizer); Cardiokinetix; NovaCardia; Medtronic Foundation; AstraZeneca(AstraZeneca)	Supported by Novartis.; Dr. Jamerson reports receiving consulting fees from Novartis, Merck, and Daiichi Sankyo, lecture fees from Novartis, Abbott, Bristol-Myers Squibb, GlaxoSmithKline, and Merck, and research support from Novartis and King Pharmaceuticals; Dr. Weber, receiving lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Forest Pharmaceuticals, GlaxoSmithKline, Novartis, and Sanofi-Aventis and consulting fees from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Forest Pharmaceuticals, Gilead, Novartis, Takeda Pharmaceuticals North America, and GlaxoSmithKline; Dr. Dahlf, receiving consulting fees from Novartis, Daiichi Sankyo, and Boehringer Ingleheim and lecture fees from Novartis, Boehringer Ingelheim, Pfizer, and Merck; Dr. Velazquez, receiving consulting and lecture fees from Novartis and grant support from Novartis, Cardiokinetix, NovaCardia, and Medtronic Foundation; Dr. Pitt, receiving consulting fees from Pfizer, Novartis, Takeda Pharmaceuticals North America, AstraZeneca, and Merck; Dr. Bakris, receiving consulting fees from Novartis, Forest Pharmaceuticals, GlaxoSmithKline, and Daiichi Sankyo, lecture fees from Novartis and Forest Pharmaceuticals, and grant support from GlaxoSmithKline; Drs. Gatlin, Shi, and Hester and Mr. Gupte, being employees of Novartis; and Drs. Shi and Hester and Mr. Gupte, owning stock in Novartis. No other potential conflict of interest relevant to this article was reported.; We thank Dr. Tom Greene of the University of Utah for his independent review of the final analysis on behalf of the Executive Committee, and Roxzana Y. Kelly and Linda Staikos for tireless technical support on the manuscript.	Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; Barzilay Joshua I, 2004, J Clin Hypertens (Greenwich), V6, P116, DOI 10.1111/j.1524-6175.2004.03216.x; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Jamerson KA, 2004, AM J HYPERTENS, V17, P793, DOI 10.1016/j.amjhyper.2004.05.004; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LUSCHER TF, 1995, CARDIOVASC DRUG THER, V9, P509, DOI 10.1007/BF00877863; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mason RP, 2005, AM J MED, V118, p54S, DOI 10.1016/j.amjmed.2005.09.021; Neutel JM, 2004, AM J HYPERTENS, V17, P37, DOI 10.1016/j.amjhyper.2003.08.002; Raicu M, 1997, J SUBMICR CYTOL PATH, V29, P317; Siragy HM, 2006, J CARDIOVASC PHARM, V47, P636, DOI 10.1097/01.fjc.0000211750.01326.b3; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Turnbull F, 2003, LANCET, V362, P1527; Weber MA, 2007, BLOOD PRESSURE, V16, P13, DOI 10.1080/08037050701217643; Zhang XP, 1998, CIRCULATION, V97, P576; Zhou MS, 2008, J HYPERTENS, V26, P494, DOI 10.1097/HJH.0b013e3282f3e39d	19	1457	1575	0	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2417	2428		10.1056/NEJMoa0806182	http://dx.doi.org/10.1056/NEJMoa0806182			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378MT	19052124				2022-12-28	WOS:000261325900003
J	Konca, AO; Avouac, JP; Sladen, A; Meltzner, AJ; Sieh, K; Fang, P; Li, ZH; Galetzka, J; Genrich, J; Chlieh, M; Natawidjaja, DH; Bock, Y; Fielding, EJ; Ji, C; Helmberger, DV				Konca, A. Ozgun; Avouac, Jean-Philippe; Sladen, Anthony; Meltzner, Aron J.; Sieh, Kerry; Fang, Peng; Li, Zhenhong; Galetzka, John; Genrich, Jeff; Chlieh, Mohamed; Natawidjaja, Danny H.; Bock, Yehuda; Fielding, Eric J.; Ji, Chen; Helmberger, Don V.			Partial rupture of a locked patch of the Sumatra megathrust during the 2007 earthquake sequence	NATURE			English	Article							ANDAMAN EARTHQUAKE; ZONE; DEFORMATION; ASPERITY; MODEL; SLIP	The great Sumatra - Andaman earthquake and tsunami of 2004 was a dramatic reminder of the importance of understanding the seismic and tsunami hazards of subduction zones(1-4). In March 2005, the Sunda megathrust ruptured again, producing an event(5) of moment magnitude (M-w) 8.6 south of the 2004 rupture area, which was the site of a similar event in 1861 (ref. 6). Concern was then focused on the Mentawai area, where large earthquakes had occurred in 1797 ( M-w = 8.8) and 1833 (M-w = 9.0)(6,7). Two earthquakes, one of M-w = 8.4 and, twelve hours later, one of M-w = 7.9, indeed occurred there on 12 September 2007. Here we show that these earthquakes ruptured only a fraction of the area ruptured in 1833 and consist of distinct asperities within a patch of the megathrust that had remained locked in the interseismic period. This indicates that the same portion of a megathrust can rupture in different patterns depending on whether asperities break as isolated seismic events or cooperate to produce a larger rupture. This variability probably arises from the influence of non- permanent barriers, zones with locally lower pre- stress due to the past earthquakes. The stress state of the portion of the Sunda megathrust that had ruptured in 1833 and 1797 was probably not adequate for the development of a single large rupture in 2007. Themoment released in 2007 amounts to only a fraction both of that released in 1833 and of the deficit of moment that had accumulated as a result of interseismic strain since 1833. The potential for a large megathrust event in the Mentawai area thus remains large.	[Konca, A. Ozgun; Avouac, Jean-Philippe; Sladen, Anthony; Meltzner, Aron J.; Sieh, Kerry; Galetzka, John; Genrich, Jeff; Natawidjaja, Danny H.; Helmberger, Don V.] CALTECH, Tecton Observ, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Fang, Peng; Bock, Yehuda] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Li, Zhenhong] Univ Glasgow, COMET, Dept Geog & Earth Sci, Glasgow G12 8QQ, Lanark, Scotland; [Chlieh, Mohamed] Univ Nice Sophia Antipolis, Inst Rech Dev, Observ Cote Azur, F-06560 Valbonne, France; [Fielding, Eric J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Ji, Chen] Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 94106 USA	California Institute of Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Glasgow; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Santa Barbara	Avouac, JP (corresponding author), CALTECH, Tecton Observ, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	avouac@gps.caltech.edu	Sladen, Anthony/A-2532-2017; Fielding, Eric Jameson/A-1288-2007; CHLIEH, Mohamed/GLR-8359-2022; Fielding, Eric/L-8187-2019; Avouac, Jean-Philippe/B-5699-2015; Li, Zhenhong/F-8705-2010; li, zh/HII-5698-2022; Konca, A Ozgun/AAM-7990-2020; Meltzner, Aron J/A-5585-2009	Sladen, Anthony/0000-0003-4126-0020; Fielding, Eric Jameson/0000-0002-6648-8067; Fielding, Eric/0000-0002-6648-8067; Avouac, Jean-Philippe/0000-0002-3060-8442; Li, Zhenhong/0000-0002-8054-7449; Konca, A Ozgun/0000-0002-3198-7763; Meltzner, Aron J/0000-0002-2955-0896; Chlieh, Mohamed/0000-0003-2252-2187	NSF [EAR-0538333]; Gordon and Betty Moore Foundation; NERC [come20001] Funding Source: UKRI; Natural Environment Research Council [earth010007, come20001] Funding Source: researchfish	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was partly funded by the NSF (grant EAR-0538333) and the Gordon and Betty Moore Foundation. This is Caltech Tectonics Observatory contribution no. 93. We thank R. Burgmann for comments and suggestions.	Abercrombie RE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000674; Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; BEN-ZION Y, 1993, J GEOPHYS RES-SOL EA, V98, P14109, DOI 10.1029/93JB01096; Briggs RW, 2006, SCIENCE, V311, P1897, DOI 10.1126/science.1122602; Burgmann R, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003648; Chlieh M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004981; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Cochard A, 1996, J GEOPHYS RES-SOL EA, V101, P25321, DOI 10.1029/96JB02095; Freymueller JT, 1999, GEOPHYS RES LETT, V26, P3233, DOI 10.1029/1999GL008356; Ji C, 2002, B SEISMOL SOC AM, V92, P1192, DOI 10.1785/0120000916; LAY T, 1982, EARTHQUAKE PRED RES, V1, P3; Liu YJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003424; MELTZNER AJ, 2007, EOS, V88; Natawidjaja DH, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004025; Natawidjaja DH, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004450; NATAWIDJAJA DH, 2004, J GEOPHYS RES, V109, DOI DOI 10.1029/2003JB0002398; NEWCOMB KR, 1987, J GEOPHYS RES-SOLID, V92, P421, DOI 10.1029/JB092iB01p00421; PACHECO JF, 1993, J GEOPHYS RES-SOL EA, V98, P14133, DOI 10.1029/93JB00349; Park SC, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004481; Perfettini H, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005398; Pritchard ME, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004258; Rosen P.A., 2004, EOS T AM GEOPHYS UN, V85, P47, DOI DOI 10.1029/2004EO050004; RUFF L, 1983, TECTONOPHYSICS, V99, P99, DOI 10.1016/0040-1951(83)90097-5; RUNDLE JB, 1987, J GEOPHYS RES-SOLID, V92, P2606, DOI 10.1029/JB092iB03p02606; Sieh K, 1999, GEOPHYS RES LETT, V26, P3141, DOI 10.1029/1999GL005409; Subarya C, 2006, NATURE, V440, P46, DOI 10.1038/nature04522; Suwa Y, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003203; THATCHER W, 1990, J GEOPHYS RES-SOLID, V95, P2609, DOI 10.1029/JB095iB03p02609	29	252	254	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					631	635		10.1038/nature07572	http://dx.doi.org/10.1038/nature07572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052626	Green Published, Green Submitted			2022-12-28	WOS:000261340000039
J	Monne, M; Han, L; Schwend, T; Burendahl, S; Jovine, L				Monne, Magnus; Han, Ling; Schwend, Thomas; Burendahl, Sofia; Jovine, Luca			Crystal structure of the ZP-N domain of ZP3 reveals the core fold of animal egg coats	NATURE			English	Article							ZONA-PELLUCIDA PROTEINS; STRUCTURE ALIGNMENT; SPERM RECEPTORS; BINDING; PREDICTION; FERTILIZATION; GLYCOPROTEIN; MODEL; TOOL; CRYSTALLOGRAPHY	Species- specific recognition between the egg extracellular matrix ( zona pellucida) and sperm is the first, crucial step of mammalian fertilization(1). Zona pellucida filament components ZP3 and ZP2 act as sperm receptors, and mice lacking either of the corresponding genes produce oocytes without a zona pellucida and are completely infertile(2). Like their counterparts in the vitelline envelope of non- mammalian eggs and many other secreted eukaryotic proteins, zona pellucida subunits polymerize using a 'zona pellucida ( ZP) domain' module(3-5), whose conserved amino- terminal part (ZP-N) was suggested to constitute a domain of its own(6). No atomic structure has been reported for ZP domain proteins, and there is no structural information on any conserved vertebrate protein that is essential for fertilization and directly involved in egg - sperm binding. Here we describe the 2.3 angstrom (angstrom) resolution structure of the ZP-N fragment of mouse primary sperm receptor ZP3. The ZP- N fold defines a new immunoglobulin superfamily subtype with a beta-sheet extension characterized by an E' strand and an invariant tyrosine residue implicated in polymerization. The structure strongly supports the presence of ZP- N repeats within the N- terminal region of ZP2 and other vertebrate zona pellucida/ vitelline envelope proteins, with implications for overall egg coat architecture, the post- fertilization block to polyspermy and speciation. Moreover, it provides an important framework for understanding human diseases caused by mutations in ZP domain proteins and developing new methods of non- hormonal contraception.	[Monne, Magnus; Han, Ling; Schwend, Thomas; Burendahl, Sofia; Jovine, Luca] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Karolinska Institutet	Jovine, L (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7, SE-14157 Huddinge, Sweden.	luca.jovine@ki.se	Jovine, Luca/E-8170-2010; Monné, Magnus/D-5642-2012; Jovine, Luca/J-3563-2019	Jovine, Luca/0000-0002-2679-6946; Monné, Magnus/0000-0003-2344-3878; Jovine, Luca/0000-0002-2679-6946	Karolinska Institutet; Swedish Research Council [2005-5102]; European Community [Marie Curie ERG 31055]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Karolinska Institutet, the Swedish Research Council (grant 2005-5102) and European Community (Marie Curie ERG 31055). We thank P. Nordlund and G. Schneider for access to the Stockholm SGC robotic crystallization facility and beamtime; H. Belrhali, J. McCarthy, R. Ravelli and M. Walsh for assistance at ESRF; P. Afonine, R. Grosse- Kunstleve and P. Zwart for help with phenix. refine; G. Murshudov for help with REFMAC; C. Chothia, F. Cotelli, J.- A. Gustafsson, R. Herbst-Irmer, A. Kohl, R. Ladenstein, M. Letarte, E. Litscher, E. Morgunova, A. Murzin, K. Nagai, L. Nilsson, D. Rhodes, R. Toftga rd and P. Wassarman for discussions and comments.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BORK P, 2005, NUCLEIC ACIDS RES, V33, pW299; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burendahl S, 2008, BIOCHEMISTRY-US, V47, P5205, DOI 10.1021/bi7025084; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; DeLano W.L, PYMOL MOL GRAPHICS S; Doren S, 1999, DEV GENES EVOL, V209, P330, DOI 10.1007/s004270050261; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; Familiari G, 2008, FRONT BIOSCI-LANDMRK, V13, P6730, DOI 10.2741/3185; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Galindo BE, 2003, P NATL ACAD SCI USA, V100, P4639, DOI 10.1073/pnas.0830022100; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hasegawa A, 2002, J REPROD IMMUNOL, V53, P91, DOI 10.1016/S0165-0378(01)00084-5; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine Luca, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091/7/11; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanai S, 2008, MOL REPROD DEV, V75, P847, DOI 10.1002/mrd.20836; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P935, DOI 10.1107/S090744490703315X; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Lindsay LL, 2004, BIOCHEM BIOPH RES CO, V324, P648, DOI 10.1016/j.bbrc.2004.09.099; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Nixon B, 2007, CELL MOL LIFE SCI, V64, P1805, DOI 10.1007/s00018-007-6552-x; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; SOMOZA JR, 1995, ACTA CRYSTALLOGR A, V51, P691, DOI 10.1107/S0108767395002315; Stebbings LA, 2004, NUCLEIC ACIDS RES, V32, pD203, DOI 10.1093/nar/gkh027; Sun W, 1999, BIOL REPROD, V60, P900, DOI 10.1095/biolreprod60.4.900; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Tian JD, 1999, P NATL ACAD SCI USA, V96, P829, DOI 10.1073/pnas.96.3.829; Tsubamoto H, 1999, BIOL REPROD, V61, P1649, DOI 10.1095/biolreprod61.6.1649; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; van den Bedem H, 2005, ACTA CRYSTALLOGR D, V61, P2, DOI 10.1107/S0907444904025697; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; WASSARMAN PM, 1991, INT REV CYTOL, V130, P85, DOI 10.1016/S0074-7696(08)61502-8; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	68	100	103	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					653	U82		10.1038/nature07599	http://dx.doi.org/10.1038/nature07599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052627	Green Published			2022-12-28	WOS:000261340000044
J	Uversky, VN; Dunker, AK				Uversky, Vladimir N.; Dunker, A. Keith			BIOCHEMISTRY Controlled Chaos	SCIENCE			English	Editorial Material							INTRINSICALLY UNSTRUCTURED PROTEINS; NATIVELY UNFOLDED PROTEINS; DISORDERED PROTEINS		[Uversky, Vladimir N.; Dunker, A. Keith] Indiana Univ, Dept Biochem & Mol Biol, Inst Intrinsically Disordered Prot Res, Ctr Computat Biol & Bioinformat,Sch Med, Indianapolis, IN 46202 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Russia	Indiana University System; Indiana University-Purdue University Indianapolis; Russian Academy of Sciences	Uversky, VN (corresponding author), Indiana Univ, Dept Biochem & Mol Biol, Inst Intrinsically Disordered Prot Res, Ctr Computat Biol & Bioinformat,Sch Med, Indianapolis, IN 46202 USA.	vuversky@iupui.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071714] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007688] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071714-01A2] Funding Source: Medline; NLM NIH HHS [R01 LM007688-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Fukuchi S, 2006, J MOL BIOL, V355, P845, DOI 10.1016/j.jmb.2005.10.037; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Paliy O, 2008, J PROTEOME RES, V7, P2234, DOI 10.1021/pr800055r; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Radivojac Predrag, 2002, Pac Symp Biocomput, P589; Romero P, 1998, Pac Symp Biocomput, P437; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	21	56	57	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1340	1341		10.1126/science.1167453	http://dx.doi.org/10.1126/science.1167453			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039128				2022-12-28	WOS:000261170600027
J	Mihola, O; Trachtulec, Z; Vlcek, C; Schimenti, JC; Forejt, J				Mihola, Ondrej; Trachtulec, Zdenek; Vlcek, Cestmir; Schimenti, John C.; Forejt, Jiri			A Mouse Speciation Gene Encodes a Meiotic Histone H3 Methyltransferase	SCIENCE			English	Article							HYBRID STERILITY; CHROMOSOME 17; WILD MOUSE; DROSOPHILA; MUSCULUS; STRAINS; REGION; MICE	Speciation genes restrict gene flow between the incipient species and related taxa. Three decades ago, we mapped a mammalian speciation gene, hybrid sterility 1 (Hst1), in the intersubspecific hybrids of house mouse. Here, we identify this gene as Prdm9, encoding a histone H3 lysine 4 trimethyltransferase. We rescued infertility in male hybrids with bacterial artificial chromosomes carrying Prdm9 from a strain with the "fertility" Hst1(f) allele. Sterile hybrids display down-regulated microrchidia 2B (Morc2b) and fail to compartmentalize gamma H2AX into the pachynema sex (XY) body. These defects, seen also in Prdm9-null mutants, are rescued by the Prdm9 transgene. Identification of a vertebrate hybrid sterility gene reveals a role for epigenetics in speciation and opens a window to a hybrid sterility gene network.	[Mihola, Ondrej; Trachtulec, Zdenek; Vlcek, Cestmir; Forejt, Jiri] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Schimenti, John C.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ctr Vertebrate Genom, Ithaca, NY 14853 USA	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Cornell University	Forejt, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague, Czech Republic.	jforejt@img.cas.cz	Forejt, Jiri/G-7719-2012; Mihola, Ondrej/AAM-7009-2020; Forejt, Jiri/AAF-5276-2019; Trachtulec, Zdenek/G-3449-2014; Vlcek, Cestmir/I-8820-2014; Mihola, Ondrej/G-6362-2014	Forejt, Jiri/0000-0002-2793-3623; Forejt, Jiri/0000-0002-2793-3623; Trachtulec, Zdenek/0000-0001-5772-9394; Mihola, Ondrej/0000-0003-3243-0825	Czech Science Foundation; Grant Agency of the Academy of Sciences of the Czech Republic; Ministry of Education, Youth and Sports of the Czech Republic; NIH	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Nachman (University of Arizona), K. Paigen (The Jackson Laboratory), and D. Barbash (Cornell University) for valuable comments. We are grateful to P. Jansa for advice with the immunofluorescence and P. Flachs for assistance. This work was funded by the Czech Science Foundation, the Grant Agency of the Academy of Sciences of the Czech Republic and the Ministry of Education, Youth and Sports of the Czech Republic (J. F. and Z. T.), and a grant from NIH (J. C. S.). J. F. was an International Fellow of the Howard Hughes Medical Institute.	Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Dobzhansky T., 1951, COPEIA; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; FOREJT J, 1981, CURRENT TRENDS HISTO, V1, P103; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Gregorova S, 1996, MAMM GENOME, V7, P107, DOI 10.1007/s003359900029; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-20; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Orr HA, 2005, P NATL ACAD SCI USA, V102, P6522, DOI 10.1073/pnas.0501893102; Osoegawa K, 2000, GENOME RES, V10, P116; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Trachtulec Z, 2005, BIOL J LINN SOC, V84, P637, DOI 10.1111/j.1095-8312.2005.00460.x; Trachtulec Z, 1997, MAMM GENOME, V8, P312, DOI 10.1007/s003359900430; Trachtulec Z, 2008, GENETICS, V178, P1777, DOI 10.1534/genetics.107.082404; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; YOSHIKI A, 1993, DEV GROWTH DIFFER, V35, P271, DOI 10.1111/j.1440-169X.1993.00271.x	25	309	317	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					373	375		10.1126/science.1163601	http://dx.doi.org/10.1126/science.1163601			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074312				2022-12-28	WOS:000262481400036
J	Blake, P; Swart, AM; Orton, J; Kitchener, H; Whelan, T; Lukka, H; Eisenhauer, E; Bacon, M; Tu, D; Parmar, MKB; Amos, C; Murray, C; Qian, W				Blake, P.; Swart, Ann Marie; Orton, J.; Kitchener, H.; Whelan, T.; Lukka, H.; Eisenhauer, E.; Bacon, M.; Tu, D.; Parmar, M. K. B.; Amos, C.; Murray, C.; Qian, W.		ASTEC-EN-5 Study Grp	Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results,, systematic review, and meta-analysis	LANCET			English	Article							SURGERY; CARCINOMA	Background Early endometrial cancer with low-risk pathological features can be successfully treated by surgery alone. External beam radiotherapy added to surgery has been investigated in several small trials, which have mainly included women at intermediate risk of recurrence. in these trials, postoperative radiotherapy has been shown to reduce the risk of isolated local recurrence but there is no evidence that it improves recurrence-free or overall survival. We report the findings from the ASTEC and EN.5 trials, which investigated adjuvant external beam radiotherapy in women with early-stage disease and pathological features suggestive of intermediate or high risk of recurrence and death from endometrial cancer. Methods Between July, 1.996, and March, 2005, 905 (789 ASTEC, 1.16 EN.5) women with intermediate-risk or high-risk early-stage disease from 112 centres in seven countries (UK, Canada, Poland, Norway, New Zealand, Australia, USA) were randomly assigned after surgery to observation (453) or to external beam radiotherapy (452). A target dose of 40-46 Gy in 20-25 daily fractions to the pelvis, treating five times a week, was specified. Primary outcome measure was overall survival, and all analyses were by intention to treat. These trials were registered ISRCTN 16571884 (ASTEC) and NCT 00002807 (EN.5). Findings After a median follow-up of 58 months, 1.35 women (68 observation, 67 external beam radiotherapy) had died. There was no evidence that overall survival with external beam radiotherapy was better than observation, hazard ratio 1. 05 (95% Cl 0.75-1.48; p=0.77). 5-year overall survival was 84% in both groups. Combining data from ASTEC and EN.5 in a meta-analysis of trials confirmed that there was no benefit in terms of overall survival (hazard ratio 1. 04; 95% Cl 0 . 84-1 . 29) and can reliably exclude an absolute benefit of external beam radiotherapy at 5 years of more than 3%. With brachytherapy used in 53% of women in ASTEC/EN.5, the local recurrence rate in the observation group at 5 years was 6. 1%. Interpretation Adjuvant external beam radiotherapy cannot be recommended as part of routine treatment for women with intermediate-risk or high-risk early-stage endometrial cancer with the aim of improving survival. The absolute benefit of external beam radiotherapy in preventing isolated local recurrence is small and is not without toxicity. Funding Medical Research Council, National Cancer Research Network, National Cancer Institute of Canada, with funds from the Canadian Cancer Society.	[Swart, Ann Marie; Parmar, M. K. B.; Amos, C.; Murray, C.; Qian, W.] MRC, Clin Trials Unit, London NW1 2DA, England; [Swart, Ann Marie] UCL, Ctr Clin Pharmacol, London, England; [Blake, P.] Royal Marsden Hosp, London SW3 6JJ, England; [Orton, J.] St James Inst Oncol, Leeds, W Yorkshire, England; [Kitchener, H.] Univ Manchester, Sch Canc & Imaging Sci, Manchester, Lancs, England; [Whelan, T.; Lukka, H.] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada; [Eisenhauer, E.; Bacon, M.; Tu, D.] Queens Univ, NCIC CTG, Kingston, ON, Canada	Medical Research Council Clinical Trials Unit; University of London; University College London; Royal Marsden NHS Foundation Trust; Saint James's University Hospital; University of Manchester; McMaster University; Queens University - Canada	Swart, AM (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	ams@ctu.mrc.ac.uk	Whelan, Timothy/D-3185-2017; Evans, Diane/F-9258-2017	Whelan, Timothy/0000-0001-9844-2023; Graham, John/0000-0003-3381-9787; Tan, Li Tee/0000-0001-9333-9190; Klimek, Malgorzata/0000-0002-6515-7557	MRC [MC_U122861379] Funding Source: UKRI; Medical Research Council [MC_U122861379] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AALDERS J, 1980, OBSTET GYNECOL, V56, P419; ABE O, 1995, NEW ENGL J MED, V333, P1444; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Kong A, 2007, ANN ONCOL, V18, P1595, DOI 10.1093/annonc/mdm066; Lefebvre C, 2001, SYSTEMATIC REV HLTH, P69; *ROYAL COLL PATH, 2001, MIN DAT HIST REP AT; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Soderini A, 2003, INT J GYNECOL CAN S1, V13, P78	10	445	455	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					137	146		10.1016/S0140-6736(08)61767-5	http://dx.doi.org/10.1016/S0140-6736(08)61767-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19070891	Green Published			2022-12-28	WOS:000262340900028
J	Branzei, D; Vanoli, F; Foiani, M				Branzei, Dana; Vanoli, Fabio; Foiani, Marco			SUMOylation regulates Rad18-mediated template switch	NATURE			English	Article							DEFECTIVE POSTREPLICATION REPAIR; UV-DAMAGED DNA; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; GROUP GENES; UBIQUITIN; REPLICATION; HELICASE; RAD18	Replication by template switch is thought to mediate DNA damage- bypass and fillings of gaps. Gap- filling repair requires homologous recombination as well as Rad18- and Rad5- mediated proliferating cell nuclear antigen ( PCNA) polyubiquitylation. However, it is unclear whether these processes are coordinated, and the physical evidence for Rad18 - Rad5- dependent template switch at replication forks is still elusive. Here we show, using genetic and physical approaches, that in budding yeast ( Saccharomyces cerevisiae) Rad18 is required for the formation of X- shaped sister chromatid junctions ( SCJs) at damaged replication forks through a process involving PCNA polyubiquitylation and the ubiquitin- conjugating enzymes Mms2 and Ubc13. The Rad18 - Mms2- mediated damage- bypass through SCJs requires the small ubiquitin- like modifier ( SUMO)- conjugating enzyme Ubc9 and SUMOylated PCNA, and is coordinated with Rad51- dependent recombination events. We propose that the Rad18 - Rad5 - Mms2- dependent SCJs represent template switch events. Altogether, our results unmask a role for PCNA ubiquitylation and SUMOylation pathways in promoting transient damage- induced replication- coupled recombination events involving sister chromatids at replication forks.	[Branzei, Dana; Vanoli, Fabio; Foiani, Marco] IFOM IEO, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; [Foiani, Marco] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Branzei, D (corresponding author), IFOM IEO, FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	dana.branzei@ifom-ieo-campus.it	Foiani, Marco/M-8234-2014; Branzei, Dana/GOG-9093-2022; Branzei, Dana/A-2806-2015	Foiani, Marco/0000-0003-4795-834X; Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888	Associazione Italiana per la Ricerca sul Cancro; Association for International Cancer Research; European Community GENICA; European Community DNA Repair; Telethon; MIUR; Ministry of Health; Buzzati-Traverso foundation	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research; European Community GENICA(European Commission); European Community DNA Repair; Telethon(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR)); Ministry of Health; Buzzati-Traverso foundation	We thank S. Jentsch and H. Ulrich for yeast strains, T. Enomoto for critical reading, and all members of our laboratories for helpful discussions. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro to D. B., Association for International Cancer Research and European Community GENICA grant to M. F. and D. B., and partly by European Community DNA Repair grant, Telethon, MIUR, and Ministry of Health to M. F. D. B. was partly supported by the Buzzati-Traverso foundation.	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Branzei D, 2004, GENES CELLS, V9, P1031, DOI 10.1111/j.1365-2443.2004.00787.x; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2007, CELL, V131, P1228, DOI 10.1016/j.cell.2007.12.007; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Motegi A, 2006, MOL CELL BIOL, V26, P1424, DOI 10.1128/MCB.26.4.1424-1433.2006; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Onoda F, 2001, MOL GEN GENET, V264, P702, DOI 10.1007/s004380000358; Otsuki M, 2007, J CELL BIOL, V179, P53, DOI 10.1083/jcb.200702183; PALLADINO F, 1992, GENETICS, V132, P23; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; SCHIESTL RH, 1990, GENETICS, V124, P817; Shekhar MPV, 2002, CANCER RES, V62, P2115; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	50	207	210	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					915	920		10.1038/nature07587	http://dx.doi.org/10.1038/nature07587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092928				2022-12-28	WOS:000261768300037
J	Ladroue, C; Carcenac, R; Leporrier, M; Gad, S; Le Hello, C; Galateau-Salle, F; Feunteun, J; Pouyssegur, J; Richard, S; Gardie, B				Ladroue, Charline; Carcenac, Romain; Leporrier, Michel; Gad, Sophie; Le Hello, Claire; Galateau-Salle, Francoise; Feunteun, Jean; Pouyssegur, Jacques; Richard, Stephane; Gardie, Betty			Brief Report: PHD2 Mutation and Congenital Erythrocytosis with Paraganglioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; HYDROXYLASE DOMAIN PROTEIN-2; OXYGEN HOMEOSTASIS; PHEOCHROMOCYTOMA; POLYCYTHEMIA; INHIBITION; INDUCTION; PATHWAY; DISEASE; CANCER	Prolyl hydroxylase domain (PHD) proteins play a major role in regulating the hypoxia-inducible factor (HIF) that induces expression of genes involved in angiogenesis, erythropoiesis, and cell metabolism, proliferation, and survival. Germ-line mutations in the prolyl hydroxylase domain 2 gene (PHD2) have been reported in patients with familial erythrocytosis but not in association with tumors. We describe a patient with erythrocytosis and recurrent paraganglioma who carries a newly discovered PHD2 mutation. This mutation affects PHD2 function and stabilizes HIF-(alpha) proteins. In addition, we demonstrate loss of heterozygosity of PHD2 in the tumor, suggesting that PHD2 could be a tumor-suppressor gene.	[Ladroue, Charline; Carcenac, Romain; Gad, Sophie; Richard, Stephane; Gardie, Betty] Univ Paris 11, Fac Med Paris Sud, Genet Oncol EPHE, F-94276 Le Kremlin Bicetre, France; [Richard, Stephane] CHU Bicetre, Serv Urol, Ctr Pilote Tumeurs Rares, Inst Natl Canc & Assistance Publ Hop Paris, F-94276 Le Kremlin Bicetre, France; [Ladroue, Charline; Carcenac, Romain; Gad, Sophie; Feunteun, Jean; Richard, Stephane; Gardie, Betty] Inst Gustave Roussy, Ecole Prat Hautes Etud, Villejuif, France; [Ladroue, Charline; Carcenac, Romain; Gad, Sophie; Feunteun, Jean; Richard, Stephane; Gardie, Betty] Inst Gustave Roussy, CNRS, FRE 2939, Villejuif, France; [Leporrier, Michel] CHU Caen, Serv Hematol Clin, F-14000 Caen, France; [Le Hello, Claire] CHU Caen, Serv Chirurg Thorac & Cardiovasc, F-14000 Caen, France; [Galateau-Salle, Francoise] CHU Caen, Lab Anat & Cytol Pathol, F-14000 Caen, France; [Pouyssegur, Jacques] Univ Nice, Inst Dev Biol & Canc Res, CNRS, UMR 6543, Nice, France; [Richard, Stephane] Hop Necker Enfants Malad, Serv Nephrol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National du Cancer (INCA) France; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Richard, S (corresponding author), Univ Paris 11, Fac Med Paris Sud, Genet Oncol EPHE, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	stephane.richard@u-psud.fr	Salle, Francoise BJ Galateau/J-1530-2015; Feunteun, Jean/AAZ-1267-2020	Salle, Francoise BJ Galateau/0000-0003-3642-0165; Feunteun, Jean/0000-0003-1212-9189; galateau salle, francoise/0000-0002-2814-1644; GAD (LAPITEAU), Sophie/0000-0002-3158-6791	French National Cancer Institute (Programme National d'Excellence Specialisee Rein); French League against Cancer (Comites du Cher et de l'Indre)	French National Cancer Institute (Programme National d'Excellence Specialisee Rein)(Institut National du Cancer (INCA) France); French League against Cancer (Comites du Cher et de l'Indre)	Supported by grants from the French National Cancer Institute ( Programme National d'Excellence Specialisee Rein) and the French League against Cancer (Comites du Cher et de l'Indre).; No potential conflict of interest relevant to this article was reported.; We thank the patient and his family for their participation and Prof. Dominique Maiza, Prof. Nicole Casadevall, Prof. Patrick Bruneval, Dr. Brigitte Bressac de Paillerets, Dr. Anne-Paule Gimenez-Roqueplo, Dr. Ahyan Ulusakarya, Johny Bombled, Caroline Chordi, and Prof. Gilbert Lenoir for their assistance.	Al-Sheikh M, 2008, BLOOD CELL MOL DIS, V40, P160, DOI 10.1016/j.bcmd.2007.07.017; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Gimenez-Roqueplo AP, 2008, CLIN EXP PHARMACOL P, V35, P376, DOI 10.1111/j.1440-1681.2008.04881.x; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kato H, 2006, INT J CANCER, V118, P1144, DOI 10.1002/ijc.21488; Lee K, 2008, MOL CANCER RES, V6, P829, DOI 10.1158/1541-7786.MCR-07-2113; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Richard S, 2004, LANCET, V363, P1231, DOI 10.1016/S0140-6736(04)15957-6; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516	22	242	249	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2685	2692		10.1056/NEJMoa0806277	http://dx.doi.org/10.1056/NEJMoa0806277			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092153				2022-12-28	WOS:000261757300008
J	Barone, BB; Yeh, HC; Snyder, CF; Peairs, KS; Stein, KB; Derr, RL; Wolff, AC; Brancati, FL				Barone, Bethany B.; Yeh, Hsin-Chieh; Snyder, Claire F.; Peairs, Kimberly S.; Stein, Kelly B.; Derr, Rachel L.; Wolff, Antonio C.; Brancati, Frederick L.			Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SQUAMOUS-CELL CANCER; PROGNOSTIC-FACTORS; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; ENDOMETRIAL CARCINOMA; BREAST-CANCER; LUNG-CANCER; RISK-FACTOR; HEPATIC RESECTION; CO-MORBIDITY	Context Diabetes mellitus appears to be a risk factor for some cancers, but the effect of preexisting diabetes on all- cause mortality in newly diagnosed cancer patients is less clear. Objective To perform a systematic review and meta- analysis comparing overall survival in cancer patients with and without preexisting diabetes. Data Sources We searched MEDLINE and EMBASE through May 15, 2008, including references of qualifying articles. Study Selection English- language, original investigations in humans with at least 3 months of follow- up were included. Titles, abstracts, and articles were reviewed by at least 2 independent readers. Of 7858 titles identified in our original search, 48 articles met our criteria. Data Extraction One reviewer performed a full abstraction and other reviewers verified accuracy. We contacted authors and obtained additional information for 3 articles with insufficient reported data. Results Studies reporting cumulative survival rates were summarized qualitatively. Studies reporting Cox proportional hazard ratios ( HRs) or Poisson relative risks were combined in a meta- analysis. A random- effects model meta- analysis of 23 articles showed that diabetes was associated with an increased mortality HR of 1.41 ( 95% confidence interval [ CI], 1.28- 1.55) compared with normoglycemic individuals across all cancer types. Subgroup analyses by type of cancer showed increased risk for cancers of the endometrium ( HR, 1.76; 95% CI, 1.34- 2.31), breast ( HR, 1.61; 95% CI, 1.46- 1.78), and colorectum ( HR, 1.32; 95% CI, 1.24- 1.41). Conclusions Patients diagnosed with cancer who have preexisting diabetes are at increased risk for long- term, all- cause mortality compared with those without diabetes.	[Barone, Bethany B.; Yeh, Hsin-Chieh; Brancati, Frederick L.] Johns Hopkins Bloomberg Sch Publ Hlth, Div Gen Internal Med, Dept Epidemiol, Baltimore, MD 21205 USA; [Snyder, Claire F.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Yeh, Hsin-Chieh; Snyder, Claire F.; Peairs, Kimberly S.; Stein, Kelly B.; Brancati, Frederick L.] Johns Hopkins Med Inst, Div Gen Internal Med, Baltimore, MD 21205 USA; [Derr, Rachel L.] Johns Hopkins Med Inst, Div Endocrinol & Metab, Baltimore, MD 21205 USA; [Snyder, Claire F.; Wolff, Antonio C.] Johns Hopkins Med Inst, Div Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Brancati, FL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Div Gen Internal Med, Dept Epidemiol, 2024 E Monument St,Ste 2-619, Baltimore, MD 21205 USA.	fbrancat@jhmi.edu	Wolff, Antonio C./T-8796-2019	Wolff, Antonio C./0000-0003-3734-1063	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Diabetes and Obesity Training [T32 DK062707]; National Institutes of Health; Health Services and Administration [T32HP10025-14]; NIDDK Diabetes Research and Training Center [P60 DK079637]; NIDDK Patient Oriented Research in Type 2 Diabetes [K24-DK62222]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, T32DK062707, P30DK079637, K24DK062222] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Diabetes and Obesity Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Services and Administration; NIDDK Diabetes Research and Training Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK Patient Oriented Research in Type 2 Diabetes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Ms Barone and Dr Derr are supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Diabetes and Obesity Training Grant (T32 DK062707). Dr Stein is supported by a National Institutes of Health fellowship from the Health Services and Administration (T32HP10025-14). Drs Yeh and Brancati are supported by the NIDDK Diabetes Research and Training Center (P60 DK079637). Dr Brancati is supported by the NIDDK Patient Oriented Research in Type 2 Diabetes grants (K24-DK62222). This work was not funded by an industry sponsor.	Beckman TJ, 2001, DIABETES CARE, V24, P2049, DOI 10.2337/diacare.24.12.2049; Begg CB, 2002, JNCI-J NATL CANCER I, V94, P1044; Chia VM, 2007, INT J GYNECOL CANCER, V17, P441, DOI 10.1111/j.1525-1438.2007.00790.x; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Colinet B, 2005, BRIT J CANCER, V93, P1098, DOI 10.1038/sj.bjc.6602836; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; De Giorgio R, 2000, ARCH INTERN MED, V160, P2217, DOI 10.1001/archinte.160.14.2217; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dominguez-Ventura A, 2007, EUR J CARDIO-THORAC, V32, P370, DOI 10.1016/j.ejcts.2007.04.002; Du W, 2005, BREAST CANCER RES TR, V91, P243, DOI 10.1007/s10549-005-0324-9; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Fleming ST, 2005, MED CARE, V43, P132, DOI 10.1097/00005650-200502000-00006; Fleming ST, 2003, J CLIN EPIDEMIOL, V56, P1064, DOI 10.1016/S0895-4356(03)00213-0; Folsom AR, 2004, GYNECOL ONCOL, V94, P740, DOI 10.1016/j.ygyno.2004.06.027; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Froehner M, 2003, UROLOGY, V61, P596, DOI 10.1016/S0090-4295(02)02250-1; Fujiwara M, 2008, J AM COLL SURGEONS, V206, P138, DOI 10.1016/j.jamcollsurg.2007.07.013; Ganti AK, 2002, MED ONCOL, V19, P233, DOI 10.1385/MO:19:4:233; GIRELLI CM, 1994, TUMORI, V80, P198, DOI 10.1177/030089169408000306; Gross CP, 2006, J AM GERIATR SOC, V54, P1898, DOI 10.1111/j.1532-5415.2006.00973.x; Hammarsten J, 2005, EUR J CANCER, V41, P2887, DOI 10.1016/j.ejca.2005.09.003; Hanbali A, 2007, ARCH INTERN MED, V167, P513, DOI 10.1001/archinte.167.5.513-a; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoke GP, 1999, J NATL MED ASSOC, V91, P144; HOPKINS MP, 1993, CANCER-AM CANCER SOC, V72, P2389, DOI 10.1002/1097-0142(19931015)72:8<2389::AID-CNCR2820720816>3.0.CO;2-R; HOPKINS MP, 1991, AM J OBSTET GYNECOL, V164, P1520, DOI 10.1016/0002-9378(91)91431-U; Huo TI, 2004, AM J GASTROENTEROL, V99, P1479, DOI 10.1111/j.1572-0241.2004.30024.x; Huo TI, 2003, EUR J GASTROEN HEPAT, V15, P1203, DOI 10.1097/00042737-200311000-00009; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Ikeda Y, 1998, HEPATOLOGY, V27, P1567, DOI 10.1002/hep.510270615; Janssen-Heijnen MLG, 2007, CRIT REV ONCOL HEMAT, V62, P172, DOI 10.1016/j.critrevonc.2006.11.005; Janssen-Heijnen MLG, 2007, EUR J CANCER, V43, P2179, DOI 10.1016/j.ejca.2007.06.008; KAPP DS, 1983, INT J RADIAT ONCOL, V9, P445, DOI 10.1016/0360-3016(83)90060-3; Karl RC, 2000, ANN SURG, V231, P635, DOI 10.1097/00000658-200005000-00003; Keating NL, 2007, MED CARE, V45, P869, DOI 10.1097/MLR.0b013e31806728e9; KELLER AZ, 1969, AM J PUBLIC HEALTH N, V59, P1139, DOI 10.2105/AJPH.59.7.1139; Ko C, 2002, J SURG RES, V105, P53, DOI 10.1006/jsre.2002.6449; Komura T, 2007, AM J GASTROENTEROL, V102, P1939, DOI 10.1111/j.1572-0241.2007.01354.x; Kouvaris J, 2001, GYNECOL OBSTET INVES, V51, P262, DOI 10.1159/000058061; Kouvaris JR, 2001, EUR J GYNAECOL ONCOL, V22, P305; KUCERA H, 1987, CANCER, V60, P1, DOI 10.1002/1097-0142(19870701)60:1<1::AID-CNCR2820600102>3.0.CO;2-S; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Lemmens VEPP, 2005, BRIT J SURG, V92, P615, DOI 10.1002/bjs.4913; LEVETAN CS, 1995, AM J MED, V99, P22, DOI 10.1016/S0002-9343(99)80100-4; Lin SY, 2007, EUR J CANCER PREV, V16, P471, DOI 10.1097/01.cej.0000236253.93984.8f; Little SA, 2002, J GASTROINTEST SURG, V6, P88, DOI 10.1016/S1091-255X(01)00019-1; Liu H, 2006, MED ONCOL, V23, P341, DOI 10.1385/MO:23:3:341; Lu TH, 2001, J CLIN EPIDEMIOL, V54, P1086, DOI 10.1016/S0895-4356(01)00383-3; Maas HAAM, 2005, GYNECOL ONCOL, V97, P104, DOI 10.1016/j.ygyno.2004.12.026; Merrick GS, 2007, CANCER, V110, P289, DOI 10.1002/cncr.22793; Merrick GS, 2006, INT J RADIAT ONCOL, V65, P669, DOI 10.1016/j.ijrobp.2006.01.030; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Morss AS, 2007, J BIOL CHEM, V282, P14635, DOI 10.1074/jbc.M608565200; Nagasue N, 1999, ANN SURG, V229, P84, DOI 10.1097/00000658-199901000-00011; National Institute of Diabetes and Digestive and Kidney Diseases, 2005, NAT DIAB STAT FACT S; Papanas N, 2006, EUR J GYNAECOL ONCOL, V27, P505; Park SM, 2006, J CLIN ONCOL, V24, P5017, DOI 10.1200/JCO.2006.07.0243; PAYNE JE, 1995, AUST NZ J SURG, V65, P398, DOI 10.1111/j.1445-2197.1995.tb01767.x; Polednak AP, 2006, CANCER DETECT PREV, V30, P466, DOI 10.1016/j.cdp.2006.07.003; Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5; Richardson LC, 2005, NAT CLIN PRACT ONCOL, V2, P48, DOI 10.1038/ncponc0062; ROSNER B, 2006, FUNDAMENTALS BIOSTAT, P361; Saydah SH, 2003, AM J EPIDEMIOL, V157, P1092, DOI 10.1093/aje/kwg100; Shonka NA, 2006, MED ONCOL, V23, P515, DOI 10.1385/MO:23:4:515; Sperti C, 2003, J GASTROINTEST SURG, V7, P953, DOI 10.1016/j.gassur.2003.09.002; Sperti C, 1996, BRIT J SURG, V83, P625, DOI 10.1002/bjs.1800830512; Steiner E, 2008, GYNECOL ONCOL, V108, P569, DOI 10.1016/j.ygyno.2007.11.025; Steiner E, 2007, EUR J GYNAECOL ONCOL, V28, P95; Steiner E, 2003, INT J GYNECOL CANCER, V13, P197, DOI 10.1046/j.1525-1438.2003.13021.x; Studzinski Zbigniew, 2003, Archives of Gynecology and Obstetrics, V267, P145, DOI 10.1007/s00404-001-0288-x; Talar-Wojnarowska R, 2003, NEOPLASMA, V50, P383; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Tammemagi CM, 2003, INT J CANCER, V103, P792, DOI 10.1002/ijc.10882; Tanisada K, 1998, Radiat Med, V16, P461; Tanisada K, 2000, INT J RADIAT ONCOL, V46, P1223, DOI 10.1016/S0360-3016(99)00518-0; Tomazic A, 2004, HEPATO-GASTROENTEROL, V51, P1832; Ujpal M, 2007, J ORAL MAXIL SURG, V65, P452, DOI 10.1016/j.joms.2006.09.015; Valery PC, 2006, LANCET, V367, P1842, DOI 10.1016/S0140-6736(06)68806-5; van de Poll-Franse LV, 2007, INT J CANCER, V120, P1986, DOI 10.1002/ijc.22532; Vasic L., 2007, ARCH ONCOL, V15, P19, DOI DOI 10.2298/AOO0702019V; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; WAGENIUS G, 1992, ANTICANCER RES, V12, P725; Wang JL, 2004, INT J GYNECOL CANCER, V14, P502, DOI 10.1111/j.1048-891x.2004.014311.x; Weiser MA, 2004, CANCER, V100, P1179, DOI 10.1002/cncr.20071; Welch HG, 2002, J NATL CANCER I, V94, P1066; Will JC, 1998, AM J EPIDEMIOL, V147, P816, DOI 10.1093/oxfordjournals.aje.a009534; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	90	620	650	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2754	2764		10.1001/jama.2008.824	http://dx.doi.org/10.1001/jama.2008.824			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088353	Green Accepted			2022-12-28	WOS:000261730400022
J	Buchanan, MA; Wilkinson, JM; Fitzgerald, JE; Prinsley, PR				Buchanan, M. A.; Wilkinson, J. M.; Fitzgerald, J. E.; Prinsley, P. R.			Is golf bad for your hearing?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Buchanan, M. A.; Prinsley, P. R.] Norfolk & Norwich Hosp, Dept Otorhinolaryngol, Norwich NR4 7UY, Norfolk, England; [Wilkinson, J. M.; Fitzgerald, J. E.] Norfolk & Norwich Hosp, Dept Audiol, Norwich NR4 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Buchanan, MA (corresponding author), Norfolk & Norwich Hosp, Dept Otorhinolaryngol, Norwich NR4 7UY, Norfolk, England.	malcolm_buchanan123@hotmail.com		prinsley, peter/0000-0002-4119-0598				Coles RRA, 2000, CLIN OTOLARYNGOL, V25, P264, DOI 10.1046/j.1365-2273.2000.00368.x; *US GOLF ASS, RUL GOLF 2008; *USA HLTH WATCH, HEAR IMP PROJ CALC	3	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2008	337								a2835	10.1136/bmj.a2835	http://dx.doi.org/10.1136/bmj.a2835			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091762				2022-12-28	WOS:000262185000008
J	Jenkins, DJA; Kendall, CWC; McKeown-Eyssen, G; Josse, RG; Silverberg, J; Booth, GL; Vidgen, E; Josse, AR; Nguyen, TH; Corrigan, S; Banach, MS; Ares, S; Mitchell, S; Emam, A; Augustin, LSA; Parker, TL; Leiter, LA				Jenkins, David J. A.; Kendall, Cyril W. C.; McKeown-Eyssen, Gail; Josse, Robert G.; Silverberg, Jay; Booth, Gillian L.; Vidgen, Edward; Josse, Andrea R.; Nguyen, Tri H.; Corrigan, Sorcha; Banach, Monica S.; Ares, Sophie; Mitchell, Sandy; Emam, Azadeh; Augustin, Livia S. A.; Parker, Tina L.; Leiter, Lawrence A.			Effect of a Low-Glycemic Index or a High-Cereal Fiber Diet on Type 2 Diabetes A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; RISK-FACTORS; LOAD; GLUCOSE; PLASMA; CARBOHYDRATE; WEIGHT	Context Clinical trials using antihyperglycemic medications to improve glycemic control have not demonstrated the anticipated cardiovascular benefits. Low - glycemic index diets may improve both glycemic control and cardiovascular risk factors for patients with type 2 diabetes but debate over their effectiveness continues due to trial limitations. Objective To test the effects of low - glycemic index diets on glycemic control and cardiovascular risk factors in patients with type 2 diabetes. Design, Setting, and Participants A randomized, parallel study design at a Canadian university hospital research center of 210 participantswith type 2 diabetes treated with antihyperglycemic medications who were recruited by newspaper advertisement and randomly assigned to receive 1 of 2 diet treatments each for 6 months between September 16, 2004, and May 22, 2007. Intervention High - cereal fiber or low - glycemic index dietary advice. Main Outcome Measures Absolute change in glycated hemoglobin A(1c) (HbA(1c)), with fasting blood glucose and cardiovascular disease risk factors as secondary measures. Results In the intention-to-treat analysis, HbA(1c) decreased by - 0.18% absolute HbA(1c) units ( 95% confidence interval [ CI], - 0.29% to - 0.07%) in the high - cereal fiber diet compared with - 0.50% absolute HbA(1c) units ( 95% CI, - 0.61% to - 0.39%) in the low - glycemic index diet ( P <. 001). There was also an increase of high- density lipoprotein cholesterol in the low - glycemic index diet by 1.7 mg/ dL ( 95% CI, 0.8- 2.6 mg/ dL) compared with a decrease of high- density lipoprotein cholesterol by - 0.2 mg/ dL ( 95% CI, - 0.9 to 0.5 mg/ dL) in the high-cereal fiber diet ( P=. 005). The reduction in dietary glycemic index related positively to the reduction in HbA(1c) concentration ( r= 0.35, P <. 001) and negatively to the increase in high- density lipoprotein cholesterol ( r=- 0.19, P=. 009). Conclusion In patients with type 2 diabetes, 6- month treatment with a low glycemic index diet resulted in moderately lower HbA(1c) levels compared with a high cereal fiber diet. Trial Registration clinicaltrials. gov identifier: NCT00438698.	[Jenkins, David J. A.; Kendall, Cyril W. C.; McKeown-Eyssen, Gail; Josse, Robert G.; Vidgen, Edward; Josse, Andrea R.; Nguyen, Tri H.; Banach, Monica S.; Emam, Azadeh; Augustin, Livia S. A.; Leiter, Lawrence A.] Univ Toronto, Dept Nutr Sci, Fac Med, Toronto, ON M5S 3E2, Canada; [Jenkins, David J. A.; Kendall, Cyril W. C.; Josse, Robert G.; Vidgen, Edward; Nguyen, Tri H.; Corrigan, Sorcha; Banach, Monica S.; Ares, Sophie; Mitchell, Sandy; Emam, Azadeh; Augustin, Livia S. A.; Parker, Tina L.; Leiter, Lawrence A.] St Michaels Hosp, Clin Nutr & Risk Factor Modificat Ctr, Toronto, ON M5B 1W8, Canada; [Jenkins, David J. A.; Josse, Robert G.; Leiter, Lawrence A.] St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; [McKeown-Eyssen, Gail] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 3E2, Canada; [Jenkins, David J. A.; Josse, Robert G.; Silverberg, Jay; Booth, Gillian L.; Leiter, Lawrence A.] Univ Toronto, Dept Med, Toronto, ON M5S 3E2, Canada; [Silverberg, Jay] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; [Kendall, Cyril W. C.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Saskatchewan	Jenkins, DJA (corresponding author), Univ Toronto, Dept Nutr Sci, Fac Med, 150 Coll St, Toronto, ON M5S 3E2, Canada.	cyril.kendall@utoronto.ca	Jenkins, David JA/A-1992-2009; Leiter, Lawrence/AAG-4059-2020; Augustin, Livia/AAC-9009-2022	Augustin, Livia/0000-0002-6673-8281; Josse, Andrea/0000-0002-7247-9466	Canadian Institutes of Health Research; Canada Research Chair Endowment of the Federal Government of Canada, and Barilla ( Italy)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Endowment of the Federal Government of Canada, and Barilla ( Italy)(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research, Canada Research Chair Endowment of the Federal Government of Canada, and Barilla ( Italy).	Ajani UA, 2004, J NUTR, V134, P1181, DOI 10.1093/jn/134.5.1181; Anderson JW, 2004, J AM COLL NUTR, V23, P5, DOI 10.1080/07315724.2004.10719338; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; Barnard ND, 2006, DIABETES CARE, V29, P1777, DOI 10.2337/dc06-0606; Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261; Chandalia M, 2000, NEW ENGL J MED, V342, P1392, DOI 10.1056/NEJM200005113421903; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coulston AM, 1997, DIABETES CARE, V20, P241, DOI 10.2337/diacare.20.3.241; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Ebbeling C B, 2001, Adv Pediatr, V48, P179; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092; Ford ES, 2001, ARCH INTERN MED, V161, P572, DOI 10.1001/archinte.161.4.572; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Franz Marion J, 2004, Diabetes Care, V27 Suppl 1, pS36; Franz MJ, 2003, DIABETES CARE, V26, P2466, DOI 10.2337/diacare.26.8.2466; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GINSBERG HN, 1991, DIABETES CARE, V14, P839, DOI 10.2337/diacare.14.9.839; Jarvi AE, 1999, DIABETES CARE, V22, P10, DOI 10.2337/diacare.22.1.10; Jenkins DJA, 2002, DIABETES CARE, V25, P1522, DOI 10.2337/diacare.25.9.1522; Klein S, 2004, DIABETES CARE, V27, P2067, DOI 10.2337/diacare.27.8.2067; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Liu SM, 2002, AM J CLIN NUTR, V75, P492, DOI 10.1093/ajcn/75.3.492; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Liu SM, 2001, AM J CLIN NUTR, V73, P560; Luscombe ND, 1999, EUR J CLIN NUTR, V53, P473, DOI 10.1038/sj.ejcn.1600779; Maki KC, 2007, AM J CLIN NUTR, V85, P724, DOI 10.1093/ajcn/85.3.724; MANNINEN V, 1992, CIRCULATION, V85, P37, DOI 10.1161/01.CIR.85.1.37; MEINERT CL, 1970, DIABETES, V19, P789; Miles JM, 2008, AM J CLIN NUTR, V87, P1; *NAT HEART LUNG BL, SAF NHLBI CHANG INT; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pi-Sunyer X, 2008, AM J CLIN NUTR, V87, P3, DOI 10.1093/ajcn/87.1.3; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; SAS, 2006, SAS STAT US GUID VER; SCHAEFER EJ, 1994, J LIPID RES, V35, P871; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Food and Drug Administration, GUID IND DIAB MELL D; *USDA, 1992, AGR HDB USDA, V8; Wolever TMS, 2008, AM J CLIN NUTR, V87, P114, DOI 10.1093/ajcn/87.1.114	47	279	291	4	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2742	2753		10.1001/jama.2008.808	http://dx.doi.org/10.1001/jama.2008.808			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088352	Bronze			2022-12-28	WOS:000261730400021
J	Aratyn-Schaus, Y; Gardel, ML				Aratyn-Schaus, Yvonne; Gardel, Margaret L.			BIOPHYSICS Clutch Dynamics	SCIENCE			English	Editorial Material							ACTIN; GROWTH; RIGIDITY		[Aratyn-Schaus, Yvonne; Gardel, Margaret L.] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Gardel, Margaret L.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Aratyn-Schaus, Y (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.	gardel@uchicago.edu	Gardel, Margaret/D-1703-2012		OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003354] Funding Source: NIH RePORTER; NIH HHS [DP1 OD003354-02, DP1 OD003354-01, DP1 OD003354] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gerbal F, 2000, BIOPHYS J, V79, P2259, DOI 10.1016/S0006-3495(00)76473-3; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Lin CH, 1997, BIOL BULL-US, V192, P183, DOI 10.2307/1542600; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Macdonald A, 2008, CELL ADHES MIGR, V2, P95, DOI 10.4161/cam.2.2.6210; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0	19	7	7	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1646	1647		10.1126/science.1168102	http://dx.doi.org/10.1126/science.1168102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074337				2022-12-28	WOS:000261608300031
J	Diallinas, G				Diallinas, George			BIOCHEMISTRY An Almost-Complete Movie	SCIENCE			English	Editorial Material							LACTOSE PERMEASE; CRYSTAL-STRUCTURE; TRANSPORTER; MECHANISM; HOMOLOG; GATE		[Diallinas, George] Univ Athens, Fac Biol, Athens 15781, Greece	National & Kapodistrian University of Athens	Diallinas, G (corresponding author), Univ Athens, Fac Biol, Athens 15781, Greece.	diallina@biol.uoa.gr	Diallinas, George/AAE-8457-2019	Diallinas, George/0000-0002-3426-726X				Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Naftalin RJ, 2007, BIOPHYS J, V92, P3474, DOI 10.1529/biophysj.106.100669; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105	11	30	30	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1644	1645		10.1126/science.1168107	http://dx.doi.org/10.1126/science.1168107			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074336				2022-12-28	WOS:000261608300030
J	Hamant, O; Heisler, MG; Jonsson, H; Krupinski, P; Uyttewaal, M; Bokov, P; Corson, F; Sahlin, P; Boudaoud, A; Meyerowitz, EM; Couder, Y; Traas, J				Hamant, Olivier; Heisler, Marcus G.; Jonsson, Henrik; Krupinski, Pawel; Uyttewaal, Magalie; Bokov, Plamen; Corson, Francis; Sahlin, Patrik; Boudaoud, Arezki; Meyerowitz, Elliot M.; Couder, Yves; Traas, Jan			Developmental Patterning by Mechanical Signals in Arabidopsis	SCIENCE			English	Article							SHOOT APICAL MERISTEM; CORTICAL MICROTUBULES; EPIDERMAL-CELLS; AUXIN TRANSPORT; GROWTH; MORPHOGENESIS; APEX; WALL; PHYLLOTAXIS; MODEL	A central question in developmental biology is whether and how mechanical forces serve as cues for cellular behavior and thereby regulate morphogenesis. We found that morphogenesis at the Arabidopsis shoot apex depends on the microtubule cytoskeleton, which in turn is regulated by mechanical stress. A combination of experiments and modeling shows that a feedback loop encompassing tissue morphology, stress patterns, and microtubule- mediated cellular properties is sufficient to account for the coordinated patterns of microtubule arrays observed in epidermal cells, as well as for patterns of apical morphogenesis.	[Heisler, Marcus G.; Meyerowitz, Elliot M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jonsson, Henrik; Krupinski, Pawel; Sahlin, Patrik] Lund Univ, Computat Biol & Biol Phys Grp, Dept Theoret Phys, S-22100 Lund, Sweden; [Bokov, Plamen; Corson, Francis; Boudaoud, Arezki] Ecole Normale Super, Phys Stat Lab, F-75231 Paris 05, France; [Bokov, Plamen; Couder, Yves] Univ Paris Diderot, F-75025 Paris 13, France; [Hamant, Olivier; Uyttewaal, Magalie; Traas, Jan] INRA, Lab Reprod & Dev Plantes, F-69364 Lyon 07, France; [Hamant, Olivier; Uyttewaal, Magalie; Traas, Jan] Univ Lyon 1, CNRS, ENS, F-69364 Lyon 07, France	California Institute of Technology; Lund University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Meyerowitz, EM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	meyerow@caltech.edu; couder@lps.ens.fr; jan.traas@ens-lyon.fr	Traas, Jan/AAZ-7004-2020; heisler, marcus G/B-9738-2015; Boudaoud, Arezki/Q-7436-2016; Meyerowitz, Elliot M/A-7118-2009	Traas, Jan/0000-0001-5107-1472; heisler, marcus G/0000-0001-5644-8398; Boudaoud, Arezki/0000-0002-2780-4717; Hamant, Olivier/0000-0001-6906-6620	International Human Frontier Science Program Organization; U. S. Department of Energy [FG02-88ER13873]; Balzan Foundation; Swedish Research Council	International Human Frontier Science Program Organization(Human Frontier Science Program); U. S. Department of Energy(United States Department of Energy (DOE)); Balzan Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank A. Roeder for critical reading of the manuscript, and P. Barbier de Reuille and IFR128 Platim for help with imaging. Supported by the International Human Frontier Science Program Organization, by U. S. Department of Energy grant FG02-88ER13873 (E.M.M.), by the Balzan Foundation (E.M.M.), and by the Swedish Research Council (H.J.).	BEENAKKER CWJ, 1986, PHYS REV LETT, V57, P2454, DOI 10.1103/PhysRevLett.57.2454; Castle ES, 1937, J CELL COMPAR PHYSL, V10, P113, DOI 10.1002/jcp.1030100110; Chan J, 2007, NAT CELL BIOL, V9, P171, DOI 10.1038/ncb1533; CLEARY AL, 1993, PLANT CELL PHYSIOL, V34, P1003; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; CYR RJ, 1994, ANNU REV CELL BIOL, V10, P153, DOI 10.1146/annurev.cb.10.110194.001101; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Dumais J, 2000, J PLANT GROWTH REGUL, V19, P7, DOI 10.1007/s003440000003; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Flugge W., 1973, STRESS IN SHELLS, Vsecond, DOI [10.1007/978-3-642-88291-3, DOI 10.1007/978-3-642-88291-3]; GLAZIER JA, 1987, PHYS REV A, V36, P306, DOI 10.1103/PhysRevA.36.306; GOODBODY KC, 1990, PROTOPLASMA, V157, P92, DOI 10.1007/BF01322641; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; GREEN PB, 1966, AUST J BIOL SCI, V19, P421, DOI 10.1071/BI9660421; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hejnowicz Z, 2005, PROTOPLASMA, V225, P243, DOI 10.1007/s00709-005-0091-9; Hejnowicz Z, 2000, PATTERN FORMATION BI, P240; HERNANDEZ LF, 1993, PLANT CELL, V5, P1725, DOI 10.1105/tpc.5.12.1725; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; HUSH JM, 1991, CELL BIOL INT REP, V15, P551, DOI 10.1016/0309-1651(91)90002-Z; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lintilhac P. M., 1984, Positional controls in plant development, P83; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peters WS, 1996, ANN BOT-LONDON, V77, P657, DOI 10.1006/anbo.1996.0082; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; SAKAGUCHI S, 1988, BOT MAG TOKYO, V101, P497, DOI 10.1007/BF02488091; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; SELKER JML, 1992, DEV BIOL, V153, P29, DOI 10.1016/0012-1606(92)90089-Y; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Traas J, 2001, INT REV CYTOL, V208, P161; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wei CF, 2001, PLANT PHYSIOL, V126, P1129, DOI 10.1104/pp.126.3.1129; WILLIAMSON RE, 1990, AUST J PLANT PHYSIOL, V17, P601, DOI 10.1071/PP9900601; WILLIAMSON RE, 1991, INT REV CYTOL, V129, P135; Wymer CL, 1996, PLANT PHYSIOL, V110, P425, DOI 10.1104/pp.110.2.425	40	609	622	5	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1650	1655		10.1126/science.1165594	http://dx.doi.org/10.1126/science.1165594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074340				2022-12-28	WOS:000261608300034
J	Pollin, TI; Damcott, CM; Shen, HQ; Ott, SH; Shelton, J; Horenstein, RB; Post, W; McLenithan, JC; Bielak, LF; Peyser, PA; Mitchell, BD; Miller, M; O'Connell, JR; Shuldiner, AR				Pollin, Toni I.; Damcott, Coleen M.; Shen, Haiqing; Ott, Sandra H.; Shelton, John; Horenstein, Richard B.; Post, Wendy; McLenithan, John C.; Bielak, Lawrence F.; Peyser, Patricia A.; Mitchell, Braxton D.; Miller, Michael; O'Connell, Jeffrey R.; Shuldiner, Alan R.			A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection	SCIENCE			English	Article							APOLIPOPROTEIN-C-III; CORONARY-HEART-DISEASE; TRIGLYCERIDE-RICH LIPOPROTEINS; A-I; NONFASTING TRIGLYCERIDES; RISK; ARTERY; GENE; CIII; ATHEROSCLEROSIS	Apolipoprotein C-III ( apoC-III) inhibits triglyceride hydrolysis and has been implicated in coronary artery disease. Through a genome- wide association study, we have found that about 5% of the Lancaster Amish are heterozygous carriers of a null mutation ( R19X) in the gene encoding apoC- III ( APOC3) and, as a result, express half the amount of apoC- III present in noncarriers. Mutation carriers compared with noncarriers had lower fasting and postprandial serum triglycerides, higher levels of HDL- cholesterol and lower levels of LDL- cholesterol. Subclinical atherosclerosis, as measured by coronary artery calcification, was less common in carriers than noncarriers, which suggests that lifelong deficiency of apoC- III has a cardioprotective effect.	[Pollin, Toni I.; Damcott, Coleen M.; Shen, Haiqing; Ott, Sandra H.; Shelton, John; Horenstein, Richard B.; McLenithan, John C.; Mitchell, Braxton D.; Miller, Michael; O'Connell, Jeffrey R.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Post, Wendy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [McLenithan, John C.; Shuldiner, Alan R.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Bielak, Lawrence F.; Peyser, Patricia A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan	Pollin, TI (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	tpollin@medicine.umaryland.edu	Talmud, Philippa J/C-4402-2008; Humphries, Stephen E/C-5075-2008; Mitchell, Braxton/CAF-0876-2022; Miller, Michael/AGX-6773-2022	Miller, Michael/0000-0002-1679-2095; Shuldiner, Alan/0000-0001-9921-4305; Mitchell, Braxton/0000-0003-4920-4744	NIH [R01 HL088119, R01 AR046838, U01 HL72515, R01 AG18728, U01 HL084756]; General Clinical Research Centers Program; National Center for Research Resources; University of Maryland General Clinical Research Center [M01 RR 16500]; University of Maryland Clinical Nutrition Research Unit [P30 DK072488]; Johns Hopkins University General Clinical Research Center [M01 RR 000052]; Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Paul Beeson Faculty Scholars in Aging Program; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500, M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088119, U01HL084756, U01HL072515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Maryland Clinical Nutrition Research Unit; Johns Hopkins University General Clinical Research Center(Johns Hopkins UniversityUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Paul Beeson Faculty Scholars in Aging Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge our Amish liaisons, field workers, and clinic staff and the extraordinary cooperation and support of the Amish community, without which these studies would not have been possible. We thank R. Agarwala and A. Schaffer for assistance in pedigree construction and K. Ryan for data management. This work was supported by NIH grants R01 HL088119, R01 AR046838, U01 HL72515, R01 AG18728, and U01 HL084756; General Clinical Research Centers Program, National Center for Research Resources (NCRR), NIH; the University of Maryland General Clinical Research Center, grant M01 RR 16500; University of Maryland Clinical Nutrition Research Unit grant P30 DK072488; the Johns Hopkins University General Clinical Research Center, grant M01 RR 000052; the Baltimore Veterans Administration Geriatric Research and Education Clinical Center (GRECC); and the Paul Beeson Faculty Scholars in Aging Program.	Auwerx J, 1996, ATHEROSCLEROSIS, V124, pS29, DOI 10.1016/0021-9150(96)05854-6; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Chan DC, 2008, J CLIN ENDOCR METAB, V93, P557, DOI 10.1210/jc.2006-2676; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; HOSPATTANKAR AV, 1986, FEBS LETT, V197, P67, DOI 10.1016/0014-5793(86)80300-3; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; KANE JP, 2001, ONLINE METABOLIC MOL, pCH114; KARATHANASIS SK, 1983, NATURE, V301, P718, DOI 10.1038/301718a0; KARATHANASIS SK, 1987, P NATL ACAD SCI USA, V84, P7198, DOI 10.1073/pnas.84.20.7198; Kawakami A, 2006, CIRCULATION, V113, P691, DOI 10.1161/CIRCULATIONAHA.105.591743; Libby P, 2007, CIRC RES, V100, P299, DOI 10.1161/01.RES.0000259393.89870.58; Liu HQ, 2000, J LIPID RES, V41, P1760; MAEDA N, 1994, J BIOL CHEM, V269, P23610; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; ORDOVAS JM, 1989, J BIOL CHEM, V264, P16339; Post W, 2007, CIRCULATION, V115, P717, DOI 10.1161/CIRCULATIONAHA.106.637512; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	32	503	562	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1702	1705		10.1126/science.1161524	http://dx.doi.org/10.1126/science.1161524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074352	Green Accepted			2022-12-28	WOS:000261608300048
J	Cecil, JE; Tavendale, R; Watt, P; Hetherington, MM; Palmer, CNA				Cecil, Joanne E.; Tavendale, Roger; Watt, Peter; Hetherington, Marion M.; Palmer, Colin N. A.			An Obesity-Associated FTO Gene Variant and Increased Energy Intake in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; ADULT OBESITY; RISK-FACTORS; HUMANS; EXPENDITURE	Background: Variation in the fat mass and obesity-associated (FTO) gene has provided the most robust associations with common obesity to date. However, the role of FTO variants in modulating specific components of energy balance is unknown. Methods: We studied 2726 Scottish children, 4 to 10 years of age, who underwent genotyping for FTO variant rs9939609 and were measured for height and weight. A subsample of 97 children was examined for possible association of the FTO variant with adiposity, energy expenditure, and food intake. Results: In the total study group and the subsample, the A allele of rs9939609 was associated with increased weight (P=0.003 and P=0.049, respectively) and body-mass index (P=0.003 and P=0.03, respectively). In the intensively phenotyped subsample, the A allele was also associated with increased fat mass (P=0.01) but not with lean mass. Although total and resting energy expenditures were increased in children with the A allele (P=0.009 and P=0.03, respectively), resting energy expenditure was identical to that predicted for the age and weight of the child, indicating that there is no defect in metabolic adaptation to obesity in persons bearing the risk-associated allele. The A allele was associated with increased energy intake (P=0.006) independently of body weight. In contrast, the weight of food ingested by children who had the allele was similar to that in children who did not have the allele (P=0.82). Conclusions: The FTO variant that confers a predisposition to obesity does not appear to be involved in the regulation of energy expenditure but may have a role in the control of food intake and food choice, suggesting a link to a hyperphagic phenotype or a preference for energy-dense foods.	[Tavendale, Roger; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Cecil, Joanne E.] Univ St Andrews, Bute Med Sch, St Andrews, Fife, Scotland; [Watt, Peter] Univ Brighton, Chelsea Sch, Brighton, E Sussex, England; [Hetherington, Marion M.] Glasgow Caledonian Univ, Dept Psychol, Glasgow G4 0BA, Lanark, Scotland	University of Dundee; University of St Andrews; University of Brighton; Glasgow Caledonian University	Palmer, CNA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland.	nuclear-receptor@dundee.ac.uk	Palmer, Colin NA/C-7053-2008; Hetherington, Marion/A-4397-2013; Cecil, Joanne E/A-3071-2010	Palmer, Colin NA/0000-0002-6415-6560; Hetherington, Marion/0000-0001-8677-5234; Cecil, Joanne/0000-0003-4779-6037	U.K. Biotechnology and Biological Sciences Research Council [D13460]	U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a grant from the U.K. Biotechnology and Biological Sciences Research Council (D13460). No potential conflict of interest relevant to this article was reported. We thank the children, parents, and schoolteachers for their enthusiastic participation in this study; Dr. Wendy Wrieden, Dr. Deborah Wallis, and Inez Murrie for their support; and Dr. Lydia Martinez, Dr. Andy Coward, and Antony Wright for their technical assistance and helpful discussions.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Ball EJ, 2001, AM J CLIN NUTR, V74, P524; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Burgert Tania S, 2006, Pediatr Endocrinol Rev, V3 Suppl 4, P555; Cecil JE, 2005, INT J OBESITY, V29, P1199, DOI 10.1038/sj.ijo.0803055; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Cecil JE, 2007, AM J CLIN NUTR, V86, P167, DOI 10.1093/ajcn/86.1.167; Cecil JE, 2006, PHYSIOL BEHAV, V88, P227, DOI 10.1016/j.physbeh.2006.05.028; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Ferreira AP, 2007, J PEDIAT-BRAZIL, V83, P21, DOI [10.2223/JPED.1562, 10.1590/S0021-75572007000100005]; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Freedman DS, 2002, J PEDIATR ENDOCR MET, V15, P1099; Garcia AL, 2005, OBES RES, V13, P626, DOI 10.1038/oby.2005.67; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; LOHMAN TG, 1986, EXERCISE SPORT SCI R, V14, P325; Lohman TG, 1989, PEDIATR EXERC SCI, V1, P19, DOI DOI 10.1123/PES.1.1.19; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; SCHOELLER DA, 1983, AM J CLIN NUTR, V38, P999, DOI 10.1093/ajcn/38.6.999; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; TSCHRITTER O, 2008, DIABETOLOGIA, V51, P1558; VanKreel BK, 1996, J MASS SPECTROM, V31, P108; Wiegand S, 2005, INT J OBESITY, V29, pS136, DOI 10.1038/sj.ijo.0803081; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	31	487	520	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2558	2566		10.1056/NEJMoa0803839	http://dx.doi.org/10.1056/NEJMoa0803839			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073975	Bronze			2022-12-28	WOS:000261534200007
J	Montell, DJ				Montell, Denise J.			Morphogenetic Cell Movements: Diversity from Modular Mechanical Properties	SCIENCE			English	Review							ZEBRAFISH LATERAL-LINE; BRANCHING MORPHOGENESIS; DROSOPHILA; MIGRATION; ADHESION; TISSUE; GASTRULATION; MYOSIN; INTERCALATION; ORGANIZATION	Animal tissue and organ development requires the orchestration of cell movements, including those of interconnected cell groups, termed collective cell movements. Such movements are incredibly diverse. Recent work suggests that two core cellular properties, cell- cell adhesion and contractility, can largely determine geometry, packing, sorting, and rearrangement of epithelial cell layers. Two additional force- generating properties, the ability to generate cell protrusions and cell adhesion to the extracellular matrix, contribute to active motility. These mechanical properties can be regulated independently in cells, suggesting that they can be employed in a combinatorial manner. A small number of properties used in combination could, in principle, generate a diverse array of cell shapes and arrangements and thus orchestrate the varied morphogenetic events observed during metazoan organ development.	[Montell, Denise J.] Ctr Cell Dynam, Dept Biol Chem, Baltimore, MD 21205 USA		Montell, DJ (corresponding author), Ctr Cell Dynam, Dept Biol Chem, Rangos Bldg,Suite 450,855 N Wolfe St, Baltimore, MD 21205 USA.	dmontell@jhmi.edu			NIH [U54 GM064346, R01GM73164]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073164, U54GM064346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by NIH grants U54 GM064346 and R01GM73164. I would like to thank A. Ewald and the anonymous reviewers for their thoughtful comments. Special thanks to the reviewer who pointed me to D. A. W. Thompson's book, an inspiring work of literature, philosophy, and science. Many thanks also to D. Gilmour for the micrograph in Fig. 1D, J. Zallen for Fig. 2, and R. Carthew for Fig. 3.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; ARCHIBALD RC, 1944, B AM MATH SOC, V24, P403; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Brodland GW, 2000, J BIOMECH ENG-T ASME, V122, P402, DOI 10.1115/1.1288205; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Ewald AJ, 2008, CURR BIOL, V18, pR615, DOI 10.1016/j.cub.2008.06.016; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez-Gonzalez R, 2008, CURR BIOL, V18, pR163, DOI 10.1016/j.cub.2007.12.030; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hilgenfeldt S, 2008, P NATL ACAD SCI USA, V105, P907, DOI 10.1073/pnas.0711077105; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Medioni C, 2005, DEVELOPMENT, V132, P3069, DOI 10.1242/dev.01886; Melani M, 2008, CURR BIOL, V18, P532, DOI 10.1016/j.cub.2008.03.024; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thompson D. A. W., 1942, GROWTH FORM, P1116; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; YOUNG PE, 1991, DEVELOPMENT, V111, P1; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	41	216	219	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1502	1505		10.1126/science.1164073	http://dx.doi.org/10.1126/science.1164073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056976				2022-12-28	WOS:000261377400038
J	Munch, E; Launey, ME; Alsem, DH; Saiz, E; Tomsia, AP; Ritchie, RO				Munch, E.; Launey, M. E.; Alsem, D. H.; Saiz, E.; Tomsia, A. P.; Ritchie, R. O.			Tough, Bio-Inspired Hybrid Materials	SCIENCE			English	Article							FRACTURE-RESISTANCE MECHANISM; HUMAN CORTICAL BONE; CRACK-PROPAGATION; LAYERED CERAMICS; POROUS CERAMICS; SILICON-CARBIDE; PORE STRUCTURE; NACRE; COMPOSITES; ALUMINA	The notion of mimicking natural structures in the synthesis of new structural materials has generated enormous interest but has yielded few practical advances. Natural composites achieve strength and toughness through complex hierarchical designs that are extremely difficult to replicate synthetically. We emulate nature's toughening mechanisms by combining two ordinary compounds, aluminum oxide and polymethyl methacrylate, into ice- templated structures whose toughness can be more than 300 times ( in energy terms) that of their constituents. The final product is a bulk hybrid ceramic- based material whose high yield strength and fracture toughness [similar to 200 megapascals (MPa) and similar to 30 MPa.m(1/2)] represent specific properties comparable to those of aluminum alloys. These model materials can be used to identify the key microstructural features that should guide the synthesis of bio- inspired ceramic- based composites with unique strength and toughness.	[Munch, E.; Launey, M. E.; Alsem, D. H.; Saiz, E.; Tomsia, A. P.; Ritchie, R. O.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Alsem, D. H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Ritchie, R. O.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ritchie, RO (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	roritchie@lbl.gov	Ritchie, Robert O/A-8066-2008	Ritchie, Robert O/0000-0002-0501-6998	Office of Science; Office of Basic Energy Sciences; Division of Materials Sciences and Engineering; U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Araki K, 2004, J AM CERAM SOC, V87, P1859; Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1; Becher PF, 1998, J AM CERAM SOC, V81, P2821, DOI 10.1111/j.1151-2916.1998.tb02702.x; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Cao JJ, 1996, J AM CERAM SOC, V79, P461, DOI 10.1111/j.1151-2916.1996.tb08145.x; Chan HM, 1997, ANNU REV MATER SCI, V27, P249, DOI 10.1146/annurev.matsci.27.1.249; COOK J, 1964, PROC R SOC LON SER-A, V282, P508, DOI 10.1098/rspa.1964.0248; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Fukasawa T, 2001, J AM CERAM SOC, V84, P230, DOI 10.1111/j.1151-2916.2001.tb00638.x; Fukasawa T, 2001, J MATER SCI, V36, P2523, DOI 10.1023/A:1017946518955; JOHNSON DR, 1995, INTERMETALLICS, V3, P99, DOI 10.1016/0966-9795(95)92674-O; Jones R.M., 1999, MECH COMPOS MATER, V2nd, DOI DOI 10.1201/9781498711067; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Kruzic JJ, 2005, J AM CERAM SOC, V88, P2236, DOI 10.1111/j.1551-2916.2005.00434.x; Kruzic JJ, 2004, J AM CERAM SOC, V87, P93, DOI 10.1111/j.1551-2916.2004.00093.x; LANGE FF, 1973, J AM CERAM SOC, V56, P518, DOI 10.1111/j.1151-2916.1973.tb12401.x; Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k; Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005; MAI YW, 1987, J AM CERAM SOC, V70, P289, DOI 10.1111/j.1151-2916.1987.tb04983.x; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; MOYA JS, 1995, ADV MATER, V7, P185, DOI 10.1002/adma.19950070219; Nalla RK, 2005, BIOMATERIALS, V26, P217, DOI 10.1016/j.biomaterials.2004.02.017; Nalla RK, 2003, BIOMATERIALS, V24, P3955, DOI 10.1016/S0142-9612(03)00278-3; Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295; PADTURE NP, 1994, J AM CERAM SOC, V77, P2518, DOI 10.1111/j.1151-2916.1994.tb04637.x; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; RITCHIE RO, 1988, MAT SCI ENG A-STRUCT, V103, P15, DOI 10.1016/0025-5416(88)90547-2; Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354; SHANG JK, 1989, METALL TRANS A, V20, P897, DOI 10.1007/BF02651656; SIGL LS, 1988, ACTA METALL MATER, V36, P945, DOI 10.1016/0001-6160(88)90149-6; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1; SWANSON PL, 1987, J AM CERAM SOC, V70, P279, DOI 10.1111/j.1151-2916.1987.tb04982.x; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Tasdemirci A, 2004, J COMPOS MATER, V38, P995, DOI 10.1177/0021998304040564; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935	41	1291	1314	72	1555	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1516	1520		10.1126/science.1164865	http://dx.doi.org/10.1126/science.1164865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056979	Green Submitted			2022-12-28	WOS:000261377400042
J	Cohen, JE				Cohen, Joel E.			Make secondary education universal	NATURE			English	Editorial Material									[Cohen, Joel E.] Rockefeller Univ, New York, NY 10065 USA; [Cohen, Joel E.] Columbia Univ, New York, NY USA	Rockefeller University; Columbia University	Cohen, JE (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	cohen@rockefeller.edu						ASHFORD L, 2006, WORLDS YOUTH DATA SH; Cohen JE, 2005, SCI AM, V293, P48, DOI 10.1038/scientificamerican0905-48; COHEN JE, 2005, FINANC DEV, V42, P8; COHEN JE, INT PERSPEC IN PRESS; Cohen Joel, 2007, ED ALL CHILDREN GLOB; Jejeebhoy S., 1995, WOMENS ED AUTONOMY R; Kravdal O, 2004, POP STUD-J DEMOG, V58, P177, DOI 10.1080/0032472042000213721; Kravdal O, 2002, DEMOGRAPHY, V39, P233, DOI 10.2307/3088337; *POP REF BUR, 2008, WOM ED FAM SIZ SEL C; United Nations Population Division, WORLD POP PROSP 2006	10	21	21	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					572	573		10.1038/456572a	http://dx.doi.org/10.1038/456572a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	378QW	19052604				2022-12-28	WOS:000261340000015
J	Chandran, S				Chandran, Siddharthan			What are the prospects of stem cell therapy for neurology?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; TRANSPLANTATION; NEURONS		[Chandran, Siddharthan] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Chandran, Siddharthan] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge CB2 0SZ, England	University of Cambridge; University of Cambridge	Chandran, S (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England.	sc222@cam.ac.uk			Medical Research Council [G0502107] Funding Source: Medline; MRC [G0502107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Chandran S, 2008, PHILOS T R SOC B, V363, P171, DOI 10.1098/rstb.2006.2019; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Compston A, 2006, ACTA NEUROL SCAND, V113, P41, DOI 10.1111/j.1600-0404.2006.00614.x; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Rosser AE, 2007, CURR OPIN NEUROL, V20, P688, DOI 10.1097/WCO.0b013e3282f132fc; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Suzuki M, 2008, TRENDS NEUROSCI, V31, P192, DOI 10.1016/j.tins.2008.01.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Wasiak J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005489.pub2; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	21	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2008	337								a1934	10.1136/bmj.a1934	http://dx.doi.org/10.1136/bmj.a1934			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QD	19042937				2022-12-28	WOS:000261827800006
J	Van Raamsdonk, CD; Bezrookove, V; Green, G; Bauer, J; Gaugler, L; O'Brien, JM; Simpson, EM; Barsh, GS; Bastian, BC				Van Raamsdonk, Catherine D.; Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; O'Brien, Joan M.; Simpson, Elizabeth M.; Barsh, Gregory S.; Bastian, Boris C.			Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi	NATURE			English	Article							KINASE-C; BRAF; MELANOCYTES; PATHWAY; CELLS	BRAF and NRAS are common targets for somatic mutations in benign and malignant neoplasms that arise from melanocytes situated in epithelial structures, and lead to constitutive activation of the mitogen- activated protein ( MAP) kinase pathway(1,2). However, BRAF and NRAS mutations are absent in a number of other melanocytic neoplasms in which the equivalent oncogenic events are currently unknown(3). Here we report frequent somatic mutations in the heterotrimeric G protein alpha-subunit, GNAQ, in blue naevi (83%) and ocular melanoma of the uvea ( 46%). The mutations occur exclusively in codon 209 in the Ras- like domain and result in constitutive activation, turning GNAQ into a dominant acting oncogene. Our results demonstrate an alternative route to MAP kinase activation in melanocytic neoplasia, providing new opportunities for therapeutic intervention.	[Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; O'Brien, Joan M.; Bastian, Boris C.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [O'Brien, Joan M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Bauer, Juergen] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Simpson, Elizabeth M.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Simpson, Elizabeth M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of British Columbia; University of British Columbia; Stanford University	Bastian, BC (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	bastian@cc.ucsf.edu	Simpson, Elizabeth/H-1183-2012; Van Raamsdonk, Catherine D./B-6207-2017; Bauer, Jurgen/B-4656-2008	Van Raamsdonk, Catherine D./0000-0002-4309-3513; Bastian, Boris/0000-0003-1836-6062; Bauer, Jurgen/0000-0001-8789-1536; Simpson, Elizabeth/0000-0002-0654-4303	National Cancer Institute [P01 CA025874 Project 2]; Melanoma Research Alliance, the Canadian Institutes of Health Research [MOP-79511]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA025874, R01CA131524] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance, the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Harbour for providing additional DNA samples from uveal melanomas and P. Viciana-Rodriguez and A. Balmain for providing advice. hTERT/CDK4<SUP>R24C</SUP>/p53<SUP>DD</SUP> melanocytes were a gift from D. Fisher, Dana Farber Cancer Institute<SUP>13</SUP>, normal human melanocytes from foreskin were a gift from M. Herlyn, and OMM1.3 and Mel202 cells were originally from B. Ksander. The melan-a cells were a gift from D. Bennett, St George's University, London23. This work was supported by grants from the National Cancer Institute (P01 CA025874 Project 2 to B.C.B.) the Melanoma Research Alliance, the Canadian Institutes of Health Research (MOP-79511 to C.D.V.R.), and the National Institutes of Health (G.S.B.).	BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; HORSMAN DE, 1993, CANCER, V71, P811, DOI 10.1002/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Mizushima J, 1998, BRIT J DERMATOL, V139, P349; POLLOCK PM, 2002, NAT GENET, V25, P25; Saldanha G, 2004, INT J CANCER, V111, P705, DOI 10.1002/ijc.20325; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Singh AD, 1998, OPHTHALMOLOGY, V105, P195, DOI 10.1016/S0161-6420(98)92205-9; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Zembowicz A, 2004, HISTOPATHOLOGY, V45, P433, DOI 10.1111/j.1365-2559.2004.01975.x; Zuidervaart W, 2005, BRIT J CANCER, V92, P2032, DOI 10.1038/sj.bjc.6602598	23	1043	1063	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					599	U108		10.1038/nature07586	http://dx.doi.org/10.1038/nature07586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19078957	Green Accepted, Green Submitted			2022-12-28	WOS:000262852200045
J	Tan, A; Parker, C				Tan, Alex; Parker, Chris			Radiotherapy in locally advanced prostate cancer	LANCET			English	Editorial Material							ANDROGEN SUPPRESSION; MANAGEMENT; IMMEDIATE; EORTC		[Tan, Alex; Parker, Chris] Inst Canc Res, Acad Unit Radiotherapy & Oncol, Sutton SM2 5PT, Surrey, England	University of London; Institute of Cancer Research - UK	Parker, C (corresponding author), Inst Canc Res, Acad Unit Radiotherapy & Oncol, Sutton SM2 5PT, Surrey, England.	chris.parker@icr.ac.uk	Tan, Alex/AAF-8585-2020	Tan, Alex/0000-0003-2902-4025	Cancer Research UK [10588] Funding Source: Medline; Medical Research Council [G0501019] Funding Source: Medline; MRC [G0501019] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aus G, 2005, EUR UROL, V48, P546, DOI 10.1016/j.eururo.2005.06.001; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Chong CCW, 2006, BJU INT, V97, P975, DOI 10.1111/j.1464-410X.2006.06065.x; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Mason M, 2005, CLIN ONCOL-UK, V17, P217, DOI 10.1016/j.clon.2005.02.013; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McLeod DG, 2006, BJU INT, V97, P247, DOI 10.1111/j.1464-410X.2005.06051.x; National Institute for Health and Care Excellence (NICE), 2008, PROST CANC DIAGN TRE; Newschaffer CJ, 2000, JNCI-J NATL CANCER I, V92, P613, DOI 10.1093/jnci/92.8.613; Payne HA, 2007, BJU INT, V99, P545, DOI 10.1111/j.1464-410X.2006.06651.x; Pilepich MV, 2005, INT J RADIAT ONCOL, V61, P1285, DOI 10.1016/j.ijrobp.2004.08.047; Studer UE, 2006, J CLIN ONCOL, V24, P1868, DOI 10.1200/JCO.2005.04.7423; WIDMARK A, 2008, LANCET          1216, DOI DOI 10.1016/S0140-6736(08)61815-2	14	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					274	276		10.1016/S0140-6736(08)61816-4	http://dx.doi.org/10.1016/S0140-6736(08)61816-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	398JJ	19091392				2022-12-28	WOS:000262728100005
J	Kawahara, A; Nishi, T; Hisano, Y; Fukui, H; Yamaguchi, A; Mochizuki, N				Kawahara, Atsuo; Nishi, Tsuyoshi; Hisano, Yu; Fukui, Hajime; Yamaguchi, Akihito; Mochizuki, Naoki			The Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors	SCIENCE			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; SPHINGOSINE 1-PHOSPHATE; ENDODERM FORMATION; HEART DEVELOPMENT; SPHINGOSINE-1-PHOSPHATE; GENETICS; PROTEIN; CASANOVA; MUTATION; SLC11A3	Sphingosine-1-phosphate ( S1P) is a secreted lipid mediator that functions in vascular development; however, it remains unclear how S1P secretion is regulated during embryogenesis. We identified a zebrafish mutant, ko157, that displays cardia bifida ( two hearts) resembling that in the S1P receptor- 2 mutant. A migration defect of myocardial precursors in the ko157 mutant is due to a mutation in a multipass transmembrane protein, Spns2, and can be rescued by S1P injection. We show that the export of S1P from cells requires Spns2. spns2 is expressed in the extraembryonic tissue yolk syncytial layer ( YSL), and the introduction of spns2 mRNA in the YSL restored the cardiac defect in the ko157 mutant. Thus, Spns2 in the YSL functions as a S1P transporter in S1P secretion, thereby regulating myocardial precursor migration.	[Kawahara, Atsuo; Fukui, Hajime; Mochizuki, Naoki] Natl Cardiovasc Ctr Hosp & Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Kawahara, Atsuo] Kyoto Univ, Fac Med, HMRO, Sakyo Ku, Kyoto 6068501, Japan; [Nishi, Tsuyoshi; Hisano, Yu; Yamaguchi, Akihito] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Nishi, Tsuyoshi; Hisano, Yu; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	National Cerebral & Cardiovascular Center - Japan; Kyoto University; Osaka University; Osaka University	Kawahara, A (corresponding author), Natl Cardiovasc Ctr Hosp & Res Inst, Dept Struct Anal, Fujishirodai 5-7-1, Osaka 5658565, Japan.	atsuo@ri.ncvc.go.jp	Fukui, Hajime/AAG-2004-2020	Fukui, Hajime/0000-0002-7652-2222	Ministry of Education, Culture, Sports, Science and Technology of Japan; National BioResource Project of Japan; Japan Society for the Promotion of Science; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National BioResource Project of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank M. Sone and M. Minamimoto for technical assistance; S. Endo and R. Hanaoka for the mutagenesis screening; T. Kitaguchi for the establishment of cmlc2: mRFP; M. Masuda, Y. Igarashi, A. Kihara, S. Mitsutake, K. Shioya, I. B. Dawid, and Y. Kaziro for support and suggestions; M. Hibi, J. S. Gutkind, and M. Tsang for critical reading and valuable suggestions; D. Y. Stainier for discussions and sharing of unpublished data; and H. Okamoto, K. Kawakami, Y. Kikuchi, H. Yanagisawa, D. Yamamoto, R. Y. Tsien, and H.- J. Tsai for fish and reagents. Supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the National BioResource Project of Japan; the Japan Society for the Promotion of Science; the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; the Ministry of Health, Labor and Welfare of Japan; and the Takeda Science Foundation. The sequences of zebrafish spns2, human Spns2, and mouse Spns2 have been deposited in the DNA Data Bank of Japan [accession numbers: AB441164 (zebrafish), AB441165 (human), AB441166 (mouse)]. The authors are filing a patent based on the results reported in this paper.	Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Matsui Takaaki, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS77, DOI 10.1038/ncpcardio0764; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schoenebeck JJ, 2007, SEMIN CELL DEV BIOL, V18, P27, DOI 10.1016/j.semcdb.2006.12.010; Sekiguchi M, 2008, J IMMUNOL, V180, P1921, DOI 10.4049/jimmunol.180.3.1921; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Young RM, 2002, DEV DYNAM, V223, P298, DOI 10.1002/dvdy.10060	25	293	304	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					524	527		10.1126/science.1167449	http://dx.doi.org/10.1126/science.1167449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19074308				2022-12-28	WOS:000262587900048
J	O'Gorman, CM; Fuller, HT; Dyer, PS				O'Gorman, Celine M.; Fuller, Hubert T.; Dyer, Paul S.			Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus	NATURE			English	Article							POLYMORPHIC DNA MARKERS; MATING-TYPE; SEQUENCE; SYSTEMS; HETEROTHALLISM; TELEOMORPH; BIOLOGY	Aspergillus fumigatus is a saprotrophic fungus whose spores are ubiquitous in the atmosphere(1). It is also an opportunistic human pathogen in immunocompromised individuals, causing potentially lethal invasive infections(2,3), and is associated with severe asthma and sinusitis(4). The species is only known to reproduce by asexual means(5), but there has been accumulating evidence for recombination and gene flow from population genetic studies(5-8), genome analysis(9,10), the presence of mating- type genes(8,10) and expression of sex- related genes(8) in the fungus. Here we show that A. fumigatus possesses a fully functional sexual reproductive cycle that leads to the production of cleistothecia and ascospores, and the teleomorph Neosartorya fumigata is described. The species has a heterothallic breeding system; isolates of complementary mating types are required for sex to occur. We demonstrate increased genotypic variation resulting from recombination between mating type and DNA fingerprint markers in ascospore progeny from an Irish environmental subpopulation. The ability of A. fumigatus to engage in sexual reproduction is highly significant in understanding the biology and evolution of the species. The presence of a sexual cycle provides an invaluable tool for classical genetic analyses and will facilitate research into the genetic basis of pathogenicity and fungicide resistance in A. fumigatus, with the aim of improving methods for the control of aspergillosis. These results also yield insights into the potential for sexual reproduction in other supposedly 'asexual' fungi.	[O'Gorman, Celine M.; Fuller, Hubert T.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland; [O'Gorman, Celine M.; Dyer, Paul S.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University College Dublin; University of Nottingham	O'Gorman, CM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland.	celine.ogorman@ucd.ie; paul.dyer@nottingham.ac.uk	O'Gorman, Celine M/E-7732-2010	O'Gorman, Celine M/0000-0001-9618-8981; Dyer, Paul/0000-0003-0237-026X	IRCSET Postgraduate Research Scholarship; EC Marie Curie Training Fellowship; British Mycological Society	IRCSET Postgraduate Research Scholarship(Irish Research Council for Science, Engineering and Technology); EC Marie Curie Training Fellowship(European Commission); British Mycological Society	We thank S. A. Balajee for access to unpublished data, C. Duggan for assistance with the Latin diagnosis, and C.O'Connell for taking the scanning electron micrographs. This work was supported by an IRCSET Postgraduate Research Scholarship, an EC Marie Curie Training Fellowship and a grant from the British Mycological Society to C.O'G.	Anderson M.J., 2003, GENOMICS PLANTS FUNG, P1; Anderson MJ, 1996, J CLIN MICROBIOL, V34, P87, DOI 10.1128/JCM.34.1.87-93.1996; AUFAUVREBROWN A, 1992, J CLIN MICROBIOL, V30, P2991, DOI 10.1128/JCM.30.11.2991-2993.1992; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Dyer Paul S., 2007, P123; DYER PS, 1992, BIOL REV, V67, P421, DOI 10.1111/j.1469-185X.1992.tb01189.x; Dyer PS, 2005, MED MYCOL, V43, pS7, DOI 10.1080/13693780400029015; DYER PS, 1993, PHYSIOL MOL PLANT P, V43, P403, DOI 10.1006/pmpp.1993.1068; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fisher R. A., 1938, STAT METHODS RES WOR; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Honegger R, 2004, MYCOL RES, V108, P480, DOI 10.1017/s0953756204009682; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Kema GHJ, 1996, CURR GENET, V30, P251, DOI 10.1007/s002940050129; Klich M.A., 2002, IDENTIFICATION COMMO; KORNERUP A., 1967, Methuen handbook of colour.; KWONCHUN.KJ, 1974, MYCOLOGIA, V66, P628, DOI 10.2307/3758166; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LIN DM, 1995, J CLIN MICROBIOL, V33, P1596, DOI 10.1128/JCM.33.6.1596-1601.1995; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Lucas JA, 2000, ADV BOT RES, V33, P225, DOI 10.1016/S0065-2296(00)33044-0; Magee PT, 2004, CURR OPIN MICROBIOL, V7, P661, DOI 10.1016/j.mib.2004.10.003; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; MULLINS J, 1976, CLIN ALLERGY, V6, P209, DOI 10.1111/j.1365-2222.1976.tb01899.x; Murtagh GJ, 1999, LICHENOLOGIST, V31, P257; Murtagh GJ, 2000, NATURE, V404, P564, DOI 10.1038/35007142; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Gorman CM, 2008, ATMOS ENVIRON, V42, P4355, DOI 10.1016/j.atmosenv.2008.01.009; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Pyrzak W, 2008, EUKARYOT CELL, V7, P1029, DOI 10.1128/EC.00380-07; Robert V, 2007, CBS YEASTS DATABASE; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Seymour FA, 2005, FUNGAL GENET BIOL, V42, P554, DOI 10.1016/j.fgb.2005.03.006; TAKADA M, 1985, MYCOTAXON, V24, P395; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varga J, 2003, INFECT GENET EVOL, V3, P3, DOI 10.1016/S1567-1348(02)00156-9; Ware SB, 2007, FUNGAL GENET BIOL, V44, P389, DOI 10.1016/j.fgb.2006.12.005; Weising K., 1995, DNA FINGERPRINTING P	47	339	358	1	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					471	U5		10.1038/nature07528	http://dx.doi.org/10.1038/nature07528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19043401				2022-12-28	WOS:000262519200045
J	Bednarek, P; Pislewska-Bednarek, M; Svatos, A; Schneider, B; Doubsky, J; Mansurova, M; Humphry, M; Consonni, C; Panstruga, R; Sanchez-Vallet, A; Molina, A; Schulze-Lefert, P				Bednarek, Pawel; Pislewska-Bednarek, Mariola; Svatos, Ales; Schneider, Bernd; Doubsky, Jan; Mansurova, Madina; Humphry, Matt; Consonni, Chiara; Panstruga, Ralph; Sanchez-Vallet, Andrea; Molina, Antonio; Schulze-Lefert, Paul			A Glucosinolate Metabolism Pathway in Living Plant Cells Mediates Broad-Spectrum Antifungal Defense	SCIENCE			English	Article							GLUTATHIONE-DEFICIENT MUTANT; ARABIDOPSIS-THALIANA; SECONDARY METABOLISM; DISEASE RESISTANCE; NONHOST RESISTANCE; BIOSYNTHESIS; MYROSINASE; CAMALEXIN; DATABASE; ENZYME	Selection pressure exerted by insects and microorganisms shapes the diversity of plant secondary metabolites. We identified a metabolic pathway for glucosinolates, known insect deterrents, that differs from the pathway activated by chewing insects. This pathway is active in living plant cells, may contribute to glucosinolate turnover, and has been recruited for broad- spectrum antifungal defense responses. The Arabidopsis CYP81F2 gene encodes a P450 monooxygenase that is essential for the pathogen- induced accumulation of 4- methoxyindol- 3- ylmethylglucosinolate, which in turn is activated by the atypical PEN2 myrosinase ( a type of beta-thioglucoside glucohydrolase) for antifungal defense. We propose that reiterated enzymatic cycles, controlling the generation of toxic molecules and their detoxification, enable the recruitment of glucosinolates in defense responses.	[Bednarek, Pawel; Pislewska-Bednarek, Mariola; Humphry, Matt; Consonni, Chiara; Panstruga, Ralph; Schulze-Lefert, Paul] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Svatos, Ales; Schneider, Bernd; Doubsky, Jan; Mansurova, Madina] Max Planck Inst Chem Ecol, D-07745 Jena, Germany; [Sanchez-Vallet, Andrea; Molina, Antonio] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, E-28223 Madrid, Spain	Max Planck Society; Max Planck Society; Universidad Politecnica de Madrid	Bednarek, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	bednarek@mpiz-koeln.mpg.de; schlef@mpiz-koeln.mpg.de	Humphry, Matthew/A-8136-2008; Panstruga, Ralph/F-3340-2011; Schulze-Lefert, Paul/B-6707-2011; Bednarek, Pawel/D-2561-2009; Svatos, Ales/A-3305-2014; Sánchez-vallet, Andrea/B-6128-2019; Molina, Antonio/G-9789-2015; Humphry, Matt/E-8072-2010; Bruening, Stefan/B-8505-2011; Schneider, Bernd/A-3287-2014; Mansurova, Madina/F-7118-2015	Panstruga, Ralph/0000-0002-3756-8957; Bednarek, Pawel/0000-0002-3064-7775; Svatos, Ales/0000-0003-1032-7288; Sánchez-vallet, Andrea/0000-0002-3668-9503; Molina, Antonio/0000-0003-3137-7938; Schneider, Bernd/0000-0003-4788-1565; Pislewska-Bednarek, Mariola/0000-0001-9241-3328; Mansurova, Madina/0000-0001-6284-8283	Max Planck Chemical Genomics Center; Spanish Ministerio de Educacion y Ciencia [BIO200600488]	Max Planck Chemical Genomics Center; Spanish Ministerio de Educacion y Ciencia(Spanish Government)	We thank J. Meier for the TGG4 antiserum and S. Rosahl and L. Westphal for pen2 pad3 seeds. Partially supported by the Max Planck Chemical Genomics Center, Spanish Ministerio de Educacion y Ciencia (MEC; grant BIO200600488) and a Ph. D. fellowship (A.S.-V.).	Andreasson E, 2001, PLANT PHYSIOL, V127, P1750, DOI 10.1104/pp.010334; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; BRUSEWITZ G, 1977, BIOCHEM J, V162, P99; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; Burow M, 2008, PHYTOCHEMISTRY, V69, P663, DOI 10.1016/j.phytochem.2007.08.027; Cejpek K, 2001, ROY SOC CH, P480; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Dixon DP, 1998, CURR OPIN PLANT BIOL, V1, P258, DOI 10.1016/S1369-5266(98)80114-3; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; MONDE K, 1994, J AM CHEM SOC, V116, P6650, DOI 10.1021/ja00094a021; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Nagano AJ, 2008, PLANT CELL PHYSIOL, V49, P969, DOI 10.1093/pcp/pcn075; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Pedras MSC, 2008, ORG BIOMOL CHEM, V6, P51, DOI 10.1039/B714743K; Pedras MSC, 2007, NAT PROD COMMUN, V2, P319; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Sherameti I, 2008, PLANT J, V54, P428, DOI 10.1111/j.1365-313X.2008.03424.x; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	39	697	730	5	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					101	106		10.1126/science.1163732	http://dx.doi.org/10.1126/science.1163732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19095900				2022-12-28	WOS:000262104100049
J	Greenfield, JR; Miller, JW; Keogh, JM; Henning, E; Satterwhite, JH; Cameron, GS; Astruc, B; Mayer, JP; Brage, S; See, TC; Lomas, DJ; O'Rahilly, S; Farooqi, IS				Greenfield, Jerry R.; Miller, Jeffrey W.; Keogh, Julia M.; Henning, Elana; Satterwhite, Julie H.; Cameron, Gregory S.; Astruc, Beatrice; Mayer, John P.; Brage, Soren; See, Teik Choon; Lomas, David J.; O'Rahilly, Stephen; Farooqi, I. Sadaf			Modulation of Blood Pressure by Central Melanocortinergic Pathways	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; OBESITY; HYPERTENSION; PREVALENCE; ACTIVATION; MUTATIONS; WEIGHT; LEPTIN; RECEPTORS; MICE	Background Weight gain and weight loss are associated with changes in blood pressure through unknown mechanisms. Central melanocortinergic signaling is implicated in the control of energy balance and blood pressure in rodents, but there is no information regarding such an association with blood pressure in humans. Methods We assessed blood pressure, heart rate, and urinary catecholamines in overweight or obese subjects with a loss-of-function mutation in MC4R, the gene encoding the melanocortin 4 receptor, and in equally overweight control subjects. We also examined the effects of an MC4R agonist administered for 7 days in 28 overweight or obese volunteers. Results The prevalence of hypertension was markedly lower in the MC4R- deficient subjects than in the control subjects ( 24% vs. 53%, P = 0.009). After the exclusion of subjects taking antihypertensive medications, blood- pressure levels were significantly lower in MC4R- deficient subjects than in control subjects, with mean (+/-SE) systolic blood pressures of 123+/-14 mm Hg and 131+/-12 mm Hg, respectively ( P = 0.02), and mean diastolic blood pressures of 73+/-10 mm Hg and 79+/-7 mm Hg, respectively ( P = 0.03). As compared with control subjects, MC4R- deficient subjects had a lower increase in heart rate on waking ( P = 0.007), a lower heart rate during euglycemic hyperinsulinemia ( P< 0.001), and lower 24- hour urinary norepinephrine excretion ( P = 0.04). The maximum tolerated daily dose of 1.0 mg of the MC4R agonist led to significant increases of 9.3+/-1.9 mm Hg in systolic blood pressure and of 6.6+/-1.1 mm Hg in diastolic blood pressure ( P< 0.001 for both comparisons) at 24 hours, as compared with placebo. Differences in blood pressure were not explained by changes in insulin levels; there were no significant adverse events. Conclusions Results of our genetic and pharmacologic studies implicate melanocortinergic signaling in the control of human blood pressure through an insulin- independent mechanism.	[Greenfield, Jerry R.; Keogh, Julia M.; Henning, Elana; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Cambridge, England; [Brage, Soren] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Cambridge, England; [See, Teik Choon; Lomas, David J.] Addenbrookes Hosp, Inst Metab Sci, Cambridge, England; [See, Teik Choon; Lomas, David J.] Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; [Miller, Jeffrey W.; Satterwhite, Julie H.; Cameron, Gregory S.; Mayer, John P.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Astruc, Beatrice] Biotrial, Rennes, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Eli Lilly	Farooqi, IS (corresponding author), Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Hills Rd,Box 289, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk	Brage, Soren/C-6415-2013; Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	Brage, Soren/0000-0002-1265-7355; O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504; LOMAS, David/0000-0003-2904-8617	National Health and Medical Research Council of Australia; Royal Australasian College of Physicians; St. Vincent's Clinic Foundation, Sydney; Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research; Medical Research Council; Eli Lilly; MRC [G9824984, MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_U106179473, G9824984] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australasian College of Physicians(General Electric); St. Vincent's Clinic Foundation, Sydney; Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Eli Lilly(Eli Lilly); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the National Health and Medical Research Council of Australia, the Royal Australasian College of Physicians, and St. Vincent's Clinic Foundation, Sydney (to Dr. Greenfield); from the Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research (to Drs. O'Rahilly and Farooqi); and from the Medical Research Council (to Drs. O'Rahilly, Brage, and Farooqi); and by Eli Lilly for the pharmacologic studies.; Drs. Miller, Satterwhite, Cameron, and Mayer report being employed by Eli Lilly and having an equity interest in the company; and Dr. O'Rahilly, receiving consulting fees from Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Alharbi KK, 2007, HUM MUTAT, V28, P294, DOI 10.1002/humu.20404; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; DUSTAN HP, 1979, CIRCULATION, V60, P1566, DOI 10.1161/01.CIR.60.7.1566; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Hall J E, 2000, Curr Hypertens Rep, V2, P139, DOI 10.1007/s11906-000-0073-4; HALL JE, 1994, AM J HYPERTENS, V7, P772, DOI 10.1093/ajh/7.8.772; Hall JE, 2000, BRAZ J MED BIOL RES, V33, P605, DOI 10.1590/S0100-879X2000000600001; Halli RW, 1997, ANQ-Q J SHORT ART N, V10, P55; Haynes WG, 1997, HYPERTENSION, V30, P619, DOI 10.1161/01.HYP.30.3.619; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KASSAB S, 1995, HYPERTENSION, V25, P893, DOI 10.1161/01.HYP.25.4.893; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Mertens IL, 2000, OBES RES, V8, P270, DOI 10.1038/oby.2000.32; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; ROCCHINI AP, 1989, HYPERTENSION, V13, P922, DOI 10.1161/01.HYP.13.6.922; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Song CK, 2005, AM J PHYSIOL-REG I, V289, pR1467, DOI 10.1152/ajpregu.00348.2005; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Vaz M, 1997, CIRCULATION, V96, P3423	28	346	356	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					44	52		10.1056/NEJMoa0803085	http://dx.doi.org/10.1056/NEJMoa0803085			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19092146	Bronze			2022-12-28	WOS:000262096800006
J	Xiao, A; Li, HT; Shechter, D; Ahn, SH; Fabrizio, LA; Erdjument-Bromage, H; Ishibe-Murakami, S; Wang, B; Tempst, P; Hofmann, K; Patel, DJ; Elledge, SJ; Allis, CD				Xiao, Andrew; Li, Haitao; Shechter, David; Ahn, Sung Hee; Fabrizio, Laura A.; Erdjument-Bromage, Hediye; Ishibe-Murakami, Satoko; Wang, Bin; Tempst, Paul; Hofmann, Kay; Patel, Dinshaw J.; Elledge, Stephen J.; Allis, C. David			WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity	NATURE			English	Article							DOUBLE-STRAND BREAKS; MASS-SPECTROMETRY; GENOMIC STABILITY; HISTONE H2AX; CHROMATIN; MDC1; COMPLEX; ISWI; ATM; PHOSPHORYLATION	DNA double- stranded breaks present a serious challenge for eukaryotic cells. The inability to repair breaks leads to genomic instability, carcinogenesis and cell death. During the double- strand break response, mammalian chromatin undergoes reorganization demarcated by H2A.X Ser 139 phosphorylation (gamma-H2A.X). However, the regulation of gamma-H2A.X phosphorylation and its precise role in chromatin remodelling during the repair process remain unclear. Here we report a new regulatory mechanism mediated by WSTF ( Williams - Beuren syndrome transcription factor, also known as BAZ1B) - a component of the WICH complex (WSTF-ISWI ATP- dependent chromatin- remodelling complex). We show that WSTF has intrinsic tyrosine kinase activity by means of a domain that shares no sequence homology to any known kinase fold. We show that WSTF phosphorylates Tyr 142 of H2A.X, and that WSTF activity has an important role in regulating several events that are critical for the DNA damage response. Our work demonstrates a new mechanism that regulates the DNA damage response and expands our knowledge of domains that contain intrinsic tyrosine kinase activity.	[Xiao, Andrew; Shechter, David; Ahn, Sung Hee; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Li, Haitao; Ishibe-Murakami, Satoko; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Fabrizio, Laura A.; Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Wang, Bin; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; [Hofmann, Kay] Miltenyi Biotec GmbH, D-50829 Cologne, Germany	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Miltenyi Biotec	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA.	alliscd@rockefeller.edu	Hofmann, Kay/D-6714-2011; Shechter, David/B-4660-2008; Li, Haitao/B-2668-2012	Hofmann, Kay/0000-0002-2289-9083; Shechter, David/0000-0001-9388-6004; Li, Haitao/0000-0001-6741-293X; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	Susan G. Komen Breast Cancer Foundation; Abby Rockefeller Mauze Trust; Starr Foundation; The Dewitt Wallace and Maloris Foundations; The Irma T. Hirschl Trust; NCI Cancer Center Support Grant [P30 CA08748]; National Institutes of Health; The Rockefeller University; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922, F32GM075486] Funding Source: NIH RePORTER	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Abby Rockefeller Mauze Trust; Starr Foundation; The Dewitt Wallace and Maloris Foundations; The Irma T. Hirschl Trust; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Rockefeller University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Nussenzweig for H2A.X<SUP>-/-</SUP> MEF cells, P. Varga-Weisz for WSTF constructs and antibodies, W. Herr for pBABE-puro vectors, J. Kim and R. Roeder for anti- BAF53 antibodies, D. Reinberg for anti- SNF2H antibodies, Z. Lou for anti- Mdc1 antibodies and Mdc1<SUP>-/-</SUP> MEF cells, L. Liang and Q. Li for their assistance in recombinant protein expression and purification, C. H. McDonald, R. G. Cook and The Rockefeller University Proteomic Core facility for H2A.X peptides. Wewould also like to thank theMillipore antibody development scientists for collaborating with us on the generation of H2A.X Tyr 142( ph) antibodies, catalogue number 07-1590. This study was supported by the following sources: Susan G. Komen Breast Cancer Foundation (A.X.), Abby Rockefeller Mauze Trust and Starr Foundation (H.L. and D.J.P.), The Dewitt Wallace and Maloris Foundations (H.L. and D.J.P.), The Irma T. Hirschl Trust (D.S.), NCI Cancer Center Support Grant P30 CA08748 (L.A.F., H.E.-B. and P.T.), research grants from National Institutes of Health to S.J.E., S.H.A. and C.D.A., and The Rockefeller University (C.D.A.). S.J.E. is an Investigator with the Howard Hughes Medical Institute. We are grateful to E. Bernstein and E. Duncan for critical reading of the manuscript.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BELLARD M, 1989, METHOD ENZYMOL, V170, P317; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Dellaire G, 2007, CELL CYCLE, V6, P1864, DOI 10.4161/cc.6.15.4560; DIMITROV S, 1994, J CELL BIOL, V126, P591, DOI 10.1083/jcb.126.3.591; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KLEINSCHMIDT JA, 1991, EMBO J, V10, P3043, DOI 10.1002/j.1460-2075.1991.tb07855.x; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; LENNOX RW, 1989, METHOD ENZYMOL, V170, P532; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Pear Warren S., 1997, P41; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Sambrook J., 2001, MOL CLONING LAB MANU; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	48	299	311	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					57	U57		10.1038/nature07668	http://dx.doi.org/10.1038/nature07668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19092802	Green Accepted			2022-12-28	WOS:000262104900029
J	Pucadyil, TJ; Schmid, SL				Pucadyil, Thomas J.; Schmid, Sandra L.			Real-Time Visualization of Dynamin-Catalyzed Membrane Fission and Vesicle Release	CELL			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; COPII VESICLE; MECHANOCHEMICAL ENZYME; BILAYER CURVATURE; GTPASE ACTIVITY; INVAGINATION; CONSTRICTION; DEFORMATION; ENDOCYTOSIS; PROTEINS	The GTPase dynamin assembles at the necks of budded vesicles in vivo and functions in membrane fission. We have developed fluid supported bilayers with excess membrane reservoir, (SUPER) templates, to assay vesicle formation and membrane fission. Consistent with previous studies, in the absence of GTP, dynamin assembles in spirals, forming long membrane tubules. GTP addition triggers disassembly, but not membrane fission, arguing against models in which fission is mediated by concerted and global GTP-driven conformational changes. In contrast, under physiological conditions in the constant presence of GTP, dynamin mediates membrane fission. Under these conditions, fluorescently labeled dynamin cooperatively organizes into self-limited assemblies that continuously cycle at the membrane and drive vesicle release. When visualized at the necks of emergent vesicles, self-limited dynamin assemblies display intensity fluctuations and persist for variable time periods before fission. Thus, self-limited assemblies of dynamin generated in the constant presence of GTP catalyze membrane fission.	[Pucadyil, Thomas J.; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	slschmid@scripps.edu	Pucadyil, Thomas/AAJ-3974-2020; Taylor, Graham/A-4027-2012	Pucadyil, Thomas/0000-0002-2907-9889; Schmid, Sandra/0000-0002-1690-7024	National Institutes of Health [R01.GM042455, R37.MH61345]; The Leukemia and Lymphoma Society; The Scripps Research Institute [19489]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061345, R37MH061345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); The Scripps Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge Malcolm R. Wood for help with electron microscopy, Vadim Frolov for help with the membrane tether-pulling experiments, and Sharmistha Acharya and Marilyn Leonard for technical assistance. We thank William Balch, Vadim Frolov, Shanti Kalipatnapu, Allen Liu, Rajesh Ramachandran, and Joshua Zimmerberg for discussions and critical comments on the manuscript. This work is supported by grants from the National Institutes of Health to S.L.S (R01.GM042455 and R37.MH61345). T.J.P. is a fellow of The Leukemia and Lymphoma Society. This is The Scripps Research Institute manuscript number 19489.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Baksh MM, 2004, NATURE, V427, P139, DOI 10.1038/nature02209; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Galneder R, 2001, BIOPHYS J, V80, P2298, DOI 10.1016/S0006-3495(01)76201-7; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miwako I, 2005, METHOD ENZYMOL, V404, P503, DOI 10.1016/S0076-6879(05)04044-9; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	34	204	206	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1263	1275		10.1016/j.cell.2008.11.020	http://dx.doi.org/10.1016/j.cell.2008.11.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19084268	Green Accepted, Bronze			2022-12-28	WOS:000261989800017
J	Grant, AM; Wileman, SM; Ramsay, CR; Mowat, NA; Krukowski, ZH; Heading, RC; Thursz, MR; Campbell, MK				Grant, Adrian M.; Wileman, Samantha M.; Ramsay, Craig R.; Mowat, N. Ashley; Krukowski, Zygmunt H.; Heading, Robert C.; Thursz, Mark R.; Campbell, Marion K.		REFLUX Trial Grp	Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROTON-PUMP INHIBITORS; LAPAROSCOPIC NISSEN FUNDOPLICATION; FOLLOW-UP	Objective To determine the relative benefits and risks of laparoscopic fundoplication surgery as an alternative to long term drug treatment for chronic gastro- oesophageal reflux disease ( GORD). Design Multicentre, pragmatic randomised trial ( with parallel preference groups). Setting 21 hospitals in the United Kingdom. Participants 357 randomised participants ( 178 surgical, 179 medical) and 453 preference participants ( 261, 192); mean age 46; 66% men. All participants had documented evidence of GORD and symptoms for > 12 months. Intervention The type of laparoscopic fundoplication used was left to the discretion of the surgeon. Those allocated to medical treatment had their treatment reviewed and adjusted as necessary by a local gastroenterologist, and subsequent clinical management was at the discretion of the clinician responsible for care. Main outcome measures The disease specific REFLUX quality of life score ( primary outcome), SF- 36, EQ- 5D, and medication use, measured at time points equivalent to three and 12 months after surgery, and surgical complications. Main results Randomised participants had received drugs for GORD for median of 32 months before trial entry. Baseline REFLUX scores were 63.6 ( SD 24.1) and 66.8 ( SD 24.5) in the surgical and medical randomised groups, respectively. Of those randomised to surgery, 111 ( 62%) actually had total or partial fundoplication. Surgical complications were uncommon with a conversion rate of 0.6% and no mortality. By 12 months, 38% ( 59/ 154) randomised to surgery ( 14% ( 14/ 104) among those who had fundoplication) were taking reflux medication versus 90% ( 147/ 164) randomised medical management. The REFLUX score favoured the randomised surgical group ( 14.0, 95% confidence interval 9.6 to 18.4; P< 0.001). Differences of a third to half of 1 SD in other health status measures also favoured the randomised surgical group. Baseline scores in the preference for surgery group were the worst; by 12 months these were better than in the preference for medical treatment group. Conclusion At least up to 12 months after surgery, laparoscopic fundoplication significantly increased measures of health status in patients with GORD. Trial registration ISRCTN15517081.	[Grant, Adrian M.; Wileman, Samantha M.; Ramsay, Craig R.; Campbell, Marion K.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Mowat, N. Ashley; Krukowski, Zygmunt H.] Aberdeen Royal Infirm, Aberdeen AB25 1LD, Scotland; [Heading, Robert C.] Glasgow Royal Infirm, Dept Gastroenterol, Glasgow G4 0SF, Lanark, Scotland; [Thursz, Mark R.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London W2 1PG, England	University of Aberdeen; University of Aberdeen; University of Glasgow; Imperial College London	Grant, AM (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Hlth Sci Bldg, Aberdeen AB25 2ZD, Scotland.	a.grant@abdn.ac.uk	Jankowski, Janusz/H-2706-2012; Ramsay, Craig/AAD-8249-2021; Campbell, Marion/ABB-7063-2020; Toh, Simon Khay Chuan/X-7081-2019	Jankowski, Janusz/0000-0003-2130-9181; Ramsay, Craig/0000-0003-4043-7349; Toh, Simon Khay Chuan/0000-0001-5110-2371; Sculpher, Mark/0000-0003-3746-9913; El-Omar, Emad/0000-0002-0011-3924; Macintyre, Iain/0000-0003-2716-8500; Thursz, Mark/0000-0002-8218-192X	NIHR Health Technology Assessment Programme [97/10/99]; Chief Scientist Office of the Scottish Government Health Directorates; Chief Scientist Office [HSRU1, HERU2, HERU1] Funding Source: researchfish	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Chief Scientist Office of the Scottish Government Health Directorates; Chief Scientist Office	This study was funded by the NIHR Health Technology Assessment Programme (as part of project No 97/10/99), and the full project report is published in Health Technology Assessment 2008; 12: 1-181. The Health Services Research Unit is funded by the Chief Scientist Office of the Scottish Government Health Directorates. The funders of this study (NCCHTA), other than the initial peer review process before funding and six monthly progress reviews, did not have any involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; nor in the decision to submit the paper for publication. The views and opinions expressed in this paper are those of the authors and do not necessarily reflect those of the Department of Health or the funders that provide institutional support for the authors.	Anvari M, 2006, SURG INNOV, V13, P238, DOI 10.1177/1553350606296389; Deng J, 2001, BRIT MED J, V322, P344, DOI 10.1136/bmj.322.7282.344; KAY L, 1994, EUR J EPIDEMIOL, V10, P559, DOI 10.1007/BF01719573; Laine L, 2000, ALIMENT PHARM THER, V14, P651; Leufkens H, 1997, ALIMENT PHARM THERAP, V11, P887, DOI 10.1046/j.1365-2036.1997.00214.x; Macran S, 2007, QUAL LIFE RES, V16, P331, DOI 10.1007/s11136-006-9005-3; Mahon D, 2005, BRIT J SURG, V92, P695, DOI 10.1002/bjs.4934; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; Neufeld M, 2007, DIS ESOPHAGUS, V20, P161, DOI 10.1111/j.1442-2050.2007.00663.x; Ross S, 2000, J ROY COLL SURG EDIN, V45, P363; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360; White IR, 2005, STAT METHODS MED RES, V14, P327, DOI 10.1191/0962280205sm406oa; Zacharoulis D, 2006, SURG ENDOSC, V20, P1662, DOI 10.1007/s00464-005-0571-1	14	69	70	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2008	337								a2664	10.1136/bmj.a2664	http://dx.doi.org/10.1136/bmj.a2664			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SS	19074946	Green Published, hybrid			2022-12-28	WOS:000262184600002
J	De Val, S; Chi, NC; Meadows, SM; Minovitsky, S; Anderson, JP; Harris, IS; Ehlers, ML; Agarwal, P; Visel, A; Xu, SM; Pennacchio, LA; Dubchak, I; Krieg, PA; Stainier, DYR; Black, BL				De Val, Sarah; Chi, Neil C.; Meadows, Stryder M.; Minovitsky, Simon; Anderson, Joshua P.; Harris, Ian S.; Ehlers, Melissa L.; Agarwal, Pooja; Visel, Axel; Xu, Shan-Mei; Pennacchio, Len A.; Dubchak, Inna; Krieg, Paul A.; Stainier, Didier Y. R.; Black, Brian L.			Combinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription Factors	CELL			English	Article							PROMOTER; VASCULOGENESIS; SEQUENCE; ENHANCER; FAMILY; ANGIOGENESIS; CANCER; MEF2C; SCL	Vascular development begins when mesodermal cells differentiate into endothelial cells, which then form primitive vessels. It has been hypothesized that endothelial-specific gene expression may be regulated combinatorially, but the transcriptional mechanisms governing specificity in vascular gene expression remain incompletely understood. Here, we identify a 44 bp transcriptional enhancer that is sufficient to direct expression specifically and exclusively to the developing vascular endothelium. This enhancer is regulated by a composite cis-acting element, the FOX:ETS motif, which is bound and synergistically activated by Forkhead and Ets transcription factors. We demonstrate that coexpression of the Forkhead protein FoxC2 and the Ets protein Etv2 induces ectopic expression of vascular genes in Xenopus embryos, and that combinatorial knockdown of the orthologous genes in zebrafish embryos disrupts vascular development. Finally, we show that FOX: ETS motifs are present in many known endothelial-specific enhancers and that this motif is an efficient predictor of endothelial enhancers in the human genome.	[De Val, Sarah; Chi, Neil C.; Anderson, Joshua P.; Harris, Ian S.; Ehlers, Melissa L.; Agarwal, Pooja; Xu, Shan-Mei; Stainier, Didier Y. R.; Black, Brian L.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chi, Neil C.; Stainier, Didier Y. R.; Black, Brian L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Meadows, Stryder M.; Krieg, Paul A.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Minovitsky, Simon; Visel, Axel; Pennacchio, Len A.; Dubchak, Inna] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Black, BL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	brian.black@ucsf.edu	Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; Stainier, Didier/0000-0002-0382-0026; Pennacchio, Len/0000-0002-8748-3732; Black, Brian/0000-0002-6664-8913	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737, R01HL064658, K08HL089330, P01HL089707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052130] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54737, R01 HL064658-08, HL64658, P01 HL089707-01A1, R01 HL054737, K08 HL089330, R01 HL064658, P01 HL089707] Funding Source: Medline; NIAMS NIH HHS [R01 AR052130, R01 AR052130-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cleaver O, 1997, DEV DYNAM, V210, P66, DOI 10.1002/(SICI)1097-0177(199709)210:1<66::AID-AJA7>3.3.CO;2-S; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; Lin Q, 1998, DEVELOPMENT, V125, P4565; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Patan S, 2004, CANC TREAT, V117, P3; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Topczewska JM, 2001, MECH DEVELOP, V100, P343, DOI 10.1016/S0925-4773(00)00534-7; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wu J, 2005, MOL CELL BIOL, V25, P1458, DOI 10.1128/MCB.25.4.1458-1474.2005	35	234	240	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1053	1064		10.1016/j.cell.2008.10.049	http://dx.doi.org/10.1016/j.cell.2008.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070576	Green Accepted, Bronze			2022-12-28	WOS:000261642800021
J	Hammond, SM; Sharpless, NE				Hammond, Scott M.; Sharpless, Norman E.			HMGA2, MicroRNAs, and Stem Cell Aging	CELL			English	Review							SELF-RENEWAL; P16(INK4A); SENESCENCE; PHENOTYPE; P19(ARF); PROTEINS; ROLES	Mammalian aging results from a replicative decline in the function of somatic stem cells and other self-renewing cells. Recent studies (Monzen et al., 2008; Nishino et al., 2008; Sanna et al., 2008; Weedon et al., 2008) link a chromatin-associated protein, HMGA2, to development, height, and mouse stem cell aging during late fetal development and young adulthood.	[Hammond, Scott M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Sharpless, Norman E.] Univ N Carolina, Dept Med & Genet, Chapel Hill, NC 27599 USA; [Hammond, Scott M.; Sharpless, Norman E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hammond, SM (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	hammond@med.unc.edu; nes@med.unc.edu		Sharpless, Norman/0000-0001-7078-9455	NIA NIH HHS [R01 AG024379] Funding Source: Medline; NIEHS NIH HHS [P01 ES014635] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES014635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Battista S, 1999, CANCER RES, V59, P4793; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; Monzen K, 2008, NAT CELL BIOL, V10, P567, DOI 10.1038/ncb1719; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Stadler BM, 2008, CELL, V132, P563, DOI 10.1016/j.cell.2008.02.005; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	20	111	117	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1013	1016		10.1016/j.cell.2008.11.026	http://dx.doi.org/10.1016/j.cell.2008.11.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070572	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000261642800017
J	Kennedy, S				Kennedy, Shaun			EPIDEMIOLOGY Why Can't We Test Our Way to Absolute Food Safety?	SCIENCE			English	Editorial Material									[Kennedy, Shaun] Univ Minnesota, Natl Ctr Food Protect & Def, Dept Homeland Secur, Ctr Excellence & Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Kennedy, S (corresponding author), Univ Minnesota, Natl Ctr Food Protect & Def, Dept Homeland Secur, Ctr Excellence & Vet Populat Med, St Paul, MN 55108 USA.	kenne108@umn.edu						Danzig R., 2003, CATASTROPHIC BIOTERR; Ferreira JL, 2004, J FOOD PROTECT, V67, P203, DOI 10.4315/0362-028X-67.1.203; International Commission on Microbiological Specifications for Foods, 1986, MICR FOODS, V2; International Commission on Microbiological Specifications for Foods, 2002, MICR FOODS; KENNEDY SP, 2007, FOOD MICROBIOLOGY FU, V3, pCH5	5	16	18	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1641	1643		10.1126/science.1163867	http://dx.doi.org/10.1126/science.1163867			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074334				2022-12-28	WOS:000261608300028
J	Czarnetzki, C; Elia, N; Lysakowski, C; Dumont, L; Landis, BN; Giger, R; Dulguerov, P; Desmeules, J; Tramer, MR				Czarnetzki, Christoph; Elia, Nadia; Lysakowski, Christopher; Dumont, Lionel; Landis, Basile N.; Giger, Roland; Dulguerov, Pavel; Desmeules, Jules; Tramer, Martin R.			Dexamethasone and Risk of Nausea and Vomiting and Postoperative Bleeding After Tonsillectomy in Children A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PEDIATRIC TONSILLECTOMY; METAANALYSIS; ADENOTONSILLECTOMY; HEMORRHAGE; STEROIDS; RATS; PAIN; CORTICOSTEROIDS; GLUCOCORTICOIDS	Context Dexamethasone is widely used to prevent postoperative nausea and vomiting ( PONV) in pediatric tonsillectomy. Objective To assess whether dexamethasone dose- dependently reduces the risk of PONV at 24 hours after tonsillectomy. Design, Setting, and Patients Randomized placebo- controlled trial conducted among 215 children undergoing elective tonsillectomy at a major public teaching hospital in Switzerland from February 2005 to December 2007. Interventions Children were randomly assigned to receive dexamethasone ( 0.05, 0.15, or 0.5 mg/ kg) or placebo intravenously after induction of anesthesia. Acetaminophen-codeine and ibuprofen were given as postoperative analgesia. Follow- up continued until the 10th postoperative day. Main Outcome Measures The primary end point was prevention of PONV at 24 hours; secondary end points were decrease in the need for ibuprofen at 24 hours and evaluation of adverse effects. Results At 24 hours, 24 of 54 participants who received placebo ( 44%; 95% confidence interval [ CI], 31%- 59%) had experienced PONV compared with 20 of 53 ( 38%; 95% CI, 25%- 52%), 13 of 54 ( 24%; 95% CI, 13%- 38%), and 6 of 52 ( 12%; 95% CI, 4%- 23%) who received dexamethasone at 0.05, 0.15, and 0.5 mg/ kg, respectively ( P < .001 for linear trend). Children who received dexamethasone received significantly less ibuprofen. There were 26 postoperative bleeding episodes in 22 children. Two of 53 ( 4%; 95% CI, 0.5%- 13%) children who received placebo had bleeding compared with 6 of 53 ( 11%; 95% CI, 4%- 23%), 2 of 51 ( 4%; 95% CI, 0.5%-13%), and 12 of 50 ( 24%; 95% CI, 13%- 38%) who received dexamethasone at 0.05, 0.15, and 0.5 mg/ kg, respectively ( P=. 003). Dexamethasone, 0.5 mg/ kg, was associated with the highest bleeding risk ( adjusted relative risk, 6.80; 95% CI, 1.77- 16.5). Eight children had to undergo emergency reoperation because of bleeding, all of whom had received dexamethasone. The trial was stopped early for safety reasons. Conclusion In this study of children undergoing tonsillectomy, dexamethasone decreased the risk of PONV dose dependently but was associated with an increased risk of postoperative bleeding. Trial Registration clinicaltrials. gov Identifier: NCT00403806.	[Czarnetzki, Christoph; Elia, Nadia; Lysakowski, Christopher; Dumont, Lionel; Tramer, Martin R.] Univ Hosp Geneva, Div Anesthesiol, CH-1211 Geneva 14, Switzerland; [Landis, Basile N.; Giger, Roland; Dulguerov, Pavel] Univ Hosp Geneva, Div Otolaryngol Head & Neck Surg, CH-1211 Geneva 14, Switzerland; [Desmeules, Jules] Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, CH-1211 Geneva 14, Switzerland; [Elia, Nadia] Univ Geneva, Inst Social & Prevent Med, Geneva, Switzerland; [Dulguerov, Pavel; Desmeules, Jules; Tramer, Martin R.] Univ Geneva, Fac Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Tramer, MR (corresponding author), Univ Hosp Geneva, Div Anesthesiol, 24 Rue Micheli Crest, CH-1211 Geneva 14, Switzerland.	martin.tramer@hcuge.ch	Dulguerov, Pavel/AAO-2899-2020; Elia, Nadia/Y-6999-2019; Dulguerov, Pavel/I-7325-2015	Elia, Nadia/0000-0003-1787-9288; Dulguerov, Pavel/0000-0001-5863-3933; Giger, Roland/0000-0002-5574-3210	EBCAP Foundation (Evidence-Based Critical Care, Anaesthesia and Pain Treatment)	EBCAP Foundation (Evidence-Based Critical Care, Anaesthesia and Pain Treatment)	This work was supported by the EBCAP Foundation (Evidence-Based Critical Care, Anaesthesia and Pain Treatment) (for the salary of Dr Elia) and institutional funds. Dexamethasone was provided by Mepha, Aesch/Basel, Switzerland.	Afman CE, 2006, OTOLARYNG HEAD NECK, V134, P181, DOI 10.1016/j.otohns.2005.11.010; April MM, 1996, ARCH OTOLARYNGOL, V122, P117; *ASS PAED AN GREAT, 2008, GUID PREV POST OP VO; Bolton CM, 2006, BRIT J ANAESTH, V97, P593, DOI 10.1093/bja/ael256; Brown P, 2004, LANCET, V364, P697; CATLIN FI, 1991, ARCH OTOLARYNGOL, V117, P649; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collison P J, 2000, Ear Nose Throat J, V79, P640; Collison PJ, 2000, ENT-EAR NOSE THROAT, V79, P646; Collison PJ, 2000, ENT-EAR NOSE THROAT, V79, P644; CORNELI HM, 2008, NEW ENGL J MED, V359, P1972; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; DEKASKI MC, 1995, GUT, V37, P613; Durmus M, 2003, ANESTH ANALG, V97, P1377, DOI 10.1213/01.ANE.0000080611.29106.9E; Eckman Mark H, 2003, Ann Intern Med, V138, pW15; Gan TJ, 2007, ANESTH ANALG, V105, P1615, DOI 10.1213/01.ane.0000295230.55439.f4; Hanasono MM, 2004, ARCH OTOLARYNGOL, V130, P917, DOI 10.1001/archotol.130.8.917; Henzi I, 2000, ANESTH ANALG, V90, P186, DOI 10.1097/00000539-200001000-00038; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hilton M, 2004, LANCET, V364, P642, DOI 10.1016/S0140-6736(04)16908-0; Kehlet H, 2007, ACTA ANAESTH SCAND, V51, P1133, DOI 10.1111/j.1399-6576.2007.01459.x; Kim MS, 2007, ANESTH ANALG, V104, P1052, DOI 10.1213/01.ane.0000263276.52287.3b; Krishna P, 2001, LARYNGOSCOPE, V111, P1358, DOI 10.1097/00005537-200108000-00008; Kujawski O, 1997, OTOLARYNG HEAD NECK, V117, P641, DOI 10.1016/S0194-5998(97)70046-9; Luo JC, 2007, J PHARMACOL EXP THER, V320, P687, DOI 10.1124/jpet.106.113035; Macassey EA, 2007, ANZ J SURG, V77, P579, DOI 10.1111/j.1445-2197.2007.04154.x; Mannucci PM, 2004, NEW ENGL J MED, V351, P683, DOI 10.1056/NEJMra040403; Marret E, 2003, ANESTHESIOLOGY, V98, P1497; MCGRATH PJ, 1982, ADV PAIN RES THER, P395; Moiniche S, 2003, ANESTH ANALG, V96, P68, DOI 10.1213/01.ANE.0000040583.65135.57; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nissen SE, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010035; OHLMS LA, 1995, ARCH OTOLARYNGOL, V121, P737; Pappas ALS, 1998, ANESTH ANALG, V87, P57, DOI 10.1097/00000539-199807000-00013; PIPER JM, 1991, ANN INTERN MED, V114, P735, DOI 10.7326/0003-4819-114-9-735; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; RUSSO CA, 2007, AHRQ PUBLICATION; Steward DL, 2001, LARYNGOSCOPE, V111, P1712, DOI 10.1097/00005537-200110000-00008; Szabo S, 2000, ALIMENT PHARM THER, V14, P33, DOI 10.1046/j.1365-2036.2000.014s1033.x; TARNAWSKI A, 1992, GASTROENTEROLOGY, V102, P695, DOI 10.1016/0016-5085(92)90123-G; THONG KL, 1978, BRIT J HAEMATOL, V38, P373, DOI 10.1111/j.1365-2141.1978.tb01057.x; Tom LWC, 1996, INT J PEDIATR OTORHI, V37, P115, DOI 10.1016/0165-5876(96)01388-2; Tramer MR, 2001, ACTA ANAESTH SCAND, V45, P4, DOI 10.1034/j.1399-6576.2001.450102.x; van den Akker EH, 2004, CLIN OTOLARYNGOL, V29, P161, DOI 10.1111/j.0307-7772.2004.00771.x; VANGIEZEN JJJ, 1994, BLOOD COAGUL FIBRIN, V5, P249, DOI 10.1097/00001721-199404000-00015; Windfuhr JP, 2005, OTOLARYNG HEAD NECK, V132, P281, DOI 10.1016/j.otohns.2004.09.007	47	121	123	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2621	2630		10.1001/jama.2008.794	http://dx.doi.org/10.1001/jama.2008.794			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066382				2022-12-28	WOS:000261503000021
J	Janssen, DJA; Alsemgeest, TPG; Widdershoven, GAM; Wouters, EFM; Schols, JMGA; Spruit, MA				Janssen, Daisy J. A.; Alsemgeest, Ton P. G.; Widdershoven, Guy A. M.; Wouters, Emiel F. M.; Schols, Jos M. G. A.; Spruit, Martijn A.			The last wish of a patient with end stage chronic obstructive pulmonary disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Janssen, Daisy J. A.; Alsemgeest, Ton P. G.] Proteion Thuis, Cent Dept Treatment & Care, NL-6085 NM Horn, Netherlands; [Widdershoven, Guy A. M.] Univ Maastricht, Sch Publ Hlth & Primary Care, CAPHRI, Fac Hlth Med & Life Sci, NL-6229 ER Maastricht, Netherlands; [Wouters, Emiel F. M.] MUMC, Dept Resp Med, NL-6229 HX Maastricht, Netherlands; [Wouters, Emiel F. M.] Ctr Integrated Rehabil Organ Failure CIRO, NL-6085 NM Horn, Netherlands; [Schols, Jos M. G. A.] Univ Maastricht, Fac Hlth Med & Life Sci, Dept Gen Practice, NL-6229 HA Maastricht, Netherlands; [Spruit, Martijn A.] Ctr Integrated Rehabil Organ Failure CIRO, Dept Res Dev & Educ, NL-6085 NM Horn, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University	Janssen, DJA (corresponding author), Proteion Thuis, Cent Dept Treatment & Care, NL-6085 NM Horn, Netherlands.	daisyjanssen@proteion.nl	Wouters, Emiel/ABD-6200-2021; Janssen, Daisy J.A./AAW-2248-2021	Janssen, Daisy J.A./0000-0002-1827-9869					0	5	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2008	337								a2701	10.1136/bmj.a2701	http://dx.doi.org/10.1136/bmj.a2701			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399BY	19064602				2022-12-28	WOS:000262776600003
J	Chan, AW; Hrobjartsson, A; Jorgensen, KJ; Gotzsche, PC; Altman, DG				Chan, An-Wen; Hrobjartsson, Asbjorn; Jorgensen, Karsten J.; Gotzsche, Peter C.; Altman, Douglas G.			Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENTION-TO-TREAT; SUBGROUP ANALYSIS; CLINICAL-TRIALS; EMPIRICAL-EVIDENCE; STATISTICAL POWER; REGISTRATION; INFORMATION; PRINCIPLE; STATEMENT; INDUSTRY	Objective To evaluate how often sample size calculations and methods of statistical analysis are pre- specified or changed in randomised trials. Design Retrospective cohort study. Data source Protocols and journal publications of published randomised parallel group trials initially approved in 1994- 5 by the scientific- ethics committees for Copenhagen and Frederiksberg, Denmark ( n= 70). Main outcome measure Proportion of protocols and publications that did not provide key information about sample size calculations and statistical methods; proportion of trials with discrepancies between information presented in the protocol and the publication. Results Only 11/ 62 trials described existing sample size calculations fully and consistently in both the protocol and the publication. The method of handling protocol deviations was described in 37 protocols and 43 publications. The method of handling missing data was described in 16 protocols and 49 publications. 39/ 49 protocols and 42/ 43 publications reported the statistical test used to analyse primary outcome measures. Unacknowledged discrepancies between protocols and publications were found for sample size calculations ( 18/ 34 trials), methods of handling protocol deviations ( 19/ 43) and missing data ( 39/ 49), primary outcome analyses ( 25/ 42), subgroup analyses ( 25/ 25), and adjusted analyses ( 23/ 28). Interim analyses were described in 13 protocols but mentioned in only five corresponding publications. Conclusion When reported in publications, sample size calculations and statistical methods were often explicitly discrepant with the protocol or not pre- specified. Such amendments were rarely acknowledged in the trial publication. The reliability of trial reports cannot be assessed without having access to the full protocols.	[Chan, An-Wen] Mayo Clin, Rochester, NY USA; [Hrobjartsson, Asbjorn; Jorgensen, Karsten J.; Gotzsche, Peter C.] Nord Cochrane Ctr, Copenhagen, Denmark; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	Mayo Clinic; University of Oxford	Chan, AW (corresponding author), Mayo Clin, Rochester, NY USA.	chan.anwen@mayo.edu		Jorgensen, Karsten/0000-0001-8554-0388				Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Altman DG, 2002, BMJ-BRIT MED J, V325, P492; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Baron G, 2005, ARTHRITIS RHEUM, V52, P1858, DOI 10.1002/art.21116; Brookes S T, 2001, Health Technol Assess, V5, P1; Chan AW, 2006, BMJ-BRIT MED J, V332, P1086, DOI 10.1136/bmj.332.7549.1086; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2008, GERMAN J EVID QUAL S, V102, ps27; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Freedman KB, 2001, J BONE JOINT SURG BR, V83B, P397, DOI 10.1302/0301-620X.83B3.10582; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1645, DOI 10.1001/jama.295.14.1645; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; Hebert Randy S, 2002, J Negat Results Biomed, V1, P1; HEMMINKI E, 1980, BRIT MED J, V280, P833, DOI 10.1136/bmj.280.6217.833; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hrachovec JB, 2001, JAMA-J AM MED ASSOC, V286, P2398, DOI 10.1001/jama.286.19.2398; Jones G, 2004, BRIT MED J, V329, P1360, DOI 10.1136/bmj.329.7479.1360; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; MacLean CH, 2003, J CLIN EPIDEMIOL, V56, P44, DOI 10.1016/S0895-4356(02)00520-6; McNamee D, 2008, LANCET, V372, P189, DOI 10.1016/S0140-6736(08)61053-3; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Moreira ED, 2001, BRAZ J MED BIOL RES, V34, P1441, DOI 10.1590/S0100-879X2001001100011; Murray GD, 2001, BRIT MED J, V322, P1461; Parker AB, 2000, AM HEART J, V139, P952, DOI 10.1067/mhj.2000.106610; *PLOS MED, GUID AUTH; Porta N, 2007, J CLIN EPIDEMIOL, V60, P663, DOI 10.1016/j.jclinepi.2006.09.013; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Schaefer H, 2006, BIOMETRICAL J, V48, P507, DOI 10.1002/bimj.200510234; Schiffner R, 2001, BRIT J DERMATOL, V144, P1154, DOI 10.1046/j.1365-2133.2001.04234.x; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Vickers AJ, 2003, J CLIN EPIDEMIOL, V56, P717, DOI 10.1016/S0895-4356(03)00141-0; Weaver CS, 2004, STROKE, V35, P1216, DOI 10.1161/01.STR.0000125010.70652.93	51	126	129	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2008	337								a2299	10.1136/bmj.a2299	http://dx.doi.org/10.1136/bmj.a2299			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NX	19056791	hybrid, Green Published			2022-12-28	WOS:000261891000001
J	Omran, H; Kobayashi, D; Olbrich, H; Tsukahara, T; Loges, NT; Hagiwara, H; Zhang, Q; Leblond, G; O'Toole, E; Hara, C; Mizuno, H; Kawano, H; Fliegauf, M; Yagi, T; Koshida, S; Miyawaki, A; Zentgraf, H; Seithe, H; Reinhardt, R; Watanabe, Y; Kamiya, R; Mitchell, DR; Takeda, H				Omran, Heymut; Kobayashi, Daisuke; Olbrich, Heike; Tsukahara, Tatsuya; Loges, Niki T.; Hagiwara, Haruo; Zhang, Qi; Leblond, Gerard; O'Toole, Eileen; Hara, Chikako; Mizuno, Hideaki; Kawano, Hiroyuki; Fliegauf, Manfred; Yagi, Toshiki; Koshida, Sumito; Miyawaki, Atsushi; Zentgraf, Hanswalter; Seithe, Horst; Reinhardt, Richard; Watanabe, Yoshinori; Kamiya, Ritsu; Mitchell, David R.; Takeda, Hiroyuki			Ktu/PF13 is required for cytoplasmic pre-assembly of axonemal dyneins	NATURE			English	Article							PRIMARY CILIARY DYSKINESIA; CHLAMYDOMONAS-REINHARDTII; KUPFFERS VESICLE; FLUID-FLOW; ARM DYNEIN; MUTATIONS; MEDAKA; PROTEIN; CHAIN; MUTANT	Cilia and flagella are highly conserved organelles that have diverse roles in cell motility and sensing extracellular signals. Motility defects in cilia and flagella often result in primary ciliary dyskinesia. However, the mechanisms underlying cilia formation and function, and in particular the cytoplasmic assembly of dyneins that power ciliary motility, are only poorly understood. Here we report a new gene, kintoun ( ktu), involved in this cytoplasmic process. This gene was first identified in a medaka mutant, and found to be mutated in primary ciliary dyskinesia patients from two affected families as well as in the pf13 mutant of Chlamydomonas. In the absence of Ktu/ PF13, both outer and inner dynein arms are missing or defective in the axoneme, leading to a loss of motility. Biochemical and immunohistochemical studies show that Ktu/ PF13 is one of the long- sought proteins involved in pre- assembly of dynein arm complexes in the cytoplasm before intraflagellar transport loads them for the ciliary compartment.	[Omran, Heymut; Olbrich, Heike; Loges, Niki T.; Fliegauf, Manfred] Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Kobayashi, Daisuke; Yagi, Toshiki; Koshida, Sumito; Kamiya, Ritsu; Takeda, Hiroyuki] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Tsukahara, Tatsuya; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Grad Sch Sci, Tokyo 1130033, Japan; [Tsukahara, Tatsuya; Watanabe, Yoshinori] Univ Tokyo, Grad Program Biophys & Biochem, Grad Sch Sci, Tokyo 1130033, Japan; [Hagiwara, Haruo] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Gunma 3718511, Japan; [Zhang, Qi; Leblond, Gerard; Mitchell, David R.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [O'Toole, Eileen] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Hara, Chikako; Mizuno, Hideaki; Kawano, Hiroyuki; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan; [Zentgraf, Hanswalter] German Canc Res Ctr, Dept Tumor Virol, D-69120 Heidelberg, Germany; [Seithe, Horst] Klinikum Nurnberg Sud, Klin Kinder & Jugendliche, D-90471 Nurnberg, Germany; [Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Freiburg; University of Tokyo; University of Tokyo; University of Tokyo; Gunma University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Colorado System; University of Colorado Boulder; RIKEN; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Omran, H (corresponding author), Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Mathildenstr 1, D-79106 Freiburg, Germany.	heymut.omran@uniklinik-freiburg.de; MitchelD@upstate.edu; htakeda@biol.s.u-tokyo.ac.jp	Mizuno, Hideaki/AAH-5737-2021; Tsukahara, Tatsuya/AAO-1707-2021; TAKEDA, HIROYUKI/G-4950-2014; Kobayashi, Daisuke/AAQ-8465-2021; Miyawaki, Atsushi/K-3569-2014	Mizuno, Hideaki/0000-0002-6983-5255; Tsukahara, Tatsuya/0000-0002-6928-8562; Miyawaki, Atsushi/0000-0002-2329-3235; Omran, Heymut/0000-0003-0282-6765; Kobayashi, Daisuke/0000-0001-9755-6168; Reinhardt, Richard/0000-0001-9376-2132; Mitchell, David/0000-0003-2821-7511; Watanabe, Yoshinori/0000-0002-5488-4812; Yagi, Toshiki/0000-0002-1379-460X	NIG Cooperative Research Program; Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms); Ministry of Education, Culture, Sports, Science and Technology ( MEXT) of Japan; Yamada Science Foundation; Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan; University of Tokyo; MEXT, Japan; ' Deutsche Forschungsgemeinschaft' [DFG Om 6/4, GRK1104]; BIOSS; NIH [GM44228]; German Ministry of Science and Education ( BMBF) [NGFN-2:01GR0414-PDN-S02T17]; 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.';  [SFB592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044228] Funding Source: NIH RePORTER	NIG Cooperative Research Program; Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology ( MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); University of Tokyo; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ' Deutsche Forschungsgemeinschaft'(German Research Foundation (DFG)); BIOSS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Science and Education ( BMBF)(Federal Ministry of Education & Research (BMBF)); 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.'; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Lo and D. Morris- Rosendahl for critical reading of this manuscript. We are grateful to M. Sugimoto, A. Ito-Igarashi, K. Nakaguchi, S. Minami, Y. H. Park, Y. Mochizuki, Y. Ozawa, K. Ohki, T. Obata, A. Heer and C. Reinhardt for excellent fish care and/or experimental assistance. We also thank A. Shimada and D. Nihei for their help in medaka experiments, J. Freshour and M. Nakatsugawa for help with Chlamydomonas, and S. King, H. Qin, W. Sale and D. Stern for antibodies. Our mutant screening was carried out mainly at the National Institute of Genetics (NIG), supported by NIG Cooperative Research Program (2002-2006). This work was supported in part by Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B), Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Yamada Science Foundation, and a Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan. D. K. was a research fellow supported by the 21th century COE program of the University of Tokyo, MEXT, Japan. This work was supported by grants to H. Omran from the ' Deutsche Forschungsgemeinschaft' DFG Om 6/4, GRK1104, BIOSS and the SFB592, and to D. R. M. from the NIH, GM44228. We would like to acknowledge the sequencing activities by K. Borzym and the Seq-Team at PI- MG, which was supported by the German Ministry of Science and Education ( BMBF) by grant NGFN-2:01GR0414-PDN-S02T17 to R. R. We are grateful for the support by the 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.'.	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; CHEN XM, 1995, PLANT CELL, V7, P1295; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; HAGIWARA H, 1990, Japanese Journal of Clinical Electron Microscopy, V23, P493; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hojo M, 2007, DEV GROWTH DIFFER, V49, P395, DOI 10.1111/j.1440-169x.2007.00937.x; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; HUANG B, 1979, J BIOL CHEM, V254, P3091; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; Kamiya R, 2002, INT REV CYTOL, V219, P115; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KING SM, 1985, P NATL ACAD SCI USA, V82, P4717, DOI 10.1073/pnas.82.14.4717; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; MITCHELL DR, 1986, CELL MOTIL CYTOSKEL, V6, P510, DOI 10.1002/cm.970060510; Mitchell DR, 1999, J CELL BIOL, V144, P293, DOI 10.1083/jcb.144.2.293; Mochizuki E, 2005, KIDNEY INT, V68, P23, DOI 10.1111/j.1523-1755.2005.00378.x; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; TAM LW, 1993, GENETICS, V135, P375; VANDORP DB, 1992, HUM GENET, V88, P331, DOI 10.1007/BF00197269; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200; Yamamoto R, 2006, FEBS LETT, V580, P6357, DOI 10.1016/j.febslet.2006.10.047; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	47	262	274	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					611	U54		10.1038/nature07471	http://dx.doi.org/10.1038/nature07471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052621	Green Accepted			2022-12-28	WOS:000261340000034
J	Sainsbury, P				Sainsbury, Peter			Commentary: Understanding social network analysis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sainsbury, Peter] Sydney SW Area Hlth Serv, Liverpool, NSW 1871, Australia		Sainsbury, P (corresponding author), Sydney SW Area Hlth Serv, Locked Bag 7008, Liverpool, NSW 1871, Australia.	sainsburyp@email.cs.nsw.gov.au		Sainsbury, Peter/0000-0002-0638-9438				Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338	1	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2008	337								a1957	10.1136/bmj.a1957	http://dx.doi.org/10.1136/bmj.a1957			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NX	19056787	hybrid			2022-12-28	WOS:000261891000004
J	Brennecke, J; Malone, CD; Aravin, AA; Sachidanandam, R; Stark, A; Hannon, GJ				Brennecke, Julius; Malone, Colin D.; Aravin, Alexei A.; Sachidanandam, Ravi; Stark, Alexander; Hannon, Gregory J.			An Epigenetic Role for Maternally Inherited piRNAs in Transposon Silencing	SCIENCE			English	Article							R-HYBRID DYSGENESIS; MENDELIAN FEMALE STERILITY; DROSOPHILA-MELANOGASTER; I-ELEMENTS; MOLECULAR-BASIS; TRANSGENES; RETROTRANSPOSITION; IDENTIFICATION; REPRESSION; REACTIVITY	In plants and mammals, small RNAs indirectly mediate epigenetic inheritance by specifying cytosine methylation. We found that small RNAs themselves serve as vectors for epigenetic information. Crosses between Drosophila strains that differ in the presence of a particular transposon can produce sterile progeny, a phenomenon called hybrid dysgenesis. This phenotype manifests itself only if the transposon is paternally inherited, suggesting maternal transmission of a factor that maintains fertility. In both P- and I- element- mediated hybrid dysgenesis models, daughters show a markedly different content of Piwi- interacting RNAs ( piRNAs) targeting each element, depending on their parents of origin. Such differences persist from fertilization through adulthood. This indicates that maternally deposited piRNAs are important for mounting an effective silencing response and that a lack of maternal piRNA inheritance underlies hybrid dysgenesis.	[Brennecke, Julius; Malone, Colin D.; Aravin, Alexei A.; Sachidanandam, Ravi; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Stark, Alexander/D-1473-2012; Brennecke, Julius/C-1626-2015; sachidanandam, ravi/Q-6916-2019; Hannon, Gregory/AAB-3568-2019; Brennecke, Julius/T-5883-2019	Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; sachidanandam, ravi/0000-0001-9844-4459; Brennecke, Julius/0000-0002-5141-0814	The Ernst Schering Foundation; Beckman fellow of the Watson School of Biological Sciences; NSF Graduate Research Fellowship; Human Frontier Science Program fellowship; NIH; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	The Ernst Schering Foundation; Beckman fellow of the Watson School of Biological Sciences; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Human Frontier Science Program fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Rooks and D. McCombie (CSHL) for help with deep sequencing, S. Jensen and S. Ronsseray for fly stocks and helpful discussions, and D. Finnegan for the I- element ORF-1 antibody. J.B. is supported by a fellowship from The Ernst Schering Foundation, C.D.M. is a Beckman fellow of the Watson School of Biological Sciences and is supported by an NSF Graduate Research Fellowship, and A.S. is supported by a Human Frontier Science Program fellowship. This work was supported by grants from NIH to G.J.H. and A.A.A. and a kind gift from K.W. Davis (to G.J.H.). Small RNA libraries are deposited at Gene Expression Omnibus ( accession no. GSE13081, data sets GSM327620 to GSM327634).	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUCHETON A, 1978, HEREDITY, V41, P357, DOI 10.1038/hdy.1978.106; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; Castro JP, 2004, GENETICA, V121, P107, DOI 10.1023/B:GENE.0000040382.48039.a2; Chambeyron S, 2005, CYTOGENET GENOME RES, V110, P215, DOI 10.1159/000084955; CROZATIER M, 1988, NUCLEIC ACIDS RES, V16, P9199, DOI 10.1093/nar/16.19.9199; Dimitri P, 2005, CYTOGENET GENOME RES, V110, P160, DOI 10.1159/000084948; Dramard X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000304; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; JENSEN S, 1995, MOL GEN GENET, V248, P381, DOI 10.1007/BF02191637; Jensen S, 2002, GENETICS, V162, P1197; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; KIDWELL MG, 1977, GENETICS, V86, P813; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Malinsky S, 2000, GENETICS, V156, P1147; Marin L, 2000, GENETICS, V155, P1841; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; PELISSON A, 1981, MOL GEN GENET, V183, P123, DOI 10.1007/BF00270149; PICARD G, 1976, GENETICS, V83, P107; Picard G, 1971, DIS, V46, P54; RONSSERAY S, 1991, GENETICS, V129, P501; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Seleme MD, 1999, GENETICS, V151, P761; VAURY C, 1990, J MOL EVOL, V31, P424, DOI 10.1007/BF02106056	28	535	555	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1387	1392		10.1126/science.1165171	http://dx.doi.org/10.1126/science.1165171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039138	Green Accepted			2022-12-28	WOS:000261170600041
J	Wilusz, JE; Freier, SM; Spector, DL				Wilusz, Jeremy E.; Freier, Susan M.; Spector, David L.			3 ' End Processing of a Long Nuclear-Retained Noncoding RNA Yields a tRNA-like Cytoplasmic RNA	CELL			English	Article							POLY(A)-LIMITING ELEMENT; MICRORNAS; MECHANISM; SEQUENCE; PROTEIN; IDENTIFICATION; TRANSCRIPTS; INHIBITOR; GENOME; TFEB	MALAT1 is a long noncoding RNA known to be misregulated in many human cancers. We have identified a highly conserved small RNA of 61 nucleotides originating from the MALAT1 locus that is broadly expressed in human tissues. Although the long MALAT1 transcript localizes to nuclear speckles, the small RNA is found exclusively in the cytoplasm. RNase P cleaves the nascent MALAT1 transcript downstream of a genomically encoded poly(A)-rich tract to simultaneously generate the 30 end of the mature MALAT1 transcript and the 50 end of the small RNA. Enzymes involved in tRNA biogenesis then further process the small RNA, consistent with its adoption of a tRNA-like structure. Our findings reveal a 30 end processing mechanism by which a single gene locus can yield both a stable nuclear-retained noncoding RNA with a short poly(A) tail-like moiety and a small tRNA-like cytoplasmic RNA.	[Wilusz, Jeremy E.; Spector, David L.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Freier, Susan M.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Cold Spring Harbor Laboratory; Isis Pharmaceuticals Inc	Spector, DL (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	spector@cshl.edu	Wilusz, Jeremy/AAG-4628-2020	Wilusz, Jeremy/0000-0001-6929-8755	Beckman Graduate Studentship; National Institutes of Health; National Institute of General Medical Sciences [42694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER	Beckman Graduate Studentship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank Tom Gingeras, Greg Hannon, Adrian Krainer, Kannanganattu Prasanth, Hongjae Sunwoo, Oliver Tam, Jeff Wilusz, Carol Wilusz, Zhenyu Xuan, and members of the Spector laboratory for many helpful discussions. We would also like to thank Chris Black and Frank Bennett for help and discussions regarding the antisense oligonucleotides, Josh Nichols and Walt Lima for performing the sucrose gradients, Sidney Altman and Masayuki Nashimoto for providing tRNA processing reagents, and Philip Leder for providing the EpH4-EV and EpH4-A6 cell lines. We thank Delphine Bernard and Alain Bessis for bringing MALAT1 to our attention. J. E. W. is supported by a Beckman Graduate Studentship at the Watson School of Biological Sciences. The work was supported by a grant to D. L. S. from the National Institutes of Health, National Institute of General Medical Sciences (42694).	Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Braidotti G, 2004, COLD SPRING HARB SYM, V69, P55, DOI 10.1101/sqb.2004.69.55; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Deng XX, 2006, TRENDS BIOCHEM SCI, V31, P526, DOI 10.1016/j.tibs.2006.07.007; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Fechter P, 2001, CELL MOL LIFE SCI, V58, P1547, DOI 10.1007/PL00000795; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Giege R, 1998, CURR OPIN STRUC BIOL, V8, P286, DOI 10.1016/S0959-440X(98)80060-2; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; Gu HD, 1999, P NATL ACAD SCI USA, V96, P8943, DOI 10.1073/pnas.96.16.8943; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jacobson MR, 1997, J CELL SCI, V110, P829; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Peng J, 2005, RNA, V11, P958, DOI 10.1261/rna.2020805; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Szymanski M, 2005, BBA-REV CANCER, V1756, P65, DOI 10.1016/j.bbcan.2005.07.005; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	486	527	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					919	932		10.1016/j.cell.2008.10.012	http://dx.doi.org/10.1016/j.cell.2008.10.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041754	Green Accepted, Bronze			2022-12-28	WOS:000261183900022
J	Phadnis, N; Orr, HA				Phadnis, Nitin; Orr, H. Allen			A Single Gene Causes Both Male Sterility and Segregation Distortion in Drosophila Hybrids	SCIENCE			English	Article							MEIOTIC-DRIVE; SEX-RATIO; UNISEXUAL STERILITY; PSEUDOOBSCURA; EVOLUTION; BOGOTA; INVIABILITY; EXPLANATION; DIVERGENCE; LOCUS	A central goal of evolutionary biology is to identify the genes and evolutionary forces that cause speciation, the emergence of reproductive isolation between populations. Despite the identification of several genes that cause hybrid sterility or inviability-many of which have evolved rapidly under positive Darwinian selection-little is known about the ecological or genomic forces that drive the evolution of postzygotic isolation. Here, we show that the same gene, Overdrive, causes both male sterility and segregation distortion in F-1 hybrids between the Bogota and U. S. subspecies of Drosophila pseudoobscura. This segregation distorter gene is essential for hybrid sterility, a strong reproductive barrier between these young taxa. Our results suggest that genetic conflict may be an important evolutionary force in speciation.	[Phadnis, Nitin; Orr, H. Allen] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Phadnis, N (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.	pdns@mail.rochester.edu			NIH [GM51932]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051932, R29GM051932] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Aquadro, J. Fry, R. Glor, H. Malik, D. Presgraves, Y. Tao, and the Orr lab for discussions; D. Lambert for advice on molecular techniques; H. Malik and N. Elde for help with PAML; and S. Schaeffer for fly stocks. Financial support was provided by NIH (GM51932). All sequences are available at GenBank (accession numbers FJ349335 to FJ349342 and FJ418600 to FJ418631). The authors declare no conflict of interest.	Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; CHARLESWORTH B, 1993, GENETICS, V133, P421; Coyne J.A., 2004, SPECIATION; COYNE JA, 1993, EVOLUTION, V47, P685, DOI 10.1111/j.1558-5646.1993.tb02123.x; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hall DW, 2004, EVOLUTION, V58, P925; HARTL DL, 1975, THEOR POPUL BIOL, V7, P168, DOI 10.1016/0040-5809(75)90012-X; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; HURST LD, 1991, GENETICS, V128, P841; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; Montchamp-Moreau C, 2006, GENETICS, V174, P1365, DOI 10.1534/genetics.105.051755; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Orr HA, 2001, GENETICS, V158, P1089; PRAKASH S, 1972, GENETICS, V72, P143; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; SCHAEFFER SW, 1991, P NATL ACAD SCI USA, V88, P6097, DOI 10.1073/pnas.88.14.6097; TAJIMA F, 1989, GENETICS, V123, P585; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Tao Y, 2007, PLOS BIOL, V5, P2576, DOI 10.1371/journal.pbio.0050293; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; WITTBRODT J, 1992, EMBO J, V11, P4239, DOI 10.1002/j.1460-2075.1992.tb05518.x	27	246	251	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					376	379		10.1126/science.1163934	http://dx.doi.org/10.1126/science.1163934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074311	Green Accepted			2022-12-28	WOS:000262481400037
J	Stanley, AJ; Ashley, D; Dalton, HR; Mowat, C; Gaya, DR; Thompson, E; Warshow, U; Groome, M; Cahill, A; Benson, G; Blatchford, O; Murray, W				Stanley, A. J.; Ashley, D.; Dalton, H. R.; Mowat, C.; Gaya, D. R.; Thompson, E.; Warshow, U.; Groome, M.; Cahill, A.; Benson, G.; Blatchford, O.; Murray, W.			Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation	LANCET			English	Article							UK COMPARATIVE AUDIT; SCORING SYSTEM; PREDICT NEED; ENDOSCOPY; CARE	Background Upper-gastrointestinal haemorrhage is a frequent reason for hospital admission. Although most risk scoring systems for this disorder incorporate endoscopic findings, the Glasgow-Blatchford bleeding score (GBS) is based on simple clinical and laboratory variables; a score of 0 identifies low-risk patients who might be suitable for outpatient management. We aimed to evaluate the GBS then assess the effect of a protocol based on this score for non-admission of low-risk individuals. Methods Our study was undertaken at four hospitals in the UK. We calculated GBS and admission (pre-endoscopy) and full (post-endoscopy) Rockall scores for consecutive patients presenting with upper-gastrointestinal haemorrhage. With receiver-operating characteristic (ROC) curves, we compared the ability of these scores to predict either need for clinical intervention or death. We then prospectively assessed at two hospitals the introduction of GBS scoring to avoid admission of low-risk patients. Findings Of 676 people presenting with upper-gastrointestinal haemorrhage, we identified 105 (16%) who scored 0 on the GBS. For prediction of need for intervention or death, GBS (area under ROC curve 0 . 90 [95% Cl 0 . 88-0.93]) was superior to full Rockall score (0 . 81 [0.77-0.84]), which in turn was better than the admission Rockall score (0.70 [0.65-0.75]). When introduced into clinical practice, 123 patients (22%) with upper-gastrointestinal haemorrhage were classified as low risk, of whom 84 (68%) were managed as outpatients without adverse events. The proportion of individuals with this condition admitted to hospital also fell (96% to 71%, p<0 . 00001). Interpretation The GBS identifies many patients presenting to general hospitals with upper-gastrointestinal haemorrhage who can be managed safely as outpatients. This score reduces admissions for this condition, allowing more appropriate use of in-patient resources. Funding None.	[Stanley, A. J.; Gaya, D. R.; Cahill, A.; Benson, G.; Murray, W.] Glasgow Royal Infirm, Dept Gastroenterol, Gastrointestinal Unit, Glasgow G4 0SF, Lanark, Scotland; [Ashley, D.; Thompson, E.] Univ Hosp N Tees, Stockton On Tees, England; [Dalton, H. R.; Warshow, U.] Royal Cornwall Hosp, Truro, England; [Mowat, C.; Groome, M.] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Blatchford, O.] Publ Hlth Dept Greater Glasgow & Clyde, Glasgow, Lanark, Scotland	University of Glasgow; University Hospital of North Tees; Royal Cornwall Hospital; University of Dundee	Stanley, AJ (corresponding author), Glasgow Royal Infirm, Dept Gastroenterol, Gastrointestinal Unit, Wards 8 & 9,Castle St, Glasgow G4 0SF, Lanark, Scotland.	Adrian.Stanley@ggc.scot.nhs.uk	Mowat, Craig/AAD-1851-2019	Mowat, Craig/0000-0002-5021-415X; Stanley, Adrian/0000-0002-9761-9795; Dalton, Harry/0000-0001-7786-5457				Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Baron RM, 1999, J THROMB THROMBOLYS, V7, P113, DOI 10.1023/A:1008873201503; Blatchford O, 1997, BMJ-BRIT MED J, V315, P510, DOI 10.1136/bmj.315.7107.510; Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; Cameron EA, 2002, EUR J GASTROEN HEPAT, V14, P497, DOI 10.1097/00042737-200205000-00006; Chen GC, 2007, AM J EMERG MED, V25, P774, DOI 10.1016/j.ajem.2006.12.024; Cipolletta L, 2002, GASTROINTEST ENDOSC, V55, P1, DOI 10.1067/mge.2002.119219; Das A, 2008, GASTROENTEROLOGY, V134, P65, DOI 10.1053/j.gastro.2007.10.037; Gralnek IM, 2004, GASTROINTEST ENDOSC, V60, P9, DOI 10.1016/S0016-5107(04)01524-X; Gralnek IM, 2002, GASTROINTEST ENDOSC, V55, P131, DOI 10.1067/mge.2002.120661; Hay JA, 1997, JAMA-J AM MED ASSOC, V278, P2151, DOI 10.1001/jama.278.24.2151; Hearnshaw SA, 2008, GUT, V57, pA12; Hearnshaw SA, 2008, GUT, V57, pA8; Imperiale TF, 2007, ARCH INTERN MED, V167, P1291, DOI 10.1001/archinte.167.12.1291; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Longstreth GF, 1998, GASTROINTEST ENDOSC, V47, P219, DOI 10.1016/S0016-5107(98)70316-5; LONGSTRETH GF, 1995, LANCET, V345, P108, DOI 10.1016/S0140-6736(95)90068-3; Masaoka T, 2007, J GASTROEN HEPATOL, V22, P1404, DOI 10.1111/j.1440-1746.2006.04762.x; Okazaki K, 2002, GUT, V51, P1, DOI 10.1136/gut.51.1.1; PACKHAM CJ, 1995, LANCET, V345, P659, DOI 10.1016/S0140-6736(95)90567-7; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Romagnuolo J, 2007, ARCH INTERN MED, V167, P265, DOI 10.1001/archinte.167.3.265; SAEED ZA, 1993, AM J GASTROENTEROL, V88, P1842	24	225	239	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					42	47		10.1016/S0140-6736(08)61769-9	http://dx.doi.org/10.1016/S0140-6736(08)61769-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19091393				2022-12-28	WOS:000262183800030
J	Tyrer, P; Kendall, T				Tyrer, Peter; Kendall, Tim			The spurious advance of antipsychotic drug therapy	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; CHRONIC-SCHIZOPHRENIA; COST-EFFECTIVENESS; 2ND-GENERATION; CATIE		[Tyrer, Peter] Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, London W6 8RP, England; [Kendall, Tim] Royal Coll Psychiatrists, Res Unit, Natl Collaborating Ctr Mental Hlth, London SW1X 8PG, England	Imperial College London; University of London; University College London	Tyrer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, London W6 8RP, England.	p.tyrer@imperial.ac.uk						Davies LM, 2007, BRIT J PSYCHIAT, V191, P14, DOI 10.1192/bjp.bp.106.028654; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; JANSSEN PAJ, 1988, J PHARMACOL EXP THER, V244, P685; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; LEUCHT S, 2008, LANCET          1205; Lewis S, 2008, BRIT J PSYCHIAT, V192, P161, DOI 10.1192/bjp.bp.107.037218; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Rosenheck RA, 2006, AM J PSYCHIAT, V163, P2080, DOI 10.1176/appi.ajp.163.12.2080; Tungaraza T, 2007, BRIT J PSYCHIAT, V191, P82, DOI 10.1192/bjp.bp.106.024547; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; VEDANTAM S, 2006, WASHINGTON POST 1003; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	14	76	83	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 3	2009	373	9657					4	5		10.1016/S0140-6736(08)61765-1	http://dx.doi.org/10.1016/S0140-6736(08)61765-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19058841				2022-12-28	WOS:000262183800005
J	Xie, YC; Yin, T; Wiegraebe, W; He, XC; Miller, D; Stark, D; Perko, K; Alexander, R; Schwartz, J; Grindley, JC; Park, J; Haug, JS; Wunderlich, JP; Li, H; Zhang, S; Johnson, T; Feldman, RA; Li, LH				Xie, Yucai; Yin, Tong; Wiegraebe, Winfried; He, Xi C.; Miller, Diana; Stark, Danny; Perko, Katherine; Alexander, Richard; Schwartz, Joel; Grindley, Justin C.; Park, Jungeun; Haug, Jeff S.; Wunderlich, Joshua P.; Li, Hua; Zhang, Simon; Johnson, Teri; Feldman, Ricardo A.; Li, Linheng			Detection of functional haematopoietic stem cell niche using real-time imaging	NATURE			English	Article							BONE-MARROW; PROGENITOR CELLS; IN-VIVO; N-CADHERIN; DIFFERENTIATION; MOBILIZATION; IDENTIFICATION; MICROSCOPY; RECEPTOR; LINEAGE	Haematopoietic stem cell (HSC) niches, although proposed decades ago(1), have only recently been identified as separate osteoblastic and vascular microenvironments(2-6). Their interrelationships and interactions with HSCs in vivo remain largely unknown. Here we report the use of a newly developed ex vivo real- time imaging technology and immunoassaying to trace the homing of purified green-fluorescent-protein- expressing (GFP(+)) HSCs. We found that transplanted HSCs tended to home to the endosteum (an inner bone surface) in irradiated mice, but were randomly distributed and unstable in non- irradiated mice. Moreover, GFP(+) HSCs were more frequently detected in the trabecular bone area compared with compact bone area, and this was validated by live imaging bioluminescence driven by the stem- cell- leukaemia ( Scl) promoter enhancer(7). HSCs home to bone marrow through the vascular system. We found that the endosteum is well vascularized and that vasculature is frequently localized near N-cadherin(+) pre-osteoblastic cells, a known niche component. By monitoring individual HSC behaviour using real- time imaging, we found that a portion of the homed HSCs underwent active division in the irradiated mice, coinciding with their expansion as measured by flow assay. Thus, in contrast to central marrow, the endosteum formed a special zone, which normally maintains HSCs but promotes their expansion in response to bone marrow damage.	[Miller, Diana; Feldman, Ricardo A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Miller, Diana; Feldman, Ricardo A.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Xie, Yucai; Yin, Tong; Wiegraebe, Winfried; He, Xi C.; Stark, Danny; Perko, Katherine; Alexander, Richard; Schwartz, Joel; Grindley, Justin C.; Park, Jungeun; Haug, Jeff S.; Wunderlich, Joshua P.; Li, Hua; Zhang, Simon; Johnson, Teri; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Xie, Yucai] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Shanghai Rui Jin Hosp, Shanghai 200025, Peoples R China; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Stowers Institute for Medical Research; Shanghai Jiao Tong University; University of Kansas; University of Kansas Medical Center	Feldman, RA (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	rfeldman@umaryland.edu; lil@stowers-institute.org		Li, Linheng/0000-0001-9963-430X; Feldman, Ricardo A./0000-0001-6090-0439	DOD [W81XWH-04-1-0801]; DRIF Award; University of Maryland; Stowers Institute for Medical Research	DOD(United States Department of Defense); DRIF Award; University of Maryland; Stowers Institute for Medical Research	We appreciate scientific support from R. Krumlauf, W. Neaves and encouragement from G. Luand W. Shen. We are grateful to D. Scadden and P. Kulesa for discussion. We thank D. Rowe for providing the Col2.3-GFP line. We thank R. Yu, L. Ma, Q. Qiu and W. Wang for technological advice, M. Hembree, A. Box, H. Marshall, E. Rendenbaugh, C. Cooper and M. Smith for technical support, S. Beckham for histology assistance, J. Perry and J. Ross for comments, and K. Tannen for proofreading. R.A.F. was supported by DOD grant W81XWH-04-1-0801 and by a DRIF Award from the University of Maryland. L.L. is supported by Stowers Institute for Medical Research.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Juopperi TA, 2007, EXP HEMATOL, V35, P335, DOI 10.1016/j.exphem.2006.09.014; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Murphy GJ, 2003, J BIOL CHEM, V278, P43556, DOI 10.1074/jbc.M302717200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osawa M, 1996, J IMMUNOL, V156, P3207; Sausville J, 2008, CLIN CANCER RES, V14, P3948, DOI 10.1158/1078-0432.CCR-07-5152; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	30	421	438	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					97	U102		10.1038/nature07639	http://dx.doi.org/10.1038/nature07639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19052548				2022-12-28	WOS:000262104900038
J	Petticrew, M				Petticrew, Mark			Billy Bunter and the obesogenic environment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Petticrew, Mark] Univ London London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Petticrew, M (corresponding author), Univ London London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, Keppel St, London WC1E 7HT, England.	mark.petticrew@lshtm.ac.uk	Petticrew, Mark/AAY-6274-2021					BUNTER B, 1976, VALIANT ANN, P20; BUTCHER JS, 1965, GREYFRIARS SCH PROSP, P6; Carnell S, 2008, INT J OBESITY, V32, P1468, DOI 10.1038/ijo.2008.127; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Department of Health Social Security, 1980, WORK GROUP IN HLTH I; Gustafsson U, 2002, SOC POLICY ADMIN, V36, P685, DOI 10.1111/1467-9515.00311; Halford JCG, 2007, APPETITE, V49, P263, DOI 10.1016/j.appet.2006.12.003; Hyde R, 2008, LANCET, V371, P2160, DOI 10.1016/S0140-6736(08)60936-8; Macdonald L, 2007, APPETITE, V49, P251, DOI 10.1016/j.appet.2006.11.004; Miller SA, 2008, INT J PEDIATR OBES, V3, P168, DOI 10.1080/17477160801915935; Moore L, 2008, J EPIDEMIOL COMMUN H, V62, P926, DOI 10.1136/jech.2007.070953; RICHARDS H, 1949, B BUNTER CLIFF HOUSE; School Food Trust, 2008, NEW RES REV SCAL JUN; Schwartz J, 2006, J AM DIET ASSOC, V106, P1412, DOI 10.1016/j.jada.2006.06.006; West P, 2007, TOB CONTROL, V16, P329, DOI 10.1136/tc.2006.018721; WILLIAMS C, 2008, GROCER          0112, P31; 2008, LEATHERMEAD MAT 0223	18	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2008	337								a2877	10.1136/bmj.a2877	http://dx.doi.org/10.1136/bmj.a2877			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088137	Green Accepted			2022-12-28	WOS:000262184900004
J	Bishai, DM				Bishai, David M.			Global initiatives in universal childhood immunisation	LANCET			English	Editorial Material									[Bishai, David M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21030 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bishai, DM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21030 USA.	dbishai@jhsph.edu	, David Bishai/GRO-4211-2022	Bishai, David/0000-0003-0714-9062				GAVI Alliance, IMM SERV SUPP; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Mavimbe JC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-108; Suarez L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e3	4	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2004	2005		10.1016/S0140-6736(08)61853-X	http://dx.doi.org/10.1016/S0140-6736(08)61853-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384LS	19070729				2022-12-28	WOS:000261746900005
J	Lim, SS; Stein, DB; Charrow, A; Murray, CJL				Lim, Stephen S.; Stein, David B.; Charrow, Alexandra; Murray, Christopher J. L.			Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage	LANCET			English	Article							VACCINATION COVERAGE; MOTHERS REPORTS; DATA QUALITY; CHILDREN; SEROEPIDEMIOLOGY; PREVALENCE; ACCURACY; VALIDITY; ANTIBODY; MEASLES	Background Substantial resources have been invested in increasing childhood immunisation coverage through global initiatives such as the Universal Childhood Immunisation (UCI) campaign and the Global Alliance on Vaccines and Immunisations (GAVI). There are longstanding concerns that target-oriented and performance-oriented initiatives such as UCI and GAVI's immunisation services support (ISS) might encourage over-reporting. We estimated the coverage of three doses of diphtheria, tetanus, and pertussis vaccine (DTP3) based on surveys using all available data. Methods We estimated DTP3 coverage by analysing unit record data from surveys and supplemented this with reported coverage from other surveys and administrative data. We used bidirectional distance-dependent regression to estimate trends in survey-based coverage in 193 countries during 1986-2006. We used standard time-series cross-sectional analysis to investigate any association in the difference between countries' official reports and survey-based coverage as the dependent variable and the presence of GAVI ISS as the independent variable, controlling for country and time effects. Findings Crude coverage of DTP3 based on surveys increased from 59% (95% uncertainty interval 51-65) in 1986 to 65% (60-68) in 1990, 70% (65-74) in 2000, and 74% (70-77) in 2006. There were substantial differences between officially reported and survey-based coverage during VCI. GAVI ISS significantly increased the difference between officially reported coverage and survey coverage. Up to 2006, in 51 countries receiving GAVI ISS payments, 7.4 million (5.7 million to 9.2 million) additional children were immunised with DTP3 based on surveys compared with officially reported estimates of 13.9 million. On the basis of the number of additional children immunised from surveys at a rate of US$20 each, GAVI ISS payments are estimated at $150 million (115 million to 184 million) compared with actual disbursements of $290 million. Interpretation Survey-based DTP3 immunisation coverage has improved more gradually and not to the level suggested by countries' official reports or WHO and UNICEF estimates. There is an urgent need for independent and contestable monitoring of health indicators in an era of global initiatives that are target-oriented and disburse funds based on performance. Funding Bill & Melinda Gates Foundation.	[Lim, Stephen S.; Stein, David B.; Charrow, Alexandra; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@u.washington.edu	Lim, Stephen S/B-4055-2012	Stein, David/0000-0003-3743-1595	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill & Melinda Gates Foundation. We thank Abdallah Bchir and Nina Schwalbe for helpful comments on drafts; Stanislava Nikolova for help with editing; Catherine Claiborne for help with editing and programme assistance; and Jennifer Berthiaume for assistance with data collation.	Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Brogan Donna, 1994, Annals of Epidemiology, V4, P302, DOI 10.1016/1047-2797(94)90086-8; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; Cutts FT, 2000, TROP MED INT HEALTH, V5, P157, DOI 10.1046/j.1365-3156.2000.00536.x; Gabutti G, 2002, EPIDEMIOL INFECT, V129, P543, DOI 10.1017/S0950268802007677; GAREABALLAH ET, 1989, B WORLD HEALTH ORGAN, V67, P669; *GAVI, IMM SERV SUPP ISS; *GAVI UNICEF, 2000, VACC IMM PROD GUID C; George K, 1990, Indian J Pediatr, V57, P588, DOI 10.1007/BF02726779; Gidding HF, 2005, AUST NZ J PUBL HEAL, V29, P48, DOI 10.1111/j.1467-842X.2005.tb00748.x; Hardon A, 2005, SOC SCI MED, V60, P345, DOI 10.1016/j.socscimed.2004.05.008; HONAKER J, 2008, WHAT DO MISSING VALU; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Jolly Richard., 2004, J HUMAN DEV, V5, P69, DOI DOI 10.1080/14649880310001660210; Katz J, 1997, INT J EPIDEMIOL, V26, P1041, DOI 10.1093/ije/26.5.1041; Katz JonathanN., 1996, POLIT ANAL, V6, DOI [10.1093/pan/6.1.1, DOI 10.1093/PAN/6.1.1]; Keele L, 2006, POLIT ANAL, V14, P186, DOI 10.1093/pan/mpj006; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; LE T, 1997, DHS ANAL REPORTS, V3; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Little R.J.A., 2002, STAT ANAL MISSING DA; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lu CL, 2006, LANCET, V368, P1088, DOI 10.1016/S0140-6736(06)69337-9; Mavimbe JC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-108; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Nigatu W, 2008, VACCINE, V26, P4769, DOI 10.1016/j.vaccine.2008.07.005; NIKOLETTI S, 1994, EPIDEMIOL INFECT, V112, P161, DOI 10.1017/S0950268800057526; OHUMA EO, 2008, EPIDEMIOL INFECT, V10, P1; Onta SR, 1998, HEALTH POLICY PLANN, V13, P131, DOI 10.1093/heapol/13.2.131; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Ramakrishnan R, 1999, Indian Pediatr, V36, P881; Ren R., 2006, DHS WORKING PAPERS, V30; Ringler M, 2003, EUR J EPIDEMIOL, V18, P161, DOI 10.1023/A:1023038705835; Ronveaux O, 2005, B WORLD HEALTH ORGAN, V83, P503; Rubin D. B., 2004, MULTIPLE IMPUTATION; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Shinall MC, 2007, PEDIATRICS, V120, pe783, DOI 10.1542/peds.2007-0052; Starling M., 2002, NEW PRODUCTS OLD SYS; Suarez L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e3; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; UN, 2007, WORLD POP PROSP; *UNICEF WHO, 2007, IMM SUMM 2007; VALADEZ JJ, 1992, AM J PUBLIC HEALTH, V82, P120, DOI 10.2105/AJPH.82.1.120; Vancelik S, 2007, INDIAN J MED RES, V126, P528; *WHO UNICEF, 1980, COUNTR REP WHO UNICE; *WHO UNICEF, WHO UNICEF JOINT REP; *WHO UNICEF, 1980, WHO UNICEF REV NAT I; 2005, GLOBAL BURDEN DIS ST	60	189	191	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2008	372	9655					2031	2046		10.1016/S0140-6736(08)61869-3	http://dx.doi.org/10.1016/S0140-6736(08)61869-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384LS	19070738				2022-12-28	WOS:000261746900024
J	Faure-Andre, G; Vargas, P; Yuseff, MI; Heuze, M; Diaz, J; Lankar, D; Steri, V; Manry, J; Hugues, S; Vascotto, F; Boulanger, J; Raposo, G; Bono, MR; Rosemblatt, M; Piel, M; Lennon-Dumenil, AM				Faure-Andre, Gabrielle; Vargas, Pablo; Yuseff, Maria-Isabel; Heuze, Melina; Diaz, Jheimmy; Lankar, Danielle; Steri, Veronica; Manry, Jeremy; Hugues, Stephanie; Vascotto, Fulvia; Boulanger, Jerome; Raposo, Graca; Bono, Maria-Rosa; Rosemblatt, Mario; Piel, Matthieu; Lennon-Dumenil, Ana-Maria			Regulation of Dendritic Cell Migration by CD74, the MHC Class II-Associated Invariant Chain	SCIENCE			English	Article							CATHEPSIN-S; ANTIGEN PRESENTATION; MYOSIN-IIA; NK CELLS; STIMULATION; TRAFFICKING; DEGRADATION; COMPLEX; CD44	Dendritic cells ( DCs) sample peripheral tissues of the body in search of antigens to present to T cells. This requires two processes, antigen processing and cell motility, originally thought to occur independently. We found that the major histocompatibility complex II- associated invariant chain (li or CD74), a known regulator of antigen processing, negatively regulates DC motility in vivo. By using microfabricated channels to mimic the confined environment of peripheral tissues, we found that wild- type DCs alternate between high and low motility, whereas li-deficient cells moved in a faster and more uniform manner. The regulation of cell motility by li depended on the actin- based motor protein myosin II. Coupling antigen processing and cell motility may enable DCs to more efficiently detect and process antigens within a defined space.	[Boulanger, Jerome; Raposo, Graca; Piel, Matthieu] Inst Curie, CNRS, UMR144, F-75005 Paris, France; [Bono, Maria-Rosa; Rosemblatt, Mario] Fdn Ciencia Vida, Santiago, Chile; [Bono, Maria-Rosa; Rosemblatt, Mario] Inst Milenio Biol Fundamental & Aplicada, Santiago, Chile; [Rosemblatt, Mario] Univ Andres Bello, Fac Ciencias Salud, Santiago, Chile; [Faure-Andre, Gabrielle; Vargas, Pablo; Yuseff, Maria-Isabel; Heuze, Melina; Diaz, Jheimmy; Lankar, Danielle; Steri, Veronica; Manry, Jeremy; Hugues, Stephanie; Vascotto, Fulvia; Lennon-Dumenil, Ana-Maria] Inst Curie, INSERM, U653, F-75005 Paris, France; [Vargas, Pablo; Bono, Maria-Rosa; Rosemblatt, Mario] Univ Chile, Dept Biol, Fac Ciencias, Santiago 3425, Chile	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universidad Andres Bello; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universidad de Chile	Piel, M (corresponding author), Inst Curie, CNRS, UMR144, 12 Rue Lhomond, F-75005 Paris, France.	mpiel@curie.fr; amlennon@curie.fr	Vargas, Pablo/L-9858-2017; VARGAS, Pablo/HHM-4543-2022; Lennon-Dumenil, Ana-Maria/I-6716-2016; Diaz, Jheimmy/AAF-6886-2019; Bono, Maria/G-7461-2014	Vargas, Pablo/0000-0002-6475-494X; VARGAS, Pablo/0000-0002-6475-494X; Vascotto, Fulvia/0000-0002-9839-3484; Manry, Jeremy/0000-0001-5998-2051; hugues, stephanie/0000-0002-1031-5909; Raposo, graca/0000-0001-9590-1298; Heuze, Melina/0000-0002-4271-2706; Boulanger, Jerome/0000-0003-0237-3743	Ministere Francais de la Recherche; Association pour la Recherche contre le Cancer; ECOS-Comision Nacional de Investigacion Cientifica y Technologica; Gobierno de Chile [CO3S01]; Institut Curie and Inserm; ARC, Fondecyt (Chile) [1060834, 1060253]; Agence Nationale pour la Recherche [ANR-06-PCVI-0010]; Human Frontiers Science Program [RGY53/2007]	Ministere Francais de la Recherche(Ministry of Research, France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ECOS-Comision Nacional de Investigacion Cientifica y Technologica; Gobierno de Chile; Institut Curie and Inserm; ARC, Fondecyt (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Human Frontiers Science Program(Human Frontier Science Program)	The authors thank T. Makushok for setting up the cell migration microchannel system; A. Azicune for cell micropatterning techniques; W. Faigle and D. Lowe for proteomics analysis; C. Recchi for help with gelatin-FITC degradation experiments; H. Overkleeft for synthesizing the LHVS; J. Roger for providing magnetic nanoparticles; M. Leberre, D. Baigl, and Y. Chen for help with microfabrication; and S. Amigorena, M. Sixt, P. Benaroch, V. Soumelis, C. Hivroz, and I. Fernandez for advice on the manuscript. A.-M. L.-D. thanks Y. Bellaiche for help with manuscript redaction. G.F.-A. was supported by a fellowship from the Ministere Francais de la Recherche and, together with M. H., from the Association pour la Recherche contre le Cancer (ARC). P.V. and M.- I.Y. benefited from ECOS-Comision Nacional de Investigacion Cientifica y Technologica, Gobierno de Chile fellowship (CO3S01), Institut Curie and Inserm fellowships, respectively. V.S. was part of the Leonardo Da Vinci project (Unipharma-Graduates, Sapienza University of Rome). This work was funded in part by grants from the ARC, Fondecyt (Chile) to M.- R.B. (1060834) and M. R. ( 1060253); Agence Nationale pour la Recherche (ANR-06-PCVI-0010) and Human Frontiers Science Program (RGY53/2007) to M.P.	Andzelm MM, 2007, J EXP MED, V204, P2285, DOI 10.1084/jem.20071143; Boes M, 2005, EUR J IMMUNOL, V35, P2552, DOI 10.1002/eji.200526323; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chao SH, 2007, LAB CHIP, V7, P641, DOI 10.1039/b618269k; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; FINK J, 2008, LAB CHIP, V453, P51; Fink J, 2007, LAB CHIP, V7, P672, DOI 10.1039/b618545b; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153	22	207	215	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1705	1710		10.1126/science.1159894	http://dx.doi.org/10.1126/science.1159894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074353				2022-12-28	WOS:000261608300049
J	Lee, HY; Chou, JY; Cheong, L; Chang, NH; Yang, SY; Leu, JY				Lee, Hsin-Yi; Chou, Jui-Yu; Cheong, Liplee; Chang, Nai-Hsin; Yang, Shi-Yow; Leu, Jun-Yi			Incompatibility of Nuclear and Mitochondrial Genomes Causes Hybrid Sterility between Two Yeast Species	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; GENUS SACCHAROMYCES; GENETIC MATERIAL; ATP SYNTHASE; SPECIATION; DROSOPHILA; EVOLUTION; SUBSTITUTION; DEFICIENCY; EPISTASIS	Hybrids between species are usually unviable or sterile. One possible mechanism causing reproductive isolation is incompatibility between genes from different species. These "speciation'' genes are interacting components that cannot function properly when mixed with alleles from other species. To test whether such genes exist in two closely related yeast species, we constructed hybrid lines in which one or two chromosomes were derived from Saccharomyces bayanus, and the rest were from Saccharomyces cerevisiae. We found that the hybrid line with Chromosome 13 substitution was completely sterile and identified Aep2, a mitochondrial protein encoded on Chromosome 13, to cause the sporulation defect as S. bayanus AEP2 is incompatible with S. cerevisiae mitochondria. This is caused by the inability of S. bayanus Aep2 protein to regulate the translation of the S. cerevisiae OLI1 mRNA. We speculate that AEP2 and OLI1 have evolved during the adaptation of S. bayanus to nonfermentable carbon sources, thereby driving speciation.	[Lee, Hsin-Yi; Chou, Jui-Yu; Cheong, Liplee; Chang, Nai-Hsin; Yang, Shi-Yow; Leu, Jun-Yi] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chou, Jui-Yu] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chou, Jui-Yu] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Leu, JY (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	jleu@imb.sinica.edu.tw	Leu, Jun-Yi/A-7364-2009	Leu, Jun-Yi/0000-0001-5445-2799	Academia Sinica of Taiwan; National Science Council ( Taiwan) [NSC96-2628-B-001-016MY3]; Human Frontier Science Program [RGY53/2007]	Academia Sinica of Taiwan(Academia Sinica - Taiwan); National Science Council ( Taiwan)(Ministry of Science and Technology, Taiwan); Human Frontier Science Program(Human Frontier Science Program)	We thank M. S. Ho, C.-Y. Huang, S. Lacefield, A. Murray, C.-T. Ting, and members of the Leu lab for helpful discussions and comments on the manuscript and H. Wilson for English editing. We also thank the Microarray Core of IMB for microarray support. This work was supported by Academia Sinica of Taiwan, National Science Council ( Taiwan) ( grant NSC96-2628-B-001-016MY3) and Human Frontier Science Program ( grant RGY53/2007).	Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; CLARKWALKER GD, 1991, CURR GENET, V20, P195, DOI 10.1007/BF00326232; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; DOBZHANSKY T., 1951, Genetics and the origin of species.; Ellis TP, 1999, GENETICS, V151, P1353; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; FINNEGAN PM, 1991, CURR GENET, V20, P53, DOI 10.1007/BF00312765; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; GREIG D, 2008, HEREDITY IN PRESS, DOI DOI 10.1038/HDY.2008.73; Greig D, 2007, PLOS GENET, V3, P281, DOI 10.1371/journal.pgen.0030021; Groth C, 2000, MOL BIOL EVOL, V17, P1833, DOI 10.1093/oxfordjournals.molbev.a026284; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; GUTHRIE C, 2004, GUIDE YEAST GENETICS; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; LIEPINS A, 1977, DEV BIOL, V57, P284, DOI 10.1016/0012-1606(77)90215-9; Lieu Pauline T, 2005, J Biomol Tech, V16, P104; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; Piskur J, 1998, INT J SYST BACTERIOL, V48, P1015, DOI 10.1099/00207713-48-3-1015; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Sackton TB, 2003, EVOLUTION, V57, P2315; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TREMBATH MK, 1975, MOL GEN GENET, V141, P9, DOI 10.1007/BF00332375; WU CI, 1994, ANNU REV GENET, V28, P283, DOI 10.1146/annurev.ge.28.120194.001435; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Yang ZH, 2000, GENETICS, V155, P431; Zeyl C, 2005, EVOLUTION, V59, P910	35	247	249	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1065	1073		10.1016/j.cell.2008.10.047	http://dx.doi.org/10.1016/j.cell.2008.10.047			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070577	Bronze			2022-12-28	WOS:000261642800022
J	Kang, LW; Crawford, N; Tang, MLK; Buttery, J; Royle, J; Gold, M; Ziegler, C; Quinn, P; Elia, S; Choo, S				Kang, Liew Woei; Crawford, Nigel; Tang, Mimi L. K.; Buttery, Jim; Royle, Jenny; Gold, Michael; Ziegler, Christine; Quinn, Patrick; Elia, Sonja; Choo, Sharon			Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALLERGY; IMMUNIZATION; ALUMINUM; CHILDREN; HISTORY; EVENTS; US	Objective To describe the outcomes of clinical evaluation, skin testing, and vaccine challenge in adolescent schoolgirls with suspected hypersensitivity to the quadrivalent human papillomavirus vaccine introduced in Australian schools in 2007. Design Retrospective cohort study. Setting Two tertiary paediatric allergy centres in Victoria and South Australia, Australia. Participants 35 schoolgirls aged 12 to 18.9 years with suspected hypersensitivity reactions to the quadrivalent human papillomavirus vaccine. Main outcome measures Clinical review and skin prick and intradermal testing with the quadrivalent vaccine and subsequent challenge with the vaccine. Results 35 schoolgirls with suspected hypersensitivity to the quadrivalent human papillomavirus vaccine were notified to the specialised immunisation services in 2007, after more than 380 000 doses had been administered in schools. Of these 35 schoolgirls, 25 agreed to further evaluation. Twenty three ( 92%) experienced reactions after the first dose. Thirteen (52%) experienced urticaria or angio- oedema, and of these, two experienced anaphylaxis. Thirteen had generalised rash, one with angio- oedema. The median time to reaction was 90 minutes. Nineteen ( 76%) underwent skin testing with the quadrivalent vaccine: all were skin prick test negative and one was intradermal test positive. Eighteen ( 72%) were subsequently challenged with the quadrivalent vaccine and three ( 12%) elected to receive the bivalent vaccine. Seventeen tolerated the challenge and one reported limited urticaria four hours after the vaccine had been administered. Only three of the 25 schoolgirls were found to have probable hypersensitivity to the quadrivalent vaccine. Conclusion True hypersensitivity to the quadrivalent human papillomavirus vaccine in Australian schoolgirls was uncommon and most tolerated subsequent doses.	[Kang, Liew Woei; Tang, Mimi L. K.; Choo, Sharon] Royal Childrens Hosp, Dept Allergy & Immunol, Parkville, Vic 3052, Australia; [Kang, Liew Woei] KK Womens & Childrens Hosp, Dept Paediat Med, Singapore, Singapore; [Crawford, Nigel; Buttery, Jim; Royle, Jenny; Elia, Sonja] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic, Australia; [Crawford, Nigel; Tang, Mimi L. K.; Buttery, Jim] Univ Melbourne, NHMRC Ctr Clin Res Excellence Child & Adolescent, Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic, Australia; [Tang, Mimi L. K.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Gold, Michael; Ziegler, Christine; Quinn, Patrick] Womens & Childrens Hosp, Dept Allergy & Immunol, Adelaide, SA, Australia	Royal Children's Hospital Melbourne; KK Women's & Children's Hospital; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Womens & Childrens Hospital Australia	Choo, S (corresponding author), Royal Childrens Hosp, Dept Allergy & Immunol, Flemington Rd, Parkville, Vic 3052, Australia.	sharon.choo@rch.org.au	Tang, Mimi/ABD-8350-2020	Tang, Mimi/0000-0002-3839-5293				Andrews RM, 1998, MED J AUSTRALIA, V168, P491, DOI 10.5694/j.1326-5377.1998.tb141412.x; Baylor NW, 2002, VACCINE, V20, pS18, DOI 10.1016/S0264-410X(02)00166-4; BRIGHTMAN CA, 1989, LANCET, V22, P903; COX NH, 1988, LANCET, V2, P43; Gold M, 2000, ARCH DIS CHILD, V83, P128, DOI 10.1136/adc.83.2.128; Tanne JH, 2007, BRIT MED J, V334, P1182, DOI 10.1136/bmj.39237.424537.4E; Nakayama T, 1999, J ALLERGY CLIN IMMUN, V103, P321, DOI 10.1016/S0091-6749(99)70508-7; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Ponvert C, 2003, EUR J DERMATOL, V13, P10; SHELLEY WB, 1995, LANCET, V345, P1312, DOI 10.1016/S0140-6736(95)90963-X; Siegrist CA, 2007, PEDIATR INFECT DIS J, V26, P979, DOI 10.1097/INF.0b013e318149dfea; Wood RA, 2007, J ALLERGY CLIN IMMUN, V120, P478, DOI 10.1016/j.jaci.2007.04.035	12	37	39	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2008	337								a2642	10.1136/bmj.a2642	http://dx.doi.org/10.1136/bmj.a2642			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NV	19050332	Green Published, hybrid			2022-12-28	WOS:000261890800001
J	Widmark, A; Klepp, O; Solberg, A; Damber, JE; Angelsen, A; Fransson, P; Lund, JA; Tasdemir, I; Hoyer, M; Wiklund, F; Fossa, SD				Widmark, Anders; Klepp, Olbjorn; Solberg, Arne; Damber, Jan-Erik; Angelsen, Anders; Fransson, Per; Lund, Jo-Asmund; Tasdemir, Ilker; Hoyer, Morten; Wiklund, Fredrik; Fossa, Sophie D.		Scandinavian Prostate Canc Grp Stu; Swedish Assoc Urological Oncology	Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial	LANCET			English	Article							BICALUTAMIDE 150 MG; MEDIAN FOLLOW-UP; QUALITY-OF-LIFE; ANDROGEN SUPPRESSION; RADIATION-THERAPY; STANDARD CARE; DEFINITIVE RADIOTHERAPY; RADICAL PROSTATECTOMY; HORMONAL-THERAPY; DOSE-RESPONSE	Background Several studies have shown the efficacy of endocrine therapy in combination with radiotherapy in high-risk prostate cancer. To assess the effect of radiotherapy, we did an open phase III study comparing endocrine therapy with and without local radiotherapy, followed by castration on progression. Methods This randomised trial included men frorn 47 centres in Norway, Sweden, and Denmark. Between February, 1996, and December, 2002,875 patients with locally advanced prostate cancer (T3; 78%; PSA<70; N0; M0) were centrally randomly assigned by computer to endocrine treatment alone (3 months of total androgen blockade followed by continuous endocrine treatment using flutamide; 439 patients), or to the same endocrine treatment combined with radiotherapy (436 patients). The primary endpoint was prostate-cancer-specific survival, and analysis was by intention to treat. This study is registered as an international standard randomised controlled trial, number ISRCTN01534787. Findings After a median follow-tip of 7.6 years, 79 men in the endocrine alone group and 37 men in the endocrine plus radiotherapy group had died of prostate cancer. The cumulative incidence at 10 years for prostate-cancer-specific mortality was 23.9% in the endocrine alone group and 11.9% in the endocrine plus radiotherapy group (difference 12 . 0%, 95% Cl 4.9-19 . 1%), for a relative risk of 0 . 44 (0.30-0.66). At 1.0 years, the cumulative incidence for overall mortality was 39.4% in the endocrine alone group and 29.6% in the endocrine plus radiotherapy group (difference 9.8%, 0.8-18.8%), for a relative risk of 0.68 (0.52-0.89). Cumulative incidence at 10 years for PSA recurrence was substantially higher in men in the endocrine-alone group (74.7% vs 25.9%, p<0 . 0001; HR 0 . 16; 0 . 12-0.20). After 5 years, urinary, rectal, and sexual problems were slightly more frequent in the endocrine plus radiotherapy group. Interpretation In patients with locally advanced or high-risk local prostate cancer, addition of local radiotherapy to endocrine treatment halved the 10-year prostate-cancer-specific mortality, and substantially decreased overall mortality with fully acceptable risk of side-effects compared with endocrine treatment alone. in the light of these data, endocrine treatment plus radiotherapy should be the new standard. Funding Schering-Plough, Abbott Scandinavia, Nordic Cancer Union, Swedish Cancer Society (070604), Norwegian Cancer Society, Lions Cancer Foundation, and Umea University.	[Widmark, Anders; Fransson, Per] Umea Univ, Dept Radiat Sci Oncol, S-90185 Umea, Sweden; [Klepp, Olbjorn] Alesund Hosp, Dept Oncol, Alesund, Norway; [Solberg, Arne; Lund, Jo-Asmund] Norwegian Univ Sci & Technol, Dept Med Oncol & Radiotherapy, Univ Trondheim Hosp, Dept Canc Res & Mol Med,St Olavs Hosp, N-7034 Trondheim, Norway; [Damber, Jan-Erik] Univ Gothenburg, Dept Urol, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Angelsen, Anders] Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7034 Trondheim, Norway; [Angelsen, Anders] Univ Trondheim Hosp, Dept Urol Surg, Trondheim, Norway; [Tasdemir, Ilker] Stavanger Univ Hosp, Urol Sect, Stavanger, Norway; [Hoyer, Morten] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fossa, Sophie D.] Norwegian Radium Hosp, Canc Clin, Natl Resource Ctr Long Term Studies Canc, Rikshosp, N-0310 Oslo, Norway	Umea University; Norwegian University of Science & Technology (NTNU); University of Gothenburg; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Stavanger University Hospital; Aarhus University; Karolinska Institutet; University of Oslo; National Hospital Norway	Widmark, A (corresponding author), Umea Univ, Dept Radiat Sci Oncol, S-90185 Umea, Sweden.	Anders.Widmark@onkologi.umu.se	Fransson, Per/AAD-8906-2020; Høyer, Morten/AAT-7058-2021	Fransson, Per/0000-0002-1248-5581; Høyer, Morten/0000-0001-8609-0008	Schering-Plough Inc; Abbott Scandinavia Inc; Nordic Cancer Union; Swedish Cancer Society [070604]; Norwegian Cancer Society; Lions Cancer Foundation; Umea University	Schering-Plough Inc(Merck & CompanySchering Plough Corporation); Abbott Scandinavia Inc; Nordic Cancer Union; Swedish Cancer Society(Swedish Cancer Society); Norwegian Cancer Society(Norwegian Cancer Society); Lions Cancer Foundation; Umea University	We thank all urologists, Surgeons, and oncologists who have recruited and followed-up these patients for many years, as well as the Scandinavian Prostate Cancer Group, and the Oncology Centre in Umea. We also thank Schering-Plough Inc and Abbott Scandinavia Inc for their unrestricted grants. We are grateful to the Nordic Cancer Union, Swedish Cancer Society (070604), Norwegian Cancer Society, Lions Cancer Foundation, and Umea University for their financial support.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Aus G, 2002, BJU INT, V90, P561, DOI 10.1046/j.1464-410X.2002.02982.x; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; BocconGibod L, 1997, EUR UROL, V32, P391, DOI 10.1159/000480795; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Boustead G, 2007, BJU INT, V99, P1383, DOI 10.1111/j.1464-410X.2007.06802.x; D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; D'Amico AV, 2007, CANCER-AM CANCER SOC, V110, P1723, DOI 10.1002/cncr.22972; Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470-2045(07)70143-2; Fransson P, 2001, CANCER-AM CANCER SOC, V92, P3111, DOI 10.1002/1097-0142(20011215)92:12<3111::AID-CNCR10160>3.0.CO;2-E; Granfors T, 2006, J UROLOGY, V176, P544, DOI 10.1016/j.juro.2006.03.092; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GRAY RJ, CMPRSK PACKAGE SERIA; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; Iversen P, 2000, J UROLOGY, V164, P1579, DOI 10.1016/S0022-5347(05)67032-2; Iversen P, 1998, UROLOGY, V51, P389, DOI 10.1016/S0090-4295(98)00004-1; Iversen P, 2002, EUR UROL, V42, P204, DOI 10.1016/S0302-2838(02)00311-1; Iversen P, 2006, SCAND J UROL NEPHROL, V40, P441, DOI 10.1080/00365590601017329; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kuban DA, 2008, INT J RADIAT ONCOL, V70, P67, DOI 10.1016/j.ijrobp.2007.06.054; Lawton CA, 2007, INT J RADIAT ONCOL, V69, P646, DOI 10.1016/j.ijrobp.2007.04.003; Mavroidis P, 2005, STRAHLENTHER ONKOL, V181, P293, DOI 10.1007/s00066-005-1313-y; McLeod DG, 2006, BJU INT, V97, P247, DOI 10.1111/j.1464-410X.2005.06051.x; Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6; Pilepich MV, 2005, INT J RADIAT ONCOL, V61, P1285, DOI 10.1016/j.ijrobp.2004.08.047; Pirl WF, 2008, PSYCHO-ONCOL, V17, P148, DOI 10.1002/pon.1206; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Roach M, 2003, J CLIN ONCOL, V21, P1904, DOI 10.1200/JCO.2003.05.004; Roach M, 2007, J CLIN ONCOL, V25, P5325, DOI 10.1200/JCO.2007.13.9931; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Tsai HK, 2007, J NATL CANCER I, V99, P1516, DOI 10.1093/jnci/djm168; Widmark A, 2003, UROLOGY, V61, P145, DOI 10.1016/S0090-4295(02)02107-6; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	34	647	659	0	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					301	308		10.1016/S0140-6736(08)61815-2	http://dx.doi.org/10.1016/S0140-6736(08)61815-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	398JJ	19091394				2022-12-28	WOS:000262728100025
J	Yarbrough, ML; Li, Y; Kinch, LN; Grishin, NV; Ball, HL; Orth, K				Yarbrough, Melanie L.; Li, Yan; Kinch, Lisa N.; Grishin, Nick V.; Ball, Haydn L.; Orth, Kim			AMPylation of Rho GTPases by Vibrio VopS Disrupts Effector Binding and Downstream Signaling	SCIENCE			English	Article							III SECRETION SYSTEM; PARAHAEMOLYTICUS; PROTEIN; ACTIVATION	The Vibrio parahaemolyticus type III effector VopS is implicated in cell rounding and the collapse of the actin cytoskeleton by inhibiting Rho guanosine triphosphatases ( GTPases). We found that VopS could act to covalently modify a conserved threonine residue on Rho, Rac, and Cdc42 with adenosine 5 '- monophosphate ( AMP). The resulting AMPylation prevented the interaction of Rho GTPases with downstream effectors, thereby inhibiting actin assembly in the infected cell. Eukaryotic proteins were also directly modified with AMP, potentially expanding the repertoire of posttranslational modifications for molecular signaling.	[Yarbrough, Melanie L.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Li, Yan; Ball, Haydn L.] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Li, Yan; Ball, Haydn L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021; Yarbrough, Melanie/T-4078-2019	Orth, Kim/0000-0002-0678-7620; Kinch, Lisa/0000-0003-3041-2615; Yarbrough, Melanie/0000-0003-2166-7552	NIH-Allergy and Infectious Disease [R01-AI056404]; Welch Foundation [I-1561, I-1505]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER	NIH-Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Alto, R. Taussig, P. Sternweis, S. Mukherjee, M. Rosen, E. Olson, J. Goldstein, M. Brown, T. Iida, T. Honda, L. McCarter, and the Orth lab for insightful discussions, critical reading, and/or generous supply of reagents. K.O. and M.L.Y. are supported by grants from NIH-Allergy and Infectious Disease (R01-AI056404) and the Welch Foundation (I-1561). L.N.K. and N.G. are supported by the Welch Foundation (I-1505) and Howard Hughes Medical Institute. K.O. is a Beckman Young Investigator, Burroughs Wellcome Investigator, and W. W. Caruth Biomedical Scholar.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Burdette DL, 2008, P NATL ACAD SCI USA, V105, P12497, DOI 10.1073/pnas.0802773105; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; CHOCK PB, 1980, ANNU REV BIOCHEM, V49, P813, DOI 10.1146/annurev.bi.49.070180.004121; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; UTSUMI R, 1982, J BACTERIOL, V151, P807, DOI 10.1128/JB.151.2.807-812.1982	14	283	303	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					269	272		10.1126/science.1166382	http://dx.doi.org/10.1126/science.1166382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19039103				2022-12-28	WOS:000262290600043
J	Li, Y; Guo, Q; Kalb, JA; Thompson, CV				Li, Y.; Guo, Q.; Kalb, J. A.; Thompson, C. V.			Matching Glass-Forming Ability with the Density of the Amorphous Phase	SCIENCE			English	Article							BULK METALLIC-GLASS; FREE-VOLUME MODEL; CU-ZR; MECHANICAL-PROPERTIES; ATOMIC PACKING; TRANSITION; ALLOYS; VISCOSITY; STABILITY	The density of the amorphous phase of metals is generally thought to be related to glass formation, but this correlation has not been demonstrated experimentally to date. In this work, systematic deflection measurements using microcantilevers and a combinatorial deposition method show a correlation between glass- forming ability and the density change upon crystallization over a broad compositional range in the copper- zirconium binary system. Distinct peaks in the density of the amorphous phase were found to correlate with specific maxima in the critical thickness for glass formation. Our findings provide quantitative data for the development of structural models of liquids that are readily quenched to the amorphous state. The experimental method developed in this work can facilitate the search for new glass- forming alloys.	[Li, Y.; Guo, Q.; Kalb, J. A.; Thompson, C. V.] Singapore MIT Alliance, Singapore 117576, Singapore; [Li, Y.; Guo, Q.] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117576, Singapore; [Kalb, J. A.; Thompson, C. V.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT)	Li, Y (corresponding author), Singapore MIT Alliance, 4 Engineering Dr 3, Singapore 117576, Singapore.	mseliy@nus.edu.sg; cthomp@mit.edu	Guo, Qiang/D-6389-2012; Li, Y/J-9029-2016; Fanli, Kong/C-1528-2008; Li, Yi/K-8838-2012	Li, Y/0000-0001-7123-681X; Li, Yi/0000-0001-7123-681X	Alexander-von-Humboldt Foundation	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation)	Q.G. acknowledges the Singapore-MIT Alliance for a graduate student fellowship and J.A.K. acknowledges partial financial support from the Alexander-von-Humboldt Foundation. We thank C. Sow for help with optical microscopy and G. Chen for help with the furnace annealing experiments.	ALTOUNIAN Z, 1982, J APPL PHYS, V53, P4755, DOI 10.1063/1.331304; ALTOUNIAN Z, 1983, PHYS REV B, V27, P4149, DOI 10.1103/PhysRevB.27.4149; Busch R, 2007, MRS BULL, V32, P620, DOI 10.1557/mrs2007.122; CALVAYRAC Y, 1983, PHILOS MAG B, V48, P323, DOI 10.1080/13642818308246485; COHEN MH, 1979, PHYS REV B, V20, P1077, DOI 10.1103/PhysRevB.20.1077; DAVIS LA, 1976, SCRIPTA METALL MATER, V10, P937, DOI 10.1016/0036-9748(76)90217-9; Egami T, 2007, J ALLOY COMPD, V434, P110, DOI 10.1016/j.jallcom.2006.08.252; EGAMI T, 1984, J NON-CRYST SOLIDS, V64, P113, DOI 10.1016/0022-3093(84)90210-2; Faupel F, 2003, REV MOD PHYS, V75, P237, DOI 10.1103/RevModPhys.75.237; Floro JA, 2001, J APPL PHYS, V89, P4886, DOI 10.1063/1.1352563; Greer AL, 2007, MRS BULL, V32, P611, DOI 10.1557/mrs2007.121; Hu X, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.172201; Inoue A, 2004, MATER TRANS, V45, P584, DOI 10.2320/matertrans.45.584; Inoue A, 1998, MATER T JIM, V39, P318, DOI 10.2320/matertrans1989.39.318; Inoue A, 2007, MRS BULL, V32, P651, DOI 10.1557/mrs2007.128; Kalb JA, 2008, J MICROELECTROMECH S, V17, P1094, DOI 10.1109/JMEMS.2008.928708; Lee JC, 2007, J MATER RES, V22, P3087, DOI [10.1557/jmr.2007.0382, 10.1557/JMR.2007.0382]; Ma D, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1922570; Mattern N, 2008, J NON-CRYST SOLIDS, V354, P1054, DOI 10.1016/j.jnoncrysol.2007.08.035; Mayr SG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.036105; Miracle DB, 2006, ACTA MATER, V54, P4317, DOI 10.1016/j.actamat.2006.06.002; Miracle DB, 2003, PHILOS MAG, V83, P2409, DOI 10.1080/1478643031000098828; Mukherjee S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.245501; Mukherjee S, 2004, ACTA MATER, V52, P3689, DOI 10.1016/j.actamat.2004.04.023; Shen TD, 1999, J MATER RES, V14, P2107, DOI 10.1557/JMR.1999.0285; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Tang MB, 2004, CHINESE PHYS LETT, V21, P901, DOI 10.1088/0256-307X/21/5/039; TURNBULL D, 1970, J CHEM PHYS, V52, P3038, DOI 10.1063/1.1673434; TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405; TURNBULL D, 1961, J CHEM PHYS, V34, P120, DOI 10.1063/1.1731549; Wang D, 2004, APPL PHYS LETT, V84, P4029, DOI 10.1063/1.1751219; Xu DH, 2004, ACTA MATER, V52, P2621, DOI 10.1016/j.actamat.2004.02.009; YAVARI AR, 1983, PHYS LETT A, V95, P165, DOI 10.1016/0375-9601(83)90825-3; Yavari AR, 1999, MATER RES SOC SYMP P, V554, P21	34	291	296	9	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1816	1819		10.1126/science.1163062	http://dx.doi.org/10.1126/science.1163062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095935				2022-12-28	WOS:000261799400046
J	Amos, LA				Amos, Linda A.			BIOCHEMISTRY Pressing Levers or Pulling Strings?	SCIENCE			English	Editorial Material							MICROTUBULE-BINDING DOMAIN; DYNEIN		[Amos, Linda A.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Amos, LA (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	laa@mrc-lmb.cam.ac.uk		Amos, Linda/0000-0001-8305-5346	MRC [MC_U105184313] Funding Source: UKRI; Medical Research Council [MC_U105184313] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Numata N, 2008, BIOCHEM SOC T, V36, P131, DOI 10.1042/BST0360131; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; UENO H, 2007, BIOPHYSICS S1, V47, pS155	9	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1647	1648		10.1126/science.1168178	http://dx.doi.org/10.1126/science.1168178			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074338				2022-12-28	WOS:000261608300032
J	Lawton, BA; Rose, SB; Elley, CR; Dowell, AC; Fenton, A; Moyes, SA				Lawton, Beverley A.; Rose, Sally B.; Elley, C. Raina; Dowell, Anthony C.; Fenton, Anna; Moyes, Simon A.			Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-HEALTH-CARE; PHYSICAL-ACTIVITY; LIFE-STYLE; GENERAL-PRACTICE; BLOOD-PRESSURE; INTERVENTION; PREVENTION; RISK	Objective To assess the effectiveness of a primary care based programme of exercise on prescription among relatively inactive women over a two year period. Design Randomised controlled trial. Setting 17 primary care practices in Wellington, New Zealand. Participants 1089 women aged 40- 74 not undertaking 30 minutes of moderate intensity physical activity on at least five days of the week. Intervention Brief physical activity intervention led by nurse with six month follow- up visit and monthly telephone support over nine months. Main outcome measure Physical activity assessed at baseline and 12 and 24 months. Secondary outcomes were quality of life ( SF- 36), weight, waist circumference, blood pressure, concentrations of fasting serum lipids, glycated haemoglobin ( HbA(1c)), glucose, insulin, and physical fitness. Results Mean age was 58.9 ( SD 7) years. Trial retention rates were 93% and 89% at 12 and 24 months, respectively. At baseline, 10% of intervention participants and 11% of control participants were achieving 150 minutes of at least moderate intensity physical activity a week. At 12 months rates increased to 43% and 30% and at 24 months to 39.3% and 32.8% ( P< 0.001), respectively. SF- 36 physical functioning ( P= 0.03) and mental health ( P< 0.05) scores improved more in intervention compared with control participants, but role physical scores were significantly lower ( P< 0.01). There were no significant differences in clinical outcomes. More falls ( P< 0.001) and injuries ( P= 0.03) were recorded in the intervention group. Conclusions This programme of exercise on prescription increased physical activity and quality of life over two years, although falls and injuries also increased. This finding supports the use of exercise on prescription programmes as part of population strategies to reduce physical inactivity. Trial registration Australian New Zealand Clinical Trials Registry (ANZCTR) ANZCTRN012605000490673.	[Lawton, Beverley A.; Rose, Sally B.; Dowell, Anthony C.] Univ Otago, Womens Hlth Res Ctr, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand; [Elley, C. Raina; Moyes, Simon A.] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Sch Populat Hlth, Auckland 1, New Zealand; [Fenton, Anna] Christchurch Womens Hosp, Christchurch, New Zealand	University of Otago; University of Auckland	Lawton, BA (corresponding author), Univ Otago, Womens Hlth Res Ctr, Dept Primary Hlth Care & Gen Practice, POB 7343, Wellington, New Zealand.	Bev.Lawton@otago.ac.nz	Moyes, Simon A/D-2574-2017	Moyes, Simon A/0000-0001-9580-1545	National Heart Foundation of New Zealand [1091, 1222]; Lottery Health Research Grants Board; Hutt Valley District Health Board; Sport and Recreation New Zealand; Maori Health Directorate (Ministry of Health)	National Heart Foundation of New Zealand; Lottery Health Research Grants Board; Hutt Valley District Health Board; Sport and Recreation New Zealand; Maori Health Directorate (Ministry of Health)	This work was supported by the National Heart Foundation of New Zealand (grant number 1091 and grant-in-aid numbers 1091 and 1222), the Lottery Health Research Grants Board, the Hutt Valley District Health Board, Sport and Recreation New Zealand, and the Maori Health Directorate ( Ministry of Health).	Canadian Society for Exercise Physiology, 2002, PHYS ACT READ QUEST; CHAUDHURY M, 2006, CARDIOVASCULAR DIS R, V1, P111; Chief Medical Officer, 2004, LEAST 5 WEEK EV IMP; Colditz GA, 2002, CANCER CAUSE CONTROL, V13, P199, DOI 10.1023/A:1015040702565; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dalziel K, 2006, AUST NZ J PUBL HEAL, V30, P57, DOI 10.1111/j.1467-842X.2006.tb00087.x; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Elley CR, 2003, PREV MED, V37, P342, DOI 10.1016/S0091-7435(03)00142-7; Elley Raina, 2004, N Z Med J, V117, pU1216; Fox KR, 1999, PUBLIC HEALTH NUTR, V2, P411, DOI 10.1017/S1368980099000567; Hillsdon M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003180.pub.2; Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; McLean G, 2004, NZ PHYS ACTIVITY QUE; MOY K, 2003, VALIDATION MOH SHORT; NICE, 2006, RAP REV EFF EX REF S; *NZ SPORT RECR NZ, 2008, WHAT AR GREEN PRESCR; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Rose Sally, 2004, N Z Med J, V117, pU1206; Rose SB, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-166; Rose Sally B, 2008, N Z Med J, V121, pU2897; Salmond C, 1998, AUST NZ J PUBL HEAL, V22, P835, DOI 10.1111/j.1467-842X.1998.tb01505.x; Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; Sorensen JB, 2006, SCAND J PRIM HEALTH, V24, P69, DOI 10.1080/02813430600700027; *SPORT RECR NZ, GREEN PRESCR; Stevens W, 1998, BRIT J SPORT MED, V32, P236, DOI 10.1136/bjsm.32.3.236; Tsai JC, 2004, CLIN EXP HYPERTENS, V26, P255, DOI 10.1081/CEH-120030234; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; VANAALST I, 2003, SPARC FACTS RESULTS; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	36	126	126	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2008	337								a2509	10.1136/bmj.a2509	http://dx.doi.org/10.1136/bmj.a2509			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CB	19074218	hybrid, Green Published			2022-12-28	WOS:000262776900002
J	Risk, JM; Macknight, RC; Day, CL				Risk, Joanna M.; Macknight, Richard C.; Day, Catherine L.			FCA does not bind abscisic acid	NATURE			English	Letter							FLOWERING-TIME; PROTEIN FCA; ARABIDOPSIS; RECEPTOR; PURIFICATION; FY		[Risk, Joanna M.; Macknight, Richard C.; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago	Risk, JM (corresponding author), Univ Otago, Dept Biochem, Dunedin 9054, New Zealand.	catherine.day@otago.ac.nz	Risk, Joanna/A-1998-2010	Macknight, Richard/0000-0003-1146-9042; Day, Catherine/0000-0003-1571-4367; Macknight, Richard/0000-0002-3300-7124				Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Marquardt S, 2006, J EXP BOT, V57, P3379, DOI 10.1093/jxb/erl073; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Razem FA, 2004, J BIOL CHEM, V279, P9922, DOI 10.1074/jbc.M311064200; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Zhang DP, 2002, PLANT PHYSIOL, V128, P714, DOI 10.1104/pp.010531	14	34	37	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223								10.1038/nature07646	http://dx.doi.org/10.1038/nature07646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19078995				2022-12-28	WOS:000261559900061
J	Sokol, DK				Sokol, Daniel K.			Paving the way for assisted suicide	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London, Univ London St Georges Hosp, London WC1E 7HU, England	St Georges University London; University of London	Sokol, DK (corresponding author), Univ London, Univ London St Georges Hosp, London WC1E 7HU, England.	daniel.sokol@talk21.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2008	337								a3010	10.1136/bmj.a3010	http://dx.doi.org/10.1136/bmj.a3010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CB	19074231				2022-12-28	WOS:000262776900018
J	Choi, H; Sell, RL; Lenert, L; Muennig, P; Goodman, RR; Gilliam, FG; Wong, JB				Choi, Hyunmi; Sell, Randall L.; Lenert, Leslie; Muennig, Peter; Goodman, Robert R.; Gilliam, Frank G.; Wong, John B.			Epilepsy Surgery for Pharmacoresistant Temporal Lobe Epilepsy A Decision Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUDDEN UNEXPECTED DEATH; MEDICALLY REFRACTORY EPILEPSY; LIFE EXPECTANCY; RISK-FACTOR; MORTALITY; LOBECTOMY; PREDICTORS; PROGNOSIS; OUTCOMES; THERAPY	Context Patients with pharmacoresistant epilepsy have increased mortality compared with the general population, but patients with pharmacoresistant temporal lobe epilepsy who meet criteria for surgery and who become seizure- free after anterior temporal lobe resection have reduced excess mortality vs those with persistent seizures. Objective To quantify the potential survival benefit of anterior temporal lobe resection for patients with pharmacoresistant temporal lobe epilepsy vs continued medical management. Design Monte Carlo simulation model that incorporates possible surgical complications and seizure status, with 10 000 runs. The model was populated with health-related quality- of- life data obtained directly from patients and data from the medical literature. Insufficient data were available to assess gamma- knife radiosurgery or vagal nerve stimulation. Main Outcome Measures Life expectancy and quality- adjusted life expectancy. Results Compared with medical management, anterior temporal lobe resection for a 35- year- old patient with an epileptogenic zone identified in the anterior temporal lobe would increase survival by 5.0 years ( 95% CI, 2.1- 9.2) with surgery preferred in 100% of the simulations. Anterior temporal lobe resection would increase qualityadjusted life expectancy by 7.5 quality- adjusted life- years ( 95%, CI, - 0.8 to 17.4) with surgery preferred in 96.5% of the simulations, primarily due to increased years spent without disabling seizures, thereby reducing seizure- related excess mortality and improving quality of life. The results were robust to sensitivity analyses. Conclusion The decision analysis model suggests that on average anterior temporal lobe resection should provide substantial gains in life expectancy and qualityadjusted life expectancy for surgically eligible patients with pharmacoresistant temporal lobe epilepsy compared with medical management.	[Choi, Hyunmi; Gilliam, Frank G.] Columbia Univ, Dept Neurol, New York, NY USA; [Goodman, Robert R.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Muennig, Peter] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; [Sell, Randall L.] Drexel Univ, Sch Publ Hlth, Dept Community Hlth & Prevent, Philadelphia, PA 19104 USA; [Lenert, Leslie] Ctr Dis Control & Prevent, Natl Ctr Publ Hlth Informat, Atlanta, GA USA; [Wong, John B.] Tufts Univ, Sch Med, Dept Med, Div Clin Decis Making,Tufts Med Ctr, Boston, MA 02111 USA	Columbia University; Columbia University; Columbia University; Drexel University; Centers for Disease Control & Prevention - USA; Tufts Medical Center; Tufts University	Choi, H (corresponding author), Neurol Inst, Columbia Comprehens Epilepsy Ctr, 710 W 168Th St,Box 210, New York, NY 10032 USA.	hc323@columbia.edu		Wong, John/0000-0003-4203-9010; Muennig, Peter/0000-0002-4234-0498	National Center for Research Resources [KL2 RR024157]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157, K12RR017648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS047551] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This publication was made possible by grant KL2 RR024157 (Dr Choi) from the National Center for Research Resources, a component of the National Institutes of Health, and NIH Roadmap for Medical Research.	Annegers JF, 1998, EPILEPSIA, V39, P206, DOI 10.1111/j.1528-1157.1998.tb01360.x; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; BAILEY P, 1951, JAMA-J AM MED ASSOC, V145, P365, DOI 10.1001/jama.1951.02920240001001; Benbadis SR, 2003, SEIZURE-EUR J EPILEP, V12, P167, DOI 10.1016/S1059-1311(02)00320-5; Burneo JG, 2008, SEIZURE-EUR J EPILEP, V17, P314, DOI 10.1016/j.seizure.2007.10.002; Burneo JG, 2006, ARCH NEUROL-CHICAGO, V63, P1106, DOI 10.1001/archneur.63.8.1106; Choi H, 2008, EPILEPSIA, V49, P1440, DOI 10.1111/j.1528-1167.2008.01601.x; DASHEIFF RM, 1991, J CLIN NEUROPHYSIOL, V8, P216, DOI 10.1097/00004691-199104000-00010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Gennaro G, 2004, CLIN NEUROPHYSIOL, V115, P1212, DOI 10.1016/j.clinph.2003.12.008; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DUCHOWNY MSH, 2008, EPILEPSY COMPREHENSI, V2, P1751; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Engel J, 1999, ARCH NEUROL-CHICAGO, V56, P1338, DOI 10.1001/archneur.56.11.1338; ENGEL J, 1993, NEUROLOGY, V43, P1612, DOI 10.1212/WNL.43.8.1612; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 1998, NEUROLOGY, V51, P1243, DOI 10.1212/WNL.51.5.1243; Engel J, 2008, EPILEPSY COMPREHENSI, V2; Engel Jerome Jr., 1993, P609; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Gilliam F, 1999, NEUROLOGY, V53, P687, DOI 10.1212/WNL.53.4.687; GOLDMAN L, 1988, NEW ENGL J MED, V319, P152, DOI 10.1056/NEJM198807213190306; Hakimi AS, 2008, EPILEPSY BEHAV, V13, P96, DOI 10.1016/j.yebeh.2008.02.003; Hennessy MJ, 1999, NEUROLOGY, V53, P1276, DOI 10.1212/WNL.53.6.1276; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Janszky J, 2005, BRAIN, V128, P395, DOI 10.1093/brain/awh358; Jeha LE, 2006, NEUROLOGY, V66, P1938, DOI 10.1212/01.wnl.0000219810.71010.9b; Jeong SW, 2005, EPILEPSIA, V46, P1273, DOI 10.1111/j.1528-1167.2005.33504.x; Kelemen A, 2006, SEIZURE-EUR J EPILEP, V15, P49, DOI 10.1016/j.seizure.2005.10.007; Kelley K, 2005, NEUROLOGY, V64, P1974, DOI 10.1212/01.WNL.0000163998.01543.CF; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Langan Y, 2005, NEUROLOGY, V64, P1131, DOI 10.1212/01.WNL.0000156352.61328.CB; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; LEE BI, 2004, NEUROL ASIA, V9, P47; Lhatoo SD, 2003, EPILEPSIA, V44, P673, DOI 10.1046/j.1528-1157.2003.46002.x; Markand ON, 2000, EPILEPSIA, V41, P749, DOI 10.1111/j.1528-1157.2000.tb00238.x; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Mohanraj R, 2006, EUR J NEUROL, V13, P277, DOI 10.1111/j.1468-1331.2006.01215.x; MUENNIG P, 2002, DESIGNIGN CONDUCTING; NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462; Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005; Nilsson L, 2003, EPILEPSIA, V44, P575, DOI 10.1046/j.1528-1157.2003.03302.x; Pasta DJ, 1999, MED DECIS MAKING, V19, P353, DOI 10.1177/0272989X9901900314; PENFIELD W, 1950, AMA ARCH NEUROL PSY, V64, P491, DOI 10.1001/archneurpsyc.1950.02310280003001; Ryvlin P, 2003, EPILEPSY RES, V56, P105, DOI 10.1016/j.eplepsyres.2003.10.001; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; Salanova V, 2002, EPILEPSIA, V43, P170, DOI 10.1046/j.1528-1157.2002.33800.x; Schwartz TH, 2006, EPILEPSIA, V47, P567, DOI 10.1111/j.1528-1167.2006.00469.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Spencer SS, 2005, NEUROLOGY, V65, P912, DOI 10.1212/01.wnl.0000176055.45774.71; Spencer SS, 2003, NEUROLOGY, V61, P1680, DOI 10.1212/01.WNL.0000098937.35486.A3; Spencer SS, 2008, NEUROLOGY, V70, P1654, DOI 10.1212/01.wnl.0000311272.33720.6b; Sperling MR, 2004, CNS SPECTRUMS, V9, P98, DOI 10.1017/S1092852900008464; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; Sperling MR, 2004, CNS SPECTRUMS, V9, P106, DOI DOI 10.1017/S1092852900008464; Stephen LJ, 2006, EPILEPSY BEHAV, V8, P434, DOI 10.1016/j.yebeh.2005.11.007; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; TSEVAT J, 1991, CIRCULATION, V83, P1194, DOI 10.1161/01.CIR.83.4.1194; Uijl SG, 2008, EPILEPSIA, V49, P1317, DOI 10.1111/j.1528-1167.2008.01695.x; Walczak TS, 2001, EPILEPSIA, V42, P804; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wiebe S, 2000, CAN J NEUROL SCI, V27, pS6, DOI 10.1017/S0317167100000561; Wiebe S, 2006, CAN J NEUROL SCI, V33, P365, DOI 10.1017/S031716710000531X; WONG JB, 1990, ANN INTERN MED, V113, P852, DOI 10.7326/0003-4819-113-11-852; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606	68	129	135	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2497	2505		10.1001/jama.2008.771	http://dx.doi.org/10.1001/jama.2008.771			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050193	Bronze			2022-12-28	WOS:000261286200018
J	Watts, G				Watts, Geoff			Regeneration games	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Bartunek J, 2006, EUR HEART J, V27, P1338, DOI 10.1093/eurheartj/ehi793; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1	3	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2008	337								a1321	10.1136/bmj.a1321	http://dx.doi.org/10.1136/bmj.a1321			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NW	19052067				2022-12-28	WOS:000261890900004
J	Akhmanova, A; Yap, AS				Akhmanova, Anna; Yap, Alpha S.			Organizing Junctions at the Cell-Cell Interface	CELL			English	Editorial Material							MINUS END; CADHERIN	The zonula adherens (ZA) is a specialized cadherin-based structure found at the contacts between epithelial cells. Meng et al. (2008) now identify a protein complex containing the microtubule minusend-binding protein Nezha, which provides a critical link between microtubules and cadherins in ZA biogenesis and maintenance.	[Akhmanova, Anna] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Yap, Alpha S.] Univ Queensland, Mol Cell Biol Div, Inst Mol Biosci, Brisbane, Qld, Australia	Erasmus University Rotterdam; Erasmus MC; University of Queensland	Akhmanova, A (corresponding author), Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.	a.akhmanova@erasmusmc.nl; a.yap@imb.uq.edu.au	Yap, Alpha S./J-1554-2014; Akhmanova, Anna S/B-8896-2011	Yap, Alpha S./0000-0002-1038-8956; Akhmanova, Anna S/0000-0002-9048-8614				Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471	9	10	10	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					791	793		10.1016/j.cell.2008.11.002	http://dx.doi.org/10.1016/j.cell.2008.11.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041742	Bronze			2022-12-28	WOS:000261183900009
J	Michelson, AM				Michelson, Alan M.			DEVELOPMENTAL BIOLOGY From Genetic Association to Genetic Switch	SCIENCE			English	Editorial Material							SICKLE-CELL-DISEASE; FETAL-HEMOGLOBIN; COMMON; BCL11A		[Michelson, Alan M.] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Michelson, AM (corresponding author), NHLBI, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA.	michelsonam@mail.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005703, Z01HL005703] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Higgs DR, 2008, P NATL ACAD SCI USA, V105, P11595, DOI 10.1073/pnas.0806633105; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105	11	5	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1803	1804		10.1126/science.1169216	http://dx.doi.org/10.1126/science.1169216			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095932				2022-12-28	WOS:000261799400043
J	Scheffler, R; Bodenheimer, T; Lombardo, P; Starfield, B; Morris, W; Treadway, K; Woodson, G; Goroll, AH; Hartstein, A; Lee, TH				Scheffler, Richard; Bodenheimer, Thomas; Lombardo, Paul; Starfield, Barbara; Morris, Walter; Treadway, Katharine; Woodson, Grattan; Goroll, Allan H.; Hartstein, Alan; Lee, Thomas H.			The Future of Primary Care-The Community Responds	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Scheffler, Richard] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Lombardo, Paul] SUNY Stony Brook, Dept Phys Assistant Educ, Stony Brook, NY 11794 USA; [Morris, Walter] Pinehurst Med Clin, Pinehurst, NC USA	University of California System; University of California Berkeley; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scheffler, R (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.								0	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2636	2639						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384PS	19092149				2022-12-28	WOS:000261757300003
J	Scrivani, SJ; Keith, DA; Kaban, LB				Scrivani, Steven J.; Keith, David A.; Kaban, Leonard B.			Medical Progress: Temporomandibular Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OCCLUSAL VARIABLES; PHYSICAL-THERAPY; MYOFASCIAL PAIN; JOINT DISORDERS; OROFACIAL PAIN; DOUBLE-BLIND; SYMPTOMS; PLACEBO; EFFICACY; OSTEOARTHRITIS		[Keith, David A.; Kaban, Leonard B.] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA; [Keith, David A.] Harvard Vanguard Med Assoc, Boston, MA USA; [Scrivani, Steven J.] Tufts Univ, Sch Dent Med, Craniofacial Pain & Headache Ctr, Boston, MA 02111 USA	Harvard University; Massachusetts General Hospital; Harvard Vanguard Medical Associates; Tufts University	Kaban, LB (corresponding author), Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, 55 Fruit St,Warren Bldg,Suite 1201, Boston, MA 02114 USA.	lkaban@partners.org			GlaxoSmithKline and Endo Pharmaceuticals; AO-Sythes Massachusetts General Hospital Pediatric Oral and Maxillofacial Surgery Fellowship	GlaxoSmithKline and Endo Pharmaceuticals; AO-Sythes Massachusetts General Hospital Pediatric Oral and Maxillofacial Surgery Fellowship	Dr. Scrivani reports receiving grant support from GlaxoSmithKline and Endo Pharmaceuticals. Dr. Kaban reports receiving grant support for fellows in his unit who hold AO-Sythes Massachusetts General Hospital Pediatric Oral and Maxillofacial Surgery Fellowship Grants. No other potential conflict of interest relevant to this article was reported.	Al-Ani Ziad, 2005, J Dent Educ, V69, P1242; ALANI Z, 2004, COCHRANE DB SYST REV, V1; Auerbach SM, 2001, J ORAL MAXIL SURG, V59, P628, DOI 10.1053/joms.2001.23371; Bhalang K, 2005, J PAIN, V6, P604, DOI 10.1016/j.jpain.2005.04.006; Bjornland T, 2007, J ORAL REHABIL, V34, P583, DOI 10.1111/j.1365-2842.2007.01759.x; Bragdon EE, 2002, PAIN, V96, P227, DOI 10.1016/S0304-3959(01)00451-1; Campbell LC, 2000, J OROFAC PAIN, V14, P112; CISNEROS GJ, 1984, J ORAL MAXIL SURG, V42, P513, DOI 10.1016/0278-2391(84)90010-7; Costen JB, 1934, ANN OTO RHINOL LARYN, V43, P1, DOI DOI 10.1177/000348943404300101; CRAANE B, 2008, COCHRANE DB SYST REV, V4; Crider A, 2005, APPL PSYCHOPHYS BIOF, V30, P333, DOI 10.1007/s10484-005-8420-5; Dao TTT, 1998, CRIT REV ORAL BIOL M, V9, P345, DOI 10.1177/10454411980090030701; De Laat A, 2003, J OROFAC PAIN, V17, P42; de Leeuw R, 2006, J ORAL MAXIL SURG, V64, P158, DOI 10.1016/j.joms.2005.10.006; de Leeuw R, 2005, ORAL SURG ORAL MED O, V100, P308, DOI 10.1016/j.tripleo.2004.11.014; de Leeuw R, 2005, ORAL SURG ORAL MED O, V99, P558, DOI 10.1016/j.tripleo.2004.05.016; De Leeuw R., 2008, OROFACIAL PAIN GUIDE, V4th; Denucci DJ, 1996, J AM DENT ASSOC, V127, P581, DOI 10.14219/jada.archive.1996.0270; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Diatchenko L, 2006, AM J MED GENET B, V141B, P449, DOI 10.1002/ajmg.b.30324; Dimitroulis G, 2005, INT J ORAL MAX SURG, V34, P345, DOI 10.1016/j.ijom.2004.10.013; Dionne RA, 1997, ORAL SURG ORAL MED O, V83, P134, DOI 10.1016/S1079-2104(97)90104-9; DWORKIN SF, 1990, J AM DENT ASSOC, V120, P273, DOI 10.14219/jada.archive.1990.0043; Dworkin SF, 2002, J OROFAC PAIN, V16, P207; Dworkin SF, 1996, J AM DENT ASSOC, V127, P1607, DOI 10.14219/jada.archive.1996.0094; DWORKIN SF, 1987, J AM DENT ASSOC, V115, P565, DOI 10.1016/S0002-8177(87)54009-0; Ekberg E, 2004, ACTA ODONTOL SCAND, V62, P343, DOI 10.1080/00016350410010063; Ferrando M, 2004, ORAL SURG ORAL MED O, V98, P153, DOI 10.1016/j.tripleo.2003.12.030; Fillingim Roger B., 1997, Journal of Orofacial Pain, V11, P48; FORDYCE WE, 1988, AM PSYCHOL, V43, P276, DOI 10.1037/0003-066X.43.4.276; Fricton James, 2007, Dent Clin North Am, V51, P61, DOI 10.1016/j.cden.2006.10.002; Fricton James, 2006, J Evid Based Dent Pract, V6, P48, DOI 10.1016/j.jebdp.2005.12.020; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; GURALNICK W, 1978, NEW ENGL J MED, V299, P123, DOI 10.1056/NEJM197807202990304; Hashimoto K, 2007, DENTOMAXILLOFAC RAD, V36, P465, DOI 10.1259/dmfr/22818643; Herman CR, 2002, J OROFAC PAIN, V16, P64; Horrell B M, 1997, Compend Contin Educ Dent, V18, P73; HORRELL BM, 1997, COMPEND CONTIN ED DE, V18, P80; HORRELL BM, 1997, COMPEND CONTIN ED DE, V18, P78; HUBER MA, 1990, ORAL SURG ORAL MED O, V70, P180, DOI 10.1016/0030-4220(90)90115-9; Israel HA, 1999, J ORAL MAXIL SURG, V57, P1034, DOI 10.1016/S0278-2391(99)90321-X; Israel HA, 1997, CRANIO, V15, P74, DOI 10.1080/08869634.1997.11745995; Israel HA, 1998, J ORAL MAXIL SURG, V56, P1023, DOI 10.1016/S0278-2391(98)90246-4; Israel HA, 1999, J ORAL MAXIL SURG, V57, P579, DOI 10.1016/S0278-2391(99)90079-4; Israel HA, 2006, J ORAL MAXIL SURG, V64, P1066, DOI 10.1016/j.joms.2006.03.012; KABAN LB, 1982, J ORAL MAXIL SURG, V40, P18, DOI 10.1016/S0278-2391(82)80010-4; KABAN LB, 2004, PEDIAT ORAL MAXILLOF, P372; Kerins C, 2004, J ORAL MAXIL SURG, V62, P989, DOI 10.1016/j.joms.2003.09.016; Kishi Y, 2007, J NEUROPSYCH CLIN N, V19, P90, DOI 10.1176/appi.neuropsych.19.1.90; Koh H, 2003, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/146751858.CD003812; Koslin Michael G, 2006, Oral Maxillofac Surg Clin North Am, V18, P329, DOI 10.1016/j.coms.2006.04.002; Laskin DM, 2008, J AM DENT ASSOC, V139, P124, DOI 10.14219/jada.archive.2008.0115; Levitt Stephen R., 1994, Journal of Orofacial Pain, V8, P25; Limchaichana N, 2006, ORAL SURG ORAL MED O, V102, P521, DOI 10.1016/j.tripleo.2006.02.001; List T, 2003, J OROFAC PAIN, V17, P301; Lobbezoo F, 2001, J OROFAC PAIN, V15, P340; Malki Ghadah A, 2004, J Clin Pediatr Dent, V29, P63; Manfredini D, 2004, CRANIO, V22, P234, DOI 10.1179/crn.2004.028; MAX MB, 1992, NEW ENGL J MED, V326, P1250, DOI 10.1056/NEJM199205073261904; MCCAIN JP, 1989, J ORAL MAXIL SURG, V47, P913, DOI 10.1016/0278-2391(89)90373-X; MCCAIN JP, 1992, J ORAL MAXIL SURG, V50, P926, DOI 10.1016/0278-2391(92)90047-4; MCCAIN JP, 1992, J ORAL MAXILLOFAC SU, V50, P1349; McNeely ML, 2006, PHYS THER, V86, P710, DOI 10.1093/ptj/86.5.710; Medlicott MS, 2006, PHYS THER, V86, P955, DOI 10.1093/ptj/86.7.955; MILAM SB, 1995, J ORAL MAXIL SURG, V53, P1448, DOI 10.1016/0278-2391(95)90675-4; Milam SB, 1998, J ORAL MAXIL SURG, V56, P214, DOI 10.1016/S0278-2391(98)90872-2; Nackley AG, 2007, PAIN, V128, P199, DOI 10.1016/j.pain.2006.09.022; NITZAN DW, 1990, J ORAL MAXIL SURG, V48, P798, DOI 10.1016/0278-2391(90)90335-Y; Okeson J., 2004, BELLS OROFACIAL PAIN, V6th; ONGHENA P, 1992, PAIN, V49, P205, DOI 10.1016/0304-3959(92)90144-Z; Parker Michael W., 1993, Journal of Orofacial Pain, V7, P337; Patel H, 2004, AM HEART J, V148, P27, DOI 10.1016/j.ahj.2004.03.005; PERROTT DH, 1990, J ORAL MAXIL SURG, V48, P1029, DOI 10.1016/0278-2391(90)90283-8; POGREL MA, 1985, ORAL SURG ORAL MED O, V60, P15, DOI 10.1016/0030-4220(85)90206-3; Pullinger AG, 2000, J PROSTHET DENT, V83, P66, DOI 10.1016/S0022-3913(00)70090-4; Raphael KG, 2003, J OROFAC PAIN, V17, P36; Ratcliffe A, 1998, J ORAL MAXIL SURG, V56, P204, DOI 10.1016/S0278-2391(98)90870-9; Richmond J, 1996, JAMA-J AM MED ASSOC, V276, P313; Rizzatti-Barbosa CM, 2003, CRANIO, V21, P116, DOI 10.1080/08869634.2003.11746239; Romanelli F, 1996, ANN PHARMACOTHER, V30, P1246, DOI 10.1177/106002809603001107; Rowbotham MC, 2005, PAIN, V113, P248, DOI 10.1016/j.pain.2004.11.021; Rowbotham MC, 2004, PAIN, V110, P697, DOI 10.1016/j.pain.2004.05.010; Schiffman E, 1988, TMJ CRANIOFACIAL PAI, P1; Schutz TCB, 2007, J DENT RES, V86, P475, DOI 10.1177/154405910708600516; Seligman DA, 2000, J PROSTHET DENT, V83, P76, DOI 10.1016/S0022-3913(00)70091-6; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sindrup SH, 2003, NEUROLOGY, V60, P1284, DOI 10.1212/01.WNL.0000058749.49264.BD; Singer Elyse, 1997, Journal of Orofacial Pain, V11, P139; SOLBERG WK, 1983, PRES C EX DIAGN MAN, P30; Stowell AW, 2007, J AM DENT ASSOC, V138, P202, DOI 10.14219/jada.archive.2007.0137; Sullivan Mark D, 2006, Phys Med Rehabil Clin N Am, V17, P381, DOI 10.1016/j.pmr.2005.12.006; Ta LE, 2004, PAIN, V111, P13, DOI 10.1016/j.pain.2004.04.029; Truelove E, 2006, J AM DENT ASSOC, V137, P1099, DOI 10.14219/jada.archive.2006.0348; Tsukiyama Y, 2001, J PROSTHET DENT, V86, P57, DOI 10.1067/mpr.2001.115399; Turk DC, 1997, ORAL SURG ORAL MED O, V83, P65, DOI 10.1016/S1079-2104(97)90093-7; Turner JA, 2001, PAIN, V92, P41, DOI 10.1016/S0304-3959(00)00469-3; Venancio RD, 2005, J ORAL REHABIL, V32, P800; WABEKE KB, 1994, THESIS U AMSTERDAM A, P91; Wassell RW, 2006, J AM DENT ASSOC, V137, P1089, DOI 10.14219/jada.archive.2006.0347; Wassell RW, 2006, J AM DENT ASSOC, V137, P1168; Zardeneta G, 1997, J ORAL MAXIL SURG, V55, P1242, DOI 10.1016/S0278-2391(97)90176-2	102	350	379	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2693	2705		10.1056/NEJMra0802472	http://dx.doi.org/10.1056/NEJMra0802472			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092154				2022-12-28	WOS:000261757300009
J	Falit, BP; Gross, CP				Falit, Benjamin P.; Gross, Cary P.			Access to Experimental Drugs for Terminally Ill Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Falit, Benjamin P.; Gross, Cary P.] Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, New Haven, CT 06520 USA; [Gross, Cary P.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA	Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu						DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; Krohmal BJ, 2007, ARCH INTERN MED, V167, P433, DOI 10.1001/archinte.167.5.433; STGEORGE D, 2004, WASH POST       0118, pW10; 2006, FED REG, V71, P75147	5	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2793	2795		10.1001/jama.2008.828	http://dx.doi.org/10.1001/jama.2008.828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088356				2022-12-28	WOS:000261730400025
J	Burgdorf, SK; Burcharth, J; Rosenberg, J				Burgdorf, Stefan K.; Burcharth, Jakob; Rosenberg, Jacob			Deport that student	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Burgdorf, Stefan K.; Burcharth, Jakob; Rosenberg, Jacob] Univ Copenhagen, Gentofte Hosp, Dept Surg Gastroenterol Z 2, DK-2900 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Burgdorf, SK (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Surg Gastroenterol Z 2, DK-2900 Copenhagen, Denmark.	stefan@stefanburgdorf.dk	Burcharth, Jakob/S-9147-2019	Burcharth, Jakob/0000-0001-8367-7831				Border and Immigration Agency, LIF UK TEST	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 15	2008	337								a2912	10.1136/bmj.a2912	http://dx.doi.org/10.1136/bmj.a2912			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SS	19074941				2022-12-28	WOS:000262184600009
J	Clubb, R; Rowcliffe, M; Lee, P; Mar, KU; Moss, C; Mason, GJ				Clubb, Ros; Rowcliffe, Marcus; Lee, Phyllis; Mar, Khyne U.; Moss, Cynthia; Mason, Georgia J.			Compromised Survivorship in Zoo Elephants	SCIENCE			English	Article									[Mason, Georgia J.] Univ Guelph, Dept Anim Sci, Guelph, ON N1G 2M7, Canada; [Clubb, Ros] RSPCA, Southwater RH13 9RS, W Sussex, England; [Rowcliffe, Marcus; Mar, Khyne U.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Lee, Phyllis] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Lee, Phyllis; Moss, Cynthia] Amboseli Trust Elephants, Nairobi, Kenya; [Mar, Khyne U.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Guelph; Zoological Society of London; University of Stirling; University of Sheffield	Mason, GJ (corresponding author), Univ Guelph, Dept Anim Sci, Guelph, ON N1G 2M7, Canada.	gmason@uoguelph.ca	U Mar, Khyne/AAO-8806-2021; Yon, Lisa K/G-4453-2011; Rowcliffe, Marcus/G-3713-2018	Yon, Lisa K/0000-0002-9765-3192; Rowcliffe, Marcus/0000-0002-4286-6887; Lee, Phyllis/0000-0002-4296-3513	Natural Science and Engineering Research Council; Amboseli Elephant Trust; Prospect Burma Foundation; Charles Wallace Burma Trust; Three Oaks Foundation; Whitney- Laing Foundation ( Rufford Small Grants); Toyota Foundation, Fantham Memorial Research Scholarship; University College London	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Amboseli Elephant Trust; Prospect Burma Foundation; Charles Wallace Burma Trust; Three Oaks Foundation; Whitney- Laing Foundation ( Rufford Small Grants); Toyota Foundation, Fantham Memorial Research Scholarship; University College London(General Electric)	J. M. thanks the Natural Science and Engineering Research Council for funding; R. C. and G. J. M. thank R. Ripley for statistical advice; P. L. and C. M. thank many conservation nongovernmental organizations and private donors for supporting the Amboseli Elephant Trust; K. U. M. thanks colleagues at M. T. E. for data compilation and comments. G. J. M. is a visiting professor at The Royal Veterinary College, London, UK. K. U. M. has received funding from Prospect Burma Foundation, Charles Wallace Burma Trust, Three Oaks Foundation, Whitney- Laing Foundation ( Rufford Small Grants), Toyota Foundation, Fantham Memorial Research Scholarship, and University College London. K. U. M. has been a paid consultant for Woburn Safari Park, UK. G. J. M. has been a paid consultant to Disney's Animal Kingdom, USA.	Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; *EUR EL GROUP, 2002, EL ZOOS SAF EUR; Hutchins M, 2006, ZOO BIOL, V25, P219, DOI 10.1002/zoo.20102	4	109	111	5	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1649	1649		10.1126/science.1164298	http://dx.doi.org/10.1126/science.1164298			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074339	Green Accepted, Green Submitted			2022-12-28	WOS:000261608300033
J	Minzenberg, MJ; Watrous, AJ; Yoon, JH; Ursu, S; Carter, CS				Minzenberg, Michael J.; Watrous, Andrew J.; Yoon, Jong H.; Ursu, Stefan; Carter, Cameron S.			Modanfinil Shifts Human Locus Coeruleus to Low-Tonic, High-Phasic Activity During Functional MRI	SCIENCE			English	Article							MODAFINIL IMPROVES COGNITION; PREFRONTAL CORTEX; INTEGRATIVE THEORY; DOPAMINE; NEURONS; PERFORMANCE; INHIBITION; VOLUNTEERS; ACTIVATION; MONOAMINES	Models of cognitive control posit a key modulatory role for the pontine locus coeruleus- norepinephrine (LC-NE) system. In nonhuman primates, phasic LC- NE activity confers adaptive adjustments in cortical gain in task- relevant brain networks, and in performance, on a trial- by- trial basis. This model has remained untested in humans. We used the pharmacological agent modafinil to promote low- tonic/ high- phasic LC- NE activity in healthy humans performing a cognitive control task during event- related functional magnetic resonance imaging ( fMRI). Modafanil administration was associated with decreased task- independent, tonic LC activity, increased task- related LC and prefrontal cortex ( PFC) activity, and enhanced LC- PFC functional connectivity. These results confirm in humans the role of the LC- NE system in PFC function and cognitive control and suggest a mechanism for therapeutic action of procognitive noradrenergic agents.	[Minzenberg, Michael J.; Watrous, Andrew J.; Yoon, Jong H.; Ursu, Stefan; Carter, Cameron S.] Univ Calif Davis, Sch Med, Dept Psychiat, Sacramento, CA 95817 USA	University of California System; University of California Davis	Minzenberg, MJ (corresponding author), Univ Calif Davis, Sch Med, Dept Psychiat, Sacramento, CA 95817 USA.	michael.minzenberg@ucdmc.ucdavis.edu	anand, amit/A-7222-2009		National Center for Research Resources [UL1 RR024146, MH059883]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059883] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by UL1 RR024146 from the National Center for Research Resources (NCRR) to M. J. M., and MH059883 to C. S. C. The authors have no disclosures to make.	AGHAJANIAN GK, 1982, SCIENCE, V215, P1391; Alvarez VA, 2002, P NATL ACAD SCI USA, V99, P4032, DOI 10.1073/pnas.062716299; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1991, J NEUROSCI, V11, P760; BAKER KG, 1989, EXP BRAIN RES, V77, P257, DOI 10.1007/BF00274983; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Brown E, 2004, J COMPUT NEUROSCI, V17, P13, DOI 10.1023/B:JCNS.0000023867.25863.a4; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; Coull JT, 1999, NEUROIMAGE, V10, P705, DOI 10.1006/nimg.1999.0513; DEARMOND SJ, 1918, STRUCTURE HUMAN BRAI; Eagle DM, 2007, PSYCHOPHARMACOLOGY, V192, P193, DOI 10.1007/s00213-007-0701-7; Ellis CM, 1999, J SLEEP RES, V8, P85, DOI 10.1046/j.1365-2869.1999.00142.x; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; Hou RH, 2005, PSYCHOPHARMACOLOGY, V181, P537, DOI 10.1007/s00213-005-0013-8; Ishimatsu M, 1996, J NEUROSCI, V16, P5196; Ivanov A, 1995, J NEUROPHYSIOL, V74, P2427, DOI 10.1152/jn.1995.74.6.2427; Lestienne R, 1997, J PHYSIOLOGY-PARIS, V91, P273, DOI 10.1016/S0928-4257(97)82407-2; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Mohanty A, 2008, CEREB CORTEX, V18, P2604, DOI 10.1093/cercor/bhn021; Muller U, 2004, PSYCHOPHARMACOLOGY, V177, P161, DOI 10.1007/s00213-004-1926-3; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Turner DC, 2004, NEUROPSYCHOPHARMACOL, V29, P1363, DOI 10.1038/sj.npp.1300457; Turner DC, 2004, BIOL PSYCHIAT, V55, P1031, DOI 10.1016/j.biopsych.2004.02.008; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8	34	127	129	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1700	1702		10.1126/science.1164908	http://dx.doi.org/10.1126/science.1164908			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074351				2022-12-28	WOS:000261608300047
J	Nordborg, M; Weigel, D				Nordborg, Magnus; Weigel, Detlef			Next-generation genetics in plants	NATURE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; ARABIDOPSIS-THALIANA; FLOWERING TIME; COMPLEX TRAITS; STRUCTURAL VARIATION; HAPLOTYPE MAP; MAIZE; DISEQUILIBRIUM; RECOMBINATION	Natural variation presents one of the fundamental challenges of modern biology. Soon, the genome sequences of thousands of individuals will be known for each of several species. But how does the genotypic variation that will be observed among these individuals translate into phenotypic variation? Plants are in many ways ideal for addressing this question, and resources that are unmatched, except in humans, have now been developed.	[Nordborg, Magnus] Univ So Calif, Los Angeles, CA 90089 USA; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	University of Southern California; Max Planck Society	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu; weigel@weigelworld.org	Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748	National Science Foundation; National Institutes of Health; German Research Foundation; German Federal Ministry of Education and Research; European Union's Sixth Framework Programme; Human Frontier Science Program; Max Planck Society	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union's Sixth Framework Programme; Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Studies of natural genetic variation are supported by the National Science Foundation and the National Institutes of Health (M.N.), and by the German Research Foundation, the German Federal Ministry of Education and Research, the European Union's Sixth Framework Programme, the Human Frontier Science Program and the Max Planck Society (D.W.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; East EM, 1910, AM NAT, V44, P65, DOI 10.1086/279117; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Macquet A, 2007, PLANT CELL, V19, P3990, DOI 10.1105/tpc.107.050179; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Nilsson-Ehle H, 1909, LUNDS U AARSKR, V5, P1; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sax K, 1923, GENETICS, V8, P552; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; YU J, 2006, NAT GENET, V38, P303; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	35	292	308	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					720	723		10.1038/nature07629	http://dx.doi.org/10.1038/nature07629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079047				2022-12-28	WOS:000261559900034
J	Lantman-de Valk, HMJV; Walsh, PN				Lantman-de Valk, Henny M. J. van Schrojenstein; Walsh, Patricia Noonan			Managing health problems in people with intellectual disabilities	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PSYCHIATRIC-DISORDER; GENERAL-PRACTICE; DOWN-SYNDROME; PREVALENCE; ADULTS; ADOLESCENTS; POPULATION; BEHAVIOR; POVERTY; PROGRAM		[Lantman-de Valk, Henny M. J. van Schrojenstein] Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Lantman-de Valk, Henny M. J. van Schrojenstein] Maastricht Univ, Governor Kremers Ctr, NL-6200 MD Maastricht, Netherlands; [Lantman-de Valk, Henny M. J. van Schrojenstein] Pepijn & Paulus Ctr, NL-6100 AA Echt, Netherlands; [Walsh, Patricia Noonan] Univ Coll Dublin, Ctr Disabil Studies, Sch Psychol, Dublin 2, Ireland	Maastricht University; Maastricht University; University College Dublin	Lantman-de Valk, HMJV (corresponding author), Maastricht Univ, Dept Gen Practice, POB 616, NL-6200 MD Maastricht, Netherlands.	henny.lantman@hag.unimaas.nl	van Schrojenstein Lantman-de Valk, H.M.J./H-8087-2014					Albanese A, 2007, ARCH DIS CHILD, V92, P629, DOI 10.1136/adc.2007.115709; Beavis J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005399; Bohmer CJM, 2001, J INTELL DISABIL RES, V45, P212, DOI 10.1046/j.1365-2788.2001.00300.x; Bohmer CJM, 2000, AM J GASTROENTEROL, V95, P1868, DOI 10.1111/j.1572-0241.2000.02238.x; Brown I., 2007, COMPREHENSIVE GUIDE, P335; Brylewski J, 2004, COCHRANE DATABASE SY; Cooper SA, 2006, J INTELL DISABIL RES, V50, P667, DOI 10.1111/j.1365-2788.2006.00824.x; Cooper SA, 2004, BMJ-BRIT MED J, V329, P414, DOI 10.1136/bmj.329.7463.414; Cooper SA, 2007, SOC PSYCH PSYCH EPID, V42, P530, DOI 10.1007/s00127-007-0197-9; Cooper SA, 2007, BRIT J PSYCHIAT, V190, P27, DOI 10.1192/bjp.bp.106.022483; Cumella S, 2000, J INTELL DISABIL RES, V44, P45, DOI 10.1046/j.1365-2788.2000.00252.x; *DEP HLTH, VAL PEOPL HLTH ACT P; *DEP HLTH SSAPS, 2003, SEEK CONS; Emerson E, 2007, J INTELL DISABIL RES, V51, P866, DOI 10.1111/j.1365-2788.2007.00951.x; Emerson E, 2007, MENT RETARD DEV D R, V13, P107, DOI 10.1002/mrdd.20144; EVENHUIS HM, J APPL RES IN PRESS; Havercamp SM, 2004, PUBLIC HEALTH REP, V119, P418, DOI 10.1016/j.phr.2004.05.006; Kwok H, 2007, CURR OPIN PSYCHIATR, V20, P443, DOI 10.1097/YCO.0b013e3282ab9941; Lantman-de Valk HV, 2007, J INTELL DISABIL RES, V51, P427, DOI 10.1111/j.1365-2788.2006.00890.x; Lantman-De Valk HMJV, 2000, FAM PRACT, V17, P405, DOI 10.1093/fampra/17.5.405; Lennox N., 2005, MANAGEMENT GUIDELINE; Lennox N, 2007, INT J EPIDEMIOL, V36, P139, DOI 10.1093/ije/dyl254; LINEHAN C, J APPL RES IN PRESS; Luckasson R, 2002, MENTAL RETARDATION D; Matthews T, 2008, J INTELL DISABIL RES, V52, P163, DOI 10.1111/j.1365-2788.2007.01025.x; Melville CA, 2007, OBES REV, V8, P223, DOI 10.1111/j.1467-789X.2006.00296.x; Meuwese-Jongejeugd A, 2006, INT J AUDIOL, V45, P660, DOI 10.1080/14992020600920812; Milton JC, 2008, BMJ-BRIT MED J, V336, P606, DOI 10.1136/bmj.39503.424653.80; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; Nicholson TRJ, 2008, BRIT MED J, V336, P322, DOI 10.1136/bmj.39457.485347.80; Nunn J, 2008, EUR J DENT EDUC, V12, P30, DOI 10.1111/j.1600-0579.2007.00478.x; Patja K, 2001, J INTELL DISABIL RES, V45, P300, DOI 10.1046/j.1365-2788.2001.00322.x; Prasher V, 2007, J INTELL DISABIL RES, V51, P312, DOI 10.1111/j.1365-2788.2006.00879.x; Rimmer JH, 2004, AM J MENT RETARD, V109, P165, DOI 10.1352/0895-8017(2004)109<165:IIPFIA>2.0.CO;2; Rodgers J, 2006, J APPL RES INTELLECT, V19, P364, DOI 10.1111/j.1468-3148.2006.00298.x; Schrager S, 2007, J INTELL DISABIL RES, V51, P253, DOI 10.1111/j.1365-2788.2006.00872.x; Straetmans JMJAA, 2007, BRIT J GEN PRACT, V57, P64; Strydom A, 2007, BRIT J PSYCHIAT, V191, P150, DOI 10.1192/bjp.bp.106.028845; Swender SL, 2006, J INTELLECT DEV DIS, V31, P95, DOI 10.1080/13668250600710880; Torr J, 2007, CURR OPIN PSYCHIATR, V20, P467, DOI 10.1097/YCO.0b013e328278520d; Turner S, 2008, J INTELL DISABIL RES, V52, P29, DOI 10.1111/j.1365-2788.2007.00971.x; Tyrer P, 2008, LANCET, V371, P57, DOI 10.1016/S0140-6736(08)60072-0; *US GOV, HLTH PEOPL 2010 DIS; van Blankenstein M, 2004, EUR J GASTROEN HEPAT, V16, P903, DOI 10.1097/00042737-200409000-00015; van Splunder J, 2006, EYE, V20, P1004, DOI 10.1038/sj.eye.6702059; Westerinen H, 2007, J INTELL DISABIL RES, V51, P715, DOI 10.1111/j.1365-2788.2007.00970.x; Wullink M, 2007, J INTELL DISABIL RES, V51, P511, DOI 10.1111/j.1365-2788.2006.00917.x	47	110	110	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2008	337								a2507	10.1136/bmj.a2507	http://dx.doi.org/10.1136/bmj.a2507			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399BY	19064601				2022-12-28	WOS:000262776600001
J	Nazem, AG				Nazem, Alexander G.			Teach Us How	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												alexander.nazem@yale.edu							0	5	5	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2463	2464		10.1001/jama.2008.767	http://dx.doi.org/10.1001/jama.2008.767			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050181				2022-12-28	WOS:000261286200001
J	Kang, SW; Hegde, RS				Kang, Sang-Wook; Hegde, Ramanujan S.			Lighting Up the Stressed ER	CELL			English	Editorial Material							UNFOLDED PROTEIN RESPONSE	Balancing the capacity for protein maturation with changes in protein flux through the endoplasmic reticulum (ER) is crucial for maintaining ER homeostasis. In this issue, Merksamer et al. (2008) exploit a redox-sensitive fluorescent protein to monitor the environment inside the ER of living yeast, illuminating how this organelle responds to different perturbations.	[Kang, Sang-Wook; Hegde, Ramanujan S.] Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Hegde, RS (corresponding author), Natl Inst Hlth, Bethesda, MD 20892 USA.	hegder@mail.nih.gov		Hegde, Ramanujan/0000-0001-8338-852X; Kang, Sang-Wook/0000-0002-8000-4823	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008752] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HD008752-08] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	6	14	15	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					787	789		10.1016/j.cell.2008.11.004	http://dx.doi.org/10.1016/j.cell.2008.11.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041740	Green Accepted, Bronze			2022-12-28	WOS:000261183900007
J	Yadav, VK; Ryu, JH; Suda, N; Tanaka, KF; Gingrich, JA; Schuetz, GN; Glorieux, FH; Chiang, CY; Zajac, JD; Insogna, KL; Mann, JJ; Hen, R; Ducy, P; Karsenty, G				Yadav, Vijay K.; Ryu, Je-Hwang; Suda, Nina; Tanaka, Kenji F.; Gingrich, Jay A.; Schuetz, Guenther; Glorieux, Francis H.; Chiang, Cherie Y.; Zajac, Jeffrey D.; Insogna, Karl L.; Mann, J. John; Hen, Rene; Ducy, Patricia; Karsenty, Gerard			Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum	CELL			English	Article							BETA-CATENIN; RECEPTOR; MASS; PROTEINS; MUTATION; MICE	Loss- and gain-of-function mutations in the broadly expressed gene Lrp5 affect bone formation, causing osteoporosis and high bone mass, respectively. Although Lrp5 is viewed as a Wnt coreceptor, osteoblast-specific disruption of beta-Catenin does not affect bone formation. Instead, we show here that Lrp5 inhibits expression of Tph1, the rate-limiting biosynthetic enzyme for serotonin in enterochromaffin cells of the duodenum. Accordingly, decreasing serotonin blood levels normalizes bone formation and bone mass in Lrp5-deficient mice, and gut-but not osteoblast-specific Lrp5 inactivation decreases bone formation in a beta-Catenin-independent manner. Moreover, gut-specific activation of Lrp5, or inactivation of Tph1, increases bone mass and prevents ovariectomy-induced bone loss. Serotonin acts on osteoblasts through the Htr1b receptor and CREB to inhibit their proliferation. By identifying duodenum-derived serotonin as a hormone inhibiting bone formation in an Lrp5-dependent manner, this study broadens our understanding of bone remodeling and suggests potential therapies to increase bone mass.	[Ducy, Patricia] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Yadav, Vijay K.; Ryu, Je-Hwang; Suda, Nina; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Tanaka, Kenji F.; Mann, J. John; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Gingrich, Jay A.] Columbia Univ, Dept Psychiat Dev Psychobiol, New York, NY 10032 USA; [Schuetz, Guenther] German Canc Res Ctr, Dept Mol Biol Cell, D-69120 Heidelberg, Germany; [Glorieux, Francis H.] McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; [Chiang, Cherie Y.; Zajac, Jeffrey D.] Univ Melbourne, Dept Med, Heidelberg, Vic 3010, Australia; [Insogna, Karl L.] Yale Sch Med, Dept Internal Med, New Haven, CT 06519 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; University of Melbourne; Yale University	Karsenty, G (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10032 USA.	pd2193@columbia.edu; gk2172@columbia.edu	Chiang, Cherie/AAR-3793-2021; Zajac, Jeffrey/ABC-3767-2021; yadav, VIJAY k/Q-2540-2016	Zajac, Jeffrey/0000-0003-3933-5708; yadav, VIJAY k/0000-0003-2345-2846; Tanaka, Kenji/0000-0003-2511-0057; Insogna, Karl/0000-0001-6973-5679	March of Dimes Foundation; National Institutes of Health; Shriners of North America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067936] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners of North America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. J. P. Bilezikian, S. Cremers, D. A. Mackey, M. Zacharin, R. Lang, S. Rao, H. Schubert, and J. Tosi for patient samples and eye analysis; G. Ren and Yung-yu Huang for superb technical assistance; and Dr. M. Gershon for his critical reading of this manuscript. This work was supported by grants from the March of Dimes Foundation and the National Institutes of Health (to G. K.) and by the Shriners of North America (F. H. G.).	Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Basselin M, 2005, NEUROPSYCHOPHARMACOL, V30, P461, DOI 10.1038/sj.npp.1300611; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FU L, 2007, GASTROENTEROLOGY, V132, P397; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HEATH MJS, 1995, CURR BIOL, V5, P997, DOI 10.1016/S0960-9822(95)00199-0; Hediger ML, 2008, J AUTISM DEV DISORD, V38, P848, DOI 10.1007/s10803-007-0453-6; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kubera M, 2000, NEUROPSYCHOPHARMACOL, V23, P89, DOI 10.1016/S0893-133X(99)00150-5; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RAND M, 1951, NATURE, V168, P385, DOI 10.1038/168385b0; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	37	600	660	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					825	837		10.1016/j.cell.2008.09.059	http://dx.doi.org/10.1016/j.cell.2008.09.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041748	Bronze, Green Accepted			2022-12-28	WOS:000261183900015
J	Smith, ER; Loeffler, J; Misra, M; Pomerantz, SR; Stemmer-Rachamimov, A; Post, MD; Harris, NL; McKenna, M				Smith, Edward R.; Loeffler, Jay; Misra, Madhusmita; Pomerantz, Stuart R.; Stemmer-Rachamimov, Anat; Post, Miriam D.; Harris, Nancy Lee; McKenna, Michael			A Boy with a Pituitary Tumor and Skull Abnormalities Pituitary adenoma, prolactin secreting, with atypical features and a high proliferation fraction. Osteoblastoma of the skull	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VALVULAR HEART-DISEASE; TRICUSPID REGURGITATION; MEDICAL THERAPY; CABERGOLINE; ADOLESCENTS; CHILDREN; HEADACHE; LESIONS; BROMOCRIPTINE; AMENORRHEA		[Smith, Edward R.] Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Loeffler, Jay] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Misra, Madhusmita] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Pomerantz, Stuart R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stemmer-Rachamimov, Anat; Post, Miriam D.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Smith, Edward R.] Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; [Loeffler, Jay] Harvard Univ, Sch Med, Dept Radiat Oncol, Cambridge, MA 02138 USA; [Misra, Madhusmita] Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; [Pomerantz, Stuart R.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Stemmer-Rachamimov, Anat; Post, Miriam D.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University	Smith, ER (corresponding author), Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.		Misra, Madhusmita/X-8807-2018	Misra, Madhusmita/0000-0002-9405-2981	Tercica; Ortho-McNeil Pharmaceutical; GE HealthCare	Tercica; Ortho-McNeil Pharmaceutical; GE HealthCare(General ElectricGE Healthcare)	Dr. Loeffler reports receiving consulting fees or being on the paid advisory boards of TransMolecular and Procore and having equity ownership in Procore; Dr. Misra, receiving grant support from Tercica and Ortho-McNeil Pharmaceutical, and Dr. Pomerantz, receiving lecture fees and grant support from GE HealthCare. No other potential conflict of interest relevant to this article was reported.	Amar A P, 1999, Pituitary, V2, P117, DOI 10.1023/A:1009931413106; Ciccarelli Antonio, 2005, Pituitary, V8, P3, DOI 10.1007/s11102-005-5079-0; Ciccarelli Antonio, 2005, Pituitary, V8, P39, DOI 10.1007/s11102-005-5084-3; Colao A, 1997, J CLIN ENDOCR METAB, V82, P3574, DOI 10.1210/jc.82.11.3574; Colao A, 2008, J CLIN ENDOCR METAB, V93, P3777, DOI 10.1210/jc.2007-1403; Delgrange E, 1997, J CLIN ENDOCR METAB, V82, P2102, DOI 10.1210/jc.82.7.2102; Dooley JM, 2005, HEADACHE, V45, P127, DOI 10.1111/j.1526-4610.2005.05026.x; Gibson SE, 2007, ARCH PATHOL LAB MED, V131, P761; Gillam MP, 2006, ENDOCR REV, V27, P485, DOI 10.1210/er.2005-9998; Hanbali F, 2004, J NEUROSURG, V100, P169, DOI 10.3171/ped.2004.100.2.0169; Hilliard AA, 2004, NEW ENGL J MED, V350, P599, DOI 10.1056/NEJMcps031794; HOWLETT TA, 1989, CLIN ENDOCRINOL, V30, P131, DOI 10.1111/j.1365-2265.1989.tb03734.x; Kars M, 2008, J CLIN ENDOCR METAB, V93, P3348, DOI 10.1210/jc.2007-2658; Knappe UJ, 1996, NEUROSURGERY, V39, P484, DOI 10.1097/00006123-199609000-00010; KONTOGEORGOS G, 2004, WHO CLASSIFICATION T, V8, P16; Lafferty AR, 1999, J CLIN ENDOCR METAB, V84, P4317, DOI 10.1210/jc.84.12.4317; Lancellotti P, 2008, EUR J ENDOCRINOL, V159, P1, DOI 10.1530/EJE-08-0213; Levy MJ, 2005, BRAIN, V128, P1921, DOI 10.1093/brain/awh525; LUCAS DR, 1994, HUM PATHOL, V25, P117, DOI 10.1016/0046-8177(94)90267-4; MALCOLM AJ, 2002, WHO CLASSIFICATION T, V4, P262; Medina LS, 1997, RADIOLOGY, V202, P819, DOI 10.1148/radiology.202.3.9051039; Pinzone JJ, 2000, J CLIN ENDOCR METAB, V85, P3053, DOI 10.1210/jc.85.9.3053; Thapar K, 1996, NEUROSURGERY, V38, P765, DOI 10.1227/00006123-199604000-00027; TYSON D, 1993, AM J DIS CHILD, V147, P1057, DOI 10.1001/archpedi.1993.02160340043011; UNNI KK, 2005, TUMORS BONES JOINTS, P126; Verges B, 2002, J CLIN ENDOCR METAB, V87, P457, DOI 10.1210/jc.87.2.457; Wakil A, 2008, EUR J ENDOCRINOL, V159, pR11, DOI 10.1530/EJE-08-0365; WEBSTER J, 1994, NEW ENGL J MED, V331, P904, DOI 10.1056/NEJM199410063311403; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830; 2002, TUMOURS SOFT TISSUE, P262	30	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2367	2377		10.1056/NEJMcpc0806983	http://dx.doi.org/10.1056/NEJMcpc0806983			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377SG	19038883				2022-12-28	WOS:000261270300010
J	Kafsack, BFC; Pena, JDO; Coppens, I; Ravindran, S; Boothroyd, JC; Carruthers, VB				Kafsack, Bjorn F. C.; Pena, Janethe D. O.; Coppens, Isabelle; Ravindran, Sandeep; Boothroyd, John C.; Carruthers, Vern B.			Rapid Membrane Disruption by a Perforin-Like Protein Facilitates Parasite Exit from Host Cells	SCIENCE			English	Article							PORE-FORMING TOXINS; TOXOPLASMA-GONDII; ATTACK; MECHANISM; DOMAIN; FAMILY; SPOROZOITES; INFECTION; DEFENSE; DEATH	Perforin-like proteins are expressed by many bacterial and protozoan pathogens, yet little is known about their function or mode of action. Here, we describe Toxoplasma perforin- like protein 1 ( TgPLP1), a secreted perforin- like protein of the intracellular protozoan pathogen Toxoplasma gondii that displays structural features necessary for pore formation. After intracellular growth, TgPLP1- deficient parasites failed to exit normally, resulting in entrapment within host cells. We show that this defect is due to an inability to rapidly permeabilize the parasitophorous vacuole membrane and host plasma membrane during exit. TgPLP1 ablation had little effect on growth in culture but resulted in a reduction greater than five orders of magnitude of acute virulence in mice. Perforin- like proteins from other intracellular pathogens may play a similar role in microbial egress and virulence.	[Kafsack, Bjorn F. C.; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Kafsack, Bjorn F. C.; Coppens, Isabelle] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Pena, Janethe D. O.] Univ Fed Uberlandia, Dept Immunol, BR-38400 Uberlandia, MG, Brazil; [Ravindran, Sandeep; Boothroyd, John C.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Uberlandia; Stanford University	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Carruthers, Vern/0000-0001-6859-8895; Kafsack, Bjorn F.C./0000-0003-0089-1096; Boothroyd, John C./0000-0001-9719-745X	NIH [RO1 AI46675]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675, R01AI021423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Schultz, S. Meshinchi, A. Silva, E. Mastrantonio, and C. Pereira for technical assistance; D. Roos and F. Dzierszinski for reagents; G. Zeiner for help with the HA-tagging; and M.-H. Huynh, L.D. Sibley, J. Swanson, and M. O'Riordan for valuable discussion and input. This work was supported by NIH grant RO1 AI46675 and a predoctoral fellowship by the American Heart Association. TgPLP1 GenBank accession number is EF102772.	Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983	20	207	215	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					530	533		10.1126/science.1165740	http://dx.doi.org/10.1126/science.1165740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19095897	Green Accepted			2022-12-28	WOS:000262587900050
J	Zaher, HS; Green, R				Zaher, Hani S.; Green, Rachel			Quality control by the ribosome following peptide bond formation	NATURE			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; CODON RECOGNITION; RELEASE FACTORS; E-SITE; TRANSLATION; ACCURACY; DISCRIMINATION; TERMINATION; ERRORS	The overall fidelity of protein synthesis has been thought to rely on the combined accuracy of two basic processes: the aminoacylation of transfer RNAs with their cognate amino acid by the aminoacyl- tRNA synthetases, and the selection of cognate aminoacyl- tRNAs by the ribosome in cooperation with the GTPase elongation factor EF- Tu. These two processes, which together ensure the specific acceptance of a correctly charged cognate tRNA into the aminoacyl ( A) site, operate before peptide bond formation. Here we report the identification of an additional mechanism that contributes to high fidelity protein synthesis after peptidyl transfer, using a well- defined in vitro bacterial translation system. In this retrospective quality control step, the incorporation of an amino acid from a non- cognate tRNA into the growing polypeptide chain leads to a general loss of specificity in the A site of the ribosome, and thus to a propagation of errors that results in abortive termination of protein synthesis.	[Zaher, Hani S.; Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			National Institutes of Health; Howard Hughes Medical Institute.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute.(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Cormack, A. Nahvi, A. Buskirk and R. Reed for helpful comments on the manuscript and members of the laboratory for useful discussions. This work was supported by the National Institutes of Health with salary support from Howard Hughes Medical Institute.	Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; BARTETZKO A, 1988, METHOD ENZYMOL, V164, P650; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P2109, DOI 10.1093/nar/21.9.2109; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Brunelle JL, 2008, RNA, V14, P1526, DOI 10.1261/rna.1057908; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; DONG HJ, 1995, J MOL BIOL, V248, P551, DOI 10.1006/jmbi.1995.0242; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; GEIGENMULLER U, 1990, EMBO J, V9, P4527, DOI 10.1002/j.1460-2075.1990.tb07904.x; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; MANLEY JL, 1978, J MOL BIOL, V125, P407, DOI 10.1016/0022-2836(78)90308-X; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; PRECUP J, 1987, J BIOL CHEM, V262, P11351; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SOLL D, 1990, EXPERIENTIA, V46, P1089; Sundararajan A, 1999, MOL CELL, V4, P1005, DOI 10.1016/S1097-2765(00)80229-4; Szaflarski W, 2008, J MOL BIOL, V380, P193, DOI 10.1016/j.jmb.2008.04.060; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300	39	155	162	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					161	U51		10.1038/nature07582	http://dx.doi.org/10.1038/nature07582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19092806	Green Accepted			2022-12-28	WOS:000262360200025
J	Kriston, L; Holzel, L; Weiser, AK; Berner, MM; Harter, M				Kriston, Levente; Hoelzel, Lars; Weiser, Ann-Kristin; Berner, Michael M.; Haerter, Martin			Meta-analysis: Are 3 Questions Enough to Detect Unhealthy Alcohol Use?	ANNALS OF INTERNAL MEDICINE			English	Review							DISORDERS IDENTIFICATION TEST; DIAGNOSTIC-TEST ACCURACY; AT-RISK DRINKING; TEST AUDIT; SCREENING-TEST; PRIMARY-CARE; HAZARDOUS DRINKERS; LABORATORY TESTS; UNITED-STATES; ABUSE	Background: Both the 10-item Alcohol Use Disorders Identification Test (AUDIT) and its abbreviated 3-item version (Alcohol Use Disorders Identification Test-Consumption [AUDIT-C]) are considered to detect unhealthy alcohol use accurately. Purpose: To examine whether the AUDIT-C is as accurate as the full AUDIT for detecting unhealthy alcohol use in adults. Data Sources: MEDLINE, EMBASE, CINAHL, Web of Science, Psyc-INFO, and BIOSIS Previews from 1998 to July 2008. Study Selection: Three independent reviewers selected studies that administered both the AUDIT and the AUDIT-C, applied a valid reference standard, avoided verification and incorporation bias, and reported relevant data. No language restrictions were applied. Data Extraction: Two reviewers extracted study characteristics and outcome data, which were cross-checked by a third reviewer. One reviewer assessed methodological quality with a standardized checklist. Data Synthesis: Fourteen studies were found. Most involved primary care patients in Europe and the United States. Sample sizes ranged between 112 and 13 438 patients, and sex and age distributions varied considerably. No statistically significant differences were found between the overall accuracy of the AUDIT and the AUDIT-C for detecting risky drinking, alcohol use disorders, or unhealthy alcohol use in primary care. Hierarchical summary receiver-operating characteristic curve analysis yielded pooled positive likelihood ratios of 6.62 for the AUDIT and 2.99 for the AUDIT-C, respectively, for detecting risky drinking; 4.03 and 3.82, respectively, for detecting any alcohol use disorder; and 4.82 and 3.91, respectively, for detecting risky drinking or any alcohol use disorder. Findings from a few studies on general population samples and inpatients suggested but did not prove that the AUDIT might be better than the AUDIT-C for identifying severe conditions, such as alcohol dependence. Limitation: Studies used different reference standards and had heterogeneous findings. Conclusion: Available evidence is inconclusive but suggests that the full AUDIT may be superior to the AUDIT-C for identifying unhealthy alcohol use in adults in some settings.	[Kriston, Levente; Hoelzel, Lars; Weiser, Ann-Kristin; Berner, Michael M.] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Sect Clin Epidemiol & Hlth Serv Res, D-79104 Freiburg, Germany; [Haerter, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kriston, L (corresponding author), Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Sect Clin Epidemiol & Hlth Serv Res, Haupstr 5, D-79104 Freiburg, Germany.	levente.kriston@uniklinik-freiburg.de	Hölzel, Lars/HGQ-1170-2022; Kriston, Levente/D-1713-2013	Kriston, Levente/0000-0003-0748-264X; Harter, Martin/0000-0001-7443-9890	German Federal Ministry of Education and Research [01EB0111]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	In part by a research grant (01EB0111) from the German Federal Ministry of Education and Research.	Aalto M, 2006, ALCOHOL CLIN EXP RES, V30, P1884, DOI 10.1111/j.1530-0277.2006.00233.x; Aertgeerts B, 2002, ACTA CLIN BELG, V57, P241, DOI 10.1179/acb.2002.048; Aertgeerts B, 2001, BRIT J GEN PRACT, V51, P206; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Babor T., 2001, BRIEF INTERVENTION H; Babor T.F., 2001, AUDIT ALCOHOL USE DI, P1; Battaglia M, 2002, BAYES LIB DIAGNOSTIC; Berner MM, 2007, J STUD ALCOHOL DRUGS, V68, P461, DOI 10.15288/jsad.2007.68.461; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; D'Onofrio G, 1998, ACAD EMERG MED, V5, P1200, DOI 10.1111/j.1553-2712.1998.tb02696.x; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DEEKS JJ, 2003, BMJ-BRIT MED J, P248; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dunn CW, 1997, J TRAUMA, V42, P299, DOI 10.1097/00005373-199702000-00021; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Gatsonis C, 2006, AM J ROENTGENOL, V187, P271, DOI 10.2214/AJR.06.0226; Gmel G, 2003, ALCOHOL RES HEALTH, V27, P52; Gomez A, 2006, AGING MENT HEALTH, V10, P558, DOI 10.1080/13607860600637729; Gomez A, 2005, J STUD ALCOHOL, V66, P305, DOI 10.15288/jsa.2005.66.305; Gordon AJ, 2001, J FAM PRACTICE, V50, P313; Gual A, 2002, ALCOHOL ALCOHOLISM, V37, P591, DOI 10.1093/alcalc/37.6.591; Harbord R., 2008, METANDI STATA MODULE; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Harwood HJ, 1999, ADDICTION, V94, P631; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Huang Y, 2007, BIOMETRICS, V63, P1181, DOI 10.1111/j.1541-0420.2007.00814.x; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Macaskill P, 2004, J CLIN EPIDEMIOL, V57, P925, DOI 10.1016/j.jclinepi.2003.12.019; Maisto SA, 2003, AM J ADDICTION, V12, pS12, DOI 10.1111/j.1521-0391.2003.tb00493.x; Moher D, 2000, BRIT J SURG, V87, P1448, DOI 10.1046/j.1365-2168.2000.01610.x; *NAT CLIN GUID, 2003, MAN HARMF DRINK ALC; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; OXFORD J, 1992, BR J ADDICT, V87, P1691; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rice DP, 1999, P ASSOC AM PHYSICIAN, V111, P119, DOI 10.1046/j.1525-1381.1999.09254.x; Rumpf HJ, 2002, ALCOHOL ALCOHOLISM, V37, P261, DOI 10.1093/alcalc/37.3.261; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Seale JP, 2006, J STUD ALCOHOL, V67, P778, DOI 10.15288/jsa.2006.67.778; Selin KH, 2006, SUBST USE MISUSE, V41, P1881, DOI 10.1080/10826080601025532; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; *STAND REP DIAGN A, 2003, ANN INTERN MED, V138, P40; Tsai MC, 2005, ALCOHOL CLIN EXP RES, V29, P53, DOI 10.1097/01.ALC.0000151986.96710.E0; Tuunanen M, 2007, DRUG ALCOHOL REV, V26, P295, DOI 10.1080/09595230701247756; Watson H, 2000, Nurs Stand, V14, P32; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	53	80	80	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					879	+		10.7326/0003-4819-149-12-200812160-00007	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00007			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075207				2022-12-28	WOS:000261771900005
J	Lukacs-Kornek, V; Turley, SJ				Lukacs-Kornek, Veronika; Turley, Shannon J.			IMMUNOLOGY Chaperone Puts the Brakes On	SCIENCE			English	Editorial Material							ANTIGEN PRESENTATION; DENDRITIC CELLS; TRAFFICKING; MIGRATION		[Lukacs-Kornek, Veronika; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Lukacs-Kornek, V (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	shannon_turley@dfci.harvard.edu						Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Rocha N, 2008, EMBO J, V27, P1, DOI 10.1038/sj.emboj.7601945; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Niel G, 2008, CURR OPIN CELL BIOL, V20, P437, DOI 10.1016/j.ceb.2008.05.011; Vascotto F, 2007, CURR OPIN IMMUNOL, V19, P93, DOI 10.1016/j.coi.2006.11.011; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368	11	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1640	1641		10.1126/science.1168103	http://dx.doi.org/10.1126/science.1168103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074333				2022-12-28	WOS:000261608300027
J	Raaijmakers, MHGP; Scadden, DT				Raaijmakers, Marc H. G. P.; Scadden, David T.			Divided within: Heterogeneity within Adult stem Cell Pools	CELL			English	Editorial Material							IN-VIVO	In this issue, Wilson et al. (2008) demonstrate that there are two functional subsets of hematopoietic stem cells that have distinctive kinetics of cell cycling. They present evidence that cells may transition between the two kinetic states, establishing one subpopulation that is ready to proliferate and another that is a deeply quiescent reserve.	[Raaijmakers, Marc H. G. P.; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Raaijmakers, Marc H. G. P.; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Raaijmakers, Marc H. G. P.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Raaijmakers, Marc H. G. P.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	dscadden@mgh.harvard.edu						Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436	9	24	25	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1006	+		10.1016/j.cell.2008.11.034	http://dx.doi.org/10.1016/j.cell.2008.11.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070570	Bronze			2022-12-28	WOS:000261642800015
J	Sieh, K; Natawidjaja, DH; Meltzner, AJ; Shen, CC; Cheng, H; Li, KS; Suwargadi, BW; Galetzka, J; Philibosian, B; Edwards, RL				Sieh, Kerry; Natawidjaja, Danny H.; Meltzner, Aron J.; Shen, Chuan-Chou; Cheng, Hai; Li, Kuei-Shu; Suwargadi, Bambang W.; Galetzka, John; Philibosian, Belle; Edwards, R. Lawrence			Earthquake Supercycles Inferred from Sea-Level Changes Recorded in the Corals of West Sumatra	SCIENCE			English	Article							ANDAMAN EARTHQUAKE; SUNDA MEGATHRUST; DEFORMATION; AFTERSLIP; SLIP	Records of relative sea- level change extracted from corals of the Mentawai islands, Sumatra, imply that this 700- kilometer- long section of the Sunda megathrust has generated broadly similar sequences of great earthquakes about every two centuries for at least the past 700 years. The moment magnitude 8.4 earthquake of September 2007 represents the first in a series of large partial failures of the Mentawai section that will probably be completed within the next several decades.	[Sieh, Kerry; Meltzner, Aron J.; Galetzka, John; Philibosian, Belle] CALTECH, Tecton Observ, Pasadena, CA 91125 USA; [Natawidjaja, Danny H.; Suwargadi, Bambang W.] Indonesian Inst Sci, Res Ctr Geotechnol, Bandung, Indonesia; [Shen, Chuan-Chou; Li, Kuei-Shu] Natl Taiwan Univ, Dept Geosci, Taipei 10764, Taiwan; [Cheng, Hai; Edwards, R. Lawrence] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	California Institute of Technology; Indonesian Institute of Sciences; National Taiwan University; University of Minnesota System; University of Minnesota Twin Cities	Sieh, K (corresponding author), Nanyang Technol Univ, Earth Observ Singapore, Singapore 639798, Singapore.	sieh@ntu.edu.sg	Philibosian, Belle/AAB-7987-2019; Shen, Chuan-Chou/H-9642-2013; Meltzner, Aron J/A-5585-2009; Edwards, R. Lawrence/I-3124-2014; lin, ke/GZM-8300-2022; CHENG, HAI/H-3413-2017	Philibosian, Belle/0000-0003-3138-4716; Shen, Chuan-Chou/0000-0003-2833-2771; Meltzner, Aron J/0000-0002-2955-0896; Edwards, R. Lawrence/0000-0002-7027-5881; CHENG, HAI/0000-0002-5305-9458	NSF [EAR-9628301, EAR-9804732, EAR-9903301, EAR-0208508, EAR-0530899, EAR-0538333, EAR-0809223, EAR-0207686, EAR-0537973]; National Science Council [94-2116-M002-012, 95&96-2752-M002-012-PAE]; LIPI (Indonesian Institute of Science); RUTI (International Joint Research Program of the Indonesian Ministry of Research and Technology); Gordon and Betty Moore Foundation	NSF(National Science Foundation (NSF)); National Science Council(Ministry of Science and Technology, Taiwan); LIPI (Indonesian Institute of Science)(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); RUTI (International Joint Research Program of the Indonesian Ministry of Research and Technology)(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work has been supported by NSF grants EAR-9628301, 9804732, 9903301, 0208508, 0530899, 0538333, and 0809223 (to K.S.) and EAR- 0207686 and 0537973 (to R.L.E.); by National Science Council grants 94-2116-M002-012 and 95&96-2752-M002-012-PAE ( to C.-C. S.); by LIPI ( Indonesian Institute of Science) and RUTI ( International Joint Research Program of the Indonesian Ministry of Research and Technology); and by the Gordon and Betty Moore Foundation. This is Caltech Tectonics Observatory contribution number 86 and Earth Observatory of Singapore contribution number 1.	Abercrombie RE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000674; Borrero JC, 2006, P NATL ACAD SCI USA, V103, P19673, DOI 10.1073/pnas.0604069103; Briggs RW, 2006, SCIENCE, V311, P1897, DOI 10.1126/science.1122602; Carver G, 2004, B SEISMOL SOC AM, V94, pS58, DOI 10.1785/0120040625; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Darwin C., 1842, STRUCTURE DISTRIBUTI; DeShon HR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024188; EDWARDS RL, 1988, EARTH PLANET SC LETT, V90, P371, DOI 10.1016/0012-821X(88)90136-7; GALETZKA J, 2008, J GEOPHYS RES, V113; Hsu YJ, 2006, SCIENCE, V312, P1921, DOI 10.1126/science.1126960; Konca AO, 2008, NATURE, V456, P631, DOI 10.1038/nature07572; Natawidjaja DH, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004025; Natawidjaja DH, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004450; Natawidjaja DH, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002398; Shen CC, 2002, CHEM GEOL, V185, P165, DOI 10.1016/S0009-2541(01)00404-1; Shen CC, 2008, GEOCHIM COSMOCHIM AC, V72, P4201, DOI 10.1016/j.gca.2008.06.011; Sieh K, 2005, NATURE, V434, P573, DOI 10.1038/434573a; SIEH K, 1989, J GEOPHYS RES-SOLID, V94, P603, DOI 10.1029/JB094iB01p00603; SIEH K, 2007, 1 INT C ACEH IND OC; SIEH K, 2006, INT WORKSH TECT PLAT; Sieh K, 2007, J EARTHQ TSUNAMI, V1, P1, DOI 10.1142/S179343110700002X; Sieh K, 2006, PHILOS T R SOC A, V364, P1947, DOI 10.1098/rsta.2006.1807; Stoddart DR, 1979, ATOLL RES B, V224, P1, DOI DOI 10.5479/SI.00775630.224.1; Zachariasen J, 2000, B SEISMOL SOC AM, V90, P897, DOI 10.1785/0119980016; Zachariasen J, 1999, J GEOPHYS RES-SOL EA, V104, P895, DOI 10.1029/1998JB900050	25	258	262	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1674	1678		10.1126/science.1163589	http://dx.doi.org/10.1126/science.1163589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074346	Green Published			2022-12-28	WOS:000261608300040
J	[Anonymous]				[Anonymous]			Cell imaging: LIGHT ACTIVATED	NATURE			English	Editorial Material																			0	2	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					826	827		10.1038/456826a	http://dx.doi.org/10.1038/456826a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079062	Bronze			2022-12-28	WOS:000261559900059
J	Chien, KR; Domian, IJ; Parker, KK				Chien, Kenneth R.; Domian, Ibrahim J.; Parker, Kevin Kit			Cardiogenesis and the Complex Biology of Regenerative Cardiovascular Medicine	SCIENCE			English	Review							BONE-MARROW-CELLS; ACUTE MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; CARDIAC PROGENITORS; SMOOTH-MUSCLE; MAMMALIAN HEART; ARTERIAL POLE; DIFFERENTIATION; CARDIOMYOCYTE	The heart is a complex organ system composed of a highly diverse set of muscle and nonmuscle cells. Understanding the pathways that drive the formation, migration, and assembly of these cells into the heart muscle tissue, the pacemaker and conduction system, and the coronary vasculature is a central problem in developmental biology. Efforts to unravel the biological complexity of in vivo cardiogenesis have identified a family of closely related multipotent cardiac progenitor cells. These progenitors must respond to non- cell- autonomous signaling cues to expand, differentiate, and ultimately integrate into the three- dimensional heart structures. Coupling tissue- engineering technologies with patient- specific cardiac progenitor biology holds great promise for the development of human cell models of human disease and may lay the foundation for novel approaches in regenerative cardiovascular medicine.	[Chien, Kenneth R.; Domian, Ibrahim J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Chien, Kenneth R.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Chien, Kenneth R.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Parker, Kevin Kit] Harvard Univ, Sch Engn & Appl Sci, Dis Biophys Grp, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	kchien@partners.org						Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bray MA, 2008, CELL MOTIL CYTOSKEL, V65, P641, DOI 10.1002/cm.20290; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cleland JGF, 2006, EUR J HEART FAIL, V8, P105, DOI 10.1016/j.ejheart.2005.12.003; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Frank DU, 2002, DEVELOPMENT, V129, P4591; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang S, 2005, CELL MOTIL CYTOSKEL, V61, P201, DOI 10.1002/cm.20077; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Lunde K, 2005, SCAND CARDIOVASC J, V39, P150, DOI 10.1080/14017430510009131; Mansour S, 2006, J AM COLL CARDIOL, V47, P1727, DOI 10.1016/j.jacc.2006.01.039; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; MENCKEN HL, 1949, DIVINE AFFLATUS MENC, P443; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Park EJ, 2008, DEVELOPMENT, V135, P3599, DOI 10.1242/dev.025437; Parker KK, 2008, CIRC RES, V103, P340, DOI 10.1161/CIRCRESAHA.108.182469; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schiekofer S, 2008, ANGIOGENESIS, V11, P289, DOI 10.1007/s10456-008-9112-6; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Walsh K, 2007, J CLIN INVEST, V117, P3176, DOI 10.1172/JCI34126; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang J, 2008, DEVELOPMENT, V135, P3611, DOI 10.1242/dev.025361; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	47	194	207	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1494	1497		10.1126/science.1163267	http://dx.doi.org/10.1126/science.1163267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056974				2022-12-28	WOS:000261377400036
J	Garner, EC				Garner, Ethan Clark			GE PRIZE ESSAY Understanding a Minimal DNA-Segregating Machine	SCIENCE			English	Editorial Material							PROKARYOTIC ACTIN HOMOLOG; DYNAMIC INSTABILITY; PARTITION; PLASMID; GROWTH		[Garner, Ethan Clark] Univ Calif San Francisco, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Garner, EC (corresponding author), Univ Calif San Francisco, San Francisco, CA 94158 USA.	egarner@mullinslab2.ucsf.edu	Garner, Ethan/J-4025-2014	Garner, Ethan/0000-0003-0141-3555				AUSTIN S, 1983, J MOL BIOL, V169, P353, DOI 10.1016/S0022-2836(83)80055-2; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3	9	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1486	1487		10.1126/science.1168506	http://dx.doi.org/10.1126/science.1168506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056970				2022-12-28	WOS:000261377400033
J	Caviglia, AD; Gariglio, S; Reyren, N; Jaccard, D; Schneider, T; Gabay, M; Thiel, S; Hammerl, G; Mannhart, J; Triscone, JM				Caviglia, A. D.; Gariglio, S.; Reyren, N.; Jaccard, D.; Schneider, T.; Gabay, M.; Thiel, S.; Hammerl, G.; Mannhart, J.; Triscone, J. -M.			Electric field control of the LaAlO3/SrTiO3 interface ground state	NATURE			English	Article							FILMS	Interfaces between complex oxides are emerging as one of the most interesting systems in condensed matter physics(1). In this special setting, in which translational symmetry is artificially broken, a variety of new and unusual electronic phases can be promoted(2). Theoretical studies predict complex phase diagrams and suggest the key role of the charge carrier density in determining the systems' ground states. A particularly fascinating system is the conducting interface between the band insulators LaAlO3 and SrTiO3 ( ref. 3). Recently two possible ground states have been experimentally identified: a magnetic state(4) and a two- dimensional superconducting condensate(5). Here we use the electric field effect to explore the phase diagramof the system. The electrostatic tuning of the carrier density allows an on/off switching of superconductivity and drives a quantum phase transition(6-8) between a two- dimensional superconducting state and an insulating state. Analyses of the magnetotransport properties in the insulating state are consistent with weak localization and do not provide evidence for magnetism. The electric field control of superconductivity demonstrated here opens the way to the development of new mesoscopic superconducting circuits.	[Caviglia, A. D.; Gariglio, S.; Reyren, N.; Jaccard, D.; Triscone, J. -M.] Univ Geneva, Dept Phys Mat Condensee, CH-1211 Geneva 4, Switzerland; [Schneider, T.] Univ Zurich, Inst Phys, CH-8057 Zurich, Switzerland; [Gabay, M.] Univ Paris 11, Phys Solides Lab, F-91405 Orsay, France; [Thiel, S.; Hammerl, G.; Mannhart, J.] Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany	University of Geneva; University of Zurich; UDICE-French Research Universities; Universite Paris Saclay; University of Augsburg	Caviglia, AD (corresponding author), Univ Geneva, Dept Phys Mat Condensee, 24 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	andrea.caviglia@unige.ch	Caviglia, Andrea/HHZ-9774-2022; Caviglia, Andrea/B-4443-2009; Reyren, Nicolas/AAA-4984-2022; Hammerl, German/E-9358-2017	Caviglia, Andrea/0000-0001-9650-3371; Caviglia, Andrea/0000-0001-9650-3371; Reyren, Nicolas/0000-0002-7745-7282; Mannhart, Jochen/0000-0001-6331-2640; Hammerl, German/0000-0002-2010-5163	Swiss National Science Foundation; European Union; Deutsche Forschungsgemeinschaft [SFB484]; European Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Science Foundation(European Science Foundation (ESF)European Commission)	We thank T. Giamarchi, L. Benfatto, T. Kopp and A.-S. Ruetschi for discussions and M. Lopes for technical assistance. We acknowledge financial support by the Swiss National Science Foundation through the National Centre of Competence in Research 'Materials with Novel Electronic Properties' MaNEP and Division II, by the European Union through the project 'Nanoxide', by the Deutsche Forschungsgemeinschaft through the SFB484, and by the European Science Foundation through the program 'Thin Films for Novel Oxide Devices'.	Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; Aubin H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094521; Basletic M, 2008, NAT MATER, V7, P621, DOI 10.1038/nmat2223; BERGMANN G, 1984, PHYS REP, V107, P1, DOI 10.1016/0370-1573(84)90103-0; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; CHRISTEN HM, 1994, PHYS REV B, V49, P12095, DOI 10.1103/PhysRevB.49.12095; Das D, 1998, PHYS REV B, V57, P14440, DOI 10.1103/PhysRevB.57.14440; FISHER MPA, 1988, PHYS REV LETT, V60, P208, DOI 10.1103/PhysRevLett.60.208; Herranz G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.216803; Hwang HY, 2006, MRS BULL, V31, P28, DOI 10.1557/mrs2006.3; Kalabukhov A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121404; Matthey D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057002; Matthey D, 2003, APPL PHYS LETT, V83, P3758, DOI 10.1063/1.1624635; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; Parendo KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197004; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Rijnders GJHM, 1997, APPL PHYS LETT, V70, P1888, DOI 10.1063/1.118687; Sachdev S., 1999, QUANTUM PHASE TRANSI; Schneider T, 1997, ACTA PHYS POL A, V91, P203, DOI 10.12693/APhysPolA.91.203; Schneider T, 2004, PHYSICS OF SUPERCONDUCTORS, VOL II, P111, DOI 10.1007/978-3-642-18914-2_4; Schneider T., 2000, PHASE TRANSITION APP; Siemons W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196802; Sondhi SL, 1997, REV MOD PHYS, V69, P315, DOI 10.1103/RevModPhys.69.315; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Willmott PR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155502	29	956	960	23	533	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					624	627		10.1038/nature07576	http://dx.doi.org/10.1038/nature07576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052624	Green Submitted			2022-12-28	WOS:000261340000037
J	D'Amico, DJ				D'Amico, Donald J.			Primary Retinal Detachment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARS-PLANA VITRECTOMY; OPTICAL COHERENCE TOMOGRAPHY; COMPARING PNEUMATIC RETINOPEXY; POSTERIOR VITREOUS DETACHMENT; SCLERAL BUCKLING SURGERY; PROLIFERATIVE VITREORETINOPATHY; VISUAL RECOVERY; CLINICAL-TRIAL; INTRAOCULAR-PRESSURE; LATTICE DEGENERATION		[D'Amico, Donald J.] Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med Coll, New York, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital	D'Amico, DJ (corresponding author), Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med Coll, 1305 York Ave,11th Fl, New York, NY 10021 USA.	djdamico@med.cornell.edu			Alcon; Research to Prevent Blindness	Alcon(Novartis); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	Dr. D'Amico reports receiving speaking fees from Alcon and a departmental grant from Research to Prevent Blindness; he also reports being the current president of the Retina Society. No other potential conflict of interest relevant to this article was reported.	Ahmadieh H, 2005, OPHTHALMOLOGY, V112, P1421, DOI 10.1016/j.ophtha.2005.02.018; Arya AV, 2006, OPHTHALMOLOGY, V113, P1724, DOI 10.1016/j.ophtha.2006.05.044; Brazitikos PD, 2005, RETINA-J RET VIT DIS, V25, P957, DOI 10.1097/00006982-200512000-00001; Brazitikos PD, 1999, RETINA-J RET VIT DIS, V19, P103, DOI 10.1097/00006982-199902000-00003; BYER NE, 1979, SURV OPHTHALMOL, V23, P213, DOI 10.1016/0039-6257(79)90048-1; BYER NE, 1974, T AM ACAD OPHTHALMOL, V78, pO114; Campo RV, 1999, OPHTHALMOLOGY, V106, P1811, DOI 10.1016/S0161-6420(99)90353-6; Cavallini GM, 2007, EUR J OPHTHALMOL, V17, P790, DOI 10.1177/112067210701700517; CHANG S, 1987, AM J OPHTHALMOL, V103, P38, DOI 10.1016/S0002-9394(14)74166-2; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Christensen U, 2005, J CATARACT REFR SURG, V31, P354, DOI 10.1016/j.jcrs.2004.04.067; DAMICO DJ, 1994, NEW ENGL J MED, V331, P95, DOI 10.1056/NEJM199407143310207; DAMICO DJ, 2000, PRINCIPLES PRACTICE, P2402; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; Eckardt C, 2005, RETINA-J RET VIT DIS, V25, P208, DOI 10.1097/00006982-200502000-00015; Eter N, 2000, GRAEF ARCH CLIN EXP, V238, P677, DOI 10.1007/s004170000167; FOOS RY, 1982, OPHTHALMOLOGY, V89, P1502; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1814, DOI 10.1016/S0161-6420(02)01119-3; Halberstadt M, 2005, EYE, V19, P891, DOI 10.1038/sj.eye.6701687; Haynie GD, 2000, PRINCIPLES PRACTICE, P2359; Heimann H, 2001, GRAEF ARCH CLIN EXP, V239, P567, DOI 10.1007/s004170100319; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; HILTON GF, 1986, OPHTHALMOLOGY, V93, P626; JAFFE NS, 1968, ARCH OPHTHALMOL-CHIC, V79, P568; Kulkarni KM, 2007, RETINA-J RET VIT DIS, V27, P1065, DOI 10.1097/IAE.0b013e3180546928; LINCOFF H, 1980, ARCH OPHTHALMOL-CHIC, V98, P1610; LINCOFF H, 1989, ARCH OPHTHALMOL-CHIC, V107, P907, DOI 10.1001/archopht.1989.01070010929043; Lindner, 1966, ACTA OPHTHALMOL    S, V87, P1; Liu F, 2006, OPHTHALMOLOGICA, V220, P174, DOI 10.1159/000091761; Lois N, 2003, SURV OPHTHALMOL, V48, P467, DOI 10.1016/S0039-6257(03)00083-3; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; McLeod D, 2004, BRIT J OPHTHALMOL, V88, P1357, DOI 10.1136/bjo.2004.050146; MELBERG NS, 1995, OPHTHALMOLOGY, V102, P1466; Mendrinos E, 2008, AM J OPHTHALMOL, V145, P1063, DOI 10.1016/j.ajo.2008.01.018; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; PEDERSON JE, 1982, ARCH OPHTHALMOL-CHIC, V100, P1150, DOI 10.1001/archopht.1982.01030040128023; Ross WH, 2008, CAN J OPHTHALMOL, V43, P65, DOI 10.3129/i07-196; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; Salicone A, 2006, OPHTHALMOLOGY, V113, P1734, DOI 10.1016/j.ophtha.2006.03.064; Saw SM, 2006, ACTA OPHTHALMOL SCAN, V84, P606, DOI 10.1111/j.1600-0420.2006.00715.x; Schwartz SG, 2006, CURR OPIN OPHTHALMOL, V17, P245, DOI 10.1097/01.icu.0000193097.28798.fc; Sharma YR, 2005, ACTA OPHTHALMOL SCAN, V83, P293, DOI 10.1111/j.1600-0420.2005.00461.x; Sodhi A, 2008, SURV OPHTHALMOL, V53, P50, DOI 10.1016/j.survophthal.2007.10.007; SPITZNAS M, 1987, GRAEF ARCH CLIN EXP, V225, P13, DOI 10.1007/BF02155797; Tasman W S, 1968, Trans Am Acad Ophthalmol Otolaryngol, V72, P217; Theodossiadis PG, 2003, RETINA-J RET VIT DIS, V23, P69, DOI 10.1097/00006982-200302000-00011; Thompson JT, 2004, AM J OPHTHALMOL, V137, P250, DOI 10.1016/j.ajo.2003.09.020; Tornambe P E, 1997, Trans Am Ophthalmol Soc, V95, P551; TORNAMBE PE, 1989, OPHTHALMOLOGY, V96, P772; TORNAMBE PE, 1991, OPHTHALMOLOGY, V98, P1115; Weichel ED, 2006, OPHTHALMOLOGY, V113, P2033, DOI 10.1016/j.ophtha.2006.05.038; WOLF GL, 1983, ANESTHESIOLOGY, V59, P547, DOI 10.1097/00000542-198312000-00011; Wolfensberger TJ, 2004, OPHTHALMOLOGY, V111, P1340, DOI 10.1016/j.ophtha.2003.12.049; Wolfensberger TJ, 2002, GRAEF ARCH CLIN EXP, V240, P85, DOI 10.1007/s00417-001-0410-6	54	88	92	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2346	2354		10.1056/NEJMcp0804591	http://dx.doi.org/10.1056/NEJMcp0804591			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377SG	19038880				2022-12-28	WOS:000261270300006
J	Kapp, C				Kapp, Clare			Profile Malcolm and Elizabeth Molyneux: making better health in Malawi	LANCET			English	Biographical-Item												clarekapp@hotmail.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1873	1873		10.1016/S0140-6736(08)61798-5	http://dx.doi.org/10.1016/S0140-6736(08)61798-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041790				2022-12-28	WOS:000261388700011
J	Cardinali, DP; Golombek, DA				Cardinali, Daniel P.; Golombek, Diego A.			Let there be sleep-on time	LANCET			English	Editorial Material							MELATONIN		[Cardinali, Daniel P.] Univ Buenos Aires, Dept Physiol, Sch Med, RA-2155 Buenos Aires, DF, Argentina; [Golombek, Diego A.] Natl Univ Quilmes, Dept Sci & Technol, Buenos Aires, DF, Argentina	University of Buenos Aires	Cardinali, DP (corresponding author), Univ Buenos Aires, Dept Physiol, Sch Med, RA-2155 Buenos Aires, DF, Argentina.	dcardinali@fmed.uba.ar		Golombek, Diego/0000-0002-6291-5586				Lewy AJ, 2007, COLD SPRING HARB SYM, V72, P623, DOI 10.1101/sqb.2007.72.055; Pandi-Perumal SR, 2008, NAT CLIN PRACT NEURO, V4, P436, DOI 10.1038/ncpneuro0847; Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001; Rajaratnam SMW, 2009, LANCET, V373, P482, DOI 10.1016/S0140-6736(08)61812-7; Reynoldson JN, 2008, ANN PHARMACOTHER, V42, P1262, DOI 10.1345/aph.1K676	5	10	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					439	441		10.1016/S0140-6736(08)61813-9	http://dx.doi.org/10.1016/S0140-6736(08)61813-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	19054553				2022-12-28	WOS:000263132800007
J	Heuer, D; Lipinski, AR; Machuy, N; Karlas, A; Wehrens, A; Siedler, F; Brinkmann, V; Meyer, TF				Heuer, Dagmar; Lipinski, Anette Rejman; Machuy, Nikolaus; Karlas, Alexander; Wehrens, Andrea; Siedler, Frank; Brinkmann, Volker; Meyer, Thomas F.			Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction	NATURE			English	Article							HOST-CELL; ENDOPLASMIC-RETICULUM; TRACHOMATIS INCLUSION; APOPTOSIS; APPARATUS; SPHINGOLIPIDS; INHERITANCE; INHIBITION; PNEUMONIAE; ACTIVATION	The obligate intracellular bacterium Chlamydia trachomatis survives and replicates within a membrane- bound vacuole, termed the inclusion, which intercepts host exocytic pathways to obtain nutrients(1-3). Like many other intracellular pathogens, C. trachomatis has a marked requirement for host cell lipids, such as sphingolipids and cholesterol, produced in the endoplasmic reticulum and the Golgi apparatus(4-6). However, the mechanisms by which intracellular pathogens acquire host cell lipids are not well understood(1-3). In particular, no host cell protein responsible for transporting Golgi-derived lipids to the chlamydial inclusions has yet been identified. Here we show that Chlamydia infection in human epithelial cells induces Golgi fragmentation to generate Golgi ministacks surrounding the bacterial inclusion. Ministack formation is triggered by the proteolytic cleavage of the Golgimatrix protein golgin-84. Inhibition of golgin-84 truncation prevents Golgi fragmentation, causing a block in lipid acquisition and maturation of C. trachomatis. Golgi fragmentation by means of RNA- interference- mediated knockdown of distinct Golgi matrix proteins before infection enhances bacterial maturation. Our data functionally connect bacteria- induced golgin-84 cleavage, Golgi ministack formation, lipid acquisition and intracellular pathogen growth. We show that C. trachomatis subverts the structure and function of an entire host cell organelle for its own advantage.	[Heuer, Dagmar; Lipinski, Anette Rejman; Machuy, Nikolaus; Karlas, Alexander; Wehrens, Andrea; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Brinkmann, Volker] Max Planck Inst Infect Biol, Microscopy Core Facil, D-10117 Berlin, Germany; [Siedler, Frank] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	meyer@mpiib-berlin.mpg.de	Brinkmann, Volker/A-6015-2009; Meyer, Thomas F. F/J-2485-2013	Meyer, Thomas F. F/0000-0002-6120-8679; Karlas, Alexander/0000-0002-2187-2057	Senate of Berlin; BMBF	Senate of Berlin; BMBF(Federal Ministry of Education & Research (BMBF))	The authors would like to thank A. Greiser, C. Goosmann, B. Laube, M. Wicht and E. Ziska for technical support; M.A. De Matteis for the gift of the GFP-GM130 fusion plasmid; H. P. Hauri for the provision of the anti-GPP130 antibody and helpful discussions; and K. Astrahantseff, S. and J. Heuer, T. Wolff and L. Ogilvie for critically reading the manuscript and helpful suggestions. This work was financially supported by the Senate of Berlin and the BMBF through the RiNA Network.	Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heuer D, 2003, CELL MICROBIOL, V5, P315, DOI 10.1046/j.1462-5822.2003.00278.x; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997	25	205	217	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					731	U8		10.1038/nature07578	http://dx.doi.org/10.1038/nature07578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19060882				2022-12-28	WOS:000263064700043
J	Turner, R; Horton, R				Turner, Richard; Horton, Richard			When childhood dies	LANCET			English	Editorial Material									[Turner, Richard; Horton, Richard] The Lancet, London NW1 7BY, England		Turner, R (corresponding author), The Lancet, London NW1 7BY, England.							GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61707-9; GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61706-7; Laming Lord, 2003, VICTORIA CLIMBIE INQ; MACMILLAN HL, 2008, LANCET          1203, DOI [DOI 10.1016/S0140-6736(08)61708-0, 10.1016/S0140-6736(21)02844-0, DOI 10.1016/S0140-6736(21)02844-0]; READING R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61709-2	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 3	2009	373	9657					3	4		10.1016/S0140-6736(08)61701-8	http://dx.doi.org/10.1016/S0140-6736(08)61701-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19056120				2022-12-28	WOS:000262183800004
J	Campanelli, A; Borradori, L				Campanelli, Alexandre; Borradori, Luca			Subungual Exostosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Campanelli, Alexandre] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Borradori, Luca] Univ Hosp Bern, CH-3010 Bern, Switzerland	University of Geneva; University of Bern; University Hospital of Bern	Campanelli, A (corresponding author), Univ Hosp Geneva, CH-1211 Geneva, Switzerland.								0	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					E31	E31		10.1056/NEJMicm074461	http://dx.doi.org/10.1056/NEJMicm074461			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092147				2022-12-28	WOS:000261757300011
J	Zalts, R; Hayek, T				Zalts, Ronen; Hayek, Tony			Postpartum Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zalts, Ronen; Hayek, Tony] Rambam Med Ctr, IL-31096 Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology	Zalts, R (corresponding author), Rambam Med Ctr, IL-31096 Haifa, Israel.	r_zalts@rambam.health.gov.il							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2706	2706		10.1056/NEJMicm065130	http://dx.doi.org/10.1056/NEJMicm065130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092155				2022-12-28	WOS:000261757300010
J	Apatira, L; Boyd, EA; Malvar, G; Evans, LR; Luce, JM; Lo, B; White, DB				Apatira, Latifat; Boyd, Elizabeth A.; Malvar, Grace; Evans, Leah R.; Luce, John M.; Lo, Bernard; White, Douglas B.			Hope, Truth, and Preparing for Death: Perspectives of Surrogate Decision Makers	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-SUSTAINING TREATMENT; CARE; FAMILIES; PROGNOSTICATION; EXPERIENCE; AMERICAN; SUPPORT; CANCER	Background: Although many physicians worry that openly discussing a poor prognosis will cause patients and families to lose hope, surrogate decision makers' perspectives on this topic are largely unknown. Objective: To determine surrogate decision makers' attitudes toward balancing hope and telling the truth when discussing prognosis. Design: Prospective, mixed-methods cohort study. Setting: 4 intensive care units at the University of California, San Francisco, Medical Center, San Francisco, California. Participants: 179 surrogate decision makers for incapacitated patients at high risk for death. Measurements: One-on-one, semistructured interviews with surrogates were conducted on the patients' 5th day of receiving mechanical ventilation. Constant comparative methods were used to inductively develop a framework to describe participants' responses. Validation methods included multidisciplinary analysis and member checking. Results: Overall, 93% (166 of 179) of surrogates felt that avoiding discussions about prognosis is an unacceptable way to maintain hope. The main explanatory theme was that timely discussion of prognosis is essential to allow family members to prepare emotionally and logistically for the possibility of a patient's death. Other themes that emerged included surrogates' belief that an accurate understanding of a patient's prognosis allows them to better support the patient and each other, a moral aversion to the idea of false hope, the perception that physicians have an obligation to discuss prognosis, and the notion that some surrogates look to physicians primarily for truth and seek hope elsewhere. A few surrogates (6 of 179) felt that physicians should withhold prognostic information because of a belief that discussing death could be emotionally damaging to the family or could negatively affect the patient's health. Limitation: The authors did not longitudinally assess whether early disclosure about prognosis predicts fewer adverse bereavement outcomes. Conclusion: Most surrogates of critically ill patients do not view withholding prognostic information as an acceptable way to maintain hope, largely because timely discussions about prognosis help families begin to prepare emotionally, existentially, and practically for the possibility that a patient will die.	[Apatira, Latifat] Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Apatira, L (corresponding author), Univ Calif San Francisco, Program Med Eth, 521 Parnassus Ave,Box 903,Suite C-126, San Francisco, CA 94143 USA.	dwhite@medicine.ucsf.edu			National Institutes of Health [KL2 RR024130]; National Center for Research Resources; National Institutes of Health Roadmap for Medical Research; University of California; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By National Institutes of Health grant KL2 RR024130 from the National Center for Research Resources, a component of the National Institutes of Health Roadmap for Medical Research (Dr. White) and the University of California Student Research Fellowship (Ms. Apatira).	Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; [Anonymous], 1999, DEATH FORETOLD PROPH; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Back Anthony L, 2003, Ann Intern Med, V138, P439; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; Barnato AE, 2004, CRIT CARE CLIN, V20, P345, DOI 10.1016/j.ccc.2004.03.002; Barry LC, 2002, AM J GERIAT PSYCHIAT, V10, P447; Braun UK, 2008, J GEN INTERN MED, V23, P267, DOI 10.1007/s11606-007-0487-7; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; Buckman R, 1996, BRIT MED J, V313, P699; Buckman R., 1992, BREAK BAD NEWS GUIDE; CARRESE JA, 1995, JAMA-J AM MED ASSOC, V274, P826, DOI 10.1001/jama.274.10.826; Charmaz K., 2006, CONSTRUCTION GROUNDE; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Cook P, 2002, ARCH DIS CHILD, V87, P36, DOI 10.1136/adc.87.1.36; Curtis JR, 2008, J PALLIAT MED, V11, P610, DOI 10.1089/jpm.2007.0209; Fadiman A., 1997, SPIRIT CATCHES YOU Y; Fagerlin A, 2001, HEALTH PSYCHOL, V20, P166, DOI 10.1037/0278-6133.20.3.166; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Glasser B.G., 1967, DISCOVERY GROUNDED T; GOOD MJD, 1990, CULT MED PSYCHIAT, V14, P59; Hebert RS, 2006, J PALLIAT MED, V9, P1164, DOI 10.1089/jpm.2006.9.1164; HOLLAND JC, 1989, J CLIN ONCOL, V7, P557, DOI 10.1200/JCO.1989.7.5.557; Jacobs LM, 2008, ARCH SURG-CHICAGO, V143, P730, DOI 10.1001/archsurg.143.8.730; Kirchhoff KT, 2002, AM J CRIT CARE, V11, P200, DOI 10.4037/ajcc2002.11.3.200; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LIBERATI A, 1986, BRIT J CANCER, V54, P319; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Sheu SJ, 2006, MED EDUC, V40, P590, DOI 10.1111/j.1365-2929.2006.02477.x; Strauss A., 1998, BASICS QUALITATIVE R; Thome H, 2003, Z SOZIOL, V32, P4; TILDEN VP, 1995, ARCH INTERN MED, V155, P633, DOI 10.1001/archinte.155.6.633; Vig EK, 2007, J GEN INTERN MED, V22, P1274, DOI 10.1007/s11606-007-0252-y; WHITE DB, MED DECIS M IN PRESS; White DB, 2007, CRIT CARE MED, V35, P442, DOI 10.1097/01.CCM.0000254723.28270.14	37	141	142	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					861	+		10.7326/0003-4819-149-12-200812160-00005	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075205	Green Accepted			2022-12-28	WOS:000261771900003
J	Tosteson, ANA; Lurie, JD; Tosteson, TD; Skinner, JS; Herkowitz, H; Albert, T; Boden, SD; Bridwell, K; Longley, M; Andersson, GB; Blood, EA; Grove, MR; Weinstein, JN				Tosteson, Anna N. A.; Lurie, Jon D.; Tosteson, Tor D.; Skinner, Jonathan S.; Herkowitz, Harry; Albert, Todd; Boden, Scott D.; Bridwell, Keith; Longley, Michael; Andersson, Gunnar B.; Blood, Emily A.; Grove, Margaret R.; Weinstein, James N.		SPORT Investigators	Surgical Treatment of Spinal Stenosis with and without Degenerative Spondylolisthesis: Cost-Effectiveness after 2 Years	ANNALS OF INTERNAL MEDICINE			English	Article							LUMBAR-DISK HERNIATION; UNITED-STATES TRENDS; RESEARCH TRIAL SPORT; NONOPERATIVE TREATMENT; FUSION; SURGERY; ARTHRODESIS; LAMINECTOMY; WINNER	Background: The SPORT (Spine Patient Outcomes Research Trial) reported favorable surgery outcomes over 2 years among patients with stenosis with and without degenerative spondylolisthesis, but the economic value of these surgeries is uncertain. Objective: To assess the short-term cost-effectiveness of spine surgery relative to nonoperative care for stenosis alone and for stenosis with spondylolisthesis. Design: Prospective cohort study. Data Sources: Resource utilization, productivity, and EuroQol EQ-5D score measured at 6 weeks and at 3, 6, 12, and 24 months after treatment among SPORT participants. Target Population: Patients with image-confirmed spinal stenosis, with and without degenerative spondylolisthesis. Time Horizon: 2 years. Perspective: Societal. Intervention: Nonoperative care or surgery (primarily decompressive laminectomy for stenosis and decompressive laminectomy with fusion for stenosis associated with degenerative spondylolisthesis). Outcome Measures: Cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: Among 634 patients with stenosis, 394 (62%) had surgery, most often decompressive laminectomy (320 of 394 [81%]). Stenosis surgeries improved health to a greater extent than nonoperative care (QALY gain, 0.17 [95% CI, 0.12 to 0.22]) at a cost of $77 600 (CI, $49 600 to $120 000) per QALY gained. Among 601 patients with degenerative spondylolisthesis, 368 (61%) had surgery, most including fusion (344 of 368 [93%]) and most with instrumentation (269 of 344 [78%]). Degenerative spondylolisthesis surgeries significantly improved health versus nonoperative care (QALY gain, 0.23 [CI, 0.19 to 0.27]), at a cost of $115 600 (CI, $90 800 to $144 900) per QALY gained. Result of Sensitivity Analysis: Surgery cost markedly affected the value of surgery. Limitation: The study used self-reported utilization data, 2-year time horizon, and as-treated analysis to address treatment non-adherence among randomly assigned participants. Conclusion: The economic value of spinal stenosis surgery at 2 years compares favorably with many health interventions. Degenerative spondylolisthesis surgery is not highly cost-effective over 2 years but could show value over a longer time horizon.	William Beaumont Hosp, Royal Oak, MI 48072 USA; [Albert, Todd] Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA; Emory Univ, Atlanta, GA 30322 USA; [Bridwell, Keith] Washington Univ, Sch Med, St Louis, MO USA; Dartmouth Med Sch, Hanover, NH USA; Nebraska Fdn Spinal Res, Omaha, NE USA; Rush Univ, Med Ctr, Chicago, IL 60612 USA	Beaumont Health; Jefferson University; Rothman Institute; Emory University; Washington University (WUSTL); Dartmouth College; Rush University	Tosteson, ANA (corresponding author), Dartmouth Med Sch, Multidisciplinary Clin Res Ctr Musculoskeletal Di, HB7505,1 Med Ctr Dr, Lebanon, NH 03756 USA.				National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [U01-AR45444, P60-AR048094, K23 AR 048138]; Office of Research on Women's Health; National Institutes of Health; National Institute of Occupational Safety and Health; Centers for Disease Control and Prevention; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR048138, P60AR048094, U01AR045444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (U01-AR45444); Office of Research on Women's Health, National Institutes of Health; and the National Institute of Occupational Safety and Health, Centers for Disease Control and Prevention. The Multidisciplinary Clinical Research Center in Musculoskeletal Diseases is funded by NIAMS (P60-AR048094). Dr. Lurie is supported by a Research Career Award from NIAMS (K23 AR 048138).	Balding DJ, 2004, APPL LONGITUDINAL AN; Birkmeyer NJO, 2002, SPINE, V27, P1361, DOI 10.1097/00007632-200206150-00020; *BUR LAB STAT, 2005, EMPL COSTS EMPL COMP; *BUR LAB STAT, 2005, EMPL COST IND; Chang RW, 1996, JAMA-J AM MED ASSOC, V275, P858, DOI 10.1001/jama.275.11.858; Dartmouth Atlas Working Group, 2000, DARTM ATL MUSC HLTH; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; Freeman BJC, 2007, SPINE, V32, P2891, DOI 10.1097/BRS.0b013e31815b75e2; Furlan AD, 2008, SPINE, V33, P339, DOI 10.1097/BRS.0b013e31816233b5; Gold MR, 1996, COST EFFECTIVENESS H; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; Katz JN, 1997, SPINE, V22, P1123, DOI 10.1097/00007632-199705150-00012; Kornblum MB, 2004, SPINE, V29, P726, DOI 10.1097/01.BRS.0000119398.22620.92; Kuntz KM, 2000, SPINE, V25, P1132, DOI 10.1097/00007632-200005010-00015; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; *RBRVS FEE SCH, 2004, PLAIN ENGL GUID; SCHMIDT K, 2004, DRG EXPERT COMPREHEN; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Soegaard R, 2006, EUR SPINE J, V15, P1165, DOI 10.1007/s00586-005-0031-6; Solberg TK, 2005, EUR SPINE J, V14, P1000, DOI 10.1007/s00586-005-0898-2; *US CENS BUR, 2004, STAT ABSTR US INC EX; van den Hout WB, 2008, BMJ-BRIT MED J, V336, P1351, DOI 10.1136/bmj.39583.709074.BE; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; 2004, RED BOOK	31	188	191	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					845	+		10.7326/0003-4819-149-12-200812160-00003	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075203	Green Accepted			2022-12-28	WOS:000261771900001
J	Hartnoll, S				Hartnoll, Sean			PHYSICS Stringing Together a Solid State	SCIENCE			English	Editorial Material							TRANSITIONS		[Hartnoll, Sean] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Hartnoll, S (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	hartnoll@physics.harvard.edu						Balasubramanian K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.061601; Bloch I, 2008, SCIENCE, V319, P1202, DOI 10.1126/science.1152501; Goldman AM, 1998, PHYS TODAY, V51, P39, DOI 10.1063/1.882069; Gomes KK, 2007, NATURE, V447, P569, DOI 10.1038/nature05881; Hartnoll SA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.031601; Hartnoll SA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144502; Herzog CP, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.085020; Sachdev S, 2008, NAT PHYS, V4, P173, DOI 10.1038/nphys894; Son DT, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.046003; Taubes G, 1999, SCIENCE, V285, P512, DOI 10.1126/science.285.5427.512	11	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1639	1640		10.1126/science.1166668	http://dx.doi.org/10.1126/science.1166668			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074332				2022-12-28	WOS:000261608300026
J	Noedl, H; Se, Y; Schaecher, K; Smith, BL; Socheat, D; Fukuda, MM				Noedl, Harald; Se, Youry; Schaecher, Kurt; Smith, Bryan L.; Socheat, Duong; Fukuda, Mark M.		ARC1 Study Consortium	Evidence of Artemisinin-Resistant Malaria in Western Cambodia	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Noedl, Harald] Med Univ Vienna, A-1090 Vienna, Austria; [Se, Youry; Schaecher, Kurt; Smith, Bryan L.; Fukuda, Mark M.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia	Medical University of Vienna; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); National Center Parasitology, Entomology & Malaria Control	Noedl, H (corresponding author), Med Univ Vienna, A-1090 Vienna, Austria.	harald.noedl@meduniwien.ac.at							0	1165	1221	1	257	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2619	2620		10.1056/NEJMc0805011	http://dx.doi.org/10.1056/NEJMc0805011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19064625				2022-12-28	WOS:000261534200032
J	Schroder, FH; Roach, M; Scardino, P				Schroder, Fritz H.; Roach, Mack, III; Scardino, Peter			Management of Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; NOMOGRAM; BRACHYTHERAPY; SURVIVAL; THERAPY; MEN		[Schroder, Fritz H.] Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands; [Roach, Mack, III] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Scardino, Peter] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA	Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center	Schroder, FH (corresponding author), Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands.							Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Arlen PM, 2008, J UROLOGY, V179, P2181, DOI 10.1016/j.juro.2008.01.099; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Karakiewicz PI, 1998, UROLOGY, V52, P1041, DOI 10.1016/S0090-4295(98)00350-1; Kattan MW, 2003, J UROLOGY, V170, P1792, DOI 10.1097/01.ju.0000091806.70171.41; Klotz L, 2007, NAT CLIN PRACT ONCOL, V4, P692, DOI 10.1038/ncponc0966; Liauw SL, 2006, INT J RADIAT ONCOL, V66, P669, DOI 10.1016/j.ijrobp.2006.05.016; Merrick GS, 2004, UROLOGY, V64, P754, DOI 10.1016/j.urology.2004.04.054; Moon K, 2006, CANCER-AM CANCER SOC, V107, P991, DOI 10.1002/cncr.22083; Parker C, 2004, LANCET ONCOL, V5, P101, DOI 10.1016/S1470-2045(04)01384-1; Pickett B, 2006, INT J RADIAT ONCOL, V65, P65, DOI 10.1016/j.ijrobp.2005.11.037; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683	17	17	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2605	2609						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073981				2022-12-28	WOS:000261534200016
J	McGuire, AL; Burke, W				McGuire, Amy L.; Burke, Wylie			An Unwelcome Side Effect of Direct-to-Consumer Personal Genome Testing Raiding the Medical Commons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TECHNOLOGY; PREVENTION; CARE		[McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA	Baylor College of Medicine; University of Washington; University of Washington Seattle	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, 1 Baylor Plaza,MS 420, Houston, TX 77030 USA.	amcguire@bcm.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004333, P50HG003374] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG004333, P50 HG003374-01, P50HG003374, P50 HG003374, R01 HG004333-01, R01 HG004333] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Cassel CK, 2007, JAMA-J AM MED ASSOC, V297, P2518, DOI 10.1001/jama.297.22.2518; *DEP HLTH HUM SERV, US SYST OV GEN TEST; Deyo RA, 2002, ANNU REV PUBL HEALTH, V23, P23, DOI 10.1146/annurev.publhealth.23.092101.134534; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V298, P1323, DOI 10.1001/jama.298.11.1323; Fenton JJ, 2003, J AM BOARD FAM PRACT, V16, P494, DOI 10.3122/jabfm.16.6.494; *GEN PUBL POL CTR, SURV DIR TO CONS TES; *GEN PUBL POL CTR, 2008, FDA REG GEN TESTS; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Wilson J JG, 1968, PUBLIC HLTH PAPERS, V34; Wilson TD, 2008, SCIENCE, V321, P1046, DOI 10.1126/science.1163029; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	13	200	205	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2669	2671		10.1001/jama.2008.803	http://dx.doi.org/10.1001/jama.2008.803			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380YW	19066388	Green Accepted			2022-12-28	WOS:000261503000027
J	Hawkes, N				Hawkes, Nigel			All change on the road to better health care	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2008	337								a2779	10.1136/bmj.a2779	http://dx.doi.org/10.1136/bmj.a2779			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399BY	19064603				2022-12-28	WOS:000262776600004
J	Purnell, B				Purnell, Beverly			New Release: The Complete Guide to Organ Repair Introduction	SCIENCE			English	Editorial Material																			0	13	13	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1489	1489		10.1126/science.322.5907.1489	http://dx.doi.org/10.1126/science.322.5907.1489			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056972				2022-12-28	WOS:000261377400034
J	Marcellin, P; Heathcote, EJ; Buti, M; Gane, E; de Man, RA; Krastev, Z; Germanidis, G; Lee, SS; Flisiak, R; Kaita, K; Manns, M; Kotzev, I; Tchernev, K; Buggisch, P; Weilert, F; Kurdas, OO; Shiffman, ML; Trinh, H; Washington, MK; Sorbel, J; Anderson, J; Snow-Lampart, A; Mondou, E; Quinn, J; Rousseau, F				Marcellin, Patrick; Heathcote, E. Jenny; Buti, Maria; Gane, Ed; de Man, Robert A.; Krastev, Zahary; Germanidis, George; Lee, Sam S.; Flisiak, Robert; Kaita, Kelly; Manns, Michael; Kotzev, Iskren; Tchernev, Konstantin; Buggisch, Peter; Weilert, Frank; Kurdas, Oya Ovung; Shiffman, Mitchell L.; Trinh, Huy; Washington, Mary Kay; Sorbel, Jeff; Anderson, Jane; Snow-Lampart, Andrea; Mondou, Elsa; Quinn, Joe; Rousseau, Franck			Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases	NOV 02-06, 2007	Boston, MA	Amer Assoc Study Liver Dis			IN-VITRO ACTIVITY; LIVER-TRANSPLANTATION; VIRUS-INFECTIONS; CONTROLLED TRIAL; NATURAL-HISTORY; HBV INFECTION; HIV-INFECTION; LAMIVUDINE; THERAPY; INTERFERON	Background: Tenofovir disoproxil fumarate (DF) is a nucleotide analogue and a potent inhibitor of human immunodeficiency virus type 1 reverse transcriptase and hepatitis B virus (HBV) polymerase. Methods: In two double-blind, phase 3 studies, we randomly assigned patients with hepatitis B e antigen (HBeAg)-negative or HBeAg-positive chronic HBV infection to receive tenofovir DF or adefovir dipivoxil (ratio, 2:1) once daily for 48 weeks. The primary efficacy end point was a plasma HBV DNA level of less than 400 copies per milliliter (69 IU per milliliter) and histologic improvement (i.e., a reduction in the Knodell necroinflammation score of 2 or more points without worsening fibrosis) at week 48. Secondary end points included viral suppression (i.e., an HBV DNA level of <400 copies per milliliter), histologic improvement, serologic response, normalization of alanine aminotransferase levels, and development of resistance mutations. Results: At week 48, in both studies, a significantly higher proportion of patients receiving tenofovir DF than of those receiving adefovir dipivoxil had reached the primary end point (P<0.001). Viral suppression occurred in more HBeAg-negative patients receiving tenofovir DF than patients receiving adefovir dipivoxil (93% vs. 63%, P<0.001) and in more HBeAg-positive patients receiving tenofovir DF than patients receiving adefovir dipivoxil (76% vs. 13%, P<0.001). Significantly more HBeAg-positive patients treated with tenofovir DF than those treated with adefovir dipivoxil had normalized alanine aminotransferase levels (68% vs. 54%, P=0.03) and loss of hepatitis B surface antigen (3% vs. 0%, P=0.02). At week 48, amino acid substitutions within HBV DNA polymerase associated with phenotypic resistance to tenofovir DF or other drugs to treat HBV infection had not developed in any of the patients. Tenofovir DF produced a similar HBV DNA response in patients who had previously received lamivudine and in those who had not. The safety profile was similar for the two treatments in both studies. Conclusions: Among patients with chronic HBV infection, tenofovir DF at a daily dose of 300 mg had superior antiviral efficacy with a similar safety profile as compared with adefovir dipivoxil at a daily dose of 10 mg through week 48. (ClinicalTrials.gov numbers, NCT00116805 and NCT00117676.).	[Sorbel, Jeff; Anderson, Jane; Snow-Lampart, Andrea; Mondou, Elsa; Quinn, Joe; Rousseau, Franck] Gilead Sci Inc, Durham, NC USA; [Marcellin, Patrick] Univ Paris 07, Hop Beaujon, Assistance Publ Hop Paris, Clichy, France; [Marcellin, Patrick] Hop Beaujon, INSERM, Unite 773, Ctr Rech Claude Bernard Hepatites Virales, Clichy, France; [Heathcote, E. Jenny] Univ Toronto, Toronto, ON, Canada; [Lee, Sam S.] Univ Calgary, Calgary, AB, Canada; [Kaita, Kelly] Univ Manitoba, John Buhler Res Ctr, Winnipeg, MB, Canada; [Buti, Maria] Hosp Gen Valle Hebron, Barcelona, Spain; [Gane, Ed] Middlemore Hosp, Auckland 6, New Zealand; [Weilert, Frank] Waikato Hosp, Hamilton, New Zealand; [de Man, Robert A.] Erasmus Univ, Ctr Med, Rotterdam, Netherlands; [Krastev, Zahary] Univ Hosp St Ivan Rilsky, Sofia, Bulgaria; [Kotzev, Iskren] Univ Hosp Sveta Marina, Varna, Bulgaria; [Tchernev, Konstantin] Med Univ Sofia, Sofia, Bulgaria; [Germanidis, George] Papageorgiou Gen Hosp Thessaloniki, Thessaloniki, Greece; [Flisiak, Robert] Med Univ Bialystok, Bialystok, Poland; [Manns, Michael] Hannover Med Sch, D-30623 Hannover, Germany; [Buggisch, Peter] Med Univ Klin Eppendorf, Hamburg, Germany; [Kurdas, Oya Ovung] Haydarpasa Numune Hosp, Istanbul, Turkey; [Shiffman, Mitchell L.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA; [Trinh, Huy] San Jose Gastroenterol, San Jose, CA USA; [Washington, Mary Kay] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Gilead Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University of Calgary; University of Manitoba; Hospital Universitari Vall d'Hebron; Waikato Hospital; Erasmus University Rotterdam; Medical University Sofia; Medical University Varna; Medical University Sofia; Papageorgiou Hospital; Medical University of Bialystok; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Istanbul Haydarpasa Numune Training & Research Hospital; Virginia Commonwealth University; Vanderbilt University	Rousseau, F (corresponding author), Gilead Sci Inc, 4611 Univ Dr, Durham, NC USA.	frank.rousseau@gilead.com	Flisiak, Robert/S-5356-2018	Flisiak, Robert/0000-0003-3394-1635; Buti Ferret, Maria/0000-0002-0732-3078				Alberti A, 2005, J HEPATOL, V43, P1098, DOI 10.1016/j.jhep.2005.10.001; Alberti A, 2005, J HEPATOL, V42, P615, DOI 10.1016/j.jhep.2005.03.003; [Anonymous], 2006, GUIDELINES USE ANTIR; Brunelle MN, 2007, ANTIMICROB AGENTS CH, V51, P2240, DOI 10.1128/AAC.01440-06; Brunelle MN, 2005, HEPATOLOGY, V41, P1391, DOI 10.1002/hep.20723; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; CHERRINGTON JM, 1995, ANTIVIR CHEM CHEMOTH, V6, P217, DOI 10.1177/095632029500600403; Delaney WE, 2006, ANTIMICROB AGENTS CH, V50, P2471, DOI 10.1128/AAC.00138-06; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Feld JJ, 2006, SEMIN LIVER DIS, V26, P116, DOI 10.1055/s-2006-939750; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; Gala S, 2008, J HEPATOL, V48, P540, DOI 10.1016/j.jhep.2007.12.018; *GIL SCI, 2007, VIR TEN DIS FUM TABL; *GIL SCI, 2006, HEPS AD DIP TABL US; Hadziyannis SJ, 2001, HEPATOLOGY, V34, P617, DOI 10.1053/jhep.2001.27834; Hadziyannis SJ, 2006, SEMIN LIVER DIS, V26, P130, DOI 10.1055/s-2006-939751; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HEIJTINK RA, 1994, ANTIMICROB AGENTS CH, V38, P2180, DOI 10.1128/AAC.38.9.2180; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; HOOFNAGLE JH, 1988, GASTROENTEROLOGY, V95, P1318, DOI 10.1016/0016-5085(88)90367-8; Kuo A, 2004, CLIN GASTROENTEROL H, V2, P266, DOI 10.1016/S1542-3565(04)00017-5; Lada O, 2004, ANTIVIR THER, V9, P353; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lin SM, 2007, J HEPATOL, V46, P45, DOI 10.1016/j.jhep.2006.08.021; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P1347, DOI 10.1002/hep.21738; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Mommeja-Marin H, 2003, HEPATOLOGY, V37, P1309, DOI 10.1053/jhep.2003.50208; Neff GW, 2004, ANN PHARMACOTHER, V38, P1999, DOI 10.1345/aph.1E280; PERRILLO RP, 1990, NEW ENGL J MED, V323, P295, DOI 10.1056/NEJM199008023230503; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Peters MG, 2006, HEPATOLOGY, V44, P1110, DOI 10.1002/hep.21388; Schiff ER, 2003, HEPATOLOGY, V38, P1419, DOI 10.1016/j.hep.2003.09.040; Thio CL, 2005, CLIN INFECT DIS, V41, P1035, DOI 10.1086/496921; van Bommel F, 2006, HEPATOLOGY, V44, P318, DOI 10.1002/hep.21253; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; van der Poorten D, 2007, J GASTROEN HEPATOL, V22, P1500, DOI 10.1111/j.1440-1746.2007.05093.x; *WHO, 2000, HEP B FACT SHEET WHO; Yuen MF, 2005, HEPATOLOGY, V42, p583A	44	885	941	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2442	2455		10.1056/NEJMoa0802878	http://dx.doi.org/10.1056/NEJMoa0802878			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	378MT	19052126	Bronze			2022-12-28	WOS:000261325900005
J	Wilson, CM; Fielder, AR				Wilson, Clare M.; Fielder, Alistair R.			Retinopathy of prematurity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VISUAL IMPAIRMENT; INTERNATIONAL CLASSIFICATION; MULTICENTER TRIAL; PLUS DISEASE; CHILDREN; PRETERM; BIRTH; POPULATION; INFANTS; STRABISMUS		[Wilson, Clare M.; Fielder, Alistair R.] City Univ London, Dept Optometry & Vis Sci, London EC1V 0HB, England	City University London	Wilson, CM (corresponding author), City Univ London, Dept Optometry & Vis Sci, London EC1V 0HB, England.	clarewil25@yahoo.com	Osman, Sanha A/B-4056-2012; Akın, Mustafa Senol/F-5143-2017; Chandra, Parijat/I-2929-2013	Akın, Mustafa Senol/0000-0003-0055-8277; Chandra, Parijat/0000-0002-7516-1410				Chiang MF, 2007, ARCH OPHTHALMOL-CHIC, V125, P875, DOI 10.1001/archopht.125.7.875; COOK RC, 1951, AM J OPHTHALMOL, V34, P1407, DOI 10.1016/0002-9394(51)90481-3; Darlow BA, 1997, BRIT J OPHTHALMOL, V81, P935, DOI 10.1136/bjo.81.11.935; Ells A, 2000, CAN J OPHTHALMOL, V35, P253, DOI 10.1016/S0008-4182(00)80073-3; Ells A, 2000, CAN J OPHTHALMOL, V35, P251, DOI 10.1016/S0008-4182(00)80072-1; Elsas FJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1110; Fledelius HC, 1996, ACTA OPHTHALMOL SCAN, V74, P297; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Holmstrom GE, 2005, ARCH OPHTHALMOL-CHIC, V123, P1404, DOI 10.1001/archopht.123.10.1404; Holmstrom G, 2006, J PEDIAT OPHTH STRAB, V43, P346, DOI 10.3928/01913913-20061101-04; Larsson EK, 2003, ARCH OPHTHALMOL-CHIC, V121, P1430, DOI 10.1001/archopht.121.10.1430; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; O'Connor A, 2007, EYE, V21, P1254, DOI 10.1038/sj.eye.6702838; O'Connor AR, 2006, BRIT J OPHTHALMOL, V90, P456, DOI 10.1136/bjo.2005.083535; O'Connor AR, 2002, PEDIATRICS, V109, P12, DOI 10.1542/peds.109.1.12; O'Connor AR, 2002, ARCH OPHTHALMOL-CHIC, V120, P767; PALMER EA, 1988, ARCH OPHTHALMOL-CHIC, V106, P471; Pennefather PM, 1999, BRIT J OPHTHALMOL, V83, P514, DOI 10.1136/bjo.83.5.514; PIKE MG, 1994, DEV MED CHILD NEUROL, V36, P849; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Rahi JS, 1998, ARCH DIS CHILD, V78, P381, DOI 10.1136/adc.78.4.381; Vollmer B, 2006, DEV MED CHILD NEUROL, V48, P348, DOI 10.1017/S0012162206000764; Wallace DK, 2008, J AAPOS, V12, P352, DOI 10.1016/j.jaapos.2007.11.022; Wilkinson AR, 2008, EARLY HUM DEV, V84, P71, DOI 10.1016/j.earlhumdev.2007.12.004; WILSON CM, 2008, INFANT, V4, P230; WILSON CM, 2007, NEW APPROACH CLASSIF, P3103; Zin Andrea, 2007, Arq. Bras. Oftalmol., V70, P875, DOI 10.1590/S0004-27492007000500028; 2006, PEDIATRICS, V117, P1468	32	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2008	337								a2648	10.1136/bmj.a2648	http://dx.doi.org/10.1136/bmj.a2648			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NW	19052064				2022-12-28	WOS:000261890900011
J	Jeziorski, A; Yan, ND; Paterson, AM; DeSellas, AM; Turner, MA; Jeffries, DS; Keller, B; Weeber, RC; McNicol, DK; Palmer, ME; McIver, K; Arseneau, K; Ginn, BK; Cumming, BF; Smol, JP				Jeziorski, Adam; Yan, Norman D.; Paterson, Andrew M.; DeSellas, Anna M.; Turner, Michael A.; Jeffries, Dean S.; Keller, Bill; Weeber, Russ C.; McNicol, Don K.; Palmer, Michelle E.; McIver, Kyle; Arseneau, Kristina; Ginn, Brian K.; Cumming, Brian F.; Smol, John P.			The Widespread Threat of Calcium Decline in Fresh Waters	SCIENCE			English	Article							SOUTH-CENTRAL ONTARIO; CRUSTACEAN ZOOPLANKTON; FORESTED CATCHMENTS; UNITED-STATES; NEW-YORK; LAKES; ACIDIFICATION; CANADA; ASSEMBLAGES; DEPOSITION	Calcium concentrations are now commonly declining in softwater boreal lakes. Although the mechanisms leading to these declines are generally well known, the consequences for the aquatic biota have not yet been reported. By examining crustacean zooplankton remains preserved in lake sediment cores, we document near extirpations of calcium- rich Daphnia species, which are keystone herbivores in pelagic food webs, concurrent with declining lake- water calcium. A large proportion ( 62%, 47 to 81% by region) of the Canadian Shield lakes we examined has a calcium concentration approaching or below the threshold at which laboratory Daphnia populations suffer reduced survival and fecundity. The ecological impacts of environmental calcium loss are likely to be both widespread and pronounced.	[Jeziorski, Adam; DeSellas, Anna M.; McIver, Kyle; Arseneau, Kristina; Ginn, Brian K.; Cumming, Brian F.; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Yan, Norman D.; Palmer, Michelle E.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Yan, Norman D.; Paterson, Andrew M.; DeSellas, Anna M.] Ontario Minist Environm, Dorset Environm Sci Ctr, Dorset, ON P0A 1E0, Canada; [Turner, Michael A.] Fisheries & Oceans Canada, Expt Lakes Area, Winnipeg, MB R3T 2N6, Canada; [Jeffries, Dean S.] Environm Canada, Natl Water Res Inst, Burlington, ON L7R 4A6, Canada; [Keller, Bill] Laurentian Univ, Ontario Minist Environm, Cooperat Freshwater Ecol Unit, Sudbury, ON P3E 2C6, Canada; [Weeber, Russ C.; McNicol, Don K.] Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada	Queens University - Canada; York University - Canada; Fisheries & Oceans Canada; Environment & Climate Change Canada; National Water Research Institute; Laurentian University; Environment & Climate Change Canada; Canadian Wildlife Service	Smol, JP (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	smolj@queensu.ca	Yan, Norman/H-5235-2013; Smol, John P/A-8838-2015; Jeziorski, Adam/AAJ-6982-2020; Keller, Wendel/G-1533-2012	Jeziorski, Adam/0000-0001-7701-7247; Smol, John/0000-0002-2499-6696; Yan, Norman/0000-0003-4870-6865	Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of the Environment; Environment Canada; Fisheries and Oceans Canada; School of Environmental Systems Engineering; University of Western Australia	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of the Environment; Environment Canada(CGIAR); Fisheries and Oceans Canada; School of Environmental Systems Engineering; University of Western Australia	This work was primarily supported by grants from the Natural Sciences and Engineering Research Council of Canada, as well as funding from the Ontario Ministry of the Environment, Environment Canada, and Fisheries and Oceans Canada. We thank the latter three agencies for the data used to develop Fig. 4. N. D. Y. thanks the School of Environmental Systems Engineering from the University of Western Australia for their support. We would also like to thank D. Schindler and S. Watmough for their valuable comments on this manuscript.	Ashforth D, 2008, LIMNOL OCEANOGR, V53, P420, DOI 10.4319/lo.2008.53.2.0420; Battarbee Richard W., 1999, P85; CHAN C, 2004, THESIS QUEENS U; CHARLES DF, 1987, BIOGEOCHEMISTRY, V3, P267, DOI 10.1007/BF02185196; Clair T.A., 2001, 16 ENV CAN; Cyr H, 1999, OECOLOGIA, V118, P306, DOI 10.1007/s004420050731; DeSellas AM, 2008, HYDROBIOLOGIA, V600, P105, DOI 10.1007/s10750-007-9180-4; Driscoll CT, 2003, ENVIRON SCI TECHNOL, V37, P2036, DOI 10.1021/es020924h; Ginn BK, 2007, CAN J FISH AQUAT SCI, V64, P1043, DOI 10.1139/F07-078; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; Hall RI, 1996, CAN J FISH AQUAT SCI, V53, P1, DOI 10.1139/cjfas-53-1-1; HAVENS KE, 1993, ENVIRON SCI TECHNOL, V27, P1621, DOI 10.1021/es00045a019; Houle D, 2006, CAN J FISH AQUAT SCI, V63, P471, DOI 10.1139/f06-007; Huntington TG, 2000, SOIL SCI SOC AM J, V64, P1845, DOI 10.2136/sssaj2000.6451845x; JEFFRIES DS, 2004, 2004 CANADIAN ACID D, pCH6; Jeziorski A, 2006, CAN J FISH AQUAT SCI, V63, P1007, DOI 10.1139/F06-019; Keller W, 2001, CAN J FISH AQUAT SCI, V58, P2011, DOI 10.1139/cjfas-58-10-2011; KIRCHNER JW, 1995, ENVIRON SCI TECHNOL, V29, P1953, DOI 10.1021/es00008a012; Korhola A., 2001, TRACKING ENV CHANGE, P5, DOI DOI 10.1007/0-306-47671-1_2; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; MacRae PSD, 2001, CAN J FISH AQUAT SCI, V58, P342, DOI 10.1139/cjfas-58-2-342; Norton S.A., 2003, TREATISE GEOCHEMISTR, V9, P367, DOI [10.1016/B0-08-043751-6/09052-6, DOI 10.1016/B0-08-043751-6/09052-6]; Skjelkvale BL, 2005, ENVIRON POLLUT, V137, P165, DOI 10.1016/j.envpol.2004.12.023; Smol J.P., 2009, POLLUTION LAKES RIVE; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114; Watmough SA, 2005, ENVIRON MONIT ASSESS, V109, P1, DOI 10.1007/s10661-005-4336-z; Watmough SA, 2003, CAN J FISH AQUAT SCI, V60, P1095, DOI [10.1139/f03-093, 10.1139/F03-093]; Watmough SA, 2008, CAN J FISH AQUAT SCI, V65, P821, DOI 10.1139/F07-196; YARI ND, 2008, CAN J FISH AQUAT SCI, V65, P862	30	235	246	6	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1374	1377		10.1126/science.1164949	http://dx.doi.org/10.1126/science.1164949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039134				2022-12-28	WOS:000261170600037
J	Lameire, N; Van Biesen, W; Vanholder, R				Lameire, Norbert; Van Biesen, Wim; Vanholder, Raymond			Acute kidney injury	LANCET			English	Editorial Material							RENAL REPLACEMENT THERAPY; INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; SODIUM-BICARBONATE; SEPTIC SHOCK; PREVENTION; MANAGEMENT; SEPSIS; AKI		[Lameire, Norbert; Van Biesen, Wim; Vanholder, Raymond] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital	Lameire, N (corresponding author), Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium.	norbert.lameire@ugent.be						Adolph E, 2008, CORONARY ARTERY DIS, V19, P413, DOI 10.1097/MCA.0b013e3283021ac6; Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; Bouchard J, 2008, ADV CHRONIC KIDNEY D, V15, P235, DOI 10.1053/j.ackd.2008.04.004; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Kellum JA, 2008, NEPHROL DIAL TRANSPL, V23, P1471, DOI 10.1093/ndt/gfn012; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Maioli M, 2008, J AM COLL CARDIOL, V52, P599, DOI 10.1016/j.jacc.2008.05.026; Murray PT, 2008, CLIN J AM SOC NEPHRO, V3, P864, DOI 10.2215/CJN.04851107; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Perel P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub3; Preiser JC, 2007, INTENS CARE MED, V33, P570, DOI 10.1007/s00134-006-0485-y; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Sakr Y, 2006, CRIT CARE MED, V34, P589, DOI 10.1097/01.CCM.0000201896.45809.E3; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Thomas G, 2007, NEPHROL DIAL TRANSPL, V22, P2849, DOI 10.1093/ndt/gfm401; Tolwani AJ, 2008, J AM SOC NEPHROL, V19, P1233, DOI 10.1681/ASN.2007111173; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Tumlin J, 2008, J AM SOC NEPHROL, V19, P1034, DOI 10.1681/ASN.2007080895; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615	22	85	88	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1863	1865		10.1016/S0140-6736(08)61794-8	http://dx.doi.org/10.1016/S0140-6736(08)61794-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041789				2022-12-28	WOS:000261388700007
J	von Seidlein, L; Deen, JL				von Seidlein, Lorenz; Deen, Jacqueline L.			Pre-referral rectal artesunate in severe malaria	LANCET			English	Editorial Material									[von Seidlein, Lorenz; Deen, Jacqueline L.] Joint Malaria Project, Tanga, Tanzania; [Deen, Jacqueline L.] Int Vaccine Inst, Seoul, South Korea	International Vaccine Institute	von Seidlein, L (corresponding author), Joint Malaria Project, Tanga, Tanzania.	lseidlein@ivi.int						Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Faiz MA, 2005, LANCET, V366, P717; Gomes M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-39; GOMES MF, 2008, LANCET, DOI DOI 10.1016/S0140-6736(08)-61734-1; Karunajeewa HA, 2007, JAMA-J AM MED ASSOC, V297, P2381, DOI 10.1001/jama.297.21.2381	5	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					522	523		10.1016/S0140-6736(08)61735-3	http://dx.doi.org/10.1016/S0140-6736(08)61735-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19059638				2022-12-28	WOS:000263333600006
J	Hyder, AA; Peden, M; Krug, E				Hyder, Adnan A.; Peden, Margie; Krug, Etienne			Child health must include injury prevention	LANCET			English	Editorial Material									[Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Dept Int Hlth, Baltimore, MD 21205 USA; [Peden, Margie; Krug, Etienne] WHO, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization	Hyder, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Dept Int Hlth, Baltimore, MD 21205 USA.	ahyder@jhsph.edu	Hyder, Adnan/AAT-9503-2021	Mary, Margaret/0000-0003-0872-9851; Hyder, Adnan/0000-0002-7292-577X				[Anonymous], WORLD HLTH REP 2002; Branche C., 2008, WORLD REPORT CHILD I; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; Lopez A, 2008, LANCET, V372, P1525, DOI 10.1016/S0140-6736(08)61632-3; Peden M., 2004, WORLD REPORT ROAD TR; Peden M, 2002, INJURY CHART BOOK GR; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; [No title captured]	8	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					102	103		10.1016/S0140-6736(08)61736-5	http://dx.doi.org/10.1016/S0140-6736(08)61736-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19081617				2022-12-28	WOS:000262340900007
J	Bashkirov, PV; Akimov, SA; Evseev, AI; Schmid, SL; Zimmerberg, J; Frolov, VA				Bashkirov, Pavel V.; Akimov, Sergey A.; Evseev, Alexey I.; Schmid, Sandra L.; Zimmerberg, Joshua; Frolov, Vadim A.			GTPase Cycle of Dynamin Is Coupled to Membrane Squeeze and Release, Leading to Spontaneous Fission	CELL			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; NERVE-TERMINALS; ENDOCYTOSIS; CURVATURE; VESICLES; TENSION; FUSION; DOMAIN; CELLS	The GTPase dynamin is critically involved in membrane fission during endocytosis. How does dynamin use the energy of GTP hydrolysis for membrane remodeling? By monitoring the ionic permeability through lipid nanotubes (NT), we found that dynamin was capable of squeezing NT to extremely small radii, depending on the NT lipid composition. However, long dynamin scaffolds did not produce fission: instead, fission followed GTPase-dependent cycles of assembly and disassembly of short dynamin scaffolds and involved a stochastic process dependent on the curvature stress imposed by dynamin. Fission happened spontaneously upon NT release from the scaffold, without leakage. Our calculations revealed that local narrowing of NT could induce cooperative lipid tilting, leading to self-merger of the inner monolayer of NT (hemifission), consistent with the absence of leakage. We propose that dynamin transmits GTP's energy to periodic assembling of a limited curvature scaffold that brings lipids to an unstable intermediate.	[Bashkirov, Pavel V.; Akimov, Sergey A.; Zimmerberg, Joshua; Frolov, Vadim A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, Bethesda, MD 20892 USA; [Bashkirov, Pavel V.; Akimov, Sergey A.; Evseev, Alexey I.] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow 119991, Russia; [Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; Scripps Research Institute	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, Bethesda, MD 20892 USA.	joshz@mail.nih.gov	Akimov, Sergey A/L-2001-2013; Akimov, Sergey/AFV-4270-2022; Akimov, Sergey A./I-6432-2015; Bashkirov, Pavel V/Y-8464-2018; Frolov, Vadim/ABH-3889-2020; Bashkirov, Pavel/J-2385-2012	Akimov, Sergey/0000-0002-7916-6032; Frolov, Vadim/0000-0002-0653-5669; Schmid, Sandra/0000-0002-1690-7024; Bashkirov, Pavel/0000-0003-2250-9759	National Institutes of Health (NIH) [R01GM42455, R37MH61345]; RFBR [08-04-00085]; CRDF GAP [RUB1-1297(5)-MO-05]; Russian Federal Agency for Science and Innovations [02.512.11.0010]; Program of Molecular and Cellular Biology RAS; Leading Scientific Schools of Russian Federation [4181.2008.4]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH061345, R01MH061345] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RFBR(Russian Foundation for Basic Research (RFBR)); CRDF GAP; Russian Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Program of Molecular and Cellular Biology RAS; Leading Scientific Schools of Russian Federation(Leading Scientific Schools Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by the National Institutes of Health (NIH) intramural program (NICHD), and grants NIH R01GM42455 and R37MH61345, RFBR 08-04-00085, and CRDF GAP RUB1-1297(5)-MO-05, Russian Federal Agency for Science and Innovations 02.512.11.0010, Program of Molecular and Cellular Biology RAS, and the grant for State Support of Leading Scientific Schools of Russian Federation 4181.2008.4. The BODIPY-labeled dynamin was generously provided by Rajesh Ramachandran. We are grateful to Vladimir Lizunov and Gennady Kushnir for their technical help and Thomas Pucadyil, Anna Shnyrova, and Yuri Chizmadzhev for a careful reading of the manuscript and fruitful discussions.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Angelova I., 1988, PROG COLL POL SCI S, V76, P59, DOI [DOI 10.1007/BFB0114157, 10.1007/bfb0114171, DOI 10.1007/BFB0114171]; BARZIV R, 1994, PHYS REV LETT, V73, P1392, DOI 10.1103/PhysRevLett.73.1392; Bashkirov PV, 2007, BIOCHEM MOSC SUPPL S, V1, P176, DOI 10.1134/S1990747807020110; Bukman DJ, 1996, PHYS REV E, V54, P5463, DOI 10.1103/PhysRevE.54.5463; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Eliasson L, 1996, J PHYSIOL-LONDON, V493, P755, DOI 10.1113/jphysiol.1996.sp021420; EVANS E, 1994, CHEM PHYS LIPIDS, V73, P39, DOI 10.1016/0009-3084(94)90173-2; FOURCADE B, 1994, PHYS REV E, V49, P5276, DOI 10.1103/PhysRevE.49.5276; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Frolov VA, 2003, BIOPHYS J, V85, P1725, DOI 10.1016/S0006-3495(03)74602-5; Frolov VA, 2008, CELL, V132, P727, DOI 10.1016/j.cell.2008.02.025; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Kozlov MM, 2001, TRAFFIC, V2, P51, DOI 10.1034/j.1600-0854.2001.020107.x; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Rappoport JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002416; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sandre O, 1999, P NATL ACAD SCI USA, V96, P10591, DOI 10.1073/pnas.96.19.10591; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	42	221	223	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1276	1286		10.1016/j.cell.2008.11.028	http://dx.doi.org/10.1016/j.cell.2008.11.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19084269	Green Accepted, Bronze			2022-12-28	WOS:000261989800018
J	Buratowski, S				Buratowski, Stephen			TRANSCRIPTION Gene Expression-Where to Start?	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; NOISE		[Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056663, R01GM046498] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056663-11, R01 GM056663, R01 GM046498-18, R01 GM046498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dichtl B, 2008, MOL CELL, V31, P617, DOI 10.1016/j.molcel.2008.08.014; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lykke-Andersen S, 2006, NAT STRUCT MOL BIOL, V13, P860, DOI 10.1038/nsmb1006-860; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468	12	39	40	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1804	1805		10.1126/science.1168805	http://dx.doi.org/10.1126/science.1168805			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095933	Green Accepted			2022-12-28	WOS:000261799400044
J	Maltais, F; Bourbeau, J; Shapiro, S; Lacasse, Y; Perrault, H; Baltzan, M; Hernandez, P; Rouleau, M; Julien, M; Parenteau, S; Paradis, B; Levy, RD; Camp, P; Lecours, R; Audet, R; Hutton, B; Penrod, JR; Picard, D; Bernard, S				Maltais, Francois; Bourbeau, Jean; Shapiro, Stan; Lacasse, Yves; Perrault, Helene; Baltzan, Marc; Hernandez, Paul; Rouleau, Michel; Julien, Marcel; Parenteau, Simon; Paradis, Bruno; Levy, Robert D.; Camp, Pat; Lecours, Richard; Audet, Richard; Hutton, Brian; Penrod, John R.; Picard, Danielle; Bernard, Sarah			Effects of Home-Based Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; EXERCISE TOLERANCE; FUNCTIONAL STATUS; HEALTH-STATUS; PROGRAMS; MANAGEMENT; DIAGNOSIS; WALK	Background: Home-based rehabilitation is a promising approach to improve access to pulmonary rehabilitation. Objective: To assess whether self-monitored, home-based rehabilitation is as effective as outpatient, hospital-based rehabilitation in patients with chronic obstructive pulmonary disease (COPD). Design: Randomized, multicenter, noninferiority trial. Setting: 10 academic and community medical centers in Canada. Patients: 252 patients with moderate to severe COPD. Intervention: After a 4-week education program, patients took part in home-based rehabilitation or outpatient, hospital-based rehabilitation for 8 weeks. They were followed for 40 weeks to complete the 1-year study. Measurements: The primary outcome was the change in Chronic Respiratory Questionnaire dyspnea subscale score at 1 year. The primary analysis took a modified intention-to-treat approach by using all patients who provided data at the specified follow-up time, regardless of their level of adherence. The analysis used regression modeling that adjusted for the effects of center, sex, and baseline level. All differences were computed as home intervention minus outpatient intervention. Results: Both interventions produced similar improvements in the Chronic Respiratory Questionnaire dyspnea subscale at 1 year: improvement in dyspnea of 0.62 (95% CI, 0.43 to 0.80) units in the home intervention (n = 107) and 0.46 (CI, 0.28 to 0.64) units in the outpatient intervention (n = 109). The difference between the 2 treatments at 1 year was small and clinically unimportant. The 95% CI of the difference did not exceed the prespecified noninferiority margin of 0.5: difference in dyspnea score of 0.16 (CI, -0.08 to 0.40). Most adverse events were related to COPD exacerbations. No serious adverse event was considered to be related to the study intervention. Limitation: The contribution of the educational program to the improvement in health status and exercise tolerance cannot be ascertained. Conclusion: Home rehabilitation is a useful, equivalent alternative to outpatient rehabilitation in patients with COPD.	[Maltais, Francois; Lacasse, Yves] Hop Laval, Ctr Pneumol, Ste Foy, PQ G1V 4G5, Canada; Univ Laval, Inst Univ Cardiol & Pneumol, Hop Laval, Quebec City, PQ, Canada; Ctr Hosp Univ Associe, Quebec City, PQ, Canada; McGill Univ, Ctr Hlth, Mt Sinai Hosp, Montreal Chest Inst, Montreal, PQ, Canada; Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada; Jewish Rehabil Hosp, Laval, PQ, Canada; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Hop Hotel Dieu, Levis, PQ, Canada; Ctr Hosp Baie Des Chaleurs, Maria, PQ, Canada; Ottawa Hosp, Clin Epidemiol Program, Ottawa Hlth Res Inst, Ottawa, ON, Canada	Laval University; Laval University; McGill University; Universite de Montreal; Dalhousie University; Queen Elizabeth II Health Sciences Centre; McGill University; St. Paul's Hospital; University of Saskatchewan; Laval University; University of Ottawa; Ottawa Hospital Research Institute	Maltais, F (corresponding author), Hop Laval, Ctr Pneumol, 2725 Chem Ste Foy, Ste Foy, PQ G1V 4G5, Canada.	francois.maltais@med.ulaval.ca; jean.bourbeau@mcgill.ca	Camp, Pat/AAY-4418-2020	Hutton, Brian/0000-0001-5662-8647	Canadian Institutes of Health Research [MCT-63162]; Fonds de la recherche en sante du Quebec; Faculty of Medicine; McGill University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Faculty of Medicine; McGill University	By a Canadian Institutes of Health Research grant (MCT-63162) and by the Respiratory Health Network of the Fonds de la recherche en sante du Quebec. Dr. Maltais is a research scholar of the Fonds de la recherche en sante du Quebec. Dr. Bourbeau is recipient of a John R. and Clara Fraser Memorial Award from the Faculty of Medicine, McGill University.	[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Bickford L S, 1995, J Cardiopulm Rehabil, V15, P406, DOI 10.1097/00008483-199511000-00002; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Bourbeau Jean, 2004, Can Respir J, V11, P480; Brooks D, 2007, CAN RESPIR J, V14, P87, DOI 10.1155/2007/951498; BUSCH AJ, 1988, PHYS THER, V68, P469, DOI 10.1093/ptj/68.4.469; Cambach W, 1997, EUR RESPIR J, V10, P104, DOI 10.1183/09031936.97.10010104; Debigare R, 1999, J Cardiopulm Rehabil, V19, P235, DOI 10.1097/00008483-199907000-00004; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lacasse Y, 1997, CAN RESPIR J, V4, DOI 10.1155/1997/717139; Laviolette L, 2008, THORAX, V63, P115, DOI 10.1136/thx.2006.076844; Maltais F, 1997, AM J RESP CRIT CARE, V155, P555, DOI 10.1164/ajrccm.155.2.9032194; MCGAVIN CR, 1977, THORAX, V32, P307, DOI 10.1136/thx.32.3.307; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; O'Donnell DE, 2004, EUR RESPIR J, V23, P832, DOI 10.1183/09031936.04.00116004; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Puente-Maestu L, 2000, EUR RESPIR J, V15, P517, DOI 10.1034/j.1399-3003.2000.15.15.x; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; Strijbos JH, 1996, CHEST, V109, P366, DOI 10.1378/chest.109.2.366; Wijkstra PJ, 1996, EUR RESPIR J, V9, P104, DOI 10.1183/09031936.96.09010104; Yohannes AM, 2004, CLIN REHABIL, V18, P444, DOI 10.1191/0269215504cr736oa	31	268	283	2	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					869	+		10.7326/0003-4819-149-12-200812160-00006	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075206				2022-12-28	WOS:000261771900004
J	Firth, PG; Zheng, H; Windsor, JS; Sutherland, AI; Imray, CH; Moore, GWK; Semple, JL; Roach, RC; Salisbury, RA				Firth, Paul G.; Zheng, Hui; Windsor, Jeremy S.; Sutherland, Andrew I.; Imray, Christopher H.; Moore, G. W. K.; Semple, John L.; Roach, Robert C.; Salisbury, Richard A.			CHRISTMAS 2008: SPORT Mortality on Mount Everest, 1921-2006: descriptive study	BRITISH MEDICAL JOURNAL			English	Article							ALTITUDE CEREBRAL EDEMA; EXTREME ALTITUDE; OXYGEN; SICKNESS; PRESSURE; DEATH	Objective To examine patterns of mortality among climbers on Mount Everest over an 86 year period. Design Descriptive study. Setting Climbing expeditions to Mount Everest, 1921-2006. Participants 14 138 mountaineers; 8030 climbers and 6108 sherpas. Main outcome measure Circumstances of deaths. Results The mortality rate among mountaineers above base camp was 1.3%. Deaths could be classified as involving trauma ( objective hazards or falls, n= 113), as non- traumatic ( high altitude illness, hypothermia, or sudden death, n= 52), or as a disappearance ( body never found, n= 27). During the spring climbing seasons from 1982 to 2006, 82.3% of deaths of climbers occurred during an attempt at reaching the summit. The death rate during all descents via standard routes was higher for climbers than for sherpas ( 2.7% ( 43/ 1585) v 0.4% ( 5/ 1231), P< 0.001; all mountaineers 1.9%). Of 94 mountaineers who died after climbing above 8000 m, 53 ( 56%) died during descent from the summit, 16 ( 17%) after turning back, 9 ( 10%) during the ascent, 4 ( 5%) before leaving the final camp, and for 12 ( 13%) the stage of the summit bid was unknown. The median time to reach the summit via standard routes was earlier for survivors than for non- survivors ( 0900- 0959 v 1300- 1359, P< 0.001). Profound fatigue ( n= 34), cognitive changes ( n= 21), and ataxia ( n= 12) were the commonest symptoms reported in non- survivors, whereas respiratory distress ( n= 5), headache ( n= 0), and nausea or vomiting ( n= 3) were rarely described. Conclusions Debilitating symptoms consistent with high altitude cerebral oedema commonly present during descent from the summit of Mount Everest. Profound fatigue and late times in reaching the summit are early features associated with subsequent death.	[Firth, Paul G.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Windsor, Jeremy S.] Heart Hosp, London, England; [Sutherland, Andrew I.] John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Imray, Christopher H.] Univ Hosp Coventry, Dept Surg, Coventry, W Midlands, England; [Moore, G. W. K.] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Semple, John L.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Roach, Robert C.] Univ Colorado, Denver Hlth Sci Ctr, Aurora, CO USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University College London Hospitals NHS Foundation Trust; University of Oxford; University of Warwick; University of Toronto; University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus	Firth, PG (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA.	pfirth@partners.org	Moore, Kent/D-8518-2011; Roach, Robert/F-4729-2011	Moore, Kent/0000-0002-3986-5605; imray, chris/0000-0001-8451-4102; Roach, Robert/0000-0002-7998-8976; Firth, Paul/0000-0003-1909-5225				BOUKREEV A, 1997, AM ALPINE J, P37; Christiansen EL, 1997, INT J IMPACT ENG, V20, P173, DOI 10.1016/S0734-743X(97)87491-X; CLARKE C, 1988, INT J SPORTS MED, V9, P170, DOI 10.1055/s-2007-1024999; EGUSKITZA X, 2000, AM ALPINE J, P135; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hawley E, 2004, HIMALAYAN DATABASE E; Huey RB, 2000, JAMA-J AM MED ASSOC, V284, P181, DOI 10.1001/jama.284.2.181-a; Huey RB, 2001, J EXP BIOL, V204, P3115; HUEY RB, 2003, AM ALPINE J, P2; Hultgren HN, 1996, WESTERN J MED, V164, P222; Imray CHE, 2005, J APPL PHYSIOL, V99, P699, DOI 10.1152/japplphysiol.00973.2004; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Mcintosh SE, 2008, HIGH ALT MED BIOL, V9, P89, DOI 10.1089/ham.2008.1047; Moore G.W.K., 2004, GEOPHYS RES LETT, V31; Moore GWK, 2006, B AM METEOROL SOC, V87, P465, DOI 10.1175/BAMS-87-4-465; Moore GWK, 2003, CLIMATIC CHANGE, V59, P101, DOI 10.1023/A:1024423925161; NIERMEYER S, 1995, NEW ENGL J MED, V333, P1248, DOI 10.1056/NEJM199511093331903; POLLARD A, 1988, LANCET, V1, P1277; PUGH LGC, 1964, J PHYSIOL-LONDON, V170, P344, DOI 10.1113/jphysiol.1964.sp007335; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Salisbury R., 2007, HIMALAYA NUMBERS; Sutherland AI, 2008, BRIT J SPORT MED, V42, P183, DOI 10.1136/bjsm.2007.045286; SUTTON JR, 1992, INT J SPORTS MED, V13, pS13, DOI 10.1055/s-2007-1024580; Thomassen O, 2007, WILD ENVIRON MED, V18, P45, DOI 10.1580/1080-6032(2007)18[45:HCEWOH]2.0.CO;2; TOWN J, 1986, MOUNTAIN, V110, P42; West JB, 1996, J APPL PHYSIOL, V81, P1850, DOI 10.1152/jappl.1996.81.4.1850; WEST JB, 2007, HIGH ALTITUDE MED PH, P24; Wu TY, 2006, HIGH ALT MED BIOL, V7, P275, DOI 10.1089/ham.2006.7.275	32	74	74	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2008	337								a2654	10.1136/bmj.a2654	http://dx.doi.org/10.1136/bmj.a2654			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CB	19074222	hybrid, Green Published			2022-12-28	WOS:000262776900004
J	Malani, A; Abou-Jawde, RM				Malani, Ashok; Abou-Jawde, Rony M.			Bone Destruction and Regeneration in a Patient with Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Malani, Ashok; Abou-Jawde, Rony M.] Heartland Reg Med Ctr, St Joseph, MO 64507 USA		Malani, A (corresponding author), Heartland Reg Med Ctr, St Joseph, MO 64507 USA.	drmalani@yahoo.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2586	2586		10.1056/NEJMicm065383	http://dx.doi.org/10.1056/NEJMicm065383			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073978				2022-12-28	WOS:000261534200010
J	Appelboam, A; Reuben, AD; Benger, JR; Beech, F; Dutson, J; Haig, S; Higginson, I; Klein, JA; Le Roux, S; Saranga, SSM; Taylor, R; Vickery, J; Powell, RJ; Lloyd, G				Appelboam, A.; Reuben, A. D.; Benger, J. R.; Beech, F.; Dutson, J.; Haig, S.; Higginson, I.; Klein, J. A.; Le Roux, S.; Saranga, S. S. M.; Taylor, R.; Vickery, J.; Powell, R. J.; Lloyd, G.			Elbow extension test to rule out elbow fracture: multicentre, prospective validation and observational study of diagnostic accuracy in adults and children	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL DECISION RULES; SIGNIFICANT INJURY; ANKLE; RADIOGRAPHY; FOOT; KNEE	Objective To determine whether full elbow extension as assessed by the elbow extension test can be used in routine clinical practice to rule out bony injury in patients presenting with elbow injury. Design Adults: multicentre prospective interventional validation study in secondary care. Children: multicentre prospective observational study in secondary care. Setting Five emergency departments in southwest England. Participants 2127 adults and children presenting to the emergency department with acute elbow injury. Intervention Elbow extension test during routine care by clinical staff to determine the need for radiography in adults and to guide follow- up in children. Main outcome measures Presence of elbow fracture on radiograph, or recovery with no indication for further review at 7- 10 days. Results Of 1740 eligible participants, 602 patients were able to fully extend their elbow; 17 of these patients had a fracture. Two adult patients with olecranon fractures needed a change in treatment. In the 1138 patients without full elbow extension, 521 fractures were identified. Overall, the test had sensitivity and specificity ( 95% confidence interval) for detecting elbow fracture of 96.8% ( 95.0 to 98.2) and 48.5% ( 45.6 to 51.4). Full elbow extension had a negative predictive value for fracture of 98.4% ( 96.3 to 99.5) in adults and 95.8% ( 92.6 to 97.8) in children. Negative likelihood ratios were 0.03 ( 0.01 to 0.08) in adults and 0.11 ( 0.06 to 0.19) in children. Conclusion The elbow extension test can be used in routine practice to inform clinical decision making. Patients who cannot fully extend their elbow after injury should be referred for radiography, as they have a nearly 50% chance of fracture. For those able to fully extend their elbow, radiography can be deferred if the practitioner is confident that an olecranon fracture is not present. Patients who do not undergo radiography should return if symptoms have not resolved within 7- 10 days.	[Appelboam, A.; Reuben, A. D.; Taylor, R.; Vickery, J.; Lloyd, G.] Royal Devon & Exeter Fdn NHS Trust, Emergency Dept, Exeter EX2 5DW, Devon, England; [Benger, J. R.; Higginson, I.] United Bristol Healthcare NHS Trust, Emergency Dept, Bristol BS2 8HW, Avon, England; [Beech, F.; Haig, S.] Bath Royal United Hosp NHS Trust, Emergency Dept, Bath BA1 3NG, Avon, England; [Dutson, J.] Bristol Royal Infirm & Gen Hosp, Emergency Dept, United Bristol Healthcare NHS Trust, Bristol BS1, Avon, England; [Klein, J. A.] Musgrave Pk Hosp, Emergency Dept, Taunton & Somerset NHS Trust, Taunton TA1 5DA, Somerset, England; [Le Roux, S.; Saranga, S. S. M.] Bristol Childrens Hosp, Emergency Dept, United Bristol Healthcare NHS Trust, Bristol BS3 8BJ, Avon, England; [Powell, R. J.] Royal Devon & Exeter Fdn NHS Trust, Res & Dev Support Unit, Exeter EX2 5DW, Devon, England	Bristol Royal Infirmary; Musgrove Park Hospital; Bristol Royal Hospital For Children; University of Exeter	Lloyd, G (corresponding author), Royal Devon & Exeter Fdn NHS Trust, Emergency Dept, Exeter EX2 5DW, Devon, England.	gavin.lloyd@rdeft.nhs.uk		Benger, Jonathan/0000-0001-6131-0916; Powell, Roy/0000-0002-4959-5717	College of Emergency Medicine	College of Emergency Medicine	Research grant from the College of Emergency Medicine. The research was independent of the funders.	Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; DILDAR S, 2007, TODAYS EMERGENCY, V12, P6; Docherty MA, 2002, SOUTHERN MED J, V95, P539; GORZACK A, 1999, BEST BETS TOPICS; Griffith JF, 2001, AM J ROENTGENOL, V176, P53, DOI 10.2214/ajr.176.1.1760053; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; HAWKSWORTH CRE, 1991, ARCH EMERG MED, V8, P253; KOOPMAN PAR, 1984, BIOMETRICS, V40, P513, DOI 10.2307/2531405; Lennon RI, 2007, EMERG MED J, V24, P86, DOI 10.1136/emj.2006.039792; Perry JJ, 2006, INJURY, V37, P1157, DOI 10.1016/j.injury.2006.07.028; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; STIELL IG, 1995, ACAD EMERG MED, V2, P966, DOI 10.1111/j.1553-2712.1995.tb03123.x; Worster Andrew, 2002, CJEM, V4, P348; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	15	34	34	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2008	337								a2428	10.1136/bmj.a2428	http://dx.doi.org/10.1136/bmj.a2428			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399BZ	19066257	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000262776700002
J	Cheyne, H; Hundley, V; Dowding, D; Bland, JM; McNamee, P; Greer, I; Styles, M; Barnett, CA; Scotland, G; Niven, C				Cheyne, Helen; Hundley, Vanora; Dowding, Dawn; Bland, J. Martin; McNamee, Paul; Greer, Ian; Styles, Maggie; Barnett, Carol A.; Scotland, Graham; Niven, Catherine			Effects of algorithm for diagnosis of active labour: cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL DECISION-MAKING; CESAREAN-SECTION; COMPLEX INTERVENTIONS; RESEARCH INFORMATION; SUPPORT-SYSTEMS; NHS DIRECT; MANAGEMENT; NURSES; WOMEN; CARE	Objective To compare the effectiveness of an algorithm for diagnosis of active labour in primiparous women with standard care in terms of maternal and neonatal outcomes. Design Cluster randomised trial. Setting Maternity units in Scotland with at least 800 annual births. Participants 4503 women giving birth for the first time, in 14 maternity units. Seven experimental clusters collected data from a baseline sample of 1029 women and a post-implementation sample of 896 women. The seven control clusters had a baseline sample of 1291 women and a post- implementation sample of 1287 women. Intervention Use of an algorithm by midwives to assist their diagnosis of active labour, compared with standard care. Main outcomes Primary outcome: use of oxytocin for augmentation of labour. Secondary outcomes: medical interventions in labour, admission management, and birth outcome. Results No significant difference was found between groups in percentage use of oxytocin for augmentation of labour ( experimental minus control, difference= 0.3, 95% confidence interval - 9.2 to 9.8; P= 0.9) or in the use of medical interventions in labour. Women in the algorithm group were more likely to be discharged from the labour suite after their first labour assessment ( difference= - 19.2, - 29.9 to - 8.6; P= 0.002) and to have more pre-labour admissions ( 0.29, 0.04 to 0.55; P= 0.03). Conclusions Use of an algorithm to assist midwives with the diagnosis of active labour in primiparous women did not result in a reduction in oxytocin use or in medical intervention in spontaneous labour. Significantly more women in the experimental group were discharged home after their first labour ward assessment. Trial registration Current Controlled Trials ISRCTN00522952.	[Cheyne, Helen; Hundley, Vanora; Niven, Catherine] Univ Stirling, Nursing Midwifery & Allied Hlth Profess Res Unit, Stirling FK9 4LA, Scotland; [Dowding, Dawn; Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Dowding, Dawn; Greer, Ian] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [McNamee, Paul; Scotland, Graham] Univ Aberdeen, Hlth Econ Res Unit, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [Styles, Maggie] Univ Stirling, Dept Nursing & Midwifery, Stirling FK9 4LA, Scotland; [Barnett, Carol A.] Kings Cross Hosp, NHS Tayside, Dundee DD3 8EA, Scotland	University of Stirling; University of York - UK; University of Hull; University of York - UK; University of Aberdeen; University of Stirling	Cheyne, H (corresponding author), Univ Stirling, Nursing Midwifery & Allied Hlth Profess Res Unit, Stirling FK9 4LA, Scotland.	h.l.cheyne@stir.ac.uk	Dowding, Dawn/J-9945-2019	Dowding, Dawn/0000-0001-5672-8605; Cheyne, Helen/0000-0001-5738-8390	Scottish Executive Chief Scientist Office Health Service Research Committee [CZH/4/245]; Chief Scientist Office [HERU1, HERU2] Funding Source: researchfish	Scottish Executive Chief Scientist Office Health Service Research Committee; Chief Scientist Office	This work was supported by the Scottish Executive Chief Scientist Office Health Service Research Committee (CZH/4/245). The research was independent of the funders.	Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Anim-Somuah M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000331.pub2; Arkes HR, 2007, MED DECIS MAKING, V27, P189, DOI 10.1177/0272989X06297391; Ball JA., 1996, BIRTHRATE PLUS FRAME; BOYLAN P, 1991, AM J PERINAT, V8, P373, DOI 10.1055/s-2007-999419; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Carlton T, 2005, J PERINAT NEONAT NUR, V19, P145, DOI 10.1097/00005237-200504000-00011; CARTMILL RSV, 1992, LANCET, V339, P1520, DOI 10.1016/0140-6736(92)91275-D; Cheyne H, 2006, J ADV NURS, V53, P625, DOI 10.1111/j.1365-2648.2006.03769.x; Cheyne H, 2003, MIDWIFERY, V19, P221, DOI 10.1016/S0266-6138(03)00020-2; Cheyne H, 2007, BR J MIDWIFERY, V15, P604, DOI DOI 10.12968/BJ0M.2007.15.10.27341; CHEYNE H, 2004, FEASIBILITY STUDY CL; Cheyne H, 2008, MIDWIFERY, V24, P199, DOI 10.1016/j.midw.2006.12.005; COREY GA, 1987, J FAM PRACTICE, V25, P127; Creedy DK, 2000, BIRTH-ISS PERINAT C, V27, P104, DOI 10.1046/j.1523-536x.2000.00104.x; Dawes R., 2002, HEURISTICS BIASES PS, P716, DOI DOI 10.1017/CBO9780511808098.042; *DEP HLTH GOV STAT, 2005, NHS MAT STAT ENGL 20; DOWING D, 2007, DO NURSES USE NEW TE; Downe S, 2001, Pract Midwife, V4, P10; Freeman JM, 2007, NEUROTHERAPEUTICS, V4, P549, DOI 10.1016/j.nurt.2007.04.003; FRIGOLETTO FD, 1995, NEW ENGL J MED, V333, P745, DOI 10.1056/NEJM199509213331201; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Green J, 2003, GREATER EXPECTATIONS; Gross MM, 2006, BJOG-INT J OBSTET GY, V113, P289, DOI 10.1111/j.1471-0528.2006.00817.x; HEMMINKI E, 1986, EUR J OBSTET GYN R B, V22, P85, DOI 10.1016/0028-2243(86)90093-6; Holmes P, 2001, BRIT J OBSTET GYNAEC, V108, P1120, DOI 10.1016/S0306-5456(01)00265-0; Hundley V, 2004, MIDWIFERY, V20, P27, DOI 10.1016/S0266-6138(03)00050-0; HUNDLEY VA, 1994, BRIT MED J, V309, P1400, DOI 10.1136/bmj.309.6966.1400; *ISD SCOTL, BIRTHS BAB; Jackson DJ, 2003, JOGNN, V32, P147, DOI 10.1177/0884217503252045; Janssen Patricia A, 2003, J Obstet Gynaecol Can, V25, P734; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Klein MC, 2006, BIRTH-ISS PERINAT C, V33, P74, DOI 10.1111/j.0730-7659.2006.00076.x; Klein Michael C, 2004, J Obstet Gynaecol Can, V26, P641; Lauzon L, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000936, DOI 10.1002/14651858.CD000936]; LOPEZZENO JA, 1992, NEW ENGL J MED, V326, P450, DOI 10.1056/NEJM199202133260705; McCaughan D, 2005, FAM PRACT, V22, P490, DOI 10.1093/fampra/cmi042; McCaughan D, 2002, J ADV NURS, V39, P46, DOI 10.1046/j.1365-2648.2002.02241.x; McNiven PS, 1998, BIRTH-ISS PERINAT C, V25, P5, DOI 10.1046/j.1523-536x.1998.00005.x; Medical Research Council (MRC), 2000, FRAM DEV EV RCTS COM; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; National Collaborating Centre for Women's and Children's Health, 2007, INTR CAR CAR HLTH WO; O'Cathain A, 2004, J ADV NURS, V45, P280, DOI 10.1046/j.1365-2648.2003.02894.x; O'cathain Alicia, 2004, J Health Serv Res Policy, V9, P226, DOI 10.1258/1355819042250221; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; ODRISCOLL K, 1984, OBSTET GYNECOL, V63, P485; ROSENTHAL GE, 1992, J GEN INTERN MED, V7, P304, DOI 10.1007/BF02598089; Ruston A, 2006, HEALTH RISK SOC, V8, P257, DOI 10.1080/13698570600871729; Sadler LC, 2000, BRIT J OBSTET GYNAEC, V107, P909, DOI 10.1111/j.1471-0528.2000.tb11091.x; *SAF MOTH, 1996, CAR NORM BIRTH PRACT; *SCOTT EX, 2002, REP EXP GROUP AC MAT; *SCOTT PROGR CLIN, 2003, OP VAG DEL SCOTL 20; SCRIMSHAW SCM, 1982, SOC SCI MED, V16, P1473, DOI 10.1016/0277-9536(82)90062-4; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; SPILBY H, 2006, LABOURING BETTER EFF; Tavakoli M, 2000, J EVAL CLIN PRACT, V6, P111, DOI 10.1046/j.1365-2753.2000.00233.x; Thompson Carl, 2004, Evid Based Nurs, V7, P68; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; Treasure T, 1998, BRIT MED J, V317, P362; Trinder L, 2000, EVIDENCE BASED PRACT, P212, DOI DOI 10.1002/9780470699003.CH10; Turnbull D, 1996, LANCET, V348, P213; TURNER MJ, 1986, J OBSTET GYNAECOL, V7, P79, DOI 10.3109/01443618609112275; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55	64	37	37	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2008	337								a2396	10.1136/bmj.a2396	http://dx.doi.org/10.1136/bmj.a2396			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399BY	19064606	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000262776600002
J	Nowak, MA				Nowak, Martin A.			Generosity: A winner's advice	NATURE			English	Editorial Material									[Nowak, Martin A.] Harvard Univ, Cambridge, MA 02138 USA; [Nowak, Martin A.] Program Evolut Dynam, Cambridge, MA 02138 USA	Harvard University	Nowak, MA (corresponding author), Harvard Univ, 1 Brattle Sq, Cambridge, MA 02138 USA.	nowak@fas.harvard.edu	Nowak, Martin A/A-6977-2008		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078986, R01 GM078986-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					579	579		10.1038/456579a	http://dx.doi.org/10.1038/456579a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	378QW	19052610	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000261340000021
J	Chan, PS; Khalid, A; Longmore, LS; Berg, RA; Kosiborod, M; Spertus, JA				Chan, Paul S.; Khalid, Adnan; Longmore, Lance S.; Berg, Robert A.; Kosiborod, Mikhail; Spertus, John A.			Hospital-wide Code Rates and Mortality Before and After Implementation of a Rapid Response Team	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL EMERGENCY TEAM; CARDIAC-ARREST; CONTROLLED-TRIAL; INTENSIVE-CARE; CARDIOPULMONARY ARRESTS; HEART-FAILURE; ANTECEDENTS; REDUCTION; SURVIVAL; DEATH	Context Rapid response teams have been shown in adult inpatients to decrease cardiopulmonary arrest ( code) rates outside of the intensive care unit ( ICU). Because a primary action of rapid response teams is to transfer patients to the ICU, their ability to reduce hospital- wide code rates and mortality remains unknown. Objective To determine rates of hospital- wide codes and mortality before and after implementation of a long- term rapid response team intervention. Design, Setting, and Patients A prospective cohort design of adult inpatients admitted between January 1, 2004, and August 31, 2007, at Saint Luke's Hospital, a 404- bed tertiary care academic hospital in Kansas City, Missouri. Rapid response team education and program rollout occurred from September 1 to December 31, 2005. A total of 24 193 patient admissions were evaluated prior to the intervention ( January 1, 2004, to August 31, 2005), and 24 978 admissions were evaluated after the intervention ( January 1, 2006, to August 31, 2007). Intervention Using standard activation criteria, a 3- member rapid response team composed of experienced ICU staff and a respiratory therapist performed the evaluation, treatment, and triage of inpatients with evidence of acute physiological decline. Main Outcome Measures Hospital- wide code rates and mortality, adjusted for preintervention trends. Results There were a total of 376 rapid response team activations. After rapid response team implementation, mean hospital- wide code rates decreased from 11.2 to 7.5 per 1000 admissions. This was not associated with a reduction in the primary end point of hospital- wide code rates ( adjusted odds ratio [ AOR], 0.76 [ 95% confidence interval {CI}, 0.57- 1.01]; P=. 06), although lower rates of non- ICU codes were observed ( non- ICU AOR, 0.59 [ 95% CI, 0.40- 0.89] vs ICU AOR, 0.95 [ 95% CI, 0.641.43]; P=. 03 for interaction). Similarly, hospital- wide mortality did not differ between the preintervention and postintervention periods ( 3.22 vs 3.09 per 100 admissions; AOR, 0.95 [ 95% CI, 0.81- 1.11]; P=. 52). Secondary analyses revealed few instances of rapid response team undertreatment or underuse that may have affected the mortality findings. Conclusion In this large single- institution study, rapid response team implementation was not associated with reductions in hospital- wide code rates or mortality.	[Chan, Paul S.; Khalid, Adnan; Longmore, Lance S.; Kosiborod, Mikhail; Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Div Cardiol, Kansas City, MO 64111 USA; [Berg, Robert A.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Arizona	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, Div Cardiol, 5th Floor,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Spertus, John/ABD-3075-2021; Kosiborod, Mikhail/HDO-1541-2022	Kosiborod, Mikhail/0000-0002-3750-9789				Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Brilli RJ, 2007, PEDIATR CRIT CARE ME, V8, P236, DOI 10.1097/01.PCC.0000262947.72442.EA; Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Kenward G, 2004, RESUSCITATION, V61, P257, DOI 10.1016/j.resuscitation.2004.01.021; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; Sharek PJ, 2007, JAMA-J AM MED ASSOC, V298, P2267, DOI 10.1001/jama.298.19.2267; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401	21	220	241	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2506	2513		10.1001/jama.2008.715	http://dx.doi.org/10.1001/jama.2008.715			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050194	Bronze			2022-12-28	WOS:000261286200019
J	Richards, T				Richards, Tessa			The medical travellers' tale	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2008	337								a2829	10.1136/bmj.a2829	http://dx.doi.org/10.1136/bmj.a2829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NW	19052071				2022-12-28	WOS:000261890900005
J	Glasziou, P; Irwig, L; Deeks, JJ				Glasziou, Paul; Irwig, Les; Deeks, Jonathan J.			When Should a New Test Become the Current Reference Standard?	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDIAL-INFARCTION; DISCREPANT ANALYSIS; CELIAC-DISEASE; ACCURACY; DIAGNOSIS; SENSITIVITY; STRATEGIES; TRIALS	The evaluation of claims that a new diagnostic test is better than the current gold standard test is hindered by the lack of a perfect reference judge. However, this problem may be sidestepped by focusing on the clinical consequences of the decision rather than on estimation of accuracy. Consequences can be assessed by use of a "fair umpire" test that is not perfect yet can discriminate between disease and nondisease cases and is not biased in favor of 1 test. This article discusses 3 principles to aid judgments about the value of new tests. First, the consequences are best examined in cases with disagreement between the current and new tests. Second, resolving these disagreements requires a fair, but not necessarily perfect, umpire test. Finally, umpire tests include consequences, such as prognosis and response to treatment, as well as causal exposures and other test results.	[Glasziou, Paul] Univ Oxford, Ctr Evidence Based Med, Dept Primary Hlth Care, Oxford OX3 7LF, England; Univ Sydney, Sydney, NSW 2006, Australia; Univ Birmingham, Birmingham, W Midlands, England	University of Oxford; University of Sydney; University of Birmingham	Glasziou, P (corresponding author), Univ Oxford, Ctr Evidence Based Med, Dept Primary Hlth Care, Oxford OX3 7LF, England.	paul.glasziou@dphpc.ox.ac.uk	Deeks, Jon/AAV-5745-2020; Glasziou, Paul/A-7832-2008	Deeks, Jon/0000-0002-8850-1971; Glasziou, Paul/0000-0001-7564-073X	UK National Institute for Health; Australian National Health; Medical Research Council [402764]	UK National Institute for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	In part by funding from a UK National Institute for Health Research program grant and from the Australian National Health and Medical Research Council Program grant 402764 to the Screening and Test Evaluation Program.	Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Bossuyt PMM, 2000, LANCET, V356, P1844, DOI 10.1016/S0140-6736(00)03246-3; Catassi C, 1997, BAILLIERE CLIN GASTR, V11, P485, DOI 10.1016/S0950-3528(97)90028-2; Doust JA, 2005, BRIT MED J, V330, P625, DOI 10.1136/bmj.330.7492.625; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Hadgu A, 1996, LANCET, V348, P592, DOI 10.1016/S0140-6736(96)05122-7; Hadgu A, 1999, J CLIN EPIDEMIOL, V52, P1231, DOI 10.1016/S0895-4356(99)00101-8; HOENIG MR, 2006, COCHRANE DB SYST REV, V3; Irwig L, 2006, BMJ-BRIT MED J, V332, P678, DOI 10.1136/bmj.332.7543.678; IRWIG LM, 1985, J CHRON DIS, V38, P899, DOI 10.1016/0021-9681(85)90125-0; Katz IA, 1998, ANN CLIN BIOCHEM, V35, P393, DOI 10.1177/000456329803500308; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Maehara T, 2007, NEUROPATHOLOGY, V27, P585, DOI 10.1111/j.1440-1789.2007.00793.x; McAdam AJ, 2000, J CLIN MICROBIOL, V38, P2027; O'Donoghue M, 2008, JAMA-J AM MED ASSOC, V300, P71, DOI 10.1001/jama.300.1.71; Ramers C, 2000, JAMA-J AM MED ASSOC, V283, P2680, DOI 10.1001/jama.283.20.2680; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; Whiting P, 2006, BMJ-BRIT MED J, V332, P875, DOI 10.1136/bmj.38771.583796.7C	23	77	80	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					816	W168		10.7326/0003-4819-149-11-200812020-00009	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047029				2022-12-28	WOS:000261645300006
J	Miller, S; Pfund, C; Pribbenow, CM; Handelsman, J				Miller, Sarah; Pfund, Christine; Pribbenow, Christine Maidl; Handelsman, Jo			THE PIPELINE Scientific Teaching in Practice	SCIENCE			English	Editorial Material									[Miller, Sarah; Pribbenow, Christine Maidl; Handelsman, Jo] Univ Wisconsin, Dept Bacteriol, Wisconsin Program Sci Teaching, Madison, WI 53706 USA; [Pfund, Christine] Univ Wisconsin, Delta Program Res Teaching & Learning, Madison, WI 53706 USA; [Pribbenow, Christine Maidl] Univ Wisconsin, Wisconsin Ctr Educ Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Handelsman, J (corresponding author), Univ Wisconsin, Dept Bacteriol, Wisconsin Program Sci Teaching, Madison, WI 53706 USA.	joh@bact.wisc.edu		Miller, Sarah/0000-0003-3348-4470	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Cloud-Hansen KA, 2008, CBE-LIFE SCI EDUC, V7, P302, DOI 10.1187/cbe.07-12-0099; Creswell JW., 2006, DESIGNING CONDUCTING; Handelsman J, 2004, SCIENCE, V304, P521, DOI 10.1126/science.1096022; Handelsman J, 2007, SCI TEACHING; Kelley DJ, 2008, CBE-LIFE SCI EDUC, V7, P202, DOI 10.1187/cbe.07-10-0094; Lam TCM, 2003, AM J EVAL, V24, P65, DOI 10.1177/109821400302400106; Markowitz Dina G, 2007, CBE Life Sci Educ, V6, P233, DOI 10.1187/cbe.07-01-0004; *NAT RES COUNC, 2003, BIO2010 TRANSF UND E; National Research Council, 1999, PEOPL LEARN; Phillips AR, 2008, CBE-LIFE SCI EDUC, V7, P96, DOI 10.1187/cbe.07-07-0052; Robertson AL, 2008, CBE-LIFE SCI EDUC, V7, P89, DOI 10.1187/cbe.07-07-0051; Rutherford F.J., 1990, SCI ALL AM; SCHONWETTER DJ, 2002, INT J ACAD DEV, V7, P1	13	28	31	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1329	1330		10.1126/science.1166032	http://dx.doi.org/10.1126/science.1166032			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039122				2022-12-28	WOS:000261170600020
J	Chandra, V; Huang, PX; Hamuro, Y; Raghuram, S; Wang, YJ; Burris, TP; Rastinejad, F				Chandra, Vikas; Huang, Pengxiang; Hamuro, Yoshitomo; Raghuram, Srilatha; Wang, Yongjun; Burris, Thomas P.; Rastinejad, Fraydoon			Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; RETINOID-X-RECEPTOR; REV-ERB-ALPHA; LIGAND-BINDING; ALLOSTERIC CONTROL; DOMAIN; IDENTIFICATION; MECHANISM; POLARITY; AGONISTS	Nuclear receptors are multi- domain transcription factors that bind to DNA elements from which they regulate gene expression. The peroxisome proliferator- activated receptors ( PPARs) form heterodimers with the retinoid X receptor ( RXR), and PPAR-gamma has been intensively studied as a drug target because of its link to insulin sensitization. Previous structural studies have focused on isolated DNA or ligand- binding segments, with no demonstration of how multiple domains cooperate to modulate receptor properties. Here we present structures of intact PPAR-gamma and RXR-alpha as a heterodimer bound to DNA, ligands and coactivator peptides. PPAR-gamma and RXR-alpha form a non- symmetric complex, allowing the ligand- binding domain ( LBD) of PPAR-gamma to contact multiple domains in both proteins. Three interfaces link PPAR-gamma and RXR-alpha, including some that are DNA dependent. The PPAR-gamma LBD cooperates with both DNA- binding domains ( DBDs) to enhance response- element binding. The A/B segments are highly dynamic, lacking folded substructures despite their gene- activation properties.	[Chandra, Vikas; Huang, Pengxiang; Raghuram, Srilatha; Rastinejad, Fraydoon] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; [Chandra, Vikas; Huang, Pengxiang; Raghuram, Srilatha; Rastinejad, Fraydoon] Univ Virginia Hlth Syst, Ctr Mol Design, Charlottesville, VA 22908 USA; [Hamuro, Yoshitomo] ExSAR Corp, Monmouth Jct, NJ 08852 USA; [Wang, Yongjun; Burris, Thomas P.] Louisiana State Univ, Pennington Biomed Res Ctr, Nucl Receptor Biol Lab, Baton Rouge, LA 70808 USA	University of Virginia; University of Virginia; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Rastinejad, F (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	fr9c@virginia.edu	Burris, Thomas P/B-3886-2016; Burris, Thomas/H-5078-2011	Burris, Thomas P/0000-0003-2922-4449; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055217] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055217-11, R01 GM055217] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Berger Joel, 2002, Diabetes Technol Ther, V4, P163, DOI 10.1089/15209150260007381; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN F, 1993, BIOCHEM BIOPH RES CO, V196, P671, DOI 10.1006/bbrc.1993.2302; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Greschik I, 2003, CURR TOP MED CHEM, V3, P1573, DOI 10.2174/1568026033451736; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sierk ML, 2001, BIOCHEMISTRY-US, V40, P12833, DOI 10.1021/bi011086r; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Staels B, 2007, THERAPIE, V62, P319, DOI 10.2515/therapie:2007051; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2	49	544	560	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					350	U33		10.1038/nature07413	http://dx.doi.org/10.1038/nature07413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19043829	Green Accepted			2022-12-28	WOS:000261039600035
J	Saavedra, S; Reed-Tsochas, F; Uzzi, B				Saavedra, Serguei; Reed-Tsochas, Felix; Uzzi, Brian			A simple model of bipartite cooperation for ecological and organizational networks	NATURE			English	Article							FOOD; EMBEDDEDNESS; EXPLOITATION; PATTERNS; RULES	In theoretical ecology, simple stochastic models that satisfy two basic conditions about the distribution of niche values and feeding ranges have proved successful in reproducing the overall structural properties of real food webs, using species richness and connectance as the only input parameters(1-4). Recently, more detailed models have incorporated higher levels of constraint in order to reproduce the actual links observed in real food webs(5,6). Here, building on previous stochastic models of consumer - resource interactions between species(1-3), we propose a highly parsimonious model that can reproduce the overall bipartite structure of cooperative partner - partner interactions, as exemplified by plant - animal mutualistic networks(7). Our stochastic model of bipartite cooperation uses simple specialization and interaction rules, and only requires three empirical input parameters. We test the bipartite cooperation model on ten large pollination data sets that have been compiled in the literature, and find that it successfully replicates the degree distribution, nestedness and modularity of the empirical networks. These properties are regarded as key to understanding cooperation in mutualistic networks(8-10). We also apply our model to an extensive data set of two classes of company engaged in joint production in the garment industry. Using the same metrics, we find that the network of manufacturer - contractor interactions exhibits similar structural patterns to plant - animal pollination networks. This surprising correspondence between ecological and organizational networks suggests that the simple rules of cooperation that generate bipartite networks may be generic, and could prove relevant in many different domains, ranging from biological systems to human society(11-14).	[Saavedra, Serguei; Reed-Tsochas, Felix] Univ Oxford, CABDyN Complex Ctr, Oxford OX1 1HP, England; [Saavedra, Serguei] Univ Oxford, Corp Reputat Ctr, Oxford OX1 1HP, England; [Reed-Tsochas, Felix] Univ Oxford, James Martin Inst, Said Business Sch, Oxford OX1 1HP, England; [Saavedra, Serguei] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Uzzi, Brian] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Uzzi, Brian] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Uzzi, Brian] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Northwestern University; Northwestern University; University of California System; University of California Berkeley	Reed-Tsochas, F (corresponding author), Univ Oxford, CABDyN Complex Ctr, Oxford OX1 1HP, England.	felix.reed-tsochas@sbs.ox.ac.uk			European Commission; MMCOMNET; CONACYT; Oxford University Corporate Reputation Centre; CABDyN Complexity Centre	European Commission(European CommissionEuropean Commission Joint Research Centre); MMCOMNET; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Oxford University Corporate Reputation Centre; CABDyN Complexity Centre	We thank J. Dunne, R. Guimera, J. Kertesz, M. Sales-Pardo, D. Stouffer and R. Williams for comments and suggestions. F.R.-T. acknowledges funding from the European Commission under the FP6 NEST Pathfinder Initiative 'Tackling Complexity in Science' (MMCOMNET project, contract no. 012999). S.S. held a Doctoral Research Studentship funded by MMCOMNET and CONACYT, and currently is supported by a Postdoctoral Fellowship at the Oxford University Corporate Reputation Centre in conjunction with the CABDyN Complexity Centre.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2006, SFI S SCI C, P143; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Carroll G. R., 2004, DEMOGRAPHY CORPORATI; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimaraes PR, 2007, J THEOR BIOL, V249, P181, DOI 10.1016/j.jtbi.2007.08.004; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hammerstein P., 2003, GENETIC CULTURAL EVO; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; Podolny J.M., 2005, STATUS SIGNALS SOCIO; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	30	116	116	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					463	466		10.1038/nature07532	http://dx.doi.org/10.1038/nature07532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19052545				2022-12-28	WOS:000262519200043
J	He, YP; Vogelstein, B; Velculescu, VE; Papadopoulos, N; Kinzler, KW				He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.			The Antisense Transcriptomes of Human Cells	SCIENCE			English	Article							GENOME; RNA	Transcription in mammalian cells can be assessed at a genome- wide level, but it has been difficult to reliably determine whether individual transcripts are derived from the plus or minus strands of chromosomes. This distinction can be critical for understanding the relationship between known transcripts ( sense) and the complementary antisense transcripts that may regulate them. Here, we describe a technique that can be used to (i) identify the DNA strand of origin for any particular RNA transcript, and (ii) quantify the number of sense and antisense transcripts from expressed genes at a global level. We examined five different human cell types and in each case found evidence for antisense transcripts in 2900 to 6400 human genes. The distribution of antisense transcripts was distinct from that of sense transcripts, was nonrandom across the genome, and differed among cell types. Antisense transcripts thus appear to be a pervasive feature of human cells, which suggests that they are a fundamental component of gene regulation.	[He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Papadopoulos, N (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	npapado1@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Papadopoulos, Nickolas/K-7272-2012	Velculescu, Victor/0000-0003-1195-438X; 	Virginia and D. K. Ludwig Fund for Cancer Research; NIH [CA57345, CA43460, CA62924, CA121113]; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA057345, R37CA043460, R01CA121113, P50CA062924, R01CA043460] Funding Source: NIH RePORTER	Virginia and D. K. Ludwig Fund for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Yu for assistance with microarrays. Supported by the Virginia and D. K. Ludwig Fund for Cancer Research and NIH grants CA57345, CA43460, CA62924, and CA121113. Under a licensing agreement between Johns Hopkins University and Genzyme, technologies related to SAGE were licensed to Genzyme for commercial purposes, and B.V., V.E.V., and K.W.K. are entitled to a share of the royalties received by the university from the sales of the licensed technologies. The university and researchers (B.V. and K.W.K.) own Genzyme stock, which is subject to certain restrictions under university policy. The terms of these arrangements are being managed by the university in accordance with its conflict-of-interest policies. There are existing patents for SAGE that have been licensed as disclosed above, and similar patents are likely to be filed for ASSAGE.	Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Carmichael GG, 2003, NAT BIOTECHNOL, V21, P371, DOI 10.1038/nbt0403-371; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Fahey ME, 2002, COMP FUNCT GENOM, V3, P244, DOI 10.1002/cfg.173; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Peters BA, 2007, GENOME RES, V17, P287, DOI 10.1101/gr.5486607; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Shendure J, 2002, GENOME BIOL, V3; Simpson AJG, 2001, COMP FUNCT GENOM, V2, P169, DOI 10.1002/cfg.81; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Timmons JA, 2006, BIOCHEM SOC T, V34, P1148, DOI 10.1042/BST0341148; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Yazgan O, 2007, BIOCHEM CELL BIOL, V85, P484, DOI 10.1139/O07-061; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	25	394	432	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1855	1857		10.1126/science.1163853	http://dx.doi.org/10.1126/science.1163853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056939	Green Accepted			2022-12-28	WOS:000261799400058
J	Thum, T; Gross, C; Fiedler, J; Fischer, T; Kissler, S; Bussen, M; Galuppo, P; Just, S; Rottbauer, W; Frantz, S; Castoldi, M; Soutschek, J; Koteliansky, V; Rosenwald, A; Basson, MA; Licht, JD; Pena, JTR; Rouhanifard, SH; Muckenthaler, MU; Tuschl, T; Martin, GR; Bauersachs, J; Engelhardt, S				Thum, Thomas; Gross, Carina; Fiedler, Jan; Fischer, Thomas; Kissler, Stephan; Bussen, Markus; Galuppo, Paolo; Just, Steffen; Rottbauer, Wolfgang; Frantz, Stefan; Castoldi, Mirco; Soutschek, Jurgen; Koteliansky, Victor; Rosenwald, Andreas; Basson, M. Albert; Licht, Jonathan D.; Pena, John T. R.; Rouhanifard, Sara H.; Muckenthaler, Martina U.; Tuschl, Thomas; Martin, Gail R.; Bauersachs, Johann; Engelhardt, Stefan			MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts	NATURE			English	Article							CARDIAC-HYPERTROPHY; HEART-FAILURE; IN-VIVO; EXPRESSION; REGULATOR; MECHANISM; SPROUTY2; MICE; PLAY	MicroRNAs comprise a broad class of small non- coding RNAs that control expression of complementary target messenger RNAs(1,2). Dysregulation of microRNAs by several mechanisms has been described in various disease states(3-5) including cardiac disease(6-10). Whereas previous studies of cardiac disease have focused on microRNAs that are primarily expressed in cardiomyocytes, the role of microRNAs expressed in other cell types of the heart is unclear. Here we show that microRNA-21 (miR-21, also known as Mirn21) regulates the ERK - MAP kinase signalling pathway in cardiac fibroblasts, which has impacts on global cardiac structure and function. miR-21 levels are increased selectively in fibroblasts of the failing heart, augmenting ERK - MAP kinase activity through inhibition of sprouty homologue 1 ( Spry1). This mechanism regulates fibroblast survival and growth factor secretion, apparently controlling the extent of interstitial fibrosis and cardiac hypertrophy. In vivo silencing of miR- 21 by a specific antagomir in a mouse pressure- overload- induced disease model reduces cardiac ERK - MAP kinase activity, inhibits interstitial fibrosis and attenuates cardiac dysfunction. These findings reveal that microRNAs can contribute to myocardial disease by an effect in cardiac fibroblasts. Our results validate miR- 21 as a disease target in heart failure and establish the therapeutic efficacy of microRNA therapeutic intervention in a cardiovascular disease setting.	[Thum, Thomas; Fiedler, Jan; Galuppo, Paolo; Frantz, Stefan; Bauersachs, Johann] Univ Wurzburg, Dept Med 1, D-97080 Wurzburg, Germany; [Thum, Thomas; Fiedler, Jan] Univ Wurzburg, Jr Res Grp, IZKF, D-97080 Wurzburg, Germany; [Gross, Carina; Fischer, Thomas; Kissler, Stephan; Engelhardt, Stefan] Univ Wurzburg, Rudolf Virchow Ctr, DFG, Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany; [Bussen, Markus] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Just, Steffen; Rottbauer, Wolfgang] Univ Heidelberg, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Castoldi, Mirco; Muckenthaler, Martina U.] Univ Heidelberg, Dept Pediat Hematol Oncol & Immunol, D-69120 Heidelberg, Germany; [Castoldi, Mirco; Muckenthaler, Martina U.] Univ Heidelberg, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Soutschek, Jurgen] Regulus Therapeut, Carlsbad, CA 92008 USA; [Koteliansky, Victor] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Basson, M. Albert] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Pena, John T. R.; Rouhanifard, Sara H.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10065 USA; [Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany	University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; University of California System; University of California San Francisco; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Isis Pharmaceuticals Inc; University of London; King's College London; Northwestern University; Feinberg School of Medicine; Rockefeller University; Technical University of Munich	Bauersachs, J (corresponding author), Univ Wurzburg, Dept Med 1, D-97080 Wurzburg, Germany.	j.bauersachs@medizin.uni-wuerzburg.de; stefan.engelhardt@tum.de	Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020; Engelhardt, Stefan/AAA-9329-2019; Basson, M. Albert/C-5565-2009; Frantz, Stefan/G-1723-2012	Licht, Jonathan/0000-0002-3942-1369; Engelhardt, Stefan/0000-0001-5378-8661; Thum, Thomas/0000-0003-4360-1511; Basson, M. Albert/0000-0001-9834-7528; /0000-0003-3062-7800; Muckenthaler, Martina/0000-0002-3778-510X; Rouhanifard, Sara/0000-0002-6991-4877	IZKF [E-31]; Deutsche Forschungsgemeinschaft [DFG TH903/7-1]; Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine; Bavarian Ministry of Technology; ProCorde; Sanofi-Aventis; US NIH [R01 CA78711]; The Medical Faculty of the University of Heidelberg; Cancer Research Net [BMBF (NGFN) 201GS0450]; Leopoldina Academy [BMBF-LPD 9901/8-141]; NATIONAL CANCER INSTITUTE [R01CA078711, R01CA059998] Funding Source: NIH RePORTER	IZKF; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine; Bavarian Ministry of Technology; ProCorde; Sanofi-Aventis(Sanofi-Aventis); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Medical Faculty of the University of Heidelberg; Cancer Research Net; Leopoldina Academy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Hemmrich, U. Keller, J. Schittl, C. Dienesch, S. Thum, A. Leupold, M. Kummel, S. Schraut, A. Lauer, S. Marquart, E. Leich and A. Horn for technical assistance. Weacknowledge the contribution of V. Benes and S. Schmidt (miChip microarray Platform, EMBL), D. Fraccarollo and K. Hu (in vivo studies), S. Leierseder and X. Loyer (primary fibroblast preparation), C. Sohn- Lee (in situ hybridization experiments) and M. Manoharan, R. Braich and B. Bhat (antagomir oligonucleotides). We also thank L. Field, T. Brand and M. Gessler for discussions. This work was supported in part by grants from the IZKF (E-31 to T. Thum), the Deutsche Forschungsgemeinschaft (DFG TH903/7-1 to T. Thum and J. B.), the Rudolf Virchow Center/ DFG Research Center for Experimental Biomedicine (S.E., S.K.), the Bavarian Ministry of Technology, ProCorde and Sanofi-Aventis (S.E.), and the US NIH (R01 CA78711 to G. R. M.). M. C. is supported by an Excellence Fellowship of The Medical Faculty of the University of Heidelberg, M.U.M. by a Cancer Research Net grant (BMBF (NGFN) 201GS0450), and M. B. by the Leopoldina Academy (BMBF-LPD 9901/ 8- 141).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kudej RK, 1997, J MOL CELL CARDIOL, V29, P2735, DOI 10.1006/jmcc.1997.0508; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li X, 1997, BIOTECHNIQUES, V23, P874, DOI 10.2144/97235st03; Merkle S, 2007, CIRC RES, V100, P645, DOI 10.1161/01.RES.0000260203.55077.61; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; THURN T, 2004, CIRC RES, V94, pE1; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhao CM, 2007, ADV INTEL SYS RES, V2, P317	30	1829	1975	1	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					980	U83		10.1038/nature07511	http://dx.doi.org/10.1038/nature07511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19043405				2022-12-28	WOS:000261768300052
J	St Johnston, D				St Johnston, Daniel			Counting Motors by Force	CELL			English	Editorial Material							ORGANELLE TRANSPORT; DROSOPHILA EMBRYOS	Properties of the microtubule motor protein kinesin-1 have been well characterized in vitro but not in the viscous environment of a cell. By measuring the force that kinesin-1 exerts on lipid droplets in fly embryos, Shubeita et al. ( 2008) determine the number of active motors per droplet and find unexpected differences between motor regulation in vivo and in vitro.	[St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.	ds139@cam.ac.uk	St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301	Cancer Research UK [A14492] Funding Source: Medline; Wellcome Trust [092096, 080007] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Howard J., 2001, MECH MOTOR PROTEINS; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2	8	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1000	1001		10.1016/j.cell.2008.11.021	http://dx.doi.org/10.1016/j.cell.2008.11.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070567	Bronze			2022-12-28	WOS:000261642800012
J	Prucca, CG; Slavin, I; Quiroga, R; Elias, EV; Rivero, FD; Saura, A; Carranza, PG; Lujan, HD				Prucca, Cesar G.; Slavin, Ileana; Quiroga, Rodrigo; Elias, Eliana V.; Rivero, Fernando D.; Saura, Alicia; Carranza, Pedro G.; Lujan, Hugo D.			Antigenic variation in Giardia lamblia is regulated by RNA interference	NATURE			English	Article							GENE; PROTEIN; IDENTIFICATION; MECHANISMS; TRANSCRIPTS; EXPRESSION; EUKARYOTE; PLANTS; FUNGI; SENSE	Giardia lamblia ( also called Giardia intestinalis) is one of the most common intestinal parasites of humans. To evade the host's immune response, Giardia undergoes antigenic variation - a process that allows the parasite to develop chronic and recurrent infections. From a repertoire of similar to 190 variant- specific surface protein ( VSP)- coding genes, Giardia expresses only one VSP on the surface of each parasite at a particular time, but spontaneously switches to a different VSP by unknown mechanisms. Here we show that regulation of VSP expression involves a system comprising RNA- dependent RNA polymerase, Dicer and Argonaute, known components of the RNA interference machinery. Clones expressing a single surface antigen efficiently transcribe several VSP genes but only accumulate transcripts encoding the VSP to be expressed. Detection of antisense RNAs corresponding to the silenced VSP genes and small RNAs from the silenced but not for the expressed vsp implicate the RNA interference pathway in antigenic variation. Remarkably, silencing of Dicer and RNA- dependent RNA polymerase leads to a change from single to multiple VSP expression in individual parasites.	[Prucca, Cesar G.; Slavin, Ileana; Quiroga, Rodrigo; Elias, Eliana V.; Rivero, Fernando D.; Saura, Alicia; Carranza, Pedro G.; Lujan, Hugo D.] Univ Catolica Cordoba, Fac Med, Lab Bioquim & Biol Mol, Cordoba, Argentina	Catholic University of Cordoba	Lujan, HD (corresponding author), Univ Catolica Cordoba, Fac Med, Lab Bioquim & Biol Mol, X5004ASK, Cordoba, Argentina.	hlujan@ucc.edu.ar	Quiroga, Rodrigo/GLT-7145-2022; Prucca, César/AAQ-4401-2020; Prucca, César Germán/AAC-4630-2021; Elias, Eliana Vanina/AAF-1997-2021; RIVERO, Fernando/AFV-5689-2022	Quiroga, Rodrigo/0000-0001-5015-0531; Prucca, César Germán/0000-0003-4165-4660; 	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Catolica de Cordoba; Howard Hughes Medical Institute; European Union CONTENT	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Catolica de Cordoba; Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Union CONTENT(European Commission)	We thank N. Gottig and M. E. Alvarez for technical support. This work was supported by grants from the Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (ANPCYT), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Universidad Catolica de Cordoba (UCC), the Howard Hughes Medical Institute (HHMI), and the European Union CONTENT project. H. D. L. is an HHMI International Research Scholar and a Member of the Scientific Investigator's Career of the CONICET.	ADAM RD, 1988, J EXP MED, V167, P109, DOI 10.1084/jem.167.1.109; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cogoni C, 1999, CURR OPIN MICROBIOL, V2, P657, DOI 10.1016/S1369-5274(99)00041-7; Deitsch KW, 1997, MICROBIOL MOL BIOL R, V61, P281, DOI 10.1128/.61.3.281-293.1997; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Elmendorf HG, 2001, NUCLEIC ACIDS RES, V29, P4674, DOI 10.1093/nar/29.22.4674; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Green-Willms NS, 1998, MOL CELL BIOL, V18, P1826, DOI 10.1128/MCB.18.4.1826; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2000, RNA, V6, P1445, DOI 10.1017/S1355838200001096; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Kloc M, 2001, INT REV CYTOL, V203, P63; Kulakova L, 2006, MOL MICROBIOL, V61, P1533, DOI 10.1111/j.1365-2958.2006.05345.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; NASH TE, 1990, EXP PARASITOL, V71, P415, DOI 10.1016/0014-4894(90)90067-M; Nash TE, 1997, PHILOS T R SOC B, V352, P1369, DOI 10.1098/rstb.1997.0122; NASH TE, 1988, J IMMUNOL, V141, P636; Nash TE, 2001, INFECT IMMUN, V69, P1922, DOI 10.1128/IAI.69.3.1922-1923.2001; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Touz MC, 2002, J BIOL CHEM, V277, P50557, DOI 10.1074/jbc.M202558200; Ullu E, 2005, EUKARYOT CELL, V4, P1155, DOI 10.1128/EC.4.6.1155-1157.2005; von Allmen N, 2005, PARASITOLOGY, V130, P389, DOI 10.1017/S0031182004006742; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; WHITE TC, 1990, NUCLEIC ACIDS RES, V18, P553, DOI 10.1093/nar/18.3.553; YEE J, 1995, P NATL ACAD SCI USA, V92, P5615, DOI 10.1073/pnas.92.12.5615; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	38	154	169	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					750	754		10.1038/nature07585	http://dx.doi.org/10.1038/nature07585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079052				2022-12-28	WOS:000261559900040
J	Dello Ioio, R; Nakamura, K; Moubayidin, L; Perilli, S; Taniguchi, M; Morita, MT; Aoyama, T; Costantino, P; Sabatini, S				Dello Ioio, Raffaele; Nakamura, Kinu; Moubayidin, Laila; Perilli, Serena; Taniguchi, Masatoshi; Morita, Miyo T.; Aoyama, Takashi; Costantino, Paolo; Sabatini, Sabrina			A Genetic Framework for the Control of Cell Division and Differentiation in the Root Meristem	SCIENCE			English	Article							ARABIDOPSIS ROOTS; AUXIN RESPONSE; CYTOKININ; EXPRESSION; PROTEINS; SPECIFICITY; REGULATORS; GROWTH; ARR1	Plant growth and development are sustained by meristems. Meristem activity is controlled by auxin and cytokinin, two hormones whose interactions in determining a specific developmental output are still poorly understood. By means of a comprehensive genetic and molecular analysis in Arabidopsis, we show that a primary cytokinin- response transcription factor, ARR1, activates the gene SHY2/IAA3 (SHY2), a repressor of auxin signaling that negatively regulates the PIN auxin transport facilitator genes: thereby, cytokinin causes auxin redistribution, prompting cell differentiation. Conversely, auxin mediates degradation of the SHY2 protein, sustaining PIN activities and cell division. Thus, the cell differentiation and division balance necessary for controlling root meristem size and root growth is the result of the interaction between cytokinin and auxin through a simple regulatory circuit converging on the SHY2 gene.	[Dello Ioio, Raffaele; Moubayidin, Laila; Perilli, Serena; Costantino, Paolo; Sabatini, Sabrina] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Lab Genom & Proteom Funzionale Sistem Mod FGPL, I-00185 Rome, Italy; [Nakamura, Kinu; Taniguchi, Masatoshi; Aoyama, Takashi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Morita, Miyo T.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	Sapienza University Rome; Kyoto University; Nara Institute of Science & Technology	Sabatini, S (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Lab Genom & Proteom Funzionale Sistem Mod FGPL, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	sabrina.sabatini@uniroma1.it	dello ioio, raffaele/P-6254-2015; Costantino, Paolo/K-4753-2015	dello ioio, raffaele/0000-0001-8679-9412; Costantino, Paolo/0000-0002-9166-2194; SABATINI, Sabrina/0000-0002-9691-6595; Morita, Miyo/0000-0002-6176-5758	Giovanni Armenise-Harvard Foundation; Istituto Pasteur- Fondazione Cenci Bolognetti; Ministero dell'Istruzione; dell'Universita e della Ricerca ( MIUR); Ricerca di Interesse Nazionale; MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area-Plant Genomics	Giovanni Armenise-Harvard Foundation; Istituto Pasteur- Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca ( MIUR)(Ministry of Education, Universities and Research (MIUR)); Ricerca di Interesse Nazionale; MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area-Plant Genomics(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	We thank B. Scheres, O. Leyser, J. Reed, and G. Jurgens for providing material and all members of the FGPL for indispensable and helpful technical support. This work was supported by a Giovanni Armenise-Harvard Foundation career development grant (to S. S.) and by Istituto Pasteur- Fondazione Cenci Bolognetti, Ministero dell'Istruzione, dell'Universita e della Ricerca ( MIUR) progetti di Ricerca di Interesse Nazionale, and MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area- Plant Genomics ( to P. C.).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dello Loio R, 2008, CURR OPIN PLANT BIOL, V11, P23, DOI 10.1016/j.pbi.2007.10.006; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Klee Harry J., 1995, P340; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; MOCKAITIS K, 2008, ANNU REV CELL DEV BI, V10, P453; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Taniguchi M, 2007, PLANT CELL PHYSIOL, V48, P263, DOI 10.1093/pcp/pcl063; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Tian Q, 1999, DEVELOPMENT, V126, P711; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659	23	636	656	13	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1380	1384		10.1126/science.1164147	http://dx.doi.org/10.1126/science.1164147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039136				2022-12-28	WOS:000261170600039
J	Oberdoerffer, P; Michan, S; Mcvay, M; Mostoslavsky, R; Vann, J; Park, SK; Hartlerode, A; Stegmuller, J; Hafner, A; Loerch, P; Wright, SM; Mills, KD; Bonni, A; Yankner, BA; Scully, R; Prolla, TA; Alt, FW; Sinclair, DA				Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Mostoslavsky, Raul; Vann, James; Park, Sang-Kyu; Hartlerode, Andrea; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Wright, Sarah M.; Mills, Kevin D.; Bonni, Azad; Yankner, Bruce A.; Scully, Ralph; Prolla, Tomas A.; Alt, Frederick W.; Sinclair, David A.			SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging	CELL			English	Article							DOUBLE-STRAND BREAKS; EMBRYONIC STEM-CELLS; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; DNA-DAMAGE; HISTONE H2AX; HETEROCHROMATIN FORMATION; CELLULAR SENESCENCE; GENOTOXIC STRESS; MATING-TYPE	Genomic instability and alterations in gene expression are hallmarks of eukaryotic aging. The yeast histone deacetylase Sir2 silences transcription and stabilizes repetitive DNA, but during aging or in response to a DNA break, the Sir complex relocalizes to sites of genomic instability, resulting in the desilencing of genes that cause sterility, a characteristic of yeast aging. Using embryonic stem cells, we show that mammalian Sir2, SIRT1, represses repetitive DNA and a functionally diverse set of genes across the mouse genome. In response to DNA damage, SIRT1 dissociates from these loci and relocalizes to DNA breaks to promote repair, resulting in transcriptional changes that parallel those in the aging mouse brain. Increased SIRT1 expression promotes survival in a mouse model of genomic instability and suppresses age-dependent transcriptional changes. Thus, DNA damage-induced redistribution of SIRT1 and other chromatin-modifying proteins may be a conserved mechanism of aging in eukaryotes.	[Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Bonni, Azad; Yankner, Bruce A.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Bonni, Azad; Yankner, Bruce A.; Sinclair, David A.] Harvard Univ, Sch Med, Glenn Labs Aging Res, Boston, MA 02115 USA; [Mostoslavsky, Raul] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Vann, James; Park, Sang-Kyu; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; [Hartlerode, Andrea; Scully, Ralph] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hartlerode, Andrea; Scully, Ralph] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Wright, Sarah M.; Mills, Kevin D.] Jackson Lab, Bar Harbor, ME 04609 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst, Boston, MA 02115 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Jackson Laboratory; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	Scully, Ralph/F-5008-2013	Sinclair, David/0000-0002-9936-436X	National Space Biomedical Research Institute [PF00903]; National Institutes of Health [NIH] [RO1GM068072, R01AG19719, NS047188, GM 073894, R01AG 020681]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072, R01GM073894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019719, R01AG020681, R01AG028730, P01AG027916] Funding Source: NIH RePORTER	National Space Biomedical Research Institute; National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D. A. S. wishes to thank B. Stillman and C. Westphal for advice and scientific discussions. We are also grateful to K. Rajewsky, D. Reinberg, D. Lamming, L. Guarente, A. Vaquero, and M. Jasin for advice and reagents. We thank E. Vollmann, J. Campbell, and D. Zimmerman for technical assistance and R. Bronson for mouse necropsy. We are especially grateful to P. Glenn, M. Collins, and L. Ellison for their support of aging research. P. O. was supported by a fellowship from the National Space Biomedical Research Institute (grant PF00903), the Sinclair Lab by grants RO1GM068072 and R01AG19719 (National Institutes of Health [NIH]), and the Glenn Foundation for Medical Research. D. A. S. and F. W. A. are Ellison Medical Foundation Senior Scholars. R. M. is a V and Kimmel Foundation Scholar. A. B. supported by NIH grant NS047188; R. S. by GM 073894; and J. V., S. P., and T. A. P. by R01AG 020681. F. W. A. is an Investigator of the Howard Hughes Medical Institute. D. A. S. is a consultant to Shaklee, Genocea, and Sirtris (a GSK company developing sirtuin-based drugs) and an inventor on Harvard patents licensed to GSK.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; CUTLER RG, 1995, MCBU, P15; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Imai S, 1998, EXP GERONTOL, V33, P555; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KLAR AJS, 1979, GENETICS, V93, P37; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lim CS, 2006, MED HYPOTHESES, V67, P341, DOI 10.1016/j.mehy.2006.01.050; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; NICHOLS NR, 1995, NEUROBIOL AGING, V16, P105, DOI 10.1016/0197-4580(95)80013-H; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Park PU, 1999, MOL CELL BIOL, V19, P3848; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; RINE J, 1979, GENETICS, V93, P877; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vijg J, 2004, MECH AGEING DEV, V125, P747, DOI 10.1016/j.mad.2004.07.004; Villeponteau B, 1997, EXP GERONTOL, V32, P383, DOI 10.1016/S0531-5565(96)00155-6; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Wu JF, 2008, J MOL NEUROSCI, V34, P1, DOI 10.1007/s12031-007-0009-4; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhu P, 2004, CELL CYCLE, V3, P1240, DOI 10.4161/cc.3.10.1195	70	584	610	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					907	918		10.1016/j.cell.2008.10.025	http://dx.doi.org/10.1016/j.cell.2008.10.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041753	Bronze, Green Accepted			2022-12-28	WOS:000261183900021
J	Pickering, N				Pickering, Neil			The importance of not being complementary	LANCET			English	Editorial Material									[Pickering, Neil] Univ Otago, Ctr Bioeth, Dunedin Sch Med, Dunedin 9054, New Zealand	University of Otago	Pickering, N (corresponding author), Univ Otago, Ctr Bioeth, Dunedin Sch Med, Dunedin 9054, New Zealand.	neil.pickering@stonebow.otago.ac.nz	Pickering, Neil/W-4131-2019					Evans M., 2001, MED HUMANITIES; Larkin Philip, 1988, COLLECTED POEMS; MOTION A, 1993, P LARKIN WRITERS LIF	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1874	1875		10.1016/S0140-6736(08)61799-7	http://dx.doi.org/10.1016/S0140-6736(08)61799-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	379IA	19058394	Bronze			2022-12-28	WOS:000261388700012
J	Iglehart, JK				Iglehart, John K.			Revisiting Duty-Hour Limits - Iom Recommendations for Patient Safety and Resident Education.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; *COMM OPT GRAD MED, 2008, RES DUT HOURS ENH SL; DINGELL JD, 2007, COMMUNICATION   0329	3	91	92	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2633	2635		10.1056/NEJMp0808736	http://dx.doi.org/10.1056/NEJMp0808736			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19052119				2022-12-28	WOS:000261757300002
J	Payne, GC; Payne, RE; Farewell, DM				Payne, Gareth C.; Payne, Rebecca E.; Farewell, Daniel M.			Rugby (the religion of Wales) and its influence on the Catholic Church. Should Pope Benedict XVI be worried?	BRITISH MEDICAL JOURNAL			English	Article								Objective To explore the perceived wisdom that papal mortality is related to the success of the Welsh rugby union team. Design Retrospective observational study of historical Vatican and sporting data. Main outcome measure Papal deaths between 1883 and the present day. Results There is no evidence of a link between papal deaths and any home nation grand slams ( when one nation succeeds in beating all other competing teams in every match). There was, however, weak statistical evidence to support an association between Welsh performance and the number of papal deaths. Conclusion Given the dominant Welsh performances of 2008, the Vatican medical team should take special care of the pontiff this Christmas.	[Payne, Gareth C.] Univ Wales Hosp, Dept Clin Neurophysiol, Cardiff CF14 4XW, Wales; [Farewell, Daniel M.] Cardiff Univ, Dept Publ Hlth & Primary Care, Sch Med, Cardiff CF14 4YS, Wales	Cardiff University	Payne, GC (corresponding author), Univ Wales Hosp, Dept Clin Neurophysiol, Heath Pk, Cardiff CF14 4XW, Wales.	garethpayne@doctors.org.uk		Farewell, Daniel/0000-0002-8871-1653	Medical Research Council [G0601724] Funding Source: Medline; MRC [G0601724] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2008	337								a2768	10.1136/bmj.a2768	http://dx.doi.org/10.1136/bmj.a2768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	390SW	19091757	hybrid, Green Published			2022-12-28	WOS:000262185000003
J	Ardolino, A; Crook, TB; Taylor, HP				Ardolino, A.; Crook, T. B.; Taylor, H. P.			How to safeguard your ring in theatre	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ardolino, A.; Crook, T. B.; Taylor, H. P.] Poole Hosp, Dept Orthopaed & Trauma, Poole BH15 2JB, Dorset, England	Poole Hospital	Ardolino, A (corresponding author), Poole Hosp, Dept Orthopaed & Trauma, Poole BH15 2JB, Dorset, England.	toni.a@doctors.org.uk						Kelsall NKR, 2006, J HOSP INFECT, V62, P450, DOI 10.1016/j.jhin.2005.09.002	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2008	337								a2592	10.1136/bmj.a2592	http://dx.doi.org/10.1136/bmj.a2592			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399BZ	19066254				2022-12-28	WOS:000262776700006
J	Tuffs, A				Tuffs, Annette			Profile A Nobel cause	BRITISH MEDICAL JOURNAL			English	Biographical-Item												atuffs@web.de							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 9	2008	337								a2930	10.1136/bmj.a2930	http://dx.doi.org/10.1136/bmj.a2930			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399BZ	19066255				2022-12-28	WOS:000262776700008
J	Rouach, N; Koulakoff, A; Abudara, V; Willecke, K; Giaume, C				Rouach, Nathalie; Koulakoff, Annette; Abudara, Veronica; Willecke, Klaus; Giaume, Christian			Astroglial Metabolic Networks Sustain Hippocampal Synaptic Transmission	SCIENCE			English	Article							GAP-JUNCTIONS; ASTROCYTES; EXPRESSION	Astrocytes provide metabolic substrates to neurons in an activity- dependent manner. However, the molecular mechanisms involved in this function, as well as its role in synaptic transmission, remain unclear. Here, we show that the gap- junction subunit proteins connexin 43 and 30 allow intercellular trafficking of glucose and its metabolites through astroglial networks. This trafficking is regulated by glutamatergic synaptic activity mediated by AMPA receptors. In the absence of extracellular glucose, the delivery of glucose or lactate to astrocytes sustains glutamatergic synaptic transmission and epileptiform activity only when they are connected by gap junctions. These results indicate that astroglial gap junctions provide an activity- dependent intercellular pathway for the delivery of energetic metabolites from blood vessels to distal neurons.	[Rouach, Nathalie; Koulakoff, Annette; Abudara, Veronica; Giaume, Christian] Coll France, INSERM, U840, F-75005 Paris, France; [Abudara, Veronica] Univ Republica, Fac Med, Montevideo, Uruguay; [Willecke, Klaus] Univ Bonn, Inst Genet, D-53117 Bonn, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universidad de la Republica, Uruguay; University of Bonn	Rouach, N (corresponding author), Coll France, INSERM, U840, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	nathalie.rouach@college-de-france.fr	Rouach, Nathalie/L-4767-2017	Rouach, Nathalie/0000-0002-5574-888X; KOULAKOFF, Annette/0000-0002-3143-2215	Human Frontier Science Program Organization (Career Development Award); Agence Nationale de la Recherche (Programme Jeunes chercheurs); INSERM; German Research Association [SFB 615, B3]; International Brain Research Organization	Human Frontier Science Program Organization (Career Development Award)(Human Frontier Science Program); Agence Nationale de la Recherche (Programme Jeunes chercheurs)(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); German Research Association(German Research Foundation (DFG)); International Brain Research Organization	We thank P. Ezan for technical assistance and R. Nicoll, G. Bonvento, J. Deitmer, and P. Magistretti for helpful discussions. This work was supported by grants from the Human Frontier Science Program Organization (Career Development Award) and Agence Nationale de la Recherche ( Programme Jeunes chercheurs) to N.R.; from INSERM to N.R., A.K., and C.G.; from the German Research Association (SFB 615, B3) to K.W.; and from International Brain Research Organization to V. A. N. R. dedicates this work to her daughter Angela.	Clarke Donald D., 1994, P645; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Kacem K, 1998, GLIA, V23, P1; Matthias K, 2003, J NEUROSCI, V23, P1750; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Simard M, 2003, J NEUROSCI, V23, P9254; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Wallraff A, 2004, GLIA, V48, P36, DOI 10.1002/glia.20040	14	602	626	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1551	1555		10.1126/science.1164022	http://dx.doi.org/10.1126/science.1164022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056987				2022-12-28	WOS:000261377400051
J	Lewis, SC; Warlow, CP; Bodenham, AR; Colam, B; Rothwell, PM; Torgerson, D; Dellagrammaticas, D; Horrocks, M; Liapis, C; Banning, AP; Gough, M; Gough, MJ				Lewis, S. C.; Warlow, C. P.; Bodenham, A. R.; Colam, B.; Rothwell, P. M.; Torgerson, D.; Dellagrammaticas, D.; Horrocks, M.; Liapis, C.; Banning, A. P.; Gough, M.; Gough, M. J.		GALA Trial Collaborative Grp	General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial	LANCET			English	Article							ENDARTERECTOMY; STENOSIS	Background The effect of carotid endarterectomy in lowering the risk of stroke ipsilateral to severe atherosclerotic carotid-artery stenosis is offset by complications during or soon after surgery. We compared surgery under general anaesthesia with that under local anaesthesia because prediction and avoidance of perioperative strokes might be easier under local anaesthesia than under general anaesthesia. Methods We undertook a parallel group, multicentre, randomised controlled trial of 3526 patients with symptomatic or asymptomatic carotid stenosis from 95 centres in 24 countries. Participants were randomly assigned to surgery under general (n=1753) or local (n=1773) anaesthesia between June, 1999 and October, 2007. The primary outcome was the proportion of patients with stroke (including retinal infarction), myocardial infarction, or death between randomisation and 30 days after surgery. Analysis was by intention to treat. The trial is registered with Current Control Trials number ISRCTNO0525237. Findings A primary outcome occurred in 84 (4.8%) patients assigned to surgery under general anaesthesia and 80 (4 . 5%) of those assigned to surgery under local anaesthesia; three events per 1000 treated were prevented with local anaesthesia (95% CI -11 to 17; risk ratio [RR] 0 . 94 [95% CI 0 . 70 to 1. 27]). The two groups did not significantly differ for quality of life, length of hospital stay, or the primary outcome in the prespecified subgroups of age, contralateral carotid occlusion, and baseline surgical risk. Interpretation We have not shown a definite difference in outcomes between general and local anaesthesia for carotid surgery. The anaesthetist and surgeon, in consultation with the patient, should decide which anaesthetic technique to use on an individual basis. Funding The Health Foundation (UK) and European Society of Vascular Surgery.	[Lewis, S. C.] Western Gen Hosp, Neurosci Trials Unit, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Lewis, SC (corresponding author), Western Gen Hosp, Neurosci Trials Unit, Div Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	steff.lewis@ed.ac.uk	Sieunarine, Kishore/AAI-5548-2020; Dellagrammaticas, Demosthenes/J-7158-2018; DE TROIA, ALESSANDRO/V-1292-2018; Ferrante, Angela Maria Rosaria/AIC-4170-2022; Modugno, Pietro/U-2975-2019; Karpenko, Andrei/AAH-1725-2020; Macleod, Malcolm Robert/B-2052-2010; Sunar, Hasan/A-8685-2018; Mansilha, Armando/ABF-1229-2020; Hrbac, Tomas/M-9596-2017; Rothwell, Peter/ABE-5913-2020; Hankey, Graeme J/H-4968-2014; Gillgren, Peter/AAB-4724-2020; MWIPATAYI, Bibombe Patrice/AAE-3000-2019; Taba, Pille/B-1014-2019; Sudlow, Cathie LM/F-3420-2010; banning, adrian p/AAF-7229-2021; Tutkavul, Kemal/AAE-2126-2019; Azevedo, Elsa I/C-1060-2014; Finocchi, Cinzia/AAA-7409-2020; Torgerson, David/L-4566-2019; Di Lazzaro, Vincenzo/L-3731-2018; Michalek, Pavel/N-9123-2017; GABRIELLI, ROBERTO/M-9253-2016; Smrcka, Martin/AAM-8872-2021; Cinelli, Giuseppe/F-5155-2011	Sieunarine, Kishore/0000-0003-4151-5505; Dellagrammaticas, Demosthenes/0000-0002-4429-7147; DE TROIA, ALESSANDRO/0000-0002-7392-9764; Ferrante, Angela Maria Rosaria/0000-0002-5653-6934; Macleod, Malcolm Robert/0000-0001-9187-9839; Mansilha, Armando/0000-0002-6722-0476; Hrbac, Tomas/0000-0002-6401-9849; Rothwell, Peter/0000-0001-9739-9211; Hankey, Graeme J/0000-0002-6044-7328; Gillgren, Peter/0000-0003-0538-3496; MWIPATAYI, Bibombe Patrice/0000-0003-1977-0382; Tutkavul, Kemal/0000-0002-0986-3924; Azevedo, Elsa I/0000-0003-3731-4508; Finocchi, Cinzia/0000-0003-4385-1203; Torgerson, David/0000-0002-1667-4275; SUNAR, HASAN/0000-0002-1276-8549; Ciccozzi, Alessandra/0000-0003-0250-7991; Di Lazzaro, Vincenzo/0000-0002-9113-5925; Sudlow, Cathie/0000-0002-7725-7520; PIROLI, Alba/0000-0002-1722-6490; Lumb, Andrew/0000-0002-6684-9205; PETRASSI, Carla/0000-0002-5933-2507; LIAPIS, CHRISTOS/0000-0002-1195-9108; Bukhari, Marwan/0000-0003-4311-5222; Myslinski, Wojciech/0000-0003-1134-5920; Karpenko, Andrey/0000-0002-8064-1857; Eckstein, Hans-Henning/0000-0002-0743-1642; Lioupis, Christos/0000-0001-6197-3218; Michalek, Pavel/0000-0001-8119-5927; fiedler, jiri/0000-0001-7886-6021; VENTURA, Marco/0000-0003-2573-8573; GABRIELLI, ROBERTO/0000-0001-7192-5076; Smrcka, Martin/0000-0002-9191-8700; Cinelli, Giuseppe/0000-0002-5319-537X; Tommasino, Concezione/0000-0001-8856-6866; SIRIGNANO, Pasqualino/0000-0002-1312-1915; Poppert, Holger/0000-0003-2189-7681; SPARTERA, Carlo/0000-0003-0401-7937; CREA, Maria Antonietta/0000-0003-3142-4175; Rutherford, John/0000-0002-0873-977X; Priban, Vladimir/0000-0001-6051-9910; chetter, ian/0000-0002-2566-6859; Rosengren, Lars/0000-0003-0505-8896; Taba, Pille/0000-0002-1315-1065; gossetti, bruno/0000-0001-6805-1785; Pal, Endre/0000-0001-6525-0754; GHILARDI, GIORGIO/0000-0002-0269-5761; White, Nicholas/0000-0002-1897-1978; Kvolik, Slavica/0000-0002-5244-9585; Pinotic, Kresimir/0000-0003-4559-5485; Iborra, Elena/0000-0003-0668-5285; Modugno, Pietro/0000-0002-8194-7567; GIMENEZ-GAIBAR, ANTONIO/0000-0002-1837-4989; Ferrero, Emanuele/0000-0002-6242-6192; corsi, fabio massimo/0000-0002-4219-4283; Lewis, Steff/0000-0003-1210-2314; Schneider, Gerhard/0000-0002-4903-0118; Verzar, Zsofia/0000-0001-5323-0748; Vlachovsky, Robert/0000-0002-2899-3580; Banning, Adrian/0000-0002-2842-7861; Milo, Ron/0000-0001-8556-2579; Przywara, Stanislaw/0000-0002-8855-3974; Aksoy, Murat/0000-0002-9116-3985; Howell, Simon/0000-0001-8467-1466; Murray, Gordon/0000-0001-9866-4734; Setacci, Francesco/0000-0002-8007-9462				Altman D.G., 2000, STAT CONFIDENCE, Vsecond; [Anonymous], 2001, BANDOLIER; Bond R, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000160.PUB2; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Gough MJ, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-28; Hakl M, 2007, BRIT J ANAESTH, V99, P415, DOI 10.1093/bja/aem171; Halliday A, 2004, LANCET, V363, P1491; McCleary AJ, 1996, EUR J VASC ENDOVASC, V12, P173, DOI 10.1016/S1078-5884(96)80103-1; Pandit JJ, 2007, BRIT J ANAESTH, V99, P159, DOI 10.1093/bja/aem160; RERKASEM K, 1996, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000126, DOI 10.1002/14651858.CD000126]; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8	16	367	381	2	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2132	2142		10.1016/S0140-6736(08)61699-2	http://dx.doi.org/10.1016/S0140-6736(08)61699-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19041130	Green Submitted			2022-12-28	WOS:000261894000036
J	Thirlwell, C; Nathan, P				Thirlwell, Christina; Nathan, Paul			Melanoma - Part 2: management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							METASTATIC MELANOMA; GENERAL-PRACTITIONERS; EXCISION MARGINS; SENTINEL-NODE; STAGE-III; DERMATOLOGISTS; ACCURACY; EFFICACY; BIOPSY; SAFETY		[Nathan, Paul] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England; [Thirlwell, Christina] Royal Free Hosp, London NW3 2QG, England	Mount Vernon Cancer Centre; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Nathan, P (corresponding author), Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England.	nathan.pd@gmail.com		Nathan, Paul/0000-0002-2327-3250				Balch CM, 2001, ANN SURG ONCOL, V8, P101, DOI 10.1007/s10434-001-0101-x; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Brochez L, 2001, J AM ACAD DERMATOL, V44, P979, DOI 10.1067/mjd.2001.113442; Chen SC, 2001, ARCH DERMATOL, V137, P1627; *DEP HLTH, 2007, GUID COMP PROV SERV; DUVIVIER AWP, 1991, CLIN EXP DERMATOL, V16, P344, DOI 10.1111/j.1365-2230.1991.tb00397.x; Eggermont AM, 2007, J CLIN ONCOL, V25; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Eton O, 1998, J CLIN ONCOL, V16, P1103, DOI 10.1200/JCO.1998.16.3.1103; Gerbert B, 2002, J CANCER EDUC, V17, P7; Gerbert B, 1998, J GEN INTERN MED, V13, P91, DOI 10.1046/j.1525-1497.1998.00024.x; GONZALEZ R, 2008, ASCO M S, V26, P9036; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Grunhagen DJ, 2004, ANN SURG, V240, P939, DOI 10.1097/01.sla.0000146147.89667.ed; Handley WS, 1907, LANCET, V1, P927; HERD RM, 1992, BMJ-BRIT MED J, V305, P1476, DOI 10.1136/bmj.305.6867.1476; Ives NJ, 2007, J CLIN ONCOL, V25, P5426, DOI 10.1200/JCO.2007.12.0253; Khorshid SM, 1998, BRIT J DERMATOL, V138, P412; Kirkwood JM, 1997, SEMIN ONCOL, V24, pS16; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Lens MB, 2007, ARCH SURG-CHICAGO, V142, P885, DOI 10.1001/archsurg.142.9.885; MACKIE RM, 1991, CLIN EXP DERMATOL, V16, P151, DOI 10.1111/j.1365-2230.1991.tb00329.x; McDermott DF, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.9552; MCWILLIAM LJ, 1991, BRIT MED J, V303, P1177, DOI 10.1136/bmj.303.6811.1177; Meyer T, 2000, CANCER, V89, P1983, DOI 10.1002/1097-0142(20001101)89:9<1983::AID-CNCR15>3.3.CO;2-J; Mori Y, 1998, INT J RADIAT ONCOL, V42, P581, DOI 10.1016/S0360-3016(98)00272-7; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; National Institute for Health and Clinical Excellence, 2006, IMPR OUTC PEOPL SKIN; OVERETT TK, 1985, CANCER, V56, P1222, DOI 10.1002/1097-0142(19850901)56:5<1222::AID-CNCR2820560544>3.0.CO;2-A; Roberts DLL, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.2001.04614.x; *ROYAL COLL PATH, 2002, STAND MIN DAT REP SK; Saenger Yvonne M, 2008, Cancer Immun, V8, P1; Selek U, 2004, INT J RADIAT ONCOL, V59, P1097, DOI 10.1016/j.ijrobp.2003.12.037; Tarhini AA, 2007, J CLIN ONCOL, V25, P3802, DOI 10.1200/JCO.2006.10.2822; Thomas JM, 2008, NAT CLIN PRACT ONCOL, V5, P18, DOI 10.1038/ncponc1014; Thomas JM, 2004, NEW ENGL J MED, V350, P757, DOI 10.1056/NEJMoa030681; Thompson JF, 1998, SEMIN SURG ONCOL, V14, P238; VERONESI U, 1991, ARCH SURG-CHICAGO, V126, P438; WATERS RA, 1991, BRIT J SURG, V78, P493, DOI 10.1002/bjs.1800780433; Weber JS, 2007, J CLIN ONCOL, V25; Wheatley K, 2007, J CLIN ONCOL, V25, P4693, DOI 10.1200/JCO.2007.13.3389; Zacest AC, 2002, J NEUROSURG, V96, P552, DOI 10.3171/jns.2002.96.3.0552	43	15	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2008	337								a2488	10.1136/bmj.a2488	http://dx.doi.org/10.1136/bmj.a2488			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NU	19047194				2022-12-28	WOS:000261890700001
J	Mullighan, CG; Phillips, LA; Su, XP; Ma, J; Miller, CB; Shurtleff, SA; Downing, JR				Mullighan, Charles G.; Phillips, Letha A.; Su, Xiaoping; Ma, Jing; Miller, Christopher B.; Shurtleff, Sheila A.; Downing, James R.			Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia	SCIENCE			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; MINIMAL RESIDUAL DISEASE; GENE REARRANGEMENTS; YOUNG-CHILDREN; IMMUNOGENOTYPE; EVOLUTION; DIAGNOSIS; SELECTION; DELETION; SUBCLONE	Most children with acute lymphoblastic leukemia ( ALL) can be cured, but the prognosis is dismal for the minority of patients who relapse after treatment. To explore the genetic basis of relapse, we performed genome- wide DNA copy number analyses on matched diagnosis and relapse samples from 61 pediatric patients with ALL. The diagnosis and relapse samples typically showed different patterns of genomic copy number abnormalities ( CNAs), with the CNAs acquired at relapse preferentially affecting genes implicated in cell cycle regulation and B cell development. Most relapse samples lacked some of the CNAs present at diagnosis, which suggests that the cells responsible for relapse are ancestral to the primary leukemia cells. Backtracking studies revealed that cells corresponding to the relapse clone were often present as minor subpopulations at diagnosis. These data suggest that genomic abnormalities contributing to ALL relapse are selected for during treatment, and they point to new targets for therapeutic intervention.	[Mullighan, Charles G.; Phillips, Letha A.; Su, Xiaoping; Miller, Christopher B.; Shurtleff, Sheila A.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Downing, JR (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org	Mullighan, Charles/H-3253-2011	Mullighan, Charles/0000-0002-1871-1850	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Ashmun and the St. Jude Flow Cytometry and Cell Sorting Shared Resource for flow sorting of leukemia samples, the St. Jude Clinical Applications Core Technology Laboratory for performing SNP arrays, L. Kiedrowski for lesion mapping and backtracking assays, and J. Stokes for assistance with artwork. Supported by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital and by the National Health and Medical Research Council of Australia (C.G.M.). Primary SNP array data are available from the authors upon request. J.R.D. has participated in gene expression profiling research sponsored by Roche. C.G.M. and J.R.D. have filed a patent application related to this work.	BEISHUIZEN A, 1994, BLOOD, V83, P2238, DOI 10.1182/blood.V83.8.2238.bloodjournal8382238; Choi S, 2007, BLOOD, V110, P632, DOI 10.1182/blood-2007-01-067785; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Davi F, 1996, BLOOD, V88, P609, DOI 10.1182/blood.V88.2.609.bloodjournal882609; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Ford AM, 2001, BLOOD, V98, P558, DOI 10.1182/blood.V98.3.558; Germano G, 2003, LEUKEMIA, V17, P1573, DOI 10.1038/sj.leu.2403008; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Irving JAE, 2005, CANCER RES, V65, P3053, DOI 10.1158/0008-5472.CAN-04-2604; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Konrad M, 2003, BLOOD, V101, P3635, DOI 10.1182/blood-2002-10-3252; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Maloney KW, 1999, BLOOD, V93, P2380, DOI 10.1182/blood.V93.7.2380.407k27_2380_2385; MARSHALL GM, 1995, LEUKEMIA, V9, P1847; Moorman AV, 2007, BLOOD, V109, P2327, DOI 10.1182/blood-2006-08-040436; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Panzer-Grumayer ER, 2005, CLIN CANCER RES, V11, P7720, DOI 10.1158/1078-0432.CCR-05-1239; Peham M, 2004, GENE CHROMOSOME CANC, V39, P156, DOI 10.1002/gcc.10305; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; RAIMONDI SC, 1993, BLOOD, V82, P576; Rivera GK, 2005, CANCER-AM CANCER SOC, V103, P368, DOI 10.1002/cncr.20743; Rosenquist R, 1999, EUR J HAEMATOL, V63, P171; Takeuchi S, 2003, ONCOGENE, V22, P6970, DOI 10.1038/sj.onc.1206974; TAYLOR JJ, 1994, LEUKEMIA, V8, P60; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	27	612	634	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1377	1380		10.1126/science.1164266	http://dx.doi.org/10.1126/science.1164266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039135	Green Accepted			2022-12-28	WOS:000261170600038
J	Puthanveettil, SV; Monje, FJ; Miniaci, MC; Choi, YB; Karl, KA; Khandros, E; Gawinowicz, MA; Sheetz, MP; Kandel, ER				Puthanveettil, Sathyanarayanan V.; Monje, Francisco J.; Miniaci, Maria Concetta; Choi, Yun-Beom; Karl, Kevin A.; Khandros, Eugene; Gawinowicz, Mary Ann; Sheetz, Michael P.; Kandel, Eric R.			A New Component in Synaptic Plasticity: Upregulation of Kinesin in the Neurons of the Gill-Withdrawal Reflex	CELL			English	Article							LONG-TERM FACILITATION; LOCAL PROTEIN-SYNTHESIS; APLYSIA SENSORY NEURONS; AXONAL-TRANSPORT; HETEROSYNAPTIC FACILITATION; NERVOUS-SYSTEM; MEMORY STORAGE; MOTOR; EXPRESSION; SYNAPSES	To explore how gene products, required for the initiation of synaptic growth, move from the cell body of the sensory neuron to its presynaptic terminals, and from the cell body of the motor neuron to its postsynaptic dendritic spines, we have investigated the anterograde transport machinery in both the sensory and motor neurons of the gill-withdrawal reflex of Aplysia. We found that the induction of long-term facilitation (LTF) by repeated applications of serotonin, a modulatory transmitter released during learning in Aplysia, requires upregulation of kinesin heavy chain (KHC) in both pre- and postsynaptic neurons. Indeed, upregulation of KHC in the presynaptic neurons alone is sufficient for the induction of LTF. However, KHC is not required for the persistence of LTF. Thus, in addition to transcriptional activation in the nucleus and local protein synthesis at the synapse, our studies have identified a third component critical for long-term learning-related plasticity: the coordinated upregulation of kinesin-mediated transport.	[Puthanveettil, Sathyanarayanan V.; Monje, Francisco J.; Miniaci, Maria Concetta; Choi, Yun-Beom; Khandros, Eugene; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Karl, Kevin A.; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Gawinowicz, Mary Ann] Columbia Univ Coll Phys & Surg, Prot Chem Core Facil, New York, NY 10032 USA; [Sheetz, Michael P.] Columbia Univ Coll Phys & Surg, Dept Biol Sci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Kavli Inst Brain Sci, New York, NY 10032 USA; [Choi, Yun-Beom] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Miniaci, Maria Concetta] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; University of Naples Federico II	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu		Miniaci, Maria/0000-0003-3844-0581	HHMI; NIH [P50 HG002806, R01 MH075026]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060762] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	members Joseph Rayman and Ilias Pavlopoulos for their critical comments on an earlier version of this manuscript. We are grateful to Peter Schieffele for the gift of anti-neurexin antibody. We thank Joun-Hun Kim for help with Piccolo antisense microinjection experiments, Aviva Olsavsky for help with the RTPCR experiments, and John Edwards of Columbia's Genome Center for help with kinesin ESTs. Special thanks to Vivian Zhu for help with cell cultures, Hannah Cho for technical help, and Charles Lam for help with graphics. This work is supported by HHMI, and NIH grants P50 HG002806 and R01 MH075026.	BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Grigoriev I S, 1999, Membr Cell Biol, V13, P23; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026	44	67	67	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					960	973		10.1016/j.cell.2008.11.003	http://dx.doi.org/10.1016/j.cell.2008.11.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041756	Bronze, Green Accepted			2022-12-28	WOS:000261183900025
J	Rupar, PA; Staroverov, VN; Baines, KM				Rupar, Paul A.; Staroverov, Viktor N.; Baines, Kim M.			A Cryptand-Encapsulated Germanium(II) Dication	SCIENCE			English	Article							CRYSTAL-STRUCTURE; CATION; COMPLEXES; CHEMISTRY; ANIONS; GERMYL; SILYL	Unlike cations of metals such as sodium or calcium, oxidized silicon and germanium centers generally require strongly bound covalent ligands. We report the synthesis and characterization of a germanium( II) dication in the form of the salt (Ge.cryptand[ 2.2.2])( O3SCF3)(2). The salt is isolated in 88% yield from the reaction of cryptand [ 2.2.2] and an N- heterocyclic carbene complex of GeCl(O3SCF3) as an air- sensitive, white solid. The crystal structure of the salt shows minimal interaction between the cryptand- encapsulated germanium( II) ion and the two -O3SCF3 counterions. These results suggest a widely expanded role of cryptands and related molecules in stabilizing nonmetallic cations.	[Rupar, Paul A.; Staroverov, Viktor N.; Baines, Kim M.] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada	Western University (University of Western Ontario)	Baines, KM (corresponding author), Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada.	kbaines2@uwo.ca	Rupar, Paul/E-6496-2010	Rupar, Paul/0000-0002-9532-116X	Natural Sciences and Engineering Research Council of Canada; University of Western Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Western Ontario	Funding was provided by the Natural Sciences and Engineering Research Council of Canada and the University of Western Ontario. Computational resources were provided by the facilities of the Shared Hierarchical Academic Research Computing Network (www.sharcnet.ca). X-ray diffraction data were collected by R. McDonald at the X-Ray Crystallography Laboratory of the Department of Chemistry, University of Alberta. EDX spectra were collected by T. Simpson of the Nanofabrication Laboratory at the University of Western Ontario. We thank Teck Cominco for a donation of GeCl<INF>4</INF>, D. Hairsine for acquisition of mass spectral data, and M. C. Jennings for helpful discussions. CCDC 704541 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre (www.ccdc.cam.ac.uk/ data_request/cif).	Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; Baines KM, 1995, COORDIN CHEM REV, V145, P157; Bertrand G, 2004, SCIENCE, V305, P783, DOI 10.1126/science.1102270; Chekhlov AN, 2006, J STRUCT CHEM+, V47, P352, DOI 10.1007/s10947-006-0306-8; Chekhlov AN, 2006, RUSS J COORD CHEM+, V32, P552, DOI 10.1134/S1070328406080033; Dias HVR, 1997, J AM CHEM SOC, V119, P4650, DOI 10.1021/ja970196b; Dietrich B., 1996, COMPREHENSIVE SUPRAM, V1, P153; Douvris C, 2008, SCIENCE, V321, P1188, DOI 10.1126/science.1159979; Ernzerhof M, 1999, J CHEM PHYS, V110, P5029, DOI 10.1063/1.478401; Frisch M.J., 2016, GAUSSIAN16 REV B01; Gaspar PP, 2005, ORGANOSILICON CHEMISTRY VI: FROM MOLECULES TO MATERIALS, P10; Gaspar PP, 2002, SCIENCE, V297, P785, DOI 10.1126/science.1075469; Jutzi P, 2004, SCIENCE, V305, P849, DOI 10.1126/science.1099879; Jutzi P, 1999, CHEM REV, V99, P969, DOI 10.1021/cr941099t; Kim KC, 2002, SCIENCE, V297, P825, DOI 10.1126/science.1073540; Krossing I, 2004, ANGEW CHEM INT EDIT, V43, P2066, DOI 10.1002/anie.200300620; Lee VY, 2007, ACCOUNTS CHEM RES, V40, P410, DOI 10.1021/ar6000473; MAYER I, 1983, CHEM PHYS LETT, V97, P270, DOI 10.1016/0009-2614(83)80005-0; Muller T, 2005, ADV ORGANOMET CHEM, V53, P155, DOI 10.1016/S0065-3055(05)53005-3; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Rupar PA, 2008, ORGANOMETALLICS, V27, P5043, DOI 10.1021/om800368d; Rupar PA, 2007, J AM CHEM SOC, V129, P15138, DOI 10.1021/ja0775725; Rupar PA, 2007, ORGANOMETALLICS, V26, P4109, DOI 10.1021/om7006198; Schleyer PV, 1997, SCIENCE, V275, P39; Schreiner, 1998, ENCY COMPUTATIONAL C, V3; Sekiguchi A, 2003, ANGEW CHEM INT EDIT, V42, P1143, DOI 10.1002/anie.200390300; Sekiguchi A, 1997, SCIENCE, V275, P60, DOI 10.1126/science.275.5296.60; Stender M, 2001, INORG CHEM, V40, P5314, DOI 10.1021/ic0155582; WIBERG KB, 1968, TETRAHEDRON, V24, P1083, DOI 10.1016/0040-4020(68)88057-3	30	121	121	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1360	1363		10.1126/science.1163033	http://dx.doi.org/10.1126/science.1163033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039131				2022-12-28	WOS:000261170600033
J	Onwude, JL				Onwude, Joseph L.			What is the most effective treatment of interstitial cystitis?	BRITISH MEDICAL JOURNAL			English	Editorial Material							BACILLUS-CALMETTE-GUERIN; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PENTOSAN POLYSULFATE; DIMETHYL-SULFOXIDE; L-ARGININE; EFFICACY		[Onwude, Joseph L.] Community Gynaecol Ltd, Chelmsford CM1 3RW, Essex, England		Onwude, JL (corresponding author), Community Gynaecol Ltd, Chelmsford CM1 3RW, Essex, England.	jlonwude@btconnect.com	ONWUDE, JOSEPH LOZE/ABA-4929-2021; ONWUDE, JOSEPH Loze/AFM-0527-2022; ONWUDE, JOSEPH Loze/AAH-2903-2022; ONWUDE, JOSEPH LOZE/ABF-7876-2021					Bade JJ, 1997, BRIT J UROL, V79, P168, DOI 10.1046/j.1464-410X.1997.03384.x; Cartledge JJ, 2000, BJU INT, V85, P421, DOI 10.1046/j.1464-410x.2000.00490.x; Hwang P, 1997, UROLOGY, V50, P39, DOI 10.1016/S0090-4295(97)00110-6; *INT CYST CLIN RES, 2007, EFF AM PAINF BLADD S; Korting GE, 1999, J UROLOGY, V161, P558, DOI 10.1016/S0022-5347(01)61950-5; Mayer R, 2005, J UROLOGY, V173, P1186, DOI 10.1097/01.ju.0000152337.82806.e8; Payne CK, 2005, J UROLOGY, V173, P1590, DOI 10.1097/01.ju.0000154631.92150.ef; Peeker R, 2000, J UROLOGY, V164, P1912, DOI 10.1016/S0022-5347(05)66916-9; PEREZMARRERO R, 1988, J UROLOGY, V140, P36, DOI 10.1016/S0022-5347(17)41478-9; Peters K, 1997, J UROLOGY, V157, P2090, DOI 10.1016/S0022-5347(01)64682-2; Sairanen J, 2005, J UROLOGY, V174, P2235, DOI 10.1097/01.ju.0000181808.45786.84; Sant GR, 2003, J UROLOGY, V170, P810, DOI 10.1097/01.ju.0000083020.06212.3d; Thilagarajah R, 2001, BJU INT, V87, P207, DOI 10.1046/j.1464-410x.2001.02031.x; van Ophoven A, 2004, J UROLOGY, V172, P533, DOI 10.1097/01.ju.0000132388.54703.4d; Warren JW, 2000, J UROLOGY, V163, P1685, DOI 10.1016/S0022-5347(05)67520-9	15	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 27	2008	337								a2325	10.1136/bmj.a2325	http://dx.doi.org/10.1136/bmj.a2325			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QC	19039011				2022-12-28	WOS:000261827700003
J	Grobler, L; Siegfried, N; Askie, L; Hooft, L; Tharyan, P; Antes, G				Grobler, Liesl; Siegfried, Nandi; Askie, Lisa; Hooft, Lotty; Tharyan, Prathap; Antes, Gerd			National and multinational prospective trial registers	LANCET			English	Editorial Material							CLINICAL-TRIALS		[Grobler, Liesl] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Grobler, Liesl; Siegfried, Nandi] MRC S Africa, S African Cochrane Ctr, Tygerberg, South Africa; [Grobler, Liesl; Siegfried, Nandi] MRC S Africa, HIV AIDS TB & Malaria Clin Trials Registry, Tygerberg, South Africa; [Askie, Lisa] Univ Sydney, Australian New Zealand Clin Trials Registry, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Hooft, Lotty] Univ Amsterdam, Acad Med Ctr, Netherlands Trial Register, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands; [Tharyan, Prathap] Christian Med Coll & Hosp, S Asian Cochrane Network & Ctr, Prof BV Moses & ICMR Adv Ctr Res Training Evidenc, Vellore 632004, Tamil Nadu, India; [Antes, Gerd] Univ Freiburg, German Cochrane Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany	University of Cape Town; University of Sydney; University of Amsterdam; Academic Medical Center Amsterdam; Christian Medical College & Hospital (CMCH) Vellore; University of Freiburg	Grobler, L (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	liesl.grobler@uct.ac.za						CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Tharyan Prathap, 2007, Indian J Med Ethics, V4, P168; Tharyan P, 2008, NATL MED J INDIA, V21, P31; *WHO, 2008, WHO INT CLIN TRIAL R; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	8	17	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 4	2008	372	9645					1201	1202		10.1016/S0140-6736(08)61498-1	http://dx.doi.org/10.1016/S0140-6736(08)61498-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19094940				2022-12-28	WOS:000259882000007
J	Shank, SS; Margoliash, D				Shank, Sylvan S.; Margoliash, Daniel			Sleep and sensorimotor integration during early vocal learning in a songbird	NATURE			English	Article							SLOW-WAVE SLEEP; ZEBRA FINCHES; HUMAN HIPPOCAMPUS; MEMORY; SPARROWS; REPLAY; CONSOLIDATION; SEQUENCES; BIRDSONG; BEHAVIOR	Behavioural studies widely implicate sleep in memory consolidation in the learning of a broad range of behaviours(1-4). During sleep, brain regions are reactivated(5,6), and specific patterns of neural activity are replayed(7-10), consistent with patterns observed in previous waking behaviour. Birdsong learning is a paradigmatic model system for skill learning(11-14). Song development in juvenile zebra finches (Taeniopygia guttata) is characterized by sleep-dependent circadian fluctuations in singing behaviour, with immediate post-sleep deterioration in song structure followed by recovery later in the day(15). In sleeping adult birds, spontaneous bursting activity of forebrain premotor neurons in the robust nucleus of the arcopallium (RA) carries information about daytime singing(16). Here we show that, in juvenile zebra finches, playback during the day of an adult 'tutor' song induced profound and tutor-song-specific changes in bursting activity of RA neurons during the following night of sleep. The night-time neuronal changes preceded tutor-song-induced changes in singing, first observed the following day. Interruption of auditory feedback greatly reduced sleep bursting and prevented the tutor-song-specific neuronal remodelling. Thus, night-time neuronal activity is shaped by the interaction of the song model (sensory template) and auditory feedback, with changes in night-time activity preceding the onset of practice associated with vocal learning. We hypothesize that night-time bursting induces adaptive changes in premotor networks during sleep as part of vocal learning. By this hypothesis, adaptive changes driven by replay of sensory information at night and by evaluation of sensory feedback during the day interact to produce the complex circadian patterns seen early in vocal development.	[Shank, Sylvan S.; Margoliash, Daniel] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Margoliash, Daniel] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Margoliash, D (corresponding author), Univ Chicago, Dept Psychol, Chicago, IL 60637 USA.	dan@bigbird.uchicago.edu			NIMH NIH HHS [R01 MH059831, R01 MH059831-09] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059831] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adret P, 2002, J COMP NEUROL, V454, P409, DOI 10.1002/cne.10459; Crandall SR, 2007, J NEUROPHYSIOL, V98, P232, DOI 10.1152/jn.00128.2007; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; EVARTS EV, 1962, SCIENCE, V135, P727, DOI 10.1126/science.135.3505.726; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Funabiki Y, 2003, J NEUROSCI, V23, P6928; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; HULTSCH H, 1989, J COMP PHYSIOL A, V165, P197, DOI 10.1007/BF00619194; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Konishi M., 1978, PERCEPTION EXPERIENC, P105; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Pytte CL, 1999, NEUROREPORT, V10, P1773, DOI 10.1097/00001756-199906030-00027; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; ZEIGLER HP, 2004, BEHAV NEUROBIOLOGY B	34	122	123	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					73	U4		10.1038/nature07615	http://dx.doi.org/10.1038/nature07615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19079238	Green Accepted			2022-12-28	WOS:000263836000035
J	Rajaratnam, SMW; Polymeropoulos, MH; Fisher, DM; Roth, T; Scott, C; Birznieks, G; Klerman, EB				Rajaratnam, Shantha M. W.; Polymeropoulos, Mihael H.; Fisher, Dennis M.; Roth, Thomas; Scott, Christin; Birznieks, Gunther; Klerman, Elizabeth B.			Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials	LANCET			English	Article							EXOGENOUS MELATONIN; CIRCADIAN-RHYTHMS; EFFICACY; PHASE; DAYTIME; SAFETY; TEMPERATURE; DISORDERS; RAMELTEON; BLIND	Background Circadian rhythm sleep disorders are common causes of insomnia for millions of individuals. We did a phase II study to establish efficacy and physiological mechanism, and a phase III study to confirm efficacy of the melatonin agonist tasimelteon (VEC-162) for treatment of transient insomnia associated with shifted sleep and wake time. Methods We undertook phase II and phase III randomised, double-blind, placebo-controlled, parallel-group studies. In a phase II study, 39 healthy individuals from two US sites were randomly assigned to tasimelteon (10 [n=9], 20 [n=81, 50 [n=71, or 100 mg [n=71) or placebo (n=8). We monitored individuals for 7 nights: 3 at baseline, 3 after a 5-h advance of sleep-wake schedule with treatment before sleep, and I after treatment; we measured plasma melatonin concentration for circadian phase assessment. in a phase III study, 411 healthy individuals from 19 US sites, who had transient insomnia induced in a sleep clinic by a 5-h advance of the sleep-wake schedule and a first-night effect in a sleep clinic, were given tasimeltecin (20 [n=1.00], 50 [n=102], or 100 mg [n=106]) or placebo (n=103) 30 min before bedtime. Prespecified primary efficacy outcomes were polysomnographic sleep efficiency (phase II study), latency to persistent sleep (phase III study), and circadian phase shifting (phase II study). Analysis was by intention to treat. Safety was assessed in both studies. These trials are registered with ClinicalTrials.gov, numbers NCT00490945 and NCT00291187. Findings In the phase II study, tasimelteon reduced sleep latency and increased sleep efficiency compared with placebo. The shift in plasma melatonin rhythm to an earlier hour was dose dependent. In the phase III study, tasimelteon improved sleep latency, sleep efficiency, and wake after sleep onset (ie, sleep maintenance). The frequency of adverse events was similar between tasimelteon and placebo. Interpretation After an abrupt advance in sleep time, tasimelteon improved sleep initiation and maintenance concurrently with a shift in endogenous circadian rhythms. Tasimelteon may have therapeutic potential for transient insomnia in circadian rhythm sleep disorders. Funding Vanda Pharmaceuticals Inc.	[Rajaratnam, Shantha M. W.; Klerman, Elizabeth B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Sleep Med,Dept Med, Boston, MA 02115 USA; [Polymeropoulos, Mihael H.; Scott, Christin; Birznieks, Gunther] Vanda Pharmaceut, Rockville, MD USA; [Rajaratnam, Shantha M. W.] Monash Univ, Sch Psychol Psychiat & Psychol Med, Clayton, Vic, Australia; [Fisher, Dennis M.] P Less Than Co, San Francisco, CA USA; [Roth, Thomas] Henry Ford Hosp, Detroit, MI 48202 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Monash University; Henry Ford Health System; Henry Ford Hospital	Klerman, EB (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Sleep Med,Dept Med, 221 Longwood Ave, Boston, MA 02115 USA.	ebklerman@hms.haward.edu	Rajaratnam, Shantha/D-8144-2012; Birznieks, Ingvars/D-4181-2012	Birznieks, Ingvars/0000-0003-4916-1254; Rajaratnam, Shantha/0000-0001-7527-8558	Brigham and Women's Hospital General Clinical Research Center; Henry Ford Hospital	Brigham and Women's Hospital General Clinical Research Center; Henry Ford Hospital	We thank the study tearns; Charles A Czeisler, Joseph Ronda, Steven W Lockley, Melissa St Hilaire, Collor O'Brien, and the research staff and physicians of Brigham and Women's Hospital General Clinical Research Center and Henry Ford Hospital for their contribution to the research.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arendt J, 2006, BRIT MED J, V332, P550, DOI 10.1136/bmj.332.7540.550; ARENDT J, 1985, CIBA F SYMP, V117, P266; Buscemi N, 2006, BMJ-BRIT MED J, V332, P385, DOI 10.1136/bmj.38731.532766.F6; Buscemi N, 2005, J GEN INTERN MED, V20, P1151, DOI 10.1111/j.1525-1497.2005.0243.x; Cajochen C, 1996, NEUROSCI LETT, V207, P209, DOI 10.1016/0304-3940(96)12517-9; Cajochen C, 1997, AM J PHYSIOL-REG I, V272, pR1189, DOI 10.1152/ajpregu.1997.272.4.R1189; Cajochen C, 1997, J BIOL RHYTHM, V12, P636, DOI 10.1177/074873049701200619; CZEISLER CA, 1990, NEW ENGL J MED, V322, P1253, DOI 10.1056/NEJM199005033221801; DEACON S, 1995, BRAIN RES, V688, P77, DOI 10.1016/0006-8993(95)96872-I; Dijk DJ, 1997, J PHYSIOL-LONDON, V505, P851, DOI 10.1111/j.1469-7793.1997.851ba.x; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Dijk DJ, 1995, NEUROSCI LETT, V201, P13, DOI 10.1016/0304-3940(95)12118-N; DOLLINS AB, 1994, P NATL ACAD SCI USA, V91, P1824, DOI 10.1073/pnas.91.5.1824; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Erman M, 2006, SLEEP MED, V7, P17, DOI 10.1016/j.sleep.2005.09.004; Erman MK, 2001, HUM PSYCHOPHARM CLIN, V16, P169, DOI 10.1002/hup.238; Fahey CD, 2006, PSYCHIAT CLIN N AM, V29, P989, DOI 10.1016/j.psc.2006.09.009; Graw P, 2001, BEHAV BRAIN RES, V121, P167, DOI 10.1016/S0166-4328(01)00158-9; Herxheimer A, 2002, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001520, DOI 10.1002/14651858.CD001520]; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; Hughes RJ, 1997, SLEEP, V20, P124, DOI 10.1093/sleep/20.2.124; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Krauchi K, 1997, AM J PHYSIOL-REG I, V272, pR1178, DOI 10.1152/ajpregu.1997.272.4.R1178; Lavie P, 1997, J BIOL RHYTHM, V12, P657, DOI 10.1177/074873049701200622; LAVIE P, 1986, ELECTROEN CLIN NEURO, V63, P414, DOI 10.1016/0013-4694(86)90123-9; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Lockley SW, 1997, J BIOL RHYTHM, V12, P16, DOI 10.1177/074873049701200104; Naylor S, 1999, AM FAM PHYSICIAN, V59, P284; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Rajaratnam SMW, 2004, J PHYSIOL-LONDON, V561, P339, DOI 10.1113/jphysiol.2004.073742; Rajaratnam SMW, 2003, J CLIN ENDOCR METAB, V88, P4303, DOI 10.1210/jc.2003-030460; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Reppert SM, 1997, J BIOL RHYTHM, V12, P528, DOI 10.1177/074873049701200606; Roth T, 2005, SLEEP, V28, P303; ROTH T, 1995, SLEEP, V18, P246, DOI 10.1093/sleep/18.4.246; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503; Santhi N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001233; Stone BM, 2000, SLEEP, V23, P663; Sumova A, 1996, NEUROSCI LETT, V218, P181, DOI 10.1016/S0304-3940(96)13159-1; U.S. Bureau of Labor Statistics, 2005, WORK FLEX SHIFT SCHE; *US BUR TRANSP STA, SCHED T 100 MARK SEG; Walsh JK, 2007, SLEEP, V30, P593, DOI 10.1093/sleep/30.5.593; WALSH JK, 1990, J CLIN PSYCHOPHARM, V10, P184; Williamson BL, 1998, CHEM RES TOXICOL, V11, P234, DOI 10.1021/tx970202h; Wyatt JK, 2006, SLEEP, V29, P609, DOI 10.1093/sleep/29.5.609; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Zammit G, 2007, J CLIN SLEEP MED, V3, P495; Zhdanova IV, 1996, SLEEP, V19, P423, DOI 10.1093/sleep/19.5.423	52	142	168	1	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					482	491		10.1016/S0140-6736(08)61812-7	http://dx.doi.org/10.1016/S0140-6736(08)61812-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	19054552				2022-12-28	WOS:000263132800031
J	Salje, J; Zuber, B; Lowe, J				Salje, Jeanne; Zuber, Benoit; Lowe, Jan			Electron Cryomicroscopy of E-coli Reveals Filament Bundles Involved in Plasmid DNA Segregation	SCIENCE			English	Article							PROKARYOTIC ACTIN HOMOLOG; DYNAMIC INSTABILITY; PARM; R1; INCOMPATIBILITY; MECHANISM; MICROSCOPY; DRIVEN	Bipolar elongation of filaments of the bacterial actin homolog ParM drives movement of newly replicated plasmid DNA to opposite poles of a bacterial cell. We used a combination of vitreous sectioning and electron cryotomography to study this DNA partitioning system directly in native, frozen cells. The diffraction patterns from overexpressed ParM bundles in electron cryotomographic reconstructions were used to unambiguously identify ParM filaments in Escherichia coli cells. Using a low- copy number plasmid encoding components required for partitioning, we observed small bundles of three to five intracellular ParM filaments that were situated close to the edge of the nucleoid. We propose that this may indicate the capture of plasmid DNA within the periphery of this loosely defined, chromosome- containing region.	[Salje, Jeanne; Zuber, Benoit; Lowe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Salje, J (corresponding author), Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	jsalje@mrc-lmb.cam.ac.uk	Zuber, Benoît/U-1952-2019; Löwe, Jan/X-6998-2019; Löwe, Jan/B-3882-2011	Zuber, Benoît/0000-0001-7725-5579; Lowe, Jan/0000-0002-5218-6615	European Molecular Biology Organization; MRC [MC_U105184294, MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184294, MC_U105184326] Funding Source: researchfish	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Gerdes (Newcastle, UK) and J. Moller-Jensen (Odense, Denmark) for kindly supplying plasmids and strains and W. Kuhlbrandt and D. Mills (Frankfurt, Germany) for generously allowing us the use of their microscope. J.S. is supported by MRC and Leverhulme Trust studentships, and B.Z. is supported by a European Molecular Biology Organization long-term fellowship. J.S. performed all experiments and their analysis except the initial cryo-sectioning that was done with B.Z.	Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Choi CL, 2008, J BIOL CHEM, V283, P28081, DOI 10.1074/jbc.M803833200; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Ebersbach G, 2005, MOL MICROBIOL, V56, P1430, DOI 10.1111/j.1365-2958.2005.04643.x; Eltsov M, 2006, J STRUCT BIOL, V156, P246, DOI 10.1016/j.jsb.2006.07.007; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; NORDSTROM K, 1980, PLASMID, V4, P332, DOI 10.1016/0147-619X(80)90071-2; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Tao WT, 2000, MOL MICROBIOL, V38, P392, DOI 10.1046/j.1365-2958.2000.02138.x; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	19	79	79	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					509	512		10.1126/science.1164346	http://dx.doi.org/10.1126/science.1164346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19095899				2022-12-28	WOS:000262587900044
J	Chan, CKF; Chen, CC; Luppen, CA; Kim, JB; DeBoer, AT; Wei, K; Helms, JA; Kuo, CJ; Kraft, DL; Weissman, IL				Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; Kim, Jae-Beom; DeBoer, Anthony T.; Wei, Kevin; Helms, Jill A.; Kuo, Calvin J.; Kraft, Daniel L.; Weissman, Irving L.			Endochondral ossification is required for haematopoietic stem-cell niche formation	NATURE			English	Article							BONE-FORMATION; ENDOTHELIAL-CELLS; C-KIT; EXPRESS; ANGIOGENESIS; OSTERIX; MICE	Little is known about the formation of niches, local micro- environments required for stem- cell maintenance. Here we develop an in vivo assay for adult haematopoietic stem- cell ( HSC) niche formation(1,2). With this assay, we identified a population of progenitor cells with surface markers CD45(-)Tie2(-)alpha(+)(V)CD105(+)Thy1.1(-) (CD105(+)Thy1(-)) that, when sorted from 15.5 days post- coitum fetal bones and transplanted under the adult mouse kidney capsule, could recruit host- derived blood vessels, produce donor- derived ectopic bones through a cartilage intermediate and generate a marrow cavity populated by host- derived long- term reconstituting HSC (LT-HSC). In contrast, CD45(-)Tie2(-)alpha(+)(V)CD105(+)Thy1(+) (CD105(+)Thy1(+)) fetal bone progenitors form bone that does not contain a marrow cavity. Suppressing expression of factors involved in endochondral ossification, such as osterix and vascular endothelial growth factor ( VEGF), inhibited niche generation. CD105(+)Thy1(-) progenitor populations derived from regions of the fetal mandible or calvaria that do not undergo endochondral ossification formed only bone without marrow in our assay. Collectively, our data implicate endochondral ossification, bone formation that proceeds through a cartilage intermediate, as a requirement for adult HSC niche formation.	[Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kim, Jae-Beom; Helms, Jill A.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Wei, Kevin; Kuo, Calvin J.] Stanford Univ, Dept Hematol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Chan, CKF (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	chazchan@stanford.edu; c3chen@stanford.edu	Chen, Ching-Cheng/C-1259-2009	Helms, Jill/0000-0002-0463-396X; Kuo, Calvin/0000-0002-7427-5985; Chen, Ching-Cheng/0000-0003-4499-0889	USPHS National Institutes of Health [2R01HL058770-08, 5R01CA086065-09, 1R01HL074267-01, 1R01NS052830-01]; NIH Pathway to Independence [5K99HL087936-02]; NIH Career Development [K08-HL076335]; Hope Street Kids; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076335, R00HL087936, R01HL058770, R01HL074267, K99HL087936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052830] Funding Source: NIH RePORTER	USPHS National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIH Pathway to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Career Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Street Kids; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Peault for suggestions; L. Jerabek for laboratory management; C. Muscat for antibody production and conjugation; Y. Park, J. K. Lee and A. K. Bershad for technical support; and T. Serwold and L. Richie for advice and reading the manuscript. This study was supported in part by a USPHS National Institutes of Health ( NIH) grant (2R01HL058770-08) and in part by a NIH grant (5R01CA086065-09), terminated by NIH Study Section, and in part by the Virginia and Daniel K. Ludwig Professorship to I.L.W. C.K.F.C. and C.A.L. are supported by an NIH Regenerative Medicine training grant. C.-C.C. is supported by an NIH Pathway to Independence award (5K99HL087936-02). D.L.K. is supported by an NIH Career Development award (K08-HL076335) and a Hope Street Kids research award, K.W. and C.J.K. are supported by NIH grants (1R01HL074267-01 and 1R01NS052830-01).	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; AYE MT, 1992, EXP HEMATOL, V20, P523; Blair HC, 1999, BIOCHEM BIOPH RES CO, V255, P778, DOI 10.1006/bbrc.1999.0260; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; GARVEY W, 1986, STAIN TECHNOL, V61, P60, DOI 10.3109/10520298609110708; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Jacobi J, 2004, CIRCULATION, V110, P2424, DOI 10.1161/01.CIR.0000145142.85645.EA; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; WEISS B, 2005, CONTEMP OBSTET GYNEC, V50, P34; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	29	313	321	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					490	U9		10.1038/nature07547	http://dx.doi.org/10.1038/nature07547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19078959	Green Accepted			2022-12-28	WOS:000262519200049
J	Gilbert, R; Kemp, A; Thoburn, J; Sidebotham, P; Radford, L; Glaser, D; MacMillan, HL				Gilbert, Ruth; Kemp, Alison; Thoburn, June; Sidebotham, Peter; Radford, Lorraine; Glaser, Danya; MacMillan, Harriet L.			Child Maltreatment 2 Recognising and responding to child maltreatment	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; PHYSICAL ABUSE; SEXUAL-ABUSE; SAFEGUARDING CHILDREN; SUBSTANCE-ABUSE; YOUNG-CHILDREN; UNITED-STATES; PROTECTION; NEGLECT; DEATH	Professionals in child health, primary care, mental health, schools, social services, and law-enforcement services all contribute to the recognition of and response to child maltreatment. In all sectors, children suspected of being maltreated are under-reported to child-protection agencies. Lack of awareness of the signs of child maltreatment and processes for reporting to child-protection agencies, and a perception that reporting might do more harm than good, are among the reasons for not reporting. Strategies to improve recognition, mainly used in paediatric practice, include training, use of questionnaires for asking children and parents about maltreatment, and evidence-based guidelines for who should be assessed by child-protection specialists. Internationally, studies suggest that policies emphasising substantiation of maltreatment without concomitant attention to welfare needs lead to less service provision for maltreated children than do those in systems for which child maltreatment is part of a broad child and family welfare response.	[Gilbert, Ruth] UCL, Inst Child Hlth, Ctr Evidence Based Child Hlth, London WC1N 1EH, England; [Gilbert, Ruth] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London WC1N 1EH, England; [Kemp, Alison] Cardiff Univ, Sch Med, Cardiff, Wales; [Thoburn, June] Univ E Anglia, Sch Social Work, Norwich NR4 7TJ, Norfolk, England; [Sidebotham, Peter] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Radford, Lorraine] Natl Soc Prevent Cruelty Children, London, England; [Glaser, Danya] Great Ormond St Hosp Sick Children, Dept Child & Adolescent Mental Hlth, London WC1N 3JH, England; [MacMillan, Harriet L.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [MacMillan, Harriet L.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [MacMillan, Harriet L.] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada	University of London; University College London; University of London; University College London; Cardiff University; University of East Anglia; University of Warwick; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; McMaster University; McMaster University; McMaster University	Gilbert, R (corresponding author), UCL, Inst Child Hlth, Ctr Evidence Based Child Hlth, 30 Guilford St, London WC1N 1EH, England.	r.gilbert@ich.ucl.ac.uk	MacMillan, Harriet/B-4530-2016; Sidebotham, Peter D/E-3011-2010; DSILVA, BROOKE/HCI-4879-2022	MacMillan, Harriet/0000-0002-1223-706X; Sidebotham, Peter D/0000-0003-4891-6926; Gilbert, Ruth/0000-0001-9347-2709	MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546B] Funding Source: researchfish; Medical Research Council [G0400546] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADAMS JA, 1988, ADOLESCENT PEDIAT G, V1, P123, DOI 10.1016/S0932-8610(88)80035-5; Ainsworth F., 2006, CHILD FAMILY SOCIAL, V11, P33, DOI DOI 10.1111/J.1365-2206.2006.00388.X; AINSWORTH F, 2002, CHILD FAMILY SOCIAL, V7, P57, DOI DOI 10.1046/J.1365-2206.2002.00228.X; *AM PROF SOC AB CH, 1998, GLOSS TERMS INT FIND; ARIS R, 2007, DOMESTIC VIOLENCE SU; *AUSTR I HLTH WELF, 2006, CHILD PROT AUSTR; Axford N., 2005, CHILD DEATH SIGNIFIC; Baginsky M, 2007, SCH SOCIAL SERVICES; Bair-Merritt MH, 2008, J PEDIATR-US, V152, P734, DOI 10.1016/j.jpeds.2008.01.035; Bair-Merritt MH, 2006, ARCH PEDIAT ADOL MED, V160, P311, DOI 10.1001/archpedi.160.3.311; Baird C, 2000, CHILD YOUTH SERV REV, V22, P839, DOI 10.1016/S0190-7409(00)00122-5; Bajanowski T, 2005, INT J LEGAL MED, V119, P213, DOI 10.1007/s00414-005-0538-8; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Belfer RA, 2001, AM J EMERG MED, V19, P122, DOI 10.1053/ajem.2001.21345; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berman JJ, 2008, FAM COMMUNITY HEALTH, V31, P126, DOI 10.1097/01.FCH.0000314573.74152.74; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Brandon M, 2008, ANAL CHILD DEATHS SE; Brandon M, 2008, CHILD FAM SOC WORK, V13, P365, DOI 10.1111/j.1365-2206.2008.00561.x; Briere J, 2001, CHILD ABUSE NEGLECT, V25, P1001, DOI 10.1016/S0145-2134(01)00253-8; BROWNE KD, 2007, CYCLES VIOLENCE RELA; CADMAN S., 2008, LIT REV CHILDREN ABU; Carter YH, 2006, ARCH DIS CHILD, V91, P740, DOI 10.1136/adc.2005.092007; Carter YH, 2007, BRIT J GEN PRACT, V57, P238; Cerezo MA, 2004, CHILD ABUSE NEGLECT, V28, P1153, DOI 10.1016/j.chiabu.2004.06.007; Chaffin M, 1996, CHILD ABUSE NEGLECT, V20, P191, DOI 10.1016/S0145-2134(95)00144-1; Chang DC, 2005, J PEDIATR SURG, V40, P114, DOI 10.1016/j.jpedsurg.2004.09.019; Chang DC, 2004, J TRAUMA, V57, P1189, DOI 10.1097/01.TA.0000145076.05111.E1; Chester DL, 2006, BURNS, V32, P222, DOI 10.1016/j.burns.2005.08.018; Cleaver H., 2006, RESPONSE CHILD PROTE; CLEAVER H, 2004, ASSESSING CHILDRENS; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Cohen JA, 2008, ARCH PEDIAT ADOL MED, V162, P447, DOI 10.1001/archpedi.162.5.447; CRAIG J, 2007, EVERYBODYS BUSINESS; CREIGHTON S, 2001, CHILDHOOD DEATHS REP, P39; CRENSHAW WB, 1995, CHILD ABUSE NEGLECT, V19, P1095, DOI 10.1016/0145-2134(95)00071-F; Crowley TJ, 2003, AM J PSYCHIAT, V160, P1461, DOI 10.1176/appi.ajp.160.8.1461; Cruickshanks P, 2007, J PAEDIATR CHILD H, V43, P34, DOI 10.1111/j.1440-1754.2007.00999.x; *DEP CHILD YOUTH F, 2005, ANN REP; *DEP CHILDR SCH FA, 2007, CHILDR YOUNG PEOPL C; *DEP ED SKILLS, WORK TOG SAF CHILDR; *DEP HLTH DART SOC, 1995, CHILD PROT MESS RES; Department for Education and Skills, 2003, EV CHILD MATT CHANG; Department of Health, 2000, ASS CHILDR THEIR FAM; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Dubowitz H, 2008, PEDIATRICS, V121, pE85, DOI 10.1542/peds.2007-0904; Dubowitz H, 2007, LANCET, V369, P1891, DOI 10.1016/S0140-6736(07)60856-3; Edleson JL, 1999, J INTERPERS VIOLENCE, V14, P839, DOI 10.1177/088626099014008004; Fantuzzo JW, 2007, J FAM VIOLENCE, V22, P543, DOI 10.1007/s10896-007-9105-z; Finkelhor D., 2008, CHILDHOOD VICTIMIZAT; Flaherty EG, 2000, ARCH PEDIAT ADOL MED, V154, P489, DOI 10.1001/archpedi.154.5.489; Flaherty EG, 2008, PEDIATRICS, V122, P611, DOI 10.1542/peds.2007-2311; Flaherty EG, 2006, CHILD MALTREATMENT, V11, P361, DOI 10.1177/1077559506292287; Flaherty Emalee G, 2008, Pediatrics, V122 Suppl 1, pS1, DOI 10.1542/peds.2008-0715c; Fleming P., 2000, SUDDEN UNEXPECTED DE; Forrester, 2000, CHILD ABUSE REV, V9, P235, DOI DOI 10.1002/1099-0852(200007/08)9:4<235::AID-CAR626>3.0.CO;2-4; Forrester D., 2006, CHILD FAMILY SOCIAL, V11, P325, DOI DOI 10.1111/J.1365-2206.2006.00415.X; Gilbert N., 1997, COMBATING CHILD ABUS; GILBERT R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61706-7; Glaser D, 2002, CHILD ABUSE NEGLECT, V26, P697, DOI 10.1016/S0145-2134(02)00342-3; Glaser D., 2001, EMOTIONAL ABUSE EMOT; Goldman J. D. G., 2005, Health Education Journal, V64, P302, DOI 10.1177/001789690506400403; Grella CE, 2006, CHILD ABUSE NEGLECT, V30, P55, DOI 10.1016/j.chiabu.2005.07.005; Hackett S., 2003, MAPPING EXPLORING SE; Haines L, 2008, ARCH DIS CHILD, V93, P4, DOI 10.1136/adc.2006.099838; Harries M., 2002, MANDATORY REPORTING; Hawkins R, 2001, CHILD ABUSE NEGLECT, V25, P1603, DOI 10.1016/S0145-2134(01)00296-4; Hegarty K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a839; Heger A, 2002, CHILD ABUSE NEGLECT, V26, P645, DOI 10.1016/S0145-2134(02)00339-3; Herman-Giddens ME, 1999, JAMA-J AM MED ASSOC, V282, P463, DOI 10.1001/jama.282.5.463; Hester M., 1998, PERIPHERY CTR DOMEST; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Hinkelman L, 2008, ELEM SCHOOL J, V108, P376, DOI 10.1086/589468; HM Government, 2018, WORKING TOGETHER SAF; Horwath J, 2007, BRIT J SOC WORK, V37, P1285, DOI 10.1093/bjsw/bcl029; HUTCHISON ED, 1993, SOC WORK, V38, P56; Hymel KP, 2006, PEDIATRICS, V118, P1296, DOI 10.1542/peds.2006-1780; Hymel KP, 2006, PEDIATRICS, V118, P421, DOI 10.1542/peds.2006-1245; Jaffe P.G., 2003, CHILD CUSTODY DOMEST; Jaudes PK, 2008, CHILD ABUSE NEGLECT, V32, P671, DOI 10.1016/j.chiabu.2007.08.007; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 2006, ARCH DIS CHILD, V91, P265, DOI 10.1136/adc.2004.066696; Jones R, 2008, PEDIATRICS, V122, P259, DOI 10.1542/peds.2007-2312; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kemp AM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1518; KEMP AM, 2008, ARCH DIS CHILD S, V93, pA107; Kenny MC, 2004, CHILD ABUSE NEGLECT, V28, P1311, DOI 10.1016/j.chiabu.2004.06.010; Kenny MC, 2001, CHILD ABUSE NEGLECT, V25, P81, DOI 10.1016/S0145-2134(00)00218-0; Kerker BD, 2000, ARCH PEDIAT ADOL MED, V154, P457, DOI 10.1001/archpedi.154.5.457; Kesner J. E., 2002, CHILDREN SCH, V24, P222, DOI DOI 10.1093/CS/24.4.222; Lane WG, 2007, CLIN ORTHOP RELAT R, P219, DOI 10.1097/BLO.0b013e31805c0849; Lanktree CB, 2008, CHILD ABUSE NEGLECT, V32, P621, DOI 10.1016/j.chiabu.2007.10.003; Leeb RebeccaT., 2008, CHILD MALTREATMENT; Levene S, 2004, ARCH DIS CHILD, V89, P443, DOI 10.1136/adc.2003.036202; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Levi BH, 2005, PEDIATRICS, V116, pE5, DOI 10.1542/peds.2004-2649; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Lonne R., 2008, REFORMING CHILD PROT; MACMILLAN HL, 2008, LANCET          1203, DOI [DOI 10.1016/S0140-6736(08)61708-0, 10.1016/S0140-6736(21)02844-0, DOI 10.1016/S0140-6736(21)02844-0]; Maguire S, 2005, ARCH DIS CHILD, V90, P182, DOI 10.1136/adc.2003.044065; Maguire S, 2008, BURNS, V34, P1072, DOI 10.1016/j.burns.2008.02.011; MAGUIRE S, 2008, ARCH DIS CHILD S, V93, pA73; MARNEFFE C, 1997, COMBATING CHILD ABUS; Mathews B, 2008, CHILD ABUSE NEGLECT, V32, P511, DOI 10.1016/j.chiabu.2007.06.010; Mathews B, 2008, CHILD MALTREATMENT, V13, P50, DOI 10.1177/1077559507310613; McDaniel M, 2006, CHILD YOUTH SERV REV, V28, P306, DOI 10.1016/j.childyouth.2005.04.010; Mcdonell JR, 2008, FAM COMMUNITY HEALTH, V31, P113, DOI 10.1097/01.FCH.0000314572.66528.fe; MCGINNIS S, 2008, SAFEGUARDING CHILDRE, P121; Melton GB, 2005, CHILD ABUSE NEGLECT, V29, P9, DOI 10.1016/j.chiabu.2004.05.005; MERTEN DF, 1983, RADIOLOGY, V146, P377, DOI 10.1148/radiology.146.2.6849085; *NAT SURV CHILD AD, 2008, DOES SUBST CHILD MAL; *NSCA, NAT SURV CHILD AD WE; Nygren P, 2004, ANN FAM MED, V2, P161, DOI 10.1370/afm.113; *OFST, 2008, OFST INSP EXP CAFC S; Peters R, 2003, CHILD ABUSE REV, V12, P416, DOI DOI 10.1002/CAR.821; Pinheiro P.S., 2006, WORLD REPORT VIOLENC; PITTS J, 2004, RES MATTERS, V17, P79; *QUEENSL GOV DEP C, 2005, CHILD PROT QUEENSL 2; *RCPCH, 2007, PAED FOR EX REL POSS; *RCPCH, 2008, RCPCH GUID CHILD DEA; READING R, 2008, LANCET          1203, DOI DOI 10.1016/S0140-6736(08)61709-2; Rimsza ME, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e11; Rodriguez CM, 2002, J INTERPERS VIOLENCE, V17, P320, DOI 10.1177/0886260502017003006; *ROYAL COLL PAED C, 2006, CHILD PROT COMP; *ROYAL COLL RAD RO, STAND RAD INV SUSP N; Sege RD, 2008, ARCH DIS CHILD, V93, P822, DOI 10.1136/adc.2006.100545; Shabde N, 2006, ARCH DIS CHILD, V91, P639, DOI 10.1136/adc.2005.085027; Sibert JR, 2002, CHILD ABUSE NEGLECT, V26, P267, DOI 10.1016/S0145-2134(01)00324-6; Sidebotham P, 2007, EMERG MED J, V24, P831, DOI 10.1136/emj.2007.051011; Sidebotham P, 2007, UNEXPECTED DEATH CHI; SIDEBOTHAM P, 2007, UNEXPECTED DEATH CHI, P75; Slep AMS, 2006, CHILD MALTREATMENT, V11, P217, DOI 10.1177/1077559506288878; *SOC, 2005, BARN UNG INS 2006; Stanley J.G.C., 2004, CHILD ABUSE REV, V13, P246, DOI [10.1002/car.855, DOI 10.1002/CAR.855]; Sundell K, 1997, CHILD ABUSE NEGLECT, V21, P93, DOI 10.1016/S0145-2134(96)00133-0; The Greenbook National Evaluation Team, 2008, GREENB IN FIN EV REP; Thoburn J., 2000, FAMILY SUPPORT CASES; Thoburn J., 2007, GLOBALISATION CHILD; Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403; TILDEN VP, 1994, AM J PUBLIC HEALTH, V84, P628, DOI 10.2105/AJPH.84.4.628; TORODE R, 2008, WORKING REFUGEES ASY; Trocme N, 2003, CAN MED ASSOC J, V169, P911, DOI 10.1016/j.chiabu.2006.02.015; TROCME N, 2004, CANADIAN INCIDENCE S; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; U.S. Department of Health and Human Services Administration on Children Youth and Families, 2008, CHILD MALTR 2006; Van Haeringen AR, 1998, CHILD ABUSE NEGLECT, V22, P159, DOI 10.1016/S0145-2134(97)00172-5; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vulliamy AP, 2000, CHILD ABUSE NEGLECT, V24, P1461, DOI 10.1016/S0145-2134(00)00199-X; Walsh C, 2002, CHILD ABUSE NEGLECT, V26, P11, DOI 10.1016/S0145-2134(01)00308-8; Walsh K, 2006, J EARLY CHILD RES, V4, P65, DOI 10.1177/1476718X06059790; WARNER JE, 1994, CHILD ABUSE NEGLECT, V18, P11, DOI 10.1016/0145-2134(94)90092-2; Webster RA, 2003, AM J PREV MED, V25, P58, DOI 10.1016/S0749-3797(03)00091-6; Webster SW, 2005, CHILD ABUSE NEGLECT, V29, P1281, DOI 10.1016/j.chiabu.2004.02.007; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008; Wiklund S., 2006, EUROPEAN J SOCIAL WO, V9, P39, DOI [DOI 10.1080/13691450500480615, 10.1080/13691450500480615]; WOLFE VV, 1991, BEHAV ASSESS, V13, P359; WOODMAN J, 2008, HLTH TECHNOL ASSESS, V12; Ystgaard M, 2004, CHILD ABUSE NEGLECT, V28, P863, DOI 10.1016/j.chiabu.2004.01.009; Zellman G. L., 1990, ROLE PROFESSIONAL BA	159	355	360	3	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					167	180		10.1016/S0140-6736(08)61707-9	http://dx.doi.org/10.1016/S0140-6736(08)61707-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19056119				2022-12-28	WOS:000262340900032
J	Carmona-Fontaine, C; Matthews, HK; Kuriyama, S; Moreno, M; Dunn, GA; Parsons, M; Stern, CD; Mayor, R				Carmona-Fontaine, Carlos; Matthews, Helen K.; Kuriyama, Sei; Moreno, Mauricio; Dunn, Graham A.; Parsons, Maddy; Stern, Claudio D.; Mayor, Roberto			Contact inhibition of locomotion in vivo controls neural crest directional migration	NATURE			English	Article							PLANAR CELL-POLARITY; GASTRULATION; XENOPUS; MORPHOGENESIS; CHEMOTAXIS; ZEBRAFISH; MOVEMENTS; BEHAVIOR; WNT11	Contact inhibition of locomotion was discovered by Abercrombie more than 50 years ago and describes the behaviour of fibroblast cells confronting each other in vitro, where they retract their protrusions and change direction on contact(1,2). Its failure was suggested to contribute to malignant invasion(3-6). However, the molecular basis of contact inhibition of locomotion and whether it also occurs in vivo are still unknown. Here we show that neural crest cells, a highly migratory and multipotent embryonic cell population, whose behaviour has been likened to malignant invasion(6-8), demonstrate contact inhibition of locomotion both in vivo and in vitro, and that this accounts for their directional migration. When two migrating neural crest cells meet, they stop, collapse their protrusions and change direction. In contrast, when a neural crest cell meets another cell type, it fails to display contact inhibition of locomotion; instead, it invades the other tissue, in the same manner as metastatic cancer cells(3,5,9). We show that inhibition of non-canonical Wnt signalling abolishes both contact inhibition of locomotion and the directionality of neural crest migration. Wnt- signalling members localize at the site of cell contact, leading to activation of RhoA in this region. These results provide the first example of contact inhibition of locomotion in vivo, provide an explanation for coherent directional migration of groups of cells and establish a previously unknown role for noncanonical Wnt signalling.	[Carmona-Fontaine, Carlos; Matthews, Helen K.; Kuriyama, Sei; Moreno, Mauricio; Stern, Claudio D.; Mayor, Roberto] UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; [Dunn, Graham A.; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; University College London; University of London; King's College London	Mayor, R (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	r.mayor@ucl.ac.uk	Matthews, Helen/A-3204-2009; Mayor, Roberto/C-6688-2008; Stern, Claudio D/C-6265-2008; Zebrafish, UCL/A-3125-2009; Carmona-Fontaine, Carlos/D-1581-2009; Ladoux, Benoit/A-9879-2013; Stern, Claudio/AAZ-7381-2021; Kuriyama, Sei/AAV-2368-2020; Parsons, Maddy/B-2203-2013	Stern, Claudio D/0000-0002-9907-889X; Stern, Claudio/0000-0002-9907-889X; Kuriyama, Sei/0000-0002-5502-7177; Parsons, Maddy/0000-0002-2021-8379; Mayor, Roberto/0000-0001-9053-9613; Matthews, Helen/0000-0001-6660-9685	Medical Research Council; Biotechnology and Biological Sciences Research Council; MRC; Boehringer Ingelheim Fonds; BBSRC [BB/D017521/1] Funding Source: UKRI; MRC [G117/506, G0100152, G0401026, G0400559] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D017521/1] Funding Source: researchfish; Medical Research Council [G0401026, G117/506, G0100152, G0400559] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Tada, M. Tawk, J. Clarke, C.- P. Heisenberg, R. Kelsh, L. Dale and S. Fraser for reagents, constructs and fish lines; C. F. Riaz for scanning electron microscopy images; and M. Bronner- Fraser, M. Raff, J. Green and A. Ridley for comments on the manuscript. This study was supported by grants to R.M. from the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council. H. K. M. and C.C.-F. are MRC and Boehringer Ingelheim Fonds PhD scholarship holders, respectively, and M.M. is an EMBO postdoctoral fellow.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; ABERCROMBIE M, 1954, NATURE, V174, P697, DOI 10.1038/174697a0; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Alfandari D, 2003, DEV BIOL, V260, P449, DOI 10.1016/S0012-1606(03)00277-X; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; DAVIS EM, 1981, J EMBRYOL EXP MORPH, V63, P29; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; DUNN GA, 1982, PHILOS T ROY SOC B, V299, P147, DOI 10.1098/rstb.1982.0121; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; HEAYSMAN JE, 1970, EXPERIENTIA, V26, P1344, DOI 10.1007/BF02113020; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Matthews HK, 2008, DEV DYNAM, V237, P3404, DOI 10.1002/dvdy.21758; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; PADDOCK SW, 1986, J CELL SCI, V81, P163; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Tada M, 2000, DEVELOPMENT, V127, P2227; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017	29	408	411	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					957	961		10.1038/nature07441	http://dx.doi.org/10.1038/nature07441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19078960	Green Accepted			2022-12-28	WOS:000261768300047
J	Sytina, OA; Heyes, DJ; Hunter, CN; Alexandre, MT; van Stokkum, IHM; van Grondelle, R; Groot, ML				Sytina, Olga A.; Heyes, Derren J.; Hunter, C. Neil; Alexandre, Maxime T.; van Stokkum, Ivo H. M.; van Grondelle, Rienk; Groot, Marie Louise			Conformational changes in an ultrafast light-driven enzyme determine catalytic activity	NATURE			English	Article							PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; DIHYDROFOLATE-REDUCTASE; DYNAMICS; SPECTROSCOPY; CHLOROPHYLLIDE; IDENTIFICATION; MUTAGENESIS; COMPLEX; PROTEIN; NADPH	The role of conformational changes in explaining the huge catalytic power of enzymes is currently one of the most challenging questions in biology(1-7). Although it is now widely regarded that enzymes modulate reaction rates by means of short- and long- range protein motions(3-7), it is almost impossible to distinguish between conformational changes and catalysis. We have solved this problem using the chlorophyll biosynthetic enzyme NADPH: protochlorophyllide ( Pchlide) oxidoreductase, which catalyses a unique light- driven reaction involving hydride and proton transfers(8). Here we report that prior excitation of the enzyme- substrate complex with a laser pulse induces a more favourable conformation of the active site, enabling the coupled hydride and proton transfer reactions to occur. This effect, which is triggered during the Pchlide excited-state lifetime and persists on a long timescale, switches the enzyme into an active state characterized by a high rate and quantum yield of formation of a catalytic intermediate. The corresponding spectral changes in the mid- infrared following the absorption of one photon reveal significant conformational changes in the enzyme, illustrating the importance of flexibility and dynamics in the structure of enzymes for their function.	[Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sytina, Olga A.; Alexandre, Maxime T.; van Stokkum, Ivo H. M.; van Grondelle, Rienk; Groot, Marie Louise] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Heyes, Derren J.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Sheffield; Vrije Universiteit Amsterdam; University of Manchester	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Firth Court, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac.uk	van Stokkum, Ivo HM/E-7175-2015; Groot, Marie Louise/E-8954-2010	van Stokkum, Ivo HM/0000-0002-6143-2021; Heyes, Derren/0000-0002-7453-1571; Groot, Marie Louise/0000-0001-5360-6987	The Netherlands Organization for Scientific Research; Dutch Foundation for Earth and Life Sciences [834.01.002]; NWO-ALW [831.00.004]; NWO-CW [700.53.307]; Biotechnology and Biological Sciences Research Council, UK	The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Foundation for Earth and Life Sciences; NWO-ALW(Netherlands Organization for Scientific Research (NWO)); NWO-CW(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by The Netherlands Organization for Scientific Research through the Dutch Foundation for Earth and Life Sciences ( Investment Grant no. 834.01.002). M. L. G. is grateful to NWO-ALW for providing financial support with a long-term fellowship (Grant no. 831.00.004) and O. S. received support from NWO-CW ( Grant no. 700.53.307). D.J.H. and C.N.H. gratefully acknowledge support from the Biotechnology and Biological Sciences Research Council, UK. We thank H. Fidder and F. van Mourik for reading the manuscript.	Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Flomenbom O, 2005, P NATL ACAD SCI USA, V102, P2368, DOI 10.1073/pnas.0409039102; GRIFFITHS WT, 1978, BIOCHEM J, V174, P681, DOI 10.1042/bj1740681; Groot ML, 2004, J PHYS CHEM B, V108, P8001, DOI 10.1021/jp037966s; HARTWICH G, 1995, J AM CHEM SOC, V117, P7784, DOI 10.1021/ja00134a025; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Iwaki M, 2006, J AM CHEM SOC, V128, P2621, DOI 10.1021/ja0556272; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MANTELE WG, 1988, P NATL ACAD SCI USA, V85, P8468, DOI 10.1073/pnas.85.22.8468; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; NABEDRYK E, 1990, BIOCHEMISTRY-US, V29, P3242, DOI 10.1021/bi00465a015; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; VALERA V, 1987, BIOCHEM BIOPH RES CO, V148, P515, DOI 10.1016/0006-291X(87)91141-7; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	31	108	110	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					1001	U89		10.1038/nature07354	http://dx.doi.org/10.1038/nature07354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092933				2022-12-28	WOS:000261768300057
J	Ballestar, E; Esteller, M				Ballestar, Esteban; Esteller, Manel			SnapShot: The Human DNA Methylome in Health and Disease	CELL			English	Editorial Material							METHYLATION; CANCER; EPIGENOMICS; CELLS		[Ballestar, Esteban; Esteller, Manel] Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Ballestar, E (corresponding author), Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid 28029, Spain.		Esteller, Manel/L-5956-2014; Ballestar, Esteban/ABG-8561-2020	Esteller, Manel/0000-0003-4490-6093; Ballestar, Esteban/0000-0002-1400-2440				Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	10	6	8	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 12	2008	135	6					1144	U25	1144.e1	10.1016/j.cell.2008.11.040	http://dx.doi.org/10.1016/j.cell.2008.11.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070582	Bronze			2022-12-28	WOS:000261642800029
J	Hameed, S				Hameed, Salman			Science and religion Bracing for Islamic Creationism	SCIENCE			English	Editorial Material									[Hameed, Salman] Hampshire Coll, Sch Cognit Sci, Amherst, MA 01002 USA; [Hameed, Salman] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA		Hameed, S (corresponding author), Hampshire Coll, Sch Cognit Sci, Amherst, MA 01002 USA.	shameed@hampshire.edu						Asghar A., 2007, P NAT ASS RES SCI TE; Bucaille Maurice, 1989, WHAT IS ORIGIN MAN; Edis Taner, 2007, ILLUSION HARMONY SCI; Hassan R, 2007, MUSLIM WORLD, V97, P437, DOI 10.1111/j.1478-1913.2007.00190.x; IAP, 2006, IAP STAT TEACH EV; Iqbal Mohammad., 1930, RECONSTRUCTION RELIG; Iqbal Muzaffar, 2006, ISLAM SCI, V4, P89; Koning D., 2006, ISIM NEWSLETTER, V18, P48; Miller JD, 2006, SCIENCE, V313, P765, DOI 10.1126/science.1126746; Nasr SeyyedHossein., 2006, ISLAM SCI, V4, P181; Nisbet MC, 2007, SCIENCE, V316, P56, DOI 10.1126/science.1142030; Numbers RL, 2006, CREATIONISTS SCI CRE; *PUNJ TXB BOARD, 2003, BIOLOGY, V12, P222	13	58	59	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1637	1638		10.1126/science.1163672	http://dx.doi.org/10.1126/science.1163672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	382LU	19074331				2022-12-28	WOS:000261608300025
J	Bhutta, MF				Bhutta, Mahmood F.			Fair and ethical trade in health procurement	LANCET			English	Editorial Material									[Bhutta, Mahmood F.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Bhutta, Mahmood F.] Int Grp, Med Fair & Eth Trade Grp, London WC1H 9JP, England	University of Oxford	Bhutta, MF (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.	fairtrade@bma.org.uk		Bhutta, Mahmood/0000-0002-4688-1670				Bhutta MF, 2006, BMJ-BRIT MED J, V333, P297, DOI 10.1136/bmj.38901.619074.55; BJURLING K, 2007, DARK SIDE HEALTHCARE; Fairtrade Foundation, 2008, ANN REV 2007 2008; KJELLSTROM T, 2007, SCAND J PUBLIC HEALT, V35, P2; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-6; *NHS PURCH SUPPL A, 2008, FRAM ETH PROC STRAT; *NHS SUPPL CHAIN, 2008, SUPPL COD COND; Ram R, 2006, SOC SCI MED, V62, P779, DOI 10.1016/j.socscimed.2005.06.034; *STOCKH COUNT COUN, 2008, SUST PROC; [No title captured]	10	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1935	1937		10.1016/S0140-6736(08)61826-7	http://dx.doi.org/10.1016/S0140-6736(08)61826-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380NE	19059038				2022-12-28	WOS:000261471600008
J	Ley, TJ; Hamilton, BH				Ley, Timothy J.; Hamilton, Barton H.			SOCIOLOGY The Gender Gap in NIH Grant Applications	SCIENCE			English	Editorial Material							ACADEMIC MEDICINE; WOMEN; STUDENTS; FACULTY; SCHOOL		[Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [Ley, Timothy J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63130 USA; [Hamilton, Barton H.] Washington Univ, Sch Med, John M Olin Sch Business, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA.	timley@wustl.edu	Hamilton, Barton H/P-5187-2015					*AAMC, REP AV FAC ROST; *AAMC, FACTS APPL MATR GRAD; Andrews NC, 2007, NEW ENGL J MED, V357, P1887, DOI 10.1056/NEJMp078198; Brown AJ, 2003, J WOMENS HEALTH, V12, P999, DOI 10.1089/154099903322643929; Buckley LM, 2000, ACAD MED, V75, P283, DOI 10.1097/00001888-200003000-00021; Hamel MB, 2006, NEW ENGL J MED, V355, P310, DOI 10.1056/NEJMe068143; Jagsi R, 2007, NEW ENGL J MED, V357, P1889, DOI 10.1056/NEJMp078163; Lambert EM, 2005, ACAD MED, V80, P797, DOI 10.1097/00001888-200509000-00003; Leboy P, 2008, SCIENTIST, V22, P67; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Martinez ED, 2007, EMBO REP, V8, P977, DOI 10.1038/sj.embor.7401110; *NAT SCI FDN, DAT TABL; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; Waisbren SE, 2008, J WOMENS HEALTH, V17, P207, DOI 10.1089/jwh.2007.0412; Witte FM, 2006, ACAD MED, V81, P648, DOI 10.1097/01.ACM.0000232421.04170.d2	15	142	142	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1472	1474		10.1126/science.1165878	http://dx.doi.org/10.1126/science.1165878			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	379DU	19056961				2022-12-28	WOS:000261377400024
J	Slack, JMW				Slack, J. M. W.			Origin of Stem Cells in Organogenesis	SCIENCE			English	Review							NEURAL CREST; BONE-MARROW; REVEALS MULTIPOTENCY; LINEAGE ANALYSIS; SOX2 FUNCTIONS; SELF-RENEWAL; MOUSE; POPULATIONS; PLASTICITY; MURINE	The development of individual organs in animal embryos involves the formation of tissue- specific stem cells that sustain cell renewal of their own tissue for the lifetime of the organism. Although details of their origin are not always known, tissue- specific stem cells usually share the expression of key transcription factors with cells of the embryonic rudiment from which they arise, and are probably in a similar developmental state. On the other hand, the isolation of pluripotent stem cells from the postnatal organism has encouraged the formulation of models of embryonic and postnatal development that are at variance with the conventional ones. Possible explanations for the existence of such cells, and the issue of whether they also exist in vivo, are discussed.	[Slack, J. M. W.] Univ Minnesota, Stem Cell Inst, McGuire Translat Res Facil, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Slack, JMW (corresponding author), Univ Minnesota, Stem Cell Inst, McGuire Translat Res Facil, 2001 6th St SE, Minneapolis, MN 55455 USA.	slack017@umn.edu		Slack, Jonathan/0000-0002-7154-6778	MRC [G0500220, G0300415] Funding Source: UKRI; Medical Research Council [G0500220, G0300415] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; Chai Y, 2000, DEVELOPMENT, V127, P1671; COHNHEIM J, 1889, LECTURES GENERAL PAT, P746; COLLAZO A, 1993, DEVELOPMENT, V118, P363; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRANK E, 1991, DEVELOPMENT, V111, P895; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HARRISON DE, 1973, P NATL ACAD SCI USA, V70, P3184, DOI 10.1073/pnas.70.11.3184; Howell JC, 2003, ANN NY ACAD SCI, V996, P158, DOI 10.1111/j.1749-6632.2003.tb03244.x; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; KROHN PL, 1962, PROC R SOC SER B-BIO, V157, P128, DOI 10.1098/rspb.1962.0066; Kucia M, 2005, LEUKEMIA, V19, P1118, DOI 10.1038/sj.leu.2403796; Kues WA, 2005, BIOL REPROD, V72, P1020, DOI 10.1095/biolreprod.104.031229; LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x; LEBLOND C. P., 1964, NAT CANCER INST MONOGR, V14, P119; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; North TE, 2004, STEM CELLS, V22, P158, DOI 10.1634/stemcells.22-2-158; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oosterhuis JW, 2007, INT J ANDROL, V30, P256, DOI 10.1111/j.1365-2605.2007.00793.x; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Ratajczak MZ, 2004, FOLIA HISTOCHEM CYTO, V42, P139; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Scotting PJ, 2006, NEUROPATH APPL NEURO, V32, P569, DOI 10.1111/J.1365-2990.2006.00797.x; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; SLACK JMW, 1985, J THEOR BIOL, V114, P463, DOI 10.1016/S0022-5193(85)80179-X; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; WILLIS RA, 1962, BORDERLAND EMBRYOLOG; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zipori D, 2005, STEM CELLS, V23, P719, DOI 10.1634/stemcells.2005-0030	57	132	134	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1498	1501		10.1126/science.1162782	http://dx.doi.org/10.1126/science.1162782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056975				2022-12-28	WOS:000261377400037
J	Mathieson, PW				Mathieson, Peter W.			Proteinuria and Immunity - An Overstated Relationship?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PODOCYTES; CYTOSKELETON		[Mathieson, Peter W.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Mathieson, Peter W.] Southmead Hosp, Bristol, Avon, England	University of Bristol; Southmead Hospital	Mathieson, PW (corresponding author), Univ Bristol, Acad Renal Unit, Bristol, Avon, England.							Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Grimbert P, 2003, J EXP MED, V198, P797, DOI 10.1084/jem.20030566; Guigonis V, 2008, PEDIATR NEPHROL, V23, P1269, DOI 10.1007/s00467-008-0814-1; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655	5	53	60	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2492	2494		10.1056/NEJMcibr0806881	http://dx.doi.org/10.1056/NEJMcibr0806881			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378MT	19052132				2022-12-28	WOS:000261325900014
J	Titov, DV; Taylor, FW; Svedhem, H; Ignatiev, NI; Markiewicz, WJ; Piccioni, G; Drossart, P				Titov, Dmitry V.; Taylor, Fredric W.; Svedhem, Hakan; Ignatiev, Nikolay I.; Markiewicz, Wojciech J.; Piccioni, Giuseppe; Drossart, Pierre			Atmospheric structure and dynamics as the cause of ultraviolet markings in the clouds of Venus	NATURE			English	Article							MIDDLE ATMOSPHERE; EXPRESS; MISSION	When seen in ultraviolet light, Venus has contrast features that arise from the non- uniform distribution of unknown absorbers within the sulphuric acid clouds(1-3) and seem to trace dynamical activity in the middle atmosphere(4). It has long been unclear whether the global pattern arises from differences in cloud top altitude (which was earlier(3) estimated to be 66-72 km), compositional variations or temperature contrasts. Here we report multiwavelength imaging that reveals that the dark low latitudes are dominated by convective mixing which brings the ultraviolet absorbers up from depth. The bright and uniform mid- latitude clouds reside in the 'cold collar', an annulus of cold air characterized by similar to 30K lower temperatures with a positive lapse rate, which suppresses vertical mixing and cuts off the supply of ultraviolet absorbers from below. In low and middle latitudes, the visible cloud top is located at a remarkably constant altitude of 72 +/- 1 km in both the ultraviolet dark and bright regions, indicating that the brightness variations result from compositional differences caused by the colder environment rather than by elevation changes. The cloud top descends to similar to 64 km in the eye of the hemispheric vortex, which appears as a depression in the upper cloud deck. The ultraviolet dark circular streaks enclose the vortex eye and are dynamically connected to it.	[Titov, Dmitry V.; Ignatiev, Nikolay I.; Markiewicz, Wojciech J.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Taylor, Fredric W.] Univ Oxford, Clarendon Lab, Subdept Atmospher Ocean & Planetary Phys, Oxford OX1 3PU, England; [Svedhem, Hakan] European Space Agcy, Estec, NL-2200 AG Noordwijk, Netherlands; [Titov, Dmitry V.; Ignatiev, Nikolay I.] Space Res Inst IKI, Moscow 117997, Russia; [Piccioni, Giuseppe] Ist Astrofis Spaziale & Fis Cosmica INAF IASF, I-00133 Rome, Italy; [Drossart, Pierre] Observ Paris, LESIA, F-92195 Meudon, France	Max Planck Society; University of Oxford; European Space Agency; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Titov, DV (corresponding author), Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	Titov@mps.mpg.de	Piccioni, Giuseppe/T-9272-2017; Drossart, Pierre/H-8670-2013	Piccioni, Giuseppe/0000-0002-7893-6808; Taylor, Fred/0000-0002-0675-9769; Ignatiev, Nikolay/0000-0002-6358-7094	UK Science and Technology Facilities Council; Italian (ASI); French (CNES); Russian Foundation for Basic Research	UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Italian (ASI)(Agenzia Spaziale Italiana (ASI)); French (CNES)(Centre National D'etudes Spatiales); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	We thank the European Space Agency (ESA) for its efforts and dedication in implementation of the Venus Express mission and the teams at ESOC and ESAC for operational support. We thank the UK Science and Technology Facilities Council, Italian (ASI) and French (CNES) space agencies for support. N.I.I. acknowledges support from the Russian Foundation for Basic Research.	CRISP D, 1997, VENUS, V2, P353; Drossart P, 2007, PLANET SPACE SCI, V55, P1653, DOI 10.1016/j.pss.2007.01.003; Esposito L. W., 1983, Venus, P484; Esposito LW, 1980, J GEOPHYS RES-SPACE, V85, P8151, DOI 10.1029/JA085iA13p08151; ESPOSITO LW, 1982, ICARUS, V51, P374, DOI 10.1016/0019-1035(82)90090-2; LELLOUCH E, 1997, VENUS, V2, P295; Limaye SS, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002814; Markiewicz WJ, 2007, NATURE, V450, P633, DOI 10.1038/nature06320; Markiewicz WJ, 2007, PLANET SPACE SCI, V55, P1701, DOI 10.1016/j.pss.2007.01.004; Patzold M, 2007, NATURE, V450, P657, DOI 10.1038/nature06239; Piccioni G, 2007, NATURE, V450, P637, DOI 10.1038/nature06209; Pollack JB, 1980, J GEOPHYS RES-SPACE, V85, P8141, DOI 10.1029/JA085iA13p08141; Rossow WB, 1980, J GEOPHYS RES-SPACE, V85, P8107, DOI 10.1029/JA085iA13p08107; Sanchez-Lavega A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033817; Svedhem H, 2007, PLANET SPACE SCI, V55, P1636, DOI 10.1016/j.pss.2007.01.013; Taylor FW, 1980, J GEOPHYS RES-SPACE, V85, P7963, DOI 10.1029/JA085iA13p07963; Taylor FW, 2007, GEOPHYS MONOGR SER, V176, P157, DOI 10.1029/176GM10; Titov DV, 2006, PLANET SPACE SCI, V54, P1279, DOI 10.1016/j.pss.2006.04.017; Titov DV, 2007, GEOPHYS MONOGR SER, V176, P121, DOI 10.1029/176GM08; Tsang CCC, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003089; Zasova LV, 2007, PLANET SPACE SCI, V55, P1712, DOI 10.1016/j.pss.2007.01.011; ZASOVA LV, 1993, ICARUS, V105, P92, DOI 10.1006/icar.1993.1113	22	63	63	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					620	623		10.1038/nature07466	http://dx.doi.org/10.1038/nature07466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052623				2022-12-28	WOS:000261340000036
J	McDonnell, WM; Guenther, E				McDonnell, William M.; Guenther, Elisabeth			Narrative Review: Do State Laws Make It Easier to Say "I'm Sorry?"	ANNALS OF INTERNAL MEDICINE			English	Review							RISK-MANAGEMENT; MEDICAL ERRORS; PATIENT SAFETY; DISCLOSURE; PHYSICIANS	Initiatives intended to reduce the frequency and impact of medical errors generally rely on recognition and disclosure of medical errors. However, fear of malpractice liability is a barrier to physician disclosure. Some U. S. state legislatures have attempted to encourage physicians to disclose medical errors by enacting "apology laws." The authors reviewed the codified statutes of each of the 50 states and the District of Columbia to determine the prevalence and characteristics of such apology laws. They found that many states have recently adopted apology laws and that there is variability in these laws. The authors review some of the important differences in these laws and explore the potential impact of apology laws.	[McDonnell, William M.] Univ Utah, Sch Med, Div Pediat Emergency Med, SJ Quinney Coll Law, Salt Lake City, UT 84158 USA; Univ Utah, Intermt Injury Control Res Ctr, Salt Lake City, UT 84158 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	McDonnell, WM (corresponding author), Univ Utah, Sch Med, Div Pediat Emergency Med, SJ Quinney Coll Law, POB 581289, Salt Lake City, UT 84158 USA.	william.mcdonnell@hsc.utah.edu			National Institute of Child Health and Human Development [K23HD043145]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD043145] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	By National Institute of Child Health and Human Development grant K23HD043145 ( Dr. Guenther).	Barach P, 2000, BMJ-BRIT MED J, V320, P759, DOI 10.1136/bmj.320.7237.759; Clinton HR, 2006, NEW ENGL J MED, V354, P2205, DOI 10.1056/NEJMp068100; Cohen JR, 2004, ANN INTERN MED, V141, P481, DOI 10.7326/0003-4819-141-6-200409210-00017; Finkelstein D, 1997, J CLIN ETHIC, V8, P330; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; Hyman David, 2008, DEPAUL LAW REV, V57, P267; Kaldjian LC, 2008, ARCH INTERN MED, V168, P40, DOI 10.1001/archinternmed.2007.12; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; Kohn K, 2000, ERR IS HUMAN BUILDIN; Kraman S S, 2001, Compr Ther, V27, P253, DOI 10.1007/s12019-001-0022-4; Kraman SS, 1999, ANN INTERN MED, V131, P963, DOI 10.7326/0003-4819-131-12-199912210-00010; Lazare A, 2006, JAMA-J AM MED ASSOC, V296, P1401, DOI 10.1001/jama.296.11.1401; Mazor KM, 2006, J GEN INTERN MED, V21, P704, DOI 10.1111/j.1525-1497.2006.00465.x; Mazor KM, 2004, ARCH INTERN MED, V164, P1690, DOI 10.1001/archinte.164.15.1690; Mazor KM, 2004, ANN INTERN MED, V140, P409, DOI 10.7326/0003-4819-140-6-200403160-00006; *NAT ETH COMM VET, 2003, DISCL ADV EV PAT; Robinson AR, 2002, ARCH INTERN MED, V162, P2186, DOI 10.1001/archinte.162.19.2186; Studdert DM, 2007, HEALTH AFFAIR, V26, P215, DOI 10.1377/hlthaff.26.1.215; Tabler NG, 2007, HLTH LAWYER, V19, P23; Taft L., 2005, ANN HLTH LAW, V14, P55; VILLA AL, 2007, TRIAL, V43, P23; Xu X, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.043	22	37	37	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					811	W167		10.7326/0003-4819-149-11-200812020-00007	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047028				2022-12-28	WOS:000261645300005
J	Chopra, AR; Louet, JF; Saha, P; An, J; DeMayo, F; Xu, JM; York, B; Karpen, S; Finegold, M; Moore, D; Chan, L; Newgard, CB; O'Malley, BW				Chopra, Atul R.; Louet, Jean-Francois; Saha, Pradip; An, Jie; DeMayo, Franco; Xu, Jianming; York, Brian; Karpen, Saul; Finegold, Milton; Moore, David; Chan, Lawrence; Newgard, Christopher B.; O'Malley, Bert W.			Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease	SCIENCE			English	Article							STEROID-RECEPTOR COACTIVATOR-2; STORAGE-DISEASE; LIVER-REGENERATION; MOUSE; GLUCOSE-6-PHOSPHATASE; GENE; SUPPRESSION; DELETION; GLUCOSE; PGC-1	Hepatic glucose production is critical for basal brain function and survival when dietary glucose is unavailable. Glucose- 6- phosphatase (G6Pase) is an essential, rate- limiting enzyme that serves as a terminal gatekeeper for hepatic glucose release into the plasma. Mutations in G6Pase result in Von Gierke's disease ( glycogen storage disease-1a), a potentially fatal genetic disorder. We have identified the transcriptional coactivator SRC-2 as a regulator of fasting hepatic glucose release, a function that SRC- 2 performs by controlling the expression of hepatic G6Pase. SRC- 2 modulates G6Pase expression directly by acting as a coactivator with the orphan nuclear receptor ROR alpha. In addition, SRC- 2 ablation, in both a whole- body and liver- specific manner, resulted in a Von Gierke's disease phenotype in mice. Our results position SRC- 2 as a critical regulator of mammalian glucose production.	[Chopra, Atul R.; Louet, Jean-Francois; Saha, Pradip; DeMayo, Franco; Xu, Jianming; York, Brian; Karpen, Saul; Moore, David; Chan, Lawrence; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Karpen, Saul] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Finegold, Milton] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [An, Jie; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Duke University	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Chopra, Atul/0000-0002-1304-3777; Louet, Jean-Francois/0000-0002-1626-7098	National Institute of Diabetes and Digestive and Kidney Diseases [PO1 DK59820]; NIH [HL51586, DK58242, PO1 DK58398]; Nuclear Receptor Signaling Atlas ( NURSA) [U19 DK062434]; Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056239, P01DK059820, R01DK058242, P01DK058398, U19DK062434] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Receptor Signaling Atlas ( NURSA); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank O. McGuinness for help with assessment of liver glycogen and triglyceride content; D. White for help with primary hepatocyte isolation; S. Zhou and J. Song for help with animal breeding; J. Barish for performing the electron microscopy; J. Lin for the RORa adenovirus; J. Lydon for the SRC- 2 F/ F mice and M. Stallcup for the SRC- 2 activation domain mutants; R. Lanz for help with QPCR setup and analysis; M. Muehlbauer for help with plasma analysis of various metabolites; H. Klein and S. Greene for help with figure and model construction; and J. Sagen and C. Foulds for helpful discussion and critical reading of the manuscript. F. D. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (grant PO1 DK59820). L.C. is supported by the NIH (grant HL51586). J.X. is supported by the NIH (DK58242). C.B.N. is supported by the NIH (grant PO1 DK58398). B.W.O. is supported by the NIDDK (grant PO1 DK59820), Nuclear Receptor Signaling Atlas (NURSA) (U19 DK062434), and a grant from the Welch Foundation.	Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gogus S, 2002, PEDIATR DEVEL PATHOL, V5, P299, DOI 10.1007/s10024-001-0139-6; Jeong JW, 2007, ENDOCRINOLOGY, V148, P4238, DOI 10.1210/en.2007-0122; Koeberl DD, 2007, MOL THER, V15, P1253, DOI 10.1038/sj.mt.6300188; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Li F, 2006, CANCER RES, V66, P5608, DOI 10.1158/0008-5472.CAN-05-4242; Liedtke AJ, 1997, J MOL CELL CARDIOL, V29, P1073, DOI 10.1006/jmcc.1996.0341; Mukherjee Atish, 2007, Nucl Recept Signal, V5, pe011, DOI 10.1621/nrs.05011; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; Nordlie R C, 1974, Curr Top Cell Regul, V8, P33; NORDLIE RC, 1979, LIFE SCI, V24, P2397, DOI 10.1016/0024-3205(79)90447-8; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Phaneuf D, 2004, DNA CELL BIOL, V23, P592, DOI 10.1089/dna.2004.23.592; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stec DE, 1999, J BIOL CHEM, V274, P21285, DOI 10.1074/jbc.274.30.21285; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025	20	127	131	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1395	1399		10.1126/science.1164847	http://dx.doi.org/10.1126/science.1164847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039140	Green Accepted			2022-12-28	WOS:000261170600043
J	Lambert, JB				Lambert, Joseph B.			CHEMISTRY A Tamed Reactive Intermediate	SCIENCE			English	Editorial Material							CATION		[Lambert, Joseph B.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University	Lambert, JB (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	jlambert@northwestern.edu						CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241; Denk MK, 1998, ACTA CRYSTALLOGR C, V54, P1830, DOI 10.1107/S0108270198009548; Jutzi P, 2004, SCIENCE, V305, P849, DOI 10.1126/science.1099879; Lambert JB, 2001, J PHYS ORG CHEM, V14, P370, DOI 10.1002/poc.377; LAPWORTH A, 1904, J CHEM SOC, V85, P32; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; PROBST T, 1990, ANGEW CHEM INT EDIT, V29, P1397, DOI 10.1002/anie.199013971; Rupar PA, 2008, SCIENCE, V322, P1360, DOI 10.1126/science.1163033; Rupar PA, 2007, J AM CHEM SOC, V129, P15138, DOI 10.1021/ja0775725; SNYDER RG, 1962, J CHEM PHYS, V36, P1356, DOI 10.1063/1.1732740	10	6	6	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1333	1334		10.1126/science.1167321	http://dx.doi.org/10.1126/science.1167321			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039124				2022-12-28	WOS:000261170600022
J	Roy, K; Hilliard, GM; Hamilton, DJ; Luo, JW; Ostmann, MM; Fleckenstein, JM				Roy, Koushik; Hilliard, George M.; Hamilton, David J.; Luo, Jiwen; Ostmann, Marguerite M.; Fleckenstein, James M.			Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells	NATURE			English	Article							HEAT-LABILE ENTEROTOXIN; TOLL-LIKE RECEPTOR-5; 2-PARTNER SECRETION; EPITHELIAL-CELLS; COLONIZATION; VIRULENCE; PROTEINS; IDENTIFICATION; ADHERENCE; FILAMENT	Adhesion to epithelial cells(1) and flagella- mediated motility are critical virulence traits for many Gram- negative pathogens, including enterotoxigenic Escherichia coli (ETEC)(2), a major cause of diarrhoea in travellers and children in developing countries(3,4). Many flagellated pathogens export putative adhesins belonging to the two- partner secretion ( TPS) family(5). However, the actual function of these adhesins remains largely undefined. Here we demonstrate that EtpA, a TPS exoprotein adhesin of enterotoxigenic E. coli(6), mimics and interacts with highly conserved regions of flagellin, the major subunit of flagella, and that these interactions are critical for adherence and intestinal colonization. Although conserved regions of flagellin are mostly buried in the flagellar shaft(7), our results suggest that they are at least transiently exposed at the tips of flagella where they capture EtpA adhesin molecules for presentation to eukaryotic receptors. Similarity of EtpA to molecules encoded by other motile pathogens suggests a potential common pattern for bacterial adhesion, whereas participation of conserved regions of flagellin in adherence has implications for development of vaccines for Gram- negative pathogens.	[Roy, Koushik; Luo, Jiwen; Fleckenstein, James M.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Hilliard, George M.; Fleckenstein, James M.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Hamilton, David J.] Univ Tennessee, Ctr Hlth Sci, Dept Comparat Med, Memphis, TN 38163 USA; [Ostmann, Marguerite M.] Vet Adm Med Ctr, Res Serv, Memphis, TN 38104 USA; [Fleckenstein, James M.] Vet Adm Med Ctr, Med Serv, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Fleckenstein, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, 956 Court Ave, Memphis, TN 38163 USA.	jflecke1@tennessee.edu	Fleckenstein, James M./P-6242-2019	Fleckenstein, James M./0000-0002-1148-697X	National Institutes of Health (National Center for Research Resources) [RR16190-05]; Department of Veterans Affairs; University of Tennessee Microbial Pathogenesis Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016190] Funding Source: NIH RePORTER	National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Veterans Affairs(US Department of Veterans Affairs); University of Tennessee Microbial Pathogenesis Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank B. Westerlund-Wikstrom for supplying anti- flagellar antisera, K. Troughton of the Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, for her assistance with transmission electron microscopy, and L. Boykins of the Integrated Microscopy Center at the University of Memphis for her assistance with scanning electron microscopy. We thank G. Byrne, H. Courtney, J. Dale, S. Dagogo-Jack and T. Strom for reading the manuscript. This research was supported by grants from the National Institutes of Health ( National Center for Research Resources) RR16190-05, the Department of Veterans Affairs and funds from the University of Tennessee Microbial Pathogenesis Research Center.	Allen KP, 2006, INFECT IMMUN, V74, P869, DOI 10.1128/IAI.74.2.869-875.2006; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Buscher AZ, 2006, MOL MICROBIOL, V61, P470, DOI 10.1111/j.1365-2958.2006.05236.x; Cummings ED, 2007, J PROTEOME RES, V6, P1603, DOI 10.1021/pr060472y; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; GOFF SP, 1991, METHOD ENZYMOL, V208, P586; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Maki-Yonekura S, 2003, P NATL ACAD SCI USA, V100, P15528, DOI 10.1073/pnas.2534343100; Mu XQ, 2008, J MOL BIOL, V376, P614, DOI 10.1016/j.jmb.2007.10.067; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Roy K, 2008, INFECT IMMUN, V76, P2106, DOI 10.1128/IAI.01304-07; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SUDAKIN V, 2005, PROTEIN PROTEIN INTE, V1, P337; Svennerholm AM, 2008, EXPERT REV VACCINES, V7, P795, DOI 10.1586/14760584.7.6.795; Torres AG, 2005, INFECT IMMUN, V73, P18, DOI 10.1128/IAI.73.1.18-29.2005; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	29	141	153	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					594	U103		10.1038/nature07568	http://dx.doi.org/10.1038/nature07568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19060885	Green Accepted			2022-12-28	WOS:000262852200044
J	Doig, GS; Simpson, F; Finfer, S; Delaney, A; Davies, AR; Mitchell, I; Dobb, G				Doig, Gordon S.; Simpson, Fiona; Finfer, Simon; Delaney, Anthony; Davies, Andrew R.; Mitchell, Imogen; Dobb, Geoff		ANZICS Clin Trials Grp	Effect of Evidence-Based Feeding Guidelines on Mortality of Critically Ill Adults A Cluster Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; ACUTE-RENAL-FAILURE; NUTRITION SUPPORT; ENTERAL NUTRITION; MULTICENTER; QUALITY; IMPLEMENTATION; DISSEMINATION; INTERVENTION; LIMITATIONS	Context Evidence demonstrates that providing nutritional support to intensive care unit ( ICU) patients within 24 hours of ICU admission reduces mortality. However, early feeding is not universally practiced. Changing practice in complex multidisciplinary environments is difficult. Evidence supporting whether guidelines can improve ICU feeding practices and patient outcomes is contradictory. Objective To determine whether evidence- based feeding guidelines, implemented using a multifaceted practice change strategy, improve feeding practices and reduce mortality in ICU patients. Design, Setting, and Patients Cluster randomized trial in ICUs of 27 community and tertiary hospitals in Australia and New Zealand. Between November 2003 and May 2004, 1118 critically ill adult patients expected to remain in the ICU longer than 2 days were enrolled. All participants completed the study. Interventions Intensive care unitswererandomlyassigned to guideline or control groups. Guideline ICUs developed an evidence- based guideline using Browman's Clinical Practice Guideline Development Cycle. A practice- change strategy composed of 18 specific interventions, leveraged by educational outreach visits, was implemented in guideline ICUs. Main Outcome Measures Hospital discharge mortality. Secondary outcomes included ICU and hospital length of stay, organ dysfunction, and feeding process measures. Results Guideline and control ICUs enrolled 561 and 557 patients, respectively. Guideline ICUs fed patients earlier ( 0.75 vs 1.37 mean days to enteral nutrition start; difference, - 0.62 [ 95% confidence interval {CI}, - 0.82 to - 0.36]; P <. 001 and 1.04 vs 1.40 mean days to parenteral nutrition start; difference, - 0.35 [ 95% CI, - 0.61 to - 0.01]; P=. 04) and achieved caloric goals more often ( 6.10 vs 5.02 mean days per 10 fed patient- days; difference, 1.07 [ 95% CI, 0.12 to 2.22]; P=. 03). Guideline and control ICUs did not differ with regard to hospital discharge mortality ( 28.9% vs 27.4%; difference, 1.4% [ 95% CI, - 6.3% to 12.0%]; P=. 75) or to hospital length of stay ( 24.2 vs 24.3 days; difference, - 0.08 [ 95% CI, - 3.8 to 4.4]; P=. 97) or ICU length of stay ( 9.1 vs 9.9 days; difference, - 0.86 [ 95% CI, - 2.6 to 1.3]; P=. 42). Conclusions Using a multifaceted practice change strategy, ICUs successfully developed and introduced an evidence- based nutritional support guideline that promoted earlier feeding and greater nutritional adequacy. However, use of the guideline did not improve clinical outcomes. Trial Registration anzctr. org. au Identifier: ACTRN12608000407392.	[Doig, Gordon S.; Simpson, Fiona; Finfer, Simon; Delaney, Anthony] Univ Sydney, Royal N Shore Hosp, No Clin Sch, Sydney, NSW 2006, Australia; [Finfer, Simon] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Davies, Andrew R.] Monash Univ, Alfred Hosp, Melbourne, Vic 3181, Australia; [Mitchell, Imogen] Canberra Hosp, Canberra, ACT, Australia; [Dobb, Geoff] Royal Perth Hosp, Perth, WA, Australia	Royal North Shore Hospital; University of Sydney; University of Sydney; Florey Institute of Neuroscience & Mental Health; Monash University; Australian National University; Canberra Hospital; Royal Perth Hospital; University of Western Australia	Doig, GS (corresponding author), Univ Sydney, Royal N Shore Hosp, No Clin Sch, Sydney, NSW 2006, Australia.	gdoig@med.usyd.edu.au	Joyce, Christopher/B-7437-2013; Delaney, Anthony/AAE-3365-2019	Finfer, Simon/0000-0002-2785-5864; Simpson, Fiona/0000-0002-4598-2488; Delaney, Anthony/0000-0002-1015-7146; Doig, Gordon/0000-0003-2141-7000; Mitchell, Imogen/0000-0001-6013-4922; Ferrie, Suzie/0000-0001-6100-0117	Australian and New Zealand Intensive Care (ANZIC) Foundation (http: //www.intensivecareappeal.com/); Novartis; Abbott Laboratories; Nutricia; Fresenius-Kabi; Baxter	Australian and New Zealand Intensive Care (ANZIC) Foundation (http: //www.intensivecareappeal.com/); Novartis(Novartis); Abbott Laboratories(Abbott Laboratories); Nutricia(Danone Nutricia); Fresenius-Kabi; Baxter	This work was supported in full by a peer-reviewed grant from the Australian and New Zealand Intensive Care (ANZIC) Foundation (http: //www.intensivecareappeal.com/). The ANZIC foundation received major support from Novartis and Abbott Laboratories and significant support from Nutricia, Fresenius-Kabi, and Baxter.	ABEL RM, 1973, NEW ENGL J MED, V288, P695, DOI 10.1056/NEJM197304052881401; Bernard GR, 1995, AM J RESP CRIT CARE, V151, pA323; Borbas C, 2000, CHEST, V118, p24S, DOI 10.1378/chest.118.2_suppl.24S; BROWMAN GP, 1995, J CLIN ONCOL, V13, P502, DOI 10.1200/JCO.1995.13.2.502; Buchan H, 2004, MED J AUSTRALIA, V180, pS48; Cook DJ, 1997, ANN INTERN MED, V127, P210, DOI 10.7326/0003-4819-127-3-199708010-00006; COOK DJ, 1995, UPD INT CAR, V19, pR19; Doig GS, 2006, CURR OPIN CRIT CARE, V12, P126, DOI 10.1097/01.ccx.0000216579.34310.84; Doig GS, 2005, ANESTH ANALG, V100, P527, DOI 10.1213/01.ANE.0000141676.12552.D0; DOIG GS, 2005, EVIDENCE BASED GUIDE; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; GRILLI R, 1994, MED CARE, V32, P202, DOI 10.1097/00005650-199403000-00002; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Gross PA, 2001, MED CARE, V39, pII55; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P74, DOI 10.1177/014860710302700174; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; HISS RG, 1978, P 17 ANN C RES MED E, P283; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jain MK, 2006, CRIT CARE MED, V34, P2362, DOI 10.1097/01.CCM.0000234044.91893.9C; *JOINT FAC INT CAR, MIN STAND INT CAR UN; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Landsberger HA, 1958, HAWTHORNE REVISITED; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Roberts PR, 1997, AM J RESP CRIT CARE, V156, P1265, DOI 10.1164/ajrccm.156.4.9607003; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; ROGERS EM, 1995, JOINT COMM J QUAL IM, V21, P324, DOI 10.1016/S1070-3241(16)30155-9; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Simpson F, 2007, J EVAL CLIN PRACT, V13, P709, DOI 10.1111/j.1365-2753.2006.00717.x; Sinuff T, 2007, CRIT CARE MED, V35, P2083, DOI 10.1097/01.ccm.0000281446.15342.74; *STAT CORP, 2001, STAT COMP PROGR REL; TOBACK FG, 1977, KIDNEY INT, V12, P193, DOI 10.1038/ki.1977.100; Walters SJ, 2009, PHARM STAT, V8, P163, DOI 10.1002/pst.334; *WHO, 2000, ACLUSTER COMP PROGR; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; ENTERAL NUTR EN FEED; 2001, STATA 7 USERS GUIDE	44	282	301	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2731	2741		10.1001/jama.2008.826	http://dx.doi.org/10.1001/jama.2008.826			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088351	Bronze			2022-12-28	WOS:000261730400020
J	West, JB				West, John B.			A New Approach to Very-High-Altitude Land Travel: The Train to Lhasa, Tibet	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OXYGEN ENRICHMENT; ROOM AIR	The train from Golmud in Qinghai Province, China, to Lhasa, Tibet, travels for more than 14 hours at an average altitude of 4500 m, the highest point being 5072 m (16 600 ft). Therefore, passengers are potentially exposed to very severe sustained hypoxia. The enterprising solution is to increase the oxygen concentration of the air in the train from 21% to between 24% and 25% by the use of oxygen generators in each passenger car. By increasing the oxygen concentration to 25%, the equivalent altitude is reduced by about 1200 m. The engineering challenge of oxygenating the whole train is immense but has been successfully accomplished. This is an extraordinary innovation in high-altitude transportation.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	West, JB (corresponding author), Univ Calif San Diego, Dept Med, 0623A,9500 Gilman Dr, La Jolla, CA 92093 USA.	jwest@ucsd.edu			National Heart, Lung, and Blood Institute [R01 HL 060968]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060968] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	From the National Heart, Lung, and Blood Institute, R01 HL 060968.	Barash IA, 2001, HIGH ALT MED BIOL, V2, P525, DOI 10.1089/152702901753397090; Forster P., 1986, ASPECTS HYPOXIA, P217; Gerard A B, 2000, High Alt Med Biol, V1, P51, DOI 10.1089/152702900320685; Murdoch, 1995, J Travel Med, V2, P255, DOI 10.1111/j.1708-8305.1995.tb00671.x; RAHN H, 1949, AM J PHYSIOL, V157, P445, DOI 10.1152/ajplegacy.1949.157.3.445; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; West JB, 2004, OBSERVATORY, V124, P1; WEST JB, 1995, RESP PHYSIOL, V99, P225, DOI 10.1016/0034-5687(94)00094-G; Wu TY, 2007, HIGH ALT MED BIOL, V8, P88, DOI 10.1089/ham.2007.1015; Wu TY, 2006, HIGH ALT MED BIOL, V7, P275, DOI 10.1089/ham.2006.7.275	10	11	13	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					898	900		10.7326/0003-4819-149-12-200812160-00009	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075209				2022-12-28	WOS:000261771900007
J	Ferriere, L; Koeberl, C; Ivanov, BA; Reimold, WU				Ferriere, Ludovic; Koeberl, Christian; Ivanov, Boris A.; Reimold, Wolf Uwe			Shock Metamorphism of Bosumtwi Impact Crater Rocks, Shock Attenuation, and Uplift Formation	SCIENCE			English	Article							SLATE ISLANDS; QUARTZ; GHANA; REEVALUATION; DEFORMATION; CANADA	Shock wave attenuation rate and formation of central uplifts are not precisely constrained for moderately sized complex impact structures. The distribution of shock metamorphism in drilled basement rocks from the 10.5- kilometer- diameter Bosumtwi crater, and results of numerical modeling of inelastic rock deformation and modification processes during uplift, constrained with petrographic data, allowed reconstruction of the pre- impact position of the drilled rocks and revealed a shock attenuation by similar to 5 gigapascals in the uppermost 200 meters of the central uplift. The proportion of shocked quartz grains and the average number of planar deformation feature sets per grain provide a sensitive indication of minor changes in shock pressure. The results further imply that for moderately sized craters the rise of the central uplift is dominated by brittle failure.	[Ferriere, Ludovic; Koeberl, Christian] Univ Vienna, Dept Lithospher Res, A-1090 Vienna, Austria; [Ivanov, Boris A.] Russian Acad Sci, Inst Dynam Geospheres, Moscow 119334, Russia; [Reimold, Wolf Uwe] Humboldt Univ, Museum Nat Hist Mineral, D-10115 Berlin, Germany	University of Vienna; Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Humboldt University of Berlin	Koeberl, C (corresponding author), Univ Vienna, Dept Lithospher Res, Althanstr 14, A-1090 Vienna, Austria.	christian.koeberl@univie.ac.at	Reimold, Wolf Uwe/AAI-6226-2021; Ivanov, Boris A/E-1413-2016	Ivanov, Boris A/0000-0002-9938-9428; Hauser, Natalia/0000-0002-6975-6186; Ferriere, Ludovic/0000-0002-9082-6230	ICDP; NSF; Austrian Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P17194-N10, P18862-N10]; Canadian Natural Sciences and Engineering Research Council; Austrian Academy of Sciences; Russian Foundation for Basic Science [08-05-00908-a]; German Science Foundation (Deutsche Forschungsgemeinschaft); Humboldt University of Berlin	ICDP; NSF(National Science Foundation (NSF)); Austrian Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Austrian Academy of Sciences; Russian Foundation for Basic Science(Russian Foundation for Basic Research (RFBR)); German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Humboldt University of Berlin	Drilling was funded by ICDP, NSF, the Austrian Fonds zur Forderung der wissenschaftlichen Forschung (FWF), the Canadian Natural Sciences and Engineering Research Council, and the Austrian Academy of Sciences. We thank DOSECC (Drilling, Observation and Sampling of the Earth's Continental Crust) for the drilling operations. This work was supported by the Austrian FWF ( grants P17194-N10 and P18862-N10) and the Austrian Academy of Sciences. B. A. I. was supported by the Russian Foundation for Basic Science (RFBR grant 08-05-00908-a), and W.U.R.'s research is supported by the German Science Foundation (Deutsche Forschungsgemeinschaft) and Humboldt University of Berlin.	Ahrens T. J., 1977, IMPACT EXPLOSION CRA, P639; CHERRY JT, 1970, PEACEFUL NUCL EXPLOS, P241; Cintala MJ, 1998, METEORIT PLANET SCI, V33, P889, DOI 10.1111/j.1945-5100.1998.tb01695.x; Coney L, 2007, METEORIT PLANET SCI, V42, P569, DOI 10.1111/j.1945-5100.2007.tb01062.x; Dressler BO, 1998, CONTRIB MINERAL PETR, V130, P275, DOI 10.1007/s004100050365; Feldman VI, 1996, DOKL AKAD NAUK+, V349, P658; Ferriere L, 2007, METEORIT PLANET SCI, V42, P611, DOI 10.1111/j.1945-5100.2007.tb01064.x; French B.M., 1998, LPI CONTRIBUTION, V954; Gibson RL, 2005, GEOL SOC AM SPEC PAP, V384, P329, DOI 10.1130/0-8137-2384-1.329; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; GRIEVE RAF, 1990, TECTONOPHYSICS, V171, P185, DOI 10.1016/0040-1951(90)90098-S; Grieve RAF, 1996, METEORIT PLANET SCI, V31, P6, DOI 10.1111/j.1945-5100.1996.tb02049.x; GRIEVE RAF, 1976, CONTRIB MINERAL PETR, V58, P37, DOI 10.1007/BF00384743; HORZ F, 1968, SHOCK METAMORPHISM N, P243; Huffman AR, 1996, TECTONOPHYSICS, V256, P165, DOI 10.1016/0040-1951(95)00162-X; Ivanov BA, 2005, SOLAR SYST RES+, V39, P381, DOI 10.1007/s11208-005-0051-0; Koeberl C., 2005, YB AUSTRIAN GEOLOGIC, V145, P31; Koeberl C, 2007, METEORIT PLANET SCI, V42, P483, DOI 10.1111/j.1945-5100.2007.tb01057.x; Masaitis V., 1999, DEEP DRILLING IMPACT; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Mitani NK, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2000JE001472; Pierazzo E, 1997, ICARUS, V127, P408, DOI 10.1006/icar.1997.5713; Robertson P. B., 1977, IMPACT EXPLOSION CRA, P687; SAZONOVA LV, 1981, IMPACTITES, P93; Scholz CA, 2002, GEOLOGY, V30, P939, DOI 10.1130/0091-7613(2002)030<0939:PCUIIT>2.0.CO;2; STOFFLER D, 1994, METEORITICS, V29, P155, DOI 10.1111/j.1945-5100.1994.tb00670.x; Stu┬ffler D., 1972, FORTSCHRITTE MINERAL, V49, P50	27	40	42	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1678	1681		10.1126/science.1166283	http://dx.doi.org/10.1126/science.1166283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074347				2022-12-28	WOS:000261608300041
J	Mulder, B				Mulder, Bela			DEVELOPMENTAL BIOLOGY On Growth and Force	SCIENCE			English	Editorial Material							CELLULOSE MICROFIBRILS; MICROTUBULES		[Mulder, Bela] FOM, Inst Atom & Mol Phys, Dept Biomol Syst, NL-1098 SJ Amsterdam, Netherlands; [Mulder, Bela] Univ Wageningen & Res Ctr, Lab Plant Cell Biol, NL-6703 BD Wageningen, Netherlands	AMOLF; Wageningen University & Research	Mulder, B (corresponding author), FOM, Inst Atom & Mol Phys, Dept Biomol Syst, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	mulder@amolf.nl	Mulder, Bela M./C-1070-2012	Mulder, Bela M./0000-0002-8620-5749				Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Emons AMC, 1998, P NATL ACAD SCI USA, V95, P7215, DOI 10.1073/pnas.95.12.7215; Emons AMC, 2007, TRENDS PLANT SCI, V12, P279, DOI 10.1016/j.tplants.2007.06.002; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Paredez AR, 2008, PLANT PHYSIOL, V147, P1723, DOI 10.1104/pp.108.120196; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Thompson D.W., 1961, GROWTH FORM; Vesk PA, 1996, PROTOPLASMA, V195, P168, DOI 10.1007/BF01279195	12	6	6	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1643	1644		10.1126/science.1168512	http://dx.doi.org/10.1126/science.1168512			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074335				2022-12-28	WOS:000261608300029
J	Shum, WWC; Da Silva, N; Mckee, M; Smith, PJS; Brown, D; Breton, S				Shum, Winnie Wai Chi; Da Silva, Nicolas; McKee, Mary; Smith, Peter J. S.; Brown, Dennis; Breton, Sylvie			Transepithelial Projections from Basal Cells Are Luminal Sensors in Pseudostratified Epithelia	CELL			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MALE REPRODUCTIVE-TRACT; ENDOTHELIAL NITRIC-OXIDE; TIGHT JUNCTIONS; H+-ATPASE; EPIDIDYMAL EPITHELIUM; INTERCALATED CELLS; BLOOD-PRESSURE; CLEAR CELLS; STEM-CELLS	Basal cells are by definition located on the basolateral side of several epithelia, and they have never been observed reaching the lumen. Using high-resolution 3D confocal imaging, we report that basal cells extend long and slender cytoplasmic projections that not only reach toward the lumen but can cross the tight junction barrier in some epithelia of the male reproductive and respiratory tracts. In this way, the basal cell plasma membrane is exposed to the luminal environment. In the epididymis, in which luminal acidification is crucial for sperm maturation and storage, these projections contain the angiotensin II type 2 receptor (AGTR2). Activation of AGTR2 by luminal angiotensin II, increases proton secretion by adjacent clear cells, which are devoid of AGTR2. We propose a paradigm in which basal cells scan and sense the luminal environment of pseudostratified epithelia and modulate epithelial function by a mechanism involving crosstalk with other epithelial cells.	[Shum, Winnie Wai Chi; Da Silva, Nicolas; McKee, Mary; Brown, Dennis; Breton, Sylvie] Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA; [Shum, Winnie Wai Chi; Da Silva, Nicolas; Brown, Dennis; Breton, Sylvie] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Smith, Peter J. S.] Marine Biol Lab, Mol Physiol Program, BioCurrents Res Ctr, Woods Hole, MA 02543 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Marine Biological Laboratory - Woods Hole	Breton, S (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA.	sbreton@partners.org	Da Silva, Nicolas/T-3528-2019	Smith, Peter/0000-0003-4400-6853	National Institute of Health [HD40793, DK38452, DK42956]; NCRR [P41 RR001395]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; Center for the Study of Inflammatory Bowel Disease [DK43341]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040793] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043341, R37DK042956, R56DK042956, R01DK042956, P01DK038452, R01DK085715, P30DK057521] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Boston Area Diabetes and Endocrinology Research Center; Center for the Study of Inflammatory Bowel Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants HD40793 (S. B.), DK38452 (S. B. and D. B.), DK42956 (D. B.), and NCRR P41 RR001395 grant (P.J.S. Smith). The Microscopy Core facility of the MGH Program in Membrane Biology receives support from the Boston Area Diabetes and Endocrinology Research Center (DK57521) and the Center for the Study of Inflammatory Bowel Disease (DK43341).	Beaulieu V, 2005, J BIOL CHEM, V280, P8452, DOI 10.1074/jbc.M412750200; Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; BROWN D, 1992, AM J PHYSIOL, V263, pC913, DOI 10.1152/ajpcell.1992.263.4.C913; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Burns AR, 2000, J CELL SCI, V113, P45; Carey RM, 2005, CURR OPIN NEPHROL HY, V14, P67, DOI 10.1097/00041552-200501000-00011; Cheung KH, 2005, J GEN PHYSIOL, V125, P443, DOI 10.1085/jgp.200409205; Clermont Y, 1970, Biology Reprod., V3, P283; Da Silva N, 2007, AM J PHYSIOL-CELL PH, V293, pC199, DOI 10.1152/ajpcell.00596.2006; Esther CR, 1996, LAB INVEST, V74, P953; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; FORD JR, 1992, EXP CELL RES, V198, P69, DOI 10.1016/0014-4827(92)90150-7; Gatti JL, 1999, BIOL REPROD, V60, P937, DOI 10.1095/biolreprod60.4.937; Gregory M, 2006, MOL REPROD DEV, V73, P580, DOI 10.1002/mrd.20467; Gregory M, 2001, ENDOCRINOLOGY, V142, P854, DOI 10.1210/en.142.2.854; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Hermo L., 2002, EPIDIDYMIS MOL CLIN, P81, DOI [10.1007/978-1-4615-0679-9_5, DOI 10.1007/978-1-4615-0679-9_5]; HINTON BT, 1995, MICROSC RES TECHNIQ, V30, P67, DOI 10.1002/jemt.1070300106; Ihrler S, 2002, VIRCHOWS ARCH, V440, P519, DOI 10.1007/s004280100537; Isnard-Bagnis C, 2003, AM J PHYSIOL-CELL PH, V284, pC220, DOI 10.1152/ajpcell.00374.2001; Jones RC, 1996, REPROD FERT DEVELOP, V8, P553, DOI 10.1071/RD9960553; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Leung GPH, 2004, MOL CELL ENDOCRINOL, V216, P5, DOI 10.1016/j.mce.2003.10.077; Leung PS, 2003, J MOL ENDOCRINOL, V30, P263, DOI 10.1677/jme.0.0300263; Leung PS, 1997, BBA-MOL CELL RES, V1357, P65, DOI 10.1016/S0167-4889(97)00015-3; Mewe M, 2006, ENDOCRINOLOGY, V147, P2051, DOI 10.1210/en.2005-1324; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Parnot C, 2004, NAT STRUCT MOL BIOL, V11, P691, DOI 10.1038/nsmb0804-691; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Pech V, 2008, J AM SOC NEPHROL, V19, P84, DOI 10.1681/ASN.2007030277; PRICE DOROTHY, 1963, NATL CANCER INST MONOGR, V12, P1; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rizzo S, 2005, CELL PROLIFERAT, V38, P363, DOI 10.1111/j.1365-2184.2005.00356.x; ROBAIRE B, 1995, BIOL REPROD, V52, P226, DOI 10.1095/biolreprod52.2.226; Rothenberger F, 2007, J AM SOC NEPHROL, V18, P2085, DOI 10.1681/ASN.2006070753; Saez F, 2004, J ANDROL, V25, P784; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Skrabanek L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-177; SMITH PJS, 2007, METHODS NEW FRONTIER, P373; STEIN B, 1997, ENDOTHELIUM CLIN PRA, P147; Takano K, 2005, J HISTOCHEM CYTOCHEM, V53, P611, DOI 10.1369/jhc.4A6539.2005; Toda N, 2007, PHARMACOL REV, V59, P54, DOI 10.1124/pr.59.1.2; van Leenders GJLH, 2003, CRIT REV ONCOL HEMAT, V46, pS3, DOI 10.1016/S1040-8428(03)00059-3; VERI JP, 1993, J ANDROL, V14, P23; Wei CW, 1997, P NATL ACAD SCI USA, V94, P6369, DOI 10.1073/pnas.94.12.6369; WONG PYD, 1978, J PHYSIOL-LONDON, V275, P13, DOI 10.1113/jphysiol.1978.sp012174; YEUNG CH, 1994, BIOL REPROD, V50, P917, DOI 10.1095/biolreprod50.4.917; Zini A, 1996, BIOL REPROD, V55, P935, DOI 10.1095/biolreprod55.5.935	57	122	129	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1108	1117		10.1016/j.cell.2008.10.020	http://dx.doi.org/10.1016/j.cell.2008.10.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070580	Green Accepted, Bronze			2022-12-28	WOS:000261642800026
J	Barry, MJ				Barry, Michael J.			Screening for Prostate Cancer among Men 75 Years of Age or Older.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Barry, Michael J.] Massachusetts Gen Hosp, John D Stoeckle Ctr Primary Care Innovat, Boston, MA 02114 USA; [Barry, Michael J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Barry, MJ (corresponding author), Massachusetts Gen Hosp, John D Stoeckle Ctr Primary Care Innovat, Boston, MA 02114 USA.							Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; WOLOSHIN S, 2008, JNCI-J NATL CANCER I, V100, P1133; Woloshin S, 2008, J NATL CANCER I, V100, P845, DOI 10.1093/jnci/djn124	6	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2515	2516		10.1056/NEJMp0807209	http://dx.doi.org/10.1056/NEJMp0807209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	381KG	19073973				2022-12-28	WOS:000261534200002
J	Seeley, TD				Seeley, Thomas D.			Martin Lindauer (1918-2008) Obituary	NATURE			English	Biographical-Item									Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Seeley, TD (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	tds5@cornell.edu							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					718	718		10.1038/456718a	http://dx.doi.org/10.1038/456718a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079045	Bronze			2022-12-28	WOS:000261559900032
J	Hall, AJ; Logan, JE; Toblin, RL; Kaplan, JA; Kraner, JC; Bixler, D; Crosby, AE; Paulozzi, LJ				Hall, Aron J.; Logan, Joseph E.; Toblin, Robin L.; Kaplan, James A.; Kraner, James C.; Bixler, Danae; Crosby, Alex E.; Paulozzi, Leonard J.			Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; OPIOID ANALGESICS; CHRONIC PAIN; DEATHS	Context Use and abuse of prescription narcotic analgesics have increased dramatically in the United States since 1990. The effect of this pharmacoepidemic has been most pronounced in rural states, including West Virginia, which experienced the nation's largest increase in drug overdose mortality rates during 1999- 2004. Objective To evaluate the risk characteristics of persons dying of unintentional pharmaceutical overdose in West Virginia, the types of drugs involved, and the role of drug abuse in the deaths. Design, Setting, and Participants Population- based, observational study using data from medical examiner, prescription drug monitoring program, and opiate treatment program records. The study population was all state residents who died of unintentional pharmaceutical overdoses in West Virginia in 2006. Main Outcome Measures Rates and rate ratios for selected demographic variables. Prevalence of specific drugs among decedents and proportion that had been prescribed to decedents. Associations between demographics and substance abuse indicators and evidence of pharmaceutical diversion, defined as a death involving a prescription drug without a documented prescription and having received prescriptions for controlled substances from 5 or more clinicians during the year prior to death ( ie, doctor shopping). Results Of 295 decedents, 198 ( 67.1%) were men and 271 ( 91.9%) were aged 18 through 54 years. Pharmaceutical diversion was associated with 186 ( 63.1%) deaths, while 63 ( 21.4%) were accompanied by evidence of doctor shopping. Prevalence of diversion was greatest among decedents aged 18 through 24 years and decreased across each successive age group. Having prescriptions for a controlled substance from 5 or more clinicians in the year prior to death was more common among women (30 [ 30.9%]) and decedents aged 35 through 44 years ( 23 [ 30.7%]) compared with men ( 33 [ 16.7%]) and other age groups ( 40 [ 18.2%]). Substance abuse indicators were identified in 279 decedents ( 94.6%), with nonmedical routes of exposure and illicit contributory drugs particularly prevalent among drug diverters. Multiple contributory substances were implicated in 234 deaths ( 79.3%). Opioid analgesics were taken by 275 decedents (93.2%), of whom only 122 ( 44.4%) had ever been prescribed these drugs. Conclusion The majority of overdose deaths in West Virginia in 2006 were associated with nonmedical use and diversion of pharmaceuticals, primarily opioid analgesics.	[Hall, Aron J.; Logan, Joseph E.; Toblin, Robin L.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Logan, Joseph E.; Toblin, Robin L.; Crosby, Alex E.; Paulozzi, Leonard J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Hall, Aron J.; Bixler, Danae] W Virginia Dept Hlth & Human Resources, Div Surveillance & Dis Control, Charleston, WV USA; [Kaplan, James A.; Kraner, James C.] W Virginia Dept Hlth & Human Resources, Off Chief Med Examiner, Charleston, WV USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hall, AJ (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, 1600 Clifton Rd NE,Mailstop A-47, Atlanta, GA 30333 USA.	ajhall@cdc.gov						[Anonymous], MOD POL US CONTR SUB; BISHAW A, EVALUATION POVERTY E; *CDCP, 2007, CDC WONDER; *CDCP, HLTH US 2006 CHARTB; Drug Abuse Warning Network, 2005, NAT EST DRUG REL EM; *DRUG ENF ADM, 2007, DEA APP REP W VIRG 2; Drug Enforcement Administration Diversion Control Division, STAT PRESCR DRUG MON; Foley K, 2000, JAMA-J AM MED ASSOC, V283, P115, DOI 10.1001/jama.283.1.115; Gilson AM, 2007, CA-CANCER J CLIN, V57, P341, DOI 10.3322/CA.57.6.341; Haddox JD, 1997, CLIN J PAIN, V13, P6; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; *NAT DRUG INT CTR, 2008, 2008R0813001 US DEP; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Substance Abuse and Mental Health Services Administration, DRUG AB WARN NETW DA; Substance Abuse and Mental Health Services Administration, RES 2005 NAT SURV DR; Substance Abuse and Mental Health Services Administration Office of Applied Studies, NSDUH REP PATT TREND; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; Toombs JD, 2005, AM FAM PHYSICIAN, V71, P1353; Trescot Andrea M, 2006, Pain Physician, V9, P1; TURLEY E, DRUG VIOLENT CRIME C; *US BUR CENS, POP AR HOUS UN DENS; *US BUR CENS, 2006 AM COMM SURV; *US BUR CENS, SMALL AR INC POV EST; *US BUR CENS, 2006 ANN STAT POP ES; *US DEP JUST DRUG, ARCOS AUT REP CONS O; Washington State Agency Medical Directors' Group, 2010, INT GUID OP DOS CHRO; Wilson PR, 1997, ANESTHESIOLOGY, V86, P995	29	615	621	1	44	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2613	2620		10.1001/jama.2008.802	http://dx.doi.org/10.1001/jama.2008.802			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066381	Bronze			2022-12-28	WOS:000261503000020
J	Canman, JC; Lewellyn, L; Laband, K; Smerdon, SJ; Desai, A; Bowerman, B; Oegema, K				Canman, Julie C.; Lewellyn, Lindsay; Laband, Kimberley; Smerdon, Stephen J.; Desai, Arshad; Bowerman, Bruce; Oegema, Karen			Inhibition of Rac by the GAP Activity of Centralspindlin Is Essential for Cytokinesis	SCIENCE			English	Article							GTPASE-ACTIVATING PROTEIN; CAENORHABDITIS-ELEGANS; CONTRACTILE RING; GENE-PRODUCT; COMPLEX; RHOA; MGCRACGAP; SPINDLE; ORGANIZATION; REQUIRE	During cytokinesis, the guanosine triphosphatase ( GTPase) RhoA orchestrates contractile ring assembly and constriction. RhoA signaling is controlled by the central spindle, a set of microtubule bundles that forms between the separating chromosomes. Centralspindlin, a protein complex consisting of the kinesin-6 ZEN-4 and the Rho family GTPase activating protein ( GAP) CYK- 4, is required for central spindle assembly and cytokinesis in Caenorhabditis elegans. However, the importance of the CYK- 4 GAP activity and whether it regulates RhoA remain unclear. We found that two separation- of- function mutations in the GAP domain of CYK- 4 lead to cytokinesis defects that mimic centralspindlin loss of function. These defects could be rescued by depletion of the GTPase Rac or its effectors, but not by depletion of RhoA. Thus, inactivation of Rac by centralspindlin functions in parallel with RhoA activation to drive contractile ring constriction during cytokinesis.	[Canman, Julie C.; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Canman, Julie C.; Lewellyn, Lindsay; Laband, Kimberley; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Smerdon, Stephen J.] Natl Inst Med Res, London NW7 1AA, England	University of Oregon; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; MRC National Institute for Medical Research	Canman, JC (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	jcanman@ucsd.edu; koegema@ucsd.edu	Canman, Julie C/A-3875-2016	Canman, Julie C/0000-0001-8135-2072; Laband, Kimberley/0000-0002-8535-2050; Smerdon, Stephen/0000-0001-5688-8465; Lewellyn, Lindsay/0000-0001-6444-5699	Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society; National Institute of General Medical Sciences [T32 GM008666]; National Cancer Institute [T32 CA067754]; Ludwig Institute for Cancer Research; NIH [GM058017]; NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, R01GM049869, T32GM007752, R01GM058017] Funding Source: NIH RePORTER; Medical Research Council [MC_U117584228] Funding Source: researchfish; MRC [MC_U117584228] Funding Source: UKRI	Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all members of the Oegema, Desai, and Bowerman labs; A. Maddox, J. Dumont, and R. Green for reading this manuscript; J. Dumont for making double- stranded RNAs; Y. Kohara for cDNA clones; and the Caenorhabditis Genetics Center for strains. Supported by the Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society (J.C.C.), National Institute of General Medical Sciences grant T32 GM008666 and National Cancer Institute grant T32 CA067754 (L.L.), the Ludwig Institute for Cancer Research (K.O. and A.D.), and NIH grant GM058017 (B.B.).	AHMED S, 1994, J BIOL CHEM, V269, P17642; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kawashima T, 2000, BLOOD, V96, P2116; LUNDQUIST EA, WORMBOOK; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; RAPPAPORT R, 1997, CYTOKINESIS ANIMAL C; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	28	127	142	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1543	1546		10.1126/science.1163086	http://dx.doi.org/10.1126/science.1163086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056985	Green Accepted			2022-12-28	WOS:000261377400049
J	Soh, MC; Croxson, M				Soh, May Ching; Croxson, Michael			Lesson of the Week Fatal thyrotoxic cardiomyopathy in a young man	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; REVERSIBLE CARDIOMYOPATHY; DRUG-THERAPY; HYPERTHYROIDISM; DISEASE; MORTALITY; DEATH		[Croxson, Michael] Greenlane Clin Ctr, Dept Endocrinol, Auckland, New Zealand; [Soh, May Ching] N Shore Hosp, Dept Med, Auckland, New Zealand		Croxson, M (corresponding author), Greenlane Clin Ctr, Dept Endocrinol, Auckland, New Zealand.	MichaelC@adhb.govt.nz	Soh, May Ching/I-1722-2019	Soh, May Ching/0000-0002-7160-7550				Boccalandro Cristina, 2003, Endocr Pract, V9, P140; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; CROXSON MS, 1977, J CLIN ENDOCR METAB, V45, P623, DOI 10.1210/jcem-45-4-623; Franklyn JA, 2005, JAMA-J AM MED ASSOC, V294, P71, DOI 10.1001/jama.294.1.71; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; GROSSMAN A, 1961, PEDIATRICS, V28, P447; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; IKRAM H, 1977, BRIT MED J, V1, P1505, DOI 10.1136/bmj.1.6075.1505; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; KO GTC, 1995, MED J AUSTRALIA, V162, P426, DOI 10.5694/j.1326-5377.1995.tb139974.x; Ngo ASY, 2006, RESUSCITATION, V70, P287, DOI 10.1016/j.resuscitation.2006.01.009; PARKER JLW, 1973, LANCET, V2, P894; SACHS RN, 1993, AM J CARDIOL, V71, P501, DOI 10.1016/0002-9149(93)90491-T; SANDLER G., 1959, QUART JOUR EXPTL PHYSIOL, V44, P282; SHIRANI J, 1993, AM J CARDIOL, V72, P365, DOI 10.1016/0002-9149(93)90691-5; Siu CW, 2007, HEART, V93, P483, DOI 10.1136/hrt.2006.100628; UMPIERREZ GE, 1995, AM J MED SCI, V310, P99	17	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2008	337								a531	10.1136/bmj.a531	http://dx.doi.org/10.1136/bmj.a531			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QD	19042936				2022-12-28	WOS:000261827800002
J	Braun, JS; Bauknecht, HC				Braun, Johann Sebastian; Bauknecht, Hans-Christian			Cancer and incontinence	LANCET			English	Editorial Material									[Braun, Johann Sebastian] United Arab Emirates Univ, Fac Med & Hlth Sci, Div Neurol, Dept Internal Med, Al Ain, U Arab Emirates; [Braun, Johann Sebastian] Charite Univ Med Berlin, Dept Neurol, D-13353 Berlin, Germany; [Bauknecht, Hans-Christian] Charite Univ Med Berlin, Dept Radiol, D-13353 Berlin, Germany	United Arab Emirates University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Braun, JS (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Div Neurol, Dept Internal Med, POB 17666, Al Ain, U Arab Emirates.	johannb@uaeu.ac.ae		Bauknecht, Hans-Christian/0000-0002-3909-9883				Grossman SA, 1999, CANCER TREAT REV, V25, P103, DOI 10.1053/ctrv.1999.0119; SCHUKNECHT B, 1992, EUR NEUROL, V32, P11, DOI 10.1159/000116780; Seute T, 2005, CANCER-AM CANCER SOC, V104, P1700, DOI 10.1002/cncr.21322	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1272	1272		10.1016/S0140-6736(08)61523-8	http://dx.doi.org/10.1016/S0140-6736(08)61523-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19094957				2022-12-28	WOS:000259882000033
J	Colantonio, JR; Vermot, J; Wu, D; Langenbacher, AD; Fraser, S; Chen, JN; Hill, KL				Colantonio, Jessica R.; Vermot, Julien; Wu, David; Langenbacher, Adam D.; Fraser, Scott; Chen, Jau-Nian; Hill, Kent L.			The dynein regulatory complex is required for ciliary motility and otolith biogenesis in the inner ear	NATURE			English	Article							TRYPANOSOMA-BRUCEI; ZEBRAFISH; CHLAMYDOMONAS; PROTEIN; MUTATIONS; GAS11; COMPONENTS; MECHANISM; HOMOLOG; ARMS	In teleosts, proper balance and hearing depend on mechanical sensors in the inner ear. These sensors include actin- based microvilli and microtubule- based cilia that extend from the surface of sensory hair cells and attach to biomineralized 'ear stones' ( or otoliths)(1). Otolith number, size and placement are under strict developmental control, but the mechanisms that ensure otolith assembly atop specific cells of the sensory epithelium are unclear. Here we demonstrate that cilia motility is required for normal otolith assembly and localization. Using in vivo video microscopy, we show that motile tether cilia at opposite poles of the otic vesicle create fluid vortices that attract otolith precursor particles, thereby biasing an otherwise random distribution to direct localized otolith seeding on tether cilia. Independent knockdown of subunits for the dynein regulatory complex and outer- arm dynein disrupt cilia motility, leading to defective otolith biogenesis. These results demonstrate a requirement for the dynein regulatory complex in vertebrates and show that cilia- driven flow is a key epigenetic factor in controlling otolith biomineralization.	[Colantonio, Jessica R.; Hill, Kent L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Langenbacher, Adam D.; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Chen, Jau-Nian; Hill, Kent L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Vermot, Julien; Wu, David; Fraser, Scott] CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California Institute of Technology	Hill, KL (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	kenthill@mednet.ucla.edu	Chen, Jau-Nian/AAM-7808-2020; Vermot, Julien/I-6568-2016; Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; , Julien/0000-0002-8924-732X; Wu, David/0000-0003-3162-3238; Chen, Jau-Nian/0000-0001-8807-3607	Human Frontier Science Program; NIH Medical Scientist Training Program at UCLA/Caltech; NIH RSDA [M07185]; Warsaw Fellowship; NSF; NIH [R01 HL081799, R01AI52348]; Beckman Young Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052348] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); NIH Medical Scientist Training Program at UCLA/Caltech(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH RSDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warsaw Fellowship; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Young Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to R. Crosbie for discussions and encouragement throughout the course of the project. We thank I. Drummond and C. Nguyen for discussions and comments on the work. We are grateful to L. Trinh, O. Bricaud and A. Collazo for sharing reagents and for providing probes, as well as to all the members of the Fraser laboratory for discussions, in particular M. Liebling and W. Supatto for sharing Matlab scripts and comments. We are grateful to Z.P. Kabututu for performing the lrrc50 reverse transcriptase PCR experiments. J.V. was supported by a fellowship from the Human Frontier Science Program, D.W. was supported by the NIH Medical Scientist Training Program at UCLA/ Caltech. J. R. C. was supported by NIH RSDA training grant no. M07185 and a Warsaw Fellowship from the MIMG Department at UCLA. A. D. L is supported by an NSF fellowship. This work was supported by NIH grant R01 HL081799 ( J. C.), NIH grant R01AI52348 and Beckman Young Investigator Award ( K. L. H.).	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bok J, 2007, DEV BIOL, V311, P69, DOI 10.1016/j.ydbio.2007.08.013; Chen JN, 1996, DEVELOPMENT, V122, P3809; Colantonio JR, 2006, TRAFFIC, V7, P538, DOI 10.1111/j.1600-0854.2006.00411.x; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hill KL, 2000, J BIOL CHEM, V275, P39369, DOI 10.1074/jbc.M006907200; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; Mowbray C, 2001, MECH DEVELOP, V108, P179, DOI 10.1016/S0925-4773(01)00479-8; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Shastry Barkur S., 2000, Microbial and Comparative Genomics, V5, P61, DOI 10.1089/10906590050179747; Sollner C., 2004, BIOMINERALIZATION PR, P229; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitmore SA, 1998, GENOMICS, V52, P325, DOI 10.1006/geno.1998.5457; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200	34	93	95	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					205	U102		10.1038/nature07520	http://dx.doi.org/10.1038/nature07520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19043402	Green Accepted			2022-12-28	WOS:000262360200035
J	Baxter, NN; Goldwasser, MA; Paszat, LF; Saskin, R; Urbach, DR; Rabeneck, L				Baxter, Nancy N.; Goldwasser, Meredith A.; Paszat, Lawrence F.; Saskin, Refik; Urbach, David R.; Rabeneck, Linda			Association of Colonoscopy and Death From Colorectal Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							NEGATIVE SCREENING COLONOSCOPY; POPULATION-BASED ANALYSIS; COLON-CANCER; UNITED-STATES; RISK; ENDOSCOPY; PATTERNS; SIGMOIDOSCOPY; SURVEILLANCE; PROTECTION	Background: Colonoscopy is advocated for screening and prevention of colorectal cancer (CRC), but randomized trials supporting the benefit of this practice are not available. Objective: To evaluate the association between colonoscopy and CRC deaths. Design: Population-based, case -control study. Setting: Ontario, Canada. Patients: Persons age 52 to 90 years who received a CRC diagnosis from January 1996 to December 2001 and died of CRC by December 2003. Five controls matched by age, sex, geographic location, and socioeconomic status were randomly selected for each case patient. Measurements: Administrative claims data were used to detect exposure to any colonoscopy and complete colonoscopy (to the cecum) from January 1992 to an index date 6 months before diagnosis in each case patient and the same assigned date in matched controls. Exposures in case patients and controls were compared by using conditional logistic regression to control for comorbid conditions. Secondary analyses were done to see whether associations differed by site of primary CRC, age, or sex. Results: 10 292 case patients and 51 460 controls were identified; 719 case patients (7.0%) and 5031 controls (9.8%) had undergone colonoscopy. Compared with controls, case patients were less likely to have undergone any attempted colonoscopy (adjusted conditional odds ratio [OR], 0.69 [95% CI, 0.63 to 0.74; P < 0.001]) or complete colonoscopy (adjusted conditional OR, 0.63 [CI, 0.57 to 0.69; P < 0.001]). Complete colonoscopy was strongly associated with fewer deaths from left-sided CRC (adjusted conditional OR, 0.33 [CI, 0.28 to 0.39]) but not from right-sided CRC (adjusted conditional OR, 0.99 [CI, 0.86 to 1.14]). Limitation: Screening could not be differentiated from diagnostic procedures. Conclusion: In usual practice, colonoscopy is associated with fewer deaths from CRC. This association is primarily limited to deaths from cancer developing in the left side of the colon.	[Baxter, Nancy N.] Univ Toronto, St Michaels Hosp, Div Gen Surg, Toronto, ON M5B 1W8, Canada; [Goldwasser, Meredith A.; Paszat, Lawrence F.; Saskin, Refik] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Urbach, David R.] Univ Toronto, Toronto, ON M5G 2C4, Canada; [Rabeneck, Linda] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Baxter, NN (corresponding author), Univ Toronto, St Michaels Hosp, Div Gen Surg, 30 Bond St 16CC-40, Toronto, ON M5B 1W8, Canada.	baxtern@smh.toronto.on.ca	Baxter, Nancy N/E-7020-2015	Baxter, Nancy N/0000-0003-4793-4620	Canadian Institutes of Health Research; American Society of Clinical Oncology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Society of Clinical Oncology	Canadian Institutes of Health Research and American Society of Clinical Oncology.	*AM COLL GASTR, COL CANC YOU CAN PRE; American Cancer Society, 2008, CANC FACTS FIG 2008; Azzoni C, 2007, INT J COLORECTAL DIS, V22, P115, DOI 10.1007/s00384-006-0093-x; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Bowles CJA, 2004, GUT, V53, P277, DOI 10.1136/gut.2003.016436; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *COL CANC PREV PRO, 2006, COL CANC SCREEN TIP; Cremers MI, 2006, DIGEST LIVER DIS, V38, P912, DOI 10.1016/j.dld.2006.04.011; Dafnis G, 2000, SCAND J GASTROENTERO, V35, P765, DOI 10.1080/003655200750023462; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Fasoli R, 2002, DIGEST LIVER DIS, V34, P833, DOI 10.1016/S1590-8658(02)80252-3; Gervaz P, 2004, J SURG ONCOL, V88, P261, DOI 10.1002/jso.20156; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Hodgson DC, 2001, JNCI-J NATL CANCER I, V93, P501, DOI 10.1093/jnci/93.7.501; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Lieberman DA, 2000, GASTROENTEROLOGY, V118, P619, DOI 10.1016/S0016-5085(00)70269-1; MORRISON AS, 1982, AM J EPIDEMIOL, V115, P6; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; *NEW YORK CIT DEP, 2005, GET CHECK; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; O'Brien MJ, 2004, CLIN GASTROENTEROL H, V2, P905, DOI 10.1016/S1542-3565(04)00392-1; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Rabeneck L, 2004, AM J GASTROENTEROL, V99, P1141, DOI 10.1111/j.1572-0241.2004.30623.x; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh G, 2007, GASTROENTEROLOGY, V132, pA81; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Singh SM, 2004, CAN MED ASSOC J, V171, P461, DOI 10.1503/cmaj.1031921; Sonnenberg A, 2008, GASTROINTEST ENDOSC, V67, P489, DOI 10.1016/j.gie.2007.08.041; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Taylor C, 2007, CAN J GASTROENTEROL, V21, P805, DOI 10.1155/2007/230420; Vinden CM., 2004, ICES RES ATLAS USE L; Watanabe T, 2006, CANCER RES, V66, P9804, DOI 10.1158/0008-5472.CAN-06-1163	46	988	1006	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					1	W1		10.7326/0003-4819-150-1-200901060-00306	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19075198				2022-12-28	WOS:000262655100001
J	Whittaker, JM; Muller, RD; Roest, WR; Wessel, P; Smith, WHF				Whittaker, Joanne M.; Muller, R. Dietmar; Roest, Walter R.; Wessel, Paul; Smith, Walter H. F.			How supercontinents and superoceans affect seafloor roughness	NATURE			English	Article							AUSTRALIAN-ANTARCTIC DISCORDANCE; MANTLE; GRAVITY; VARIABILITY; SEAMOUNTS; BASALTS; PLUME	Seafloor roughness varies considerably across the world's ocean basins and is fundamental to controlling the circulation and mixing of heat in the ocean(1) and dissipating eddy kinetic energy(2). Models derived from analyses of active mid- ocean ridges suggest that ocean floor roughness depends on seafloor spreading rates(3), with rougher basement forming below a half- spreading rate threshold of 30 - 35 mm yr(-1) ( refs 4, 5), as well as on the local interaction of mid- ocean ridges with mantle plumes or coldspots(6). Here we present a global analysis of marine gravity- derived roughness, sediment thickness, seafloor isochrons and palaeo-spreading rates(7) of Cretaceous to Cenozoic ridge flanks. Our analysis reveals that, after eliminating effects related to spreading rate and sediment thickness, residual roughness anomalies of 5 - 20 m Gal remain over large swaths of ocean floor. We found that the roughness as a function of palaeo- spreading directions and isochron orientations(7) indicates that most of the observed excess roughness is not related to spreading obliquity, as this effect is restricted to relatively rare occurrences of very high obliquity angles (>45 degrees). Cretaceous Atlantic ocean floor, formed over mantle previously overlain by the Pangaea supercontinent, displays anomalously low roughness away from mantle plumes and is independent of spreading rates. We attribute this observation to a sub-Pangaean supercontinental mantle temperature anomaly(8) leading to slightly thicker than normal Late Jurassic and Cretaceous Atlantic crust(9), reduced brittle fracturing and smoother basement relief. In contrast, ocean crust formed above Pacific superswells(10), probably reflecting metasomatized lithosphere underlain by mantle at only slightly elevated temperatures(11), is not associated with basement roughness anomalies. These results highlight a fundamental difference in the nature of large- scale mantle upwellings below supercontinents and superoceans, and their impact on oceanic crustal accretion.	[Whittaker, Joanne M.; Muller, R. Dietmar] Univ Sydney, Earthbyte Grp, Sch Geosci, Sydney, NSW 2006, Australia; [Roest, Walter R.] IFREMER, Ctr Brest, Dept Marine Geosci, F-29280 Plouzane, France; [Wessel, Paul] Univ Hawaii Manoa, Dept Geol & Geophys, SOEST, Honolulu, HI 96822 USA; [Smith, Walter H. F.] NOAA, Silver Spring, MD 20910 USA	University of Sydney; Ifremer; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA	Whittaker, JM (corresponding author), GETECH, Kitson House,Elmete Hall,Elmete Lane, Leeds LS8 2LJ, W Yorkshire, England.	jw@getech.com	Smith, Walter H F/AAM-6681-2020; Müller, Dietmar/L-1200-2019; Whittaker, Joanne M/B-3695-2010; Smith, Walter H.F./F-5627-2010	Smith, Walter H F/0000-0002-8814-015X; Müller, Dietmar/0000-0002-3334-5764; Whittaker, Joanne M/0000-0002-3170-3935; Smith, Walter H.F./0000-0002-8814-015X; Roest, Walter/0000-0002-1071-8732				Abelson M, 1997, EARTH PLANET SC LETT, V148, P405, DOI 10.1016/S0012-821X(97)00054-X; Chen YJ, 2000, GEOL SOC AM SPEC PAP, P161; COFFIN MF, 1994, REV GEOPHYS, V32, P1, DOI 10.1029/93RG02508; Coltice N, 2007, GEOLOGY, V35, P391, DOI 10.1130/G23240A.1; de Alteriis G, 1998, TERRA NOVA, V10, P177, DOI 10.1046/j.1365-3121.1998.00190.x; DIVINS D, 2004, TOTAL SEDIMENT THICK; Finn CA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000723; Gille ST, 2000, GEOPHYS RES LETT, V27, P1251, DOI 10.1029/1999GL007003; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; Klitgord K. D., 1986, GEOLOGY N AM, P351, DOI DOI 10.1130/DNAG-GNA-M.351; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; MALINVERNO A, 1991, NATURE, V352, P58, DOI 10.1038/352058a0; Marks KM, 1999, J GEOPHYS RES-SOL EA, V104, P4967, DOI 10.1029/1998JB900075; McHone JG, 2000, TECTONOPHYSICS, V316, P287, DOI 10.1016/S0040-1951(99)00260-7; McNutt MK, 1998, REV GEOPHYS, V36, P211, DOI 10.1029/98RG00255; Meyzen CM, 2007, NATURE, V447, P1069, DOI 10.1038/natureO5920; Meyzen CM, 2003, NATURE, V421, P731, DOI 10.1038/nature01424; Minshull TA, 1999, GEOPHYS J INT, V136, P286, DOI 10.1046/j.1365-246X.1999.00722.x; Montesi LGJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031067; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; Ritzwoller MH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002522; Sandwell DT, 2005, GEOPHYS J INT, V163, P79, DOI 10.1111/j.1365-246X.2005.02724.x; SMALL C, 1989, J GEOPHYS RES-SOLID, V94, P17383, DOI 10.1029/JB094iB12p17383; Smith WHF, 1998, ANNU REV EARTH PL SC, V26, P697, DOI 10.1146/annurev.earth.26.1.697; SMITH WHF, 1994, J GEOPHYS RES-SOL EA, V99, P21803, DOI 10.1029/94JB00988; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442; Wessel P, 2001, J GEOPHYS RES-SOL EA, V106, P19431, DOI 10.1029/2000JB000083; WEST BP, 1994, EARTH PLANET SC LETT, V128, P135, DOI 10.1016/0012-821X(94)90141-4; Whittaker JM, 2007, SCIENCE, V318, P83, DOI 10.1126/science.1143769	30	23	24	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					938	U73		10.1038/nature07573	http://dx.doi.org/10.1038/nature07573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092932	Green Published			2022-12-28	WOS:000261768300042
J	Ernst, E				Ernst, E.			Frankincense: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BOSWELLIA-SERRATA EXTRACT; DOUBLE-BLIND; OSTEOARTHRITIS; TRIAL; THERAPY; KNEE; EFFICACY; COLITIS; ACIDS; RESIN	Objective To assess evidence from randomised clinical trials about the effectiveness of extracts of Boswellia serrata ( frankincense). Design Systematic review. Data sources Electronic searches on Medline, Embase, Cinahl, Amed, and Cochrane Library. Hand searches of conference proceedings, bibliographies, and departmental files. Review methods All randomised clinical trials of B serrata extract as a treatment for any human medical condition were included and studies of B serrata preparations combined with other ingredients were excluded. Titles and abstracts of all retrieved articles were read and hard copies of all relevant articles were obtained. Selection of studies, data extraction and validation were done by the author. The Jadad score was used to evaluate the methodological quality of all included trials. Results Of 47 potentially relevant studies, seven met all inclusion criteria ( five placebo controlled, two with active controls). The included trials related to asthma, rheumatoid arthritis, Crohn's disease, osteoarthritis, and collagenous colitis. Results of all trials indicated that B serrata extracts were clinically effective. Three studies were of good methodological quality. No serious safety issues were noted. Conclusions The evidence for the effectiveness of B serrata extracts is encouraging but not compelling.	[Ernst, E.] Univ Exeter, Peninsula Med Sch, Exeter EX2 4NT, Devon, England; [Ernst, E.] Univ Plymouth, Exeter EX2 4NT, Devon, England	University of Exeter; University of Plymouth	Ernst, E (corresponding author), Univ Exeter, Peninsula Med Sch, Exeter EX2 4NT, Devon, England.	edzard.ernst@pms.ac.uk						AMMON HP, 2008, PLANTA MED, V72, P1100; BADRIA FA, 2002, ALT COMPL THER   DEC, P341; Chopra A, 2004, JCR-J CLIN RHEUMATOL, V10, P236, DOI 10.1097/01.rhu.0000138087.47382.6d; EMST E, 2007, COMPLEMENTARY THERAP; Ernst E, 2004, POSTGRAD MED J, V80, P249, DOI 10.1136/pgmj.2004.021527; Ernst E, 1997, NATURE, V385, P480, DOI 10.1038/385480c0; Gerhardt H, 2001, Z GASTROENTEROL, V39, P11, DOI 10.1055/s-2001-10708; Gupta I, 1998, Eur J Med Res, V3, P511; Gupta I, 2001, PLANTA MED, V67, P391, DOI 10.1055/s-2001-15802; Gupta I, 1997, Eur J Med Res, V2, P37; HUGHES K, 2007, INCENSE BIBLE; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kimmatkar N, 2003, PHYTOMEDICINE, V10, P3, DOI 10.1078/094471103321648593; Knaus U, 1996, PHYTOMEDICINE, V3, P77, DOI 10.1016/S0944-7113(96)80016-X; KULKARNI RR, 1991, J ETHNOPHARMACOL, V33, P91, DOI 10.1016/0378-8741(91)90167-C; Madisch A, 2007, INT J COLORECTAL DIS, V22, P1445, DOI 10.1007/s00384-007-0364-1; PARDHY RS, 1978, INDIAN J CHEM B, V16, P176; Sander O, 1998, Z RHEUMATOL, V57, P11, DOI 10.1007/s003930050051; Sengupta K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2461; Sontakke S, 2007, INDIAN J PHARMACOL, V39, P27	20	45	51	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2008	337								a2813	10.1136/bmj.a2813	http://dx.doi.org/10.1136/bmj.a2813			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091760	Green Published, hybrid			2022-12-28	WOS:000262185000006
J	Ganly, P; Saleem, M; Marr, H; Burt, M; Florkowski, C; Williamson, A				Ganly, Peter; Saleem, Mohamed; Marr, Helen; Burt, Michael; Florkowski, Christopher; Williamson, Adrienne			Not walking or communicating-is all well?	LANCET			English	Editorial Material							COPPER DEFICIENCY		[Ganly, Peter; Saleem, Mohamed; Marr, Helen; Florkowski, Christopher] Christchurch Hosp, Canterbury Hlth Labs, Christchurch 8140, New Zealand; [Burt, Michael; Williamson, Adrienne] Christchurch Hosp, Dept Med, Christchurch 8140, New Zealand	Canterbury Health Laboratories; Christchurch Hospital New Zealand; Christchurch Hospital New Zealand	Ganly, P (corresponding author), Christchurch Hosp, Canterbury Hlth Labs, POB 151, Christchurch 8140, New Zealand.	peter.ganly@cdhb.govt.nz	Ganly, Peter/B-8355-2008; Florkowski, Christopher/ABF-9504-2020	Ganly, Peter/0000-0003-0335-2063				Abella E, 2002, AM J CLIN PATHOL, V118, P582, DOI 10.1309/2Y7X-YDXK-006B-XLT2; Fong T, 2007, HAEMATOLOGICA, V92, P1429, DOI 10.3324/haematol.11314; Kumar N, 2004, NEUROLOGY, V63, P33, DOI 10.1212/01.WNL.0000132644.52613.FA	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2086	2086		10.1016/S0140-6736(08)61870-X	http://dx.doi.org/10.1016/S0140-6736(08)61870-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19070739				2022-12-28	WOS:000261746900026
J	Griffith, EM; Paytan, A; Caldeira, K; Bullen, TD; Thomas, E				Griffith, Elizabeth M.; Paytan, Adina; Caldeira, Ken; Bullen, Thomas D.; Thomas, Ellen			A Dynamic Marine Calcium Cycle During the Past 28 Million Years	SCIENCE			English	Article							SEAWATER CHEMISTRY; CHEMICAL EVOLUTION; ISOTOPE RECORD; FRACTIONATION; MONITOR	Multiple lines of evidence have shown that the isotopic composition and concentration of calcium in seawater have changed over the past 28 million years. A high- resolution, continuous seawater calcium isotope ratio curve from marine ( pelagic) barite reveals distinct features in the evolution of the seawater calcium isotopic ratio suggesting changes in seawater calcium concentrations. The most pronounced increase in the delta Ca-44/40 value of seawater (of 0.3 per mil) occurred over roughly 4 million years following a period of low values around 13 million years ago. The major change in marine calcium corresponds to a climatic transition and global change in the carbon cycle and suggests a reorganization of the global biogeochemical system.	[Griffith, Elizabeth M.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Griffith, Elizabeth M.; Paytan, Adina] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Bullen, Thomas D.] US Geol Survey, Div Water Resources, Branch Reg Res, Menlo Pk, CA 94025 USA; [Thomas, Ellen] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Thomas, Ellen] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA	Stanford University; University of California System; University of California Santa Cruz; Carnegie Institution for Science; United States Department of the Interior; United States Geological Survey; Yale University; Wesleyan University	Griffith, EM (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Bldg 320,Room 118, Stanford, CA 94305 USA.	egriffith@ucsc.edu	Caldeira, Ken/E-7914-2011; Thomas, Ellen/E-5573-2011	Caldeira, Ken/0000-0002-4591-643X; Griffith, Elizabeth/0000-0002-7919-4551; Thomas, Ellen/0000-0002-7141-9904	NSF CAREER [OCE-0449732]; National Defense Science and Engineering Graduate Fellowship; NSF Graduate Research Fellowship	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Defense Science and Engineering Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF))	Samples provided by the Integrated Ocean Drilling Program. We thank A. Eisenhauer, J. Fitzpatrick, W. A. Griffith, R. Jones, and G. Li for analytical assistance. Supported by NSF CAREER Grant OCE-0449732 (A.P.) and by a National Defense Science and Engineering Graduate Fellowship and an NSF Graduate Research Fellowship (E.M.G.).	Amini M, 2008, GEOCHIM COSMOCHIM AC, V72, P4107, DOI 10.1016/j.gca.2008.05.055; Budyko MI, 1987, HIST EARTHS ATMOSPHE; Conrad CP, 2007, GEOLOGY, V35, P29, DOI 10.1130/G22759A.1; De La Rocha CL, 2000, SCIENCE, V289, P1176, DOI 10.1126/science.289.5482.1176; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Fantle MS, 2005, EARTH PLANET SC LETT, V237, P102, DOI 10.1016/j.epsl.2005.06.024; Farkas J, 2007, GEOCHIM COSMOCHIM AC, V71, P5117, DOI 10.1016/j.gca.2007.09.004; Griffith EM, 2008, GEOCHIM COSMOCHIM AC, V72, P5641, DOI 10.1016/j.gca.2008.08.010; Gussone N, 2005, GEOCHIM COSMOCHIM AC, V69, P4485, DOI 10.1016/j.gca.2005.06.003; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Hathorne EC, 2006, EARTH PLANET SC LETT, V246, P393, DOI 10.1016/j.epsl.2006.04.020; HEUSER A, 2005, PALEOCEANOGRAPHY, V20, DOI DOI 10.1029/2004PA01048; HODELL DA, 1989, EARTH PLANET SC LETT, V92, P165, DOI 10.1016/0012-821X(89)90044-7; Holbourn A, 2005, NATURE, V438, P483, DOI 10.1038/nature04123; Holland HD, 2005, AM J SCI, V305, P220, DOI 10.2475/ajs.305.3.220; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Lyle M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000777; Paytan A, 2004, SCIENCE, V304, P1663, DOI 10.1126/science.1095258; PAYTAN A, 1993, NATURE, V366, P445, DOI 10.1038/366445a0; Ridgwell AJ, 2003, SCIENCE, V302, P859, DOI 10.1126/science.1088342; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Schmitt AD, 2003, EARTH PLANET SC LETT, V213, P503, DOI 10.1016/S0012-821X(03)00341-8; Sime NG, 2007, GEOCHIM COSMOCHIM AC, V71, P3979, DOI 10.1016/j.gca.2007.06.009; Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1; Turchyn AV, 2004, SCIENCE, V303, P2004, DOI 10.1126/science.1092296; Urey H.C., 1952, PLANETS THEIR ORIGIN, DOI [10.1063/1.3067687, DOI 10.1063/1.3067687]; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhu P, 1998, GEOCHIM COSMOCHIM AC, V62, P1691, DOI 10.1016/S0016-7037(98)00110-0	30	70	74	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1671	1674		10.1126/science.1163614	http://dx.doi.org/10.1126/science.1163614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074345				2022-12-28	WOS:000261608300039
J	Robbiani, DF; Bothmer, A; Callen, E; Reina-San-Martin, B; Dorsett, Y; Difilippantonio, S; Bolland, DJ; Chen, HT; Corcoran, AE; Nussenzweig, A; Nussenzweig, MC				Robbiani, Davide F.; Bothmer, Anne; Callen, Elsa; Reina-San-Martin, Bernardo; Dorsett, Yair; Difilippantonio, Simone; Bolland, Daniel J.; Chen, Hua Tang; Corcoran, Anne E.; Nussenzweig, Andre; Nussenzweig, Michel C.			AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations	CELL			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; HEAVY-CHAIN LOCUS; CENTER B-CELLS; SOMATIC HYPERMUTATION; BURKITT-LYMPHOMA; IN-VIVO; ANTIBODY DIVERSIFICATION; MURINE PLASMACYTOMAS	Chromosomal translocation requires formation of paired double-strand DNA breaks (DSBs) on heterologous chromosomes. One of the most well characterized oncogenic translocations juxtaposes c-myc and the immunoglobulin heavy-chain locus (IgH) and is found in Burkitt's lymphomas in humans and plasmacytomas in mice. DNA breaks in IgH leading to c-myc/IgH translocations are created by activation-induced cytidine deaminase ( AID) during antibody class switch recombination or somatic hypermutation. However, the source of DNA breaks at c-myc is not known. Here, we provide evidence for the c-myc promoter region being required in targeting AID-mediated DNA damage to produce DSBs in c-myc that lead to c-myc/IgH translocations in primary B lymphocytes. Thus, in addition to producing somatic mutations and DNA breaks in antibody genes, AID is also responsible for the DNA lesions in oncogenes that are required for their translocation.	[Robbiani, Davide F.; Bothmer, Anne; Reina-San-Martin, Bernardo; Dorsett, Yair; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Callen, Elsa; Difilippantonio, Simone; Chen, Hua Tang; Nussenzweig, Andre] NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA; [Bolland, Daniel J.; Corcoran, Anne E.] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	Bolland, Daniel/AAE-5185-2020; Nussenzweig, Michel/AAE-7292-2019; Reina-San-Martin, Bernardo/I-9484-2016; Robbiani, Davide F./AAF-7662-2019	Bolland, Daniel/0000-0003-3674-9913; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Robbiani, Davide F./0000-0001-7379-3484	NIH; National Cancer Institute; Center for Cancer Research; Leukemia and Lymphoma Society; Howard Hughes Medical Institute Investigator; Biotechnology and Biological Sciences Research Council [BB/F012217/1, BBS/E/B/0000C163] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526] Funding Source: NIH RePORTER; BBSRC [BB/F012217/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute Investigator(Howard Hughes Medical Institute); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	All members of the Nussenzweig lab for discussions. Dr. Barry Stoddard ( Fred Hutchinson Cancer Research Center, Seattle) for suggestions on catalytically inactive I-SceI*. The Rockefeller University Gene Targeting Facility, Klara Velinzon, and Tamara Shengelia for FACSorting, Matthias Muellenbeck and Nancy Wong for technical assistance, and David Bosque and Tom Eisenreich for help in managing the mouse colonies. The work was supported in part by NIH grants to M. C. N. The A. N. lab was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. D. F. R. is a Fellow of the Leukemia and Lymphoma Society, and M. C. N. is a Howard Hughes Medical Institute Investigator.	ADAMS JM, 1982, P NATL ACAD SCI-BIOL, V79, P6966, DOI 10.1073/pnas.79.22.6966; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; BOLES TC, 1987, BIOCHEMISTRY-US, V26, P367, DOI 10.1021/bi00376a006; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; CORY S, 1983, EMBO J, V2, P213, DOI 10.1002/j.1460-2075.1983.tb01407.x; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Egli D, 2004, GENOME RES, V14, P1382, DOI 10.1101/gr.2279804; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jankovic M, 2007, NAT IMMUNOL, V8, P801, DOI 10.1038/ni1498; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reddy MC, 2005, RADIAT RES, V164, P345, DOI 10.1667/RR3419.1; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1	77	324	333	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1028	1038		10.1016/j.cell.2008.09.062	http://dx.doi.org/10.1016/j.cell.2008.09.062			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070574	Green Accepted, Bronze			2022-12-28	WOS:000261642800019
J	Steinbrook, R				Steinbrook, Robert			Physician-Assisted Death - From Oregon to Washington State.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						GANZINI L, 2008, BMJ-BRIT MED J, V337, P973; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; Quill TE, 2007, NEW ENGL J MED, V356, P1911, DOI 10.1056/NEJMp078061; *TASK FORC IMPR CA, OR DEATH DIGN ACT GU	4	21	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2513	2515		10.1056/NEJMp0809394	http://dx.doi.org/10.1056/NEJMp0809394			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	381KG	19073972				2022-12-28	WOS:000261534200001
J	Christakis, NA				Christakis, Nicholas A.			This allergies hysteria is just nuts	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, MA 02138 USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009						0	14	14	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 10	2008	337								a2880	10.1136/bmj.a2880	http://dx.doi.org/10.1136/bmj.a2880			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CA	19073662				2022-12-28	WOS:000262776800007
J	Avierinos, JF; Inamo, J; Grigioni, F; Gersh, B; Shub, C; Enriquez-Sarano, M				Avierinos, Jean-Francois; Inamo, Jocelyn; Grigioni, Francesco; Gersh, Bernard; Shub, Clarence; Enriquez-Sarano, Maurice			Sex Differences in Morphology and Outcomes of Mitral Valve Prolapse	ANNALS OF INTERNAL MEDICINE			English	Article							POPULATION-BASED SAMPLE; TERM-FOLLOW-UP; DOPPLER-ECHOCARDIOGRAPHY; AORTIC REGURGITATION; NATURAL-HISTORY; REFERRAL BIAS; PREVALENCE; DIAGNOSIS; DISEASE; EPIDEMIOLOGY	Background: Mitral valve prolapse is more common in women than in men, but men more often have surgery for severe regurgitation. Objective: To compare morphology and outcomes of mitral valve prolapse in men and women. Design: Retrospective cohort study. Setting: The Mayo Clinic, Rochester, Minnesota. Patients: 4461 women and 3768 men who received a diagnosis of mitral valve prolapse by echocardiography from 1989 to 1998 ( 896 Olmsted County residents and 7333 referred patients). Measurements: Mitral prolapse characteristics ( localization, leaflet thickening or flail, regurgitation), ventricular and atrial characteristics, cardiac surgery, and mortality. Results: Compared with men, women had less posterior prolapse (22% vs. 31%), less flail (2% vs. 8%), more leaflet thickening (32% vs. 28%), and less frequent severe regurgitation (10% vs. 23%) ( P < 0.001 for all comparisons). Regardless of the severity of regurgitation, left ventricular and atrial diameters were smaller in women than in men but were larger in women after normalization to body surface area. Among patients with severe regurgitation, women were less likely than men to undergo cardiac valve surgery (52% vs. 60%; adjusted risk ratio, 0.79 [95% CI, 0.74 to 0.84]). At 15 years, women with no or mild mitral regurgitation had better odds of survival than men (87% vs. 77%; adjusted risk ratio, 0.82 [CI, 0.76 to 0.89]), but those with severe regurgitation had worse survival than men ( 60% vs. 68%; adjusted risk ratio, 1.13 [CI, 1.01 to 1.26]). The survival rate 10 years after surgery was similar in women and men (77% vs. 79%; P = 0.14). Observations in Olmsted County patients and referred patients were similar. Limitation: Diagnoses were based on echocardiography, and clinical data at initial diagnosis, reason for index echocardiography, and cause of all deaths were lacking. Conclusion: Morphology and severity of mitral valve prolapse differ according to sex. Among patients with severe regurgitation, women have higher mortality and lower surgery rates than men.	[Enriquez-Sarano, Maurice] Mayo Clin, Rochester, MN 55905 USA; Hop Enfants La Timone, Marseille, France; Osped Univ Bologna, Bologna, Italy	Mayo Clinic; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Bologna	Enriquez-Sarano, M (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu	Grigioni, Francesco/AAL-3603-2020; INAMO, Jocelyn/AGZ-1674-2022	GRIGIONI, FRANCESCO/0000-0002-4767-7073; Avierinos, Jean Francois/0000-0002-3775-8371	NIAMS NIH HHS [R01 AR030582, R01 AR030582-43] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Devereux R B, 1989, Cardiovasc Clin, V19, P243; Devereux RB, 2001, AM J MED, V111, P679, DOI 10.1016/S0002-9343(01)00981-0; Dujardin KS, 1999, CIRCULATION, V99, P1851, DOI 10.1161/01.CIR.99.14.1851; DUREN DR, 1988, J AM COLL CARDIOL, V11, P42; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; Flack JM, 1999, AM HEART J, V138, P486, DOI 10.1016/S0002-8703(99)70151-1; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; GUTMAN J, 1983, AM J CARDIOL, V51, P336, DOI 10.1016/S0002-9149(83)80061-7; Iung B, 2002, EUR HEART J, V23, P1253, DOI 10.1053/euhj.2002.3320; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Klodas E, 1996, CIRCULATION, V94, P2472, DOI 10.1161/01.CIR.94.10.2472; Kokmen E, 1996, J CLIN EPIDEMIOL, V49, P79, DOI 10.1016/0895-4356(95)00031-3; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; LEVINE RA, 1987, CIRCULATION, V75, P756, DOI 10.1161/01.CIR.75.4.756; LEVY D, 1987, AM HEART J, V113, P1281, DOI 10.1016/0002-8703(87)90956-2; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; MACMAHON SW, 1987, AM J CARDIOL, V59, P105, DOI 10.1016/S0002-9149(87)80080-2; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MELTON LJ, 1985, MAYO CLIN PROC, V60, P880, DOI 10.1016/S0025-6196(12)64794-6; MINTZ GS, 1980, AM J CARDIOL, V45, P253, DOI 10.1016/0002-9149(80)90643-8; Mitts WR, 2004, AM HEART J, V148, P144, DOI 10.1016/j.ahj.2004.01.021; Mohty D, 2001, CIRCULATION, V104, pI1; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; SALIVE ME, 1994, MAYO CLIN PROC, V69, P808, DOI 10.1016/S0025-6196(12)61105-7; Singh RG, 2000, AM J CARDIOL, V85, P193, DOI 10.1016/S0002-9149(99)00645-1; Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400; Trochu JN, 2000, J AM COLL CARDIOL, V35, P1890, DOI 10.1016/S0735-1097(00)00617-3; WISENBAUGH T, 1994, CIRCULATION, V89, P191, DOI 10.1161/01.CIR.89.1.191; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	37	97	100	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					787	W164		10.7326/0003-4819-149-11-200812020-00003	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047025	Green Accepted			2022-12-28	WOS:000261645300002
J	Kaplan, N; Moore, IK; Fondufe-Mittendorf, Y; Gossett, AJ; Tillo, D; Field, Y; LeProust, EM; Hughes, TR; Lieb, JD; Widom, J; Segal, E				Kaplan, Noam; Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Gossett, Andrea J.; Tillo, Desiree; Field, Yair; LeProust, Emily M.; Hughes, Timothy R.; Lieb, Jason D.; Widom, Jonathan; Segal, Eran			The DNA-encoded nucleosome organization of a eukaryotic genome	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HIGH-RESOLUTION; MULTIPLE ALIGNMENT; PROMOTER ELEMENT; YEAST GENOME; SEQUENCE; HISTONE; TRANSCRIPTION; SITES; CORE	Nucleosome organization is critical for gene regulation(1). In living cells this organization is determined by multiple factors, including the action of chromatin remodellers(2), competition with site-specific DNA-binding proteins(3), and the DNA sequence preferences of the nucleosomes themselves(4-8). However, it has been difficult to estimate the relative importance of each of these mechanisms in vivo(7,9-11), because in vivo nucleosome maps reflect the combined action of all influencing factors. Here we determine the importance of nucleosome DNA sequence preferences experimentally by measuring the genome-wide occupancy of nucleosomes assembled on purified yeast genomic DNA. The resulting map, in which nucleosome occupancy is governed only by the intrinsic sequence preferences of nucleosomes, is similar to in vivo nucleosome maps generated in three different growth conditions. In vitro, nucleosome depletion is evident at many transcription factor binding sites and around gene start and end sites, indicating that nucleosome depletion at these sites in vivo is partly encoded in the genome. We confirm these results with a micrococcal nuclease-independent experiment that measures the relative affinity of nucleosomes for similar to 40,000 double-stranded 150-base-pair oligonucleotides. Using our in vitro data, we devise a computational model of nucleosome sequence preferences that is significantly correlated with in vivo nucleosome occupancy in Caenorhabditis elegans. Our results indicate that the intrinsic DNA sequence preferences of nucleosomes have a central role in determining the organization of nucleosomes in vivo.	[Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Widom, Jonathan] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Kaplan, Noam; Field, Yair; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Gossett, Andrea J.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Gossett, Andrea J.; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tillo, Desiree; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [LeProust, Emily M.] Genom LSSU, Agilent Technol Inc, Santa Clara, CA 95051 USA; [Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Hughes, Timothy R.] Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	Northwestern University; Weizmann Institute of Science; Weizmann Institute of Science; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; Agilent Technologies; University of Toronto; University of Toronto	Widom, J (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-widom@northwestern.edu; eran.segal@weizmann.ac.il	Kaplan, Noam/K-4383-2019; Kaplan, Noam/A-3544-2011; Segal, Eran/AAF-4855-2019	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987; Segal, Eran/0000-0002-6859-1164; Gossett, Andrea/0000-0002-9471-3970; Lieb, Jason/0000-0001-7601-8061	CIHR; NIH; European Research Council (ERC); NSERC; Lineberger Comprehensive Cancer Center; University Cancer Research Funds; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054692, R01GM058617, R01GM072518] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Lineberger Comprehensive Cancer Center; University Cancer Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kelkar for bioinformatics support in handling the sequencing files, P. Mieczkowski and J. McPherson for Illumina sequencing ( library preparation and instrument operation), and the members of our respective laboratories for technical assistance, discussions and comments on the manuscript. The UNC sequencing facility is funded by the Lineberger Comprehensive Cancer Center and University Cancer Research Funds. J. W. acknowledges the use of instruments at Northwestern University's Keck Biophysics Facility. This work was supported by a grant from CIHR to T. R. H. and C. Nislow, a grant from the NIH to J. D. L., a grant from the NIH to J. W., and grants from the European Research Council (ERC) and NIH to E. S. D. T. holds an NSERC postgraduate scholarship. N.K. is a Clore scholar. E. S. is the incumbent of the Soretta and Henry Shapiro career development chair.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Bolshoy A, 1996, COMPUT APPL BIOSCI, V12, P383; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Graber JH, 1999, NUCLEIC ACIDS RES, V27, P888, DOI 10.1093/nar/27.3.888; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	37	885	902	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					362	U129		10.1038/nature07667	http://dx.doi.org/10.1038/nature07667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19092803	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000264285600046
J	Zhu, LQ; Gibson, P; Currle, DS; Tong, Y; Richardson, RJ; Bayazitov, IT; Poppleton, H; Zakharenko, S; Ellison, DW; Gilbertson, RJ				Zhu, Liqin; Gibson, Paul; Currle, D. Spencer; Tong, Yiai; Richardson, Robert J.; Bayazitov, Ildar T.; Poppleton, Helen; Zakharenko, Stanislav; Ellison, David W.; Gilbertson, Richard J.			Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation	NATURE			English	Article							HEMATOPOIETIC STEM; PERIVASCULAR NICHE; COLORECTAL-CANCER; TUMOR-GROWTH; MOUSE; IDENTIFICATION; MUTATION; GENE; TUMORIGENESIS; POLYPOSIS	Cancer stem cells are remarkably similar to normal stem cells: both self- renew, are multipotent and express common surface markers, for example, prominin 1 ( PROM1, also called CD133)(1). What remains unclear is whether cancer stem cells are the direct progeny of mutated stem cells or more mature cells that reacquire stem cell properties during tumour formation. Answering this question will require knowledge of whether normal stem cells are susceptible to cancer- causing mutations; however, this has proved difficult to test because the identity of most adult tissue stem cells is not known. Here, using an inducible Cre, nuclear LacZ reporter allele knocked into the Prom1 locus (Prom1(C-L)), we show that Prom1 is expressed in a variety of developing and adult tissues. Lineage- tracing studies of adult Prom1(+/C-L) mice containing the Rosa26-YFP reporter allele showed that Prom1(+) cells are located at the base of crypts in the small intestine, co- express Lgr5 ( ref. 2), generate the entire intestinal epithelium, and are therefore the small intestinal stem cell. Prom1 was reported recently to mark cancer stem cells of human intestinal tumours that arise frequently as a consequence of aberrant wingless ( Wnt) signalling(3-5). Activation of endogenous Wnt signalling in Prom1(+/C-L) mice containing a Cre- dependent mutant allele of beta-catenin (Ctnnb1(lox(ex3))) resulted in a gross disruption of crypt architecture and a disproportionate expansion of Prom1(+) cells at the crypt base. Lineage tracing demonstrated that the progeny of these cells replaced the mucosa of the entire small intestine with neoplastic tissue that was characterized by focal high- grade intraepithelial neoplasia and crypt adenoma formation. Although all neoplastic cells arose from Prom1(+) cells in these mice, only 7% of tumour cells retained Prom1 expression. Our data indicate that Prom1 marks stem cells in the adult small intestine that are susceptible to transformation into tumours retaining a fraction of mutant Prom1(+) tumour cells.	[Zhu, Liqin; Gibson, Paul; Currle, D. Spencer; Tong, Yiai; Richardson, Robert J.; Bayazitov, Ildar T.; Poppleton, Helen; Zakharenko, Stanislav; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Ellison, David W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gilbertson, RJ (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Richard.Gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021; Zakharenko, Stanislav/D-3287-2013; Ellison, David/N-4806-2018	Gilbertson, Richard James/0000-0001-7539-9472; Zakharenko, Stanislav/0000-0001-8115-202X; 	National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA129541, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	R.J.G. holds the Sydney Schlobohm Leadership Chair of Research from the Brain Tumor Society and the Howard C. Schott Research Chair from the Malia's Cord Foundation, and is supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765), the Collaborative Ependymoma Research Network (CERN) and by the American Lebanese Syrian Associated Charities (ALSAC). We are grateful to the staff of the ARC for technical assistance.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SHMELKOV SV, 2008, J CLIN INVEST, V22, P22; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sparks AB, 1998, CANCER RES, V58, P1130; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318	30	493	518	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					603	U114		10.1038/nature07589	http://dx.doi.org/10.1038/nature07589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19092805	Green Accepted			2022-12-28	WOS:000262852200046
J	Kitchener, H; Swart, AMC; Qian, W; Amos, C; Parmar, MKB				Kitchener, H.; Swart, A. M. C.; Qian, W.; Amos, C.; Parmar, M. K. B.		ASTEC Study Grp	Efficacy of systematic pelvic endometrial cancer (MRC ASTEC trial): a randomised study	LANCET			English	Article							STAGE-I; LYMPHADENECTOMY; CARCINOMA; SURVIVAL; ADENOCARCINOMA	Background Hysterectomy and bilateral salpingo-oophorectomy (BSO) is the standard surgery for stage I endometrial cancer. Systematic pelvic lymphadenectomy has been used to establish whether there is extra-uterine disease and as a therapeutic procedure; however, randomised trials need to be done to assess therapeutic efficacy. The ASTEC surgical trial investigated whether pelvic lymphadenectomy could improve survival of women with endometrial cancer. Methods From 85 centres in four countries, 1408 women with histologically proven endometrial carcinoma thought preoperatively to be confined to the corpus were randomly allocated by a minimisation method to standard surgery (hysterectomy and BSO, peritoneal washings, and palpation of para-aortic nodes; n=704) or standard surgery plus lymphadenectomy (n=704). The primary outcome measure was overall survival. To control for postsurgical treatment, women with early-stage disease at intermediate or high risk of recurrence were randomised (independent of lymph-node status) into the ASTEC radiotherapy trial. Analysis was by intention to treat. This study is registered, number ISRCTN 1.6571884. Findings After a median follow-up of 37 months (IQR 24-58), 191 women (88 standard surgery group, 103 lymphadenectomy group) had died, with a hazard ratio (HR) of 1.16 (95% Cl 0.87-1.54; p=0.31) in favour of standard surgery and an absolute difference in 5-year overall survival of 1% (95% Cl -4 to 6). 251 women died or had recurrent disease (1.07 standard surgery group, 144 lymphadenectomy group), with an HR of 1.35 (1.06-1.73; p=0.017) in favour of standard surgery and an absolute difference in 5-year recurrence-free survival of 6% (1-12). With adjustment for baseline characteristics and pathology details, the HR for overall survival was 1 . 04 (0.74-1.45; p=0 . 83) and for recurrence-free survival was 1. 25 (0.93-1.66; p=0.14). Interpretation Our results show no evidence of benefit in terms of overall or recurrence-free survival for pelvic lymphadenectonny in women with early endometrial cancer. Pelvic lymphadenectomy cannot be recommended as routine procedure for therapeutic purposes outside of clinical trials. Funding Medical Research Council and National Cancer Research Network.	[Swart, A. M. C.; Qian, W.; Amos, C.; Parmar, M. K. B.] MRC, Clin Trials Unit, Canc Grp, London NW1 2DA, England; [Swart, A. M. C.] UCL, Ctr Clin Pharmacol, London, England; [Kitchener, H.] Univ Manchester, Sch Canc & Imaging Sci, Manchester, Lancs, England	Medical Research Council Clinical Trials Unit; University of London; University College London; University of Manchester	Swart, AMC (corresponding author), MRC, Clin Trials Unit, Canc Grp, 222 Euston Rd, London NW1 2DA, England.	ams@ctu.mrc.ac.uk	de Barros Lopes, Alberto/B-2116-2018	de Barros Lopes, Alberto/0000-0002-8796-3891; Ind, Thomas/0000-0001-5260-199X; Klimek, Malgorzata/0000-0002-6515-7557	MRC CTU; Medical Research Council [MC_U122861379] Funding Source: researchfish; MRC [MC_U122861379] Funding Source: UKRI	MRC CTU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the women who participated in this trial; the research staff at the clinical centres who helped to recruit women and provide data; and Babak Oskooei for providing statistical input into preliminary analyses. The trial was funded by the MRC through core funding to the MRC CTU.	*AM CANC SOC, 2006, CANC FACTS FIG 2008; *ASTEC EN 5 WRIT C, ADJ EXT BEAM RAD TRE; BORONOW RC, 1984, OBSTET GYNECOL, V63, P825; Boyle P, 2003, INT J GYNECOL OBSTET, V83, P179, DOI 10.1016/S0020-7292(03)90121-4; Cancer Research UK, CANCERSTATS CORP UT; Chan JK, 2006, CANCER, V107, P1823, DOI 10.1002/cncr.22185; Cragun JM, 2005, J CLIN ONCOL, V23, P3668, DOI 10.1200/JCO.2005.04.144; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Fanning J, 2001, GYNECOL ONCOL, V82, P371, DOI 10.1006/gyno.2001.6276; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; KILGORE LC, 1995, GYNECOL ONCOL, V56, P29, DOI 10.1006/gyno.1995.1005; Kong A, 2007, ANN ONCOL, V18, P1595, DOI 10.1093/annonc/mdm066; Lefebvre C, 2001, SYSTEMATIC REV HLTH, P69; Lutman CV, 2006, GYNECOL ONCOL, V102, P92, DOI 10.1016/j.ygyno.2005.11.032; Mohan DS, 1998, GYNECOL ONCOL, V70, P165, DOI 10.1006/gyno.1998.5098; MORROW CP, 1991, GYNECOL ONCOL, V40, P55, DOI 10.1016/0090-8258(91)90086-K; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Sant M, 2003, ANN ONCOL, V14, pV61, DOI 10.1093/annonc/mdg754; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Trimble EL, 1998, GYNECOL ONCOL, V71, P340, DOI 10.1006/gyno.1998.5254; WELLS M, 2001, MINIMUM DATASET HIST	21	1295	1337	2	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					125	136		10.1016/S0140-6736(08)61766-3	http://dx.doi.org/10.1016/S0140-6736(08)61766-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19070889	Green Published			2022-12-28	WOS:000262340900027
J	Bottiger, BW; Arntz, H; Chamberlain, DA; Bluhmki, E; Belmans, A; Danays, T; Carli, PA; Adgey, JA; Bode, C; Wenzel, V				Bottiger, Bernd W.; Arntz, Hans-Richard; Chamberlain, Douglas A.; Bluhmki, Erich; Belmans, Ann; Danays, Thierry; Carli, Pierre A.; Adgey, Jennifer A.; Bode, Christoph; Wenzel, Volker		TROICA Trial Investigators; European Resuscitation Council Stu	Thrombolysis during Resuscitation for Out-of-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	28th Congress of the European-Society-of-Cardiology/World Congress of Cardiology	SEP 02-06, 2006	Barcelona, SPAIN	European Soc Cardiol, World Heart Federat			TISSUE-PLASMINOGEN ACTIVATOR; CHEST COMPRESSION DEVICE; CARDIOPULMONARY-RESUSCITATION; TERM SURVIVAL; TENECTEPLASE; EPINEPHRINE; THERAPY; SAFETY; REPERFUSION; ADHESION	Background: Approximately 70% of persons who have an out-of-hospital cardiac arrest have underlying acute myocardial infarction or pulmonary embolism. Therefore, thrombolysis during cardiopulmonary resuscitation may improve survival. Methods: In a double-blind, multicenter trial, we randomly assigned adult patients with witnessed out-of-hospital cardiac arrest to receive tenecteplase or placebo during cardiopulmonary resuscitation. Adjunctive heparin or aspirin was not used. The primary end point was 30-day survival; the secondary end points were hospital admission, return of spontaneous circulation, 24-hour survival, survival to hospital discharge, and neurologic outcome. Results: After blinded review of data from the first 443 patients, the data and safety monitoring board recommended discontinuation of enrollment of asystolic patients because of low survival, and the protocol was amended. Subsequently, the trial was terminated prematurely for futility after enrolling a total of 1050 patients. Tenecteplase was administered to 525 patients and placebo to 525 patients; the two treatment groups had similar clinical profiles. We did not detect any significant differences between tenecteplase and placebo in the primary end point of 30-day survival (14.7% vs. 17.0%; P=0.36; relative risk, 0.87; 95% confidence interval, 0.65 to 1.15) or in the secondary end points of hospital admission (53.5% vs. 55.0%, P=0.67), return of spontaneous circulation (55.0% vs. 54.6%, P=0.96), 24-hour survival (30.6% vs. 33.3%, P=0.39), survival to hospital discharge (15.1% vs. 17.5%, P=0.33), or neurologic outcome (P=0.69). There were more intracranial hemorrhages in the tenecteplase group. Conclusions: When tenecteplase was used without adjunctive antithrombotic therapy during advanced life support for out-of-hospital cardiac arrest, we did not detect an improvement in outcome, in comparison with placebo. (ClinicalTrials.gov number, NCT00157261.).	[Bottiger, Bernd W.] Univ Cologne, Dept Anesthesiol & Postoperat Intens Care Med, D-50937 Cologne, Germany; [Bottiger, Bernd W.] Heidelberg Univ, Heidelberg, Germany; [Arntz, Hans-Richard] Benjamin Franklin Med Ctr, Charite, Berlin, Germany; [Chamberlain, Douglas A.] Cardiff Univ, Prehosp Emergency Res Unit, Sch Med, Cardiff, Wales; [Bluhmki, Erich] Boehringer Ingelheim KG, Biberach, Germany; [Belmans, Ann] Katholieke Univ Leuven, Ctr Biostat, Louvain, Belgium; [Danays, Thierry] Boehringer Ingelheim KG, Reims, France; [Carli, Pierre A.] Hop Necker Enfants Malad, Serv Aide Med Urgence Paris, Paris, France; [Adgey, Jennifer A.] Royal Victoria Hosp, Reg Med Cardiol Ctr, Belfast BT12 6BA, Antrim, North Ireland; [Bode, Christoph] Univ Freiburg, Freiburg, Germany; [Wenzel, Volker] Innsbruck Med Univ, Innsbruck, Austria	University of Cologne; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cardiff University; Boehringer Ingelheim; KU Leuven; Boehringer Ingelheim; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; Medical University of Innsbruck	Bottiger, BW (corresponding author), Univ Cologne, Dept Anesthesiol & Postoperat Intens Care Med, Kerpener Str 62, D-50937 Cologne, Germany.	bernd.boettiger@uk-koeln.de	Hachimi Idrissi, Said/I-6422-2018; Blobner, Manfred/R-4411-2017; Roessler, Markus Soeren/I-7834-2013; Pesenti, Antonio/H-7483-2012	Hachimi Idrissi, Said/0000-0002-8455-1410; Blobner, Manfred/0000-0002-0370-5247; Pesenti, Antonio/0000-0003-2593-729X; Breckwoldt, Jan/0000-0003-1716-1970; Valentin, Andreas/0000-0001-7443-3595; tazarourte, karim/0000-0002-3376-1258; Rosell-Ortiz, Fernando/0000-0003-0260-9955; Genzwuerker, Harald/0000-0002-5495-629X				AbuLaban RB, 2003, NEW ENGL J MED, V349, P1487; Afshar-Kharghan V, 2006, CURR OPIN HEMATOL, V13, P34, DOI 10.1097/01.moh.0000190107.54790.de; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Arntz HR, 2008, RESUSCITATION, V76, P180, DOI 10.1016/j.resuscitation.2007.07.012; BOTTIGER BW, 1995, CIRCULATION, V92, P2572, DOI 10.1161/01.CIR.92.9.2572; Bottiger BW, 2002, CRIT CARE MED, V30, P2473, DOI 10.1097/01.CCM.0000034689.78033.E2; Bottiger BW, 2001, LANCET, V357, P1583, DOI 10.1016/S0140-6736(00)04726-7; Bottiger BW, 1996, ACTA ANAESTH SCAND, V40, P631; Bozeman WP, 2006, RESUSCITATION, V69, P399, DOI 10.1016/j.resuscitation.2005.09.027; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Fatovich DM, 2004, RESUSCITATION, V61, P309, DOI 10.1016/j.resuscitation.2004.01.016; Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, 1994, LANCET, V343, P311; Fischer M, 1996, INTENS CARE MED, V22, P1214; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; Gueugniaud PY, 1998, NEW ENGL J MED, V339, P1595, DOI 10.1056/NEJM199811263392204; Gurbel PA, 2005, BLOOD COAGUL FIBRIN, V16, P1, DOI 10.1097/00001721-200501000-00001; Hallstrom A, 2006, JAMA-J AM MED ASSOC, V295, P2620, DOI 10.1001/jama.295.22.2620; Hoke RS, 2004, RESUSCITATION, V63, P327, DOI 10.1016/j.resuscitation.2004.05.019; Human Milk Banking Association of North America, 1995, GUID GOOD CLIN PRACT, P1; *INT CONS SCI, 2000, CIRCULATION S1, V102, P1; Janata K, 2003, RESUSCITATION, V57, P49, DOI 10.1016/S0300-9572(02)00430-6; Langhelle A, 2003, RESUSCITATION, V56, P247, DOI 10.1016/S0300-9572(02)00409-4; Lederer W, 2004, RESUSCITATION, V61, P123, DOI 10.1016/j.resuscitation.2003.12.016; Lederer W, 2001, RESUSCITATION, V50, P71, DOI 10.1016/S0300-9572(01)00317-3; Li X, 2006, RESUSCITATION, V70, P31, DOI 10.1016/j.resuscitation.2005.11.016; Nolan J, 2005, RESUSCITATION, V64, P5, DOI 10.1016/S0300-9572(04)00468-X; Ong MEH, 2006, JAMA-J AM MED ASSOC, V295, P2629, DOI 10.1001/jama.295.22.2629; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; SILFVAST T, 1991, J INTERN MED, V229, P331, DOI 10.1111/j.1365-2796.1991.tb00355.x; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Spohr F, 2005, EUR J CLIN INVEST, V35, P315, DOI 10.1111/j.1365-2362.2005.01491.x; Spohr F, 2003, DRUG SAFETY, V26, P367; STIELL IG, 1992, NEW ENGL J MED, V327, P1045, DOI 10.1056/NEJM199210083271502; Van de Werf F, 2001, EUR HEART J, V22, P2253, DOI 10.1053/euhj.2001.2686; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; 2005, CIRCULATION S4, V112, P1	37	242	265	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2651	2662		10.1056/NEJMoa070570	http://dx.doi.org/10.1056/NEJMoa070570			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	384PS	19092151	Bronze			2022-12-28	WOS:000261757300005
J	Christianson, AD; Goremychkin, EA; Osborn, R; Rosenkranz, S; Lumsden, MD; Malliakas, CD; Todorov, IS; Claus, H; Chung, DY; Kanatzidis, MG; Bewley, RI; Guidi, T				Christianson, A. D.; Goremychkin, E. A.; Osborn, R.; Rosenkranz, S.; Lumsden, M. D.; Malliakas, C. D.; Todorov, I. S.; Claus, H.; Chung, D. Y.; Kanatzidis, M. G.; Bewley, R. I.; Guidi, T.			Unconventional superconductivity in Ba0.6K0.4Fe2As2 from inelastic neutron scattering	NATURE			English	Article							MAGNETIC EXCITATIONS; LAO1-XFXFEAS	A new family of superconductors containing layers of iron arsenide(1-3) has attracted considerable interest because of their high transition temperatures (T-c), some of which are > 50 K, and because of similarities with the high-T-c copper oxide superconductors. In both the iron arsenides and the copper oxides, superconductivity arises when an antiferromagnetically ordered phase has been suppressed by chemical doping(4). A universal feature of the copper oxide superconductors is the existence of a resonant magnetic excitation, localized in both energy and wavevector, within the superconducting phase(5-9). This resonance, which has also been observed in several heavy- fermion superconductors(10-12), is predicted to occur when the sign of the superconducting energy gap takes opposite values on different parts of the Fermi surface(13), an unusual gap symmetry which implies that the electron pairing interaction is repulsive at short range(14). Angle- resolved photoelectron spectroscopy shows no evidence of gap anisotropy in the iron arsenides, but such measurements are insensitive to the phase of the gap on separate parts of the Fermi surface(15). Here we report inelastic neutron scattering observations of a magnetic resonance below T-c in Ba0.6K0.4Fe2As2, a phase- sensitive measurement demonstrating that the superconducting energy gap has unconventional symmetry in the iron arsenide superconductors.	[Goremychkin, E. A.; Osborn, R.; Rosenkranz, S.; Malliakas, C. D.; Todorov, I. S.; Claus, H.; Chung, D. Y.; Kanatzidis, M. G.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Christianson, A. D.; Lumsden, M. D.] Oak Ridge Natl Lab, Neutron Scattering Sci Div, Oak Ridge, TN 37831 USA; [Goremychkin, E. A.; Bewley, R. I.; Guidi, T.] Rutherford Appleton Lab, ISIS Pulsed Neutron & Muon Facil, Didcot OX11 0QX, Oxon, England; [Malliakas, C. D.; Kanatzidis, M. G.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Northwestern University	Osborn, R (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	rosborn@anl.gov	Instrument, Merlin/AAB-5400-2020; Osborn, Raymond/E-8676-2011; christianson, andrew D/A-3277-2016; Spectrometer, Merlin/AAC-8401-2020; Guidi, Tatiana/H-6280-2011; Lumsden, Mark/F-5366-2012; Goremychkin, Eugene/L-8413-2017; Rosenkranz, Stephan/E-4672-2011	Osborn, Raymond/0000-0001-9565-3140; christianson, andrew D/0000-0003-3369-5884; Guidi, Tatiana/0000-0001-9320-2960; Lumsden, Mark/0000-0002-5472-9660; Goremychkin, Eugene/0000-0003-0856-3951; Rosenkranz, Stephan/0000-0002-5659-0383; Chung, Duck Young/0000-0002-1315-2631	Division of Materials Sciences; Engineering Division; Scientific User Facilities Division of the Office of Basic Energy Sciences; US Department of Energy Office of Science.	Division of Materials Sciences(United States Department of Energy (DOE)); Engineering Division; Scientific User Facilities Division of the Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy Office of Science.(United States Department of Energy (DOE))	We acknowledge discussions with M. Norman and C. Stock. This work was supported by the Division of Materials Sciences and Engineering Division and the Scientific User Facilities Division of the Office of Basic Energy Sciences, US Department of Energy Office of Science.	Bewley RI, 2006, PHYSICA B, V385-86, P1029, DOI 10.1016/j.physb.2006.05.328; Chang J, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024503; Dai PC, 2000, NATURE, V406, P965, DOI 10.1038/35023094; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Ding H, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/47001; Fong HF, 1999, NATURE, V398, P588, DOI 10.1038/19255; He H, 2002, SCIENCE, V295, P1045, DOI 10.1126/science.1067877; HUANG Q, 2008, MAGNETIC ORDER BAFE2; Hufner S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/6/062501; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Korshunov MM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.140509; Liu C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.177005; Maier TA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020514; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; MOOK HA, 1993, PHYS REV LETT, V70, P3490, DOI 10.1103/PhysRevLett.70.3490; Park T, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/32/322204; Ren ZA, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/17002; ROSSATMIGNOD J, 1991, PHYSICA C, V185, P86, DOI 10.1016/0921-4534(91)91955-4; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Sasmal K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107007; Sato NK, 2001, NATURE, V410, P340, DOI 10.1038/35066519; Stock C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.087001; Stockert O, 2008, PHYSICA B, V403, P973, DOI 10.1016/j.physb.2007.10.110; YANG L, 2008, BAND STRUCTURE ELECT	25	511	516	6	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					930	932		10.1038/nature07625	http://dx.doi.org/10.1038/nature07625			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092931	Green Submitted, Green Published			2022-12-28	WOS:000261768300040
J	Richerson, PJ; Boyd, R				Richerson, Peter J.; Boyd, Robert			Being human: Migration: An engine for social change	NATURE			English	Editorial Material									[Richerson, Peter J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Boyd, Robert] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA	University of California System; University of California Davis; University of California System; University of California Los Angeles	Richerson, PJ (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.	pjricherson@ucdavis.edu; rboyd@anthro.ucla.edu							0	13	15	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					877	877		10.1038/456877a	http://dx.doi.org/10.1038/456877a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	384TY	19092915	Bronze			2022-12-28	WOS:000261768300021
J	Wang, YL; Juranek, S; Li, HT; Sheng, G; Tuschl, T; Patel, DJ				Wang, Yanli; Juranek, Stefan; Li, Haitao; Sheng, Gang; Tuschl, Thomas; Patel, Dinshaw J.			Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex	NATURE			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; RISC; SIRNAS; SLICER; INTERFERENCE; CLEAVAGE; INSIGHTS; DISEASE	Here we report on a 3.0 angstrom crystal structure of a ternary complex of wild- type Thermus thermophilus argonaute bound to a 5 '- phosphorylated 21- nucleotide guide DNA and a 20- nucleotide target RNA containing cleavage- preventing mismatches at the 10 - 11 step. The seed segment ( positions 2 to 8) adopts an A- helical- like Watson - Crick paired duplex, with both ends of the guide strand anchored in the complex. An arginine, inserted between guide- strand bases 10 and 11 in the binary complex, locking it in an inactive conformation, is released on ternary complex formation. The nucleic- acid- binding channel between the PAZ- and PIWI- containing lobes of argonaute widens on formation of a more open ternary complex. The relationship of structure to function was established by determining cleavage activity of ternary complexes containing position- dependent base mismatch, bulge and 2 '- O- methyl modifications. Consistent with the geometry of the ternary complex, bulges residing in the seed segments of the target, but not the guide strand, were better accommodated and their complexes were catalytically active.	[Wang, Yanli; Li, Haitao; Sheng, Gang; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Juranek, Stefan; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	ttuschl@mail.rockefeller.edu; pateld@mskcc.org	wang, yanli/G-3306-2010; Li, Haitao/B-2668-2012	Li, Haitao/0000-0001-6741-293X; Wang, Yanli/0000-0002-5969-1745	National Institutes of Health; Starr Foundation; US Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by funds from the National Institutes of Health and the Starr Foundation to D.J.P. and T.T. We would like to thank the staff of NE-CAT beam line at the Advanced Photon Source, Argonne National Laboratory, supported by the US Department of Energy, for assistance with data collection.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	41	412	441	8	85	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					921	U72		10.1038/nature07666	http://dx.doi.org/10.1038/nature07666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092929	Green Accepted			2022-12-28	WOS:000261768300038
J	Anderson, DJ				Anderson, Deborah J.			Coca-Cola douches and contraception	BRITISH MEDICAL JOURNAL			English	Editorial Material							SPERMATOZOA; INFECTION		[Anderson, Deborah J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Anderson, Deborah J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Boston University; Harvard University; Harvard Medical School	Anderson, DJ (corresponding author), Boston Univ, Sch Med, 670 Albany St,Suite 516, Boston, MA 02118 USA.	Deborah.Anderson@BMC.org		Anderson, Deborah/0000-0002-2848-7290	NIAID NIH HHS [R56 AI071909] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1966, FUGS; Ayehunie S, 2006, TOXICOL IN VITRO, V20, P689, DOI 10.1016/j.tiv.2005.10.002; Cooper TG, 2006, FERTIL STERIL, V85, P220, DOI 10.1016/j.fertnstert.2005.07.1286; Douglas RJ, 2007, BMJ-BRIT MED J, V335, P1281, DOI 10.1136/bmj.39419.449942.AD; HONG CY, 1987, HUM TOXICOL, V6, P395, DOI 10.1177/096032718700600508; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Ness RB, 2005, AM J EPIDEMIOL, V161, P186, DOI 10.1093/aje/kwi025; NWOHA PU, 1992, CONTRACEPTION, V46, P537, DOI 10.1016/0010-7824(92)90118-D; Tanne JH, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1992; TIETZE C, 1959, AM J OBSTET GYNECOL, V78, P650, DOI 10.1016/0002-9378(59)90541-1; Trussell J, 1999, FAM PLANN PERSPECT, V31, P64, DOI 10.2307/2991641; UMPIERRE SA, 1985, NEW ENGL J MED, V313, P1351; Zhang J, 1997, AM J PUBLIC HEALTH, V87, P1207, DOI 10.2105/AJPH.87.7.1207	13	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2008	337								a2873	10.1136/bmj.a2873	http://dx.doi.org/10.1136/bmj.a2873			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091763				2022-12-28	WOS:000262185000009
J	Leeflang, MMG; Deeks, JJ; Gatsonis, C; Bossuyt, PMM				Leeflang, Mariska M. G.; Deeks, Jonathan J.; Gatsonis, Constantine; Bossuyt, Patrick M. M.		Cochrane Diagnostic Test Accuracy	Systematic Reviews of Diagnostic Test Accuracy	ANNALS OF INTERNAL MEDICINE			English	Review							MATRIX PROTEIN 22; TRANSITIONAL-CELL CARCINOMA; OPTIMAL SEARCH STRATEGIES; VOIDED URINE CYTOLOGY; BTA STAT TEST; BLADDER-CANCER; PUBLICATION BIAS; METAANALYSIS; SPECIFICITY; SENSITIVITY	More and more systematic reviews of diagnostic test accuracy studies are being published, but they can be methodologically challenging. In this paper, the authors present some of the recent developments in the methodology for conducting systematic reviews of diagnostic test accuracy studies. Restrictive electronic search filters are discouraged, as is the use of summary quality scores. Methods for meta-analysis should take into account the paired nature of the estimates and their dependence on threshold. Authors of these reviews are advised to use the hierarchical summary receiver-operating characteristic or the bivariate model for the data analysis. Challenges that remain are the poor reporting of original diagnostic test accuracy studies and difficulties with the interpretation of the results of diagnostic test accuracy research.	[Deeks, Jonathan J.] Univ Birmingham, Sch Hlth & Populat Sci, Unit Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Leeflang, Mariska M. G.; Bossuyt, Patrick M. M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Dutch Cochrane Ctr, Amsterdam, Netherlands; Univ Birmingham, Unit Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA	University of Birmingham; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Birmingham; Brown University	Deeks, JJ (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Unit Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England.	j.deeks@bham.ac.uk	Deeks, Jon/AAV-5745-2020; Bossuyt, Patrick M/AAR-1183-2021; Craig, Jonathan/E-2813-2013; Bossuyt, Patrick M./B-4557-2016; Rutjes, Anne/L-8750-2017; D'Amico, Roberto/I-8106-2014; Leeflang, Mariska/AAF-8199-2019; Vlassov, Valentin/F-4720-2013	Deeks, Jon/0000-0002-8850-1971; Bossuyt, Patrick M/0000-0003-4427-0128; Craig, Jonathan/0000-0002-2548-4035; Bossuyt, Patrick M./0000-0003-4427-0128; Rutjes, Anne/0000-0001-9782-779X; D'Amico, Roberto/0000-0002-3211-6687; Leeflang, Mariska/0000-0001-5960-0471; Mallett, Sue/0000-0002-0596-8200; Whiting, Penny/0000-0003-1138-5682; Takwoingi, Yemisi/0000-0002-5828-9746; Moore, Theresa/0000-0003-3719-6361; Vlassov, Valentin/0000-0003-2845-2992; Watine, Joseph/0000-0002-7881-0594; Sterne, Jonathan/0000-0001-8496-6053	UK National Institute for Health Research [RNC/018/0003]; National Cancer Institute [2U01CA079778]; Cochrane Collaboration; NATIONAL CANCER INSTITUTE [U01CA079778] Funding Source: NIH RePORTER	UK National Institute for Health Research(National Institute for Health Research (NIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cochrane Collaboration; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the UK National Institute for Health Research (grant RNC/018/0003), the National Cancer Institute (grant 2U01CA079778), and the Cochrane Collaboration.	Abbate I, 1998, ANTICANCER RES, V18, P3803; Arends LR, 2008, MED DECIS MAKING, V28, P621, DOI 10.1177/0272989X08319957; Bachmann LM, 2006, BRIT MED J, V332, P1127, DOI 10.1136/bmj.38793.637789.2F; Bachmann LM, 2002, J AM MED INFORM ASSN, V9, P653, DOI 10.1197/jamia.M1124; Bossuyt PMM, 2008, SEMIN HEMATOL, V45, P189, DOI 10.1053/j.seminhematol.2008.04.001; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Casella R, 2000, J UROLOGY, V164, P1926, DOI 10.1016/S0022-5347(05)66920-0; Chahal R, 2001, EUR UROL, V40, P415, DOI 10.1159/000049809; *COCHR COLL, 2008, COCHR MAN; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DEEKS JJ, 2009, COCHRANE HD IN PRESS; Deville WLJM, 2000, J CLIN EPIDEMIOL, V53, P65, DOI 10.1016/S0895-4356(99)00144-4; Doust JA, 2005, J CLIN EPIDEMIOL, V58, P444, DOI 10.1016/j.jclinepi.2004.09.011; Dukic V, 2003, BIOMETRICS, V59, P936, DOI 10.1111/j.0006-341X.2003.00108.x; Ewald B, 2006, J CLIN EPIDEMIOL, V59, P798, DOI 10.1016/j.jclinepi.2005.11.025; Gatsonis C, 2006, AM J ROENTGENOL, V187, P271, DOI 10.2214/AJR.06.0226; Giannopoulos A, 2001, J UROLOGY, V166, P470, DOI 10.1016/S0022-5347(05)65965-4; Glas AS, 2003, J UROLOGY, V169, P1975, DOI 10.1097/01.ju.0000067461.30468.6d; Glasziou PP, 2001, DECISION MAKING HLTH; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Haynes RB, 2004, BMJ-BRIT MED J, V328, P1040, DOI 10.1136/bmj.38068.557998.EE; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Khan KS, 2005, BEST PRACT RES CL OB, V19, P37, DOI 10.1016/j.bpobgyn.2004.10.012; Khan KS, 2001, EUR J OBSTET GYN R B, V95, P6, DOI 10.1016/S0301-2115(00)00463-2; KNOTTNERUS JA, 2002, BMJ BOOKS; Lahme S, 2001, UROL INT, V66, P72, DOI 10.1159/000056574; Landman J, 1998, UROLOGY, V52, P398, DOI 10.1016/S0090-4295(98)00219-2; Lee KH, 2001, YONSEI MED J, V42, P14, DOI 10.3349/ymj.2001.42.1.14; Leeflang M, 2007, CLIN CHEM, V53, P164, DOI 10.1373/clinchem.2006.076398; Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032; Leeflang MMG, 2006, J CLIN EPIDEMIOL, V59, P234, DOI 10.1016/j.jclinepi.2005.07.014; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Lokeshwar VB, 2006, UROL ONCOL-SEMIN ORI, V24, P528, DOI 10.1016/j.urolonc.2006.07.003; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Macaskill P, 2004, J CLIN EPIDEMIOL, V57, P925, DOI 10.1016/j.jclinepi.2003.12.019; Miyanaga N, 1999, INT J UROL, V6, P173, DOI 10.1046/j.1442-2042.1999.06437.x; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Oge Omer, 2001, International Urology and Nephrology, V32, P367, DOI 10.1023/A:1017509418440; Paoluzzi M, 1999, Arch Ital Urol Androl, V71, P13; Puhan MA, 2005, ANN INTERN MED, V143, P184, DOI 10.7326/0003-4819-143-3-200508020-00004; Ramakumar S, 1999, J UROLOGY, V161, P388, DOI 10.1016/S0022-5347(01)61899-8; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sharma S, 1999, J UROLOGY, V162, P53, DOI 10.1097/00005392-199907000-00014; Smidt N, 2005, RADIOLOGY, V235, P347, DOI 10.1148/radiol.2352040507; Smidt N, 2006, NEUROLOGY, V67, P792, DOI 10.1212/01.wnl.0000238386.41398.30; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Sozen S, 1999, EUR UROL, V36, P225, DOI 10.1159/000068002; Stengel D, 2003, J MED SCREEN, V10, P47, DOI 10.1258/096914103321610806; Steurer J, 2002, BRIT MED J, V324, P824, DOI 10.1136/bmj.324.7341.824; THORNBURY JR, 1994, AM J ROENTGENOL, V162, P1; Whiting P, 2006, BMJ-BRIT MED J, V332, P875, DOI 10.1136/bmj.38771.583796.7C; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-20; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082; Zippe C, 1999, J UROLOGY, V161, P62, DOI 10.1016/S0022-5347(01)62063-9; Zwinderman AH, 2008, STAT MED, V27, P687, DOI 10.1002/sim.2992	65	876	893	2	47	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					889	+		10.7326/0003-4819-149-12-200812160-00008	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075208	Green Accepted			2022-12-28	WOS:000261771900006
J	Foex, BA				Foex, Bernard A.			Back to the future: emergency departments and ancient Greek warfare	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Foex, Bernard A.] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England	University of Manchester	Foex, BA (corresponding author), Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, Lancs, England.	Bernard.foex@cmmc.nhs.uk						Department of Health, 2008, NHS NEXT STAG REV OU; 1973, AGE ALEXANDER, P384	2	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 15	2008	337								a2761	10.1136/bmj.a2761	http://dx.doi.org/10.1136/bmj.a2761			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	390SS	19074940				2022-12-28	WOS:000262184600011
J	Maksymovych, P; Sorescu, DC; Jordan, KD; Yates, JT				Maksymovych, Peter; Sorescu, Dan C.; Jordan, Kenneth D.; Yates, John T., Jr.			Collective Reactivity of Molecular Chains Self-Assembled on a Surface	SCIENCE			English	Article							METAL INTERFACES; ELECTRON; PHOTOCHEMISTRY; SPECTROSCOPY; DYNAMICS; AU(111); ATOMS	Self- assembly of molecules on surfaces is a route toward not only creating structures, but also engineering chemical reactivity afforded by the intermolecular interactions. Dimethyldisulfide (CH(3)SSCH(3)) molecules self- assemble into linear chains on single- crystal gold surfaces. Injecting low- energy electrons into individual molecules in the self- assembled structures with the tip of a scanning tunneling microscope led to a propagating chemical reaction along the molecular chain as sulfur- sulfur bonds were broken and then reformed to produce new CH(3)SSCH(3) molecules. Theoretical and experimental evidence supports a mechanism involving electron attachment followed by dissociation of a CH(3)SSCH(3) molecule and initiation of a chain reaction by one or both of the resulting CH(3)S intermediates.	[Maksymovych, Peter; Jordan, Kenneth D.; Yates, John T., Jr.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Maksymovych, Peter; Jordan, Kenneth D.; Yates, John T., Jr.] Univ Pittsburgh, Ctr Mol & Mat Simulat, Pittsburgh, PA 15260 USA; [Maksymovych, Peter] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Sorescu, Dan C.] US DOE, Natl Energy Technol Lab, Pittsburgh, PA 15236 USA; [Yates, John T., Jr.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; United States Department of Energy (DOE); National Energy Technology Laboratory - USA; University of Virginia	Yates, JT (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	johnt@virginia.edu	Maksymovych, Petro/C-3922-2016	Maksymovych, Petro/0000-0003-0822-8459	W.M. Keck Foundation; Army Research Office; NSF [CHE0518253]	W.M. Keck Foundation(W.M. Keck Foundation); Army Research Office; NSF(National Science Foundation (NSF))	We thank D. B. Dougherty for fruitful discussions. P. M. and J.T.Y were supported by the W.M. Keck Foundation and the Army Research Office, and K.D.J acknowledges support from NSF through grant CHE0518253. A grant of computer time at the Pittsburgh Supercomputer Center is gratefully acknowledged. P.M. performed part of this research as a Eugene P. Wigner Fellow and staff member at the Oak Ridge National Laboratory, managed by UT-Battelle, for the U. S. Department of Energy under contract DE-AC05-00OR22725.	Akai-Kasaya M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.255501; Bartels L, 1998, PHYS REV LETT, V80, P2004, DOI 10.1103/PhysRevLett.80.2004; Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166; CARLSON DD, 1973, CAN J CHEM, V51, P1410, DOI 10.1139/v73-211; Franke KJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036807; Giorgi JB, 2000, J CHEM PHYS, V113, P807, DOI 10.1063/1.481856; Harikumar KR, 2006, J AM CHEM SOC, V128, P16791, DOI 10.1021/ja062874c; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; Ho W, 2002, J CHEM PHYS, V117, P11033, DOI 10.1063/1.1521153; Lindstrom CD, 2006, CHEM REV, V106, P4281, DOI 10.1021/cr0501689; Maksymovych P, 2006, J PHYS CHEM B, V110, P21161, DOI 10.1021/jp0625964; Maksymovych P, 2006, J AM CHEM SOC, V128, P10642, DOI 10.1021/ja062006f; Maksymovych P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.016101; Nilius N, 2002, SCIENCE, V297, P1853, DOI 10.1126/science.1075242; Okawa Y, 2001, NATURE, V409, P683, DOI 10.1038/35055625; Pennec Y, 2007, NAT NANOTECHNOL, V2, P99, DOI 10.1038/nnano.2006.212; POLANYI M, 1932, ATOMIC REACTIONS; Sainoo Y, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.246102; Scifo L, 2006, NANO LETT, V6, P1711, DOI 10.1021/nl061018w; Temirov R, 2006, NATURE, V444, P350, DOI 10.1038/nature05270; Tripa CE, 1999, NATURE, V398, P591, DOI 10.1038/19260; Ueba H, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2007631; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Yates JT, 2006, CHEM REV, V106, P4113, DOI 10.1021/cr040180l; Zhu XY, 2004, SURF SCI REP, V56, P1, DOI 10.1016/j.surfrep.2004.09.002	25	74	74	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1664	1667		10.1126/science.1165291	http://dx.doi.org/10.1126/science.1165291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074343				2022-12-28	WOS:000261608300037
J	Macdonald, S; Brown, K; Wyatt, M				Macdonald, S.; Brown, K.; Wyatt, M.			A case of life threatening postpartum haemorrhage	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ARTERIAL EMBOLIZATION; OBSTETRIC HEMORRHAGE; MANAGEMENT		[Macdonald, S.; Brown, K.; Wyatt, M.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust	Wyatt, M (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	mike.wyatt@nuth.nhs.uk		Wyatt, Michael G/0000-0002-9144-4437				BLynch C, 1997, BRIT J OBSTET GYNAEC, V104, P372, DOI 10.1111/j.1471-0528.1997.tb11471.x; BURCHELL R C, 1968, Journal of Obstetrics and Gynaecology of the British Commonwealth, V75, P642; BURKE G, 1991, PROGR OBSTET GYNAECO, V9, P111; Chan C, 1997, INT J GYNECOL OBSTET, V58, P251, DOI 10.1016/S0020-7292(97)00090-8; Chitrit Y, 2000, AM J OBSTET GYNECOL, V182, P727, DOI 10.1067/mob.2000.101533; Doumouchtsis SK, 2007, OBSTET GYNECOL SURV, V62, P540, DOI 10.1097/01.ogx.0000271137.81361.93; Drife J, 1997, BRIT J OBSTET GYNAEC, V104, P275, DOI 10.1111/j.1471-0528.1997.tb11453.x; Hansch E, 1999, AM J OBSTET GYNECOL, V180, P1454, DOI 10.1016/S0002-9378(99)70036-0; *HEALTHC COMM, 2006, INV 10 MAT DEATHS FO; Pelage JP, 1998, RADIOLOGY, V208, P359, DOI 10.1148/radiology.208.2.9680559; Royal College of Obstetricians and Gynaecologists, 2007, ROL EM EL INT RAD PO; STILL DK, 1999, HIGH RISK PREGNANCY, P1231; STONES RW, 1993, EUR J OBSTET GYN R B, V48, P15, DOI 10.1016/0028-2243(93)90047-G; World Health Organization, 1989, PREV MAN POSTP HAEM	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2008	337								a2425	10.1136/bmj.a2425	http://dx.doi.org/10.1136/bmj.a2425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NW	19052063				2022-12-28	WOS:000261890900012
J	Guay, J				Guay, Joanne			The GALA trial: answers it gives, answers it does not	LANCET			English	Editorial Material							CERVICAL PLEXUS BLOCK; CAROTID-ENDARTERECTOMY; DEEP; ANESTHESIA; SURGERY		[Guay, Joanne] Univ Montreal, Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada	Universite de Montreal	Guay, J (corresponding author), Univ Montreal, Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada.	joanne.quay@umontreal.ca						Armitage PBG, 2002, ANAL MEANS PROPORTIO, P83; de Sousa AA, 2005, SURG NEUROL, V63, P22, DOI 10.1016/j.surneu.2004.09.011; *GALA TRIAL COLL G, 2008, LANCET          1127, DOI DOI 10.1016/S0140-6736(08)61699-2; Guay J, 2007, J CARDIOTHOR VASC AN, V21, P127, DOI 10.1053/j.jvca.2006.07.022; Guay J, 2008, CURR OPIN ANESTHESIO, V21, P638, DOI 10.1097/ACO.0b013e328308bb70; Hobson RW, 2008, J VASC SURG, V48, P480, DOI 10.1016/j.jvs.2008.05.036; Luebke T, 2007, EUR J VASC ENDOVASC, V34, P470, DOI 10.1016/j.ejvs.2007.06.001; McGlade DP, 1996, J CARDIOTHOR VASC AN, V10, P593, DOI 10.1016/S1053-0770(96)80135-2; Pandit JJ, 2007, BRIT J ANAESTH, V99, P159, DOI 10.1093/bja/aem160; Pandit JJ, 2000, ANESTH ANALG, V91, P781, DOI 10.1097/00000539-200010000-00004; Stoneham MD, 1998, ANESTHESIOLOGY, V89, P907, DOI 10.1097/00000542-199810000-00015; Takolander R, 1990, Eur J Vasc Surg, V4, P265, DOI 10.1016/S0950-821X(05)80205-1	12	21	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2008	372	9656					2092	2093		10.1016/S0140-6736(08)61700-6	http://dx.doi.org/10.1016/S0140-6736(08)61700-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19041129				2022-12-28	WOS:000261894000006
J	Alley, RB; Horgan, HJ; Joughin, I; Cuffey, KM; Dupont, TK; Parizek, BR; Anandakrishnan, S; Bassis, J				Alley, Richard B.; Horgan, Huw J.; Joughin, Ian; Cuffey, Kurt M.; Dupont, Todd K.; Parizek, Byron R.; Anandakrishnan, Sridhar; Bassis, Jeremy			A Simple Law for Ice-Shelf Calving	SCIENCE			English	Article									[Alley, Richard B.; Horgan, Huw J.; Anandakrishnan, Sridhar] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Joughin, Ian] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Cuffey, Kurt M.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [Dupont, Todd K.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Parizek, Byron R.] Penn State Dubois, Du Bois, PA 15801 USA; [Bassis, Jeremy] Scripps Inst Oceanog, La Jolla, CA 92037 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Alley, RB (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	rba6@psu.edu	Joughin, Ian R/A-2998-2008; Bassis, Jeremy N/J-1706-2012; Horgan, Huw/I-5847-2019; Joughin, Ian/AAR-7778-2021; Bassis, Jeremy/ABB-8628-2021	Joughin, Ian R/0000-0001-6229-679X; Bassis, Jeremy N/0000-0003-2946-7176; Horgan, Huw/0000-0002-4836-0078; Joughin, Ian/0000-0001-6229-679X; Bassis, Jeremy/0000-0003-2946-7176	NSF [0424589, 0440899, 0531211, 0758274, 0809106]; NASA [NRA04OES02]; Gary Comer Science and Education Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Gary Comer Science and Education Foundation	Partial funding was provided by NSF ( including grants 0424589, 0440899, 0531211, 0758274, and 0809106), NASA NRA04OES02, and the Gary Comer Science and Education Foundation. We thank two anonymous reviewers.	Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; DUPONT TK, 2008, 14 ANN W ANT IC SHEE; MEIER MF, 1990, SEA LEVEL CHANGE, P171	3	76	77	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1344	1344		10.1126/science.1162543	http://dx.doi.org/10.1126/science.1162543			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039129				2022-12-28	WOS:000261170600028
J	Brovkin, V; Claussen, M				Brovkin, Victor; Claussen, Martin			Comment on "Climate-Driven Ecosystem Succession in the Sahara: The Past 6000 Years"	SCIENCE			English	Editorial Material							ARABIAN PENINSULA; NORTHERN AFRICA; ABRUPT CHANGE; MIDHOLOCENE; VEGETATION; REGION	Kropelin et al. ( Research Articles, 9 May 2008, p. 765) interpreted a sediment record from Lake Yoa in the east- central part of North Africa as support for a weak biogeophysical climate- vegetation feedback in the Sahara during the mid- Holocene. We argue that the new data do not invalidate earlier modeling results on strong land- atmosphere coupling in the Western Sahara for which the Lake Yoa record is far less representative.	[Brovkin, Victor; Claussen, Martin] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Claussen, Martin] Univ Hamburg, Inst Meteorol, D-20146 Hamburg, Germany	Max Planck Society; University of Hamburg	Brovkin, V (corresponding author), Max Planck Inst Meteorol, Bundesstr 55, D-20146 Hamburg, Germany.	victor.brovkin@zmaw.de	Brovkin, Victor/C-2803-2016; Brovkin, Victor/I-7450-2012	Brovkin, Victor/0000-0001-6420-3198; 				Brovkin V, 1998, J GEOPHYS RES-ATMOS, V103, P31613, DOI 10.1029/1998JD200006; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Claussen M, 1997, CLIM DYNAM, V13, P247, DOI 10.1007/s003820050164; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Claussen M, 1997, GLOBAL ECOL BIOGEOGR, V6, P369, DOI 10.2307/2997337; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Jolly D, 1998, J BIOGEOGR, V25, P1007, DOI 10.1046/j.1365-2699.1998.00238.x; Knorr W, 2001, GEOPHYS RES LETT, V28, P3489, DOI 10.1029/2001GL013283; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Liu Z, 2007, QUATERNARY SCI REV, V26, P1818, DOI 10.1016/j.quascirev.2007.03.002; Pachur HJ, 2000, J AFR EARTH SCI, V30, P929, DOI 10.1016/S0899-5362(00)00061-0; Renssen H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016155; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Tsvetsinskaya EA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014096	14	32	32	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906								10.1126/science.1163381	http://dx.doi.org/10.1126/science.1163381			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039121				2022-12-28	WOS:000261170600016
J	Honjoh, S; Yamamoto, T; Uno, M; Nishida, E				Honjoh, Sakiko; Yamamoto, Takuya; Uno, Masaharu; Nishida, Eisuke			Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C-elegans	NATURE			English	Article							LIFE-SPAN EXTENSION; RESTRICTION-INDUCED LONGEVITY; MESSENGER-RNA TRANSLATION; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; TOR; DAF-16; DEPRIVATION; INHIBITION; RESISTANCE	Dietary restriction is the most effective and reproducible intervention to extend lifespan in divergent species(1). In mammals, two regimens of dietary restriction, intermittent fasting ( IF) and chronic caloric restriction, have proven to extend lifespan and reduce the incidence of age- related disorders(2). An important characteristic of IF is that it can increase lifespan even when there is little or no overall decrease in calorie intake(2). The molecular mechanisms underlying IF- induced longevity, however, remain largely unknown. Here we establish an IF regimen that effectively extends the lifespan of Caenorhabditis elegans, and show that the low molecular weight GTPase RHEB- 1 has a dual role in lifespan regulation; RHEB- 1 is required for the IF- induced longevity, whereas inhibition of RHEB- 1 mimics the caloric- restriction effects. RHEB- 1 exerts its effects in part by the insulin/ insulin growth factor ( IGF)- like signalling effector DAF- 16 in IF. Our analyses demonstrate that most fasting- induced upregulated genes require RHEB- 1 function for their induction, and that RHEB- 1 and TOR signalling are required for the fasting- induced downregulation of an insulin- like peptide, INS- 7. These findings identify the essential role of signalling by RHEB- 1 in IF- induced longevity and gene expression changes, and suggest a molecular link between the IF- induced longevity and the insulin/ IGF- like signalling pathway.	[Honjoh, Sakiko; Yamamoto, Takuya; Uno, Masaharu; Nishida, Eisuke] Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	L50174@sakura.kudpc.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947; Uno, Masaharu/0000-0001-7770-3941	Ministry of Education, Culture, Sports, Science and Technology of Japan; NIH National Center for Research Resources	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank members of our laboratory for technical comments and helpful discussion. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E.N.). Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRENNER S, 1974, GENETICS, V77, P71; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Malone EA, 1996, GENETICS, V143, P1193; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Weinkove D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-1	33	171	179	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					726	U6		10.1038/nature07583	http://dx.doi.org/10.1038/nature07583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079239				2022-12-28	WOS:000263064700042
J	Barker, N; Ridgway, RA; van Es, JH; van de Wetering, M; Begthel, H; van den Born, M; Danenberg, E; Clarke, AR; Sansom, OJ; Clevers, H				Barker, Nick; Ridgway, Rachel A.; van Es, Johan H.; van de Wetering, Marc; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; Clarke, Alan R.; Sansom, Owen J.; Clevers, Hans			Crypt stem cells as the cells-of-origin of intestinal cancer	NATURE			English	Article							MOUSE SMALL INTESTINE; BETA-CATENIN; COLORECTAL-CANCER; PANETH CELLS; IN-VIVO; GENE; APC; DIFFERENTIATION; EPITHELIUM; COLON	Intestinal cancer is initiated by Wnt- pathway- activating mutations in genes such as adenomatous polyposis coli ( APC). As in most cancers, the cell of origin has remained elusive. In a previously established Lgr5 ( leucine- rich- repeat containing G- protein-coupled receptor 5) knockin mouse model, a tamoxifen- inducible Cre recombinase is expressed in long- lived intestinal stem cells(1). Here we show that deletion of Apc in these stem cells leads to their transformation within days. Transformed stem cells remain located at crypt bottoms, while fuelling a growing microadenoma. These microadenomas show unimpeded growth and develop into macroscopic adenomas within 3-5 weeks. The distribution of Lgr5(+) cells within stem- cell- derived adenomas indicates that a stem cell/ progenitor cell hierarchy is maintained in early neoplastic lesions. When Apc is deleted in short- lived transit- amplifying cells using a different cre mouse, the growth of the induced microadenomas rapidly stalls. Even after 30 weeks, large adenomas are very rare in these mice. We conclude that stem- cell- specific loss of Apc results in progressively growing neoplasia.	[Barker, Nick; van Es, Johan H.; van de Wetering, Marc; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Ridgway, Rachel A.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Clarke, Alan R.] Cardiff Sch Biosci, Cardiff CF10 3US, Wales	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Beatson Institute; Cardiff University	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@niob.knaw.nl	clarke, alan r/P-2820-2014; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011; Barker, Nick/AAE-9833-2021; van+Es, Johan/ABD-5411-2021; Clarke, Alan R/A-6256-2008	Barker, Nick/0000-0003-3566-4475; Danenberg, Esther/0000-0002-1799-4457; Clarke, Alan/0000-0002-4281-426X; Sansom, Owen J./0000-0001-9540-3010	Cancer Research UK; KWF program [PF-HUBR-2007-3956]; MRC [G0301154] Funding Source: UKRI; Medical Research Council [G0301154] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); KWF program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Cozijnsen, J. Korving, C. Nixon, M. Macdonald and B. Doyle for technical help. O.J.S. is funded by Cancer Research UK. N. B. and H. C. are supported by KWF program grant PF-HUBR-2007-3956.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P65, DOI 10.1002/aja.1001600106; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; POTTEN CS, 1975, B CANCER, V62, P419; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039	30	1526	1569	6	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					608	U119		10.1038/nature07602	http://dx.doi.org/10.1038/nature07602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19092804				2022-12-28	WOS:000262852200047
J	Elde, NC; Child, SJ; Geballe, AP; Malik, HS				Elde, Nels C.; Child, Stephanie J.; Geballe, Adam P.; Malik, Harmit S.			Protein kinase R reveals an evolutionary model for defeating viral mimicry	NATURE			English	Article							POSITIVE SELECTION; SUBSTRATE RECOGNITION; MOLECULAR MIMICRY; ANTIVIRAL PROTEIN; CRYSTAL-STRUCTURE; PKR; YEAST; BACTERIAL; RNA; K3L	Distinguishing self from non- self is a fundamental biological challenge. Many pathogens exploit the challenge of self discrimination by employing mimicry to subvert key cellular processes including the cell cycle, apoptosis and cytoskeletal dynamics(1-5). Other mimics interfere with immunity(6,7). Poxviruses encode K3L, a mimic of eIF2 alpha, which is the substrate of protein kinase R ( PKR), an important component of innate immunity in vertebrates(8,9). The PKR - K3L interaction exemplifies the conundrum imposed by viral mimicry. To be effective, PKR must recognize a conserved substrate (eIF2 alpha) while avoiding rapidly evolving substrate mimics such as K3L. Using the PKR - K3L system and a combination of phylogenetic and functional analyses, we uncover evolutionary strategies by which host proteins can overcome mimicry. We find that PKR has evolved under intense episodes of positive selection in primates. The ability of PKR to evade viral mimics is partly due to positive selection at sites most intimately involved in eIF2 alpha recognition. We also find that adaptive changes on multiple surfaces of PKR produce combinations of substitutions that increase the odds of defeating mimicry. Thus, although it can seem that pathogens gain insurmountable advantages by mimicking cellular components, host factors such as PKR can compete in molecular 'arms races' with mimics because of evolutionary flexibility at protein interaction interfaces challenged by mimicry.	[Elde, Nels C.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Child, Stephanie J.; Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Geballe, Adam P.] Univ Washington, Dept Med, Seattle, WA 98115 USA; [Geballe, Adam P.] Univ Washington, Dept Microbiol, Seattle, WA 98115 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; Child, Stephanie/0000-0002-1987-9540	NIH [AI026672]; Searle Scholar; Burroughs Wellcome Investigator Award; Ellison Medical Foundation Fellow of the Life Sciences Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026672, R29AI026672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar; Burroughs Wellcome Investigator Award(Burroughs Wellcome Fund); Ellison Medical Foundation Fellow of the Life Sciences Research Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Dever for yeast strains and advice; J. Tartaglia and B. Jacobs for valuable reagents; and S. Biggins and S. Furuyama for yeast expression plasmids and advice, and M. Emerman, S. Henikoff, S. Biggins, A. Turkewitz, D. Gottschling, D. Koshland, E. Smith, J. Kerns, S. Sawyer and D. Vermaak for comments and suggestions. We are supported by NIH grant AI026672 (A.P.G.) and a Searle Scholar and Burroughs Wellcome Investigator Award (H.S.M.). N.C.E. is an Ellison Medical Foundation Fellow of the Life Sciences Research Foundation.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Babkin IV, 2006, MOL BIOL+, V40, P20; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DeLano WL, 2004, PYMOL USERS MANUAL; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Earl PL, 2001, CURR PROTOCOLS PROTE, DOI [10.1002/0471140864.ps0512s13, DOI 10.1002/0471140864.PS0512S13]; Essbauer S, 2001, VIRUS GENES, V23, P347, DOI 10.1023/A:1012533625571; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Sawyer SL, 2006, P NATL ACAD SCI USA, V103, P17614, DOI 10.1073/pnas.0605468103; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; TARTAGLIA J, 1992, AIDS RES HUM RETROV, V8, P1445, DOI 10.1089/aid.1992.8.1445; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	172	176	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					485	U8		10.1038/nature07529	http://dx.doi.org/10.1038/nature07529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19043403	Green Accepted			2022-12-28	WOS:000262519200048
J	Clay, NK; Adio, AM; Denoux, C; Jander, G; Ausubel, FM				Clay, Nicole K.; Adio, Adewale M.; Denoux, Carine; Jander, Georg; Ausubel, Frederick M.			Glucosinolate Metabolites Required for an Arabidopsis Innate Immune Response	SCIENCE			English	Article							GLUTATHIONE-DEFICIENT MUTANT; METAL-BINDING PEPTIDES; NONHOST RESISTANCE; DISEASE RESISTANCE; ABC TRANSPORTER; ABSCISIC-ACID; ETHYLENE; THALIANA; DEFENSE; IDENTIFICATION	The perception of pathogen or microbe- associated molecular pattern molecules by plants triggers a basal defense response analogous to animal innate immunity and is defined partly by the deposition of the glucan polymer callose at the cell wall at the site of pathogen contact. Transcriptional and metabolic profiling in Arabidopsis mutants, coupled with the monitoring of pathogen- triggered callose deposition, have identified major roles in pathogen response for the plant hormone ethylene and the secondary metabolite 4- methoxy- indol- 3- ylmethylglucosinolate. Two genes, PEN2 and PEN3, are also necessary for resistance to pathogens and are required for both callose deposition and glucosinolate activation, suggesting that the pathogen- triggered callose response is required for resistance to microbial pathogens. Our study shows that well-studied plant metabolites, previously identified as important in avoiding damage by herbivores, are also required as a component of the plant defense response against microbial pathogens.	[Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Adio, Adewale M.; Jander, Georg] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Cornell University; Boyce Thompson Institute for Plant Research	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Massachusetts Gen Hosp, Boston, MA 02114 USA.	ausubel@molbio.mgh.harvard.edu	Bruening, Stefan/B-8505-2011; Jander, Georg/E-7101-2012		NIH National Research Service Award-Kirschstein Postdoctoral Fellowship [R37-GM48707]; NSF [IOS-0718733, DBI-0500550, MCB-0519898]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI066817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707] Funding Source: NIH RePORTER	NIH National Research Service Award-Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Abel for ugt74B1-2; J.L. Celenza for atr1-3, atr4-1/cyp83B1, cyp79B2 cyp79B3, and trp3-1; C.S. Cobbett for cad1-3/pcs1 and cad2-1/gsh1; P.L. Conklin for vtc1-1 and vtc2-1; R. Blum for pcs1-1, pcs2-1, and pcs1-1 pcs2-1; S. C. Somerville for pcs1-2; and Arabidopsis Biological Resource Center for insertion lines. Ph. D. stipend support to N.K.C. comes from NIH National Research Service Award-Kirschstein Postdoctoral Fellowship. Support to A.M.A. and G.J. comes from NSF grants IOS-0718733 and DBI-0500550. Support to F.M.A. comes from NSF grant MCB-0519898 and NIH grant R37-GM48707.	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Cazale AC, 2001, FEBS LETT, V507, P215, DOI 10.1016/S0014-5793(01)02976-3; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Conklin PL, 2000, GENETICS, V154, P847; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; HOWDEN R, 1992, PLANT PHYSIOL, V100, P100, DOI 10.1104/pp.100.1.100; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Pedras MSC, 2007, CHEM COMMUN, P368, DOI 10.1039/b615424g; Radwanski ER, 1996, MOL GEN GENET, V253, P353; Rea PA, 1998, ANNU REV PLANT PHYS, V49, P727, DOI 10.1146/annurev.arplant.49.1.727; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; SONGNUAN W, 2008, BIOL PLANT MICROBE I, V6; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; 2007, PLOS GENET, V3, P1687	59	764	801	10	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					95	101		10.1126/science.1164627	http://dx.doi.org/10.1126/science.1164627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19095898	Green Accepted			2022-12-28	WOS:000262104100048
J	Gurdon, JB; Melton, DA				Gurdon, J. B.; Melton, D. A.			Nuclear Reprogramming in Cells	SCIENCE			English	Review							PLURIPOTENT STEM-CELLS; CHROMATIN; GENERATION; DECONDENSATION; FIBROBLASTS; ACTIVATION; EXPRESSION; DYNAMICS; LIVER	Nuclear reprogramming describes a switch in gene expression of one kind of cell to that of another unrelated cell type. Early studies in frog cloning provided some of the first experimental evidence for reprogramming. Subsequent procedures included mammalian somatic cell nuclear transfer, cell fusion, induction of pluripotency by ectopic gene expression, and direct reprogramming. Through these methods it becomes possible to derive one kind of specialized cell ( such as a brain cell) from another, more accessible, tissue ( such as skin) in the same individual. This has potential applications for cell replacement without the immunosuppression treatments that are required when cells are transferred between genetically different individuals. This article provides some background to this field, a discussion of mechanisms and efficiency, and comments on prospects for future nuclear reprogramming research.	[Gurdon, J. B.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 12N, England; [Gurdon, J. B.] Univ Cambridge, Dept Zool, Cambridge CB2 12N, England; [Melton, D. A.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	University of Cambridge; University of Cambridge; Harvard University; Howard Hughes Medical Institute	Gurdon, JB (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 12N, England.		Young, Richard A/F-6495-2012; Wilson, Matthew H/K-3193-2013	Young, Richard A/0000-0001-8855-8647; GURDON, JOHN/0000-0002-5621-3799	Wellcome Trust (UK); European Commission Cells into Organs; Harvard Stem Cell Institute; NIH; Medical Research Council [G0300723B] Funding Source: researchfish	Wellcome Trust (UK)(Wellcome Trust); European Commission Cells into Organs(European CommissionEuropean Commission Joint Research Centre); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	J.B.G. thanks the Wellcome Trust (UK) and the European Commission Cells into Organs for support. D.A.M. is an HHMI investigator and is supported in part by the Harvard Stem Cell Institute and NIH. J.B.G. serves on the Harvard Stem Cell Institute Advisory Board.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; BRIGGS ROBERT, 1957, J MORPH, V100, P269, DOI 10.1002/jmor.1051000204; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; HARRIS H, 1967, J CELL SCI, V2, P23; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lowry N, 2008, EXP NEUROL, V209, P510, DOI 10.1016/j.expneurol.2007.09.031; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Saeki H, 2005, P NATL ACAD SCI USA, V102, P5697, DOI 10.1073/pnas.0409824102; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Tecirlioglu RT, 2006, STEM CELL REV, V2, P277, DOI 10.1007/BF02698054; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	238	255	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1811	1815		10.1126/science.1160810	http://dx.doi.org/10.1126/science.1160810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095934				2022-12-28	WOS:000261799400045
J	Abramson, JS; Chatterji, M; Rahemtullah, A; Barnes, JA				Abramson, Jeremy S.; Chatterji, Manjil; Rahemtullah, Aliyah; Barnes, Jeffrey A.			A Woman with Splenomegaly and Anemia Splenic marginal-zone lymphoma, with an IgM paraprotein, antiphospholipid antibodies (lupus anticoagulant and IgM anticardiolipin antibody), and autoimmune hemolytic anemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL LYMPHOMA; VILLOUS LYMPHOCYTES; B-CELL; WALDENSTROMS MACROGLOBULINEMIA; CLINICOPATHOLOGICAL ENTITY; RITUXIMAB MONOTHERAPY; CLINICAL PRESENTATION; PROGNOSTIC-FACTORS; FACTOR-VIII; SERIES		[Abramson, Jeremy S.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Chatterji, Manjil] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rahemtullah, Aliyah] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Abramson, Jeremy S.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Chatterji, Manjil] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Rahemtullah, Aliyah] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Abramson, JS (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.		Abramson, Jeremy/N-5178-2019					Algara P, 2002, BLOOD, V99, P1299, DOI 10.1182/blood.V99.4.1299; Arcaini L, 2004, CANCER, V100, P107, DOI 10.1002/cncr.11893; Arcaini L, 2006, BLOOD, V107, P4643, DOI 10.1182/blood-2005-11-4659; Belhadj K, 2003, BLOOD, V102, P4261, DOI 10.1182/blood-2003-05-1675; Bennett M, 2005, HAEMATOLOGICA, V90, P856; Berger F, 2000, BLOOD, V95, P1950, DOI 10.1182/blood.V95.6.1950; BEUTLER E, 2006, WILLIAMS HEMATOLOGY, P1009; BRODY JI, 1979, NEW ENGL J MED, V300, P408, DOI 10.1056/NEJM197902223000806; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; CIAUDO M, 1991, AM J HEMATOL, V38, P271, DOI 10.1002/ajh.2830380404; DHODAPKAR MV, 1994, BLOOD, V84, P1620; Endo T, 2000, AM J HEMATOL, V63, P145, DOI 10.1002/(SICI)1096-8652(200003)63:3<145::AID-AJH7>3.3.CO;2-5; Garratty G, 2005, SEMIN HEMATOL, V42, P156, DOI 10.1053/j.seminhematol.2005.04.005; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Iannitto E, 2004, CANCER-AM CANCER SOC, V101, P2050, DOI 10.1002/cncr.20596; ISAACSON PG, 2001, WHO CLASSIFICATION T, P135; Jaffe ES, 2001, WHO CLASSIFICATION T; Kalpadakis C, 2007, HEMATOL ONCOL, V25, P127, DOI 10.1002/hon.820; Kyriakou DS, 2002, EUR J GASTROEN HEPAT, V14, P1383, DOI 10.1097/00042737-200212000-00016; MARCHAND A, 1980, JAMA-J AM MED ASSOC, V243, P1909, DOI 10.1001/jama.243.19.1909; Martin SE, 2006, LEUKEMIA LYMPHOMA, V47, P1994, DOI 10.1080/10428190600731972; MAZURIER C, 1980, THROMB HAEMOSTASIS, V44, P115; MULLIGAN SP, 1991, BRIT J HAEMATOL, V78, P206, DOI 10.1111/j.1365-2141.1991.tb04417.x; Murakami H, 1997, AM J HEMATOL, V56, P173, DOI 10.1002/(SICI)1096-8652(199711)56:3<173::AID-AJH7>3.0.CO;2-V; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Papadaki T, 2007, AM J SURG PATHOL, V31, P438, DOI 10.1097/01.pas.0000213419.08009.b0; Parry-Jones N, 2003, BRIT J HAEMATOL, V120, P759, DOI 10.1046/j.1365-2141.2003.04165.x; RAO KPP, 1988, ARCH PATHOL LAB MED, V112, P47; SAWAMURA M, 1994, ANN HEMATOL, V68, P251, DOI 10.1007/BF01737426; Stamatopoulos K, 2004, MOL MED, V10, P89, DOI 10.2119/2005-00001.Stamatopoulos; Tefferi A, 1997, BRIT J HAEMATOL, V96, P850, DOI 10.1046/j.1365-2141.1997.d01-2088.x; Thieblemont C, 2002, CLIN LYMPHOMA, V3, P41, DOI 10.3816/CLM.2002.n.010; Tsimberidou AM, 2006, CANCER-AM CANCER SOC, V107, P125, DOI 10.1002/cncr.21931; Vallisa D, 2005, J CLIN ONCOL, V23, P468, DOI 10.1200/JCO.2005.06.008; Van Cott EM, 1998, HEMATOL ONCOL CLIN N, V12, P1141, DOI 10.1016/S0889-8588(05)70047-2; VANCOTT EM, 2001, CLIN DIAGNOSIS MANAG, P642; Ziakas PD, 2006, LEUKEMIA LYMPHOMA, V47, P772	41	5	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2707	2718		10.1056/NEJMcpc0806981	http://dx.doi.org/10.1056/NEJMcpc0806981			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092156				2022-12-28	WOS:000261757300012
J	Impellizzeri, CMV; McKean, JP; Castangia, P; Roy, AL; Henkel, C; Brunthaler, A; Wucknitz, O				Impellizzeri, C. M. Violette; McKean, John P.; Castangia, Paola; Roy, Alan L.; Henkel, Christian; Brunthaler, Andreas; Wucknitz, Olaf			A gravitationally lensed water maser in the early Universe	NATURE			English	Article							MG 0414+0534; ACCRETION DISK; EMISSION; GALAXY; H2O; ABSORPTION; J0414+0534; REDSHIFT; PARSEC; MEGAMASER	Water masers(1-4) are found in dense molecular clouds closely associated with supermassive black holes at the centres of active galaxies. On the basis of the understanding of the local water- maser luminosity function(5), it was expected that masers at intermediate and high redshifts would be extremely rare. However, galaxies at redshifts z > 2 might be quite different from those found locally, not least because of more frequent mergers and interaction events. Here we use gravitational lensing to search for masers at higher redshifts than would otherwise be possible, and find a water maser at redshift 2.64 in the dust- and gas- rich, gravitationally lensed type- 1 quasar MGJ0414+0534 ( refs 6 - 13). The isotropic luminosity is 10,000L.(L., solar luminosity), which is twice that of the most powerful local water maser(14) and half that of the most distant maser previously known(15). Using the locally determined luminosity function5, the probability of finding a maser this luminous associated with any single active galaxy is 10(-6). The fact that we see such a maser in the first galaxy we observe must mean that the volume densities and luminosities of masers are higher at redshift 2.64.	[Impellizzeri, C. M. Violette; McKean, John P.; Castangia, Paola; Roy, Alan L.; Henkel, Christian; Brunthaler, Andreas] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Castangia, Paola] Osservatorio Astron Cagliari, INAF, I-09012 Capoterra, CA, Italy; [Wucknitz, Olaf] Argelander Inst Astron, D-53121 Bonn, Germany	Max Planck Society; Istituto Nazionale Astrofisica (INAF); University of Bonn	Impellizzeri, CMV (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	violette@mpifr-bonn.mpg.de		Roy, Alan/0000-0002-1931-0135; Impellizzeri, Violette/0000-0002-3443-2472; Castangia, Paola/0000-0002-2318-8531; Brunthaler, Andreas/0000-0003-4468-761X	European Community's Sixth Framework Marie Curie Research Training Network 'ANGLES'; Priority and Emmy-Noether- Programmes of the Deutsche Forschungsgemeinschaft	European Community's Sixth Framework Marie Curie Research Training Network 'ANGLES'; Priority and Emmy-Noether- Programmes of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Our results are based on observations made using the 100-m telescope of the Max- Planck-Institut fur Radioastronomie at Effelsberg and the EVLA, which is operated by the National Radio Astronomy Observatory, a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. The authors are grateful to A. Kraus and M. Claussen, who helped make these observations. J. P. McK. was supported by the European Community's Sixth Framework Marie Curie Research Training Network 'ANGLES'. A.B. and O.W. were supported by the Priority and Emmy- Noether- Programmes of the Deutsche Forschungsgemeinschaft, respectively.	ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; Barvainis R, 2005, ASTROPHYS J, V628, pL89, DOI 10.1086/432666; Barvainis R, 1998, ASTROPHYS J, V492, pL13, DOI 10.1086/311090; BRAATZ J, 2007, IAU S, V242, P402; Claussen MJ, 1998, ASTROPHYS J, V500, pL129, DOI 10.1086/311405; Curran SJ, 2007, MON NOT R ASTRON SOC, V382, pL11, DOI 10.1111/j.1745-3933.2007.00379.x; Eliasdottir A, 2006, ASTROPHYS J SUPPL S, V166, P443, DOI 10.1086/507131; Gallimore JF, 1996, ASTROPHYS J, V462, P740, DOI 10.1086/177187; Greenhill LJ, 2004, NEW ASTRON REV, V48, P1079, DOI 10.1016/j.newar.2004.10.002; Greenhill LJ, 2003, ASTROPHYS J, V590, P162, DOI 10.1086/374862; Henkel C, 2005, ASTROPHYS SPACE SCI, V295, P107, DOI 10.1007/s10509-005-3668-z; Henkel C, 2005, ASTRON ASTROPHYS, V436, P75, DOI 10.1051/0004-6361:20042175; Herrnstein JR, 1999, NATURE, V400, P539, DOI 10.1038/22972; HEWITT JN, 1992, ASTRON J, V104, P968, DOI 10.1086/116290; KOEKEMOER AM, 1995, NATURE, V378, P697, DOI 10.1038/378697a0; Kondratko PT, 2008, ASTROPHYS J, V678, P87, DOI 10.1086/586879; Lawrence CR, 1995, ASTRON J, V110, P2570, DOI 10.1086/117713; Lo KY, 2005, ANNU REV ASTRON ASTR, V43, P625, DOI 10.1146/annurev.astro.41.011802.094927; MIYOSHI M, 1995, NATURE, V373, P127, DOI 10.1038/373127a0; Moore CB, 1999, ASTROPHYS J, V510, pL87, DOI 10.1086/311818; Morganti R, 2004, NEW ASTRON REV, V48, P1195, DOI 10.1016/j.newar.2004.09.022; NEUFELD DA, 1994, ASTROPHYS J, V436, pL127, DOI 10.1086/187649; Peck AB, 2003, ASTROPHYS J, V590, P149, DOI 10.1086/374924; Riechers DA, 2006, ASTROPHYS J, V645, pL13, DOI 10.1086/505908; Ros E, 2000, ASTRON ASTROPHYS, V362, P845; Tarchi A, 2003, ASTRON ASTROPHYS, V407, pL33, DOI 10.1051/0004-6361:20031062; Tarchi A, 2002, ASTRON ASTROPHYS, V385, P1049, DOI 10.1051/0004-6361:20020199; Tonry JL, 1999, ASTRON J, V117, P2034, DOI 10.1086/300834; Trotter CS, 2000, ASTROPHYS J, V535, P671, DOI 10.1086/308861; Wilner DJ, 1999, ASTRON J, V117, P1139, DOI 10.1086/300795	30	42	42	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					927	929		10.1038/nature07544	http://dx.doi.org/10.1038/nature07544			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092930	Green Submitted			2022-12-28	WOS:000261768300039
J	Kang, RJ; Wan, JM; Arstikaitis, P; Takahashi, H; Huang, K; Bailey, AO; Thompson, JX; Roth, AF; Drisdel, RC; Mastro, R; Green, WN; Yates, JR; Davis, NG; El-Husseini, A				Kang, Rujun; Wan, Junmei; Arstikaitis, Pamela; Takahashi, Hideto; Huang, Kun; Bailey, Aaron O.; Thompson, James X.; Roth, Amy F.; Drisdel, Renaldo C.; Mastro, Ryan; Green, William N.; Yates, John R., III; Davis, Nicholas G.; El-Husseini, Alaa			Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation	NATURE			English	Article							DENDRITIC SPINE DEVELOPMENT; RHO-FAMILY GTPASES; PROTEIN PALMITOYLATION; NEURONAL EXCITABILITY; MORPHOGENESIS; CDC42; SYNAPSES; TRAFFICKING; PLASTICITY; STABILITY	Palmitoylation regulates diverse aspects of neuronal protein trafficking and function. Here a global characterization of rat neural palmitoyl- proteomes identifies most of the known neural palmitoyl proteins - 68 in total, plus more than 200 new palmitoyl- protein candidates, with further testing confirming palmitoylation for 21 of these candidates. The new palmitoyl proteins include neurotransmitter receptors, transporters, adhesion molecules, scaffolding proteins, as well as SNAREs and other vesicular trafficking proteins. Of particular interest is the finding of palmitoylation for a brain- specific Cdc42 splice variant. The palmitoylated Cdc42 isoform ( Cdc42- palm) differs from the canonical, prenylated form ( Cdc42- prenyl), both with regard to localization and function: Cdc42- palm concentrates in dendritic spines and has a special role in inducing these post- synaptic structures. Furthermore, assessing palmitoylation dynamics in drug- induced activity models identifies rapidly induced changes for Cdc42 as well as for other synaptic palmitoyl proteins, suggesting that palmitoylation may participate broadly in the activity- driven changes that shape synapse morphology and function.	[Wan, Junmei; Roth, Amy F.; Davis, Nicholas G.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Kang, Rujun; Arstikaitis, Pamela; Takahashi, Hideto; Huang, Kun; El-Husseini, Alaa] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Bailey, Aaron O.; Thompson, James X.; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA; [Drisdel, Renaldo C.; Mastro, Ryan; Green, William N.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Wayne State University; University of British Columbia; Scripps Research Institute; University of Chicago	Davis, NG (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	rkang@interchange.ubc.ca; ndavis@med.wayne.edu	Bailey, Aaron/ABB-8522-2021; Takahashi, Hideto/T-2650-2018	Bailey, Aaron/0000-0001-8063-3032; Takahashi, Hideto/0000-0002-6473-5060	Canadian Institutes for Health Research [A.E.H-20R90479, A.E.H-20R91909]; Michael Smith foundation for Health Research [A.E.-H., 20R52464]; EJLB Foundation and Neuroscience Canada [A.E.-H., 20R61933]; National Institutes of Health [GM65525, RR011823, NS043782, DA13602, DA019695]; Peter F. McManus Trust; Uehara Memorial Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS043782, R01NS043782, R01NS032693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA019695, R01DA013602] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith foundation for Health Research(Michael Smith Foundation for Health Research); EJLB Foundation and Neuroscience Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peter F. McManus Trust; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This paper is dedicated to the memory of our friend and colleague, Alaa El-Husseini, whose ideas about palmitoylation and plasticity inspired this work (deceased 23 Dec 2007). We thank J. Levinson, M.-F. Lise, C. Jiang and E. Yu for technical assistance. This work was supported by grants to A.E.-H. from the Canadian Institutes for Health Research (CIHR) (A.E.-H., 20R90479 and 20R91909), the Michael Smith foundation for Health Research (A.E.-H., 20R52464), the EJLB Foundation and Neuroscience Canada (A.E.-H., 20R61933), as well as from grants from the National Institutes of Health to N.G.D. (GM65525), J.R.Y. (RR011823) and W.N.G.(NS043782, DA13602 and DA019695), and the Peter F. McManus Trust. H. T. was supported by a research fellowship from the Uehara Memorial Foundation. We thank L. Raymond, Y.T. Wang, K. Gerrow, R. Hines, M. Prior and I. Papanayotou for comments on manuscript.	Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Halpain S, 1998, J NEUROSCI, V18, P9835; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hering H, 2003, J NEUROSCI, V23, P3262; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Marks PW, 1996, GENOMICS, V38, P13, DOI 10.1006/geno.1996.0586; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOLLNER S, 1995, FEBS LETT, V371, P241, DOI 10.1016/0014-5793(95)00864-6; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Negishi M, 2005, NEUROSCIENTIST, V11, P187, DOI 10.1177/1073858404268768; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Scott EK, 2003, J NEUROSCI, V23, P3118; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wilson AL, 1998, BIOCHEM J, V333, P497, DOI 10.1042/bj3330497	32	407	411	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					904	909		10.1038/nature07605	http://dx.doi.org/10.1038/nature07605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092927	Green Accepted			2022-12-28	WOS:000261768300035
J	Blazeby, JM; Barham, CP; Donovan, JL				Blazeby, Jane M.; Barham, C. Paul; Donovan, Jenny L.			Commentary: Randomised trials of surgical and non-surgical treatment: a role model for the future	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Blazeby, Jane M.; Donovan, Jenny L.] Univ Bristol, Dept Social Med, Bristol BS9 2PS, Avon, England; [Blazeby, Jane M.; Barham, C. Paul] Univ Hosp Bristol NHS Fdn Trust, Bristol BS2 8HW, Avon, England	University of Bristol; University of Bristol	Blazeby, JM (corresponding author), Univ Bristol, Dept Social Med, Bristol BS9 2PS, Avon, England.	j.m.blazeby@bris.ac.uk	Blazeby, Jane/H-6703-2019	Blazeby, Jane/0000-0002-3354-3330				Grant AM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2664; Macran S, 2007, QUAL LIFE RES, V16, P331, DOI 10.1007/s11136-006-9005-3; *US FDA, 2006, GUID IND PAT REP OUT	3	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 15	2008	337								a2747	10.1136/bmj.a2747	http://dx.doi.org/10.1136/bmj.a2747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SS	19074947	hybrid			2022-12-28	WOS:000262184600001
J	Burn, J; Bishop, DT; Mecklin, JP; Macrae, F; Moslein, G; Olschwang, S; Bisgaard, ML; Ramesar, R; Eccles, D; Maher, ER; Bertario, L; Jarvinen, HJ; Lindblom, A; Evans, DG; Lubinski, J; Morrison, PJ; Ho, JWC; Vasen, HFA; Side, L; Thomas, HJW; Scott, RJ; Dunlop, M; Barker, G; Elliott, F; Jass, JR; Fodde, R; Lynch, HT; Mathers, JC				Burn, John; Bishop, D. Timothy; Mecklin, Jukka-Pekka; Macrae, Finlay; Moeslein, Gabriela; Olschwang, Sylviane; Bisgaard, Marie-Luise; Ramesar, Raj; Eccles, Diana; Maher, Eamonn R.; Bertario, Lucio; Jarvinen, Heikki J.; Lindblom, Annika; Evans, D. Gareth; Lubinski, Jan; Morrison, Patrick J.; Ho, Judy W. C.; Vasen, Hans F. A.; Side, Lucy; Thomas, Huw J. W.; Scott, Rodney J.; Dunlop, Malcolm; Barker, Gail; Elliott, Faye; Jass, Jeremy R.; Fodde, Ricardo; Lynch, Henry T.; Mathers, John C.		CAPP2 Investigators	Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL TUMORIGENESIS; RANDOMIZED-TRIAL; CANCER; RISK; PREVENTION; RECURRENCE; APOPTOSIS; ADENOMAS; BUTYRATE	Background: Observational and epidemiologic data indicate that the use of aspirin reduces the risk of colorectal neoplasia; however, the effects of aspirin in the Lynch syndrome (hereditary nonpolyposis colon cancer) are not known. Resistant starch has been associated with an antineoplastic effect on the colon. Methods: In a randomized, placebo-controlled trial, we used a two-by-two design to investigate the effects of aspirin, at a dose of 600 mg per day, and resistant starch (Novelose), at a dose of 30 g per day, in reducing the risk of adenoma and carcinoma among persons with the Lynch syndrome. Results: Among 1071 persons in 43 centers, 62 were ineligible to participate in the study, 72 did not enter the study, and 191 withdrew from the study. These three categories were equally distributed across the study groups. Over a mean period of 29 months (range, 7 to 74), colonic adenoma or carcinoma developed in 141 participants. Of 693 participants randomly assigned to receive aspirin or placebo, neoplasia developed in 66 participants receiving aspirin (18.9%), as compared with 65 receiving placebo (19.0%) (relative risk, 1.0; 95% confidence interval [CI], 0.7 to 1.4). There were no significant differences between the two groups with respect to the development of advanced neoplasia (7.4% and 9.9%, respectively; P=0.33). Among the 727 participants receiving resistant starch or placebo, neoplasia developed in 67 participants receiving starch (18.7%), as compared with 68 receiving placebo (18.4%) (relative risk, 1.0; 95% CI, 0.7 to 1.4). Advanced adenomas and colorectal cancers were evenly distributed in the two groups. The prevalence of serious adverse events was low, and the events were evenly distributed. Conclusions: The use of aspirin, resistant starch, or both for up to 4 years has no effect on the incidence of colorectal adenoma or carcinoma among carriers of the Lynch syndrome. (Current Controlled Trials number, ISRCTN59521990.).	[Burn, John; Barker, Gail] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Bishop, D. Timothy; Elliott, Faye] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Eccles, Diana] Princess Anne Hosp, Southampton, Hants, England; [Maher, Eamonn R.] Univ Birmingham, Birmingham, W Midlands, England; [Evans, D. Gareth] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Morrison, Patrick J.] Belfast City Hosp, Belfast BT9 7AD, Antrim, North Ireland; [Side, Lucy] Churchill Hosp, Oxford OX3 7LJ, England; [Thomas, Huw J. W.; Jass, Jeremy R.] St Marks Hosp, London EC1V 2PS, England; [Dunlop, Malcolm] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Mecklin, Jukka-Pekka] Jyvaskyla Cent Hosp, Jyvaskyla, Finland; [Macrae, Finlay] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Scott, Rodney J.] John Hunter Hosp, New Lambton, Australia; [Moeslein, Gabriela] St Josefs Hosp, Bochum, Germany; [Olschwang, Sylviane] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Bisgaard, Marie-Luise] Univ Copenhagen, Danish Hereditary Nonpolyposis Colon Canc Registe, Hvidovre, Denmark; [Ramesar, Raj] Univ Cape Town, Observatory, South Africa; [Bertario, Lucio] Ist Nazl Studio & Cura Tumori, I-20133 Milan, Italy; [Jarvinen, Heikki J.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Lindblom, Annika] Karolinska Inst, Stockholm, Sweden; [Lubinski, Jan] Int Hereditary Canc Ctr, Szczecin, Poland; [Ho, Judy W. C.] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Vasen, Hans F. A.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Fodde, Ricardo] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Lynch, Henry T.] Creighton Univ, Med Ctr, Omaha, NE USA	Newcastle University - UK; Newcastle University - UK; University of Leeds; University of Birmingham; University of Manchester; Belfast City Hospital; University of Oxford; Imperial College London; University of Edinburgh; Central Finland Central Hospital; Royal Melbourne Hospital; John Hunter Hospital; Ruhr University Bochum; UNICANCER; Institut Paoli-Calmette (IPC); University of Copenhagen; University of Cape Town; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; University of Hong Kong; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Creighton University	Burn, J (corresponding author), Newcastle Univ, Int Ctr Life, Inst Human Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	john.burn@ncl.ac.uk	Evans, D Gareth/AAB-4308-2022; Mecklin, Jukka-Pekka/AAC-9650-2019; Side, Lucy/A-6990-2011; Mecklin, Jukka-Pekka/AAB-5378-2020; Fodde, Riccardo/AAW-9394-2021; Dunlop, Malcolm/F-1973-2011; Scott, Rodney/B-2827-2013; Ramesar, Rajkumar/I-6941-2015; MAHER, EAMONN/A-9507-2008	Evans, D Gareth/0000-0002-8482-5784; Mecklin, Jukka-Pekka/0000-0003-4895-2249; Fodde, Riccardo/0000-0001-9839-4324; Lubinski, Jan/0000-0003-2931-3003; Eccles, Diana M/0000-0002-9935-3169; Vasen, Hans/0000-0003-2682-2603; Bertario, Lucio/0000-0001-5653-1431; Dunlop, Malcolm/0000-0002-3033-5851; Scott, Rodney/0000-0001-7724-3404; Ramesar, Rajkumar/0000-0001-5688-1634; Bishop, Tim/0000-0002-8752-8785; Mathers, John/0000-0003-3406-3002; Burn, John/0000-0002-9823-2322; Goldberg, Paul/0000-0003-1612-7519; MAHER, EAMONN/0000-0002-6226-6918	Bayer, National Starch and Chemical; U. K. Medical Research Council [G0100496]; Cancer Research U.K [C1297/A5013, C588/A4994]; European Union [PL96/3694]; Cancer Council Victoria (Australia); Technology and Human Resources for Industry Programme South Africa; Finnish Cancer Foundation; MRC [MC_U127527198, G0100496] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [D20173] Funding Source: researchfish; Medical Research Council [G0100496, MC_U127527198] Funding Source: researchfish	Bayer, National Starch and Chemical(Bayer AG); U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research U.K(Cancer Research UK); European Union(European Commission); Cancer Council Victoria (Australia)(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Technology and Human Resources for Industry Programme South Africa; Finnish Cancer Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Bayer, National Starch and Chemical, and grants from the U. K. Medical Research Council (G0100496), Cancer Research U. K. (C1297/A5013 and C588/A4994), the European Union (PL96/3694), the Cancer Council Victoria (Australia), The Technology and Human Resources for Industry Programme South Africa, and the Finnish Cancer Foundation. No potential conflict of interest relevant to this article was reported.; We thank the participants in the CAPP2 study who agreed to undergo randomization and receive daily study agents for up to 4 years; Kirsi Pylvanainen (Jyvaskyla, Finland), Pascale Ives ( Melbourne, Australia), and Su Werner (Dusseldorf, Germany), our leading recruiters; and Pam Chapman, the project manager in its early stages.	Asp NG, 1996, NUTR RES REV, V9, P1, DOI 10.1079/NRR19960004; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Bauer-Marinovic M, 2006, CARCINOGENESIS, V27, P1849, DOI 10.1093/carcin/bgl025; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; CASSIDY A, 1994, BRIT J CANCER, V69, P937, DOI 10.1038/bjc.1994.181; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Goel A, 2003, CANCER RES, V63, P1608; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Le Leu RK, 2007, CARCINOGENESIS, V28, P240, DOI 10.1093/carcin/bgl245; Le Leu RK, 2003, CARCINOGENESIS, V24, P1347, DOI 10.1093/carcin/bgg098; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Perrin P, 2001, GUT, V48, P53, DOI 10.1136/gut.48.1.53; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Toden S, 2006, CANCER BIOL THER, V5, P267, DOI 10.4161/cbt.5.3.2382; US Preventive Services Task Force, 2007, ANN INTERN MED, V146, P361, DOI 10.7326/0003-4819-146-5-200703060-00008; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Williams EA, 2003, P NUTR SOC, V62, P107, DOI 10.1079/PNS2002230; Williamson SLH, 1999, CARCINOGENESIS, V20, P805, DOI 10.1093/carcin/20.5.805	23	209	218	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2567	2578		10.1056/NEJMoa0801297	http://dx.doi.org/10.1056/NEJMoa0801297			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073976	Green Published			2022-12-28	WOS:000261534200008
J	Grillmair, CJ; Burrows, A; Charbonneau, D; Armus, L; Stauffer, J; Meadows, V; van Cleve, J; von Braun, K; Levine, D				Grillmair, Carl J.; Burrows, Adam; Charbonneau, David; Armus, Lee; Stauffer, John; Meadows, Victoria; van Cleve, Jeffrey; von Braun, Kaspar; Levine, Deborah			Strong water absorption in the dayside emission spectrum of the planet HD189733b	NATURE			English	Article							EXTRASOLAR PLANET; INFRARED-EMISSION; GIANT PLANETS; LIGHT CURVES; HD 209458B; ATMOSPHERE; CONTRAST; SEARCH	Recent observations of the extrasolar planet HD189733b did not reveal the presence of water in the emission spectrumof the planet(1). Yet models of such 'hot- Jupiter' planets predict an abundance of atmospheric water vapour(2). Validating and constraining these models is crucial to understanding the physics and chemistry of planetary atmospheres in extreme environments. Indications of the presence of water in the atmosphere of HD189733b have recently been found in transmission spectra(3,4), where the planet's atmosphere selectively absorbs the light of the parent star, and in broadband photometry(5). Here we report the detection of strong water absorption in a high- signal- to- noise, mid- infrared emission spectrumof the planet itself. We find both a strong downturn in the flux ratio below 10 mu m and discrete spectral features that are characteristic of strong absorption by water vapour. The differences between these and previous observations are significant and admit the possibility that predicted planetary- scale dynamical weather structures(6) may alter the emission spectrum over time. Models that match the observed spectrum and the broadband photometry suggest that heat redistribution from the dayside to the nightside is weak. Reconciling this with the high nightside temperature(7) will require a better understanding of atmospheric circulation or possible additional energy sources.	[Grillmair, Carl J.; Armus, Lee; Stauffer, John; Levine, Deborah] Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Burrows, Adam] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Charbonneau, David] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Meadows, Victoria] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [van Cleve, Jeffrey] Ball Aerosp & Technol Corp, Boulder, CO 80306 USA; [von Braun, Kaspar] CALTECH, Michelson Sci Ctr, Pasadena, CA 91125 USA	Princeton University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Washington; University of Washington Seattle; Ball Aerospace & Technologies; California Institute of Technology	Grillmair, CJ (corresponding author), Spitzer Sci Ctr, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	carl@ipac.caltech.edu		Charbonneau, David/0000-0002-9003-484X; Grillmair, Carl/0000-0003-4072-169X; Armus, Lee/0000-0003-3498-2973	NASA [NNGO4GL22G]; JPL/Caltech	NASA(National Aeronautics & Space Administration (NASA)); JPL/Caltech	This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory (JPL), California Institute of Technology (Caltech), under a contract with NASA. Support for this work was provided by NASA through an award issued by JPL/Caltech. This study was supported in part by NASA (grant NNGO4GL22G).	Barman TS, 2008, ASTROPHYS J LETT, V676, pL61, DOI 10.1086/587056; Barnes JR, 2007, MON NOT R ASTRON SOC, V382, P473, DOI 10.1111/j.1365-2966.2007.12394.x; Bouchy F, 2005, ASTRON ASTROPHYS, V444, pL15, DOI 10.1051/0004-6361:200500201; Burrows A, 2008, ASTROPHYS J, V678, P1436, DOI 10.1086/533518; Burrows A, 2007, ASTROPHYS J, V668, pL171, DOI 10.1086/522834; Burrows A, 2006, ASTROPHYS J, V650, P1140, DOI 10.1086/507269; Burrows A, 2005, ASTROPHYS J, V625, pL135, DOI 10.1086/431242; Burrows A, 2005, NATURE, V433, P261, DOI 10.1038/nature03244; Charbonneau D, 2008, ASTROPHYS J, V686, P1341, DOI 10.1086/591635; Deming D, 2006, ASTROPHYS J, V644, P560, DOI 10.1086/503358; Ehrenreich D, 2007, ASTROPHYS J, V668, pL179, DOI 10.1086/522792; Fortney JJ, 2007, ASTROPHYS J, V666, pL45, DOI 10.1086/521603; Grillmair CJ, 2007, ASTROPHYS J, V658, pL115, DOI 10.1086/513741; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Pont F, 2008, MON NOT R ASTRON SOC, V385, P109, DOI 10.1111/j.1365-2966.2008.12852.x; Rauscher E, 2008, ASTROPHYS J, V681, P1646, DOI 10.1086/589499; Richardson LJ, 2007, NATURE, V445, P892, DOI 10.1038/nature05636; SHOWMAN AP, ASTROPHYS J UNPUB; Swain MR, 2008, ASTROPHYS J, V674, P482, DOI 10.1086/523832; Swain MR, 2008, NATURE, V452, P329, DOI 10.1038/nature06823; Tinetti G, 2007, NATURE, V448, P169, DOI 10.1038/nature06002; Torres G, 2008, ASTROPHYS J, V677, P1324, DOI 10.1086/529429	25	205	207	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					767	769		10.1038/nature07574	http://dx.doi.org/10.1038/nature07574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079054	Green Submitted			2022-12-28	WOS:000261559900043
J	Karunajeewa, HA; Mueller, I; Senn, M; Lin, E; Law, I; Gomorrai, PS; Oa, O; Griffin, S; Kotab, K; Suano, P; Tarongka, N; Ura, A; Lautu, D; Page-Sharp, M; Wong, R; Salman, S; Siba, P; Ilett, KF; Davis, TME				Karunajeewa, Harin A.; Mueller, Ivo; Senn, Michele; Lin, Enmoore; Law, Irwin; Gomorrai, P. Servina; Oa, Olive; Griffin, Suzanne; Kotab, Kaye; Suano, Penias; Tarongka, Nandao; Ura, Alice; Lautu, Dulcie; Page-Sharp, Madhu; Wong, Rina; Salman, Sam; Siba, Peter; Ilett, Kenneth F.; Davis, Timothy M. E.			A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLUS SULFADOXINE-PYRIMETHAMINE; PLASMODIUM-FALCIPARUM MALARIA; ARTEMETHER-LUMEFANTRINE; DIHYDROARTEMISININ-PIPERAQUINE; UNCOMPLICATED FALCIPARUM; VIVAX MALARIA; RURAL AREA; EFFICACY; ARTESUNATE; DRUG	Background: Malaria control is difficult where there is intense year-round transmission of multiple plasmodium species, such as in Papua New Guinea. Methods: Between April 2005 and July 2007, we conducted an open-label, randomized, parallel-group study of conventional chloroquine-sulfadoxine-pyrimethamine and artesunate-sulfadoxine-pyrimethamine, dihydroartemisinin-piperaquine, and artemether-lumefantrine in children in Papua New Guinea 0.5 to 5 years of age who had falciparum or vivax malaria. The primary end point was the rate of adequate clinical and parasitologic response at day 42 after the start of treatment with regard to Plasmodium falciparum, after correction for reinfections identified through polymerase-chain-reaction (PCR) genotyping of polymorphic loci in parasite DNA. Secondary end points included the rate of adequate clinical and parasitologic response at day 42 with regard to P. vivax without correction through PCR genotyping. Results: Of 2802 febrile children screened, 482 with falciparum malaria and 195 with vivax malaria were included. The highest rate of adequate clinical and parasitologic response for P. falciparum was in the artemether-lumefantrine group (95.2%), as compared with 81.5% in the chloroquine-sulfadoxine-pyrimethamine group (P=0.003), 85.4% in the artesunate-sulfadoxine-pyrimethamine group (P=0.02), and 88.0% in the dihydroartemisinin-piperaquine group (P=0.06). The rate of adequate clinical and parasitologic response for P. vivax in the dihydroartemisinin-piperaquine group (69.4%) was more than twice that in each of the other three treatment groups. The in vitro chloroquine and piperaquine levels that inhibited growth of local P. falciparum isolates by 50% correlated significantly (P<0.001). Rash occurred more often with artesunate-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine than with chloroquine-sulfadoxine-pyrimethamine (P=0.004 for both comparisons). Conclusions: The most effective regimens were artemether-lumefantrine against P. falciparum and dihydroartemisinin-piperaquine against P. vivax. The relatively high rate of treatment failure with dihydroartemisinin-piperaquine against P. falciparum may reflect cross-resistance between chloroquine and piperaquine. (Australian New Zealand Clinical Trials Registry number, ACTRN12605000550606.).	[Karunajeewa, Harin A.; Law, Irwin; Page-Sharp, Madhu; Wong, Rina; Salman, Sam; Ilett, Kenneth F.; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Mueller, Ivo; Senn, Michele; Lin, Enmoore; Gomorrai, P. Servina; Oa, Olive; Griffin, Suzanne; Kotab, Kaye; Suano, Penias; Tarongka, Nandao; Ura, Alice; Lautu, Dulcie; Siba, Peter] Papua New Guinea Inst Med Res, Madang, Papua N Guinea	University of Western Australia; PNG Institute Of Medical Research	Davis, TME (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, POB 480, Fremantle, WA 6959, Australia.	tdavis@cyllene.uwa.edu.au	Mueller, Ivo/C-7251-2013; Salman, Sam/V-6271-2018; Davis, Timothy ME/M-5144-2014	Mueller, Ivo/0000-0001-6554-6889; Salman, Sam/0000-0002-8276-6784; Davis, Timothy/0000-0003-0749-7411; Law, Irwin/0000-0002-1194-677X; Lin, Enmoore/0000-0002-8584-7627	WHO Western Pacific Region; Rotary against Malaria in Papua New Guinea; National Health and Medical Research Council of Australia [353663]	WHO Western Pacific Region; Rotary against Malaria in Papua New Guinea; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by grants from the WHO Western Pacific Region, Rotary against Malaria in Papua New Guinea, and the National Health and Medical Research Council of Australia (no. 353663).; No potential conflict of interest relevant to this article was reported.; We thank Sister Valsi Kurian and the staff of Alexishafen Health Center for their kind cooperation during the study; Sister Maria Goretti, Jovitha Lammey, Wesley Sikuma, Donald Paiva, Bernard (Ben) Maamu, Lena Lorry, Petronilla Wapon, Jane Simbrandu, Merilyn Uranoli, Peter Maku, Moses Lagog, Thomas Adi guma, Jonah Iga, John Taime, Michelle England, Thomas Schulz, and Kaye Baea for clinical, laboratory, database, or logistic assistance; Wendy Davis for help with statistical analysis; and Peter Zimmerman for review of a previous draft of the manuscript.	Basco LK, 2003, ANTIMICROB AGENTS CH, V47, P1391, DOI 10.1128/AAC.47.4.1391-1394.2003; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; Checchi F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-59; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Davis TME, 2005, MED J AUSTRALIA, V182, P181, DOI 10.5694/j.1326-5377.2005.tb06650.x; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Faye B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-80; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Felger Ingrid, 2002, Methods Mol Med, V72, P117, DOI 10.1385/1-59259-271-6:117; GENTON B, 1995, ANN TROP MED PARASIT, V89, P377, DOI 10.1080/00034983.1995.11812966; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI 10.1111/j.1365-2125.2003.02004.x; Hutagalung R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-46; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Karunajeewa HA, 2008, ANTIMICROB AGENTS CH, V52, P237, DOI 10.1128/AAC.00555-07; Kitua AY, 1997, TROP MED INT HEALTH, V2, P325; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Mansor SM, 1996, J CHROMATOGR B, V682, P321, DOI 10.1016/0378-4347(96)00086-2; Marfurt J, 2007, AM J TROP MED HYG, V77, P947, DOI 10.4269/ajtmh.2007.77.947; Mohamed AO, 2006, ANN TROP MED PARASIT, V100, P5, DOI 10.1179/136485906X86239; MOIR JS, 1989, ANN TROP MED PARASIT, V83, P305, DOI 10.1080/00034983.1989.11812349; Mukhtar EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-92; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Myint HY, 2007, T ROY SOC TROP MED H, V101, P858, DOI 10.1016/j.trstmh.2007.05.018; Papua New Guinea Department of Health, 2000, STAND TREATM COMM IL; Price RN, 2007, ANTIMICROB AGENTS CH, V51, P4090, DOI 10.1128/AAC.00486-07; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Sim IK, 2005, ANTIMICROB AGENTS CH, V49, P2407, DOI 10.1128/AAC.49.6.2407-2411.2005; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; TANGPUKDEE N, 2005, ASIAN J TROP MED PUB, V36, P1085; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; *WHO, 2006, WHOHTMMAL20061108; *WHO, 1994, INT PHARM WHO, V4; WHO, 2003, ASS MON ANT DRUG EFF; World Health Organization, 2006, WHO CHILD GROWTH STA; Zongo I, 2007, LANCET, V369, P826; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0	41	150	150	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2545	2557		10.1056/NEJMoa0804915	http://dx.doi.org/10.1056/NEJMoa0804915			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19064624	Bronze			2022-12-28	WOS:000261534200006
J	Rockman, MV				Rockman, Matthew V.			Reverse engineering the genotype-phenotype map with natural genetic variation	NATURE			English	Review							QUANTITATIVE TRAIT LOCI; INTEGRATIVE GENOMICS APPROACH; REGULATORY NETWORKS; WIDE ASSOCIATION; LINKAGE ANALYSIS; EXPRESSION DATA; COMPLEX TRAITS; YEAST; DISEASE; INFERENCE	The genetic variation that occurs naturally in a population is a powerful resource for studying how genotype affects phenotype. Each allele is a perturbation of the biological system, and genetic crosses, through the processes of recombination and segregation, randomize the distribution of these alleles among the progeny of a cross. The randomized genetic perturbations affect traits directly and indirectly, and the similarities and differences between traits in their responses to common perturbations allow inferences about whether variation in a trait is a cause of a phenotype (such as disease) or whether the trait variation is, instead, an effect of that phenotype. It is then possible to use this information about causes and effects to build models of probabilistic 'causal networks'. These networks are beginning to define the outlines of the 'genotype - phenotype map'.	NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA	New York University	Rockman, MV (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, 100 Washington Sq E, New York, NY 10003 USA.	mrockman@nyu.edu			Jane Coffin Childs Memorial Fund for Medical Research; New York University	Jane Coffin Childs Memorial Fund for Medical Research; New York University	I thank the Jane Coffin Childs Memorial Fund for Medical Research and New York University for support, and L. Chen for discussion.	Alberts R, 2005, GENETICS, V171, P1437, DOI 10.1534/genetics.105.045930; [Anonymous], J MINISTRY AGR; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Bing N, 2005, GENETICS, V170, P533, DOI 10.1534/genetics.105.041103; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Carlborg O, 2005, BIOINFORMATICS, V21, P2383, DOI 10.1093/bioinformatics/bti241; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Churchill GA, 2006, MAMM GENOME, V17, P465, DOI 10.1007/s00335-006-1100-9; Cotsapas CJ, 2006, MAMM GENOME, V17, P490, DOI 10.1007/s00335-005-0186-9; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Fisher R.A., 1930, GENETICAL THEORY NAT; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Huttenhower C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-250; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jia ZY, 2007, GENETICS, V176, P611, DOI 10.1534/genetics.106.065599; Kendziorski CM, 2006, BIOMETRICS, V62, P19, DOI 10.1111/j.1541-0420.2005.00437.x; Kulathinal RJ, 2008, P NATL ACAD SCI USA, V105, P10051, DOI 10.1073/pnas.0801848105; Kulp DC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-125; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Li HQ, 2005, HUM MOL GENET, V14, P1119, DOI 10.1093/hmg/ddi124; Li RH, 2006, PLOS GENET, V2, P1046, DOI 10.1371/journal.pgen.0020114; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Lynch M., 1998, GENETICS ANAL QUANTI; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ohta T, 2003, J BIOSCIENCES, V28, P371, DOI 10.1007/BF02705113; Omholt SW, 2000, GENETICS, V155, P969; OYAMA S, 2000, ONTOGENY INFORMATION; Perez-Enciso M, 2004, GENETICS, V166, P547, DOI 10.1534/genetics.166.1.547; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Ronald J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000678; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schliekelman P, 2008, GENETICS, V178, P2201, DOI 10.1534/genetics.107.076687; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stamatoyannopoulos JA, 2004, GENOMICS, V84, P449, DOI 10.1016/j.ygeno.2004.05.002; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stylianou IM, 2008, GENETICS, V178, P1795, DOI 10.1534/genetics.107.081216; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Tu ZD, 2006, BIOINFORMATICS, V22, pE489, DOI 10.1093/bioinformatics/btl234; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	74	163	166	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					738	744		10.1038/nature07633	http://dx.doi.org/10.1038/nature07633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079051				2022-12-28	WOS:000261559900038
J	Thomas, T; Saravanan, B; Blake, F				Thomas, Toral; Saravanan, Balasubramanian; Blake, Fiona			A man with congenital abnormalities and psychotic symptoms	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIO-FACIAL SYNDROME; CHROMOSOME 22Q11 DELETIONS; SCHIZOPHRENIA; GENETICS; SPECTRUM		[Thomas, Toral; Saravanan, Balasubramanian; Blake, Fiona] Fulbourne Hosp, Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge CB21 5EF, England; [Saravanan, Balasubramanian] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; King's College London	Thomas, T (corresponding author), Fulbourne Hosp, Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge CB21 5EF, England.	toral.thomas@cpft.nhs.uk						Driscoll DA, 2006, METH MOLEC MED, V126, P43; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; Gothelf D, 1999, SCHIZOPHR RES, V35, P105, DOI 10.1016/S0920-9964(98)00114-5; Le Page H, 2006, J CAN ACAD CHILD ADO, V15, P179; Murphy KC, 1998, BRIT J PSYCHIAT, V172, P180, DOI 10.1192/bjp.172.2.180; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Papolos DF, 1996, AM J PSYCHIAT, V153, P1541; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shprintzen RJ, 2005, CURR OPIN PEDIATR, V17, P725, DOI 10.1097/01.mop.0000184465.73833.0b; Swillen A, 1997, J MED GENET, V34, P453, DOI 10.1136/jmg.34.6.453; Yates JRW, 1996, BMJ-BRIT MED J, V312, P1021	12	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2008	337								a2706	10.1136/bmj.a2706	http://dx.doi.org/10.1136/bmj.a2706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CA	19073692				2022-12-28	WOS:000262776800004
J	Charlesworth, D				Charlesworth, Deborah			EVOLUTION Competitive Centromeres	SCIENCE			English	Editorial Material							MEIOTIC DRIVE; SEGREGATION; DROSOPHILA; MIMULUS		[Charlesworth, Deborah] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Charlesworth, D (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland.	deborah.charlesworth@ed.ac.uk	Charlesworth, Deborah/F-3071-2011					de Villena FPM, 2001, GENETICS, V159, P1179; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; HUDSON RR, 1994, GENETICS, V136, P1329; Malik HS, 2001, GENETICS, V157, P1293; Moyle LC, 2006, MOL BIOL EVOL, V23, P973, DOI 10.1093/molbev/msj112; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969; Talbert Paul B, 2004, J Biol, V3, P18, DOI 10.1186/jbiol11; Trivers R. L., 2006, GENES CONFLICT; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; Wu CA, 2008, HEREDITY, V100, P220, DOI 10.1038/sj.hdy.6801018; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602	13	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1484	1485		10.1126/science.1167573	http://dx.doi.org/10.1126/science.1167573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056969				2022-12-28	WOS:000261377400032
J	Evans, RL				Evans, Rob L.			GEOCHEMISTRY Carbon in Charge	SCIENCE			English	Editorial Material							UPPER-MANTLE; ELECTRICAL-CONDUCTIVITY; MELT; WATER; DIOXIDE; OLIVINE		[Evans, Rob L.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Evans, RL (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	revans@whoi.edu	evans, rob/C-6887-2011	Evans, Robert/0000-0001-5585-0684				Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; Booker JR, 2004, NATURE, V429, P399, DOI 10.1038/naturt02565; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Dasgupta R, 2007, GEOLOGY, V35, P135, DOI 10.1130/G22856A.1; Dobson DP, 1996, EARTH PLANET SC LETT, V143, P207, DOI 10.1016/0012-821X(96)00139-2; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Gaillard F, 2008, SCIENCE, V322, P1363, DOI 10.1126/science.1164446; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; Lee WJ, 1997, CONTRIB MINERAL PETR, V127, P1, DOI 10.1007/s004100050261; LIZARRALDE D, 1995, J GEOPHYS RES-SOL EA, V100, P17837, DOI 10.1029/95JB01244; MINARIK WG, 1995, EARTH PLANET SC LETT, V133, P423, DOI 10.1016/0012-821X(95)00085-Q; Walter MJ, 2008, NATURE, V454, P622, DOI 10.1038/nature07132; Wang DJ, 2006, NATURE, V443, P977, DOI 10.1038/nature05256; Yang YJ, 2007, EARTH PLANET SC LETT, V258, P260, DOI 10.1016/j.epsl.2007.03.040; Yoshino T, 2006, NATURE, V443, P973, DOI 10.1038/nature05223	17	4	5	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1338	1340		10.1126/science.1166260	http://dx.doi.org/10.1126/science.1166260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039127				2022-12-28	WOS:000261170600026
J	Gillum, MP; Zhang, D; Zhang, XM; Erion, DM; Jamison, RA; Choi, C; Dong, J; Shanabrough, M; Duenas, HR; Frederick, DW; Hsiao, JJ; Horvath, TL; Lo, CM; Tso, P; Cline, GW; Shulman, GI				Gillum, Matthew P.; Zhang, Dongyan; Zhang, Xian-Man; Erion, Derek M.; Jamison, Rachel A.; Choi, Cheolsoo; Dong, Jianying; Shanabrough, Marya; Duenas, Hillary R.; Frederick, David W.; Hsiao, Jennifer J.; Horvath, Tamas L.; Lo, Chun Min; Tso, Pat; Cline, Gary W.; Shulman, Gerald I.			N-acylphosphatidylethanolamine, a Gut-Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake	CELL			English	Article							NERVOUS-SYSTEM CONTROL; ENERGY-INTAKE; DIETARY-FAT; BODY-WEIGHT; RECEPTOR; OLEOYLETHANOLAMIDE; BRAIN; ACTIVATION; GLUCOSE	N-acylphosphatidylethanolamines (NAPEs) are a relatively abundant group of plasma lipids of unknown physiological significance. Here, we show that NAPEs are secreted into circulation from the small intestine in response to ingested fat and that systemic administration of the most abundant circulating NAPE, at physiologic doses, decreases food intake in rats without causing conditioned taste aversion. Furthermore, C-14-radiolabeled NAPE enters the brain and is particularly concentrated in the hypothalamus, and intracerebroventricular infusions of nanomolar amounts of NAPE reduce food intake, collectively suggesting that its effects may be mediated through direct interactions with the central nervous system. Finally, chronic NAPE infusion results in a reduction of both food intake and body weight, suggesting that NAPE and long-acting NAPE analogs may be novel therapeutic targets for the treatment of obesity.	[Gillum, Matthew P.; Zhang, Dongyan; Erion, Derek M.; Jamison, Rachel A.; Dong, Jianying; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Gillum, Matthew P.; Zhang, Xian-Man; Erion, Derek M.; Jamison, Rachel A.; Choi, Cheolsoo; Frederick, David W.; Hsiao, Jennifer J.; Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Gillum, Matthew P.; Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shanabrough, Marya; Duenas, Hillary R.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; [Lo, Chun Min; Tso, Pat] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45627 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; University System of Ohio; University of Cincinnati	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064; Gillum, Matthew/0000-0003-4893-012X	United States Public Health Service [R01 DK-40936, P30 DK-45735, U24 DK-76169]; Endocrine Society Research; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169, P30DK045735, U24DK059635, R01DK040936, R01DK049230, R24DK085638] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Endocrine Society Research; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Drs. James Pickel and George Kunos for kindly providing us with the CB1<SUP>-/-</SUP> mice and Maya Kotas for incisive commentary. This work was supported by grants from the United States Public Health Service (R01 DK-40936, P30 DK-45735, and U24 DK-76169), an Endocrine Society Research Fellowship (M. P. G.), and a Distinguished Clinical ScientistAward (G. I. S.) from the American Diabetes Association.	Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Carter RJ, 1999, J NEUROSCI, V19, P3248; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Donahoo W, 2008, OBESITY, V16, P64, DOI 10.1038/oby.2007.31; Emond M, 2001, PHYSIOL BEHAV, V72, P123, DOI 10.1016/S0031-9384(00)00393-0; Fry M, 2007, PHYSIOL BEHAV, V91, P413, DOI 10.1016/j.physbeh.2007.04.003; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Halford JCG, 1998, PHARMACOL BIOCHEM BE, V61, P159, DOI 10.1016/S0091-3057(98)00032-X; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Holder JL, 2000, HUM MOL GENET, V9, P101; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kobelt P, 2005, AM J PHYSIOL-REG I, V288, pR751, DOI 10.1152/ajpregu.00094.2004; Little TJ, 2007, AM J CLIN NUTR, V86, P531, DOI 10.1093/ajcn/86.3.531; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MISELIS RR, 1975, AM J PHYSIOL, V229, P1438, DOI 10.1152/ajplegacy.1975.229.5.1438; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Petersen G, 2006, BBA-MOL CELL BIOL L, V1761, P143, DOI 10.1016/j.bbalip.2005.12.011; Riley Anthony L, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0806es29; Rowland NE, 1997, REGUL PEPTIDES, V71, P171, DOI 10.1016/S0167-0115(97)01034-3; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104	33	114	118	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					813	824		10.1016/j.cell.2008.10.043	http://dx.doi.org/10.1016/j.cell.2008.10.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041747	Green Accepted, Bronze			2022-12-28	WOS:000261183900014
J	Rancati, G; Pavelka, N; Fleharty, B; Noll, A; Trimble, R; Walton, K; Perera, A; Staehling-Hampton, K; Seidel, CW; Li, R				Rancati, Giulia; Pavelka, Norman; Fleharty, Brian; Noll, Aaron; Trimble, Rhonda; Walton, Kendra; Perera, Anoja; Staehling-Hampton, Karen; Seidel, Chris W.; Li, Rong			Aneuploidy Underlies Rapid Adaptive Evolution of Yeast Cells Deprived of a Conserved Cytokinesis Motor	CELL			English	Article							HSP90 MOLECULAR CHAPERONE; WHOLE-GENOME DUPLICATION; LARGE POPULATIONS; BUDDING YEAST; GENE; PROTEIN; ORGANIZATION; PERSPECTIVE; POLYPLOIDY; RING	The ability to evolve is a fundamental feature of biological systems, but the mechanisms underlying this capacity and the evolutionary dynamics of conserved core processes remain elusive. We show that yeast cells deleted of MYO1, encoding the only myosin II normally required for cytokinesis, rapidly evolved divergent pathways to restore growth and cytokinesis. The evolved cytokinesis phenotypes correlated with specific changes in the transcriptome. Polyploidy and aneuploidy were common genetic alterations in the best evolved strains, and aneuploidy could account for gene expression changes due directly to altered chromosome stoichiometry as well as to downstream effects. The phenotypic effect of aneuploidy could be recapitulated with increased copy numbers of specific regulatory genes in myo1 Delta cells. These results demonstrate the evolvability of even a well-conserved process and suggest that changes in chromosome stoichiometry provide a source of heritable variation driving the emergence of adaptive phenotypes when the cell division machinery is strongly perturbed.	[Rancati, Giulia; Pavelka, Norman; Fleharty, Brian; Noll, Aaron; Trimble, Rhonda; Walton, Kendra; Perera, Anoja; Staehling-Hampton, Karen; Seidel, Chris W.; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Phys, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers-institute.org	Pavelka, Norman/G-4577-2018	Pavelka, Norman/0000-0003-4542-9970; Rancati, Giulia/0000-0003-0835-0139	NIH [GM058864]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Authors thank W. Bosl, O. Rando, and B. Rubinstein for stimulating discussions, J. Haug and J. Wunderlich for technical assistance with flow cytometry, F. Guo for technical assistance with electron microscopy, K. Zueckert-Gaudenz and A. Peak for suggestions and assistance in the preparation of genomic DNA samples and in microarray hybridizations, G. Hattem for help with bioinformatics analysis, A. Paulson for assistance in microarray data submission to public repositories, P. Baumann and X. Wang for suggestions and assistance with pulsed-field gel electrophoresis, G. Chen for help with strain construction, T. Nichols and M. Toth for media preparation and laboratory management, J. Rine for plasmids, and A. Murray, B. Slaughter, and S. Wai for critical reading of the manuscript. This paper is dedicated to the memory of Karen A. Pavelka. This work was supported by NIH GM058864 to R. L.	ADAMS AEM, 1991, METHOD ENZYMOL, V194, P729; Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; [Anonymous], 1861, ORIGIN SPECIES MEANS; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Buscemi G, 2000, J CELL SCI, V113, P1199; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Carter AJR, 2002, P ROY SOC B-BIOL SCI, V269, P953, DOI 10.1098/rspb.2002.1968; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; GILLESPIE JH, 1984, SCIENCE, V224, P732, DOI 10.1126/science.224.4650.732; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; MURRAY AW, 1986, CELL, V45, P529, DOI 10.1016/0092-8674(86)90284-9; Nagasaki A, 2002, J CELL SCI, V115, P2241; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Oeffinger M, 2003, EMBO J, V22, P6573, DOI 10.1093/emboj/cdg616; Ohta T, 2002, P NATL ACAD SCI USA, V99, P16134, DOI 10.1073/pnas.252626899; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schmidt M, 2002, J CELL SCI, V115, P293; Shafaatian R, 1996, MOL GEN GENET, V252, P101, DOI 10.1007/BF02173210; Sherman F., 1974, METHODS YEAST GENETI; Spence JM, 2006, CHROMOSOMA, V115, P60, DOI 10.1007/s00412-005-0032-6; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Tolliday N, 2003, MOL BIOL CELL, V14, P798, DOI 10.1091/mbc.E02-09-0558; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; WAGNER A, 2005, ROBUSTNESS EVOLVABIL, V1; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Weinreich DM, 2005, EVOLUTION, V59, P1175; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	48	233	236	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					879	893		10.1016/j.cell.2008.09.039	http://dx.doi.org/10.1016/j.cell.2008.09.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041751	Green Accepted, Bronze			2022-12-28	WOS:000261183900019
